{ "100000000000000000000001": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 6.81640625, "end_logit": -0.13134765625, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000000002": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 6.79296875, "end_logit": -0.11749267578125, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000000004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 6.765625, "end_logit": -0.09661865234375, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000000006": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 6.80078125, "end_logit": -0.130859375, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000000010": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010775025886693324 }, { "start_logit": 7.5390625, "end_logit": -0.7080078125, "text": "", "probability": 0.9989224974113308 } ], "100000000000000000000012": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.4375, "end_logit": -0.67724609375, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000000013": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.57421875, "end_logit": -0.7587890625, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000000015": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.61328125, "end_logit": -0.73583984375, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000000017": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.52734375, "end_logit": -0.6640625, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000000018": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009966076912722927 }, { "start_logit": 7.5703125, "end_logit": -0.6591796875, "text": "", "probability": 0.9990033923087277 } ], "100000000000000000000019": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.48046875, "end_logit": -0.67578125, "text": "", "probability": 0.99889266101491 } ], "100000000000000000000021": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 7.48828125, "end_logit": -0.8759765625, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000000022": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.46484375, "end_logit": -0.8427734375, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000000027": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000330152725097801 }, { "start_logit": 8.0546875, "end_logit": -0.0404052734375, "text": "", "probability": 0.9996698472749022 } ], "100000000000000000000028": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003125878098696676 }, { "start_logit": 8.0703125, "end_logit": -2.956390380859375e-05, "text": "", "probability": 0.9996874121901304 } ], "100000000000000000000029": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003077430764601415 }, { "start_logit": 8.0390625, "end_logit": 0.047943115234375, "text": "", "probability": 0.9996922569235399 } ], "100000000000000000000031": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005953406662444657 }, { "start_logit": 8.109375, "end_logit": -0.68212890625, "text": "", "probability": 0.9994046593337557 } ], "100000000000000000000032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005703157070783359 }, { "start_logit": 8.1328125, "end_logit": -0.66552734375, "text": "", "probability": 0.9994296842929216 } ], "100000000000000000000035": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006337125082498782 }, { "start_logit": 8.015625, "end_logit": -0.65185546875, "text": "", "probability": 0.9993662874917502 } ], "100000000000000000000040": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.359375, "end_logit": -0.4951171875, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000000042": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.3125, "end_logit": -0.492431640625, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000000050": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 7.47265625, "end_logit": -0.1737060546875, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000000053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.83984375, "end_logit": -0.54150390625, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000000057": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.6953125, "end_logit": -0.81787109375, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000000059": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.66015625, "end_logit": -0.861328125, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000000062": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.87109375, "end_logit": -0.57275390625, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000000064": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.2421875, "end_logit": -0.537109375, "text": "", "probability": 0.998774432551617 } ], "100000000000000000000075": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.2890625, "end_logit": -0.5732421875, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000000077": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.28515625, "end_logit": -0.51708984375, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000000079": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.2578125, "end_logit": -0.5439453125, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000000085": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00013342001090985438 }, { "start_logit": 8.078125, "end_logit": 0.84130859375, "text": "", "probability": 0.9998665799890902 } ], "100000000000000000000087": [ { "start_logit": 15.0859375, "end_logit": 5.77734375, "text": "Ensuring the Safety of COVID-19 Vaccines", "probability": 0.2958984375 }, { "start_logit": 15.0859375, "end_logit": 5.65234375, "text": "Ensuring the Safety of COVID-19", "probability": 0.26123046875 }, { "start_logit": 15.0859375, "end_logit": 4.91796875, "text": "Ensuring the Safety of COVID-19 Vaccines\n\u203a\f10/30/22, 9:31 AM Allergic Reactions", "probability": 0.125244140625 }, { "start_logit": 14.109375, "end_logit": 5.65234375, "text": "\nRelated Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.09912109375 }, { "start_logit": 13.6875, "end_logit": 5.77734375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.07366943359375 }, { "start_logit": 13.6875, "end_logit": 5.65234375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.06500244140625 }, { "start_logit": 12.53125, "end_logit": 5.77734375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.0231781005859375 }, { "start_logit": 12.53125, "end_logit": 5.65234375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0204620361328125 }, { "start_logit": 12.3515625, "end_logit": 5.77734375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.01922607421875 }, { "start_logit": 12.3515625, "end_logit": 5.65234375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0169677734375 }, { "start_logit": 8.1015625, "end_logit": -0.99462890625, "text": "", "probability": 2.980232238769531e-07 } ], "100000000000000000000090": [ { "start_logit": 15.0859375, "end_logit": 5.7734375, "text": "Ensuring the Safety of COVID-19 Vaccines", "probability": 0.2958984375 }, { "start_logit": 15.0859375, "end_logit": 5.65234375, "text": "Ensuring the Safety of COVID-19", "probability": 0.26123046875 }, { "start_logit": 15.0859375, "end_logit": 4.91015625, "text": "Ensuring the Safety of COVID-19 Vaccines\n\u203a\f10/30/22, 9:31 AM Allergic Reactions", "probability": 0.125244140625 }, { "start_logit": 14.109375, "end_logit": 5.65234375, "text": "\nRelated Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.09912109375 }, { "start_logit": 13.6875, "end_logit": 5.7734375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.07366943359375 }, { "start_logit": 13.6875, "end_logit": 5.65234375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.06500244140625 }, { "start_logit": 12.53125, "end_logit": 5.7734375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.0231781005859375 }, { "start_logit": 12.53125, "end_logit": 5.65234375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0204620361328125 }, { "start_logit": 12.3515625, "end_logit": 5.7734375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.01922607421875 }, { "start_logit": 12.3515625, "end_logit": 5.65234375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0169677734375 }, { "start_logit": 8.09375, "end_logit": -0.9814453125, "text": "", "probability": 2.980232238769531e-07 } ], "100000000000000000000091": [ { "start_logit": 15.0859375, "end_logit": 5.77734375, "text": "Ensuring the Safety of COVID-19 Vaccines", "probability": 0.29638671875 }, { "start_logit": 15.0859375, "end_logit": 5.6484375, "text": "Ensuring the Safety of COVID-19", "probability": 0.261474609375 }, { "start_logit": 15.0859375, "end_logit": 4.91015625, "text": "Ensuring the Safety of COVID-19 Vaccines\n\u203a\f10/30/22, 9:31 AM Allergic Reactions", "probability": 0.12548828125 }, { "start_logit": 14.109375, "end_logit": 5.6484375, "text": "\nRelated Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0977783203125 }, { "start_logit": 13.6875, "end_logit": 5.77734375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.07379150390625 }, { "start_logit": 13.6875, "end_logit": 5.6484375, "text": " COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.06512451171875 }, { "start_logit": 12.53125, "end_logit": 5.77734375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.0232086181640625 }, { "start_logit": 12.53125, "end_logit": 5.6484375, "text": "Related Pages\nInformation about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.0205078125 }, { "start_logit": 12.3515625, "end_logit": 5.77734375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19 Vaccines", "probability": 0.019256591796875 }, { "start_logit": 12.3515625, "end_logit": 5.6484375, "text": "Information about COVID-19 Vaccines for People with Allergies\n\u203a\nPossible Side Effects\n\u203a\nEnsuring the Safety of COVID-19", "probability": 0.016998291015625 }, { "start_logit": 7.98046875, "end_logit": -0.96630859375, "text": "", "probability": 2.980232238769531e-07 } ], "100000000000000000000092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.5078125, "end_logit": -0.422607421875, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000000096": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -33.71875, "end_logit": 13.5390625, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000000098": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982370018 }, { "start_logit": -33.6875, "end_logit": 13.5390625, "text": "", "probability": 1.7629981167074253e-09 } ], "100000000000000000000099": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999981810384 }, { "start_logit": -33.6875, "end_logit": 13.5625, "text": "", "probability": 1.8189616842444243e-09 } ], "100000000000000000000112": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 6.6640625, "end_logit": -0.160888671875, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000000114": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 6.57421875, "end_logit": -0.1568603515625, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000000115": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001524786391225749 }, { "start_logit": 6.609375, "end_logit": -0.12353515625, "text": "", "probability": 0.9984752136087741 } ], "100000000000000000000117": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 7.0546875, "end_logit": -0.55078125, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000000120": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.07421875, "end_logit": -0.6201171875, "text": "", "probability": 0.998426887834651 } ], "100000000000000000000121": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015916259996820179 }, { "start_logit": 7.046875, "end_logit": -0.60595703125, "text": "", "probability": 0.998408374000318 } ], "100000000000000000000125": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.453125, "end_logit": -0.595703125, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000000131": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 7.42578125, "end_logit": -0.6416015625, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000000133": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.25390625, "end_logit": -0.443115234375, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000000135": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.25390625, "end_logit": -0.458251953125, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000000148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.5078125, "end_logit": -0.64208984375, "text": "", "probability": 0.998959681497187 } ], "100000000000000000000149": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.46875, "end_logit": -0.73486328125, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000000155": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -33.875, "end_logit": 13.6875, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000000158": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008072304985619872 }, { "start_logit": 7.41796875, "end_logit": -0.29541015625, "text": "", "probability": 0.9991927695014381 } ], "100000000000000000000162": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.28125, "end_logit": -0.326171875, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000000164": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005357805383473944 }, { "start_logit": 8.0546875, "end_logit": -0.52294921875, "text": "", "probability": 0.9994642194616526 } ], "100000000000000000000166": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005442132624325574 }, { "start_logit": 8.1015625, "end_logit": -0.58740234375, "text": "", "probability": 0.9994557867375674 } ], "100000000000000000000170": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.54296875, "end_logit": -0.39453125, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000000179": [ { "start_logit": 18.5625, "end_logit": 9.0390625, "text": " Canada Lynx", "probability": 0.5361328125 }, { "start_logit": 18.421875, "end_logit": 8.0234375, "text": "Reducing", "probability": 0.168701171875 }, { "start_logit": 17.71875, "end_logit": 7.0546875, "text": " Kentucky Zoo", "probability": 0.032196044921875 }, { "start_logit": 15.578125, "end_logit": 9.0390625, "text": " COVID-19 in a Canada Lynx", "probability": 0.0275421142578125 }, { "start_logit": 16.53125, "end_logit": 8.0234375, "text": "Related Pages\nReducing", "probability": 0.0258636474609375 }, { "start_logit": 15.4765625, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.024688720703125 }, { "start_logit": 15.4609375, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0242919921875 }, { "start_logit": 15.3671875, "end_logit": 9.0390625, "text": "\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.022125244140625 }, { "start_logit": 15.3125, "end_logit": 9.0390625, "text": "\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0207977294921875 }, { "start_logit": 18.5625, "end_logit": 5.68359375, "text": " Canada Lyn", "probability": 0.0189361572265625 }, { "start_logit": 18.5625, "end_logit": 5.6796875, "text": " Canada Lynx at a Pennsylvania Zoo\nConfirmation of COVID-19 in Hyenas at a Colorado Zoo", "probability": 0.0189361572265625 }, { "start_logit": 18.421875, "end_logit": 5.65625, "text": "Reducing the Risk of SARS-CoV-2", "probability": 0.01593017578125 }, { "start_logit": 18.421875, "end_logit": 5.48828125, "text": "Red", "probability": 0.013427734375 }, { "start_logit": 17.71875, "end_logit": 6.1484375, "text": " Kentucky Zoo\u200b\nUSDA Confirms SARS-CoV-2 in Mink in Utah\nConfirmation of COVID-19 in Pet Dog in New York", "probability": 0.01300811767578125 }, { "start_logit": 18.5625, "end_logit": 5.1015625, "text": " Canada Lynx at a Pennsylvania Zoo", "probability": 0.0104522705078125 }, { "start_logit": 17.125, "end_logit": 6.37109375, "text": " New York", "probability": 0.008941650390625 }, { "start_logit": 17.125, "end_logit": 6.0078125, "text": " New York\nUSDA Statement on the Confirmation of COVID-19 Infection in a Tiger in New York", "probability": 0.006145477294921875 }, { "start_logit": 17.71875, "end_logit": 5.140625, "text": " Kentucky", "probability": 0.004711151123046875 }, { "start_logit": 15.390625, "end_logit": 7.2265625, "text": "Texas A&M Research Uncovers First Known COVID-19 UK Variant", "probability": 0.003726959228515625 }, { "start_logit": 16.203125, "end_logit": 6.37109375, "text": " New York\nConfirmation of COVID-19 in Two Pet Cats in New York", "probability": 0.0035572052001953125 }, { "start_logit": 10.140625, "end_logit": -0.96435546875, "text": "", "probability": 0.0 } ], "100000000000000000000182": [ { "start_logit": 18.5625, "end_logit": 9.0390625, "text": " Canada Lynx", "probability": 0.5361328125 }, { "start_logit": 18.421875, "end_logit": 8.0234375, "text": "Reducing", "probability": 0.168701171875 }, { "start_logit": 17.71875, "end_logit": 7.0546875, "text": " Kentucky Zoo", "probability": 0.032196044921875 }, { "start_logit": 15.578125, "end_logit": 9.0390625, "text": " COVID-19 in a Canada Lynx", "probability": 0.0275421142578125 }, { "start_logit": 16.53125, "end_logit": 8.0234375, "text": "Related Pages\nReducing", "probability": 0.0258636474609375 }, { "start_logit": 15.4765625, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.024688720703125 }, { "start_logit": 15.4609375, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0242919921875 }, { "start_logit": 15.3671875, "end_logit": 9.0390625, "text": "\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.022125244140625 }, { "start_logit": 15.3125, "end_logit": 9.0390625, "text": "\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0207977294921875 }, { "start_logit": 18.5625, "end_logit": 5.68359375, "text": " Canada Lyn", "probability": 0.0189361572265625 }, { "start_logit": 18.5625, "end_logit": 5.6796875, "text": " Canada Lynx at a Pennsylvania Zoo\nConfirmation of COVID-19 in Hyenas at a Colorado Zoo", "probability": 0.0189361572265625 }, { "start_logit": 18.421875, "end_logit": 5.65625, "text": "Reducing the Risk of SARS-CoV-2", "probability": 0.01593017578125 }, { "start_logit": 18.421875, "end_logit": 5.48828125, "text": "Red", "probability": 0.013427734375 }, { "start_logit": 17.71875, "end_logit": 6.1484375, "text": " Kentucky Zoo\u200b\nUSDA Confirms SARS-CoV-2 in Mink in Utah\nConfirmation of COVID-19 in Pet Dog in New York", "probability": 0.01300811767578125 }, { "start_logit": 18.5625, "end_logit": 5.1015625, "text": " Canada Lynx at a Pennsylvania Zoo", "probability": 0.0104522705078125 }, { "start_logit": 17.125, "end_logit": 6.37109375, "text": " New York", "probability": 0.008941650390625 }, { "start_logit": 17.125, "end_logit": 6.0078125, "text": " New York\nUSDA Statement on the Confirmation of COVID-19 Infection in a Tiger in New York", "probability": 0.006145477294921875 }, { "start_logit": 17.71875, "end_logit": 5.140625, "text": " Kentucky", "probability": 0.004711151123046875 }, { "start_logit": 15.390625, "end_logit": 7.2265625, "text": "Texas A&M Research Uncovers First Known COVID-19 UK Variant", "probability": 0.003726959228515625 }, { "start_logit": 16.203125, "end_logit": 6.37109375, "text": " New York\nConfirmation of COVID-19 in Two Pet Cats in New York", "probability": 0.0035572052001953125 }, { "start_logit": 10.171875, "end_logit": -0.9306640625, "text": "", "probability": 0.0 } ], "100000000000000000000183": [ { "start_logit": 18.5625, "end_logit": 9.0390625, "text": " Canada Lynx", "probability": 0.5361328125 }, { "start_logit": 18.421875, "end_logit": 8.0234375, "text": "Reducing", "probability": 0.168701171875 }, { "start_logit": 17.71875, "end_logit": 7.0546875, "text": " Kentucky Zoo", "probability": 0.032196044921875 }, { "start_logit": 15.578125, "end_logit": 9.0390625, "text": " COVID-19 in a Canada Lynx", "probability": 0.0275421142578125 }, { "start_logit": 16.53125, "end_logit": 8.0234375, "text": "Related Pages\nReducing", "probability": 0.0258636474609375 }, { "start_logit": 15.4765625, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.024688720703125 }, { "start_logit": 15.4609375, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0242919921875 }, { "start_logit": 15.3671875, "end_logit": 9.0390625, "text": "\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.022125244140625 }, { "start_logit": 15.3125, "end_logit": 9.0390625, "text": "\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0207977294921875 }, { "start_logit": 18.5625, "end_logit": 5.68359375, "text": " Canada Lyn", "probability": 0.0189361572265625 }, { "start_logit": 18.5625, "end_logit": 5.6796875, "text": " Canada Lynx at a Pennsylvania Zoo\nConfirmation of COVID-19 in Hyenas at a Colorado Zoo", "probability": 0.0189361572265625 }, { "start_logit": 18.421875, "end_logit": 5.65625, "text": "Reducing the Risk of SARS-CoV-2", "probability": 0.01593017578125 }, { "start_logit": 18.421875, "end_logit": 5.48828125, "text": "Red", "probability": 0.013427734375 }, { "start_logit": 17.71875, "end_logit": 6.1484375, "text": " Kentucky Zoo\u200b\nUSDA Confirms SARS-CoV-2 in Mink in Utah\nConfirmation of COVID-19 in Pet Dog in New York", "probability": 0.01300811767578125 }, { "start_logit": 18.5625, "end_logit": 5.1015625, "text": " Canada Lynx at a Pennsylvania Zoo", "probability": 0.0104522705078125 }, { "start_logit": 17.125, "end_logit": 6.37109375, "text": " New York", "probability": 0.008941650390625 }, { "start_logit": 17.125, "end_logit": 6.0078125, "text": " New York\nUSDA Statement on the Confirmation of COVID-19 Infection in a Tiger in New York", "probability": 0.006145477294921875 }, { "start_logit": 17.71875, "end_logit": 5.140625, "text": " Kentucky", "probability": 0.004711151123046875 }, { "start_logit": 15.390625, "end_logit": 7.2265625, "text": "Texas A&M Research Uncovers First Known COVID-19 UK Variant", "probability": 0.003726959228515625 }, { "start_logit": 16.203125, "end_logit": 6.37109375, "text": " New York\nConfirmation of COVID-19 in Two Pet Cats in New York", "probability": 0.0035572052001953125 }, { "start_logit": 10.125, "end_logit": -0.97119140625, "text": "", "probability": 0.0 } ], "100000000000000000000186": [ { "start_logit": 18.5625, "end_logit": 9.0390625, "text": " Canada Lynx", "probability": 0.53662109375 }, { "start_logit": 18.421875, "end_logit": 8.0234375, "text": "Reducing", "probability": 0.1688232421875 }, { "start_logit": 17.703125, "end_logit": 7.0546875, "text": " Kentucky Zoo", "probability": 0.031219482421875 }, { "start_logit": 15.578125, "end_logit": 9.0390625, "text": " COVID-19 in a Canada Lynx", "probability": 0.027557373046875 }, { "start_logit": 16.53125, "end_logit": 8.0234375, "text": "Related Pages\nReducing", "probability": 0.02587890625 }, { "start_logit": 15.484375, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0251007080078125 }, { "start_logit": 15.4609375, "end_logit": 9.0390625, "text": "\n\uf209\n\uf209\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.0243072509765625 }, { "start_logit": 15.3828125, "end_logit": 9.0390625, "text": "\n\uf209\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.022491455078125 }, { "start_logit": 15.3125, "end_logit": 9.0390625, "text": "\nMedia Announcements\nConfirmation of COVID-19 in a Canada Lynx", "probability": 0.02081298828125 }, { "start_logit": 18.5625, "end_logit": 5.68359375, "text": " Canada Lyn", "probability": 0.0189361572265625 }, { "start_logit": 18.5625, "end_logit": 5.6796875, "text": " Canada Lynx at a Pennsylvania Zoo\nConfirmation of COVID-19 in Hyenas at a Colorado Zoo", "probability": 0.0189361572265625 }, { "start_logit": 18.421875, "end_logit": 5.65234375, "text": "Reducing the Risk of SARS-CoV-2", "probability": 0.0159454345703125 }, { "start_logit": 18.421875, "end_logit": 5.4921875, "text": "Red", "probability": 0.013427734375 }, { "start_logit": 17.703125, "end_logit": 6.140625, "text": " Kentucky Zoo\u200b\nUSDA Confirms SARS-CoV-2 in Mink in Utah\nConfirmation of COVID-19 in Pet Dog in New York", "probability": 0.01261138916015625 }, { "start_logit": 18.5625, "end_logit": 5.10546875, "text": " Canada Lynx at a Pennsylvania Zoo", "probability": 0.01062774658203125 }, { "start_logit": 17.125, "end_logit": 6.37109375, "text": " New York", "probability": 0.00894927978515625 }, { "start_logit": 17.125, "end_logit": 6.0078125, "text": " New York\nUSDA Statement on the Confirmation of COVID-19 Infection in a Tiger in New York", "probability": 0.006145477294921875 }, { "start_logit": 17.703125, "end_logit": 5.14453125, "text": " Kentucky", "probability": 0.004642486572265625 }, { "start_logit": 15.390625, "end_logit": 7.25, "text": "Texas A&M Research Uncovers First Known COVID-19 UK Variant", "probability": 0.003787994384765625 }, { "start_logit": 16.203125, "end_logit": 6.37109375, "text": " New York\nConfirmation of COVID-19 in Two Pet Cats in New York", "probability": 0.003559112548828125 }, { "start_logit": 10.125, "end_logit": -0.95068359375, "text": "", "probability": 0.0 } ], "100000000000000000000195": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.1640625, "end_logit": -0.61083984375, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000000197": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000800953612508541 }, { "start_logit": 7.55859375, "end_logit": -0.42919921875, "text": "", "probability": 0.9991990463874916 } ], "100000000000000000000198": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.53125, "end_logit": -0.5068359375, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000000202": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 7.12890625, "end_logit": -0.58544921875, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000000211": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 6.59765625, "end_logit": -0.26416015625, "text": "", "probability": 0.998224739467894 } ], "100000000000000000000213": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 6.75, "end_logit": -0.35595703125, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000000214": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.68359375, "end_logit": -0.284912109375, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000000215": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.5078125, "end_logit": -0.57421875, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000000216": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.48046875, "end_logit": -0.5927734375, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000000217": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.5546875, "end_logit": -0.63232421875, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000000219": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.68359375, "end_logit": -0.62255859375, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000000222": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020111583418261515 }, { "start_logit": 6.23828125, "end_logit": -0.031524658203125, "text": "", "probability": 0.9979888416581738 } ], "100000000000000000000226": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022083887960902254 }, { "start_logit": 6.21875, "end_logit": -0.1043701171875, "text": "", "probability": 0.9977916112039098 } ], "100000000000000000000237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 6.63671875, "end_logit": -0.2320556640625, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000000242": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.76953125, "end_logit": -0.58056640625, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000000247": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010044163312604223 }, { "start_logit": 7.44140625, "end_logit": -0.54052734375, "text": "", "probability": 0.9989955836687396 } ], "100000000000000000000249": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.42578125, "end_logit": -0.59130859375, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000000251": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.5078125, "end_logit": -0.607421875, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000000252": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.4609375, "end_logit": -0.662109375, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000000254": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 7.16796875, "end_logit": -0.826171875, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000000255": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014895173647107272 }, { "start_logit": 7.24609375, "end_logit": -0.73779296875, "text": "", "probability": 0.9985104826352893 } ], "100000000000000000000256": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.32421875, "end_logit": -0.810546875, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000000257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017342079835090854 }, { "start_logit": 7.171875, "end_logit": -0.8173828125, "text": "", "probability": 0.998265792016491 } ], "100000000000000000000262": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.5234375, "end_logit": -0.5615234375, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000000265": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.45703125, "end_logit": -0.5830078125, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000000274": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016040892528226655 }, { "start_logit": 7.359375, "end_logit": -0.92529296875, "text": "", "probability": 0.9983959107471775 } ], "100000000000000000000286": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026522597057856566 }, { "start_logit": 7.0390625, "end_logit": -1.107421875, "text": "", "probability": 0.9973477402942144 } ], "100000000000000000000289": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.1953125, "end_logit": -0.24658203125, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000000291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000914613686670093 }, { "start_logit": 7.21484375, "end_logit": -0.218994140625, "text": "", "probability": 0.99908538631333 } ], "100000000000000000000292": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.203125, "end_logit": -0.6474609375, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000000294": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.28125, "end_logit": -0.6865234375, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000000298": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 7.171875, "end_logit": -0.66015625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000000299": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016040892528226655 }, { "start_logit": 7.20703125, "end_logit": -0.7734375, "text": "", "probability": 0.9983959107471775 } ], "100000000000000000000304": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 7.125, "end_logit": -0.7958984375, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000000306": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.48828125, "end_logit": -0.56591796875, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000000310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010608151804637727 }, { "start_logit": 7.40234375, "end_logit": -0.5537109375, "text": "", "probability": 0.9989391848195363 } ], "100000000000000000000311": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.50390625, "end_logit": -0.57373046875, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000000321": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 6.89453125, "end_logit": -0.388916015625, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000000325": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.3828125, "end_logit": -0.65966796875, "text": "", "probability": 0.998798108681489 } ], "100000000000000000000329": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.359375, "end_logit": -0.63916015625, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000000331": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 7.16796875, "end_logit": -0.82861328125, "text": "", "probability": 0.998238530319926 } ], "100000000000000000000333": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.2109375, "end_logit": -0.84814453125, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000000334": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 7.18359375, "end_logit": -0.7861328125, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000000342": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.7578125, "end_logit": -0.8369140625, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000000344": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 6.8203125, "end_logit": -0.521484375, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000000351": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006487308181403439 }, { "start_logit": 7.6328125, "end_logit": -0.2939453125, "text": "", "probability": 0.9993512691818597 } ], "100000000000000000000354": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006932422985664928 }, { "start_logit": 7.55078125, "end_logit": -0.2783203125, "text": "", "probability": 0.9993067577014336 } ], "100000000000000000000356": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 7.16015625, "end_logit": -0.74365234375, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000000369": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018675659778932805 }, { "start_logit": 7.10546875, "end_logit": -0.82275390625, "text": "", "probability": 0.9981324340221067 } ], "100000000000000000000372": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018821859100764038 }, { "start_logit": 7.1796875, "end_logit": -0.908203125, "text": "", "probability": 0.9981178140899236 } ], "100000000000000000000379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021322616859826855 }, { "start_logit": 6.609375, "end_logit": -0.460205078125, "text": "", "probability": 0.9978677383140173 } ], "100000000000000000000380": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.03515625, "end_logit": -0.459716796875, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000000383": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 6.96875, "end_logit": -0.416259765625, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000000385": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 6.9609375, "end_logit": -0.418212890625, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000000388": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.41796875, "end_logit": -0.52001953125, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000000391": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.375, "end_logit": -0.372314453125, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000000396": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999265073 }, { "start_logit": -34.28125, "end_logit": 13.2421875, "text": "", "probability": 7.349269563756212e-10 } ], "100000000000000000000398": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017891591615951197 }, { "start_logit": 6.85546875, "end_logit": -0.53173828125, "text": "", "probability": 0.9982108408384048 } ], "100000000000000000000399": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 6.77734375, "end_logit": -0.442138671875, "text": "", "probability": 0.998231648313891 } ], "100000000000000000000400": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018969200744787132 }, { "start_logit": 6.84375, "end_logit": -0.576171875, "text": "", "probability": 0.9981030799255213 } ], "100000000000000000000405": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 6.6796875, "end_logit": -0.34375, "text": "", "probability": 0.998231648313891 } ], "100000000000000000000407": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.16015625, "end_logit": -0.564453125, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000000410": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.30078125, "end_logit": -0.5751953125, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000000413": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 6.84375, "end_logit": -0.11566162109375, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000000415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 6.78125, "end_logit": -0.0780029296875, "text": "", "probability": 0.998774432551617 } ], "100000000000000000000419": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.4453125, "end_logit": -0.7626953125, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000000421": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.46875, "end_logit": -0.7802734375, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000000422": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.41796875, "end_logit": -0.77197265625, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000000423": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.44921875, "end_logit": -0.8173828125, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000000426": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0038244836446372104 }, { "start_logit": 5.9921875, "end_logit": -0.4306640625, "text": "", "probability": 0.9961755163553627 } ], "100000000000000000000429": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003678508928875723 }, { "start_logit": 5.96875, "end_logit": -0.3681640625, "text": "", "probability": 0.9963214910711243 } ], "100000000000000000000433": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.5, "end_logit": -1.0322265625, "text": "", "probability": 0.998451238905712 } ], "100000000000000000000434": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015548133490423032 }, { "start_logit": 7.50390625, "end_logit": -1.0390625, "text": "", "probability": 0.9984451866509576 } ], "100000000000000000000436": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022083887960902254 }, { "start_logit": 7.46875, "end_logit": -1.3564453125, "text": "", "probability": 0.9977916112039098 } ], "100000000000000000000445": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 7.14453125, "end_logit": -0.806640625, "text": "", "probability": 0.998231648313891 } ], "100000000000000000000448": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017342079835090854 }, { "start_logit": 7.1796875, "end_logit": -0.82421875, "text": "", "probability": 0.998265792016491 } ], "100000000000000000000450": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.671875, "end_logit": -0.89013671875, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000000451": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.7109375, "end_logit": -0.9033203125, "text": "", "probability": 0.998896973358602 } ], "100000000000000000000453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.70703125, "end_logit": -0.884765625, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000000454": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.6796875, "end_logit": -0.8916015625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000000458": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002115703400593114 }, { "start_logit": 7.21875, "end_logit": -1.0615234375, "text": "", "probability": 0.9978842965994068 } ], "100000000000000000000463": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020667944781501153 }, { "start_logit": 7.24609375, "end_logit": -1.0673828125, "text": "", "probability": 0.9979332055218498 } ], "100000000000000000000466": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.35546875, "end_logit": -0.369873046875, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000000469": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008796062064765496 }, { "start_logit": 7.37890625, "end_logit": -0.34375, "text": "", "probability": 0.9991203937935235 } ], "100000000000000000000472": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001707367485760838 }, { "start_logit": 6.7578125, "end_logit": -0.386962890625, "text": "", "probability": 0.9982926325142392 } ], "100000000000000000000474": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 6.70703125, "end_logit": -0.34375, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000000475": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.453125, "end_logit": -0.78369140625, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000000476": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.4453125, "end_logit": -0.76611328125, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000000477": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016420666692028368 }, { "start_logit": 7.35546875, "end_logit": -0.94580078125, "text": "", "probability": 0.9983579333307973 } ], "100000000000000000000485": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 7.15625, "end_logit": -0.7900390625, "text": "", "probability": 0.998285961520812 } ], "100000000000000000000489": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.35546875, "end_logit": -0.802734375, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000000491": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 7.375, "end_logit": -1.177734375, "text": "", "probability": 0.997965182999252 } ], "100000000000000000000495": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 7.37890625, "end_logit": -1.140625, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000000500": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020190139004485808 }, { "start_logit": 7.30859375, "end_logit": -1.103515625, "text": "", "probability": 0.9979809860995514 } ], "100000000000000000000504": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002725582659228603 }, { "start_logit": 6.83203125, "end_logit": -0.93017578125, "text": "", "probability": 0.9972744173407714 } ], "100000000000000000000506": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002822832897761561 }, { "start_logit": 6.74609375, "end_logit": -0.87744140625, "text": "", "probability": 0.9971771671022386 } ], "100000000000000000000507": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002406088839117293 }, { "start_logit": 6.97265625, "end_logit": -0.9453125, "text": "", "probability": 0.9975939111608827 } ], "100000000000000000000508": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021827164453451808 }, { "start_logit": 7.0546875, "end_logit": -0.92919921875, "text": "", "probability": 0.9978172835546547 } ], "100000000000000000000513": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013831174237397678 }, { "start_logit": 6.9921875, "end_logit": -0.4091796875, "text": "", "probability": 0.9986168825762602 } ], "100000000000000000000518": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.35546875, "end_logit": -0.83642578125, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000000521": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001579259428801316 }, { "start_logit": 7.171875, "end_logit": -0.7236328125, "text": "", "probability": 0.9984207405711987 } ], "100000000000000000000529": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023504828600259954 }, { "start_logit": 6.765625, "end_logit": -0.71435546875, "text": "", "probability": 0.9976495171399739 } ], "100000000000000000000536": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.40234375, "end_logit": -0.78076171875, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000000538": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.3671875, "end_logit": -0.76318359375, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000000539": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.4765625, "end_logit": -0.8525390625, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000000540": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 7.48828125, "end_logit": -0.8505859375, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000000546": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 7.2421875, "end_logit": -0.7978515625, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000000548": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.2734375, "end_logit": -0.755859375, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000000555": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020992734296664648 }, { "start_logit": 7.49609375, "end_logit": -1.3310546875, "text": "", "probability": 0.9979007265703336 } ], "100000000000000000000557": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000758359964634202 }, { "start_logit": 7.3828125, "end_logit": -0.1995849609375, "text": "", "probability": 0.9992416400353659 } ], "100000000000000000000560": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.36328125, "end_logit": -0.3486328125, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000000562": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002540992626578983 }, { "start_logit": 6.546875, "end_logit": -0.57421875, "text": "", "probability": 0.997459007373421 } ], "100000000000000000000567": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.5234375, "end_logit": -0.603515625, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000000568": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0028118586602633557 }, { "start_logit": 6.5546875, "end_logit": -0.6826171875, "text": "", "probability": 0.9971881413397367 } ], "100000000000000000000569": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.578125, "end_logit": -0.6552734375, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000000573": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025608708425093117 }, { "start_logit": 6.62890625, "end_logit": -0.66455078125, "text": "", "probability": 0.9974391291574908 } ], "100000000000000000000578": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002934951744713737 }, { "start_logit": 6.64453125, "end_logit": -0.81640625, "text": "", "probability": 0.9970650482552862 } ], "100000000000000000000582": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002790037654330648 }, { "start_logit": 6.625, "end_logit": -0.74755859375, "text": "", "probability": 0.9972099623456693 } ], "100000000000000000000584": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0031236485998533104 }, { "start_logit": 6.51953125, "end_logit": -0.755859375, "text": "", "probability": 0.9968763514001466 } ], "100000000000000000000585": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030160662173845665 }, { "start_logit": 6.55859375, "end_logit": -0.75927734375, "text": "", "probability": 0.9969839337826155 } ], "100000000000000000000586": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0028671585933937862 }, { "start_logit": 6.57421875, "end_logit": -0.724609375, "text": "", "probability": 0.9971328414066062 } ], "100000000000000000000588": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021827164453451808 }, { "start_logit": 6.66796875, "end_logit": -0.5439453125, "text": "", "probability": 0.9978172835546547 } ], "100000000000000000000590": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001987774212383911 }, { "start_logit": 6.6796875, "end_logit": -0.46142578125, "text": "", "probability": 0.998012225787616 } ], "100000000000000000000592": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020033332861764124 }, { "start_logit": 6.6796875, "end_logit": -0.470458984375, "text": "", "probability": 0.9979966667138236 } ], "100000000000000000000598": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999959009065 }, { "start_logit": -34.65625, "end_logit": 15.34375, "text": "", "probability": 4.099093422706265e-09 } ], "100000000000000000000599": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003004343016200306 }, { "start_logit": 6.46484375, "end_logit": -0.65966796875, "text": "", "probability": 0.9969956569837995 } ], "100000000000000000000602": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002550912421286719 }, { "start_logit": 6.58203125, "end_logit": -0.61328125, "text": "", "probability": 0.9974490875787134 } ], "100000000000000000000605": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029008577108601222 }, { "start_logit": 6.52734375, "end_logit": -0.6865234375, "text": "", "probability": 0.99709914228914 } ], "100000000000000000000606": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0028449096649795012 }, { "start_logit": 6.49609375, "end_logit": -0.638671875, "text": "", "probability": 0.9971550903350206 } ], "100000000000000000000617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002662612717117335 }, { "start_logit": 6.58984375, "end_logit": -0.66455078125, "text": "", "probability": 0.9973373872828826 } ], "100000000000000000000618": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 6.546875, "end_logit": -0.58740234375, "text": "", "probability": 0.997429131960124 } ], "100000000000000000000623": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 6.69140625, "end_logit": -0.728515625, "text": "", "probability": 0.997429131960124 } ], "100000000000000000000624": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002601093793750775 }, { "start_logit": 6.69140625, "end_logit": -0.7421875, "text": "", "probability": 0.9973989062062492 } ], "100000000000000000000626": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.625, "end_logit": -0.70166015625, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000000628": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004924510374080036 }, { "start_logit": 6.83203125, "end_logit": -1.5244140625, "text": "", "probability": 0.99507548962592 } ], "100000000000000000000630": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004573864277626818 }, { "start_logit": 6.89453125, "end_logit": -1.5107421875, "text": "", "probability": 0.9954261357223732 } ], "100000000000000000000636": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021997980436915168 }, { "start_logit": 6.9375, "end_logit": -0.81884765625, "text": "", "probability": 0.9978002019563085 } ], "100000000000000000000643": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002260640836446661 }, { "start_logit": 6.87109375, "end_logit": -0.78173828125, "text": "", "probability": 0.9977393591635534 } ], "100000000000000000000644": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001964661439513743 }, { "start_logit": 6.90625, "end_logit": -0.6767578125, "text": "", "probability": 0.9980353385604862 } ], "100000000000000000000654": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.98046875, "end_logit": -1.05859375, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000000656": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026939142019792367 }, { "start_logit": 6.8984375, "end_logit": -0.982421875, "text": "", "probability": 0.9973060857980207 } ], "100000000000000000000657": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027149854690051763 }, { "start_logit": 6.609375, "end_logit": -0.701171875, "text": "", "probability": 0.9972850145309949 } ], "100000000000000000000659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003185060821449478 }, { "start_logit": 6.53515625, "end_logit": -0.78759765625, "text": "", "probability": 0.9968149391785505 } ], "100000000000000000000661": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027362210991480392 }, { "start_logit": 6.609375, "end_logit": -0.71240234375, "text": "", "probability": 0.997263778900852 } ], "100000000000000000000668": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0044337652006436815 }, { "start_logit": 6.89453125, "end_logit": -1.478515625, "text": "", "probability": 0.9955662347993564 } ], "100000000000000000000669": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004982269730421259 }, { "start_logit": 6.73046875, "end_logit": -1.43359375, "text": "", "probability": 0.9950177302695786 } ], "100000000000000000000670": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005001672249929073 }, { "start_logit": 6.7421875, "end_logit": -1.4501953125, "text": "", "probability": 0.994998327750071 } ], "100000000000000000000671": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 6.83984375, "end_logit": -0.3720703125, "text": "", "probability": 0.998451238905712 } ], "100000000000000000000672": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 6.8671875, "end_logit": -0.352294921875, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000000674": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 6.8359375, "end_logit": -0.36669921875, "text": "", "probability": 0.998451238905712 } ], "100000000000000000000675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 6.8359375, "end_logit": -0.340087890625, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000000678": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002387409209862363 }, { "start_logit": 6.62890625, "end_logit": -0.5947265625, "text": "", "probability": 0.9976125907901375 } ], "100000000000000000000681": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002406088839117293 }, { "start_logit": 6.640625, "end_logit": -0.61279296875, "text": "", "probability": 0.9975939111608827 } ], "100000000000000000000684": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003222484324002434 }, { "start_logit": 6.5390625, "end_logit": -0.80322265625, "text": "", "probability": 0.9967775156759975 } ], "100000000000000000000688": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0031726828424851893 }, { "start_logit": 6.53515625, "end_logit": -0.787109375, "text": "", "probability": 0.9968273171575148 } ], "100000000000000000000689": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0031974869372464253 }, { "start_logit": 6.50390625, "end_logit": -0.7626953125, "text": "", "probability": 0.9968025130627537 } ], "100000000000000000000690": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0032603461032026495 }, { "start_logit": 6.5, "end_logit": -0.77880859375, "text": "", "probability": 0.9967396538967973 } ], "100000000000000000000696": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023688742552270873 }, { "start_logit": 6.8125, "end_logit": -0.76904296875, "text": "", "probability": 0.9976311257447729 } ], "100000000000000000000708": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0035380860570885376 }, { "start_logit": 7.1484375, "end_logit": -1.5078125, "text": "", "probability": 0.9964619139429115 } ], "100000000000000000000709": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003621685478675127 }, { "start_logit": 7.12890625, "end_logit": -1.509765625, "text": "", "probability": 0.996378314521325 } ], "100000000000000000000711": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026522597057856566 }, { "start_logit": 6.89453125, "end_logit": -0.96484375, "text": "", "probability": 0.9973477402942144 } ], "100000000000000000000714": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002611247603490656 }, { "start_logit": 6.9609375, "end_logit": -1.0166015625, "text": "", "probability": 0.9973887523965093 } ], "100000000000000000000716": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026522597057856566 }, { "start_logit": 6.89453125, "end_logit": -0.9658203125, "text": "", "probability": 0.9973477402942144 } ], "100000000000000000000717": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024154832575663415 }, { "start_logit": 6.76171875, "end_logit": -0.736328125, "text": "", "probability": 0.9975845167424336 } ], "100000000000000000000728": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021322616859826855 }, { "start_logit": 6.73828125, "end_logit": -0.58984375, "text": "", "probability": 0.9978677383140173 } ], "100000000000000000000736": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024630070555115235 }, { "start_logit": 6.6328125, "end_logit": -0.6279296875, "text": "", "probability": 0.9975369929444886 } ], "100000000000000000000748": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027149854690051763 }, { "start_logit": 6.66796875, "end_logit": -0.76171875, "text": "", "probability": 0.9972850145309949 } ], "100000000000000000000749": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002790037654330648 }, { "start_logit": 6.6015625, "end_logit": -0.72265625, "text": "", "probability": 0.9972099623456693 } ], "100000000000000000000750": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029926652453546383 }, { "start_logit": 6.64453125, "end_logit": -0.8359375, "text": "", "probability": 0.9970073347546454 } ], "100000000000000000000753": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003311519060269664 }, { "start_logit": 6.64453125, "end_logit": -0.9365234375, "text": "", "probability": 0.9966884809397303 } ], "100000000000000000000756": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.32421875, "end_logit": -0.591796875, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000000762": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.390625, "end_logit": -0.66748046875, "text": "", "probability": 0.998798108681489 } ], "100000000000000000000769": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.4140625, "end_logit": -0.75634765625, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000000773": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.13671875, "end_logit": -0.403564453125, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000000774": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 7.34765625, "end_logit": -0.59375, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000000778": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 6.609375, "end_logit": -0.265869140625, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000000780": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 6.51171875, "end_logit": -0.1641845703125, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000000786": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.421875, "end_logit": -0.5947265625, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000000787": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.51171875, "end_logit": -0.6171875, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000000796": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 7.3125, "end_logit": -1.064453125, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000000801": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.26171875, "end_logit": -0.143798828125, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000000803": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.171875, "end_logit": -0.1846923828125, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000000805": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.265625, "end_logit": -0.1824951171875, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000000806": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000859247658728013 }, { "start_logit": 7.1796875, "end_logit": -0.12225341796875, "text": "", "probability": 0.999140752341272 } ], "100000000000000000000807": [ { "start_logit": 17.203125, "end_logit": 7.515625, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.14501953125 }, { "start_logit": 17.203125, "end_logit": 7.26171875, "text": "Getting", "probability": 0.1129150390625 }, { "start_logit": 16.78125, "end_logit": 7.515625, "text": " COVID-19 vaccination", "probability": 0.09503173828125 }, { "start_logit": 17.203125, "end_logit": 6.9296875, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.080078125 }, { "start_logit": 17.203125, "end_logit": 6.8125, "text": "Getting S", "probability": 0.07177734375 }, { "start_logit": 16.46875, "end_logit": 7.515625, "text": "Symptoms associated with COVID-19 vaccination", "probability": 0.06951904296875 }, { "start_logit": 17.203125, "end_logit": 6.51953125, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination vs infection", "probability": 0.0533447265625 }, { "start_logit": 16.78125, "end_logit": 6.9296875, "text": " COVID-19", "probability": 0.0533447265625 }, { "start_logit": 17.203125, "end_logit": 6.31640625, "text": "Getting Sick", "probability": 0.04351806640625 }, { "start_logit": 16.46875, "end_logit": 6.9296875, "text": "Symptoms associated with COVID-19", "probability": 0.03900146484375 }, { "start_logit": 15.8984375, "end_logit": 7.515625, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.03900146484375 }, { "start_logit": 16.78125, "end_logit": 6.51953125, "text": " COVID-19 vaccination vs infection", "probability": 0.03497314453125 }, { "start_logit": 15.5625, "end_logit": 7.515625, "text": " Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.028106689453125 }, { "start_logit": 16.46875, "end_logit": 6.51953125, "text": "Symptoms associated with COVID-19 vaccination vs infection", "probability": 0.0255889892578125 }, { "start_logit": 16.78125, "end_logit": 6.171875, "text": " COVID-19 vaccination vs infection\n\uf1aa\f10/30/22, 9:34 AM Benefits of Getting A COVID-19", "probability": 0.0247955322265625 }, { "start_logit": 15.8984375, "end_logit": 6.9296875, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.0218963623046875 }, { "start_logit": 16.46875, "end_logit": 6.171875, "text": "Symptoms associated with COVID-19 vaccination vs infection\n\uf1aa\f10/30/22, 9:34 AM Benefits of Getting A COVID-19", "probability": 0.0181427001953125 }, { "start_logit": 15.5625, "end_logit": 6.9296875, "text": " Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.0157623291015625 }, { "start_logit": 15.8984375, "end_logit": 6.51953125, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination vs infection", "probability": 0.01457977294921875 }, { "start_logit": 15.5625, "end_logit": 6.8125, "text": " S", "probability": 0.01390838623046875 }, { "start_logit": 8.34375, "end_logit": -1.029296875, "text": "", "probability": 0.0 } ], "100000000000000000000810": [ { "start_logit": 17.203125, "end_logit": 7.515625, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.14501953125 }, { "start_logit": 17.203125, "end_logit": 7.26171875, "text": "Getting", "probability": 0.1129150390625 }, { "start_logit": 16.78125, "end_logit": 7.515625, "text": " COVID-19 vaccination", "probability": 0.09503173828125 }, { "start_logit": 17.203125, "end_logit": 6.9296875, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.080078125 }, { "start_logit": 17.203125, "end_logit": 6.8125, "text": "Getting S", "probability": 0.07177734375 }, { "start_logit": 16.46875, "end_logit": 7.515625, "text": "Symptoms associated with COVID-19 vaccination", "probability": 0.06951904296875 }, { "start_logit": 17.203125, "end_logit": 6.51953125, "text": "Getting Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination vs infection", "probability": 0.0533447265625 }, { "start_logit": 16.78125, "end_logit": 6.9296875, "text": " COVID-19", "probability": 0.0533447265625 }, { "start_logit": 17.203125, "end_logit": 6.31640625, "text": "Getting Sick", "probability": 0.04351806640625 }, { "start_logit": 16.46875, "end_logit": 6.9296875, "text": "Symptoms associated with COVID-19", "probability": 0.03900146484375 }, { "start_logit": 15.8984375, "end_logit": 7.515625, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.03900146484375 }, { "start_logit": 16.78125, "end_logit": 6.51953125, "text": " COVID-19 vaccination vs infection", "probability": 0.03497314453125 }, { "start_logit": 15.5625, "end_logit": 7.515625, "text": " Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination", "probability": 0.028106689453125 }, { "start_logit": 16.46875, "end_logit": 6.51953125, "text": "Symptoms associated with COVID-19 vaccination vs infection", "probability": 0.0255889892578125 }, { "start_logit": 16.78125, "end_logit": 6.171875, "text": " COVID-19 vaccination vs infection\n\uf1aa\f10/30/22, 9:34 AM Benefits of Getting A COVID-19", "probability": 0.0247955322265625 }, { "start_logit": 15.8984375, "end_logit": 6.9296875, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.0218963623046875 }, { "start_logit": 16.46875, "end_logit": 6.171875, "text": "Symptoms associated with COVID-19 vaccination vs infection\n\uf1aa\f10/30/22, 9:34 AM Benefits of Getting A COVID-19", "probability": 0.0181427001953125 }, { "start_logit": 15.5625, "end_logit": 6.9296875, "text": " Sick\n\uf1aa\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19", "probability": 0.0157623291015625 }, { "start_logit": 15.8984375, "end_logit": 6.51953125, "text": "\n\u2022\n\u2022\n\u2022\nSymptoms associated with COVID-19 vaccination vs infection", "probability": 0.01457977294921875 }, { "start_logit": 15.5625, "end_logit": 6.8125, "text": " S", "probability": 0.01390838623046875 }, { "start_logit": 8.3125, "end_logit": -1.0224609375, "text": "", "probability": 0.0 } ], "100000000000000000000813": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020748668989992733 }, { "start_logit": 5.9453125, "end_logit": 0.2293701171875, "text": "", "probability": 0.9979251331010007 } ], "100000000000000000000820": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.5703125, "end_logit": -0.5048828125, "text": "", "probability": 0.999147433358729 } ], "100000000000000000000822": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.4453125, "end_logit": -0.92724609375, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000000824": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.546875, "end_logit": -0.994140625, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000000825": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004038591571505557 }, { "start_logit": 5.73828125, "end_logit": -0.2294921875, "text": "", "probability": 0.9959614084284943 } ], "100000000000000000000828": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003469890732315233 }, { "start_logit": 5.8359375, "end_logit": -0.1749267578125, "text": "", "probability": 0.9965301092676847 } ], "100000000000000000000833": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009436192455752619 }, { "start_logit": 7.23828125, "end_logit": -0.274658203125, "text": "", "probability": 0.9990563807544247 } ], "100000000000000000000838": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 6.94921875, "end_logit": -0.476318359375, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000000843": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 7.34765625, "end_logit": -0.91015625, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000000846": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.3515625, "end_logit": -0.8310546875, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000000850": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999999530176 }, { "start_logit": -31.671875, "end_logit": 7.890625, "text": "", "probability": 4.6982308496569967e-11 } ], "100000000000000000000851": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999999530176 }, { "start_logit": -31.65625, "end_logit": 7.87890625, "text": "", "probability": 4.6982308496569967e-11 } ], "100000000000000000000852": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.48828125, "end_logit": -0.7529296875, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000000863": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.33203125, "end_logit": -0.5048828125, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000000875": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.60546875, "end_logit": -0.51220703125, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000000877": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010044163312604223 }, { "start_logit": 7.35546875, "end_logit": -0.454345703125, "text": "", "probability": 0.9989955836687396 } ], "100000000000000000000879": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.34765625, "end_logit": -0.443115234375, "text": "", "probability": 0.99899949559909 } ], "100000000000000000000881": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.34765625, "end_logit": -0.39697265625, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000000885": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.546875, "end_logit": -0.3369140625, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000000888": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008199321062135582 }, { "start_logit": 7.51171875, "end_logit": -0.405517578125, "text": "", "probability": 0.9991800678937864 } ], "100000000000000000000903": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.37890625, "end_logit": -0.3740234375, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000000907": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.2734375, "end_logit": -0.367431640625, "text": "", "probability": 0.99899949559909 } ], "100000000000000000000910": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.32421875, "end_logit": -0.50341796875, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000000912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.35546875, "end_logit": -0.436767578125, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000000916": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 6.78125, "end_logit": -0.1561279296875, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000000921": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 8.046875, "end_logit": -0.56201171875, "text": "", "probability": 0.99943852125386 } ], "100000000000000000000930": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000767292412858718 }, { "start_logit": 7.51171875, "end_logit": -0.341064453125, "text": "", "probability": 0.9992327075871412 } ], "100000000000000000000934": [ { "start_logit": 15.625, "end_logit": 12.1953125, "text": "Fever", "probability": 0.81640625 }, { "start_logit": 15.625, "end_logit": 9.5546875, "text": "F", "probability": 0.059173583984375 }, { "start_logit": 15.625, "end_logit": 8.9765625, "text": "Fever (a temperature", "probability": 0.032684326171875 }, { "start_logit": 11.7578125, "end_logit": 12.1953125, "text": "ever", "probability": 0.0172271728515625 }, { "start_logit": 15.625, "end_logit": 8.1640625, "text": "Fever (a temperature of 100", "probability": 0.01448822021484375 }, { "start_logit": 15.3125, "end_logit": 8.1640625, "text": " 100", "probability": 0.0106048583984375 }, { "start_logit": 14.3984375, "end_logit": 8.9765625, "text": " temperature", "probability": 0.0096588134765625 }, { "start_logit": 15.625, "end_logit": 7.72265625, "text": "Fever (a temperature of 100.4", "probability": 0.00936126708984375 }, { "start_logit": 15.3125, "end_logit": 7.72265625, "text": " 100.4", "probability": 0.006847381591796875 }, { "start_logit": 15.625, "end_logit": 7.33984375, "text": "Fever (a", "probability": 0.006435394287109375 }, { "start_logit": 14.3984375, "end_logit": 8.1640625, "text": " temperature of 100", "probability": 0.0042877197265625 }, { "start_logit": 15.625, "end_logit": 6.53125, "text": "Fever (", "probability": 0.0028553009033203125 }, { "start_logit": 14.3984375, "end_logit": 7.72265625, "text": " temperature of 100.4", "probability": 0.002765655517578125 }, { "start_logit": 15.625, "end_logit": 5.921875, "text": "Fever (a temperature of 100.4 or higher", "probability": 0.0015516281127929688 }, { "start_logit": 12.3671875, "end_logit": 8.9765625, "text": "a temperature", "probability": 0.0012674331665039062 }, { "start_logit": 15.3125, "end_logit": 5.921875, "text": " 100.4 or higher", "probability": 0.0011358261108398438 }, { "start_logit": 15.625, "end_logit": 5.26953125, "text": "Fever (a temperature of 100.4 or higher is considered an emergency)\nLethargy (being overly tired or inactive)\nRunny", "probability": 0.0008053779602050781 }, { "start_logit": 15.625, "end_logit": 5.23046875, "text": "Fever (a temperature of 100.", "probability": 0.0007801055908203125 }, { "start_logit": 11.7578125, "end_logit": 8.9765625, "text": "ever (a temperature", "probability": 0.0006890296936035156 }, { "start_logit": 15.3125, "end_logit": 5.26953125, "text": " 100.4 or higher is considered an emergency)\nLethargy (being overly tired or inactive)\nRunny", "probability": 0.0005888938903808594 }, { "start_logit": 7.34765625, "end_logit": -1.2314453125, "text": "", "probability": 0.0 } ], "100000000000000000000935": [ { "start_logit": 15.625, "end_logit": 12.1953125, "text": "Fever", "probability": 0.81591796875 }, { "start_logit": 15.625, "end_logit": 9.5546875, "text": "F", "probability": 0.059112548828125 }, { "start_logit": 15.625, "end_logit": 8.9765625, "text": "Fever (a temperature", "probability": 0.03265380859375 }, { "start_logit": 11.7578125, "end_logit": 12.1953125, "text": "ever", "probability": 0.0172119140625 }, { "start_logit": 15.625, "end_logit": 8.1796875, "text": "Fever (a temperature of 100", "probability": 0.0149383544921875 }, { "start_logit": 15.3203125, "end_logit": 8.1796875, "text": " 100", "probability": 0.01093292236328125 }, { "start_logit": 14.3984375, "end_logit": 8.9765625, "text": " temperature", "probability": 0.00965118408203125 }, { "start_logit": 15.625, "end_logit": 7.7265625, "text": "Fever (a temperature of 100.4", "probability": 0.0093536376953125 }, { "start_logit": 15.3203125, "end_logit": 7.7265625, "text": " 100.4", "probability": 0.006946563720703125 }, { "start_logit": 15.625, "end_logit": 7.33984375, "text": "Fever (a", "probability": 0.00643157958984375 }, { "start_logit": 14.3984375, "end_logit": 8.1796875, "text": " temperature of 100", "probability": 0.0043487548828125 }, { "start_logit": 15.625, "end_logit": 6.53125, "text": "Fever (", "probability": 0.0028533935546875 }, { "start_logit": 14.3984375, "end_logit": 7.7265625, "text": " temperature of 100.4", "probability": 0.0027637481689453125 }, { "start_logit": 15.625, "end_logit": 5.92578125, "text": "Fever (a temperature of 100.4 or higher", "probability": 0.0015506744384765625 }, { "start_logit": 12.375, "end_logit": 8.9765625, "text": "a temperature", "probability": 0.0012664794921875 }, { "start_logit": 15.3203125, "end_logit": 5.92578125, "text": " 100.4 or higher", "probability": 0.00115203857421875 }, { "start_logit": 15.625, "end_logit": 5.28515625, "text": "Fever (a temperature of 100.4 or higher is considered an emergency)\nLethargy (being overly tired or inactive)\nRunny", "probability": 0.0008168220520019531 }, { "start_logit": 15.3203125, "end_logit": 5.5859375, "text": " 100.4 or higher is considered an emergency)\nLethargy (being overly tired or inactive)\nRunny nose", "probability": 0.0008168220520019531 }, { "start_logit": 15.625, "end_logit": 5.234375, "text": "Fever (a temperature of 100.", "probability": 0.0007796287536621094 }, { "start_logit": 11.7578125, "end_logit": 8.9765625, "text": "ever (a temperature", "probability": 0.0006880760192871094 }, { "start_logit": 7.375, "end_logit": -1.265625, "text": "", "probability": 0.0 } ], "100000000000000000000936": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001700722411435288 }, { "start_logit": 6.81640625, "end_logit": -0.440185546875, "text": "", "probability": 0.9982992775885648 } ], "100000000000000000000940": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015608892178478949 }, { "start_logit": 6.9140625, "end_logit": -0.4521484375, "text": "", "probability": 0.9984391107821522 } ], "100000000000000000000957": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005838324581912443 }, { "start_logit": 8.03125, "end_logit": -0.5869140625, "text": "", "probability": 0.9994161675418086 } ], "100000000000000000000963": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007208380258812108 }, { "start_logit": 8.03125, "end_logit": -0.79833984375, "text": "", "probability": 0.9992791619741188 } ], "100000000000000000000964": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007208380258812108 }, { "start_logit": 8.0078125, "end_logit": -0.775390625, "text": "", "probability": 0.9992791619741188 } ], "100000000000000000000966": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006986756664856787 }, { "start_logit": 8.0625, "end_logit": -0.79736328125, "text": "", "probability": 0.9993013243335144 } ], "100000000000000000000970": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006487308181403439 }, { "start_logit": 7.9765625, "end_logit": -0.63623046875, "text": "", "probability": 0.9993512691818597 } ], "100000000000000000000971": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006538155503558285 }, { "start_logit": 8.0234375, "end_logit": -0.6923828125, "text": "", "probability": 0.9993461844496442 } ], "100000000000000000000973": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006214630161383599 }, { "start_logit": 7.96484375, "end_logit": -0.583984375, "text": "", "probability": 0.9993785369838617 } ], "100000000000000000000975": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995254956 }, { "start_logit": -33.53125, "end_logit": 12.0546875, "text": "", "probability": 4.745045065396272e-10 } ], "100000000000000000000976": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995812512 }, { "start_logit": -33.5, "end_logit": 11.8984375, "text": "", "probability": 4.187487573070005e-10 } ], "100000000000000000000978": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995542443 }, { "start_logit": -33.53125, "end_logit": 12.0078125, "text": "", "probability": 4.457557318200031e-10 } ], "100000000000000000000985": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.6953125, "end_logit": -0.475341796875, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000000989": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002590979364429334 }, { "start_logit": 6.0703125, "end_logit": -0.1190185546875, "text": "", "probability": 0.9974090206355707 } ], "100000000000000000000995": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009966076912722927 }, { "start_logit": 7.234375, "end_logit": -0.32373046875, "text": "", "probability": 0.9990033923087277 } ], "100000000000000000000996": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.19140625, "end_logit": -0.322509765625, "text": "", "probability": 0.998959681497187 } ], "100000000000000000000999": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.28125, "end_logit": -0.36474609375, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000001000": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.16015625, "end_logit": -0.42236328125, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000001004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005484792388673105 }, { "start_logit": 8.4140625, "end_logit": -0.90478515625, "text": "", "probability": 0.9994515207611326 } ], "100000000000000000001011": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999978059133 }, { "start_logit": -32.9375, "end_logit": 12.9921875, "text": "", "probability": 2.1940866052503023e-09 } ], "100000000000000000001014": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012793074828344202 }, { "start_logit": 7.21484375, "end_logit": -0.55517578125, "text": "", "probability": 0.9987206925171654 } ], "100000000000000000001015": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 7.19921875, "end_logit": -0.60302734375, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000001022": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.48828125, "end_logit": -0.6083984375, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000001026": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.625, "end_logit": -0.64013671875, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000001027": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015608892178478949 }, { "start_logit": 7.37890625, "end_logit": -0.91845703125, "text": "", "probability": 0.9984391107821522 } ], "100000000000000000001030": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.44921875, "end_logit": -0.93505859375, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000001039": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.4375, "end_logit": -0.64990234375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000001043": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.4375, "end_logit": -0.62548828125, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000001045": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003175087886569813 }, { "start_logit": 8.015625, "end_logit": 0.037109375, "text": "", "probability": 0.9996824912113431 } ], "100000000000000000001047": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006851713149506406 }, { "start_logit": 7.87109375, "end_logit": -0.58544921875, "text": "", "probability": 0.9993148286850494 } ], "100000000000000000001050": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.6328125, "end_logit": -0.6279296875, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000001051": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.6953125, "end_logit": -0.57861328125, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000001053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.66015625, "end_logit": -0.591796875, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000001058": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.17578125, "end_logit": -0.81103515625, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000001059": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 7.109375, "end_logit": -0.75732421875, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000001061": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 6.75390625, "end_logit": -0.407958984375, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000001064": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 6.6484375, "end_logit": -0.30029296875, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000001067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 7.15234375, "end_logit": -0.65673828125, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000001069": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.1640625, "end_logit": -0.6943359375, "text": "", "probability": 0.998451238905712 } ], "100000000000000000001078": [ { "start_logit": 17.75, "end_logit": 10.6640625, "text": "Paxlovid", "probability": 0.296630859375 }, { "start_logit": 17.75, "end_logit": 9.8515625, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.1317138671875 }, { "start_logit": 17.75, "end_logit": 9.609375, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children", "probability": 0.1041259765625 }, { "start_logit": 17.75, "end_logit": 9.25, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.07269287109375 }, { "start_logit": 16.984375, "end_logit": 9.8515625, "text": "Adults; children ages 12\nyears", "probability": 0.062164306640625 }, { "start_logit": 16.84375, "end_logit": 9.8515625, "text": " 12\nyears", "probability": 0.053192138671875 }, { "start_logit": 16.984375, "end_logit": 9.609375, "text": "Adults; children", "probability": 0.04840087890625 }, { "start_logit": 16.984375, "end_logit": 9.25, "text": "Adults; children ages 12\nyears and older", "probability": 0.0338134765625 }, { "start_logit": 15.5234375, "end_logit": 10.6640625, "text": "Treatment Who When How\nNirmatrelvir with Ritonavi\n(Paxlovid", "probability": 0.032257080078125 }, { "start_logit": 16.84375, "end_logit": 9.25, "text": " 12\nyears and older", "probability": 0.0293731689453125 }, { "start_logit": 16.734375, "end_logit": 9.328125, "text": " Adults and children", "probability": 0.0284576416015625 }, { "start_logit": 15.0, "end_logit": 10.6640625, "text": " Ritonavi\n(Paxlovid", "probability": 0.018951416015625 }, { "start_logit": 17.75, "end_logit": 7.76171875, "text": "Pax", "probability": 0.0164794921875 }, { "start_logit": 15.5234375, "end_logit": 9.8515625, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.014312744140625 }, { "start_logit": 15.5234375, "end_logit": 9.609375, "text": "Antiviral\n\uf209\nAdults; children", "probability": 0.01114654541015625 }, { "start_logit": 17.75, "end_logit": 7.30859375, "text": "Paxlov", "probability": 0.01047515869140625 }, { "start_logit": 17.75, "end_logit": 7.2421875, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults;", "probability": 0.0098419189453125 }, { "start_logit": 16.171875, "end_logit": 8.8359375, "text": "Monoclonal antibody\n\uf209 Adults; children ages 12\nyears", "probability": 0.0098419189453125 }, { "start_logit": 15.0, "end_logit": 9.8515625, "text": " Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.00841522216796875 }, { "start_logit": 15.5234375, "end_logit": 9.25, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.007904052734375 }, { "start_logit": 8.9765625, "end_logit": -0.8896484375, "text": "", "probability": 0.0 } ], "100000000000000000001079": [ { "start_logit": 17.75, "end_logit": 10.6640625, "text": "Paxlovid", "probability": 0.296875 }, { "start_logit": 17.75, "end_logit": 9.8515625, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.1318359375 }, { "start_logit": 17.75, "end_logit": 9.6171875, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children", "probability": 0.1058349609375 }, { "start_logit": 17.75, "end_logit": 9.25, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.07281494140625 }, { "start_logit": 16.984375, "end_logit": 9.8515625, "text": "Adults; children ages 12\nyears", "probability": 0.062255859375 }, { "start_logit": 16.84375, "end_logit": 9.8515625, "text": " 12\nyears", "probability": 0.053253173828125 }, { "start_logit": 16.984375, "end_logit": 9.6171875, "text": "Adults; children", "probability": 0.0484619140625 }, { "start_logit": 16.984375, "end_logit": 9.25, "text": "Adults; children ages 12\nyears and older", "probability": 0.033843994140625 }, { "start_logit": 15.5234375, "end_logit": 10.6640625, "text": "Treatment Who When How\nNirmatrelvir with Ritonavi\n(Paxlovid", "probability": 0.03228759765625 }, { "start_logit": 16.84375, "end_logit": 9.25, "text": " 12\nyears and older", "probability": 0.0294036865234375 }, { "start_logit": 16.734375, "end_logit": 9.328125, "text": " Adults and children", "probability": 0.0284881591796875 }, { "start_logit": 14.9921875, "end_logit": 10.6640625, "text": " Ritonavi\n(Paxlovid", "probability": 0.01898193359375 }, { "start_logit": 17.75, "end_logit": 7.76953125, "text": "Pax", "probability": 0.0164947509765625 }, { "start_logit": 15.53125, "end_logit": 9.8515625, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.0143280029296875 }, { "start_logit": 15.53125, "end_logit": 9.6171875, "text": "Antiviral\n\uf209\nAdults; children", "probability": 0.0115203857421875 }, { "start_logit": 17.75, "end_logit": 7.30859375, "text": "Paxlov", "probability": 0.0104827880859375 }, { "start_logit": 17.75, "end_logit": 7.24609375, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults;", "probability": 0.00984954833984375 }, { "start_logit": 14.9921875, "end_logit": 9.8515625, "text": " Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.0084228515625 }, { "start_logit": 15.53125, "end_logit": 9.25, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.00791168212890625 }, { "start_logit": 14.9921875, "end_logit": 9.6171875, "text": " Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children", "probability": 0.006664276123046875 }, { "start_logit": 8.6875, "end_logit": -1.0009765625, "text": "", "probability": 0.0 } ], "100000000000000000001082": [ { "start_logit": 17.75, "end_logit": 10.6640625, "text": "Paxlovid", "probability": 0.296875 }, { "start_logit": 17.75, "end_logit": 9.8515625, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.1318359375 }, { "start_logit": 17.75, "end_logit": 9.6171875, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children", "probability": 0.1058349609375 }, { "start_logit": 17.75, "end_logit": 9.25, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.07281494140625 }, { "start_logit": 16.984375, "end_logit": 9.8515625, "text": "Adults; children ages 12\nyears", "probability": 0.062255859375 }, { "start_logit": 16.84375, "end_logit": 9.8515625, "text": " 12\nyears", "probability": 0.053253173828125 }, { "start_logit": 16.984375, "end_logit": 9.6171875, "text": "Adults; children", "probability": 0.0484619140625 }, { "start_logit": 16.984375, "end_logit": 9.25, "text": "Adults; children ages 12\nyears and older", "probability": 0.033843994140625 }, { "start_logit": 15.5234375, "end_logit": 10.6640625, "text": "Treatment Who When How\nNirmatrelvir with Ritonavi\n(Paxlovid", "probability": 0.03228759765625 }, { "start_logit": 16.84375, "end_logit": 9.25, "text": " 12\nyears and older", "probability": 0.0294036865234375 }, { "start_logit": 16.734375, "end_logit": 9.328125, "text": " Adults and children", "probability": 0.0284881591796875 }, { "start_logit": 15.0, "end_logit": 10.6640625, "text": " Ritonavi\n(Paxlovid", "probability": 0.01898193359375 }, { "start_logit": 17.75, "end_logit": 7.76171875, "text": "Pax", "probability": 0.0164947509765625 }, { "start_logit": 15.53125, "end_logit": 9.8515625, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.0143280029296875 }, { "start_logit": 15.53125, "end_logit": 9.6171875, "text": "Antiviral\n\uf209\nAdults; children", "probability": 0.0115203857421875 }, { "start_logit": 17.75, "end_logit": 7.3046875, "text": "Paxlov", "probability": 0.0104827880859375 }, { "start_logit": 17.75, "end_logit": 7.24609375, "text": "Paxlovid)\nAntiviral\n\uf209\nAdults;", "probability": 0.00984954833984375 }, { "start_logit": 15.0, "end_logit": 9.8515625, "text": " Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children ages 12\nyears", "probability": 0.0084228515625 }, { "start_logit": 15.53125, "end_logit": 9.25, "text": "Antiviral\n\uf209\nAdults; children ages 12\nyears and older", "probability": 0.00791168212890625 }, { "start_logit": 15.0, "end_logit": 9.6171875, "text": " Ritonavi\n(Paxlovid)\nAntiviral\n\uf209\nAdults; children", "probability": 0.006771087646484375 }, { "start_logit": 8.6328125, "end_logit": -1.044921875, "text": "", "probability": 0.0 } ], "100000000000000000001084": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.6171875, "end_logit": -0.71923828125, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000001087": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.64453125, "end_logit": -0.69677734375, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000001090": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.1484375, "end_logit": -0.40576171875, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000001092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.24609375, "end_logit": -0.4208984375, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000001094": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.16015625, "end_logit": -0.451171875, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000001097": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023596606820630445 }, { "start_logit": 6.53125, "end_logit": -0.485107421875, "text": "", "probability": 0.9976403393179369 } ], "100000000000000000001100": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002434382008505326 }, { "start_logit": 6.53515625, "end_logit": -0.51904296875, "text": "", "probability": 0.9975656179914948 } ], "100000000000000000001104": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.83984375, "end_logit": -0.646484375, "text": "", "probability": 0.997965182999252 } ], "100000000000000000001106": [ { "start_logit": 15.1796875, "end_logit": 10.4453125, "text": "People", "probability": 0.31005859375 }, { "start_logit": 15.1796875, "end_logit": 10.2109375, "text": "People have been seriously harmed and even died after taking products", "probability": 0.245361328125 }, { "start_logit": 15.1796875, "end_logit": 9.65625, "text": "People have been seriously", "probability": 0.1419677734375 }, { "start_logit": 15.1796875, "end_logit": 9.1875, "text": "People have been seriously harmed and even died", "probability": 0.0888671875 }, { "start_logit": 15.1796875, "end_logit": 8.484375, "text": "People have been seriously harmed and even died after taking products\nnot approved for use to treat or prevent COVID-19, even products", "probability": 0.043304443359375 }, { "start_logit": 13.3671875, "end_logit": 10.2109375, "text": " taking products", "probability": 0.0400390625 }, { "start_logit": 13.2578125, "end_logit": 10.2109375, "text": " harmed and even died after taking products", "probability": 0.035919189453125 }, { "start_logit": 12.9921875, "end_logit": 10.2109375, "text": " seriously harmed and even died after taking products", "probability": 0.02752685546875 }, { "start_logit": 12.9921875, "end_logit": 9.65625, "text": " seriously", "probability": 0.01593017578125 }, { "start_logit": 13.2578125, "end_logit": 9.1875, "text": " harmed and even died", "probability": 0.01279449462890625 }, { "start_logit": 12.9921875, "end_logit": 9.1875, "text": " seriously harmed and even died", "probability": 0.0099639892578125 }, { "start_logit": 13.671875, "end_logit": 8.484375, "text": " COVID-19, even products", "probability": 0.00966644287109375 }, { "start_logit": 13.3671875, "end_logit": 8.484375, "text": " taking products\nnot approved for use to treat or prevent COVID-19, even products", "probability": 0.007068634033203125 }, { "start_logit": 13.2578125, "end_logit": 8.484375, "text": " harmed and even died after taking products\nnot approved for use to treat or prevent COVID-19, even products", "probability": 0.006435394287109375 }, { "start_logit": 12.9921875, "end_logit": 8.484375, "text": " seriously harmed and even died after taking products\nnot approved for use to treat or prevent COVID-19, even products", "probability": 0.00485992431640625 }, { "start_logit": 8.3359375, "end_logit": -0.351318359375, "text": "", "probability": 0.0 } ], "100000000000000000001108": [ { "start_logit": 15.1796875, "end_logit": 10.4453125, "text": "People", "probability": 0.332275390625 }, { "start_logit": 15.1796875, "end_logit": 10.21875, "text": "People have been seriously harmed and even died after taking products", "probability": 0.26708984375 }, { "start_logit": 15.1796875, "end_logit": 9.65625, "text": "People have been seriously", "probability": 0.152099609375 }, { "start_logit": 15.1796875, "end_logit": 9.1875, "text": "People have been seriously harmed and even died", "probability": 0.09521484375 }, { "start_logit": 13.375, "end_logit": 10.21875, "text": " taking products", "probability": 0.043609619140625 }, { "start_logit": 13.2578125, "end_logit": 10.21875, "text": " harmed and even died after taking products", "probability": 0.038482666015625 }, { "start_logit": 12.9921875, "end_logit": 10.21875, "text": " seriously harmed and even died after taking products", "probability": 0.0299530029296875 }, { "start_logit": 12.9921875, "end_logit": 9.65625, "text": " seriously", "probability": 0.017059326171875 }, { "start_logit": 13.2578125, "end_logit": 9.1875, "text": " harmed and even died", "probability": 0.01371002197265625 }, { "start_logit": 12.9921875, "end_logit": 9.1875, "text": " seriously harmed and even died", "probability": 0.01067352294921875 }, { "start_logit": 8.09375, "end_logit": -0.39404296875, "text": "", "probability": 0.0 } ], "100000000000000000001116": [ { "start_logit": 13.3828125, "end_logit": 7.0859375, "text": "COVID-19", "probability": 0.467529296875 }, { "start_logit": 12.2421875, "end_logit": 7.0859375, "text": "Espa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nCOVID-19", "probability": 0.1494140625 }, { "start_logit": 12.125, "end_logit": 7.0859375, "text": "Vaccines & Immunizations Home\nCOVID-19", "probability": 0.134033203125 }, { "start_logit": 13.3828125, "end_logit": 5.24609375, "text": "COVID-19 Vaccination", "probability": 0.073974609375 }, { "start_logit": 12.90625, "end_logit": 5.1796875, "text": "10", "probability": 0.043487548828125 }, { "start_logit": 12.625, "end_logit": 5.32421875, "text": " COVID-19 Vaccination Clinical and Professional Resources | CDC\nEspa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations", "probability": 0.03778076171875 }, { "start_logit": 12.2421875, "end_logit": 5.32421875, "text": "Espa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations", "probability": 0.02557373046875 }, { "start_logit": 12.2421875, "end_logit": 5.24609375, "text": "Espa\u00f1ol | Other Languages\nVaccines & Immunizations\nVaccines & Immunizations Home\nCOVID-19 Vaccination", "probability": 0.023651123046875 }, { "start_logit": 12.125, "end_logit": 5.32421875, "text": "Vaccines & Immunizations", "probability": 0.022918701171875 }, { "start_logit": 12.125, "end_logit": 5.24609375, "text": "Vaccines & Immunizations Home\nCOVID-19 Vaccination", "probability": 0.0211944580078125 }, { "start_logit": 7.95703125, "end_logit": -0.96435546875, "text": "", "probability": 6.556510925292969e-07 } ], "100000000000000000001119": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005316132776684706 }, { "start_logit": 7.7578125, "end_logit": -0.2176513671875, "text": "", "probability": 0.9994683867223316 } ], "100000000000000000001121": [ { "start_logit": 17.078125, "end_logit": 7.078125, "text": "Children and Adolescents\nHomebound Persons\nDialysis", "probability": 0.478515625 }, { "start_logit": 17.078125, "end_logit": 6.76171875, "text": "Children", "probability": 0.35009765625 }, { "start_logit": 15.2109375, "end_logit": 7.078125, "text": "Dialysis", "probability": 0.0733642578125 }, { "start_logit": 14.5625, "end_logit": 7.078125, "text": "Homebound Persons\nDialysis", "probability": 0.038665771484375 }, { "start_logit": 14.4375, "end_logit": 7.078125, "text": " Adults and People with\nDisabilities\nChildren and Adolescents\nHomebound Persons\nDialysis", "probability": 0.03411865234375 }, { "start_logit": 14.4375, "end_logit": 6.76171875, "text": " Adults and People with\nDisabilities\nChildren", "probability": 0.02496337890625 }, { "start_logit": 8.359375, "end_logit": -0.62939453125, "text": "", "probability": 0.0 } ], "100000000000000000001125": [ { "start_logit": 17.09375, "end_logit": 7.078125, "text": "Children and Adolescents\nHomebound Persons\nDialysis", "probability": 0.384033203125 }, { "start_logit": 17.09375, "end_logit": 6.76171875, "text": "Children", "probability": 0.281005859375 }, { "start_logit": 17.09375, "end_logit": 6.16015625, "text": "Children and Adolescents\nHomebound Persons\nDialysis Patients\nHealthcare Personnel\nTeachers, School Staff", "probability": 0.1527099609375 }, { "start_logit": 15.2109375, "end_logit": 7.078125, "text": "Dialysis", "probability": 0.058013916015625 }, { "start_logit": 14.5625, "end_logit": 7.078125, "text": "Homebound Persons\nDialysis", "probability": 0.0305633544921875 }, { "start_logit": 14.4296875, "end_logit": 7.078125, "text": " Adults and People with\nDisabilities\nChildren and Adolescents\nHomebound Persons\nDialysis", "probability": 0.0265655517578125 }, { "start_logit": 15.2109375, "end_logit": 6.16015625, "text": "Dialysis Patients\nHealthcare Personnel\nTeachers, School Staff", "probability": 0.0234375 }, { "start_logit": 14.4296875, "end_logit": 6.76171875, "text": " Adults and People with\nDisabilities\nChildren", "probability": 0.0194244384765625 }, { "start_logit": 14.5625, "end_logit": 6.16015625, "text": "Homebound Persons\nDialysis Patients\nHealthcare Personnel\nTeachers, School Staff", "probability": 0.01215362548828125 }, { "start_logit": 14.5390625, "end_logit": 6.16015625, "text": "Teachers, School Staff", "probability": 0.01197052001953125 }, { "start_logit": 8.359375, "end_logit": -0.6142578125, "text": "", "probability": 0.0 } ], "100000000000000000001126": [ { "start_logit": 17.09375, "end_logit": 7.08203125, "text": "Children and Adolescents\nHomebound Persons\nDialysis", "probability": 0.482666015625 }, { "start_logit": 17.09375, "end_logit": 6.7578125, "text": "Children", "probability": 0.34765625 }, { "start_logit": 15.203125, "end_logit": 7.08203125, "text": "Dialysis", "probability": 0.0728759765625 }, { "start_logit": 14.578125, "end_logit": 7.08203125, "text": "Homebound Persons\nDialysis", "probability": 0.03900146484375 }, { "start_logit": 14.4296875, "end_logit": 7.08203125, "text": " Adults and People with\nDisabilities\nChildren and Adolescents\nHomebound Persons\nDialysis", "probability": 0.03387451171875 }, { "start_logit": 14.4296875, "end_logit": 6.7578125, "text": " Adults and People with\nDisabilities\nChildren", "probability": 0.0243988037109375 }, { "start_logit": 8.265625, "end_logit": -0.62939453125, "text": "", "probability": 0.0 } ], "100000000000000000001127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004373344035182828 }, { "start_logit": 8.4609375, "end_logit": -0.7255859375, "text": "", "probability": 0.9995626655964818 } ], "100000000000000000001128": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004339325170191996 }, { "start_logit": 8.4609375, "end_logit": -0.72021484375, "text": "", "probability": 0.9995660674829807 } ], "100000000000000000001129": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042720789094732544 }, { "start_logit": 8.5234375, "end_logit": -0.76708984375, "text": "", "probability": 0.9995727921090527 } ], "100000000000000000001134": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.5, "end_logit": -0.38330078125, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000001136": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000302973407808812 }, { "start_logit": 8.671875, "end_logit": -0.568359375, "text": "", "probability": 0.9996970265921912 } ], "100000000000000000001138": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00031999824407395836 }, { "start_logit": 8.5, "end_logit": -0.455322265625, "text": "", "probability": 0.9996800017559261 } ], "100000000000000000001141": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005357805383473944 }, { "start_logit": 7.8359375, "end_logit": -0.30322265625, "text": "", "probability": 0.9994642194616526 } ], "100000000000000000001142": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 7.83203125, "end_logit": -0.349609375, "text": "", "probability": 0.99943852125386 } ], "100000000000000000001145": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005442132624325574 }, { "start_logit": 7.86328125, "end_logit": -0.34912109375, "text": "", "probability": 0.9994557867375674 } ], "100000000000000000001149": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.16015625, "end_logit": -0.235595703125, "text": "", "probability": 0.999018828118793 } ], "100000000000000000001151": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994538487 }, { "start_logit": -33.59375, "end_logit": 12.265625, "text": "", "probability": 5.46151339212149e-10 } ], "100000000000000000001153": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994276383 }, { "start_logit": -33.625, "end_logit": 12.3515625, "text": "", "probability": 5.723616892186642e-10 } ], "100000000000000000001154": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994094697 }, { "start_logit": -33.625, "end_logit": 12.3828125, "text": "", "probability": 5.905303995456778e-10 } ], "100000000000000000001159": [ { "start_logit": 19.0, "end_logit": 11.0546875, "text": " \u201cN/A\u201d", "probability": 0.54345703125 }, { "start_logit": 19.0, "end_logit": 10.1171875, "text": " \u201cN/A", "probability": 0.212890625 }, { "start_logit": 19.0, "end_logit": 9.3671875, "text": " \u201cN/A\u201d or entered as \u201c0.\u201d\nJurisdict", "probability": 0.10052490234375 }, { "start_logit": 19.0, "end_logit": 9.0, "text": " \u201cN/A\u201d or entered as \u201c0.\u201d", "probability": 0.069091796875 }, { "start_logit": 15.5, "end_logit": 11.0546875, "text": " federal entities, these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.01641845703125 }, { "start_logit": 14.65625, "end_logit": 11.0546875, "text": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.00705718994140625 }, { "start_logit": 14.6171875, "end_logit": 11.0546875, "text": "\nas \u201cN/A\u201d", "probability": 0.006732940673828125 }, { "start_logit": 15.5, "end_logit": 10.1171875, "text": " federal entities, these metrics are displayed\nas \u201cN/A", "probability": 0.006427764892578125 }, { "start_logit": 14.46875, "end_logit": 11.0546875, "text": " these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.00585174560546875 }, { "start_logit": 16.046875, "end_logit": 9.3671875, "text": "Jurisdict", "probability": 0.005161285400390625 }, { "start_logit": 15.5, "end_logit": 9.8515625, "text": " federal entities", "probability": 0.004852294921875 }, { "start_logit": 15.5, "end_logit": 9.4453125, "text": " federal entities, these metrics", "probability": 0.0032329559326171875 }, { "start_logit": 15.5, "end_logit": 9.3671875, "text": " federal entities, these metrics are displayed\nas \u201cN/A\u201d or entered as \u201c0.\u201d\nJurisdict", "probability": 0.0030345916748046875 }, { "start_logit": 14.65625, "end_logit": 10.1171875, "text": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A", "probability": 0.0027637481689453125 }, { "start_logit": 14.6171875, "end_logit": 10.1171875, "text": "\nas \u201cN/A", "probability": 0.0026378631591796875 }, { "start_logit": 14.46875, "end_logit": 10.1171875, "text": " these metrics are displayed\nas \u201cN/A", "probability": 0.0022907257080078125 }, { "start_logit": 15.5, "end_logit": 9.0, "text": " federal entities, these metrics are displayed\nas \u201cN/A\u201d or entered as \u201c0.\u201d", "probability": 0.002086639404296875 }, { "start_logit": 14.65625, "end_logit": 9.8515625, "text": "When the denominator data are not available for federal entities", "probability": 0.002086639404296875 }, { "start_logit": 15.03125, "end_logit": 9.3671875, "text": " \u201c0.\u201d\nJurisdict", "probability": 0.0019006729125976562 }, { "start_logit": 14.65625, "end_logit": 9.4453125, "text": "When the denominator data are not available for federal entities, these metrics", "probability": 0.0013904571533203125 }, { "start_logit": 7.21484375, "end_logit": -0.63330078125, "text": "", "probability": 0.0 } ], "100000000000000000001162": [ { "start_logit": 19.0, "end_logit": 11.0546875, "text": " \u201cN/A\u201d", "probability": 0.6083984375 }, { "start_logit": 19.0, "end_logit": 10.1171875, "text": " \u201cN/A", "probability": 0.23828125 }, { "start_logit": 19.0, "end_logit": 9.0, "text": " \u201cN/A\u201d or entered as \u201c0.\u201d", "probability": 0.07733154296875 }, { "start_logit": 15.5, "end_logit": 11.0546875, "text": " federal entities, these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.01837158203125 }, { "start_logit": 14.65625, "end_logit": 11.0546875, "text": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.007904052734375 }, { "start_logit": 14.6171875, "end_logit": 11.0546875, "text": "\nas \u201cN/A\u201d", "probability": 0.007537841796875 }, { "start_logit": 15.5, "end_logit": 10.1171875, "text": " federal entities, these metrics are displayed\nas \u201cN/A", "probability": 0.00719451904296875 }, { "start_logit": 14.46875, "end_logit": 11.0546875, "text": " these metrics are displayed\nas \u201cN/A\u201d", "probability": 0.006549835205078125 }, { "start_logit": 15.5, "end_logit": 9.8515625, "text": " federal entities", "probability": 0.00543212890625 }, { "start_logit": 15.5, "end_logit": 9.4453125, "text": " federal entities, these metrics", "probability": 0.0036182403564453125 }, { "start_logit": 14.65625, "end_logit": 10.1171875, "text": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A", "probability": 0.003093719482421875 }, { "start_logit": 14.6171875, "end_logit": 10.1171875, "text": "\nas \u201cN/A", "probability": 0.00295257568359375 }, { "start_logit": 14.46875, "end_logit": 10.1171875, "text": " these metrics are displayed\nas \u201cN/A", "probability": 0.0025653839111328125 }, { "start_logit": 15.5, "end_logit": 9.0, "text": " federal entities, these metrics are displayed\nas \u201cN/A\u201d or entered as \u201c0.\u201d", "probability": 0.0023365020751953125 }, { "start_logit": 14.65625, "end_logit": 9.8515625, "text": "When the denominator data are not available for federal entities", "probability": 0.0023365020751953125 }, { "start_logit": 14.65625, "end_logit": 9.4453125, "text": "When the denominator data are not available for federal entities, these metrics", "probability": 0.001556396484375 }, { "start_logit": 15.03125, "end_logit": 9.0, "text": " \u201c0.\u201d", "probability": 0.0014619827270507812 }, { "start_logit": 14.46875, "end_logit": 9.4453125, "text": " these metrics", "probability": 0.0012903213500976562 }, { "start_logit": 14.65625, "end_logit": 9.0, "text": "When the denominator data are not available for federal entities, these metrics are displayed\nas \u201cN/A\u201d or entered as \u201c0.\u201d", "probability": 0.0010042190551757812 }, { "start_logit": 14.65625, "end_logit": 8.9921875, "text": "When the denominator data", "probability": 0.0010042190551757812 }, { "start_logit": 7.2265625, "end_logit": -0.66162109375, "text": "", "probability": 0.0 } ], "100000000000000000001163": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001455062938532843 }, { "start_logit": 7.1171875, "end_logit": -0.587890625, "text": "", "probability": 0.9985449370614672 } ], "100000000000000000001169": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010566838241698937 }, { "start_logit": 7.98046875, "end_logit": -1.1279296875, "text": "", "probability": 0.9989433161758301 } ], "100000000000000000001176": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00032250721198683237 }, { "start_logit": 8.171875, "end_logit": -0.1326904296875, "text": "", "probability": 0.9996774927880132 } ], "100000000000000000001178": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00031503869408133935 }, { "start_logit": 8.1953125, "end_logit": -0.1292724609375, "text": "", "probability": 0.9996849613059188 } ], "100000000000000000001180": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.56640625, "end_logit": -0.78466796875, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000001181": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.6171875, "end_logit": -0.83447265625, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000001184": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.56640625, "end_logit": -0.8251953125, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000001186": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.47265625, "end_logit": -0.79052734375, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000001191": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030753698500482337 }, { "start_logit": 6.24609375, "end_logit": -0.466796875, "text": "", "probability": 0.9969246301499518 } ], "100000000000000000001196": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015608892178478949 }, { "start_logit": 7.3125, "end_logit": -0.85009765625, "text": "", "probability": 0.9984391107821522 } ], "100000000000000000001200": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001294368035454269 }, { "start_logit": 7.43359375, "end_logit": -0.78515625, "text": "", "probability": 0.9987056319645456 } ], "100000000000000000001201": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013777325890227494 }, { "start_logit": 7.40625, "end_logit": -0.82177734375, "text": "", "probability": 0.9986222674109773 } ], "100000000000000000001205": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.1875, "end_logit": -0.373779296875, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000001207": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.40234375, "end_logit": -0.1986083984375, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000001214": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 6.890625, "end_logit": -0.396484375, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000001217": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001579259428801316 }, { "start_logit": 6.8046875, "end_logit": -0.35498046875, "text": "", "probability": 0.9984207405711987 } ], "100000000000000000001219": [ { "start_logit": 18.8125, "end_logit": 10.6640625, "text": " 87%", "probability": 0.60205078125 }, { "start_logit": 17.3125, "end_logit": 10.6640625, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian and Other Pacific Islanders\n*Among 87%", "probability": 0.13427734375 }, { "start_logit": 17.875, "end_logit": 8.90625, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.04095458984375 }, { "start_logit": 17.6875, "end_logit": 8.90625, "text": " October 26, 2022", "probability": 0.033966064453125 }, { "start_logit": 15.7265625, "end_logit": 10.6640625, "text": "NHOPI: Native Hawaiian and Other Pacific Islanders\n*Among 87%", "probability": 0.0277252197265625 }, { "start_logit": 17.875, "end_logit": 8.328125, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.022979736328125 }, { "start_logit": 17.6875, "end_logit": 8.328125, "text": " October 26, 2022\nFile Details: 1", "probability": 0.0190582275390625 }, { "start_logit": 17.515625, "end_logit": 8.328125, "text": " 1", "probability": 0.0160369873046875 }, { "start_logit": 17.875, "end_logit": 7.87890625, "text": " COVID-19", "probability": 0.0146026611328125 }, { "start_logit": 16.78125, "end_logit": 8.90625, "text": "Graphic: COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.01372528076171875 }, { "start_logit": 16.734375, "end_logit": 8.90625, "text": "Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.013092041015625 }, { "start_logit": 18.8125, "end_logit": 6.515625, "text": " 8", "probability": 0.00958251953125 }, { "start_logit": 17.3125, "end_logit": 8.0078125, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian and Other Pacific Islanders", "probability": 0.00943756103515625 }, { "start_logit": 16.78125, "end_logit": 8.328125, "text": "Graphic: COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.00769805908203125 }, { "start_logit": 16.734375, "end_logit": 8.328125, "text": "Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.007343292236328125 }, { "start_logit": 17.3125, "end_logit": 7.73046875, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian", "probability": 0.007228851318359375 }, { "start_logit": 17.875, "end_logit": 7.0, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States", "probability": 0.006092071533203125 }, { "start_logit": 15.7734375, "end_logit": 8.90625, "text": "Administrations in the United States \u2013 October 26, 2022", "probability": 0.005046844482421875 }, { "start_logit": 16.78125, "end_logit": 7.87890625, "text": "Graphic: COVID-19", "probability": 0.00489044189453125 }, { "start_logit": 17.875, "end_logit": 6.68359375, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1 MB", "probability": 0.00445556640625 }, { "start_logit": 8.9609375, "end_logit": -0.83251953125, "text": "", "probability": 0.0 } ], "100000000000000000001223": [ { "start_logit": 18.8125, "end_logit": 10.6640625, "text": " 87%", "probability": 0.59912109375 }, { "start_logit": 17.328125, "end_logit": 10.6640625, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian and Other Pacific Islanders\n*Among 87%", "probability": 0.137939453125 }, { "start_logit": 17.875, "end_logit": 8.8984375, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.040771484375 }, { "start_logit": 17.6875, "end_logit": 8.8984375, "text": " October 26, 2022", "probability": 0.0338134765625 }, { "start_logit": 15.7265625, "end_logit": 10.6640625, "text": "NHOPI: Native Hawaiian and Other Pacific Islanders\n*Among 87%", "probability": 0.027587890625 }, { "start_logit": 17.875, "end_logit": 8.328125, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.0228729248046875 }, { "start_logit": 17.6875, "end_logit": 8.328125, "text": " October 26, 2022\nFile Details: 1", "probability": 0.0189666748046875 }, { "start_logit": 17.515625, "end_logit": 8.328125, "text": " 1", "probability": 0.015960693359375 }, { "start_logit": 17.875, "end_logit": 7.87890625, "text": " COVID-19", "probability": 0.01453399658203125 }, { "start_logit": 16.78125, "end_logit": 8.8984375, "text": "Graphic: COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.0136566162109375 }, { "start_logit": 16.734375, "end_logit": 8.8984375, "text": "Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022", "probability": 0.01282501220703125 }, { "start_logit": 18.8125, "end_logit": 6.52734375, "text": " 8", "probability": 0.00968170166015625 }, { "start_logit": 17.328125, "end_logit": 8.0, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian and Other Pacific Islanders", "probability": 0.0095367431640625 }, { "start_logit": 16.78125, "end_logit": 8.328125, "text": "Graphic: COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.007659912109375 }, { "start_logit": 17.328125, "end_logit": 7.734375, "text": " American Indian/Alaska Native\nNHOPI: Native Hawaiian", "probability": 0.0073089599609375 }, { "start_logit": 16.734375, "end_logit": 8.328125, "text": "Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1", "probability": 0.0073089599609375 }, { "start_logit": 17.875, "end_logit": 7.0, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States", "probability": 0.006061553955078125 }, { "start_logit": 15.7734375, "end_logit": 8.8984375, "text": "Administrations in the United States \u2013 October 26, 2022", "probability": 0.004947662353515625 }, { "start_logit": 16.78125, "end_logit": 7.87890625, "text": "Graphic: COVID-19", "probability": 0.0048675537109375 }, { "start_logit": 17.875, "end_logit": 6.68359375, "text": " COVID-19 Updated (Bivalent) Booster\nAdministrations in the United States \u2013 October 26, 2022\nFile Details: 1 MB", "probability": 0.00443267822265625 }, { "start_logit": 9.015625, "end_logit": -0.828125, "text": "", "probability": 0.0 } ], "100000000000000000001230": [ { "start_logit": 11.6328125, "end_logit": 6.6484375, "text": " Puerto Rico", "probability": 0.300048828125 }, { "start_logit": 11.6328125, "end_logit": 6.3671875, "text": " Puerto Rico) and 2020", "probability": 0.2264404296875 }, { "start_logit": 10.53125, "end_logit": 6.6484375, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico", "probability": 0.1004638671875 }, { "start_logit": 11.6328125, "end_logit": 5.3515625, "text": " Puerto Rico) and 2020 U.S. Census", "probability": 0.08203125 }, { "start_logit": 10.53125, "end_logit": 6.3671875, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020", "probability": 0.07586669921875 }, { "start_logit": 10.21875, "end_logit": 6.3671875, "text": " 2020", "probability": 0.05548095703125 }, { "start_logit": 11.6328125, "end_logit": 4.9375, "text": " Puerto", "probability": 0.05377197265625 }, { "start_logit": 10.53125, "end_logit": 5.3515625, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020 U.S. Census", "probability": 0.027252197265625 }, { "start_logit": 10.53125, "end_logit": 5.17578125, "text": " 2019 U.S. Census", "probability": 0.0227813720703125 }, { "start_logit": 10.21875, "end_logit": 5.3515625, "text": " 2020 U.S. Census", "probability": 0.0199432373046875 }, { "start_logit": 10.53125, "end_logit": 4.94140625, "text": " 2019", "probability": 0.0180206298828125 }, { "start_logit": 10.53125, "end_logit": 4.9375, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto", "probability": 0.0180206298828125 }, { "start_logit": 6.546875, "end_logit": -1.1806640625, "text": "", "probability": 7.152557373046875e-07 } ], "100000000000000000001231": [ { "start_logit": 11.6328125, "end_logit": 6.6484375, "text": " Puerto Rico", "probability": 0.210693359375 }, { "start_logit": 11.6328125, "end_logit": 6.3671875, "text": " Puerto Rico) and 2020", "probability": 0.1590576171875 }, { "start_logit": 11.6328125, "end_logit": 6.33984375, "text": " Puerto Rico) and 2020 U.S. Census Estimates (territories", "probability": 0.1541748046875 }, { "start_logit": 10.53125, "end_logit": 6.6484375, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico", "probability": 0.070556640625 }, { "start_logit": 11.6328125, "end_logit": 5.3515625, "text": " Puerto Rico) and 2020 U.S. Census", "probability": 0.0576171875 }, { "start_logit": 10.5859375, "end_logit": 6.33984375, "text": "territories", "probability": 0.054107666015625 }, { "start_logit": 10.53125, "end_logit": 6.3671875, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020", "probability": 0.05328369140625 }, { "start_logit": 10.53125, "end_logit": 6.33984375, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020 U.S. Census Estimates (territories", "probability": 0.0516357421875 }, { "start_logit": 10.21875, "end_logit": 6.3671875, "text": " 2020", "probability": 0.038970947265625 }, { "start_logit": 11.6328125, "end_logit": 4.9375, "text": " Puerto", "probability": 0.03778076171875 }, { "start_logit": 10.21875, "end_logit": 6.33984375, "text": " 2020 U.S. Census Estimates (territories", "probability": 0.03778076171875 }, { "start_logit": 10.53125, "end_logit": 5.3515625, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto Rico) and 2020 U.S. Census", "probability": 0.0191497802734375 }, { "start_logit": 10.53125, "end_logit": 5.17578125, "text": " 2019 U.S. Census", "probability": 0.0159912109375 }, { "start_logit": 10.21875, "end_logit": 5.3515625, "text": " 2020 U.S. Census", "probability": 0.014007568359375 }, { "start_logit": 10.53125, "end_logit": 4.94140625, "text": " 2019", "probability": 0.01265716552734375 }, { "start_logit": 10.53125, "end_logit": 4.9375, "text": " 2019 U.S. Census Estimates (states, D.C., Puerto", "probability": 0.01265716552734375 }, { "start_logit": 6.5234375, "end_logit": -1.1982421875, "text": "", "probability": 4.76837158203125e-07 } ], "100000000000000000001241": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.2265625, "end_logit": -0.039031982421875, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000001246": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 6.84765625, "end_logit": -0.319091796875, "text": "", "probability": 0.998539250425049 } ], "100000000000000000001248": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 6.86328125, "end_logit": -0.37646484375, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000001249": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000893445612873136 }, { "start_logit": 7.625, "end_logit": -0.60400390625, "text": "", "probability": 0.9991065543871269 } ], "100000000000000000001251": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.4921875, "end_logit": -0.541015625, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000001253": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.55859375, "end_logit": -0.57275390625, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000001255": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.78515625, "end_logit": -0.82666015625, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000001258": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009966076912722927 }, { "start_logit": 7.6875, "end_logit": -0.77587890625, "text": "", "probability": 0.9990033923087277 } ], "100000000000000000001267": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.09765625, "end_logit": -0.7333984375, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000001268": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 7.09375, "end_logit": -0.7587890625, "text": "", "probability": 0.998231648313891 } ], "100000000000000000001270": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 6.93359375, "end_logit": -0.62060546875, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000001271": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.91796875, "end_logit": -0.5888671875, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000001275": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001700722411435288 }, { "start_logit": 7.25390625, "end_logit": -0.88037109375, "text": "", "probability": 0.9982992775885648 } ], "100000000000000000001278": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00202690008046383 }, { "start_logit": 6.70703125, "end_logit": -0.5068359375, "text": "", "probability": 0.9979730999195362 } ], "100000000000000000001285": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004231587478161331 }, { "start_logit": 6.125, "end_logit": -0.6640625, "text": "", "probability": 0.9957684125218387 } ], "100000000000000000001289": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0038996206725778896 }, { "start_logit": 6.18359375, "end_logit": -0.6416015625, "text": "", "probability": 0.9961003793274221 } ], "100000000000000000001290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003945406806602023 }, { "start_logit": 6.20703125, "end_logit": -0.673828125, "text": "", "probability": 0.9960545931933981 } ], "100000000000000000001292": [ { "start_logit": 14.953125, "end_logit": 9.3671875, "text": " COVID-19", "probability": 0.43310546875 }, { "start_logit": 14.953125, "end_logit": 8.6328125, "text": " COVID-19 vaccines", "probability": 0.2110595703125 }, { "start_logit": 14.140625, "end_logit": 9.3671875, "text": "Can COVID-19", "probability": 0.1922607421875 }, { "start_logit": 14.140625, "end_logit": 8.6328125, "text": "Can COVID-19 vaccines", "probability": 0.09368896484375 }, { "start_logit": 14.140625, "end_logit": 8.34375, "text": "Can", "probability": 0.06964111328125 }, { "start_logit": 6.5546875, "end_logit": -0.99853515625, "text": "", "probability": 0.0 } ], "100000000000000000001293": [ { "start_logit": 14.953125, "end_logit": 9.3671875, "text": " COVID-19", "probability": 0.43310546875 }, { "start_logit": 14.953125, "end_logit": 8.6328125, "text": " COVID-19 vaccines", "probability": 0.2110595703125 }, { "start_logit": 14.140625, "end_logit": 9.3671875, "text": "Can COVID-19", "probability": 0.1922607421875 }, { "start_logit": 14.140625, "end_logit": 8.6328125, "text": "Can COVID-19 vaccines", "probability": 0.09368896484375 }, { "start_logit": 14.140625, "end_logit": 8.34375, "text": "Can", "probability": 0.06964111328125 }, { "start_logit": 6.42578125, "end_logit": -0.9794921875, "text": "", "probability": 0.0 } ], "100000000000000000001297": [ { "start_logit": 14.953125, "end_logit": 9.3671875, "text": " COVID-19", "probability": 0.623046875 }, { "start_logit": 14.140625, "end_logit": 9.3671875, "text": "Can COVID-19", "probability": 0.276611328125 }, { "start_logit": 14.140625, "end_logit": 8.34375, "text": "Can", "probability": 0.1002197265625 }, { "start_logit": 6.41796875, "end_logit": -0.99755859375, "text": "", "probability": 0.0 } ], "100000000000000000001301": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.6484375, "end_logit": -0.76220703125, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000001310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.3828125, "end_logit": -0.98681640625, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000001314": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006214630161383599 }, { "start_logit": 8.421875, "end_logit": -1.0400390625, "text": "", "probability": 0.9993785369838617 } ], "100000000000000000001318": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 8.2890625, "end_logit": -0.98583984375, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000001321": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009326360013054126 }, { "start_logit": 7.8515625, "end_logit": -0.876953125, "text": "", "probability": 0.9990673639986946 } ], "100000000000000000001322": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.3984375, "end_logit": -0.79248046875, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000001324": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013777325890227494 }, { "start_logit": 7.44921875, "end_logit": -0.86376953125, "text": "", "probability": 0.9986222674109773 } ], "100000000000000000001325": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.47265625, "end_logit": -0.830078125, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000001326": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 7.09765625, "end_logit": -0.84716796875, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000001330": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019723357407638166 }, { "start_logit": 7.06640625, "end_logit": -0.83837890625, "text": "", "probability": 0.9980276642592362 } ], "100000000000000000001332": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023141263296893675 }, { "start_logit": 6.9765625, "end_logit": -0.90869140625, "text": "", "probability": 0.9976858736703106 } ], "100000000000000000001337": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023781237181166506 }, { "start_logit": 6.88671875, "end_logit": -0.84814453125, "text": "", "probability": 0.9976218762818835 } ], "100000000000000000001344": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027469009484408103 }, { "start_logit": 6.51171875, "end_logit": -0.61669921875, "text": "", "probability": 0.9972530990515591 } ], "100000000000000000001350": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027362210991480392 }, { "start_logit": 6.75, "end_logit": -0.85302734375, "text": "", "probability": 0.997263778900852 } ], "100000000000000000001355": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002833849844246685 }, { "start_logit": 6.6953125, "end_logit": -0.8310546875, "text": "", "probability": 0.9971661501557534 } ], "100000000000000000001356": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 6.5859375, "end_logit": -0.6259765625, "text": "", "probability": 0.997429131960124 } ], "100000000000000000001360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002511463513809854 }, { "start_logit": 6.59375, "end_logit": -0.61083984375, "text": "", "probability": 0.9974885364861902 } ], "100000000000000000001364": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.62109375, "end_logit": -0.42529296875, "text": "", "probability": 0.997965182999252 } ], "100000000000000000001376": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.875, "end_logit": -0.685546875, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000001378": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030873693457091405 }, { "start_logit": 6.27734375, "end_logit": -0.5, "text": "", "probability": 0.9969126306542909 } ], "100000000000000000001382": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003185060821449478 }, { "start_logit": 6.1796875, "end_logit": -0.43212890625, "text": "", "probability": 0.9968149391785505 } ], "100000000000000000001387": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002107472437884964 }, { "start_logit": 6.86328125, "end_logit": -0.70361328125, "text": "", "probability": 0.997892527562115 } ], "100000000000000000001388": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021742253421720634 }, { "start_logit": 6.83203125, "end_logit": -0.7041015625, "text": "", "probability": 0.9978257746578281 } ], "100000000000000000001389": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001987774212383911 }, { "start_logit": 6.9453125, "end_logit": -0.728515625, "text": "", "probability": 0.998012225787616 } ], "100000000000000000001391": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002434382008505326 }, { "start_logit": 6.4140625, "end_logit": -0.39794921875, "text": "", "probability": 0.9975656179914948 } ], "100000000000000000001392": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024249142667552444 }, { "start_logit": 6.41015625, "end_logit": -0.3916015625, "text": "", "probability": 0.9975750857332447 } ], "100000000000000000001393": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 6.37890625, "end_logit": -0.349365234375, "text": "", "probability": 0.997603269129871 } ], "100000000000000000001394": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 8.203125, "end_logit": -0.92041015625, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000001397": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 8.0859375, "end_logit": -0.908203125, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000001398": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 7.11328125, "end_logit": -0.5009765625, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000001402": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.19921875, "end_logit": -0.486083984375, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000001404": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022343624199449986 }, { "start_logit": 6.8046875, "end_logit": -0.70361328125, "text": "", "probability": 0.997765637580055 } ], "100000000000000000001406": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021997980436915168 }, { "start_logit": 6.76171875, "end_logit": -0.64501953125, "text": "", "probability": 0.9978002019563085 } ], "100000000000000000001410": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012743262913872736 }, { "start_logit": 7.1171875, "end_logit": -0.452880859375, "text": "", "probability": 0.9987256737086126 } ], "100000000000000000001412": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.10546875, "end_logit": -0.48583984375, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000001427": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016420666692028368 }, { "start_logit": 6.86328125, "end_logit": -0.45458984375, "text": "", "probability": 0.9983579333307973 } ], "100000000000000000001428": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 6.90234375, "end_logit": -0.49560546875, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000001429": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 6.921875, "end_logit": -0.50537109375, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000001434": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.765625, "end_logit": -0.318603515625, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000001435": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 6.8203125, "end_logit": -0.3681640625, "text": "", "probability": 0.998426887834651 } ], "100000000000000000001439": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 8.03125, "end_logit": -0.80517578125, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000001448": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002822832897761561 }, { "start_logit": 6.26171875, "end_logit": -0.392578125, "text": "", "probability": 0.9971771671022386 } ], "100000000000000000001453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024630070555115235 }, { "start_logit": 6.8203125, "end_logit": -0.8154296875, "text": "", "probability": 0.9975369929444886 } ], "100000000000000000001455": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025016967402642916 }, { "start_logit": 6.78515625, "end_logit": -0.7958984375, "text": "", "probability": 0.9974983032597357 } ], "100000000000000000001461": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.33203125, "end_logit": -0.50927734375, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000001467": [ { "start_logit": 15.96875, "end_logit": 8.3828125, "text": "People who previously received SARS-CoV-2 antibody products", "probability": 0.5439453125 }, { "start_logit": 15.96875, "end_logit": 6.96875, "text": "People who previously received SARS-CoV-2 antibody", "probability": 0.13330078125 }, { "start_logit": 14.5625, "end_logit": 8.3828125, "text": " SARS-CoV-2 antibody products", "probability": 0.13330078125 }, { "start_logit": 15.96875, "end_logit": 6.12109375, "text": "People who previously received SARS-CoV-2", "probability": 0.05731201171875 }, { "start_logit": 13.4921875, "end_logit": 8.3828125, "text": "\nPeople who previously received SARS-CoV-2 antibody products", "probability": 0.04608154296875 }, { "start_logit": 14.5625, "end_logit": 6.96875, "text": " SARS-CoV-2 antibody", "probability": 0.03265380859375 }, { "start_logit": 12.53125, "end_logit": 8.3828125, "text": "\uf1aa\nPeople who previously received SARS-CoV-2 antibody products", "probability": 0.0174713134765625 }, { "start_logit": 14.5625, "end_logit": 6.12109375, "text": " SARS-CoV-2", "probability": 0.01404571533203125 }, { "start_logit": 13.4921875, "end_logit": 6.96875, "text": "\nPeople who previously received SARS-CoV-2 antibody", "probability": 0.01128387451171875 }, { "start_logit": 13.4921875, "end_logit": 6.12109375, "text": "\nPeople who previously received SARS-CoV-2", "probability": 0.004779815673828125 }, { "start_logit": 12.53125, "end_logit": 6.96875, "text": "\uf1aa\nPeople who previously received SARS-CoV-2 antibody", "probability": 0.0042877197265625 }, { "start_logit": 12.53125, "end_logit": 6.12109375, "text": "\uf1aa\nPeople who previously received SARS-CoV-2", "probability": 0.001842498779296875 }, { "start_logit": 7.1328125, "end_logit": -0.935546875, "text": "", "probability": 0.0 } ], "100000000000000000001478": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013831174237397678 }, { "start_logit": 7.5703125, "end_logit": -0.98681640625, "text": "", "probability": 0.9986168825762602 } ], "100000000000000000001481": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.59765625, "end_logit": -0.9814453125, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000001495": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.13671875, "end_logit": -0.302001953125, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000001497": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.13671875, "end_logit": -0.29345703125, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000001506": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.7265625, "end_logit": -0.418212890625, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000001509": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001919237453341115 }, { "start_logit": 6.6953125, "end_logit": -0.4423828125, "text": "", "probability": 0.998080762546659 } ], "100000000000000000001511": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030396496140834887 }, { "start_logit": 5.99609375, "end_logit": -0.2012939453125, "text": "", "probability": 0.9969603503859165 } ], "100000000000000000001515": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029579027682491575 }, { "start_logit": 5.9765625, "end_logit": -0.1578369140625, "text": "", "probability": 0.997042097231751 } ], "100000000000000000001517": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999606622 }, { "start_logit": -32.5625, "end_logit": 10.9140625, "text": "", "probability": 3.9337805266108655e-10 } ], "100000000000000000001519": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999746016 }, { "start_logit": -32.3125, "end_logit": 10.2265625, "text": "", "probability": 2.539839600651081e-10 } ], "100000000000000000001521": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00511967623806183 }, { "start_logit": 5.12890625, "end_logit": 0.1424560546875, "text": "", "probability": 0.9948803237619381 } ], "100000000000000000001525": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00506033203196621 }, { "start_logit": 5.1171875, "end_logit": 0.1654052734375, "text": "", "probability": 0.9949396679680339 } ], "100000000000000000001526": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026939142019792367 }, { "start_logit": 6.44140625, "end_logit": -0.525390625, "text": "", "probability": 0.9973060857980207 } ], "100000000000000000001527": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027791905585136147 }, { "start_logit": 6.46484375, "end_logit": -0.58154296875, "text": "", "probability": 0.9972208094414864 } ], "100000000000000000001529": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027791905585136147 }, { "start_logit": 6.4375, "end_logit": -0.55322265625, "text": "", "probability": 0.9972208094414864 } ], "100000000000000000001534": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999987101631 }, { "start_logit": -33.15625, "end_logit": 12.6953125, "text": "", "probability": 1.289836976596949e-09 } ], "100000000000000000001547": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 7.140625, "end_logit": -0.814453125, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000001554": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024919678536153497 }, { "start_logit": 7.234375, "end_logit": -1.244140625, "text": "", "probability": 0.9975080321463846 } ], "100000000000000000001555": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025212683210456455 }, { "start_logit": 7.234375, "end_logit": -1.25390625, "text": "", "probability": 0.9974787316789544 } ], "100000000000000000001561": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002822832897761561 }, { "start_logit": 7.12890625, "end_logit": -1.26171875, "text": "", "probability": 0.9971771671022386 } ], "100000000000000000001562": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -34.65625, "end_logit": 16.15625, "text": "", "probability": 0.0 } ], "100000000000000000001571": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -38.25, "end_logit": 24.9375, "text": "", "probability": 0.0 } ], "100000000000000000001572": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -34.59375, "end_logit": 16.28125, "text": "", "probability": 0.0 } ], "100000000000000000001576": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -33.90625, "end_logit": 16.328125, "text": "", "probability": 0.0 } ], "100000000000000000001578": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -34.4375, "end_logit": 16.3125, "text": "", "probability": 0.0 } ], "100000000000000000001579": [ { "start_logit": 17.8125, "end_logit": 9.234375, "text": " three", "probability": 0.238525390625 }, { "start_logit": 16.9375, "end_logit": 9.234375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three", "probability": 0.09942626953125 }, { "start_logit": 16.9375, "end_logit": 9.0703125, "text": " two", "probability": 0.083740234375 }, { "start_logit": 17.8125, "end_logit": 8.171875, "text": " three-dose series", "probability": 0.08245849609375 }, { "start_logit": 16.65625, "end_logit": 9.234375, "text": " 6 months\nthrough 17 years\na three", "probability": 0.0750732421875 }, { "start_logit": 17.8125, "end_logit": 8.03125, "text": " three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0716552734375 }, { "start_logit": 16.9375, "end_logit": 8.609375, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months", "probability": 0.053253173828125 }, { "start_logit": 16.65625, "end_logit": 8.609375, "text": " 6 months", "probability": 0.040191650390625 }, { "start_logit": 16.9375, "end_logit": 8.3046875, "text": " two-dose series", "probability": 0.03955078125 }, { "start_logit": 16.9375, "end_logit": 8.171875, "text": " two-dose series using the age-appropriate Moderna COVID-19 Vaccine product for children ages 6 months\nthrough 17 years\na three-dose series", "probability": 0.03436279296875 }, { "start_logit": 16.65625, "end_logit": 8.171875, "text": " 6 months\nthrough 17 years\na three-dose series", "probability": 0.0259552001953125 }, { "start_logit": 17.8125, "end_logit": 6.921875, "text": " three-dose", "probability": 0.02362060546875 }, { "start_logit": 16.65625, "end_logit": 8.03125, "text": " 6 months\nthrough 17 years\na three-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.0225372314453125 }, { "start_logit": 16.296875, "end_logit": 8.1875, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna", "probability": 0.0183868408203125 }, { "start_logit": 16.296875, "end_logit": 8.1015625, "text": " 6/23/22 update also adds availability of age-appropriate\nModerna COVID-19 Vaccine for 6 years through 17 years of age", "probability": 0.0170135498046875 }, { "start_logit": 16.28125, "end_logit": 8.1015625, "text": " 6 years through 17 years of age", "probability": 0.0164947509765625 }, { "start_logit": 16.515625, "end_logit": 7.81640625, "text": " two", "probability": 0.0157470703125 }, { "start_logit": 16.078125, "end_logit": 8.1875, "text": "Moderna", "probability": 0.01477813720703125 }, { "start_logit": 16.9375, "end_logit": 7.2578125, "text": " two-dose series using the age-appropriate Moderna", "probability": 0.013671875 }, { "start_logit": 16.515625, "end_logit": 7.671875, "text": " two-dose series using the age-appropriate Pfizer-BioNTech", "probability": 0.013671875 }, { "start_logit": -34.40625, "end_logit": 16.3125, "text": "", "probability": 0.0 } ], "100000000000000000001587": [ { "start_logit": 14.4921875, "end_logit": 7.51953125, "text": "9/1/22", "probability": 0.1507568359375 }, { "start_logit": 14.5234375, "end_logit": 6.93359375, "text": " COVID-19 vaccine", "probability": 0.0859375 }, { "start_logit": 14.4921875, "end_logit": 6.93359375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.083251953125 }, { "start_logit": 14.5234375, "end_logit": 6.83984375, "text": " COVID-19 vaccine booster", "probability": 0.07818603515625 }, { "start_logit": 14.5234375, "end_logit": 6.83203125, "text": " COVID-19", "probability": 0.07818603515625 }, { "start_logit": 14.4921875, "end_logit": 6.83984375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.0758056640625 }, { "start_logit": 14.4921875, "end_logit": 6.83203125, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.0758056640625 }, { "start_logit": 14.4921875, "end_logit": 6.546875, "text": "9/1/22 Update (Revises 2", "probability": 0.056365966796875 }, { "start_logit": 14.4921875, "end_logit": 6.453125, "text": "9/1/", "probability": 0.051300048828125 }, { "start_logit": 14.4921875, "end_logit": 6.046875, "text": "9/1/22 Update (Revises", "probability": 0.0341796875 }, { "start_logit": 12.9765625, "end_logit": 7.51953125, "text": "1/22", "probability": 0.03314208984375 }, { "start_logit": 14.4921875, "end_logit": 5.96875, "text": "9/", "probability": 0.0321044921875 }, { "start_logit": 13.2265625, "end_logit": 6.93359375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0234832763671875 }, { "start_logit": 13.1875, "end_logit": 6.93359375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.02276611328125 }, { "start_logit": 13.2265625, "end_logit": 6.83984375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.021392822265625 }, { "start_logit": 13.2265625, "end_logit": 6.83203125, "text": " 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.021392822265625 }, { "start_logit": 13.1875, "end_logit": 6.83984375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.020721435546875 }, { "start_logit": 13.1875, "end_logit": 6.83203125, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.020416259765625 }, { "start_logit": 12.9765625, "end_logit": 6.93359375, "text": "1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0182952880859375 }, { "start_logit": 12.9765625, "end_logit": 6.83984375, "text": "1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.01666259765625 }, { "start_logit": 7.5234375, "end_logit": -0.82177734375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001588": [ { "start_logit": 14.4921875, "end_logit": 7.51953125, "text": "9/1/22", "probability": 0.1435546875 }, { "start_logit": 14.5234375, "end_logit": 6.93359375, "text": " COVID-19 vaccine", "probability": 0.081787109375 }, { "start_logit": 14.4921875, "end_logit": 6.93359375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0792236328125 }, { "start_logit": 14.5234375, "end_logit": 6.83984375, "text": " COVID-19 vaccine booster", "probability": 0.07440185546875 }, { "start_logit": 14.5234375, "end_logit": 6.83203125, "text": " COVID-19", "probability": 0.07440185546875 }, { "start_logit": 14.4921875, "end_logit": 6.83984375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.0721435546875 }, { "start_logit": 14.4921875, "end_logit": 6.83203125, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.0721435546875 }, { "start_logit": 14.4921875, "end_logit": 6.546875, "text": "9/1/22 Update (Revises 2", "probability": 0.05364990234375 }, { "start_logit": 14.4921875, "end_logit": 6.453125, "text": "9/1/", "probability": 0.048828125 }, { "start_logit": 14.5234375, "end_logit": 6.32421875, "text": " COVID-19 vaccine booster doses):\nThird primary dose/booster dose COVID-19", "probability": 0.044464111328125 }, { "start_logit": 14.28125, "end_logit": 6.32421875, "text": "\nThird primary dose/booster dose COVID-19", "probability": 0.035186767578125 }, { "start_logit": 14.4921875, "end_logit": 6.046875, "text": "9/1/22 Update (Revises", "probability": 0.03253173828125 }, { "start_logit": 12.9765625, "end_logit": 7.51953125, "text": "1/22", "probability": 0.031524658203125 }, { "start_logit": 14.4921875, "end_logit": 5.96875, "text": "9/", "probability": 0.030548095703125 }, { "start_logit": 13.2265625, "end_logit": 6.93359375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0223541259765625 }, { "start_logit": 13.1875, "end_logit": 6.93359375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.02166748046875 }, { "start_logit": 14.5234375, "end_logit": 5.56640625, "text": " COVID-19 vaccine booster doses):\nThird primary dose/booster dose COVID-19 vaccination", "probability": 0.02099609375 }, { "start_logit": 13.2265625, "end_logit": 6.83984375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.020355224609375 }, { "start_logit": 13.2265625, "end_logit": 6.83203125, "text": " 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.020355224609375 }, { "start_logit": 13.1875, "end_logit": 6.83984375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.0197296142578125 }, { "start_logit": 7.59375, "end_logit": -0.83349609375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001589": [ { "start_logit": 14.4921875, "end_logit": 7.51953125, "text": "9/1/22", "probability": 0.175537109375 }, { "start_logit": 14.515625, "end_logit": 6.9375, "text": " COVID-19 vaccine", "probability": 0.10003662109375 }, { "start_logit": 14.4921875, "end_logit": 6.9375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0985107421875 }, { "start_logit": 14.515625, "end_logit": 6.828125, "text": " COVID-19", "probability": 0.08966064453125 }, { "start_logit": 14.4921875, "end_logit": 6.828125, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.0869140625 }, { "start_logit": 14.4921875, "end_logit": 6.546875, "text": "9/1/22 Update (Revises 2", "probability": 0.06561279296875 }, { "start_logit": 14.4921875, "end_logit": 6.453125, "text": "9/1/", "probability": 0.05975341796875 }, { "start_logit": 14.4921875, "end_logit": 6.046875, "text": "9/1/22 Update (Revises", "probability": 0.039794921875 }, { "start_logit": 12.9765625, "end_logit": 7.51953125, "text": "1/22", "probability": 0.03857421875 }, { "start_logit": 14.4921875, "end_logit": 5.96875, "text": "9/", "probability": 0.037384033203125 }, { "start_logit": 13.2265625, "end_logit": 6.9375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.02734375 }, { "start_logit": 13.1875, "end_logit": 6.9375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.026519775390625 }, { "start_logit": 13.2265625, "end_logit": 6.828125, "text": " 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.02490234375 }, { "start_logit": 13.1875, "end_logit": 6.828125, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.023773193359375 }, { "start_logit": 12.9765625, "end_logit": 6.9375, "text": "1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.02130126953125 }, { "start_logit": 12.9765625, "end_logit": 6.828125, "text": "1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.0193939208984375 }, { "start_logit": 13.2265625, "end_logit": 6.546875, "text": " 2", "probability": 0.018798828125 }, { "start_logit": 13.1875, "end_logit": 6.546875, "text": "Revises 2", "probability": 0.0179443359375 }, { "start_logit": 12.9765625, "end_logit": 6.546875, "text": "1/22 Update (Revises 2", "probability": 0.01464080810546875 }, { "start_logit": 12.9765625, "end_logit": 6.453125, "text": "1/", "probability": 0.01332855224609375 }, { "start_logit": 7.41015625, "end_logit": -0.8623046875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001591": [ { "start_logit": 14.4921875, "end_logit": 7.51953125, "text": "9/1/22", "probability": 0.1439208984375 }, { "start_logit": 14.515625, "end_logit": 6.93359375, "text": " COVID-19 vaccine", "probability": 0.08197021484375 }, { "start_logit": 14.4921875, "end_logit": 6.93359375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0794677734375 }, { "start_logit": 14.515625, "end_logit": 6.83984375, "text": " COVID-19 vaccine booster", "probability": 0.07464599609375 }, { "start_logit": 14.515625, "end_logit": 6.828125, "text": " COVID-19", "probability": 0.073486328125 }, { "start_logit": 14.4921875, "end_logit": 6.83984375, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.0723876953125 }, { "start_logit": 14.4921875, "end_logit": 6.828125, "text": "9/1/22 Update (Revises 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.07122802734375 }, { "start_logit": 14.4921875, "end_logit": 6.546875, "text": "9/1/22 Update (Revises 2", "probability": 0.053802490234375 }, { "start_logit": 14.4921875, "end_logit": 6.453125, "text": "9/1/", "probability": 0.048980712890625 }, { "start_logit": 14.515625, "end_logit": 6.328125, "text": " COVID-19 vaccine booster doses):\nThird primary dose/booster dose COVID-19", "probability": 0.044586181640625 }, { "start_logit": 14.28125, "end_logit": 6.328125, "text": "\nThird primary dose/booster dose COVID-19", "probability": 0.0352783203125 }, { "start_logit": 14.4921875, "end_logit": 6.0390625, "text": "9/1/22 Update (Revises", "probability": 0.032623291015625 }, { "start_logit": 12.9765625, "end_logit": 7.51953125, "text": "1/22", "probability": 0.0316162109375 }, { "start_logit": 14.4921875, "end_logit": 5.96875, "text": "9/", "probability": 0.0306396484375 }, { "start_logit": 13.2265625, "end_logit": 6.93359375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.0224151611328125 }, { "start_logit": 13.1875, "end_logit": 6.93359375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine", "probability": 0.021728515625 }, { "start_logit": 14.515625, "end_logit": 5.5625, "text": " COVID-19 vaccine booster doses):\nThird primary dose/booster dose COVID-19 vaccination", "probability": 0.020721435546875 }, { "start_logit": 13.2265625, "end_logit": 6.83984375, "text": " 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.020416259765625 }, { "start_logit": 13.2265625, "end_logit": 6.828125, "text": " 2/11/22 Update to add reference to bivalent COVID-19", "probability": 0.020416259765625 }, { "start_logit": 13.1875, "end_logit": 6.83984375, "text": "Revises 2/11/22 Update to add reference to bivalent COVID-19 vaccine booster", "probability": 0.019775390625 }, { "start_logit": 7.60546875, "end_logit": -0.91259765625, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001598": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.76953125, "end_logit": -0.372314453125, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000001604": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00202690008046383 }, { "start_logit": 7.0, "end_logit": -0.80029296875, "text": "", "probability": 0.9979730999195362 } ], "100000000000000000001605": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002511463513809854 }, { "start_logit": 6.7890625, "end_logit": -0.80615234375, "text": "", "probability": 0.9974885364861902 } ], "100000000000000000001608": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 6.74609375, "end_logit": -0.71533203125, "text": "", "probability": 0.997603269129871 } ], "100000000000000000001612": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016941031558503918 }, { "start_logit": 6.921875, "end_logit": -0.54248046875, "text": "", "probability": 0.9983058968441496 } ], "100000000000000000001617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.0234375, "end_logit": -0.283203125, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000001620": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.0234375, "end_logit": -0.32958984375, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000001628": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 6.921875, "end_logit": -0.669921875, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000001629": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002305125202793809 }, { "start_logit": 6.609375, "end_logit": -0.5390625, "text": "", "probability": 0.9976948747972061 } ], "100000000000000000001630": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001980039959665187 }, { "start_logit": 6.71875, "end_logit": -0.49609375, "text": "", "probability": 0.9980199600403347 } ], "100000000000000000001633": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018969200744787132 }, { "start_logit": 6.83203125, "end_logit": -0.56689453125, "text": "", "probability": 0.9981030799255213 } ], "100000000000000000001634": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.3515625, "end_logit": -0.59326171875, "text": "", "probability": 0.99883958037482 } ], "100000000000000000001644": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 6.84375, "end_logit": -0.136962890625, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000001646": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030873693457091405 }, { "start_logit": 5.98046875, "end_logit": -0.2025146484375, "text": "", "probability": 0.9969126306542909 } ], "100000000000000000001647": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002768385516913781 }, { "start_logit": 6.01171875, "end_logit": -0.12359619140625, "text": "", "probability": 0.9972316144830862 } ], "100000000000000000001648": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 6.1640625, "end_logit": -0.2012939453125, "text": "", "probability": 0.997429131960124 } ], "100000000000000000001652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002889581017773627 }, { "start_logit": 5.5078125, "end_logit": 0.3349609375, "text": "", "probability": 0.9971104189822263 } ], "100000000000000000001654": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0031603528150713385 }, { "start_logit": 5.46875, "end_logit": 0.283447265625, "text": "", "probability": 0.9968396471849287 } ], "100000000000000000001655": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003446431746378948 }, { "start_logit": 8.0078125, "end_logit": -0.0343017578125, "text": "", "probability": 0.999655356825362 } ], "100000000000000000001657": [ { "start_logit": 17.453125, "end_logit": 6.703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.31640625 }, { "start_logit": 17.453125, "end_logit": 6.60546875, "text": "Medicare or Medicaid", "probability": 0.2880859375 }, { "start_logit": 16.15625, "end_logit": 6.546875, "text": " balance billing", "probability": 0.07403564453125 }, { "start_logit": 15.6953125, "end_logit": 6.60546875, "text": " COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.049285888671875 }, { "start_logit": 17.453125, "end_logit": 4.47265625, "text": "Medicare or Medica", "probability": 0.03387451171875 }, { "start_logit": 15.6953125, "end_logit": 5.95703125, "text": " COVID-19 Vaccine administration fees", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.703125, "text": " Medicaid reimbursement", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.60546875, "text": " Medicaid", "probability": 0.0236663818359375 }, { "start_logit": 16.15625, "end_logit": 5.37890625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees", "probability": 0.022918701171875 }, { "start_logit": 15.1484375, "end_logit": 6.32421875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0215301513671875 }, { "start_logit": 14.953125, "end_logit": 6.32421875, "text": "may seek appropriate reimbursement", "probability": 0.017852783203125 }, { "start_logit": 15.1484375, "end_logit": 5.95703125, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01503753662109375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.01412200927734375 }, { "start_logit": 16.203125, "end_logit": 4.7265625, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC", "probability": 0.01265716552734375 }, { "start_logit": 14.953125, "end_logit": 5.95703125, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01227569580078125 }, { "start_logit": 16.203125, "end_logit": 4.54296875, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19", "probability": 0.010498046875 }, { "start_logit": 16.15625, "end_logit": 4.50390625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement", "probability": 0.009552001953125 }, { "start_logit": 13.875, "end_logit": 6.703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.0088348388671875 }, { "start_logit": 16.15625, "end_logit": 4.41015625, "text": " balance bill", "probability": 0.008697509765625 }, { "start_logit": 14.2421875, "end_logit": 6.32421875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.008697509765625 }, { "start_logit": 9.2890625, "end_logit": -1.068359375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001659": [ { "start_logit": 17.453125, "end_logit": 6.703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.31640625 }, { "start_logit": 17.453125, "end_logit": 6.60546875, "text": "Medicare or Medicaid", "probability": 0.2880859375 }, { "start_logit": 16.15625, "end_logit": 6.546875, "text": " balance billing", "probability": 0.07403564453125 }, { "start_logit": 15.6953125, "end_logit": 6.60546875, "text": " COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.049285888671875 }, { "start_logit": 17.453125, "end_logit": 4.47265625, "text": "Medicare or Medica", "probability": 0.03387451171875 }, { "start_logit": 15.6953125, "end_logit": 5.95703125, "text": " COVID-19 Vaccine administration fees", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.703125, "text": " Medicaid reimbursement", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.60546875, "text": " Medicaid", "probability": 0.0236663818359375 }, { "start_logit": 16.15625, "end_logit": 5.37890625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees", "probability": 0.022918701171875 }, { "start_logit": 15.1484375, "end_logit": 6.32421875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0215301513671875 }, { "start_logit": 14.953125, "end_logit": 6.32421875, "text": "may seek appropriate reimbursement", "probability": 0.017852783203125 }, { "start_logit": 15.1484375, "end_logit": 5.95703125, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01503753662109375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.01412200927734375 }, { "start_logit": 16.203125, "end_logit": 4.7265625, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC", "probability": 0.01265716552734375 }, { "start_logit": 14.953125, "end_logit": 5.95703125, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01227569580078125 }, { "start_logit": 16.203125, "end_logit": 4.54296875, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19", "probability": 0.010498046875 }, { "start_logit": 16.15625, "end_logit": 4.50390625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement", "probability": 0.009552001953125 }, { "start_logit": 13.875, "end_logit": 6.703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.0088348388671875 }, { "start_logit": 16.15625, "end_logit": 4.41015625, "text": " balance bill", "probability": 0.008697509765625 }, { "start_logit": 14.2421875, "end_logit": 6.32421875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.008697509765625 }, { "start_logit": 9.2734375, "end_logit": -1.10546875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001663": [ { "start_logit": 17.453125, "end_logit": 6.69921875, "text": "Medicare or Medicaid reimbursement", "probability": 0.3154296875 }, { "start_logit": 17.453125, "end_logit": 6.6015625, "text": "Medicare or Medicaid", "probability": 0.287353515625 }, { "start_logit": 16.15625, "end_logit": 6.56640625, "text": " balance billing", "probability": 0.074951171875 }, { "start_logit": 15.7109375, "end_logit": 6.6015625, "text": " COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.049896240234375 }, { "start_logit": 17.453125, "end_logit": 4.4765625, "text": "Medicare or Medica", "probability": 0.0343017578125 }, { "start_logit": 15.7109375, "end_logit": 5.95703125, "text": " COVID-19 Vaccine administration fees", "probability": 0.02630615234375 }, { "start_logit": 14.9609375, "end_logit": 6.69921875, "text": " Medicaid reimbursement", "probability": 0.0258941650390625 }, { "start_logit": 14.9609375, "end_logit": 6.6015625, "text": " Medicaid", "probability": 0.023590087890625 }, { "start_logit": 16.15625, "end_logit": 5.38671875, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees", "probability": 0.023223876953125 }, { "start_logit": 15.140625, "end_logit": 6.32421875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0214691162109375 }, { "start_logit": 14.9453125, "end_logit": 6.32421875, "text": "may seek appropriate reimbursement", "probability": 0.01751708984375 }, { "start_logit": 15.140625, "end_logit": 5.95703125, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.0147552490234375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.01407623291015625 }, { "start_logit": 16.203125, "end_logit": 4.7265625, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC", "probability": 0.0126190185546875 }, { "start_logit": 14.9453125, "end_logit": 5.95703125, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.012237548828125 }, { "start_logit": 16.203125, "end_logit": 4.55859375, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19", "probability": 0.01062774658203125 }, { "start_logit": 16.15625, "end_logit": 4.51171875, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement", "probability": 0.009674072265625 }, { "start_logit": 16.15625, "end_logit": 4.4140625, "text": " balance bill", "probability": 0.00867462158203125 }, { "start_logit": 13.8671875, "end_logit": 6.69921875, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.00867462158203125 }, { "start_logit": 14.2265625, "end_logit": 6.32421875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.00853729248046875 }, { "start_logit": 9.2734375, "end_logit": -1.0908203125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001664": [ { "start_logit": 17.453125, "end_logit": 6.69921875, "text": "Medicare or Medicaid reimbursement", "probability": 0.3154296875 }, { "start_logit": 17.453125, "end_logit": 6.6015625, "text": "Medicare or Medicaid", "probability": 0.287353515625 }, { "start_logit": 16.15625, "end_logit": 6.56640625, "text": " balance billing", "probability": 0.074951171875 }, { "start_logit": 15.7109375, "end_logit": 6.6015625, "text": " COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.049896240234375 }, { "start_logit": 17.453125, "end_logit": 4.4765625, "text": "Medicare or Medica", "probability": 0.0343017578125 }, { "start_logit": 15.7109375, "end_logit": 5.95703125, "text": " COVID-19 Vaccine administration fees", "probability": 0.02630615234375 }, { "start_logit": 14.9609375, "end_logit": 6.69921875, "text": " Medicaid reimbursement", "probability": 0.0258941650390625 }, { "start_logit": 14.9609375, "end_logit": 6.6015625, "text": " Medicaid", "probability": 0.023590087890625 }, { "start_logit": 16.15625, "end_logit": 5.38671875, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees", "probability": 0.023223876953125 }, { "start_logit": 15.140625, "end_logit": 6.32421875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0214691162109375 }, { "start_logit": 14.9453125, "end_logit": 6.32421875, "text": "may seek appropriate reimbursement", "probability": 0.01751708984375 }, { "start_logit": 15.140625, "end_logit": 5.95703125, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.0147552490234375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.01407623291015625 }, { "start_logit": 16.203125, "end_logit": 4.7265625, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC", "probability": 0.0126190185546875 }, { "start_logit": 14.9453125, "end_logit": 5.95703125, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.012237548828125 }, { "start_logit": 16.203125, "end_logit": 4.55859375, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19", "probability": 0.01062774658203125 }, { "start_logit": 16.15625, "end_logit": 4.51171875, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement", "probability": 0.009674072265625 }, { "start_logit": 16.15625, "end_logit": 4.4140625, "text": " balance bill", "probability": 0.00867462158203125 }, { "start_logit": 13.8671875, "end_logit": 6.69921875, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.00867462158203125 }, { "start_logit": 14.2265625, "end_logit": 6.32421875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.00853729248046875 }, { "start_logit": 9.234375, "end_logit": -1.12109375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001665": [ { "start_logit": 17.453125, "end_logit": 6.703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.31640625 }, { "start_logit": 17.453125, "end_logit": 6.60546875, "text": "Medicare or Medicaid", "probability": 0.2880859375 }, { "start_logit": 16.15625, "end_logit": 6.546875, "text": " balance billing", "probability": 0.07403564453125 }, { "start_logit": 15.6953125, "end_logit": 6.60546875, "text": " COVID-19 Vaccine administration fees for\nthe vaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.049285888671875 }, { "start_logit": 17.453125, "end_logit": 4.47265625, "text": "Medicare or Medica", "probability": 0.03387451171875 }, { "start_logit": 15.6953125, "end_logit": 5.95703125, "text": " COVID-19 Vaccine administration fees", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.703125, "text": " Medicaid reimbursement", "probability": 0.025970458984375 }, { "start_logit": 14.9609375, "end_logit": 6.60546875, "text": " Medicaid", "probability": 0.0236663818359375 }, { "start_logit": 16.15625, "end_logit": 5.37890625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement of COVID-19 vaccine administration fees", "probability": 0.022918701171875 }, { "start_logit": 15.1484375, "end_logit": 6.32421875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0215301513671875 }, { "start_logit": 14.953125, "end_logit": 6.32421875, "text": "may seek appropriate reimbursement", "probability": 0.017852783203125 }, { "start_logit": 15.1484375, "end_logit": 5.95703125, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01503753662109375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.01412200927734375 }, { "start_logit": 16.203125, "end_logit": 4.7265625, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC", "probability": 0.01265716552734375 }, { "start_logit": 14.953125, "end_logit": 5.95703125, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01227569580078125 }, { "start_logit": 16.203125, "end_logit": 4.54296875, "text": "COVID-19 Vaccine Administration Fees (updated 4/8/2022)\nAll organizations and providers participating in the CDC COVID-19", "probability": 0.010498046875 }, { "start_logit": 16.15625, "end_logit": 4.50390625, "text": " balance billing, from the vaccine recipient\nFor additional information on filing claims for reimbursement", "probability": 0.009552001953125 }, { "start_logit": 13.875, "end_logit": 6.703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.0088348388671875 }, { "start_logit": 16.15625, "end_logit": 4.41015625, "text": " balance bill", "probability": 0.008697509765625 }, { "start_logit": 14.2421875, "end_logit": 6.32421875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.008697509765625 }, { "start_logit": 9.328125, "end_logit": -1.095703125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000001673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000914613686670093 }, { "start_logit": 7.6875, "end_logit": -0.69091796875, "text": "", "probability": 0.99908538631333 } ], "100000000000000000001678": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.6875, "end_logit": -0.67822265625, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000001680": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0001214817528055836 }, { "start_logit": 8.125, "end_logit": 0.89306640625, "text": "", "probability": 0.9998785182471945 } ], "100000000000000000001681": [ { "start_logit": 17.125, "end_logit": 7.83984375, "text": " July 2021", "probability": 0.248779296875 }, { "start_logit": 16.359375, "end_logit": 7.765625, "text": " June 2021", "probability": 0.10699462890625 }, { "start_logit": 16.34375, "end_logit": 7.765625, "text": " 2021", "probability": 0.1053466796875 }, { "start_logit": 16.046875, "end_logit": 7.83984375, "text": " 2021", "probability": 0.08465576171875 }, { "start_logit": 16.296875, "end_logit": 7.4765625, "text": " 2021", "probability": 0.07586669921875 }, { "start_logit": 15.9453125, "end_logit": 7.4765625, "text": " February 2021", "probability": 0.052978515625 }, { "start_logit": 16.359375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.041900634765625 }, { "start_logit": 16.34375, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.040618896484375 }, { "start_logit": 16.203125, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.03582763671875 }, { "start_logit": 15.1640625, "end_logit": 7.83984375, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.03472900390625 }, { "start_logit": 17.125, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.03369140625 }, { "start_logit": 15.046875, "end_logit": 7.765625, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.02880859375 }, { "start_logit": 17.125, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0270538330078125 }, { "start_logit": 16.296875, "end_logit": 5.91796875, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.015899658203125 }, { "start_logit": 14.7265625, "end_logit": 7.4765625, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.015655517578125 }, { "start_logit": 16.046875, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.0114593505859375 }, { "start_logit": 15.9453125, "end_logit": 5.91796875, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.01110076904296875 }, { "start_logit": 16.203125, "end_logit": 5.51171875, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00965118408203125 }, { "start_logit": 15.46875, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00965118408203125 }, { "start_logit": 16.046875, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0092010498046875 }, { "start_logit": 9.09375, "end_logit": -0.6318359375, "text": "", "probability": 0.0 } ], "100000000000000000001683": [ { "start_logit": 17.140625, "end_logit": 7.82421875, "text": " July 2021", "probability": 0.251953125 }, { "start_logit": 16.34375, "end_logit": 7.75, "text": " June 2021", "probability": 0.10498046875 }, { "start_logit": 16.328125, "end_logit": 7.75, "text": " 2021", "probability": 0.1033935546875 }, { "start_logit": 16.03125, "end_logit": 7.82421875, "text": " 2021", "probability": 0.0831298828125 }, { "start_logit": 16.28125, "end_logit": 7.48046875, "text": " 2021", "probability": 0.07568359375 }, { "start_logit": 15.9453125, "end_logit": 7.48046875, "text": " February 2021", "probability": 0.05364990234375 }, { "start_logit": 16.34375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0411376953125 }, { "start_logit": 16.328125, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0411376953125 }, { "start_logit": 16.203125, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.036285400390625 }, { "start_logit": 15.171875, "end_logit": 7.82421875, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.035186767578125 }, { "start_logit": 17.140625, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.034637451171875 }, { "start_logit": 15.0390625, "end_logit": 7.75, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.02825927734375 }, { "start_logit": 17.140625, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.02783203125 }, { "start_logit": 14.71875, "end_logit": 7.48046875, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.0158538818359375 }, { "start_logit": 16.28125, "end_logit": 5.9140625, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.0156097412109375 }, { "start_logit": 16.03125, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.01142120361328125 }, { "start_logit": 15.9453125, "end_logit": 5.9140625, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.0112457275390625 }, { "start_logit": 16.203125, "end_logit": 5.51953125, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00977325439453125 }, { "start_logit": 15.4765625, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00977325439453125 }, { "start_logit": 16.03125, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.00917816162109375 }, { "start_logit": -34.0, "end_logit": 15.15625, "text": "", "probability": 0.0 } ], "100000000000000000001684": [ { "start_logit": 17.125, "end_logit": 7.83984375, "text": " July 2021", "probability": 0.248779296875 }, { "start_logit": 16.359375, "end_logit": 7.765625, "text": " June 2021", "probability": 0.10699462890625 }, { "start_logit": 16.34375, "end_logit": 7.765625, "text": " 2021", "probability": 0.1053466796875 }, { "start_logit": 16.046875, "end_logit": 7.83984375, "text": " 2021", "probability": 0.08465576171875 }, { "start_logit": 16.296875, "end_logit": 7.4765625, "text": " 2021", "probability": 0.07586669921875 }, { "start_logit": 15.9453125, "end_logit": 7.4765625, "text": " February 2021", "probability": 0.052978515625 }, { "start_logit": 16.359375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.041900634765625 }, { "start_logit": 16.34375, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.040618896484375 }, { "start_logit": 16.203125, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.03582763671875 }, { "start_logit": 15.1640625, "end_logit": 7.83984375, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.03472900390625 }, { "start_logit": 17.125, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.03369140625 }, { "start_logit": 15.046875, "end_logit": 7.765625, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.02880859375 }, { "start_logit": 17.125, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0270538330078125 }, { "start_logit": 16.296875, "end_logit": 5.91796875, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.015899658203125 }, { "start_logit": 14.7265625, "end_logit": 7.4765625, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.015655517578125 }, { "start_logit": 16.046875, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.0114593505859375 }, { "start_logit": 15.9453125, "end_logit": 5.91796875, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.01110076904296875 }, { "start_logit": 16.203125, "end_logit": 5.51171875, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00965118408203125 }, { "start_logit": 15.46875, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00965118408203125 }, { "start_logit": 16.046875, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0092010498046875 }, { "start_logit": 9.1796875, "end_logit": -0.57861328125, "text": "", "probability": 0.0 } ], "100000000000000000001687": [ { "start_logit": 17.140625, "end_logit": 7.82421875, "text": " July 2021", "probability": 0.250732421875 }, { "start_logit": 16.34375, "end_logit": 7.75, "text": " June 2021", "probability": 0.1044921875 }, { "start_logit": 16.328125, "end_logit": 7.75, "text": " 2021", "probability": 0.1029052734375 }, { "start_logit": 16.03125, "end_logit": 7.82421875, "text": " 2021", "probability": 0.08270263671875 }, { "start_logit": 16.28125, "end_logit": 7.48046875, "text": " 2021", "probability": 0.0753173828125 }, { "start_logit": 15.9453125, "end_logit": 7.48046875, "text": " February 2021", "probability": 0.053375244140625 }, { "start_logit": 16.34375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.040924072265625 }, { "start_logit": 16.328125, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.040924072265625 }, { "start_logit": 16.203125, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.036102294921875 }, { "start_logit": 15.171875, "end_logit": 7.82421875, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.035003662109375 }, { "start_logit": 17.140625, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.034454345703125 }, { "start_logit": 15.0390625, "end_logit": 7.75, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.0281219482421875 }, { "start_logit": 17.140625, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0276947021484375 }, { "start_logit": 14.71875, "end_logit": 7.48046875, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.015777587890625 }, { "start_logit": 16.28125, "end_logit": 5.9140625, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.015533447265625 }, { "start_logit": 16.03125, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.01136016845703125 }, { "start_logit": 15.9453125, "end_logit": 5.9140625, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.0111846923828125 }, { "start_logit": 16.203125, "end_logit": 5.51953125, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00972747802734375 }, { "start_logit": 15.4765625, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00972747802734375 }, { "start_logit": 16.03125, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.0091400146484375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "", "probability": 0.00496673583984375 } ], "100000000000000000001688": [ { "start_logit": 17.125, "end_logit": 7.83203125, "text": " July 2021", "probability": 0.24755859375 }, { "start_logit": 16.359375, "end_logit": 7.75390625, "text": " June 2021", "probability": 0.10650634765625 }, { "start_logit": 16.328125, "end_logit": 7.75390625, "text": " 2021", "probability": 0.1031494140625 }, { "start_logit": 16.046875, "end_logit": 7.83203125, "text": " 2021", "probability": 0.08428955078125 }, { "start_logit": 16.296875, "end_logit": 7.4765625, "text": " 2021", "probability": 0.07672119140625 }, { "start_logit": 15.9453125, "end_logit": 7.4765625, "text": " February 2021", "probability": 0.053558349609375 }, { "start_logit": 16.359375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.042327880859375 }, { "start_logit": 16.328125, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.041046142578125 }, { "start_logit": 16.21875, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.036224365234375 }, { "start_logit": 15.171875, "end_logit": 7.83203125, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.035125732421875 }, { "start_logit": 17.125, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.034027099609375 }, { "start_logit": 15.046875, "end_logit": 7.75390625, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.0286712646484375 }, { "start_logit": 17.125, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.02734375 }, { "start_logit": 16.296875, "end_logit": 5.91796875, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.016082763671875 }, { "start_logit": 14.7109375, "end_logit": 7.4765625, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.0155792236328125 }, { "start_logit": 16.046875, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.0115814208984375 }, { "start_logit": 15.9453125, "end_logit": 5.91796875, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.01122283935546875 }, { "start_logit": 16.203125, "end_logit": 5.515625, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00975799560546875 }, { "start_logit": 15.4765625, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00975799560546875 }, { "start_logit": 16.046875, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.00930023193359375 }, { "start_logit": 9.1015625, "end_logit": -0.57080078125, "text": "", "probability": 0.0 } ], "100000000000000000001689": [ { "start_logit": 17.140625, "end_logit": 7.82421875, "text": " July 2021", "probability": 0.251953125 }, { "start_logit": 16.34375, "end_logit": 7.75, "text": " June 2021", "probability": 0.10498046875 }, { "start_logit": 16.328125, "end_logit": 7.75, "text": " 2021", "probability": 0.1033935546875 }, { "start_logit": 16.03125, "end_logit": 7.82421875, "text": " 2021", "probability": 0.0831298828125 }, { "start_logit": 16.28125, "end_logit": 7.48046875, "text": " 2021", "probability": 0.07568359375 }, { "start_logit": 15.9453125, "end_logit": 7.48046875, "text": " February 2021", "probability": 0.05364990234375 }, { "start_logit": 16.34375, "end_logit": 6.8203125, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0411376953125 }, { "start_logit": 16.328125, "end_logit": 6.8203125, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0411376953125 }, { "start_logit": 16.203125, "end_logit": 6.8203125, "text": "The Advisory Committee on Immunization Practices", "probability": 0.036285400390625 }, { "start_logit": 15.171875, "end_logit": 7.82421875, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on\nImmunization Practices \u2014 United States, July 2021", "probability": 0.035186767578125 }, { "start_logit": 17.140625, "end_logit": 5.84765625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.034637451171875 }, { "start_logit": 15.0390625, "end_logit": 7.75, "text": " Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.02825927734375 }, { "start_logit": 17.140625, "end_logit": 5.625, "text": " July 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.02783203125 }, { "start_logit": 14.71875, "end_logit": 7.48046875, "text": " 2021\nInterim Recommendation for Use of Janssen COVID-19 Vaccine \u2014 United States, February 2021", "probability": 0.0158538818359375 }, { "start_logit": 16.28125, "end_logit": 5.9140625, "text": " 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.0156097412109375 }, { "start_logit": 16.03125, "end_logit": 5.84765625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee", "probability": 0.01142120361328125 }, { "start_logit": 15.9453125, "end_logit": 5.9140625, "text": " February 2021\nInterim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine, United States 2020", "probability": 0.0112457275390625 }, { "start_logit": 16.203125, "end_logit": 5.51953125, "text": "COVID-19 vaccination providers are required to\nimplement all recommendations of the ACIP, adopted by the CDC Director", "probability": 0.00977325439453125 }, { "start_logit": 15.4765625, "end_logit": 6.2421875, "text": " mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.00977325439453125 }, { "start_logit": 16.03125, "end_logit": 5.625, "text": " 2021\nUse of mRNA COVID-19 Vaccine After Reports of Myocarditis", "probability": 0.00917816162109375 }, { "start_logit": -34.4375, "end_logit": 15.6953125, "text": "", "probability": 0.0 } ], "100000000000000000001691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018969200744787132 }, { "start_logit": 7.3125, "end_logit": -1.0458984375, "text": "", "probability": 0.9981030799255213 } ], "100000000000000000001704": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046190583290238484 }, { "start_logit": 7.71484375, "end_logit": -0.037078857421875, "text": "", "probability": 0.9995380941670976 } ], "100000000000000000001710": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.24609375, "end_logit": -0.2763671875, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000001713": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.484375, "end_logit": -0.5771484375, "text": "", "probability": 0.99899949559909 } ], "100000000000000000001714": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010691263618290232 }, { "start_logit": 7.46484375, "end_logit": -0.62548828125, "text": "", "probability": 0.998930873638171 } ], "100000000000000000001716": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.43359375, "end_logit": -0.60791015625, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000001717": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.39453125, "end_logit": -0.61669921875, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000001719": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.46875, "end_logit": -0.6455078125, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000001721": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012399961359154668 }, { "start_logit": 7.1328125, "end_logit": -0.440185546875, "text": "", "probability": 0.9987600038640845 } ], "100000000000000000001722": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.171875, "end_logit": -0.468017578125, "text": "", "probability": 0.998774432551617 } ], "100000000000000000001727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.78515625, "end_logit": -0.67236328125, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000001731": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.703125, "end_logit": -0.54052734375, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000001733": [ { "start_logit": 20.0625, "end_logit": 11.0234375, "text": " life-threatening", "probability": 0.3203125 }, { "start_logit": 19.953125, "end_logit": 11.0234375, "text": "Death\nA life-threatening", "probability": 0.28271484375 }, { "start_logit": 19.953125, "end_logit": 9.8828125, "text": "Death", "probability": 0.09185791015625 }, { "start_logit": 20.0625, "end_logit": 9.0390625, "text": " life-threaten", "probability": 0.043365478515625 }, { "start_logit": 20.0625, "end_logit": 8.9296875, "text": " life", "probability": 0.03948974609375 }, { "start_logit": 19.953125, "end_logit": 9.0390625, "text": "Death\nA life-threaten", "probability": 0.03948974609375 }, { "start_logit": 17.9375, "end_logit": 11.0234375, "text": "\nDeath\nA life-threatening", "probability": 0.03826904296875 }, { "start_logit": 19.953125, "end_logit": 8.9296875, "text": "Death\nA life", "probability": 0.03485107421875 }, { "start_logit": 20.0625, "end_logit": 8.5390625, "text": " life-threatening AE", "probability": 0.02630615234375 }, { "start_logit": 19.953125, "end_logit": 8.5390625, "text": "Death\nA life-threatening AE", "probability": 0.023956298828125 }, { "start_logit": 16.984375, "end_logit": 11.0234375, "text": "Serious AEs per FDA are defined as:\nDeath\nA life-threatening", "probability": 0.01451873779296875 }, { "start_logit": 17.9375, "end_logit": 9.8828125, "text": "\nDeath", "probability": 0.0120391845703125 }, { "start_logit": 17.9375, "end_logit": 9.0390625, "text": "\nDeath\nA life-threaten", "probability": 0.005176544189453125 }, { "start_logit": 17.9375, "end_logit": 8.9296875, "text": "\nDeath\nA life", "probability": 0.0047149658203125 }, { "start_logit": 16.984375, "end_logit": 9.8828125, "text": "Serious AEs per FDA are defined as:\nDeath", "probability": 0.0047149658203125 }, { "start_logit": 20.0625, "end_logit": 6.71484375, "text": " life-threatening AE\nInpatient hospitalization or prolongation of existing hospitalization\nA persistent or significant incapacity or substantial disruption", "probability": 0.004291534423828125 }, { "start_logit": 20.0625, "end_logit": 6.57421875, "text": " life-th", "probability": 0.00373077392578125 }, { "start_logit": 20.0625, "end_logit": 6.54296875, "text": " life-thre", "probability": 0.0036144256591796875 }, { "start_logit": 19.953125, "end_logit": 6.57421875, "text": "Death\nA life-th", "probability": 0.0033435821533203125 }, { "start_logit": 19.953125, "end_logit": 6.54296875, "text": "Death\nA life-thre", "probability": 0.0032405853271484375 }, { "start_logit": 8.71875, "end_logit": -0.9580078125, "text": "", "probability": 0.0 } ], "100000000000000000001735": [ { "start_logit": 20.0625, "end_logit": 11.03125, "text": " life-threatening", "probability": 0.319091796875 }, { "start_logit": 19.953125, "end_logit": 11.03125, "text": "Death\nA life-threatening", "probability": 0.285888671875 }, { "start_logit": 19.953125, "end_logit": 9.8828125, "text": "Death", "probability": 0.0914306640625 }, { "start_logit": 20.0625, "end_logit": 9.0390625, "text": " life-threaten", "probability": 0.043182373046875 }, { "start_logit": 20.0625, "end_logit": 8.9296875, "text": " life", "probability": 0.039306640625 }, { "start_logit": 19.953125, "end_logit": 9.0390625, "text": "Death\nA life-threaten", "probability": 0.039306640625 }, { "start_logit": 17.9375, "end_logit": 11.03125, "text": "\nDeath\nA life-threatening", "probability": 0.038116455078125 }, { "start_logit": 19.953125, "end_logit": 8.9296875, "text": "Death\nA life", "probability": 0.034698486328125 }, { "start_logit": 20.0625, "end_logit": 8.5390625, "text": " life-threatening AE", "probability": 0.02618408203125 }, { "start_logit": 19.953125, "end_logit": 8.5390625, "text": "Death\nA life-threatening AE", "probability": 0.0238494873046875 }, { "start_logit": 16.984375, "end_logit": 11.03125, "text": "Serious AEs per FDA are defined as:\nDeath\nA life-threatening", "probability": 0.0146942138671875 }, { "start_logit": 17.9375, "end_logit": 9.8828125, "text": "\nDeath", "probability": 0.01198577880859375 }, { "start_logit": 17.9375, "end_logit": 9.0390625, "text": "\nDeath\nA life-threaten", "probability": 0.005153656005859375 }, { "start_logit": 17.9375, "end_logit": 8.9296875, "text": "\nDeath\nA life", "probability": 0.004695892333984375 }, { "start_logit": 16.984375, "end_logit": 9.8828125, "text": "Serious AEs per FDA are defined as:\nDeath", "probability": 0.004695892333984375 }, { "start_logit": 20.0625, "end_logit": 6.70703125, "text": " life-threatening AE\nInpatient hospitalization or prolongation of existing hospitalization\nA persistent or significant incapacity or substantial disruption", "probability": 0.004207611083984375 }, { "start_logit": 20.0625, "end_logit": 6.578125, "text": " life-th", "probability": 0.0037136077880859375 }, { "start_logit": 20.0625, "end_logit": 6.5390625, "text": " life-thre", "probability": 0.003543853759765625 }, { "start_logit": 19.953125, "end_logit": 6.578125, "text": "Death\nA life-th", "probability": 0.003330230712890625 }, { "start_logit": 19.953125, "end_logit": 6.5390625, "text": "Death\nA life-thre", "probability": 0.00322723388671875 }, { "start_logit": 8.4921875, "end_logit": -1.0107421875, "text": "", "probability": 0.0 } ], "100000000000000000001738": [ { "start_logit": 20.0625, "end_logit": 11.03125, "text": " life-threatening", "probability": 0.318603515625 }, { "start_logit": 19.953125, "end_logit": 11.03125, "text": "Death\nA life-threatening", "probability": 0.28564453125 }, { "start_logit": 19.953125, "end_logit": 9.8828125, "text": "Death", "probability": 0.09130859375 }, { "start_logit": 20.0625, "end_logit": 9.046875, "text": " life-threaten", "probability": 0.043792724609375 }, { "start_logit": 20.0625, "end_logit": 8.9296875, "text": " life", "probability": 0.039276123046875 }, { "start_logit": 19.953125, "end_logit": 9.046875, "text": "Death\nA life-threaten", "probability": 0.039276123046875 }, { "start_logit": 17.9375, "end_logit": 11.03125, "text": "\nDeath\nA life-threatening", "probability": 0.038055419921875 }, { "start_logit": 19.953125, "end_logit": 8.9296875, "text": "Death\nA life", "probability": 0.03466796875 }, { "start_logit": 20.0625, "end_logit": 8.5390625, "text": " life-threatening AE", "probability": 0.026153564453125 }, { "start_logit": 19.953125, "end_logit": 8.5390625, "text": "Death\nA life-threatening AE", "probability": 0.0238189697265625 }, { "start_logit": 16.984375, "end_logit": 11.03125, "text": "Serious AEs per FDA are defined as:\nDeath\nA life-threatening", "probability": 0.01467132568359375 }, { "start_logit": 17.9375, "end_logit": 9.8828125, "text": "\nDeath", "probability": 0.01197052001953125 }, { "start_logit": 17.9375, "end_logit": 9.046875, "text": "\nDeath\nA life-threaten", "probability": 0.005229949951171875 }, { "start_logit": 17.9375, "end_logit": 8.9296875, "text": "\nDeath\nA life", "probability": 0.004688262939453125 }, { "start_logit": 16.984375, "end_logit": 9.8828125, "text": "Serious AEs per FDA are defined as:\nDeath", "probability": 0.004688262939453125 }, { "start_logit": 20.0625, "end_logit": 6.71484375, "text": " life-threatening AE\nInpatient hospitalization or prolongation of existing hospitalization\nA persistent or significant incapacity or substantial disruption", "probability": 0.004268646240234375 }, { "start_logit": 20.0625, "end_logit": 6.57421875, "text": " life-th", "probability": 0.0037097930908203125 }, { "start_logit": 20.0625, "end_logit": 6.5390625, "text": " life-thre", "probability": 0.0035400390625 }, { "start_logit": 19.953125, "end_logit": 6.57421875, "text": "Death\nA life-th", "probability": 0.0033245086669921875 }, { "start_logit": 19.953125, "end_logit": 6.5390625, "text": "Death\nA life-thre", "probability": 0.003223419189453125 }, { "start_logit": 8.3828125, "end_logit": -1.0068359375, "text": "", "probability": 0.0 } ], "100000000000000000001743": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 6.8515625, "end_logit": -0.2408447265625, "text": "", "probability": 0.998654139598703 } ], "100000000000000000001745": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 6.8671875, "end_logit": -0.1488037109375, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000001748": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 6.91015625, "end_logit": -0.1568603515625, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000001751": [ { "start_logit": 15.0859375, "end_logit": 9.0703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.2200927734375 }, { "start_logit": 15.0859375, "end_logit": 8.9921875, "text": "Medicare or Medicaid", "probability": 0.20361328125 }, { "start_logit": 15.0859375, "end_logit": 8.984375, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement, including through balance billing", "probability": 0.200439453125 }, { "start_logit": 15.0859375, "end_logit": 8.3203125, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement", "probability": 0.10400390625 }, { "start_logit": 13.796875, "end_logit": 8.984375, "text": " balance billing", "probability": 0.0556640625 }, { "start_logit": 15.0859375, "end_logit": 6.9609375, "text": "Medicare or Medica", "probability": 0.026702880859375 }, { "start_logit": 15.0859375, "end_logit": 6.92578125, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement, including through balance bill", "probability": 0.02587890625 }, { "start_logit": 13.4609375, "end_logit": 8.2734375, "text": " COVID-19 Vaccine administration fees", "probability": 0.01953125 }, { "start_logit": 12.8984375, "end_logit": 8.7109375, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.017242431640625 }, { "start_logit": 15.0859375, "end_logit": 6.44140625, "text": "Medicare", "probability": 0.0159454345703125 }, { "start_logit": 12.40625, "end_logit": 9.0703125, "text": " Medicaid reimbursement", "probability": 0.01497650146484375 }, { "start_logit": 12.40625, "end_logit": 8.9921875, "text": " Medicaid", "probability": 0.014068603515625 }, { "start_logit": 12.40625, "end_logit": 8.984375, "text": " Medicaid reimbursement\nmay not seek any reimbursement, including through balance billing", "probability": 0.01385498046875 }, { "start_logit": 13.71875, "end_logit": 7.6640625, "text": " COVID-19 Vaccine at\nno out-of-pocket cost to the recipient\nmay not deny anyone vaccination based on the vaccine recipient\u2019s coverage", "probability": 0.01363372802734375 }, { "start_logit": 12.8984375, "end_logit": 8.2734375, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01113128662109375 }, { "start_logit": 12.3828125, "end_logit": 8.7109375, "text": "may seek appropriate reimbursement", "probability": 0.0102996826171875 }, { "start_logit": 11.875, "end_logit": 9.0703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.0088043212890625 }, { "start_logit": 12.2109375, "end_logit": 8.7109375, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.00867462158203125 }, { "start_logit": 11.875, "end_logit": 8.9921875, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.008270263671875 }, { "start_logit": 13.796875, "end_logit": 6.92578125, "text": " balance bill", "probability": 0.00707244873046875 }, { "start_logit": 6.80078125, "end_logit": -0.6953125, "text": "", "probability": 0.0 } ], "100000000000000000001753": [ { "start_logit": 15.09375, "end_logit": 9.0703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.30224609375 }, { "start_logit": 15.09375, "end_logit": 8.9921875, "text": "Medicare or Medicaid", "probability": 0.283935546875 }, { "start_logit": 15.09375, "end_logit": 8.3125, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement", "probability": 0.142822265625 }, { "start_logit": 15.09375, "end_logit": 6.9609375, "text": "Medicare or Medica", "probability": 0.0372314453125 }, { "start_logit": 13.453125, "end_logit": 8.2734375, "text": " COVID-19 Vaccine administration fees", "probability": 0.0264129638671875 }, { "start_logit": 12.8984375, "end_logit": 8.71875, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0240631103515625 }, { "start_logit": 15.09375, "end_logit": 6.4375, "text": "Medicare", "probability": 0.0218963623046875 }, { "start_logit": 12.3984375, "end_logit": 9.0703125, "text": " Medicaid reimbursement", "probability": 0.02056884765625 }, { "start_logit": 12.3984375, "end_logit": 8.9921875, "text": " Medicaid", "probability": 0.019012451171875 }, { "start_logit": 13.71875, "end_logit": 7.6640625, "text": " COVID-19 Vaccine at\nno out-of-pocket cost to the recipient\nmay not deny anyone vaccination based on the vaccine recipient\u2019s coverage", "probability": 0.0187225341796875 }, { "start_logit": 12.8984375, "end_logit": 8.2734375, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.01528167724609375 }, { "start_logit": 12.390625, "end_logit": 8.71875, "text": "may seek appropriate reimbursement", "probability": 0.0143585205078125 }, { "start_logit": 12.2109375, "end_logit": 8.71875, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.01209259033203125 }, { "start_logit": 11.8671875, "end_logit": 9.0703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.01209259033203125 }, { "start_logit": 11.8671875, "end_logit": 8.9921875, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.01117706298828125 }, { "start_logit": 12.3984375, "end_logit": 8.3125, "text": " Medicaid reimbursement\nmay not seek any reimbursement", "probability": 0.00971221923828125 }, { "start_logit": 12.390625, "end_logit": 8.2734375, "text": "may seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.009124755859375 }, { "start_logit": 13.453125, "end_logit": 6.9609375, "text": " COVID-19 Vaccine administration fees for the\nvaccine recipient, such as:\nvaccine recipient\u2019s private insurance company\nMedicare or Medica", "probability": 0.007106781005859375 }, { "start_logit": 13.71875, "end_logit": 6.6171875, "text": " COVID-19", "probability": 0.006679534912109375 }, { "start_logit": 11.8671875, "end_logit": 8.3125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement\nmay not seek any reimbursement", "probability": 0.005710601806640625 }, { "start_logit": 6.73828125, "end_logit": -0.6953125, "text": "", "probability": 0.0 } ], "100000000000000000001754": [ { "start_logit": 15.0859375, "end_logit": 9.0703125, "text": "Medicare or Medicaid reimbursement", "probability": 0.2203369140625 }, { "start_logit": 15.0859375, "end_logit": 8.9921875, "text": "Medicare or Medicaid", "probability": 0.2037353515625 }, { "start_logit": 15.0859375, "end_logit": 8.984375, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement, including through balance billing", "probability": 0.20068359375 }, { "start_logit": 15.0859375, "end_logit": 8.3203125, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement", "probability": 0.10406494140625 }, { "start_logit": 13.796875, "end_logit": 8.984375, "text": " balance billing", "probability": 0.05572509765625 }, { "start_logit": 15.0859375, "end_logit": 6.95703125, "text": "Medicare or Medica", "probability": 0.0267333984375 }, { "start_logit": 15.0859375, "end_logit": 6.9296875, "text": "Medicare or Medicaid reimbursement\nmay not seek any reimbursement, including through balance bill", "probability": 0.0258941650390625 }, { "start_logit": 13.453125, "end_logit": 8.2734375, "text": " COVID-19 Vaccine administration fees", "probability": 0.019256591796875 }, { "start_logit": 12.8984375, "end_logit": 8.7109375, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0172576904296875 }, { "start_logit": 15.0859375, "end_logit": 6.4375, "text": "Medicare", "probability": 0.015960693359375 }, { "start_logit": 12.3984375, "end_logit": 9.0703125, "text": " Medicaid reimbursement", "probability": 0.01499176025390625 }, { "start_logit": 12.3984375, "end_logit": 8.9921875, "text": " Medicaid", "probability": 0.01386260986328125 }, { "start_logit": 13.71875, "end_logit": 7.66015625, "text": " COVID-19 Vaccine at\nno out-of-pocket cost to the recipient\nmay not deny anyone vaccination based on the vaccine recipient\u2019s coverage", "probability": 0.01364898681640625 }, { "start_logit": 12.3984375, "end_logit": 8.984375, "text": " Medicaid reimbursement\nmay not seek any reimbursement, including through balance billing", "probability": 0.01364898681640625 }, { "start_logit": 12.8984375, "end_logit": 8.2734375, "text": " COVID-19 vaccination\nmay seek appropriate reimbursement from a program or plan that covers COVID-19 Vaccine administration fees", "probability": 0.011138916015625 }, { "start_logit": 12.3828125, "end_logit": 8.7109375, "text": "may seek appropriate reimbursement", "probability": 0.01030731201171875 }, { "start_logit": 11.875, "end_logit": 9.0703125, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid reimbursement", "probability": 0.00881195068359375 }, { "start_logit": 12.2109375, "end_logit": 8.7109375, "text": " COVID-19 vaccination is the sole medical service provided\nmay not require additional medical services to receive COVID-19 vaccination\nmay seek appropriate reimbursement", "probability": 0.0086822509765625 }, { "start_logit": 11.875, "end_logit": 8.9921875, "text": "\nvaccine recipient\u2019s private insurance company\nMedicare or Medicaid", "probability": 0.00827789306640625 }, { "start_logit": 13.796875, "end_logit": 6.9296875, "text": " balance bill", "probability": 0.007080078125 }, { "start_logit": 6.828125, "end_logit": -0.66015625, "text": "", "probability": 0.0 } ], "100000000000000000001760": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006142271998613951 }, { "start_logit": 7.4296875, "end_logit": -0.03656005859375, "text": "", "probability": 0.9993857728001386 } ], "100000000000000000001761": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006238938360910443 }, { "start_logit": 7.42578125, "end_logit": -0.04595947265625, "text": "", "probability": 0.9993761061639089 } ], "100000000000000000001769": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.39453125, "end_logit": -0.4140625, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000001772": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.5625, "end_logit": -0.002010345458984375, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000001783": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.29296875, "end_logit": -0.0672607421875, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000001784": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007236572645054245 }, { "start_logit": 7.28515625, "end_logit": -0.056396484375, "text": "", "probability": 0.9992763427354946 } ], "100000000000000000001786": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 6.984375, "end_logit": -0.455322265625, "text": "", "probability": 0.998539250425049 } ], "100000000000000000001787": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.078125, "end_logit": -0.462158203125, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000001789": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.03125, "end_logit": -0.2498779296875, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000001797": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 8.1953125, "end_logit": -1.3271484375, "text": "", "probability": 0.998959681497187 } ], "100000000000000000001803": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.15625, "end_logit": -0.52392578125, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000001810": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.03515625, "end_logit": -0.140869140625, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000001816": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 7.19140625, "end_logit": -0.58154296875, "text": "", "probability": 0.998654139598703 } ], "100000000000000000001818": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.2109375, "end_logit": -0.60791015625, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000001821": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 6.84375, "end_logit": -0.308837890625, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000001825": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 6.77734375, "end_logit": -0.272216796875, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000001827": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012793074828344202 }, { "start_logit": 7.859375, "end_logit": -1.19921875, "text": "", "probability": 0.9987206925171654 } ], "100000000000000000001833": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.921875, "end_logit": -0.478515625, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000001834": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 6.95703125, "end_logit": -0.443603515625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000001835": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 6.9140625, "end_logit": -0.440673828125, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000001839": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 6.85546875, "end_logit": -0.306640625, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000001841": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 6.875, "end_logit": -0.272216796875, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000001844": [ { "start_logit": 18.828125, "end_logit": 8.984375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "probability": 0.32080078125 }, { "start_logit": 17.984375, "end_logit": 9.1015625, "text": " Temple, TX", "probability": 0.1563720703125 }, { "start_logit": 17.984375, "end_logit": 8.2421875, "text": " Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest", "probability": 0.065185546875 }, { "start_logit": 17.640625, "end_logit": 8.5078125, "text": " Temple, TX", "probability": 0.06121826171875 }, { "start_logit": 16.765625, "end_logit": 9.3515625, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.059326171875 }, { "start_logit": 17.90625, "end_logit": 8.0546875, "text": " Portland, OR", "probability": 0.050750732421875 }, { "start_logit": 16.78125, "end_logit": 9.1015625, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nBaylor Scott and White Health, Temple, TX", "probability": 0.04620361328125 }, { "start_logit": 16.3125, "end_logit": 9.3515625, "text": "University of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.037139892578125 }, { "start_logit": 17.265625, "end_logit": 8.2421875, "text": "Kaiser Permanente Northwest", "probability": 0.031768798828125 }, { "start_logit": 17.265625, "end_logit": 8.0546875, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.026336669921875 }, { "start_logit": 18.828125, "end_logit": 6.4375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance (AZ", "probability": 0.025115966796875 }, { "start_logit": 17.90625, "end_logit": 7.16015625, "text": " Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.0205078125 }, { "start_logit": 17.640625, "end_logit": 7.265625, "text": " Temple, TX\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah", "probability": 0.017547607421875 }, { "start_logit": 17.640625, "end_logit": 7.25390625, "text": " Temple, TX\nUniversity of Arizona, Tucson", "probability": 0.01727294921875 }, { "start_logit": 17.09375, "end_logit": 7.6953125, "text": " Tucson", "probability": 0.01548004150390625 }, { "start_logit": 16.953125, "end_logit": 7.6953125, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nUniversity of Arizona, Tucson", "probability": 0.0136566162109375 }, { "start_logit": 17.265625, "end_logit": 7.16015625, "text": "Kaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.01081085205078125 }, { "start_logit": 17.09375, "end_logit": 7.0703125, "text": " Tucson, AZ\nMel and Enid Zuckerman College of Public Health, Tucson", "probability": 0.0082855224609375 }, { "start_logit": 16.96875, "end_logit": 7.16015625, "text": "St. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.00803375244140625 }, { "start_logit": 16.9375, "end_logit": 7.1953125, "text": "AZ Heroes) Study\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.00803375244140625 }, { "start_logit": -33.53125, "end_logit": 15.765625, "text": "", "probability": 0.0 } ], "100000000000000000001848": [ { "start_logit": 10.7890625, "end_logit": 22.546875, "text": "K", "probability": 0.748046875 }, { "start_logit": 13.2890625, "end_logit": 18.375, "text": " Portland, OR", "probability": 0.1383056640625 }, { "start_logit": 13.2890625, "end_logit": 17.15625, "text": " Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0408935546875 }, { "start_logit": 10.7890625, "end_logit": 18.375, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.01136016845703125 }, { "start_logit": 10.7265625, "end_logit": 18.375, "text": " Northwest, Portland, OR", "probability": 0.01067352294921875 }, { "start_logit": 10.7890625, "end_logit": 18.078125, "text": "Kaiser Permanente Northwest", "probability": 0.00856781005859375 }, { "start_logit": 10.7265625, "end_logit": 18.078125, "text": " Northwest", "probability": 0.00804901123046875 }, { "start_logit": 11.625, "end_logit": 17.15625, "text": " Tucson", "probability": 0.007808685302734375 }, { "start_logit": 11.4921875, "end_logit": 17.15625, "text": "St. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.00688934326171875 }, { "start_logit": 10.7890625, "end_logit": 17.15625, "text": "Kaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0033588409423828125 }, { "start_logit": 11.625, "end_logit": 16.296875, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah", "probability": 0.00330352783203125 }, { "start_logit": 10.7265625, "end_logit": 17.15625, "text": " Northwest, Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0031528472900390625 }, { "start_logit": 18.828125, "end_logit": 8.984375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "probability": 0.0029621124267578125 }, { "start_logit": 11.2578125, "end_logit": 16.21875, "text": "RVTN", "probability": 0.002101898193359375 }, { "start_logit": 17.984375, "end_logit": 9.1015625, "text": " Temple, TX", "probability": 0.0014438629150390625 }, { "start_logit": 18.171875, "end_logit": 8.359375, "text": "Kaiser Permanente Northwest", "probability": 0.0008225440979003906 }, { "start_logit": 18.171875, "end_logit": 8.109375, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.0006403923034667969 }, { "start_logit": 17.984375, "end_logit": 8.2421875, "text": " Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest", "probability": 0.0006022453308105469 }, { "start_logit": 17.640625, "end_logit": 8.5078125, "text": " Temple, TX", "probability": 0.0005655288696289062 }, { "start_logit": 16.765625, "end_logit": 9.3515625, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.0005483627319335938 }, { "start_logit": -30.9375, "end_logit": 15.8984375, "text": "", "probability": 0.0 } ], "100000000000000000001850": [ { "start_logit": 18.828125, "end_logit": 8.984375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "probability": 0.296875 }, { "start_logit": 17.984375, "end_logit": 9.1015625, "text": " Temple, TX", "probability": 0.1446533203125 }, { "start_logit": 18.171875, "end_logit": 8.359375, "text": "Kaiser Permanente Northwest", "probability": 0.0823974609375 }, { "start_logit": 17.984375, "end_logit": 8.2421875, "text": " Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest", "probability": 0.060302734375 }, { "start_logit": 17.640625, "end_logit": 8.5078125, "text": " Temple, TX", "probability": 0.056640625 }, { "start_logit": 16.765625, "end_logit": 9.3515625, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.054901123046875 }, { "start_logit": 17.90625, "end_logit": 8.0546875, "text": " Portland, OR", "probability": 0.046966552734375 }, { "start_logit": 16.78125, "end_logit": 9.1015625, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nBaylor Scott and White Health, Temple, TX", "probability": 0.042755126953125 }, { "start_logit": 16.3125, "end_logit": 9.3515625, "text": "University of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.03436279296875 }, { "start_logit": 17.265625, "end_logit": 8.2421875, "text": "Kaiser Permanente Northwest", "probability": 0.029388427734375 }, { "start_logit": 17.265625, "end_logit": 8.0546875, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.0243682861328125 }, { "start_logit": 18.828125, "end_logit": 6.4375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance (AZ", "probability": 0.0232391357421875 }, { "start_logit": 17.90625, "end_logit": 7.16015625, "text": " Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.0189666748046875 }, { "start_logit": 17.640625, "end_logit": 7.265625, "text": " Temple, TX\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah", "probability": 0.0162353515625 }, { "start_logit": 17.640625, "end_logit": 7.25390625, "text": " Temple, TX\nUniversity of Arizona, Tucson", "probability": 0.0159759521484375 }, { "start_logit": 17.09375, "end_logit": 7.6953125, "text": " Tucson", "probability": 0.01432037353515625 }, { "start_logit": 16.953125, "end_logit": 7.6953125, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nUniversity of Arizona, Tucson", "probability": 0.01263427734375 }, { "start_logit": 17.265625, "end_logit": 7.16015625, "text": "Kaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.01000213623046875 }, { "start_logit": 17.09375, "end_logit": 7.0703125, "text": " Tucson, AZ\nMel and Enid Zuckerman College of Public Health, Tucson", "probability": 0.00766754150390625 }, { "start_logit": 16.96875, "end_logit": 7.16015625, "text": "St. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.0074310302734375 }, { "start_logit": -34.5, "end_logit": 16.484375, "text": "", "probability": 0.0 } ], "100000000000000000001852": [ { "start_logit": 10.7890625, "end_logit": 22.546875, "text": "K", "probability": 0.748046875 }, { "start_logit": 13.2890625, "end_logit": 18.375, "text": " Portland, OR", "probability": 0.1383056640625 }, { "start_logit": 13.2890625, "end_logit": 17.15625, "text": " Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0408935546875 }, { "start_logit": 10.7890625, "end_logit": 18.375, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.01136016845703125 }, { "start_logit": 10.7265625, "end_logit": 18.375, "text": " Northwest, Portland, OR", "probability": 0.01067352294921875 }, { "start_logit": 10.7890625, "end_logit": 18.078125, "text": "Kaiser Permanente Northwest", "probability": 0.00856781005859375 }, { "start_logit": 10.7265625, "end_logit": 18.078125, "text": " Northwest", "probability": 0.00804901123046875 }, { "start_logit": 11.625, "end_logit": 17.15625, "text": " Tucson", "probability": 0.007808685302734375 }, { "start_logit": 11.4921875, "end_logit": 17.15625, "text": "St. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.00688934326171875 }, { "start_logit": 10.7890625, "end_logit": 17.15625, "text": "Kaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0033588409423828125 }, { "start_logit": 11.625, "end_logit": 16.296875, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah", "probability": 0.00330352783203125 }, { "start_logit": 10.7265625, "end_logit": 17.15625, "text": " Northwest, Portland, OR\nSt. Luke\u2019s Hospital, St. Louis, MO\nUniversity of Arizona, Tucson", "probability": 0.0031528472900390625 }, { "start_logit": 18.828125, "end_logit": 8.984375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "probability": 0.0029621124267578125 }, { "start_logit": 11.2578125, "end_logit": 16.21875, "text": "RVTN", "probability": 0.002101898193359375 }, { "start_logit": 17.984375, "end_logit": 9.1015625, "text": " Temple, TX", "probability": 0.0014438629150390625 }, { "start_logit": 18.171875, "end_logit": 8.359375, "text": "Kaiser Permanente Northwest", "probability": 0.0008225440979003906 }, { "start_logit": 18.171875, "end_logit": 8.109375, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.0006403923034667969 }, { "start_logit": 17.984375, "end_logit": 8.2421875, "text": " Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest", "probability": 0.0006022453308105469 }, { "start_logit": 17.640625, "end_logit": 8.5078125, "text": " Temple, TX", "probability": 0.0005655288696289062 }, { "start_logit": 16.765625, "end_logit": 9.3515625, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.0005483627319335938 }, { "start_logit": -30.859375, "end_logit": 15.875, "text": "", "probability": 0.0 } ], "100000000000000000001859": [ { "start_logit": 18.828125, "end_logit": 8.984375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance", "probability": 0.2705078125 }, { "start_logit": 17.984375, "end_logit": 9.1015625, "text": " Temple, TX", "probability": 0.1318359375 }, { "start_logit": 18.171875, "end_logit": 8.359375, "text": "Kaiser Permanente Northwest", "probability": 0.07513427734375 }, { "start_logit": 18.171875, "end_logit": 8.109375, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.05853271484375 }, { "start_logit": 17.984375, "end_logit": 8.2421875, "text": " Temple, TX\n\uf209\f10/30/22, 9:20 AM COVID-19 Vaccine Effectiveness Research | CDC\nKaiser Permanente Northwest", "probability": 0.054962158203125 }, { "start_logit": 17.640625, "end_logit": 8.5078125, "text": " Temple, TX", "probability": 0.0516357421875 }, { "start_logit": 16.765625, "end_logit": 9.3515625, "text": " Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.050048828125 }, { "start_logit": 17.875, "end_logit": 8.109375, "text": " Portland, OR", "probability": 0.04351806640625 }, { "start_logit": 17.90625, "end_logit": 8.0546875, "text": " Portland, OR", "probability": 0.042816162109375 }, { "start_logit": 16.78125, "end_logit": 9.1015625, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nBaylor Scott and White Health, Temple, TX", "probability": 0.038970947265625 }, { "start_logit": 16.3125, "end_logit": 9.3515625, "text": "University of Utah, Salt Lake City, UT\nCASCADIA", "probability": 0.031341552734375 }, { "start_logit": 17.265625, "end_logit": 8.2421875, "text": "Kaiser Permanente Northwest", "probability": 0.02679443359375 }, { "start_logit": 17.265625, "end_logit": 8.0546875, "text": "Kaiser Permanente Northwest, Portland, OR", "probability": 0.022216796875 }, { "start_logit": 18.828125, "end_logit": 6.4375, "text": "Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance (AZ", "probability": 0.0211944580078125 }, { "start_logit": 17.90625, "end_logit": 7.16015625, "text": " Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.0172882080078125 }, { "start_logit": 17.640625, "end_logit": 7.265625, "text": " Temple, TX\nUniversity of Arizona, Tucson, AZ\nUniversity of Miami, Miami, FL\nUniversity of Utah", "probability": 0.014801025390625 }, { "start_logit": 17.640625, "end_logit": 7.25390625, "text": " Temple, TX\nUniversity of Arizona, Tucson", "probability": 0.01456451416015625 }, { "start_logit": 17.09375, "end_logit": 7.6953125, "text": " Tucson", "probability": 0.01305389404296875 }, { "start_logit": 16.953125, "end_logit": 7.6953125, "text": " Healthcare providers/first responders/essential and other frontline workers\nParticipating Sites\nUniversity of Arizona, Tucson", "probability": 0.0115203857421875 }, { "start_logit": 17.265625, "end_logit": 7.16015625, "text": "Kaiser Permanente Northwest, Portland, OR\nSt. Luke\u2019s Hospital, Duluth, MN\nUniversity of Arizona, Tucson", "probability": 0.00911712646484375 }, { "start_logit": -33.21875, "end_logit": 14.0546875, "text": "", "probability": 0.0 } ], "100000000000000000001864": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": 6.390625, "end_logit": -0.154296875, "text": "", "probability": 0.0 } ], "100000000000000000001865": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": -34.71875, "end_logit": 16.0625, "text": "", "probability": 0.0 } ], "100000000000000000001868": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": 5.76171875, "end_logit": -0.35009765625, "text": "", "probability": 0.0 } ], "100000000000000000001869": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": 5.75, "end_logit": -0.374755859375, "text": "", "probability": 0.0 } ], "100000000000000000001871": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": 7.296875, "end_logit": -0.638671875, "text": "", "probability": 0.0 } ], "100000000000000000001872": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": -33.875, "end_logit": 15.5625, "text": "", "probability": 0.0 } ], "100000000000000000001873": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68603515625 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.09283447265625 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.041839599609375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034149169921875 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.02618408203125 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210418701171875 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.01885986328125 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174407958984375 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.017181396484375 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.01009368896484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.00476837158203125 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.004619598388671875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004016876220703125 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.00337982177734375 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.0032787322998046875 }, { "start_logit": 16.1875, "end_logit": 8.3359375, "text": "Ness Testing (PREVENT ) Sites\nOutcome: Symptomatic SARS-CoV-2 infections\nPopulation: Healthcare personnel", "probability": 0.0032787322998046875 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031261444091796875 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0027599334716796875 }, { "start_logit": 15.9609375, "end_logit": 8.3359375, "text": "PREVENT ) Sites\nOutcome: Symptomatic SARS-CoV-2 infections\nPopulation: Healthcare personnel", "probability": 0.0025920867919921875 }, { "start_logit": 16.1875, "end_logit": 8.0625, "text": "Ness Testing (PREVENT ) Sites\nOutcome: Symptomatic SARS-CoV-2 infections", "probability": 0.0024738311767578125 }, { "start_logit": 7.71875, "end_logit": -0.83154296875, "text": "", "probability": 0.0 } ], "100000000000000000001876": [ { "start_logit": 20.0, "end_logit": 9.875, "text": " 8,319", "probability": 0.68701171875 }, { "start_logit": 19.515625, "end_logit": 8.3515625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.093017578125 }, { "start_logit": 20.0, "end_logit": 7.078125, "text": " 8,319 locations across the United States", "probability": 0.04193115234375 }, { "start_logit": 20.0, "end_logit": 6.8828125, "text": " 8", "probability": 0.034210205078125 }, { "start_logit": 16.734375, "end_logit": 9.875, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections\nPopulation: Anyone seeking testing at a pharmacy\nParticipating sites: 8,319", "probability": 0.0262298583984375 }, { "start_logit": 20.0, "end_logit": 6.38671875, "text": " 8,319 locations across the United States and its territories\nIVY\nInfluenza and Other Viruses", "probability": 0.0210723876953125 }, { "start_logit": 19.515625, "end_logit": 6.765625, "text": " Household transmission", "probability": 0.018890380859375 }, { "start_logit": 19.515625, "end_logit": 6.68359375, "text": " Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0174713134765625 }, { "start_logit": 17.84375, "end_logit": 8.3515625, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories", "probability": 0.0172119140625 }, { "start_logit": 19.515625, "end_logit": 6.140625, "text": " Household transmission among community members confirmed with SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2", "probability": 0.0101165771484375 }, { "start_logit": 17.234375, "end_logit": 7.671875, "text": "Colorado", "probability": 0.0047760009765625 }, { "start_logit": 17.953125, "end_logit": 6.92578125, "text": " Westat\n\uf209 \uf20c\nTest-negative prospective case control\n\uf1aa\nIncreasing Community Access to Testing (IC", "probability": 0.00463104248046875 }, { "start_logit": 17.84375, "end_logit": 6.89453125, "text": " SARS-CoV-2\nPopulation: Households of community members with positive SARS-CoV-2 tests recruited from national commercial\nlaboratories\nExternal partner", "probability": 0.004024505615234375 }, { "start_logit": 17.796875, "end_logit": 6.765625, "text": "National Protocol\nOutcome: Household transmission", "probability": 0.003387451171875 }, { "start_logit": 17.84375, "end_logit": 6.68359375, "text": " SARS-CoV-2", "probability": 0.003284454345703125 }, { "start_logit": 17.796875, "end_logit": 6.68359375, "text": "National Protocol\nOutcome: Household transmission among community members confirmed with SARS-CoV-2", "probability": 0.0031337738037109375 }, { "start_logit": 16.9375, "end_logit": 7.42578125, "text": "ICATT) program\nOutcome: Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.002765655517578125 }, { "start_logit": 17.234375, "end_logit": 6.9296875, "text": "Colorado\nFlorida\nGeorgia\nIowa\nMaryland\nMassachusetts\nMichigan\nMinnesota\nMissouri\nNew York", "probability": 0.0022563934326171875 }, { "start_logit": 16.734375, "end_logit": 7.42578125, "text": " Symptomatic and asymptomatic SARS-CoV-2 infections", "probability": 0.0022563934326171875 }, { "start_logit": 16.921875, "end_logit": 7.21484375, "text": " Healthcare personnel", "probability": 0.0022220611572265625 }, { "start_logit": -34.71875, "end_logit": 16.0625, "text": "", "probability": 0.0 } ], "100000000000000000001880": [ { "start_logit": 19.265625, "end_logit": 9.1875, "text": "Indiana", "probability": 0.395263671875 }, { "start_logit": 19.265625, "end_logit": 8.4140625, "text": "Indiana)\nUniversity of Colorado (Colorado", "probability": 0.183837890625 }, { "start_logit": 18.21875, "end_logit": 8.4140625, "text": "Colorado", "probability": 0.06353759765625 }, { "start_logit": 17.203125, "end_logit": 9.1875, "text": "Kaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.05023193359375 }, { "start_logit": 17.4375, "end_logit": 8.890625, "text": "\nFLU-VE Network", "probability": 0.047210693359375 }, { "start_logit": 16.953125, "end_logit": 9.1875, "text": "California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.039154052734375 }, { "start_logit": 17.09375, "end_logit": 8.890625, "text": "Emerging Infection Program Sites\n\uf209 \uf20c\nFLU-VE Network", "probability": 0.03350830078125 }, { "start_logit": 17.203125, "end_logit": 8.4140625, "text": "Kaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.02337646484375 }, { "start_logit": 16.609375, "end_logit": 8.890625, "text": "FLU-VE Network", "probability": 0.0206298828125 }, { "start_logit": 16.953125, "end_logit": 8.4140625, "text": "California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.0182037353515625 }, { "start_logit": 17.203125, "end_logit": 8.0625, "text": "Kaiser Permanente Northwest", "probability": 0.0163116455078125 }, { "start_logit": 16.078125, "end_logit": 9.1875, "text": "Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.0163116455078125 }, { "start_logit": 19.265625, "end_logit": 5.94140625, "text": "Indiana)\nUniversity of Colorado (Color", "probability": 0.0153350830078125 }, { "start_logit": 16.28125, "end_logit": 8.890625, "text": " Infection Program Sites\n\uf209 \uf20c\nFLU-VE Network", "probability": 0.01485443115234375 }, { "start_logit": 15.9375, "end_logit": 9.1875, "text": "Kaiser Permanente Northern California (California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.0141754150390625 }, { "start_logit": 16.953125, "end_logit": 8.0625, "text": "California)\nKaiser Permanente Northwest", "probability": 0.01270294189453125 }, { "start_logit": 16.96875, "end_logit": 7.96875, "text": " Temple, TX", "probability": 0.011749267578125 }, { "start_logit": 17.640625, "end_logit": 6.99609375, "text": "Columbia University (New York", "probability": 0.00873565673828125 }, { "start_logit": 16.078125, "end_logit": 8.4140625, "text": "Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.007587432861328125 }, { "start_logit": 17.484375, "end_logit": 6.99609375, "text": " Influenza Vaccine Effectiveness Network", "probability": 0.00746917724609375 }, { "start_logit": 9.6484375, "end_logit": -0.607421875, "text": "", "probability": 0.0 } ], "100000000000000000001881": [ { "start_logit": 19.28125, "end_logit": 9.1875, "text": "Indiana", "probability": 0.399658203125 }, { "start_logit": 19.28125, "end_logit": 8.4140625, "text": "Indiana)\nUniversity of Colorado (Colorado", "probability": 0.1829833984375 }, { "start_logit": 18.21875, "end_logit": 8.4140625, "text": "Colorado", "probability": 0.063232421875 }, { "start_logit": 17.21875, "end_logit": 9.1875, "text": "Kaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.05078125 }, { "start_logit": 17.4375, "end_logit": 8.875, "text": "\nFLU-VE Network", "probability": 0.0462646484375 }, { "start_logit": 16.953125, "end_logit": 9.1875, "text": "California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.038970947265625 }, { "start_logit": 17.09375, "end_logit": 8.875, "text": "Emerging Infection Program Sites\n\uf209 \uf20c\nFLU-VE Network", "probability": 0.032806396484375 }, { "start_logit": 17.21875, "end_logit": 8.4140625, "text": "Kaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.02325439453125 }, { "start_logit": 16.609375, "end_logit": 8.875, "text": "FLU-VE Network", "probability": 0.0202178955078125 }, { "start_logit": 16.953125, "end_logit": 8.4140625, "text": "California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.0181121826171875 }, { "start_logit": 16.09375, "end_logit": 9.1875, "text": "Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.0164947509765625 }, { "start_logit": 17.21875, "end_logit": 8.0390625, "text": "Kaiser Permanente Northwest", "probability": 0.0159912109375 }, { "start_logit": 19.28125, "end_logit": 5.92578125, "text": "Indiana)\nUniversity of Colorado (Color", "probability": 0.0152587890625 }, { "start_logit": 16.28125, "end_logit": 8.875, "text": " Infection Program Sites\n\uf209 \uf20c\nFLU-VE Network", "probability": 0.01456451416015625 }, { "start_logit": 15.9375, "end_logit": 9.1875, "text": "Kaiser Permanente Northern California (California)\nKaiser Permanente Northwest (Oregon and Washington)\nRegenstrief Institute (Indiana", "probability": 0.0141143798828125 }, { "start_logit": 16.953125, "end_logit": 8.0390625, "text": "California)\nKaiser Permanente Northwest", "probability": 0.012451171875 }, { "start_logit": 16.953125, "end_logit": 7.97265625, "text": " Temple, TX", "probability": 0.01151275634765625 }, { "start_logit": 17.640625, "end_logit": 7.0, "text": "Columbia University (New York", "probability": 0.00868988037109375 }, { "start_logit": 16.09375, "end_logit": 8.4140625, "text": "Oregon and Washington)\nRegenstrief Institute (Indiana)\nUniversity of Colorado (Colorado", "probability": 0.007549285888671875 }, { "start_logit": 17.484375, "end_logit": 6.99609375, "text": " Influenza Vaccine Effectiveness Network", "probability": 0.007434844970703125 }, { "start_logit": 9.75, "end_logit": -0.5546875, "text": "", "probability": 0.0 } ], "100000000000000000001889": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004784256262873459 }, { "start_logit": 7.58984375, "end_logit": 0.053924560546875, "text": "", "probability": 0.9995215743737126 } ], "100000000000000000001894": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008693673928062171 }, { "start_logit": 7.2578125, "end_logit": -0.2127685546875, "text": "", "probability": 0.9991306326071938 } ], "100000000000000000001895": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000893445612873136 }, { "start_logit": 7.21484375, "end_logit": -0.1949462890625, "text": "", "probability": 0.9991065543871269 } ], "100000000000000000001898": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 8.03125, "end_logit": -0.8212890625, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000001907": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 7.12109375, "end_logit": -0.367919921875, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000001908": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010691263618290232 }, { "start_logit": 7.21875, "end_logit": -0.3779296875, "text": "", "probability": 0.998930873638171 } ], "100000000000000000001913": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005907104251718618 }, { "start_logit": 7.94921875, "end_logit": -0.5166015625, "text": "", "probability": 0.9994092895748281 } ], "100000000000000000001916": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009697519677825861 }, { "start_logit": 7.05078125, "end_logit": -0.112060546875, "text": "", "probability": 0.9990302480322174 } ], "100000000000000000001917": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.0390625, "end_logit": -0.11962890625, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000001920": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009436192455752619 }, { "start_logit": 7.0078125, "end_logit": -0.041961669921875, "text": "", "probability": 0.9990563807544247 } ], "100000000000000000001925": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007643033095615911 }, { "start_logit": 7.6171875, "end_logit": -0.43994140625, "text": "", "probability": 0.9992356966904383 } ], "100000000000000000001926": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006986756664856787 }, { "start_logit": 7.73828125, "end_logit": -0.473876953125, "text": "", "probability": 0.9993013243335144 } ], "100000000000000000001928": [ { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.176025390625 }, { "start_logit": 14.9140625, "end_logit": 9.171875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.0858154296875 }, { "start_logit": 14.7421875, "end_logit": 9.171875, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.0711669921875 }, { "start_logit": 14.9140625, "end_logit": 8.9375, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.06683349609375 }, { "start_logit": 14.625, "end_logit": 9.171875, "text": " COVID-19 vaccination; COVID-19 vaccines", "probability": 0.063720703125 }, { "start_logit": 14.7421875, "end_logit": 8.9375, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.057159423828125 }, { "start_logit": 14.625, "end_logit": 8.9375, "text": " COVID-19 vaccination", "probability": 0.05047607421875 }, { "start_logit": 14.328125, "end_logit": 9.171875, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.04736328125 }, { "start_logit": 14.9140625, "end_logit": 8.53125, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.044525146484375 }, { "start_logit": 14.9140625, "end_logit": 8.4453125, "text": "Enroll pregnant people who plan to receive COVID-19", "probability": 0.041168212890625 }, { "start_logit": 14.1328125, "end_logit": 9.171875, "text": " COVID-19 vaccines", "probability": 0.039276123046875 }, { "start_logit": 14.7421875, "end_logit": 8.53125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.0380859375 }, { "start_logit": 14.328125, "end_logit": 8.9375, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.0374755859375 }, { "start_logit": 14.7421875, "end_logit": 8.4453125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.03466796875 }, { "start_logit": 14.625, "end_logit": 8.53125, "text": " COVID-19 vaccination; COVID-19", "probability": 0.033599853515625 }, { "start_logit": 14.625, "end_logit": 8.4453125, "text": " COVID-19", "probability": 0.030609130859375 }, { "start_logit": 14.328125, "end_logit": 8.53125, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.0249786376953125 }, { "start_logit": 14.328125, "end_logit": 8.4453125, "text": "\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.023101806640625 }, { "start_logit": 14.1328125, "end_logit": 8.53125, "text": " COVID-19", "probability": 0.0203857421875 }, { "start_logit": 14.7421875, "end_logit": 7.52734375, "text": "The study", "probability": 0.01378631591796875 }, { "start_logit": 7.30859375, "end_logit": -0.8916015625, "text": "", "probability": 0.0 } ], "100000000000000000001929": [ { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.1748046875 }, { "start_logit": 14.9140625, "end_logit": 9.171875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.085205078125 }, { "start_logit": 14.7421875, "end_logit": 9.171875, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.0706787109375 }, { "start_logit": 14.9140625, "end_logit": 8.9375, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.06640625 }, { "start_logit": 14.625, "end_logit": 9.171875, "text": " COVID-19 vaccination; COVID-19 vaccines", "probability": 0.06329345703125 }, { "start_logit": 14.7421875, "end_logit": 8.9375, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.056793212890625 }, { "start_logit": 14.625, "end_logit": 8.9375, "text": " COVID-19 vaccination", "probability": 0.05010986328125 }, { "start_logit": 14.328125, "end_logit": 9.171875, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.04705810546875 }, { "start_logit": 14.9140625, "end_logit": 8.53125, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.044219970703125 }, { "start_logit": 14.9140625, "end_logit": 8.4453125, "text": "Enroll pregnant people who plan to receive COVID-19", "probability": 0.0408935546875 }, { "start_logit": 14.1328125, "end_logit": 9.171875, "text": " COVID-19 vaccines", "probability": 0.039031982421875 }, { "start_logit": 14.7421875, "end_logit": 8.53125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.037811279296875 }, { "start_logit": 14.328125, "end_logit": 8.9375, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.0372314453125 }, { "start_logit": 14.7421875, "end_logit": 8.4453125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.034423828125 }, { "start_logit": 14.625, "end_logit": 8.53125, "text": " COVID-19 vaccination; COVID-19", "probability": 0.033355712890625 }, { "start_logit": 14.625, "end_logit": 8.4453125, "text": " COVID-19", "probability": 0.0303955078125 }, { "start_logit": 14.328125, "end_logit": 8.53125, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.024810791015625 }, { "start_logit": 14.328125, "end_logit": 8.4453125, "text": "\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.02294921875 }, { "start_logit": 14.9140625, "end_logit": 7.734375, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines will be given as part of the\nstudy\nCollect baseline", "probability": 0.0202484130859375 }, { "start_logit": 14.1328125, "end_logit": 8.53125, "text": " COVID-19", "probability": 0.0202484130859375 }, { "start_logit": 7.37890625, "end_logit": -0.935546875, "text": "", "probability": 0.0 } ], "100000000000000000001932": [ { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.173828125 }, { "start_logit": 14.921875, "end_logit": 9.1796875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.084716796875 }, { "start_logit": 14.7421875, "end_logit": 9.1796875, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.07135009765625 }, { "start_logit": 14.921875, "end_logit": 8.9375, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.0670166015625 }, { "start_logit": 14.625, "end_logit": 9.1796875, "text": " COVID-19 vaccination; COVID-19 vaccines", "probability": 0.06396484375 }, { "start_logit": 14.7421875, "end_logit": 8.9375, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.056427001953125 }, { "start_logit": 14.625, "end_logit": 8.9375, "text": " COVID-19 vaccination", "probability": 0.0498046875 }, { "start_logit": 14.3359375, "end_logit": 9.1796875, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.047515869140625 }, { "start_logit": 14.921875, "end_logit": 8.53125, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.044647216796875 }, { "start_logit": 14.921875, "end_logit": 8.4453125, "text": "Enroll pregnant people who plan to receive COVID-19", "probability": 0.041290283203125 }, { "start_logit": 14.1328125, "end_logit": 9.1796875, "text": " COVID-19 vaccines", "probability": 0.038787841796875 }, { "start_logit": 14.7421875, "end_logit": 8.53125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.03759765625 }, { "start_logit": 14.3359375, "end_logit": 8.9375, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.03759765625 }, { "start_logit": 14.7421875, "end_logit": 8.4453125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.034210205078125 }, { "start_logit": 14.625, "end_logit": 8.53125, "text": " COVID-19 vaccination; COVID-19", "probability": 0.033172607421875 }, { "start_logit": 14.625, "end_logit": 8.4453125, "text": " COVID-19", "probability": 0.03021240234375 }, { "start_logit": 14.3359375, "end_logit": 8.53125, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.0250396728515625 }, { "start_logit": 14.3359375, "end_logit": 8.4453125, "text": "\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.0228118896484375 }, { "start_logit": 14.921875, "end_logit": 7.73046875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines will be given as part of the\nstudy\nCollect baseline", "probability": 0.0201263427734375 }, { "start_logit": 14.1328125, "end_logit": 8.53125, "text": " COVID-19", "probability": 0.0201263427734375 }, { "start_logit": 7.3984375, "end_logit": -0.9384765625, "text": "", "probability": 0.0 } ], "100000000000000000001934": [ { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.173828125 }, { "start_logit": 14.921875, "end_logit": 9.1796875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.084716796875 }, { "start_logit": 14.7421875, "end_logit": 9.1796875, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.07135009765625 }, { "start_logit": 14.921875, "end_logit": 8.9375, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.0670166015625 }, { "start_logit": 14.625, "end_logit": 9.1796875, "text": " COVID-19 vaccination; COVID-19 vaccines", "probability": 0.06396484375 }, { "start_logit": 14.7421875, "end_logit": 8.9375, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.056427001953125 }, { "start_logit": 14.625, "end_logit": 8.9375, "text": " COVID-19 vaccination", "probability": 0.0498046875 }, { "start_logit": 14.3359375, "end_logit": 9.1796875, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines", "probability": 0.047515869140625 }, { "start_logit": 14.921875, "end_logit": 8.53125, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.044647216796875 }, { "start_logit": 14.921875, "end_logit": 8.4453125, "text": "Enroll pregnant people who plan to receive COVID-19", "probability": 0.041290283203125 }, { "start_logit": 14.1328125, "end_logit": 9.1796875, "text": " COVID-19 vaccines", "probability": 0.038787841796875 }, { "start_logit": 14.7421875, "end_logit": 8.53125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.03759765625 }, { "start_logit": 14.3359375, "end_logit": 8.9375, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination", "probability": 0.03759765625 }, { "start_logit": 14.7421875, "end_logit": 8.4453125, "text": "The study will:\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.034210205078125 }, { "start_logit": 14.625, "end_logit": 8.53125, "text": " COVID-19 vaccination; COVID-19", "probability": 0.033172607421875 }, { "start_logit": 14.625, "end_logit": 8.4453125, "text": " COVID-19", "probability": 0.03021240234375 }, { "start_logit": 14.3359375, "end_logit": 8.53125, "text": "\nEnroll pregnant people who plan to receive COVID-19 vaccination; COVID-19", "probability": 0.0250396728515625 }, { "start_logit": 14.3359375, "end_logit": 8.4453125, "text": "\nEnroll pregnant people who plan to receive COVID-19", "probability": 0.0228118896484375 }, { "start_logit": 14.921875, "end_logit": 7.73046875, "text": "Enroll pregnant people who plan to receive COVID-19 vaccination; COVID-19 vaccines will be given as part of the\nstudy\nCollect baseline", "probability": 0.0201263427734375 }, { "start_logit": 14.1328125, "end_logit": 8.53125, "text": " COVID-19", "probability": 0.0201263427734375 }, { "start_logit": 7.37109375, "end_logit": -0.92333984375, "text": "", "probability": 0.0 } ], "100000000000000000001936": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 6.976470974169522e-05 }, { "start_logit": 8.5234375, "end_logit": 1.0458984375, "text": "", "probability": 0.9999302352902583 } ], "100000000000000000001939": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.2734375, "end_logit": -0.457275390625, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000001944": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007466114612710287 }, { "start_logit": 7.796875, "end_logit": -0.59716796875, "text": "", "probability": 0.999253388538729 } ], "100000000000000000001945": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008626077580284025 }, { "start_logit": 7.6875, "end_logit": -0.63134765625, "text": "", "probability": 0.9991373922419715 } ], "100000000000000000001948": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.7734375, "end_logit": -0.55615234375, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000001951": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.55078125, "end_logit": -0.447265625, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000001954": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.0, "end_logit": -0.006732940673828125, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000001958": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022083887960902254 }, { "start_logit": 6.94140625, "end_logit": -0.828125, "text": "", "probability": 0.9977916112039098 } ], "100000000000000000001961": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.20703125, "end_logit": -0.33251953125, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000001971": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 7.578125, "end_logit": -0.383544921875, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000001977": [ { "start_logit": 16.546875, "end_logit": 12.1875, "text": "VAERS", "probability": 0.262451171875 }, { "start_logit": 16.546875, "end_logit": 11.8828125, "text": "VAERS)\nVAERS", "probability": 0.195068359375 }, { "start_logit": 16.546875, "end_logit": 11.265625, "text": "VAERS)\nVAERS functionality permits analysis of adverse events", "probability": 0.1043701171875 }, { "start_logit": 15.453125, "end_logit": 12.1875, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.087890625 }, { "start_logit": 15.6015625, "end_logit": 11.8828125, "text": "VAERS", "probability": 0.0751953125 }, { "start_logit": 15.6015625, "end_logit": 11.265625, "text": "VAERS functionality permits analysis of adverse events", "probability": 0.040863037109375 }, { "start_logit": 16.546875, "end_logit": 10.2890625, "text": "VAERS)\nVAERS functionality", "probability": 0.039642333984375 }, { "start_logit": 14.421875, "end_logit": 12.1875, "text": "IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.031341552734375 }, { "start_logit": 16.546875, "end_logit": 9.8359375, "text": "VA", "probability": 0.0247955322265625 }, { "start_logit": 14.421875, "end_logit": 11.8828125, "text": "IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS)\nVAERS", "probability": 0.023284912109375 }, { "start_logit": 16.546875, "end_logit": 9.640625, "text": "VAERS)\nVAERS functionality permits analysis of adverse events (AE", "probability": 0.0205535888671875 }, { "start_logit": 14.7734375, "end_logit": 11.265625, "text": " adverse events", "probability": 0.0175933837890625 }, { "start_logit": 15.6015625, "end_logit": 10.2890625, "text": "VAERS functionality", "probability": 0.0152740478515625 }, { "start_logit": 16.546875, "end_logit": 9.09375, "text": "VAERS)\nVA", "probability": 0.01189422607421875 }, { "start_logit": 13.328125, "end_logit": 12.1875, "text": "Passive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.010498046875 }, { "start_logit": 15.453125, "end_logit": 9.890625, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance", "probability": 0.00884246826171875 }, { "start_logit": 15.453125, "end_logit": 9.8359375, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VA", "probability": 0.00830841064453125 }, { "start_logit": 15.6015625, "end_logit": 9.640625, "text": "VAERS functionality permits analysis of adverse events (AE", "probability": 0.00804901123046875 }, { "start_logit": 13.328125, "end_logit": 11.8828125, "text": "Passive Surveillance\nVaccine Adverse Event Reporting System (VAERS)\nVAERS", "probability": 0.007801055908203125 }, { "start_logit": 16.546875, "end_logit": 8.5, "text": "VAERS)\nVAERS functionality permits analysis", "probability": 0.006572723388671875 }, { "start_logit": 8.3046875, "end_logit": -0.465576171875, "text": "", "probability": 0.0 } ], "100000000000000000001979": [ { "start_logit": 16.53125, "end_logit": 12.1875, "text": "VAERS", "probability": 0.2626953125 }, { "start_logit": 16.53125, "end_logit": 11.875, "text": "VAERS)\nVAERS", "probability": 0.192138671875 }, { "start_logit": 16.53125, "end_logit": 11.265625, "text": "VAERS)\nVAERS functionality permits analysis of adverse events", "probability": 0.1044921875 }, { "start_logit": 15.4453125, "end_logit": 12.1875, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.0880126953125 }, { "start_logit": 15.59375, "end_logit": 11.875, "text": "VAERS", "probability": 0.0753173828125 }, { "start_logit": 15.59375, "end_logit": 11.265625, "text": "VAERS functionality permits analysis of adverse events", "probability": 0.040924072265625 }, { "start_logit": 16.53125, "end_logit": 10.2890625, "text": "VAERS)\nVAERS functionality", "probability": 0.0390625 }, { "start_logit": 14.4296875, "end_logit": 12.1875, "text": "IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.032379150390625 }, { "start_logit": 16.53125, "end_logit": 9.8359375, "text": "VA", "probability": 0.02520751953125 }, { "start_logit": 14.4296875, "end_logit": 11.875, "text": "IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VAERS)\nVAERS", "probability": 0.023681640625 }, { "start_logit": 16.53125, "end_logit": 9.640625, "text": "VAERS)\nVAERS functionality permits analysis of adverse events (AE", "probability": 0.02056884765625 }, { "start_logit": 14.7734375, "end_logit": 11.265625, "text": " adverse events", "probability": 0.01788330078125 }, { "start_logit": 15.59375, "end_logit": 10.2890625, "text": "VAERS functionality", "probability": 0.015289306640625 }, { "start_logit": 16.53125, "end_logit": 9.1015625, "text": "VAERS)\nVA", "probability": 0.01190185546875 }, { "start_logit": 13.3359375, "end_logit": 12.1875, "text": "Passive Surveillance\nVaccine Adverse Event Reporting System (VAERS", "probability": 0.01084136962890625 }, { "start_logit": 15.4453125, "end_logit": 9.8828125, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance", "probability": 0.00885009765625 }, { "start_logit": 15.4453125, "end_logit": 9.8359375, "text": "Indian Health Service (IHS) Vaccine Safety Monitoring Systems\nPassive Surveillance\nVaccine Adverse Event Reporting System (VA", "probability": 0.0084381103515625 }, { "start_logit": 15.59375, "end_logit": 9.640625, "text": "VAERS functionality permits analysis of adverse events (AE", "probability": 0.008056640625 }, { "start_logit": 13.3359375, "end_logit": 11.875, "text": "Passive Surveillance\nVaccine Adverse Event Reporting System (VAERS)\nVAERS", "probability": 0.0079345703125 }, { "start_logit": 16.53125, "end_logit": 8.5, "text": "VAERS)\nVAERS functionality permits analysis", "probability": 0.0065765380859375 }, { "start_logit": 8.5, "end_logit": -0.343505859375, "text": "", "probability": 0.0 } ], "100000000000000000001987": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.2578125, "end_logit": -0.54052734375, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000001988": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.3203125, "end_logit": -0.62109375, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000001993": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.54296875, "end_logit": -0.54931640625, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000001997": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.64453125, "end_logit": -0.56689453125, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000002000": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001796149154900369 }, { "start_logit": 7.2109375, "end_logit": -0.89013671875, "text": "", "probability": 0.9982038508450997 } ], "100000000000000000002001": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 7.25, "end_logit": -0.96337890625, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000002002": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 7.2421875, "end_logit": -0.908203125, "text": "", "probability": 0.998231648313891 } ], "100000000000000000002004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 7.19921875, "end_logit": -0.91259765625, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000002007": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.3125, "end_logit": -0.3896484375, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000002010": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999618725 }, { "start_logit": -33.625, "end_logit": 11.9453125, "text": "", "probability": 3.8127508235732506e-10 } ], "100000000000000000002013": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999683912 }, { "start_logit": -33.625, "end_logit": 11.7421875, "text": "", "probability": 3.160881453314576e-10 } ], "100000000000000000002014": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996789342 }, { "start_logit": -33.59375, "end_logit": 11.734375, "text": "", "probability": 3.2106580933024515e-10 } ], "100000000000000000002020": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000800953612508541 }, { "start_logit": 7.84765625, "end_logit": -0.7177734375, "text": "", "probability": 0.9991990463874916 } ], "100000000000000000002027": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 7.0390625, "end_logit": -0.78759765625, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000002028": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 7.07421875, "end_logit": -0.8232421875, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000002029": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.26171875, "end_logit": -0.51953125, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000002030": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.21484375, "end_logit": -0.4677734375, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000002033": [ { "start_logit": 17.15625, "end_logit": 7.63671875, "text": "VAERS", "probability": 0.41650390625 }, { "start_logit": 16.703125, "end_logit": 6.9609375, "text": "VAERS", "probability": 0.1331787109375 }, { "start_logit": 17.15625, "end_logit": 5.6875, "text": "VAERS)\nMyocarditis", "probability": 0.05908203125 }, { "start_logit": 15.9609375, "end_logit": 6.484375, "text": " June 2021", "probability": 0.03936767578125 }, { "start_logit": 16.25, "end_logit": 6.15625, "text": " September 2021", "probability": 0.03814697265625 }, { "start_logit": 16.703125, "end_logit": 5.65625, "text": "VAERS)\nThe Advisory Committee on Immunization Practices", "probability": 0.036407470703125 }, { "start_logit": 16.015625, "end_logit": 6.046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0270538330078125 }, { "start_logit": 16.25, "end_logit": 5.75, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.025421142578125 }, { "start_logit": 15.9609375, "end_logit": 6.046875, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.025421142578125 }, { "start_logit": 15.0, "end_logit": 6.9609375, "text": " 5\u201311 years after COVID-19 vaccination: Updates from v-safe and the Vaccine\nAdverse Event Reporting System (VAERS", "probability": 0.024627685546875 }, { "start_logit": 17.15625, "end_logit": 4.7734375, "text": "VA", "probability": 0.0238800048828125 }, { "start_logit": 15.4609375, "end_logit": 6.484375, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.0238800048828125 }, { "start_logit": 15.4140625, "end_logit": 6.484375, "text": " 2021", "probability": 0.02313232421875 }, { "start_logit": 16.25, "end_logit": 5.64453125, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.0227813720703125 }, { "start_logit": 16.140625, "end_logit": 5.65625, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0207366943359375 }, { "start_logit": 15.4140625, "end_logit": 6.046875, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0149383544921875 }, { "start_logit": 14.8671875, "end_logit": 6.484375, "text": " Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.01318359375 }, { "start_logit": 15.4609375, "end_logit": 5.75, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.01163482666015625 }, { "start_logit": 15.4609375, "end_logit": 5.64453125, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.01042938232421875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.009796142578125 }, { "start_logit": -34.3125, "end_logit": 15.3203125, "text": "", "probability": 0.0 } ], "100000000000000000002038": [ { "start_logit": 17.15625, "end_logit": 7.63671875, "text": "VAERS", "probability": 0.41650390625 }, { "start_logit": 16.703125, "end_logit": 6.9609375, "text": "VAERS", "probability": 0.1331787109375 }, { "start_logit": 17.15625, "end_logit": 5.6875, "text": "VAERS)\nMyocarditis", "probability": 0.05908203125 }, { "start_logit": 15.9609375, "end_logit": 6.484375, "text": " June 2021", "probability": 0.03936767578125 }, { "start_logit": 16.25, "end_logit": 6.15625, "text": " September 2021", "probability": 0.03814697265625 }, { "start_logit": 16.703125, "end_logit": 5.65625, "text": "VAERS)\nThe Advisory Committee on Immunization Practices", "probability": 0.036407470703125 }, { "start_logit": 16.015625, "end_logit": 6.046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0270538330078125 }, { "start_logit": 16.25, "end_logit": 5.75, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.025421142578125 }, { "start_logit": 15.9609375, "end_logit": 6.046875, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.025421142578125 }, { "start_logit": 15.0, "end_logit": 6.9609375, "text": " 5\u201311 years after COVID-19 vaccination: Updates from v-safe and the Vaccine\nAdverse Event Reporting System (VAERS", "probability": 0.024627685546875 }, { "start_logit": 17.15625, "end_logit": 4.7734375, "text": "VA", "probability": 0.0238800048828125 }, { "start_logit": 15.4609375, "end_logit": 6.484375, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.0238800048828125 }, { "start_logit": 15.4140625, "end_logit": 6.484375, "text": " 2021", "probability": 0.02313232421875 }, { "start_logit": 16.25, "end_logit": 5.64453125, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.0227813720703125 }, { "start_logit": 16.140625, "end_logit": 5.65625, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0207366943359375 }, { "start_logit": 15.4140625, "end_logit": 6.046875, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0149383544921875 }, { "start_logit": 14.8671875, "end_logit": 6.484375, "text": " Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.01318359375 }, { "start_logit": 15.4609375, "end_logit": 5.75, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.01163482666015625 }, { "start_logit": 15.4609375, "end_logit": 5.64453125, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.01042938232421875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.009796142578125 }, { "start_logit": 6.19140625, "end_logit": -0.163818359375, "text": "", "probability": 0.0 } ], "100000000000000000002046": [ { "start_logit": 17.15625, "end_logit": 7.63671875, "text": "VAERS", "probability": 0.41650390625 }, { "start_logit": 16.703125, "end_logit": 6.9609375, "text": "VAERS", "probability": 0.1331787109375 }, { "start_logit": 17.15625, "end_logit": 5.6875, "text": "VAERS)\nMyocarditis", "probability": 0.05908203125 }, { "start_logit": 15.9609375, "end_logit": 6.484375, "text": " June 2021", "probability": 0.03936767578125 }, { "start_logit": 16.25, "end_logit": 6.15625, "text": " September 2021", "probability": 0.03814697265625 }, { "start_logit": 16.703125, "end_logit": 5.65625, "text": "VAERS)\nThe Advisory Committee on Immunization Practices", "probability": 0.036407470703125 }, { "start_logit": 16.015625, "end_logit": 6.046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0270538330078125 }, { "start_logit": 16.25, "end_logit": 5.75, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.025421142578125 }, { "start_logit": 15.9609375, "end_logit": 6.046875, "text": " June 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.025421142578125 }, { "start_logit": 15.0, "end_logit": 6.9609375, "text": " 5\u201311 years after COVID-19 vaccination: Updates from v-safe and the Vaccine\nAdverse Event Reporting System (VAERS", "probability": 0.024627685546875 }, { "start_logit": 17.15625, "end_logit": 4.7734375, "text": "VA", "probability": 0.0238800048828125 }, { "start_logit": 15.4609375, "end_logit": 6.484375, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.0238800048828125 }, { "start_logit": 15.4140625, "end_logit": 6.484375, "text": " 2021", "probability": 0.02313232421875 }, { "start_logit": 16.25, "end_logit": 5.64453125, "text": " September 2021\nUse of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.0227813720703125 }, { "start_logit": 16.140625, "end_logit": 5.65625, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0207366943359375 }, { "start_logit": 15.4140625, "end_logit": 6.046875, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0149383544921875 }, { "start_logit": 14.8671875, "end_logit": 6.484375, "text": " Advisory\nCommittee on Immunization Practices \u2014 United States, June 2021", "probability": 0.01318359375 }, { "start_logit": 15.4609375, "end_logit": 5.75, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee", "probability": 0.01163482666015625 }, { "start_logit": 15.4609375, "end_logit": 5.64453125, "text": " mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory\nCommittee on Immunization Practices", "probability": 0.01042938232421875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.009796142578125 }, { "start_logit": -33.53125, "end_logit": 4.44921875, "text": "", "probability": 0.0 } ], "100000000000000000002052": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.4609375, "end_logit": -0.82958984375, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000002053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.45703125, "end_logit": -0.8154296875, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000002054": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014048677545435851 }, { "start_logit": 7.34765625, "end_logit": -0.78076171875, "text": "", "probability": 0.9985951322454563 } ], "100000000000000000002055": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 7.375, "end_logit": -0.7763671875, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000002057": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018675659778932805 }, { "start_logit": 6.44140625, "end_logit": -0.1588134765625, "text": "", "probability": 0.9981324340221067 } ], "100000000000000000002058": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 6.3828125, "end_logit": -0.1461181640625, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000002059": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 6.4453125, "end_logit": -0.1610107421875, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000002061": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -34.0, "end_logit": 13.8203125, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000002062": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -34.0, "end_logit": 13.8046875, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000002064": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999984920278 }, { "start_logit": -33.9375, "end_logit": 13.625, "text": "", "probability": 1.5079722015620545e-09 } ], "100000000000000000002065": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.203125, "end_logit": -0.330078125, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000002073": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002511463513809854 }, { "start_logit": 6.421875, "end_logit": -0.437255859375, "text": "", "probability": 0.9974885364861902 } ], "100000000000000000002074": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002511463513809854 }, { "start_logit": 6.41796875, "end_logit": -0.43505859375, "text": "", "probability": 0.9974885364861902 } ], "100000000000000000002079": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027149854690051763 }, { "start_logit": 6.37109375, "end_logit": -0.46533203125, "text": "", "probability": 0.9972850145309949 } ], "100000000000000000002081": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 6.828125, "end_logit": 0.030609130859375, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000002083": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010775025886693324 }, { "start_logit": 6.8359375, "end_logit": -0.0037994384765625, "text": "", "probability": 0.9989224974113308 } ], "100000000000000000002086": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.40625, "end_logit": -0.64697265625, "text": "", "probability": 0.99883958037482 } ], "100000000000000000002092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009622125595974061 }, { "start_logit": 6.9453125, "end_logit": -0.0002155303955078125, "text": "", "probability": 0.9990377874404025 } ], "100000000000000000002099": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009436192455752619 }, { "start_logit": 7.2734375, "end_logit": -0.308837890625, "text": "", "probability": 0.9990563807544247 } ], "100000000000000000002101": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009326360013054126 }, { "start_logit": 7.390625, "end_logit": -0.415283203125, "text": "", "probability": 0.9990673639986946 } ], "100000000000000000002108": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.16015625, "end_logit": -0.642578125, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000002109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 6.93359375, "end_logit": -0.5400390625, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000002114": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006932422985664928 }, { "start_logit": 8.0, "end_logit": -0.72509765625, "text": "", "probability": 0.9993067577014336 } ], "100000000000000000002120": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008199321062135582 }, { "start_logit": 7.73828125, "end_logit": -0.63134765625, "text": "", "probability": 0.9991800678937864 } ], "100000000000000000002121": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 6.67578125, "end_logit": -0.37841796875, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000002123": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 6.625, "end_logit": -0.33984375, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000002129": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.12890625, "end_logit": -0.435546875, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000002130": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013198634624794732 }, { "start_logit": 7.1484375, "end_logit": -0.51904296875, "text": "", "probability": 0.9986801365375205 } ], "100000000000000000002132": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.125, "end_logit": -0.45654296875, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000002133": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005274784125231481 }, { "start_logit": 7.31640625, "end_logit": 0.2322998046875, "text": "", "probability": 0.9994725215874769 } ], "100000000000000000002134": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005254230495830163 }, { "start_logit": 7.359375, "end_logit": 0.1912841796875, "text": "", "probability": 0.9994745769504169 } ], "100000000000000000002140": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 6.93359375, "end_logit": -0.163818359375, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000002141": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 6.93359375, "end_logit": -0.148681640625, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000002142": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 6.84375, "end_logit": -0.134033203125, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000002145": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.73828125, "end_logit": -0.75439453125, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000002148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.77734375, "end_logit": -0.787109375, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000002151": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002621440946167595 }, { "start_logit": 6.375, "end_logit": -0.434326171875, "text": "", "probability": 0.9973785590538324 } ], "100000000000000000002155": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 6.484375, "end_logit": -0.1859130859375, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000002157": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 6.51171875, "end_logit": -0.1466064453125, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000002161": [ { "start_logit": 16.59375, "end_logit": 8.4296875, "text": "ACOG", "probability": 0.1484375 }, { "start_logit": 16.046875, "end_logit": 8.4296875, "text": "COVID-19 Vaccination among Pregnant People\nManagement of Anaphylaxis after COVID-19 Vaccination\nACOG", "probability": 0.0845947265625 }, { "start_logit": 16.046875, "end_logit": 8.4296875, "text": " Anaphylaxis after COVID-19 Vaccination\nACOG", "probability": 0.0845947265625 }, { "start_logit": 17.421875, "end_logit": 6.98046875, "text": " Healthcare and Public Health\nConsiderations for the Use of COVID-19 Vaccines Currently Available in the U.S.\nCOVID-19", "probability": 0.0794677734375 }, { "start_logit": 16.59375, "end_logit": 7.80859375, "text": "ACOG Vaccine Confidence Training\nACOG", "probability": 0.0794677734375 }, { "start_logit": 16.046875, "end_logit": 8.2421875, "text": "COVID-19 Vaccination among Pregnant People\nManagement of Anaphylaxis", "probability": 0.07012939453125 }, { "start_logit": 16.046875, "end_logit": 8.2421875, "text": " Anaphylaxis", "probability": 0.07012939453125 }, { "start_logit": 16.328125, "end_logit": 7.80859375, "text": "ACOG", "probability": 0.060943603515625 }, { "start_logit": 16.046875, "end_logit": 7.80859375, "text": "COVID-19 Vaccination among Pregnant People\nManagement of Anaphylaxis after COVID-19 Vaccination\nACOG Vaccine Confidence Training\nACOG", "probability": 0.045989990234375 }, { "start_logit": 16.046875, "end_logit": 7.80859375, "text": " Anaphylaxis after COVID-19 Vaccination\nACOG Vaccine Confidence Training\nACOG", "probability": 0.045989990234375 }, { "start_logit": 15.4296875, "end_logit": 8.4296875, "text": "Management of Anaphylaxis after COVID-19 Vaccination\nACOG", "probability": 0.045989990234375 }, { "start_logit": 15.4296875, "end_logit": 8.2421875, "text": "Management of Anaphylaxis", "probability": 0.03814697265625 }, { "start_logit": 16.53125, "end_logit": 6.8828125, "text": "Related Pages\nAllergic Reactions", "probability": 0.02923583984375 }, { "start_logit": 17.421875, "end_logit": 5.8671875, "text": " Healthcare and Public Health\nConsiderations for the Use of COVID-19 Vaccines", "probability": 0.02581787109375 }, { "start_logit": 15.4296875, "end_logit": 7.80859375, "text": "Management of Anaphylaxis after COVID-19 Vaccination\nACOG Vaccine Confidence Training\nACOG", "probability": 0.0246124267578125 }, { "start_logit": 16.046875, "end_logit": 6.98046875, "text": "COVID-19", "probability": 0.0200958251953125 }, { "start_logit": 17.421875, "end_logit": 5.390625, "text": " Healthcare and Public Health\nConsiderations for the Use of COVID-19", "probability": 0.016143798828125 }, { "start_logit": 15.6796875, "end_logit": 6.8828125, "text": "Allergic Reactions", "probability": 0.01258087158203125 }, { "start_logit": 16.53125, "end_logit": 5.8671875, "text": "Related Pages\nAllergic Reactions\n\u203a\nFor Healthcare and Public Health\nConsiderations for the Use of COVID-19 Vaccines", "probability": 0.0107574462890625 }, { "start_logit": 16.53125, "end_logit": 5.390625, "text": "Related Pages\nAllergic Reactions\n\u203a\nFor Healthcare and Public Health\nConsiderations for the Use of COVID-19", "probability": 0.006626129150390625 }, { "start_logit": 8.5390625, "end_logit": -1.1474609375, "text": "", "probability": 0.0 } ], "100000000000000000002166": [ { "start_logit": 18.265625, "end_logit": 10.6640625, "text": " N\nEngl J Med2021;", "probability": 0.54248046875 }, { "start_logit": 16.84375, "end_logit": 10.6640625, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.1287841796875 }, { "start_logit": 16.34375, "end_logit": 10.6640625, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.078125 }, { "start_logit": 18.265625, "end_logit": 8.34375, "text": " N\nEngl J Med202", "probability": 0.0528564453125 }, { "start_logit": 18.265625, "end_logit": 8.2265625, "text": " N\nEngl J Med2021; 384:2273", "probability": 0.047393798828125 }, { "start_logit": 18.265625, "end_logit": 7.734375, "text": " N\nEngl J Med2021; 384:2273-2282", "probability": 0.02874755859375 }, { "start_logit": 18.265625, "end_logit": 7.29296875, "text": " N\nEngl J Med2021; 384", "probability": 0.0185546875 }, { "start_logit": 14.875, "end_logit": 10.6640625, "text": " Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.0179901123046875 }, { "start_logit": 16.84375, "end_logit": 8.34375, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med202", "probability": 0.01275634765625 }, { "start_logit": 16.84375, "end_logit": 8.2265625, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273", "probability": 0.01125335693359375 }, { "start_logit": 16.84375, "end_logit": 7.9765625, "text": "Preliminary Findings of mRNA", "probability": 0.00876617431640625 }, { "start_logit": 18.265625, "end_logit": 6.453125, "text": " N\nEngl J Med2021; 384:22", "probability": 0.0079803466796875 }, { "start_logit": 16.34375, "end_logit": 8.34375, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med202", "probability": 0.0077362060546875 }, { "start_logit": 16.34375, "end_logit": 8.2265625, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273", "probability": 0.00682830810546875 }, { "start_logit": 18.265625, "end_logit": 6.20703125, "text": " N\nEngl J Med2021; 384:2273-2282. DOI: https://doi.org/10.1056/NEJMoa2104983", "probability": 0.006214141845703125 }, { "start_logit": 16.34375, "end_logit": 7.9765625, "text": " mRNA", "probability": 0.00531768798828125 }, { "start_logit": 13.6171875, "end_logit": 10.6640625, "text": " Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.005153656005859375 }, { "start_logit": 16.84375, "end_logit": 7.29296875, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384", "probability": 0.00447845458984375 }, { "start_logit": 16.84375, "end_logit": 7.2578125, "text": "P", "probability": 0.004276275634765625 }, { "start_logit": 16.34375, "end_logit": 7.734375, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273-2282", "probability": 0.004207611083984375 }, { "start_logit": 8.0859375, "end_logit": -1.0703125, "text": "", "probability": 0.0 } ], "100000000000000000002169": [ { "start_logit": 18.28125, "end_logit": 10.65625, "text": " N\nEngl J Med2021;", "probability": 0.54150390625 }, { "start_logit": 16.84375, "end_logit": 10.65625, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.128662109375 }, { "start_logit": 16.34375, "end_logit": 10.65625, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.0780029296875 }, { "start_logit": 18.28125, "end_logit": 8.3359375, "text": " N\nEngl J Med202", "probability": 0.053619384765625 }, { "start_logit": 18.28125, "end_logit": 8.2265625, "text": " N\nEngl J Med2021; 384:2273", "probability": 0.047332763671875 }, { "start_logit": 18.28125, "end_logit": 7.73828125, "text": " N\nEngl J Med2021; 384:2273-2282", "probability": 0.029144287109375 }, { "start_logit": 18.28125, "end_logit": 7.296875, "text": " N\nEngl J Med2021; 384", "probability": 0.018829345703125 }, { "start_logit": 14.875, "end_logit": 10.65625, "text": " Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.0179595947265625 }, { "start_logit": 16.84375, "end_logit": 8.3359375, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med202", "probability": 0.01273345947265625 }, { "start_logit": 16.84375, "end_logit": 8.2265625, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273", "probability": 0.01123809814453125 }, { "start_logit": 16.84375, "end_logit": 7.9765625, "text": "Preliminary Findings of mRNA", "probability": 0.00875091552734375 }, { "start_logit": 18.28125, "end_logit": 6.453125, "text": " N\nEngl J Med2021; 384:22", "probability": 0.00809478759765625 }, { "start_logit": 16.34375, "end_logit": 8.3359375, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med202", "probability": 0.007724761962890625 }, { "start_logit": 16.34375, "end_logit": 8.2265625, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273", "probability": 0.006816864013671875 }, { "start_logit": 18.28125, "end_logit": 6.20703125, "text": " N\nEngl J Med2021; 384:2273-2282. DOI: https://doi.org/10.1056/NEJMoa2104983", "probability": 0.006305694580078125 }, { "start_logit": 16.34375, "end_logit": 7.9765625, "text": " mRNA", "probability": 0.00531005859375 }, { "start_logit": 13.609375, "end_logit": 10.65625, "text": " Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021;", "probability": 0.00506591796875 }, { "start_logit": 16.84375, "end_logit": 7.296875, "text": "Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384", "probability": 0.0044708251953125 }, { "start_logit": 16.84375, "end_logit": 7.2578125, "text": "P", "probability": 0.004268646240234375 }, { "start_logit": 16.34375, "end_logit": 7.73828125, "text": " mRNA Covid-19 Vaccine Safety in Pregnant Persons. N\nEngl J Med2021; 384:2273-2282", "probability": 0.004199981689453125 }, { "start_logit": 8.109375, "end_logit": -1.1142578125, "text": "", "probability": 0.0 } ], "100000000000000000002172": [ { "start_logit": 16.65625, "end_logit": 10.84375, "text": " Eight", "probability": 0.60791015625 }, { "start_logit": 16.65625, "end_logit": 9.2578125, "text": " Eight Integrated Health Care Organizations", "probability": 0.1234130859375 }, { "start_logit": 14.5078125, "end_logit": 10.84375, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight", "probability": 0.07037353515625 }, { "start_logit": 16.65625, "end_logit": 8.4453125, "text": " Eight Integrated Health Care Organ", "probability": 0.054779052734375 }, { "start_logit": 14.5078125, "end_logit": 10.390625, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-A", "probability": 0.045440673828125 }, { "start_logit": 14.5078125, "end_logit": 9.4453125, "text": " COVID-19", "probability": 0.0175018310546875 }, { "start_logit": 14.5078125, "end_logit": 9.2578125, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight Integrated Health Care Organizations", "probability": 0.01451873779296875 }, { "start_logit": 12.8671875, "end_logit": 10.84375, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight", "probability": 0.01385498046875 }, { "start_logit": 14.5078125, "end_logit": 8.828125, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age", "probability": 0.009521484375 }, { "start_logit": 12.8671875, "end_logit": 10.390625, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-A", "probability": 0.0086669921875 }, { "start_logit": 14.5078125, "end_logit": 8.4453125, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight Integrated Health Care Organ", "probability": 0.006439208984375 }, { "start_logit": 14.5078125, "end_logit": 8.2890625, "text": " COVID-19 Vaccine During Pregnancy and Preterm", "probability": 0.0055084228515625 }, { "start_logit": 11.90625, "end_logit": 10.84375, "text": "Gestational-Age at Birth \u2014 Eight", "probability": 0.00525665283203125 }, { "start_logit": 11.6640625, "end_logit": 10.84375, "text": " Birth \u2014 Eight", "probability": 0.004093170166015625 }, { "start_logit": 12.8671875, "end_logit": 9.4453125, "text": "Receipt of COVID-19", "probability": 0.0033931732177734375 }, { "start_logit": 11.90625, "end_logit": 10.390625, "text": "Gestational-A", "probability": 0.0033435821533203125 }, { "start_logit": 12.8671875, "end_logit": 9.1328125, "text": "Rece", "probability": 0.002483367919921875 }, { "start_logit": 12.8671875, "end_logit": 8.828125, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age", "probability": 0.0018177032470703125 }, { "start_logit": 12.8671875, "end_logit": 8.2890625, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm", "probability": 0.001068115234375 }, { "start_logit": 11.90625, "end_logit": 9.2578125, "text": "Gestational-Age at Birth \u2014 Eight Integrated Health Care Organizations", "probability": 0.001068115234375 }, { "start_logit": 6.87109375, "end_logit": -0.62451171875, "text": "", "probability": 0.0 } ], "100000000000000000002174": [ { "start_logit": 16.640625, "end_logit": 10.8515625, "text": " Eight", "probability": 0.7578125 }, { "start_logit": 14.5078125, "end_logit": 10.8515625, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight", "probability": 0.089111328125 }, { "start_logit": 14.5078125, "end_logit": 10.3984375, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-A", "probability": 0.056671142578125 }, { "start_logit": 14.5078125, "end_logit": 9.4453125, "text": " COVID-19", "probability": 0.0218353271484375 }, { "start_logit": 12.8671875, "end_logit": 10.8515625, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age at Birth \u2014 Eight", "probability": 0.01727294921875 }, { "start_logit": 14.5078125, "end_logit": 8.828125, "text": " COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age", "probability": 0.01187896728515625 }, { "start_logit": 12.8671875, "end_logit": 10.3984375, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-A", "probability": 0.01097869873046875 }, { "start_logit": 14.5078125, "end_logit": 8.28125, "text": " COVID-19 Vaccine During Pregnancy and Preterm", "probability": 0.00676727294921875 }, { "start_logit": 11.90625, "end_logit": 10.8515625, "text": "Gestational-Age at Birth \u2014 Eight", "probability": 0.006557464599609375 }, { "start_logit": 11.6796875, "end_logit": 10.8515625, "text": " Birth \u2014 Eight", "probability": 0.005268096923828125 }, { "start_logit": 12.8671875, "end_logit": 9.4453125, "text": "Receipt of COVID-19", "probability": 0.00423431396484375 }, { "start_logit": 11.90625, "end_logit": 10.3984375, "text": "Gestational-A", "probability": 0.00423431396484375 }, { "start_logit": 12.8671875, "end_logit": 9.1328125, "text": "Rece", "probability": 0.0030975341796875 }, { "start_logit": 12.8671875, "end_logit": 8.828125, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-\nGestational-Age", "probability": 0.00226593017578125 }, { "start_logit": 12.8671875, "end_logit": 8.28125, "text": "Receipt of COVID-19 Vaccine During Pregnancy and Preterm", "probability": 0.0013322830200195312 }, { "start_logit": 11.90625, "end_logit": 8.828125, "text": "Gestational-Age", "probability": 0.0008740425109863281 }, { "start_logit": 6.8984375, "end_logit": -0.59033203125, "text": "", "probability": 0.0 } ], "100000000000000000002180": [ { "start_logit": 19.8125, "end_logit": 5.32421875, "text": " New\n8. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19", "probability": 0.16748046875 }, { "start_logit": 17.265625, "end_logit": 7.3671875, "text": " JAMA. 2022;327(15):1478-1487", "probability": 0.10003662109375 }, { "start_logit": 19.8125, "end_logit": 4.5625, "text": " New\n8. Fell DB, Dhinsa T, Alton GD, et al. Association of COVID-19 Vaccination", "probability": 0.07794189453125 }, { "start_logit": 16.96875, "end_logit": 7.3671875, "text": " 2022;327(15):1478-1487", "probability": 0.07550048828125 }, { "start_logit": 19.8125, "end_logit": 4.40234375, "text": " New\n8", "probability": 0.066650390625 }, { "start_logit": 17.265625, "end_logit": 6.9609375, "text": " JAMA. 2022;", "probability": 0.066650390625 }, { "start_logit": 19.8125, "end_logit": 4.36328125, "text": " New", "probability": 0.0635986328125 }, { "start_logit": 17.65625, "end_logit": 6.42578125, "text": " https://doi.org/10.1001/jama.2022.4255", "probability": 0.05792236328125 }, { "start_logit": 16.96875, "end_logit": 6.9609375, "text": " 2022;", "probability": 0.050323486328125 }, { "start_logit": 17.265625, "end_logit": 6.42578125, "text": " JAMA. 2022;327(15):1478-1487. DOI: https://doi.org/10.1001/jama.2022.4255", "probability": 0.0391845703125 }, { "start_logit": 16.625, "end_logit": 6.9609375, "text": " COVID-19 Vaccination in Pregnancy With Adverse Peripartum\nOutcomes. JAMA. 2022;", "probability": 0.035675048828125 }, { "start_logit": 17.265625, "end_logit": 6.3046875, "text": " JAMA. 2022;327", "probability": 0.034576416015625 }, { "start_logit": 16.96875, "end_logit": 6.42578125, "text": " 2022;327(15):1478-1487. DOI: https://doi.org/10.1001/jama.2022.4255", "probability": 0.0291290283203125 }, { "start_logit": 16.96875, "end_logit": 6.3046875, "text": " 2022;327", "probability": 0.026092529296875 }, { "start_logit": 17.265625, "end_logit": 5.9375, "text": " JAMA. 2022;327(15):1478", "probability": 0.024139404296875 }, { "start_logit": 16.578125, "end_logit": 6.6015625, "text": "\nCong", "probability": 0.0237579345703125 }, { "start_logit": 16.625, "end_logit": 6.3046875, "text": " COVID-19 Vaccination in Pregnancy With Adverse Peripartum\nOutcomes. JAMA. 2022;327", "probability": 0.0185089111328125 }, { "start_logit": 16.96875, "end_logit": 5.9375, "text": " 2022;327(15):1478", "probability": 0.0179290771484375 }, { "start_logit": 16.625, "end_logit": 5.9375, "text": " COVID-19 Vaccination in Pregnancy With Adverse Peripartum\nOutcomes. JAMA. 2022;327(15):1478", "probability": 0.01271820068359375 }, { "start_logit": 15.9140625, "end_logit": 6.6015625, "text": " COVID-19 Vaccination During Early Pregnancy With Risk of\nCong", "probability": 0.01213836669921875 }, { "start_logit": 8.5, "end_logit": -1.5947265625, "text": "", "probability": 0.0 } ], "100000000000000000002183": [ { "start_logit": 12.1328125, "end_logit": 10.4453125, "text": "Dagan", "probability": 0.310302734375 }, { "start_logit": 12.1328125, "end_logit": 10.1953125, "text": "D", "probability": 0.24169921875 }, { "start_logit": 12.921875, "end_logit": 8.515625, "text": " N, Barda N, Biron", "probability": 0.09918212890625 }, { "start_logit": 10.5546875, "end_logit": 10.4453125, "text": "agan", "probability": 0.06402587890625 }, { "start_logit": 12.4609375, "end_logit": 8.515625, "text": " Barda N, Biron", "probability": 0.06207275390625 }, { "start_logit": 12.921875, "end_logit": 7.93359375, "text": " N, Barda", "probability": 0.055633544921875 }, { "start_logit": 12.1328125, "end_logit": 8.515625, "text": "Dagan N, Barda N, Biron", "probability": 0.04541015625 }, { "start_logit": 12.4609375, "end_logit": 7.93359375, "text": " Barda", "probability": 0.034820556640625 }, { "start_logit": 11.578125, "end_logit": 8.515625, "text": " Biron", "probability": 0.0258636474609375 }, { "start_logit": 12.1328125, "end_logit": 7.93359375, "text": "Dagan N, Barda", "probability": 0.0250701904296875 }, { "start_logit": 11.390625, "end_logit": 8.515625, "text": " N, Biron", "probability": 0.021453857421875 }, { "start_logit": 10.5546875, "end_logit": 8.515625, "text": "agan N, Barda N, Biron", "probability": 0.00922393798828125 }, { "start_logit": 10.5546875, "end_logit": 7.93359375, "text": "agan N, Barda", "probability": 0.005176544189453125 }, { "start_logit": 6.6328125, "end_logit": -0.6162109375, "text": "", "probability": 0.0 } ], "100000000000000000002186": [ { "start_logit": 12.1328125, "end_logit": 10.4453125, "text": "Dagan", "probability": 0.310302734375 }, { "start_logit": 12.1328125, "end_logit": 10.1953125, "text": "D", "probability": 0.24169921875 }, { "start_logit": 12.921875, "end_logit": 8.515625, "text": " N, Barda N, Biron", "probability": 0.09918212890625 }, { "start_logit": 10.5546875, "end_logit": 10.4453125, "text": "agan", "probability": 0.06402587890625 }, { "start_logit": 12.4609375, "end_logit": 8.515625, "text": " Barda N, Biron", "probability": 0.06207275390625 }, { "start_logit": 12.921875, "end_logit": 7.93359375, "text": " N, Barda", "probability": 0.055633544921875 }, { "start_logit": 12.1328125, "end_logit": 8.515625, "text": "Dagan N, Barda N, Biron", "probability": 0.04541015625 }, { "start_logit": 12.4609375, "end_logit": 7.93359375, "text": " Barda", "probability": 0.034820556640625 }, { "start_logit": 11.5703125, "end_logit": 8.515625, "text": " Biron", "probability": 0.0258636474609375 }, { "start_logit": 12.1328125, "end_logit": 7.93359375, "text": "Dagan N, Barda", "probability": 0.0250701904296875 }, { "start_logit": 11.390625, "end_logit": 8.515625, "text": " N, Biron", "probability": 0.021453857421875 }, { "start_logit": 10.5546875, "end_logit": 8.515625, "text": "agan N, Barda N, Biron", "probability": 0.00922393798828125 }, { "start_logit": 10.5546875, "end_logit": 7.93359375, "text": "agan N, Barda", "probability": 0.005176544189453125 }, { "start_logit": 6.52734375, "end_logit": -0.60498046875, "text": "", "probability": 0.0 } ], "100000000000000000002196": [ { "start_logit": 8.53125, "end_logit": 12.8828125, "text": "DO", "probability": 0.416015625 }, { "start_logit": 10.328125, "end_logit": 9.6484375, "text": " https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie", "probability": 0.09881591796875 }, { "start_logit": 8.53125, "end_logit": 11.15625, "text": "DOI:", "probability": 0.0745849609375 }, { "start_logit": 10.328125, "end_logit": 9.328125, "text": " https://doi.org/10.1038/s41591-021-01666", "probability": 0.07232666015625 }, { "start_logit": 10.328125, "end_logit": 9.28125, "text": " https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie A, Woodruff", "probability": 0.0689697265625 }, { "start_logit": 10.328125, "end_logit": 9.171875, "text": " https://doi.org/10.1038/s41591", "probability": 0.06182861328125 }, { "start_logit": 8.21875, "end_logit": 11.15625, "text": "I:", "probability": 0.0545654296875 }, { "start_logit": 8.96875, "end_logit": 9.6484375, "text": " Sekkarie", "probability": 0.0257720947265625 }, { "start_logit": 9.2109375, "end_logit": 9.28125, "text": " Woodruff", "probability": 0.0227508544921875 }, { "start_logit": 8.96875, "end_logit": 9.28125, "text": " Sekkarie A, Woodruff", "probability": 0.0177001953125 }, { "start_logit": 8.53125, "end_logit": 9.6484375, "text": "DOI: https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie", "probability": 0.0166473388671875 }, { "start_logit": 8.21875, "end_logit": 9.6484375, "text": "I: https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie", "probability": 0.01216888427734375 }, { "start_logit": 8.53125, "end_logit": 9.328125, "text": "DOI: https://doi.org/10.1038/s41591-021-01666", "probability": 0.01198577880859375 }, { "start_logit": 8.53125, "end_logit": 9.28125, "text": "DOI: https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie A, Woodruff", "probability": 0.01143646240234375 }, { "start_logit": 8.53125, "end_logit": 9.171875, "text": "DOI: https://doi.org/10.1038/s41591", "probability": 0.01024627685546875 }, { "start_logit": 8.21875, "end_logit": 9.328125, "text": "I: https://doi.org/10.1038/s41591-021-01666", "probability": 0.0087738037109375 }, { "start_logit": 8.21875, "end_logit": 9.28125, "text": "I: https://doi.org/10.1038/s41591-021-01666-2\n16. Sekkarie A, Woodruff", "probability": 0.00836181640625 }, { "start_logit": 8.21875, "end_logit": 9.171875, "text": "I: https://doi.org/10.1038/s41591", "probability": 0.00749969482421875 }, { "start_logit": 5.94921875, "end_logit": -0.22900390625, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000002199": [ { "start_logit": 16.5625, "end_logit": 10.9765625, "text": " SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.185546875 }, { "start_logit": 16.875, "end_logit": 10.578125, "text": " BNT162b2 messenger RNA", "probability": 0.1715087890625 }, { "start_logit": 16.1875, "end_logit": 10.9765625, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.1275634765625 }, { "start_logit": 16.5625, "end_logit": 10.578125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.12548828125 }, { "start_logit": 16.875, "end_logit": 9.484375, "text": " BNT162b2", "probability": 0.057464599609375 }, { "start_logit": 16.875, "end_logit": 9.3828125, "text": " BNT162b2 messenger", "probability": 0.051483154296875 }, { "start_logit": 16.875, "end_logit": 9.2890625, "text": " BNT162b2 messenger RNA vaccine", "probability": 0.046905517578125 }, { "start_logit": 16.5625, "end_logit": 9.484375, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2", "probability": 0.04205322265625 }, { "start_logit": 16.5625, "end_logit": 9.3828125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger", "probability": 0.037689208984375 }, { "start_logit": 16.5625, "end_logit": 9.2890625, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA vaccine", "probability": 0.0343017578125 }, { "start_logit": 14.5390625, "end_logit": 10.9765625, "text": " Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0247039794921875 }, { "start_logit": 14.5, "end_logit": 10.9765625, "text": " O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0235748291015625 }, { "start_logit": 16.5625, "end_logit": 8.4296875, "text": " SARS-CoV-2", "probability": 0.01476287841796875 }, { "start_logit": 16.5625, "end_logit": 8.0859375, "text": " SARS-CoV-2 immunoglobulin", "probability": 0.010467529296875 }, { "start_logit": 16.1875, "end_logit": 8.4296875, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2", "probability": 0.0101470947265625 }, { "start_logit": 13.65625, "end_logit": 10.9765625, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0101470947265625 }, { "start_logit": 13.3515625, "end_logit": 10.9765625, "text": " Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.007541656494140625 }, { "start_logit": 16.1875, "end_logit": 8.0859375, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin", "probability": 0.00719451904296875 }, { "start_logit": 13.65625, "end_logit": 10.578125, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.006862640380859375 }, { "start_logit": 16.875, "end_logit": 6.97265625, "text": " BNT162", "probability": 0.00464630126953125 }, { "start_logit": 7.1875, "end_logit": -0.951171875, "text": "", "probability": 0.0 } ], "100000000000000000002201": [ { "start_logit": 16.5625, "end_logit": 10.9765625, "text": " SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.185546875 }, { "start_logit": 16.875, "end_logit": 10.578125, "text": " BNT162b2 messenger RNA", "probability": 0.1715087890625 }, { "start_logit": 16.1875, "end_logit": 10.9765625, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.1275634765625 }, { "start_logit": 16.5625, "end_logit": 10.578125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.12548828125 }, { "start_logit": 16.875, "end_logit": 9.484375, "text": " BNT162b2", "probability": 0.057464599609375 }, { "start_logit": 16.875, "end_logit": 9.3828125, "text": " BNT162b2 messenger", "probability": 0.051483154296875 }, { "start_logit": 16.875, "end_logit": 9.2890625, "text": " BNT162b2 messenger RNA vaccine", "probability": 0.046905517578125 }, { "start_logit": 16.5625, "end_logit": 9.484375, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2", "probability": 0.04205322265625 }, { "start_logit": 16.5625, "end_logit": 9.3828125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger", "probability": 0.037689208984375 }, { "start_logit": 16.5625, "end_logit": 9.2890625, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA vaccine", "probability": 0.0343017578125 }, { "start_logit": 14.5390625, "end_logit": 10.9765625, "text": " Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0247039794921875 }, { "start_logit": 14.5, "end_logit": 10.9765625, "text": " O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0235748291015625 }, { "start_logit": 16.5625, "end_logit": 8.4296875, "text": " SARS-CoV-2", "probability": 0.01476287841796875 }, { "start_logit": 16.5625, "end_logit": 8.0859375, "text": " SARS-CoV-2 immunoglobulin", "probability": 0.010467529296875 }, { "start_logit": 16.1875, "end_logit": 8.4296875, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2", "probability": 0.0101470947265625 }, { "start_logit": 13.65625, "end_logit": 10.9765625, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0101470947265625 }, { "start_logit": 13.3515625, "end_logit": 10.9765625, "text": " Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.007541656494140625 }, { "start_logit": 16.1875, "end_logit": 8.0859375, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin", "probability": 0.00719451904296875 }, { "start_logit": 13.65625, "end_logit": 10.578125, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.006862640380859375 }, { "start_logit": 16.875, "end_logit": 6.97265625, "text": " BNT162", "probability": 0.00464630126953125 }, { "start_logit": 7.19140625, "end_logit": -0.99072265625, "text": "", "probability": 0.0 } ], "100000000000000000002204": [ { "start_logit": 16.5625, "end_logit": 10.9765625, "text": " SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.185546875 }, { "start_logit": 16.875, "end_logit": 10.578125, "text": " BNT162b2 messenger RNA", "probability": 0.1715087890625 }, { "start_logit": 16.1875, "end_logit": 10.9765625, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.1275634765625 }, { "start_logit": 16.5625, "end_logit": 10.578125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.12548828125 }, { "start_logit": 16.875, "end_logit": 9.484375, "text": " BNT162b2", "probability": 0.057464599609375 }, { "start_logit": 16.875, "end_logit": 9.3828125, "text": " BNT162b2 messenger", "probability": 0.051483154296875 }, { "start_logit": 16.875, "end_logit": 9.2890625, "text": " BNT162b2 messenger RNA vaccine", "probability": 0.046905517578125 }, { "start_logit": 16.5625, "end_logit": 9.484375, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2", "probability": 0.04205322265625 }, { "start_logit": 16.5625, "end_logit": 9.3828125, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger", "probability": 0.037689208984375 }, { "start_logit": 16.5625, "end_logit": 9.2890625, "text": " SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA vaccine", "probability": 0.0343017578125 }, { "start_logit": 14.5390625, "end_logit": 10.9765625, "text": " Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0247039794921875 }, { "start_logit": 14.5, "end_logit": 10.9765625, "text": " O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0235748291015625 }, { "start_logit": 16.5625, "end_logit": 8.4296875, "text": " SARS-CoV-2", "probability": 0.01476287841796875 }, { "start_logit": 16.5625, "end_logit": 8.0859375, "text": " SARS-CoV-2 immunoglobulin", "probability": 0.010467529296875 }, { "start_logit": 16.1875, "end_logit": 8.4296875, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2", "probability": 0.0101470947265625 }, { "start_logit": 13.65625, "end_logit": 10.9765625, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.0101470947265625 }, { "start_logit": 13.3515625, "end_logit": 10.9765625, "text": " Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies", "probability": 0.007541656494140625 }, { "start_logit": 16.1875, "end_logit": 8.0859375, "text": "Nir O, Schwartz A, Toussia-Cohen S, et al. Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin", "probability": 0.00719451904296875 }, { "start_logit": 13.65625, "end_logit": 10.578125, "text": " Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies\namong parturient women treated with BNT162b2 messenger RNA", "probability": 0.006862640380859375 }, { "start_logit": 16.875, "end_logit": 6.97265625, "text": " BNT162", "probability": 0.00464630126953125 }, { "start_logit": 7.109375, "end_logit": -0.9658203125, "text": "", "probability": 0.0 } ], "100000000000000000002214": [ { "start_logit": 19.625, "end_logit": 12.3515625, "text": " Drugs and Lactation Database", "probability": 0.79638671875 }, { "start_logit": 19.625, "end_logit": 10.09375, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.08392333984375 }, { "start_logit": 19.625, "end_logit": 8.859375, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US", "probability": 0.0244140625 }, { "start_logit": 19.625, "end_logit": 8.359375, "text": " Drugs and Lactation", "probability": 0.01480865478515625 }, { "start_logit": 19.625, "end_logit": 8.1640625, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine", "probability": 0.01209259033203125 }, { "start_logit": 17.578125, "end_logit": 10.09375, "text": " 2006", "probability": 0.01084136962890625 }, { "start_logit": 17.375, "end_logit": 10.09375, "text": " Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.00884246826171875 }, { "start_logit": 15.03125, "end_logit": 12.3515625, "text": " 2022;13:852928. Published 2022 Apr 8. 26. Drugs and Lactation Database", "probability": 0.008056640625 }, { "start_logit": 14.953125, "end_logit": 12.3515625, "text": " Published 2022 Apr 8. 26. Drugs and Lactation Database", "probability": 0.007564544677734375 }, { "start_logit": 17.0625, "end_logit": 10.09375, "text": " National Library of Medicine (US); 2006", "probability": 0.0064697265625 }, { "start_logit": 19.625, "end_logit": 7.5, "text": " Drugs", "probability": 0.006275177001953125 }, { "start_logit": 19.625, "end_logit": 6.87109375, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library", "probability": 0.00335693359375 }, { "start_logit": 17.375, "end_logit": 8.953125, "text": " The Effects of COVID-19 Vaccination on\nLactating Women: A Systematic Review of the Literature. Front Immunol. 2022;", "probability": 0.0028285980224609375 }, { "start_logit": 19.625, "end_logit": 6.61328125, "text": " Drugs and Lact", "probability": 0.002574920654296875 }, { "start_logit": 17.375, "end_logit": 8.859375, "text": " Bethesda (MD): National Library of Medicine (US", "probability": 0.002574920654296875 }, { "start_logit": 16.015625, "end_logit": 10.09375, "text": "LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.0022716522216796875 }, { "start_logit": 17.578125, "end_logit": 8.5, "text": " 2006-. COVID-19\nVaccines. [Updated 2022", "probability": 0.0022029876708984375 }, { "start_logit": 17.0625, "end_logit": 8.859375, "text": " National Library of Medicine (US", "probability": 0.0018835067749023438 }, { "start_logit": 17.375, "end_logit": 8.5, "text": " Bethesda (MD): National Library of Medicine (US); 2006-. COVID-19\nVaccines. [Updated 2022", "probability": 0.001796722412109375 }, { "start_logit": 17.0625, "end_logit": 8.5, "text": " National Library of Medicine (US); 2006-. COVID-19\nVaccines. [Updated 2022", "probability": 0.0013141632080078125 }, { "start_logit": 8.1640625, "end_logit": -1.166015625, "text": "", "probability": 0.0 } ], "100000000000000000002217": [ { "start_logit": 19.625, "end_logit": 12.3515625, "text": " Drugs and Lactation Database", "probability": 0.79443359375 }, { "start_logit": 19.625, "end_logit": 10.09375, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.083740234375 }, { "start_logit": 19.625, "end_logit": 8.8671875, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US", "probability": 0.024749755859375 }, { "start_logit": 19.625, "end_logit": 8.3671875, "text": " Drugs and Lactation", "probability": 0.01500701904296875 }, { "start_logit": 19.625, "end_logit": 8.15625, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine", "probability": 0.01206207275390625 }, { "start_logit": 17.59375, "end_logit": 10.09375, "text": " 2006", "probability": 0.01097869873046875 }, { "start_logit": 17.375, "end_logit": 10.09375, "text": " Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.00882720947265625 }, { "start_logit": 15.0234375, "end_logit": 12.3515625, "text": " 2022;13:852928. Published 2022 Apr 8. 26. Drugs and Lactation Database", "probability": 0.00803375244140625 }, { "start_logit": 14.96875, "end_logit": 12.3515625, "text": " Published 2022 Apr 8. 26. Drugs and Lactation Database", "probability": 0.00754547119140625 }, { "start_logit": 17.0625, "end_logit": 10.09375, "text": " National Library of Medicine (US); 2006", "probability": 0.0064544677734375 }, { "start_logit": 19.625, "end_logit": 7.5, "text": " Drugs", "probability": 0.006259918212890625 }, { "start_logit": 19.625, "end_logit": 6.87109375, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library", "probability": 0.00334930419921875 }, { "start_logit": 17.359375, "end_logit": 8.953125, "text": " The Effects of COVID-19 Vaccination on\nLactating Women: A Systematic Review of the Literature. Front Immunol. 2022;", "probability": 0.002777099609375 }, { "start_logit": 17.375, "end_logit": 8.8671875, "text": " Bethesda (MD): National Library of Medicine (US", "probability": 0.0026092529296875 }, { "start_logit": 19.625, "end_logit": 6.61328125, "text": " Drugs and Lact", "probability": 0.0025691986083984375 }, { "start_logit": 19.625, "end_logit": 6.546875, "text": " Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD", "probability": 0.0024127960205078125 }, { "start_logit": 16.015625, "end_logit": 10.09375, "text": "LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006", "probability": 0.00226593017578125 }, { "start_logit": 17.59375, "end_logit": 8.5, "text": " 2006-. COVID-19\nVaccines. [Updated 2022", "probability": 0.002231597900390625 }, { "start_logit": 17.0625, "end_logit": 8.8671875, "text": " National Library of Medicine (US", "probability": 0.0019092559814453125 }, { "start_logit": 17.375, "end_logit": 8.5, "text": " Bethesda (MD): National Library of Medicine (US); 2006-. COVID-19\nVaccines. [Updated 2022", "probability": 0.00179290771484375 }, { "start_logit": 8.28125, "end_logit": -1.2099609375, "text": "", "probability": 0.0 } ], "100000000000000000002227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.25, "end_logit": -0.44189453125, "text": "", "probability": 0.998896973358602 } ], "100000000000000000002228": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 7.16015625, "end_logit": -0.406005859375, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000002234": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 6.6640625, "end_logit": -0.24462890625, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000002235": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.39453125, "end_logit": -0.72509765625, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000002237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.37109375, "end_logit": -0.6611328125, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000002238": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.390625, "end_logit": -0.7734375, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000002245": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010775025886693324 }, { "start_logit": 7.625, "end_logit": -0.79150390625, "text": "", "probability": 0.9989224974113308 } ], "100000000000000000002246": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.5078125, "end_logit": -0.82666015625, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000002248": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.16796875, "end_logit": -0.404296875, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000002251": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.1796875, "end_logit": -0.436767578125, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000002254": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.0859375, "end_logit": -0.349609375, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000002255": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.109375, "end_logit": -0.297119140625, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000002257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.25, "end_logit": -0.38232421875, "text": "", "probability": 0.998959681497187 } ], "100000000000000000002261": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.5859375, "end_logit": -0.79052734375, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000002264": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009622125595974061 }, { "start_logit": 7.2265625, "end_logit": -0.282470703125, "text": "", "probability": 0.9990377874404025 } ], "100000000000000000002265": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.23046875, "end_logit": -0.3095703125, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000002266": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.28125, "end_logit": -0.33056640625, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000002267": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.21484375, "end_logit": -0.288330078125, "text": "", "probability": 0.999018828118793 } ], "100000000000000000002270": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021405892581107663 }, { "start_logit": 6.875, "end_logit": -0.72900390625, "text": "", "probability": 0.9978594107418892 } ], "100000000000000000002277": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002287227605869875 }, { "start_logit": 6.6015625, "end_logit": -0.52197265625, "text": "", "probability": 0.9977127723941301 } ], "100000000000000000002279": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00225184727950302 }, { "start_logit": 6.5625, "end_logit": -0.470458984375, "text": "", "probability": 0.997748152720497 } ], "100000000000000000002287": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.609375, "end_logit": -0.92431640625, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000002291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.6015625, "end_logit": -0.91796875, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000002294": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 7.765625, "end_logit": -0.5517578125, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000002297": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003640086870995012 }, { "start_logit": 8.0859375, "end_logit": -0.1693115234375, "text": "", "probability": 0.9996359913129005 } ], "100000000000000000002298": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042720789094732544 }, { "start_logit": 8.046875, "end_logit": -0.28857421875, "text": "", "probability": 0.9995727921090527 } ], "100000000000000000002304": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001707367485760838 }, { "start_logit": 7.0078125, "end_logit": -0.63525390625, "text": "", "probability": 0.9982926325142392 } ], "100000000000000000002308": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009622125595974061 }, { "start_logit": 7.67578125, "end_logit": -0.73095703125, "text": "", "probability": 0.9990377874404025 } ], "100000000000000000002309": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.62109375, "end_logit": -0.72802734375, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000002313": [ { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 34.53125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immun", "probability": 0.125 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -34.0625, "end_logit": 26.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised", "probability": 3.266334533691406e-05 }, { "start_logit": -33.0, "end_logit": 25.203125, "text": " 2 months", "probability": 3.218650817871094e-05 }, { "start_logit": -34.0625, "end_logit": 26.265625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocom", "probability": 3.218650817871094e-05 }, { "start_logit": -34.0625, "end_logit": 26.265625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocom", "probability": 3.218650817871094e-05 }, { "start_logit": -34.0625, "end_logit": 26.265625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocom", "probability": 3.218650817871094e-05 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002316": [ { "start_logit": 10.6640625, "end_logit": 11.390625, "text": " 2 months", "probability": 0.169677734375 }, { "start_logit": 9.96875, "end_logit": 11.6953125, "text": " 2 months", "probability": 0.11297607421875 }, { "start_logit": 10.3125, "end_logit": 11.203125, "text": " monovalent", "probability": 0.09814453125 }, { "start_logit": 7.90234375, "end_logit": 13.546875, "text": " Moderna", "probability": 0.09222412109375 }, { "start_logit": 9.5234375, "end_logit": 11.6953125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.072998046875 }, { "start_logit": 9.78125, "end_logit": 11.390625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.06964111328125 }, { "start_logit": 10.75, "end_logit": 10.328125, "text": " monovalent", "probability": 0.06341552734375 }, { "start_logit": 10.671875, "end_logit": 10.25, "text": "Moderna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks", "probability": 0.054229736328125 }, { "start_logit": 10.671875, "end_logit": 10.21875, "text": "Moderna", "probability": 0.05255126953125 }, { "start_logit": 9.796875, "end_logit": 10.6484375, "text": "Johnson & Johnson's Janssen", "probability": 0.033416748046875 }, { "start_logit": 8.9921875, "end_logit": 11.390625, "text": " 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0313720703125 }, { "start_logit": 9.5234375, "end_logit": 10.4375, "text": "BIVALENT", "probability": 0.020904541015625 }, { "start_logit": 9.5546875, "end_logit": 10.375, "text": " 2 months", "probability": 0.020263671875 }, { "start_logit": 8.7265625, "end_logit": 11.203125, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.020263671875 }, { "start_logit": 8.59375, "end_logit": 11.203125, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.017608642578125 }, { "start_logit": 10.3125, "end_logit": 9.296875, "text": " monovalent Novavax", "probability": 0.01458740234375 }, { "start_logit": 7.90234375, "end_logit": 11.6953125, "text": " Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.014373779296875 }, { "start_logit": 9.2421875, "end_logit": 10.328125, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.01392364501953125 }, { "start_logit": 8.7265625, "end_logit": 10.828125, "text": " 2 months", "probability": 0.01392364501953125 }, { "start_logit": 9.3515625, "end_logit": 10.1796875, "text": " 2 months", "probability": 0.0135040283203125 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002321": [ { "start_logit": -34.46875, "end_logit": 36.78125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received", "probability": 0.333251953125 }, { "start_logit": -34.46875, "end_logit": 36.78125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received", "probability": 0.333251953125 }, { "start_logit": -34.46875, "end_logit": 36.78125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received", "probability": 0.333251953125 }, { "start_logit": -34.46875, "end_logit": 28.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the", "probability": 6.783008575439453e-05 }, { "start_logit": -34.46875, "end_logit": 28.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the", "probability": 6.783008575439453e-05 }, { "start_logit": -34.46875, "end_logit": 28.28125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the", "probability": 6.783008575439453e-05 }, { "start_logit": -33.0, "end_logit": 25.203125, "text": " 2 months", "probability": 1.3589859008789062e-05 }, { "start_logit": -33.875, "end_logit": 25.203125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 5.662441253662109e-06 }, { "start_logit": -33.5, "end_logit": 24.0, "text": "3 weeks", "probability": 2.4437904357910156e-06 }, { "start_logit": -33.71875, "end_logit": 24.140625, "text": " 2 months", "probability": 2.2649765014648438e-06 }, { "start_logit": -33.90625, "end_logit": 24.15625, "text": " 2 months", "probability": 1.9073486328125e-06 }, { "start_logit": -34.46875, "end_logit": 24.703125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months", "probability": 1.9073486328125e-06 }, { "start_logit": -34.46875, "end_logit": 24.703125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months", "probability": 1.9073486328125e-06 }, { "start_logit": -34.46875, "end_logit": 24.703125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months", "probability": 1.9073486328125e-06 }, { "start_logit": -34.46875, "end_logit": 24.65625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most", "probability": 1.7881393432617188e-06 }, { "start_logit": -34.46875, "end_logit": 24.65625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most", "probability": 1.7881393432617188e-06 }, { "start_logit": -34.46875, "end_logit": 24.65625, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most", "probability": 1.7881393432617188e-06 }, { "start_logit": -33.875, "end_logit": 23.890625, "text": "BIVALENT", "probability": 1.5497207641601562e-06 }, { "start_logit": -36.1875, "end_logit": 26.1875, "text": "Johnson & Johnson's Janssen", "probability": 1.4901161193847656e-06 }, { "start_logit": -33.5, "end_logit": 23.421875, "text": "3", "probability": 1.3709068298339844e-06 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002322": [ { "start_logit": -34.3125, "end_logit": 30.96875, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [", "probability": 0.94482421875 }, { "start_logit": -34.3125, "end_logit": 27.296875, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1", "probability": 0.024017333984375 }, { "start_logit": -33.0, "end_logit": 25.203125, "text": " 2 months", "probability": 0.0110015869140625 }, { "start_logit": -33.875, "end_logit": 25.203125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.00458526611328125 }, { "start_logit": -33.5, "end_logit": 24.0, "text": "3 weeks", "probability": 0.002002716064453125 }, { "start_logit": -34.3125, "end_logit": 24.8125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]", "probability": 0.002002716064453125 }, { "start_logit": -33.71875, "end_logit": 24.140625, "text": " 2 months", "probability": 0.0018520355224609375 }, { "start_logit": -33.90625, "end_logit": 24.15625, "text": " 2 months", "probability": 0.0015592575073242188 }, { "start_logit": -33.875, "end_logit": 23.890625, "text": "BIVALENT", "probability": 0.0012340545654296875 }, { "start_logit": -33.5, "end_logit": 23.421875, "text": "3", "probability": 0.0011234283447265625 }, { "start_logit": -33.5, "end_logit": 23.171875, "text": "3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks", "probability": 0.0008749961853027344 }, { "start_logit": -34.3125, "end_logit": 23.953125, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\n", "probability": 0.0008482933044433594 }, { "start_logit": -34.625, "end_logit": 24.15625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0007605552673339844 }, { "start_logit": -38.03125, "end_logit": 27.53125, "text": "Johnson & Johnson's Janssen", "probability": 0.0007367134094238281 }, { "start_logit": -34.6875, "end_logit": 24.140625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0007033348083496094 }, { "start_logit": -34.1875, "end_logit": 23.4375, "text": "3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT", "probability": 0.0005736351013183594 }, { "start_logit": -34.1875, "end_logit": 23.234375, "text": "3 weeks", "probability": 0.0004684925079345703 }, { "start_logit": -38.125, "end_logit": 27.0625, "text": " 2 months", "probability": 0.00041985511779785156 }, { "start_logit": -34.625, "end_logit": 23.4375, "text": "BIVALENT", "probability": 0.0003705024719238281 }, { "start_logit": -35.34375, "end_logit": 24.0, "text": "Pfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks", "probability": 0.00031685829162597656 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002323": [ { "start_logit": 10.6640625, "end_logit": 11.390625, "text": " 2 months", "probability": 0.169677734375 }, { "start_logit": 9.96875, "end_logit": 11.6953125, "text": " 2 months", "probability": 0.11297607421875 }, { "start_logit": 10.3125, "end_logit": 11.203125, "text": " monovalent", "probability": 0.09814453125 }, { "start_logit": 7.90234375, "end_logit": 13.546875, "text": " Moderna", "probability": 0.09222412109375 }, { "start_logit": 9.5234375, "end_logit": 11.6953125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.072998046875 }, { "start_logit": 9.78125, "end_logit": 11.390625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.06964111328125 }, { "start_logit": 10.75, "end_logit": 10.328125, "text": " monovalent", "probability": 0.06341552734375 }, { "start_logit": 10.671875, "end_logit": 10.25, "text": "Moderna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks", "probability": 0.054229736328125 }, { "start_logit": 10.671875, "end_logit": 10.21875, "text": "Moderna", "probability": 0.05255126953125 }, { "start_logit": 9.796875, "end_logit": 10.6484375, "text": "Johnson & Johnson's Janssen", "probability": 0.033416748046875 }, { "start_logit": 8.9921875, "end_logit": 11.390625, "text": " 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0313720703125 }, { "start_logit": 9.5234375, "end_logit": 10.4375, "text": "BIVALENT", "probability": 0.020904541015625 }, { "start_logit": 9.5546875, "end_logit": 10.375, "text": " 2 months", "probability": 0.020263671875 }, { "start_logit": 8.7265625, "end_logit": 11.203125, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.020263671875 }, { "start_logit": 8.59375, "end_logit": 11.203125, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.017608642578125 }, { "start_logit": 10.3125, "end_logit": 9.296875, "text": " monovalent Novavax", "probability": 0.01458740234375 }, { "start_logit": 7.90234375, "end_logit": 11.6953125, "text": " Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.014373779296875 }, { "start_logit": 9.2421875, "end_logit": 10.328125, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.01392364501953125 }, { "start_logit": 8.7265625, "end_logit": 10.828125, "text": " 2 months", "probability": 0.01392364501953125 }, { "start_logit": 9.3515625, "end_logit": 10.1796875, "text": " 2 months", "probability": 0.0135040283203125 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002331": [ { "start_logit": 14.6015625, "end_logit": 10.1953125, "text": " 2 months", "probability": 0.45361328125 }, { "start_logit": 14.5234375, "end_logit": 9.0390625, "text": " monovalent", "probability": 0.1319580078125 }, { "start_logit": 11.9765625, "end_logit": 10.2265625, "text": "ALENT", "probability": 0.033905029296875 }, { "start_logit": 11.9765625, "end_logit": 10.1953125, "text": "ALENT) BOOSTER\nAt least 2 months", "probability": 0.032867431640625 }, { "start_logit": 13.0546875, "end_logit": 9.1015625, "text": " 2 months", "probability": 0.032318115234375 }, { "start_logit": 13.0546875, "end_logit": 9.0390625, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.0303955078125 }, { "start_logit": 12.890625, "end_logit": 9.1015625, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0276641845703125 }, { "start_logit": 12.890625, "end_logit": 9.0390625, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.0259857177734375 }, { "start_logit": 11.7421875, "end_logit": 10.1953125, "text": " BOOSTER\nAt least 2 months", "probability": 0.0259857177734375 }, { "start_logit": 14.5234375, "end_logit": 7.3671875, "text": " monovalent Novavax", "probability": 0.0247955322265625 }, { "start_logit": 13.671875, "end_logit": 8.171875, "text": " 8 weeks", "probability": 0.0236663818359375 }, { "start_logit": 12.953125, "end_logit": 8.8828125, "text": " 2 months", "probability": 0.0236663818359375 }, { "start_logit": 11.9765625, "end_logit": 9.8671875, "text": "AL", "probability": 0.0236663818359375 }, { "start_logit": 14.6015625, "end_logit": 7.13671875, "text": " 2", "probability": 0.021209716796875 }, { "start_logit": 14.5234375, "end_logit": 7.1328125, "text": " monovalent Novavax booster\nis available in limited situations\nMore details: Novavax", "probability": 0.0196075439453125 }, { "start_logit": 12.890625, "end_logit": 8.5078125, "text": "3 weeks", "probability": 0.01528167724609375 }, { "start_logit": 12.5078125, "end_logit": 8.8203125, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.014129638671875 }, { "start_logit": 12.4921875, "end_logit": 8.8203125, "text": " 2 months", "probability": 0.01390838623046875 }, { "start_logit": 12.140625, "end_logit": 9.1015625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0130615234375 }, { "start_logit": 12.140625, "end_logit": 9.0390625, "text": "BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.01227569580078125 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002333": [ { "start_logit": 14.6015625, "end_logit": 10.1953125, "text": " 2 months", "probability": 0.45361328125 }, { "start_logit": 14.5234375, "end_logit": 9.0390625, "text": " monovalent", "probability": 0.1319580078125 }, { "start_logit": 11.9765625, "end_logit": 10.2265625, "text": "ALENT", "probability": 0.033905029296875 }, { "start_logit": 11.9765625, "end_logit": 10.1953125, "text": "ALENT) BOOSTER\nAt least 2 months", "probability": 0.032867431640625 }, { "start_logit": 13.0546875, "end_logit": 9.1015625, "text": " 2 months", "probability": 0.032318115234375 }, { "start_logit": 13.0546875, "end_logit": 9.0390625, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.0303955078125 }, { "start_logit": 12.890625, "end_logit": 9.1015625, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0276641845703125 }, { "start_logit": 12.890625, "end_logit": 9.0390625, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.0259857177734375 }, { "start_logit": 11.7421875, "end_logit": 10.1953125, "text": " BOOSTER\nAt least 2 months", "probability": 0.0259857177734375 }, { "start_logit": 14.5234375, "end_logit": 7.3671875, "text": " monovalent Novavax", "probability": 0.0247955322265625 }, { "start_logit": 13.671875, "end_logit": 8.171875, "text": " 8 weeks", "probability": 0.0236663818359375 }, { "start_logit": 12.953125, "end_logit": 8.8828125, "text": " 2 months", "probability": 0.0236663818359375 }, { "start_logit": 11.9765625, "end_logit": 9.8671875, "text": "AL", "probability": 0.0236663818359375 }, { "start_logit": 14.6015625, "end_logit": 7.13671875, "text": " 2", "probability": 0.021209716796875 }, { "start_logit": 14.5234375, "end_logit": 7.1328125, "text": " monovalent Novavax booster\nis available in limited situations\nMore details: Novavax", "probability": 0.0196075439453125 }, { "start_logit": 12.890625, "end_logit": 8.5078125, "text": "3 weeks", "probability": 0.01528167724609375 }, { "start_logit": 12.5078125, "end_logit": 8.8203125, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.014129638671875 }, { "start_logit": 12.4921875, "end_logit": 8.8203125, "text": " 2 months", "probability": 0.01390838623046875 }, { "start_logit": 12.140625, "end_logit": 9.1015625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0130615234375 }, { "start_logit": 12.140625, "end_logit": 9.0390625, "text": "BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.01227569580078125 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002337": [ { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 32.84375, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPf", "probability": 0.0555419921875 }, { "start_logit": -33.625, "end_logit": 26.671875, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPfizer", "probability": 0.00011593103408813477 }, { "start_logit": -33.625, "end_logit": 26.671875, "text": "\u2022\n\u2022\n-\n-\n\u2022\n\u2022\n\u2022 TM\nPre-teens, Teens and Adults Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nPfizer-BioNTech\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nAGE GROUP\n18 YEARS AND OLDER\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nModerna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 3rd dose\nor last booster\nUp to Date: Immediately after the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nJohnson & Johnson's Janssen\n\uf1aa\nPRIMARY SERIES\nADDITIONAL DOSE\nAt least 4 weeks after 1st dose\nand should be Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nor last booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nAGE GROUP\n18 YEARS AND OLDER\nAGE GROUP\nNovavax\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent Novavax booster\nis available in limited situations\nMore details: Novavax booster\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nPRIMARY SERIES\nPRIMARY SERIES\n3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\f10/30/22, 9:28 AM COVID-19 Vaccines for People Who Are Moderately or Severely Immunocompromised | CDC\nUp to Date: Immediately after you have received the most recent booster recommended for you [ 1 ]\nChildren Ages 6 Months-11 Years Who Are Moderately or Severely\nImmunocompromised\nAGE GROUP\nAGE GROUP\nPfizer", "probability": 0.00011593103408813477 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002340": [ { "start_logit": 16.15625, "end_logit": 8.25, "text": " 2 months", "probability": 0.29541015625 }, { "start_logit": 15.4453125, "end_logit": 8.25, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.1439208984375 }, { "start_logit": 16.421875, "end_logit": 6.921875, "text": " monovalent", "probability": 0.10211181640625 }, { "start_logit": 15.4921875, "end_logit": 7.453125, "text": "Johnson & Johnson's Janssen", "probability": 0.0679931640625 }, { "start_logit": 14.4453125, "end_logit": 8.25, "text": " 4 weeks after 2nd dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.052978515625 }, { "start_logit": 15.25, "end_logit": 7.4140625, "text": " 2 months", "probability": 0.051361083984375 }, { "start_logit": 15.109375, "end_logit": 7.18359375, "text": " 2 months", "probability": 0.035858154296875 }, { "start_logit": 15.0, "end_logit": 7.12109375, "text": " 2 months", "probability": 0.030181884765625 }, { "start_logit": 14.8125, "end_logit": 7.12109375, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0250244140625 }, { "start_logit": 15.0, "end_logit": 6.921875, "text": " 2 months after 2nd dose\nA monovalent", "probability": 0.024627685546875 }, { "start_logit": 15.4453125, "end_logit": 6.3515625, "text": "BIVALENT", "probability": 0.0217437744140625 }, { "start_logit": 14.8125, "end_logit": 6.921875, "text": "3 weeks after 1st dose\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months after 2nd dose\nA monovalent", "probability": 0.0204315185546875 }, { "start_logit": 14.3046875, "end_logit": 7.4140625, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.020111083984375 }, { "start_logit": 14.5078125, "end_logit": 7.1328125, "text": "4 weeks", "probability": 0.018585205078125 }, { "start_logit": 14.5078125, "end_logit": 7.05078125, "text": "4 weeks after 1st dose\nPRIMARY SERIES\nAt least 4 weeks", "probability": 0.0171966552734375 }, { "start_logit": 16.15625, "end_logit": 5.36328125, "text": " 2", "probability": 0.0164031982421875 }, { "start_logit": 14.4453125, "end_logit": 7.05078125, "text": " 4 weeks", "probability": 0.0161590576171875 }, { "start_logit": 14.171875, "end_logit": 7.18359375, "text": " Pfizer-BioNTech\nor Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0140380859375 }, { "start_logit": 14.8125, "end_logit": 6.4609375, "text": "3 weeks", "probability": 0.0129852294921875 }, { "start_logit": 14.140625, "end_logit": 7.1328125, "text": "Moderna\n\uf1aa\nPRIMARY SERIES\nPRIMARY SERIES\n4 weeks", "probability": 0.0129852294921875 }, { "start_logit": -38.96875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000002341": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026522597057856566 }, { "start_logit": 6.0859375, "end_logit": -0.156005859375, "text": "", "probability": 0.9973477402942144 } ], "100000000000000000002342": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00268343980885746 }, { "start_logit": 6.1171875, "end_logit": -0.20068359375, "text": "", "probability": 0.9973165601911425 } ], "100000000000000000002343": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030515101629349155 }, { "start_logit": 5.96484375, "end_logit": -0.174072265625, "text": "", "probability": 0.9969484898370652 } ], "100000000000000000002344": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002800926967120973 }, { "start_logit": 6.05859375, "end_logit": -0.18408203125, "text": "", "probability": 0.9971990730328789 } ], "100000000000000000002347": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002757622367395409 }, { "start_logit": 6.09375, "end_logit": -0.20458984375, "text": "", "probability": 0.9972423776326046 } ], "100000000000000000002354": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.640625, "end_logit": -0.5693359375, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000002355": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.59765625, "end_logit": -0.58349609375, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000002356": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.70703125, "end_logit": -0.56005859375, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000002358": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008167381046669486 }, { "start_logit": 7.7265625, "end_logit": -0.61572265625, "text": "", "probability": 0.999183261895333 } ], "100000000000000000002359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009622125595974061 }, { "start_logit": 7.53125, "end_logit": -0.5869140625, "text": "", "probability": 0.9990377874404025 } ], "100000000000000000002360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000872767030892148 }, { "start_logit": 6.78515625, "end_logit": 0.258056640625, "text": "", "probability": 0.9991272329691079 } ], "100000000000000000002361": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008263575992788699 }, { "start_logit": 6.82421875, "end_logit": 0.275146484375, "text": "", "probability": 0.9991736424007212 } ], "100000000000000000002362": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 6.85546875, "end_logit": 0.291259765625, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000002364": [ { "start_logit": 16.125, "end_logit": 9.8125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.21142578125 }, { "start_logit": 15.96875, "end_logit": 9.65625, "text": "Advanced or untreated", "probability": 0.1546630859375 }, { "start_logit": 15.96875, "end_logit": 9.390625, "text": "Advanced", "probability": 0.11859130859375 }, { "start_logit": 16.125, "end_logit": 8.9921875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.09381103515625 }, { "start_logit": 15.96875, "end_logit": 9.15625, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.09381103515625 }, { "start_logit": 15.96875, "end_logit": 8.921875, "text": "Advanced or untreated HIV infection", "probability": 0.07421875 }, { "start_logit": 15.96875, "end_logit": 8.6484375, "text": "Advanced or untreated HIV", "probability": 0.056884765625 }, { "start_logit": 14.9609375, "end_logit": 9.15625, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.034515380859375 }, { "start_logit": 16.125, "end_logit": 7.8203125, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency", "probability": 0.02862548828125 }, { "start_logit": 16.125, "end_logit": 7.5390625, "text": "Moderate", "probability": 0.0216064453125 }, { "start_logit": 13.7890625, "end_logit": 9.65625, "text": " untreated", "probability": 0.0173492431640625 }, { "start_logit": 16.125, "end_logit": 7.23046875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease", "probability": 0.01605224609375 }, { "start_logit": 13.46875, "end_logit": 9.8125, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01483917236328125 }, { "start_logit": 15.96875, "end_logit": 7.22265625, "text": "Advanced or untreated HIV infection (people with HIV and CD4", "probability": 0.01351165771484375 }, { "start_logit": 13.296875, "end_logit": 9.8125, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0124969482421875 }, { "start_logit": 13.7890625, "end_logit": 9.15625, "text": " untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.01052093505859375 }, { "start_logit": 13.7890625, "end_logit": 8.921875, "text": " untreated HIV infection", "probability": 0.00846099853515625 }, { "start_logit": 13.46875, "end_logit": 8.9921875, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.006587982177734375 }, { "start_logit": 13.7890625, "end_logit": 8.6484375, "text": " untreated HIV", "probability": 0.006381988525390625 }, { "start_logit": 13.296875, "end_logit": 8.9921875, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.005462646484375 }, { "start_logit": 7.3359375, "end_logit": -0.351318359375, "text": "", "probability": 0.0 } ], "100000000000000000002366": [ { "start_logit": 16.140625, "end_logit": 9.8046875, "text": "Moderate or severe primary immunodeficiency", "probability": 0.211181640625 }, { "start_logit": 15.96875, "end_logit": 9.65625, "text": "Advanced or untreated", "probability": 0.154541015625 }, { "start_logit": 15.96875, "end_logit": 9.390625, "text": "Advanced", "probability": 0.1185302734375 }, { "start_logit": 16.140625, "end_logit": 9.0, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.09521484375 }, { "start_logit": 15.96875, "end_logit": 9.15625, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.09375 }, { "start_logit": 15.96875, "end_logit": 8.921875, "text": "Advanced or untreated HIV infection", "probability": 0.07415771484375 }, { "start_logit": 15.96875, "end_logit": 8.640625, "text": "Advanced or untreated HIV", "probability": 0.055938720703125 }, { "start_logit": 14.9609375, "end_logit": 9.15625, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.03448486328125 }, { "start_logit": 16.140625, "end_logit": 7.82421875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency", "probability": 0.0294952392578125 }, { "start_logit": 16.140625, "end_logit": 7.5234375, "text": "Moderate", "probability": 0.021575927734375 }, { "start_logit": 13.78125, "end_logit": 9.65625, "text": " untreated", "probability": 0.017333984375 }, { "start_logit": 16.140625, "end_logit": 7.2265625, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease", "probability": 0.0162811279296875 }, { "start_logit": 13.46875, "end_logit": 9.8046875, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01482391357421875 }, { "start_logit": 15.96875, "end_logit": 7.21484375, "text": "Advanced or untreated HIV infection (people with HIV and CD4", "probability": 0.01349639892578125 }, { "start_logit": 13.296875, "end_logit": 9.8046875, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01229095458984375 }, { "start_logit": 13.78125, "end_logit": 9.15625, "text": " untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0105133056640625 }, { "start_logit": 13.78125, "end_logit": 8.921875, "text": " untreated HIV infection", "probability": 0.00832366943359375 }, { "start_logit": 13.46875, "end_logit": 9.0, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.006580352783203125 }, { "start_logit": 13.78125, "end_logit": 8.640625, "text": " untreated HIV", "probability": 0.00627899169921875 }, { "start_logit": 13.296875, "end_logit": 9.0, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.0055389404296875 }, { "start_logit": 7.38671875, "end_logit": -0.30517578125, "text": "", "probability": 0.0 } ], "100000000000000000002369": [ { "start_logit": 16.140625, "end_logit": 9.8046875, "text": "Moderate or severe primary immunodeficiency", "probability": 0.211181640625 }, { "start_logit": 15.96875, "end_logit": 9.65625, "text": "Advanced or untreated", "probability": 0.154541015625 }, { "start_logit": 15.96875, "end_logit": 9.390625, "text": "Advanced", "probability": 0.1185302734375 }, { "start_logit": 16.140625, "end_logit": 9.0, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.09521484375 }, { "start_logit": 15.96875, "end_logit": 9.15625, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.09375 }, { "start_logit": 15.96875, "end_logit": 8.921875, "text": "Advanced or untreated HIV infection", "probability": 0.07415771484375 }, { "start_logit": 15.96875, "end_logit": 8.640625, "text": "Advanced or untreated HIV", "probability": 0.055938720703125 }, { "start_logit": 14.9609375, "end_logit": 9.15625, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.03448486328125 }, { "start_logit": 16.140625, "end_logit": 7.82421875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease, severe combined\nimmunodeficiency", "probability": 0.0294952392578125 }, { "start_logit": 16.140625, "end_logit": 7.5234375, "text": "Moderate", "probability": 0.021575927734375 }, { "start_logit": 13.78125, "end_logit": 9.65625, "text": " untreated", "probability": 0.017333984375 }, { "start_logit": 16.140625, "end_logit": 7.2265625, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency disease", "probability": 0.0162811279296875 }, { "start_logit": 13.46875, "end_logit": 9.8046875, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01482391357421875 }, { "start_logit": 15.96875, "end_logit": 7.21484375, "text": "Advanced or untreated HIV infection (people with HIV and CD4", "probability": 0.01349639892578125 }, { "start_logit": 13.296875, "end_logit": 9.8046875, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01229095458984375 }, { "start_logit": 13.78125, "end_logit": 9.15625, "text": " untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0105133056640625 }, { "start_logit": 13.78125, "end_logit": 8.921875, "text": " untreated HIV infection", "probability": 0.00832366943359375 }, { "start_logit": 13.46875, "end_logit": 9.0, "text": " taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.006580352783203125 }, { "start_logit": 13.78125, "end_logit": 8.640625, "text": " untreated HIV", "probability": 0.00627899169921875 }, { "start_logit": 13.296875, "end_logit": 9.0, "text": "transplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.0055389404296875 }, { "start_logit": 7.3515625, "end_logit": -0.306396484375, "text": "", "probability": 0.0 } ], "100000000000000000002373": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012399961359154668 }, { "start_logit": 7.31640625, "end_logit": -0.62548828125, "text": "", "probability": 0.9987600038640845 } ], "100000000000000000002374": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.32421875, "end_logit": -0.65185546875, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000002376": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.29296875, "end_logit": -0.64794921875, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000002382": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 6.63671875, "end_logit": -0.287841796875, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000002385": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.6328125, "end_logit": -0.2666015625, "text": "", "probability": 0.998285961520812 } ], "100000000000000000002389": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016229670614688403 }, { "start_logit": 7.00390625, "end_logit": -0.58251953125, "text": "", "probability": 0.9983770329385311 } ], "100000000000000000002390": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.10546875, "end_logit": -0.6298828125, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000002391": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 6.40625, "end_logit": -0.067138671875, "text": "", "probability": 0.998238530319926 } ], "100000000000000000002394": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 6.3203125, "end_logit": -0.058563232421875, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000002396": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001964661439513743 }, { "start_logit": 6.6796875, "end_logit": -0.45068359375, "text": "", "probability": 0.9980353385604862 } ], "100000000000000000002397": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 6.7421875, "end_logit": -0.42822265625, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000002398": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.7890625, "end_logit": -0.421630859375, "text": "", "probability": 0.998285961520812 } ], "100000000000000000002413": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 6.9921875, "end_logit": -0.70556640625, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000002414": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 7.0390625, "end_logit": -0.6513671875, "text": "", "probability": 0.998319058298613 } ], "100000000000000000002415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017342079835090854 }, { "start_logit": 7.05859375, "end_logit": -0.70263671875, "text": "", "probability": 0.998265792016491 } ], "100000000000000000002420": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.33203125, "end_logit": -0.26416015625, "text": "", "probability": 0.999147433358729 } ], "100000000000000000002422": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.09375, "end_logit": -0.595703125, "text": "", "probability": 0.998498817743263 } ], "100000000000000000002426": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007124459916397521 }, { "start_logit": 7.78125, "end_logit": -0.5361328125, "text": "", "probability": 0.9992875540083602 } ], "100000000000000000002429": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007466114612710287 }, { "start_logit": 7.6953125, "end_logit": -0.497802734375, "text": "", "probability": 0.999253388538729 } ], "100000000000000000002432": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.12890625, "end_logit": -0.365478515625, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000002433": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 7.16015625, "end_logit": -0.485595703125, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000002435": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.1796875, "end_logit": -0.3798828125, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000002437": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.20703125, "end_logit": -0.440185546875, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000002443": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022430878512891728 }, { "start_logit": 6.57421875, "end_logit": -0.475341796875, "text": "", "probability": 0.9977569121487109 } ], "100000000000000000002444": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022083887960902254 }, { "start_logit": 6.62890625, "end_logit": -0.5166015625, "text": "", "probability": 0.9977916112039098 } ], "100000000000000000002453": [ { "start_logit": 17.109375, "end_logit": 14.9765625, "text": "ACOG", "probability": 0.5791015625 }, { "start_logit": 15.65625, "end_logit": 14.9765625, "text": "ASRM), American College of Obstetricians and Gynecologists (ACOG", "probability": 0.13330078125 }, { "start_logit": 15.3828125, "end_logit": 14.9765625, "text": " American College of Obstetricians and Gynecologists (ACOG", "probability": 0.10223388671875 }, { "start_logit": 14.765625, "end_logit": 14.9765625, "text": "American Society of Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (ACOG", "probability": 0.055572509765625 }, { "start_logit": 15.65625, "end_logit": 13.5703125, "text": "ASRM", "probability": 0.032684326171875 }, { "start_logit": 17.109375, "end_logit": 11.5390625, "text": "AC", "probability": 0.01861572265625 }, { "start_logit": 15.65625, "end_logit": 12.7890625, "text": "ASRM), American College of Obstetricians and Gynecologists", "probability": 0.01496124267578125 }, { "start_logit": 14.765625, "end_logit": 13.5703125, "text": "American Society of Reproductive Medicine (ASRM", "probability": 0.01361846923828125 }, { "start_logit": 15.3828125, "end_logit": 12.7890625, "text": " American College of Obstetricians and Gynecologists", "probability": 0.011474609375 }, { "start_logit": 15.65625, "end_logit": 12.171875, "text": "AS", "probability": 0.0081329345703125 }, { "start_logit": 14.765625, "end_logit": 12.7890625, "text": "American Society of Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists", "probability": 0.00623321533203125 }, { "start_logit": 15.65625, "end_logit": 11.5390625, "text": "ASRM), American College of Obstetricians and Gynecologists (AC", "probability": 0.0042877197265625 }, { "start_logit": 12.0390625, "end_logit": 14.9765625, "text": " Society of Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (ACOG", "probability": 0.0036106109619140625 }, { "start_logit": 14.765625, "end_logit": 12.171875, "text": "American Society of Reproductive Medicine (AS", "probability": 0.003337860107421875 }, { "start_logit": 15.3828125, "end_logit": 11.5390625, "text": " American College of Obstetricians and Gynecologists (AC", "probability": 0.003284454345703125 }, { "start_logit": 15.65625, "end_logit": 10.875, "text": "ASRM), American College of Obstetricians", "probability": 0.002223968505859375 }, { "start_logit": 14.765625, "end_logit": 11.703125, "text": "American Society of Reproductive Medicine", "probability": 0.0020885467529296875 }, { "start_logit": 14.765625, "end_logit": 11.5390625, "text": "American Society of Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (AC", "probability": 0.0017862319946289062 }, { "start_logit": 11.328125, "end_logit": 14.9765625, "text": " Reproductive Medicine (ASRM), American College of Obstetricians and Gynecologists (ACOG", "probability": 0.0017862319946289062 }, { "start_logit": 17.109375, "end_logit": 9.1328125, "text": "ACOG)", "probability": 0.001678466796875 }, { "start_logit": 7.0234375, "end_logit": -0.447509765625, "text": "", "probability": 0.0 } ], "100000000000000000002457": [ { "start_logit": 20.125, "end_logit": 10.3984375, "text": "ACOG", "probability": 0.388427734375 }, { "start_logit": 19.71875, "end_logit": 10.3984375, "text": " American College of Obstetricians and Gynecologists (ACOG", "probability": 0.2587890625 }, { "start_logit": 18.8125, "end_logit": 10.3984375, "text": " 3. American College of Obstetricians and Gynecologists (ACOG", "probability": 0.1044921875 }, { "start_logit": 19.71875, "end_logit": 8.9453125, "text": " American College of Obstetricians and Gynecologists", "probability": 0.0595703125 }, { "start_logit": 18.8125, "end_logit": 8.9453125, "text": " 3. American College of Obstetricians and Gynecologists", "probability": 0.0240631103515625 }, { "start_logit": 20.125, "end_logit": 7.41796875, "text": "AC", "probability": 0.0196380615234375 }, { "start_logit": 19.46875, "end_logit": 8.0234375, "text": " American Society for Reproductive Medicine (ASRM", "probability": 0.01873779296875 }, { "start_logit": 19.46875, "end_logit": 7.94921875, "text": " American Society for Reproductive Medicine", "probability": 0.017333984375 }, { "start_logit": 19.46875, "end_logit": 7.73828125, "text": " American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the\nCoronavirus (COVID-19", "probability": 0.0139312744140625 }, { "start_logit": 19.71875, "end_logit": 7.41796875, "text": " American College of Obstetricians and Gynecologists (AC", "probability": 0.01308441162109375 }, { "start_logit": 19.359375, "end_logit": 7.78125, "text": " UPDATE No. 16", "probability": 0.01308441162109375 }, { "start_logit": 20.125, "end_logit": 6.97265625, "text": "ACOG). COVID-19", "probability": 0.012481689453125 }, { "start_logit": 18.8125, "end_logit": 8.28125, "text": " 3", "probability": 0.012481689453125 }, { "start_logit": 19.71875, "end_logit": 6.97265625, "text": " American College of Obstetricians and Gynecologists (ACOG). COVID-19", "probability": 0.0083160400390625 }, { "start_logit": 18.328125, "end_logit": 8.28125, "text": " COVID-19 Vaccine: Frequently Asked Questions. Available at:\ncovid-19-vaccine-frequently-asked-questions/ . 3", "probability": 0.007694244384765625 }, { "start_logit": 19.71875, "end_logit": 6.78515625, "text": " American College of Obstetricians", "probability": 0.006893157958984375 }, { "start_logit": 18.015625, "end_logit": 8.28125, "text": "About the COVID-19 Vaccine: Frequently Asked Questions. Available at:\ncovid-19-vaccine-frequently-asked-questions/ . 3", "probability": 0.005626678466796875 }, { "start_logit": 20.125, "end_logit": 6.13671875, "text": "ACOG). COVID-19 Vaccination", "probability": 0.00545501708984375 }, { "start_logit": 18.8125, "end_logit": 7.41796875, "text": " 3. American College of Obstetricians and Gynecologists (AC", "probability": 0.00528717041015625 }, { "start_logit": 19.46875, "end_logit": 6.58203125, "text": " American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the\nCoronavirus (COVID-19) Pandemic: UPDATE", "probability": 0.004383087158203125 }, { "start_logit": 8.6796875, "end_logit": -1.0341796875, "text": "", "probability": 0.0 } ], "100000000000000000002460": [ { "start_logit": 20.140625, "end_logit": 10.390625, "text": "ACOG", "probability": 0.389892578125 }, { "start_logit": 19.71875, "end_logit": 10.390625, "text": " American College of Obstetricians and Gynecologists (ACOG", "probability": 0.255615234375 }, { "start_logit": 18.8125, "end_logit": 10.390625, "text": " 3. American College of Obstetricians and Gynecologists (ACOG", "probability": 0.103271484375 }, { "start_logit": 19.71875, "end_logit": 8.953125, "text": " American College of Obstetricians and Gynecologists", "probability": 0.06072998046875 }, { "start_logit": 18.8125, "end_logit": 8.953125, "text": " 3. American College of Obstetricians and Gynecologists", "probability": 0.0245361328125 }, { "start_logit": 20.140625, "end_logit": 7.4375, "text": "AC", "probability": 0.020355224609375 }, { "start_logit": 19.46875, "end_logit": 8.0234375, "text": " American Society for Reproductive Medicine (ASRM", "probability": 0.0188140869140625 }, { "start_logit": 19.46875, "end_logit": 7.9453125, "text": " American Society for Reproductive Medicine", "probability": 0.0171356201171875 }, { "start_logit": 19.46875, "end_logit": 7.73046875, "text": " American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the\nCoronavirus (COVID-19", "probability": 0.01398468017578125 }, { "start_logit": 19.71875, "end_logit": 7.4375, "text": " American College of Obstetricians and Gynecologists (AC", "probability": 0.01334381103515625 }, { "start_logit": 19.359375, "end_logit": 7.78125, "text": " UPDATE No. 16", "probability": 0.0131378173828125 }, { "start_logit": 20.140625, "end_logit": 6.96484375, "text": "ACOG). COVID-19", "probability": 0.01273345947265625 }, { "start_logit": 18.8125, "end_logit": 8.28125, "text": " 3", "probability": 0.0125274658203125 }, { "start_logit": 19.71875, "end_logit": 6.96484375, "text": " American College of Obstetricians and Gynecologists (ACOG). COVID-19", "probability": 0.0083465576171875 }, { "start_logit": 18.328125, "end_logit": 8.28125, "text": " COVID-19 Vaccine: Frequently Asked Questions. Available at:\ncovid-19-vaccine-frequently-asked-questions/ . 3", "probability": 0.007724761962890625 }, { "start_logit": 19.71875, "end_logit": 6.78125, "text": " American College of Obstetricians", "probability": 0.00691986083984375 }, { "start_logit": 18.015625, "end_logit": 8.28125, "text": "About the COVID-19 Vaccine: Frequently Asked Questions. Available at:\ncovid-19-vaccine-frequently-asked-questions/ . 3", "probability": 0.005649566650390625 }, { "start_logit": 20.140625, "end_logit": 6.140625, "text": "ACOG). COVID-19 Vaccination", "probability": 0.00556182861328125 }, { "start_logit": 18.8125, "end_logit": 7.4375, "text": " 3. American College of Obstetricians and Gynecologists (AC", "probability": 0.005390167236328125 }, { "start_logit": 19.46875, "end_logit": 6.58203125, "text": " American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the\nCoronavirus (COVID-19) Pandemic: UPDATE", "probability": 0.004398345947265625 }, { "start_logit": 8.7734375, "end_logit": -0.98095703125, "text": "", "probability": 0.0 } ], "100000000000000000002469": [ { "start_logit": 16.1875, "end_logit": 9.3046875, "text": "N Engl J Med. 2021", "probability": 0.362060546875 }, { "start_logit": 15.25, "end_logit": 9.3046875, "text": " Med. 2021", "probability": 0.141845703125 }, { "start_logit": 15.2421875, "end_logit": 9.3046875, "text": " 2021", "probability": 0.1395263671875 }, { "start_logit": 16.1875, "end_logit": 7.58203125, "text": "N Engl J Med. 2021;384", "probability": 0.06390380859375 }, { "start_logit": 16.1875, "end_logit": 7.3984375, "text": "N", "probability": 0.0538330078125 }, { "start_logit": 16.1875, "end_logit": 6.95703125, "text": "N Engl J Med. 2021;384(24):2273-2282", "probability": 0.034210205078125 }, { "start_logit": 16.1875, "end_logit": 6.95703125, "text": "N Engl J Med. 2021;384(24):2273", "probability": 0.034210205078125 }, { "start_logit": 13.6640625, "end_logit": 9.3046875, "text": " Engl J Med. 2021", "probability": 0.0288238525390625 }, { "start_logit": 15.25, "end_logit": 7.58203125, "text": " Med. 2021;384", "probability": 0.0250396728515625 }, { "start_logit": 15.2421875, "end_logit": 7.58203125, "text": " 2021;384", "probability": 0.0250396728515625 }, { "start_logit": 15.25, "end_logit": 6.95703125, "text": " Med. 2021;384(24):2273-2282", "probability": 0.01338958740234375 }, { "start_logit": 15.25, "end_logit": 6.95703125, "text": " Med. 2021;384(24):2273", "probability": 0.01338958740234375 }, { "start_logit": 15.2421875, "end_logit": 6.95703125, "text": " 2021;384(24):2273-2282", "probability": 0.01338958740234375 }, { "start_logit": 15.2421875, "end_logit": 6.95703125, "text": " 2021;384(24):2273", "probability": 0.01338958740234375 }, { "start_logit": 16.1875, "end_logit": 5.703125, "text": "N Engl J Med. 2021;384(24):2273-2282. 10. Razzaghi H, Meghani", "probability": 0.00980377197265625 }, { "start_logit": 15.078125, "end_logit": 6.59375, "text": " 10. Razzaghi H, Meghani M, Pingali C, et al. COVID-19", "probability": 0.00787353515625 }, { "start_logit": 14.8203125, "end_logit": 6.59375, "text": " COVID-19", "probability": 0.006038665771484375 }, { "start_logit": 13.6640625, "end_logit": 7.58203125, "text": " Engl J Med. 2021;384", "probability": 0.00516510009765625 }, { "start_logit": 14.546875, "end_logit": 6.59375, "text": " Razzaghi H, Meghani M, Pingali C, et al. COVID-19", "probability": 0.00463104248046875 }, { "start_logit": 13.4765625, "end_logit": 7.58203125, "text": "384", "probability": 0.00428009033203125 }, { "start_logit": 7.78125, "end_logit": -0.9755859375, "text": "", "probability": 0.0 } ], "100000000000000000002472": [ { "start_logit": 16.1875, "end_logit": 9.3046875, "text": "N Engl J Med. 2021", "probability": 0.361328125 }, { "start_logit": 15.25, "end_logit": 9.3046875, "text": " Med. 2021", "probability": 0.1414794921875 }, { "start_logit": 15.25, "end_logit": 9.3046875, "text": " 2021", "probability": 0.1414794921875 }, { "start_logit": 16.1875, "end_logit": 7.58203125, "text": "N Engl J Med. 2021;384", "probability": 0.06378173828125 }, { "start_logit": 16.1875, "end_logit": 7.3984375, "text": "N", "probability": 0.0537109375 }, { "start_logit": 16.1875, "end_logit": 6.95703125, "text": "N Engl J Med. 2021;384(24):2273", "probability": 0.034149169921875 }, { "start_logit": 16.1875, "end_logit": 6.953125, "text": "N Engl J Med. 2021;384(24):2273-2282", "probability": 0.034149169921875 }, { "start_logit": 13.6640625, "end_logit": 9.3046875, "text": " Engl J Med. 2021", "probability": 0.0287628173828125 }, { "start_logit": 15.25, "end_logit": 7.58203125, "text": " Med. 2021;384", "probability": 0.024993896484375 }, { "start_logit": 15.25, "end_logit": 7.58203125, "text": " 2021;384", "probability": 0.024993896484375 }, { "start_logit": 15.25, "end_logit": 6.95703125, "text": " Med. 2021;384(24):2273", "probability": 0.01336669921875 }, { "start_logit": 15.25, "end_logit": 6.953125, "text": " Med. 2021;384(24):2273-2282", "probability": 0.01336669921875 }, { "start_logit": 15.25, "end_logit": 6.95703125, "text": " 2021;384(24):2273", "probability": 0.01336669921875 }, { "start_logit": 15.25, "end_logit": 6.953125, "text": " 2021;384(24):2273-2282", "probability": 0.01336669921875 }, { "start_logit": 16.1875, "end_logit": 5.70703125, "text": "N Engl J Med. 2021;384(24):2273-2282. 10. Razzaghi H, Meghani", "probability": 0.0097808837890625 }, { "start_logit": 15.078125, "end_logit": 6.59375, "text": " 10. Razzaghi H, Meghani M, Pingali C, et al. COVID-19", "probability": 0.0078582763671875 }, { "start_logit": 14.8203125, "end_logit": 6.59375, "text": " COVID-19", "probability": 0.0060272216796875 }, { "start_logit": 13.6640625, "end_logit": 7.58203125, "text": " Engl J Med. 2021;384", "probability": 0.005153656005859375 }, { "start_logit": 14.5390625, "end_logit": 6.59375, "text": " Razzaghi H, Meghani M, Pingali C, et al. COVID-19", "probability": 0.004547119140625 }, { "start_logit": 13.4765625, "end_logit": 7.58203125, "text": "384", "probability": 0.0042724609375 }, { "start_logit": 7.71484375, "end_logit": -0.98974609375, "text": "", "probability": 0.0 } ], "100000000000000000002474": [ { "start_logit": 14.6171875, "end_logit": 8.3125, "text": "Orvieto", "probability": 0.419921875 }, { "start_logit": 15.84375, "end_logit": 5.9609375, "text": " No", "probability": 0.1363525390625 }, { "start_logit": 15.84375, "end_logit": 5.875, "text": " Noach-Hirsh M, Segev-Zah", "probability": 0.12420654296875 }, { "start_logit": 14.6171875, "end_logit": 6.96875, "text": "Or", "probability": 0.109619140625 }, { "start_logit": 15.1015625, "end_logit": 5.9609375, "text": " R, No", "probability": 0.06439208984375 }, { "start_logit": 15.1015625, "end_logit": 5.875, "text": " R, Noach-Hirsh M, Segev-Zah", "probability": 0.05865478515625 }, { "start_logit": 14.6171875, "end_logit": 5.9609375, "text": "Orvieto R, No", "probability": 0.0396728515625 }, { "start_logit": 14.6171875, "end_logit": 5.875, "text": "Orvieto R, Noach-Hirsh M, Segev-Zah", "probability": 0.036712646484375 }, { "start_logit": 13.3359375, "end_logit": 5.875, "text": " Segev-Zah", "probability": 0.01019287109375 }, { "start_logit": 7.72265625, "end_logit": -0.9716796875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000002476": [ { "start_logit": 14.6171875, "end_logit": 8.3125, "text": "Orvieto", "probability": 0.2841796875 }, { "start_logit": 15.84375, "end_logit": 6.37890625, "text": " Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.138427734375 }, { "start_logit": 15.84375, "end_logit": 5.9609375, "text": " No", "probability": 0.09228515625 }, { "start_logit": 15.84375, "end_logit": 5.875, "text": " Noach-Hirsh M, Segev-Zah", "probability": 0.083984375 }, { "start_logit": 14.6171875, "end_logit": 6.96875, "text": "Or", "probability": 0.07415771484375 }, { "start_logit": 15.1015625, "end_logit": 6.37890625, "text": " R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.06646728515625 }, { "start_logit": 15.1015625, "end_logit": 5.9609375, "text": " R, No", "probability": 0.043548583984375 }, { "start_logit": 14.6640625, "end_logit": 6.37890625, "text": " Nahum R, Aizer", "probability": 0.04290771484375 }, { "start_logit": 14.6171875, "end_logit": 6.37890625, "text": "Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.040924072265625 }, { "start_logit": 15.1015625, "end_logit": 5.875, "text": " R, Noach-Hirsh M, Segev-Zah", "probability": 0.0396728515625 }, { "start_logit": 14.6171875, "end_logit": 5.9609375, "text": "Orvieto R, No", "probability": 0.0268402099609375 }, { "start_logit": 14.6171875, "end_logit": 5.875, "text": "Orvieto R, Noach-Hirsh M, Segev-Zah", "probability": 0.0248260498046875 }, { "start_logit": 14.0625, "end_logit": 6.37890625, "text": " Haas J, Nahum R, Aizer", "probability": 0.0233306884765625 }, { "start_logit": 13.3359375, "end_logit": 6.37890625, "text": " Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.0113677978515625 }, { "start_logit": 13.3359375, "end_logit": 5.875, "text": " Segev-Zah", "probability": 0.006893157958984375 }, { "start_logit": 7.7734375, "end_logit": -1.0205078125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000002478": [ { "start_logit": 14.6171875, "end_logit": 8.3125, "text": "Orvieto", "probability": 0.2841796875 }, { "start_logit": 15.84375, "end_logit": 6.37890625, "text": " Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.138427734375 }, { "start_logit": 15.84375, "end_logit": 5.9609375, "text": " No", "probability": 0.09228515625 }, { "start_logit": 15.84375, "end_logit": 5.875, "text": " Noach-Hirsh M, Segev-Zah", "probability": 0.083984375 }, { "start_logit": 14.6171875, "end_logit": 6.96875, "text": "Or", "probability": 0.07415771484375 }, { "start_logit": 15.1015625, "end_logit": 6.37890625, "text": " R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.06646728515625 }, { "start_logit": 15.1015625, "end_logit": 5.9609375, "text": " R, No", "probability": 0.043548583984375 }, { "start_logit": 14.6640625, "end_logit": 6.37890625, "text": " Nahum R, Aizer", "probability": 0.04290771484375 }, { "start_logit": 14.6171875, "end_logit": 6.37890625, "text": "Orvieto R, Noach-Hirsh M, Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.040924072265625 }, { "start_logit": 15.1015625, "end_logit": 5.875, "text": " R, Noach-Hirsh M, Segev-Zah", "probability": 0.0396728515625 }, { "start_logit": 14.6171875, "end_logit": 5.9609375, "text": "Orvieto R, No", "probability": 0.0268402099609375 }, { "start_logit": 14.6171875, "end_logit": 5.875, "text": "Orvieto R, Noach-Hirsh M, Segev-Zah", "probability": 0.0248260498046875 }, { "start_logit": 14.0625, "end_logit": 6.37890625, "text": " Haas J, Nahum R, Aizer", "probability": 0.0233306884765625 }, { "start_logit": 13.3359375, "end_logit": 6.37890625, "text": " Segev-Zahav A, Haas J, Nahum R, Aizer", "probability": 0.0113677978515625 }, { "start_logit": 13.3359375, "end_logit": 5.875, "text": " Segev-Zah", "probability": 0.006893157958984375 }, { "start_logit": 7.71484375, "end_logit": -1.0205078125, "text": "", "probability": 0.0 } ], "100000000000000000002481": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002115703400593114 }, { "start_logit": 6.96484375, "end_logit": -0.8076171875, "text": "", "probability": 0.9978842965994068 } ], "100000000000000000002485": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023504828600259954 }, { "start_logit": 6.796875, "end_logit": -0.74560546875, "text": "", "probability": 0.9976495171399739 } ], "100000000000000000002486": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018458483368165377 }, { "start_logit": 7.0546875, "end_logit": -0.76318359375, "text": "", "probability": 0.9981541516631836 } ], "100000000000000000002487": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001727458626729702 }, { "start_logit": 7.125, "end_logit": -0.76416015625, "text": "", "probability": 0.9982725413732704 } ], "100000000000000000002490": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.37109375, "end_logit": -0.1483154296875, "text": "", "probability": 0.999270671160687 } ], "100000000000000000002491": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.3828125, "end_logit": -0.159423828125, "text": "", "probability": 0.999270671160687 } ], "100000000000000000002492": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.38671875, "end_logit": -0.1693115234375, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000002496": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.54296875, "end_logit": -0.46435546875, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000002499": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.55859375, "end_logit": -0.44482421875, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000002501": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.9609375, "end_logit": -0.734375, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000002502": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 7.87109375, "end_logit": -0.69189453125, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000002504": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007916296072837431 }, { "start_logit": 7.84765625, "end_logit": -0.705078125, "text": "", "probability": 0.9992083703927161 } ], "100000000000000000002517": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999981523939 }, { "start_logit": -33.6875, "end_logit": 13.578125, "text": "", "probability": 1.847606162725329e-09 } ], "100000000000000000002518": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999980937446 }, { "start_logit": -33.65625, "end_logit": 13.578125, "text": "", "probability": 1.906255477934772e-09 } ], "100000000000000000002529": [ { "start_logit": 22.0625, "end_logit": 19.453125, "text": " Monovalent", "probability": 0.7216796875 }, { "start_logit": 21.140625, "end_logit": 19.015625, "text": " Monovalent", "probability": 0.1883544921875 }, { "start_logit": 22.0625, "end_logit": 16.328125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.031707763671875 }, { "start_logit": 18.609375, "end_logit": 19.453125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent", "probability": 0.023193359375 }, { "start_logit": 19.671875, "end_logit": 17.9375, "text": " Monovalent", "probability": 0.01497650146484375 }, { "start_logit": 21.140625, "end_logit": 15.7265625, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.007076263427734375 }, { "start_logit": 17.125, "end_logit": 19.015625, "text": "\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent", "probability": 0.0033416748046875 }, { "start_logit": 16.171875, "end_logit": 19.453125, "text": "\nPrimary series: Monovalent", "probability": 0.0020275115966796875 }, { "start_logit": 18.609375, "end_logit": 16.921875, "text": "\nBlue", "probability": 0.0018453598022460938 }, { "start_logit": 18.609375, "end_logit": 16.671875, "text": "\nBlue vial cap with\nmagenta", "probability": 0.0014371871948242188 }, { "start_logit": 18.609375, "end_logit": 16.328125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0010194778442382812 }, { "start_logit": 15.5234375, "end_logit": 19.015625, "text": "\nPrimary series: Monovalent", "probability": 0.00067901611328125 }, { "start_logit": 19.671875, "end_logit": 14.8125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0006580352783203125 }, { "start_logit": 18.28125, "end_logit": 15.890625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months", "probability": 0.0004813671112060547 }, { "start_logit": 18.28125, "end_logit": 15.6171875, "text": " Bivalent\nDose 2 to 3 At least 8 weeks", "probability": 0.00036334991455078125 }, { "start_logit": 15.9375, "end_logit": 17.9375, "text": "\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0003521442413330078 }, { "start_logit": 18.28125, "end_logit": 15.015625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months", "probability": 0.00020062923431396484 }, { "start_logit": 15.25, "end_logit": 17.9375, "text": "Red vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00017702579498291016 }, { "start_logit": 17.125, "end_logit": 15.8984375, "text": "\nBlue", "probability": 0.00015151500701904297 }, { "start_logit": 17.125, "end_logit": 15.734375, "text": "\nBlue vial cap with\npurple", "probability": 0.00012958049774169922 }, { "start_logit": -33.40625, "end_logit": 15.0, "text": "", "probability": 0.0 } ], "100000000000000000002531": [ { "start_logit": 22.0625, "end_logit": 19.453125, "text": " Monovalent", "probability": 0.7216796875 }, { "start_logit": 21.140625, "end_logit": 19.015625, "text": " Monovalent", "probability": 0.1883544921875 }, { "start_logit": 22.0625, "end_logit": 16.328125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.031707763671875 }, { "start_logit": 18.609375, "end_logit": 19.453125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent", "probability": 0.023193359375 }, { "start_logit": 19.671875, "end_logit": 17.9375, "text": " Monovalent", "probability": 0.01497650146484375 }, { "start_logit": 21.140625, "end_logit": 15.7265625, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.007076263427734375 }, { "start_logit": 17.125, "end_logit": 19.015625, "text": "\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent", "probability": 0.0033416748046875 }, { "start_logit": 16.171875, "end_logit": 19.453125, "text": "\nPrimary series: Monovalent", "probability": 0.0020275115966796875 }, { "start_logit": 18.609375, "end_logit": 16.921875, "text": "\nBlue", "probability": 0.0018453598022460938 }, { "start_logit": 18.609375, "end_logit": 16.671875, "text": "\nBlue vial cap with\nmagenta", "probability": 0.0014371871948242188 }, { "start_logit": 18.609375, "end_logit": 16.328125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0010194778442382812 }, { "start_logit": 15.5234375, "end_logit": 19.015625, "text": "\nPrimary series: Monovalent", "probability": 0.00067901611328125 }, { "start_logit": 19.671875, "end_logit": 14.8125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0006580352783203125 }, { "start_logit": 18.28125, "end_logit": 15.890625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months", "probability": 0.0004813671112060547 }, { "start_logit": 18.28125, "end_logit": 15.6171875, "text": " Bivalent\nDose 2 to 3 At least 8 weeks", "probability": 0.00036334991455078125 }, { "start_logit": 15.9375, "end_logit": 17.9375, "text": "\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0003521442413330078 }, { "start_logit": 18.28125, "end_logit": 15.015625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months", "probability": 0.00020062923431396484 }, { "start_logit": 15.25, "end_logit": 17.9375, "text": "Red vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00017702579498291016 }, { "start_logit": 17.125, "end_logit": 15.8984375, "text": "\nBlue", "probability": 0.00015151500701904297 }, { "start_logit": 17.125, "end_logit": 15.734375, "text": "\nBlue vial cap with\npurple", "probability": 0.00012958049774169922 }, { "start_logit": -34.03125, "end_logit": 16.109375, "text": "", "probability": 0.0 } ], "100000000000000000002535": [ { "start_logit": 22.0625, "end_logit": 19.453125, "text": " Monovalent", "probability": 0.7216796875 }, { "start_logit": 21.140625, "end_logit": 19.015625, "text": " Monovalent", "probability": 0.1883544921875 }, { "start_logit": 22.0625, "end_logit": 16.328125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.031707763671875 }, { "start_logit": 18.609375, "end_logit": 19.453125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent", "probability": 0.023193359375 }, { "start_logit": 19.671875, "end_logit": 17.9375, "text": " Monovalent", "probability": 0.01497650146484375 }, { "start_logit": 21.140625, "end_logit": 15.7265625, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.007076263427734375 }, { "start_logit": 17.125, "end_logit": 19.015625, "text": "\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent", "probability": 0.0033416748046875 }, { "start_logit": 16.171875, "end_logit": 19.453125, "text": "\nPrimary series: Monovalent", "probability": 0.0020275115966796875 }, { "start_logit": 18.609375, "end_logit": 16.921875, "text": "\nBlue", "probability": 0.0018453598022460938 }, { "start_logit": 18.609375, "end_logit": 16.671875, "text": "\nBlue vial cap with\nmagenta", "probability": 0.0014371871948242188 }, { "start_logit": 18.609375, "end_logit": 16.328125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0010194778442382812 }, { "start_logit": 15.5234375, "end_logit": 19.015625, "text": "\nPrimary series: Monovalent", "probability": 0.00067901611328125 }, { "start_logit": 19.671875, "end_logit": 14.8125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0006580352783203125 }, { "start_logit": 18.28125, "end_logit": 15.890625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months", "probability": 0.0004813671112060547 }, { "start_logit": 18.28125, "end_logit": 15.6171875, "text": " Bivalent\nDose 2 to 3 At least 8 weeks", "probability": 0.00036334991455078125 }, { "start_logit": 15.9375, "end_logit": 17.9375, "text": "\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0003521442413330078 }, { "start_logit": 18.28125, "end_logit": 15.015625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months", "probability": 0.00020062923431396484 }, { "start_logit": 15.25, "end_logit": 17.9375, "text": "Red vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00017702579498291016 }, { "start_logit": 17.125, "end_logit": 15.8984375, "text": "\nBlue", "probability": 0.00015151500701904297 }, { "start_logit": 17.125, "end_logit": 15.734375, "text": "\nBlue vial cap with\npurple", "probability": 0.00012958049774169922 }, { "start_logit": -38.6875, "end_logit": 24.65625, "text": "", "probability": 0.0 } ], "100000000000000000002537": [ { "start_logit": 22.0625, "end_logit": 19.453125, "text": " Monovalent", "probability": 0.7216796875 }, { "start_logit": 21.140625, "end_logit": 19.015625, "text": " Monovalent", "probability": 0.1883544921875 }, { "start_logit": 22.0625, "end_logit": 16.328125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.031707763671875 }, { "start_logit": 18.609375, "end_logit": 19.453125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent", "probability": 0.023193359375 }, { "start_logit": 19.671875, "end_logit": 17.9375, "text": " Monovalent", "probability": 0.01497650146484375 }, { "start_logit": 21.140625, "end_logit": 15.7265625, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.007076263427734375 }, { "start_logit": 17.125, "end_logit": 19.015625, "text": "\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent", "probability": 0.0033416748046875 }, { "start_logit": 16.171875, "end_logit": 19.453125, "text": "\nPrimary series: Monovalent", "probability": 0.0020275115966796875 }, { "start_logit": 18.609375, "end_logit": 16.921875, "text": "\nBlue", "probability": 0.0018453598022460938 }, { "start_logit": 18.609375, "end_logit": 16.671875, "text": "\nBlue vial cap with\nmagenta", "probability": 0.0014371871948242188 }, { "start_logit": 18.609375, "end_logit": 16.328125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0010194778442382812 }, { "start_logit": 15.5234375, "end_logit": 19.015625, "text": "\nPrimary series: Monovalent", "probability": 0.00067901611328125 }, { "start_logit": 19.671875, "end_logit": 14.8125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0006580352783203125 }, { "start_logit": 18.28125, "end_logit": 15.890625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months", "probability": 0.0004813671112060547 }, { "start_logit": 18.28125, "end_logit": 15.6171875, "text": " Bivalent\nDose 2 to 3 At least 8 weeks", "probability": 0.00036334991455078125 }, { "start_logit": 15.9375, "end_logit": 17.9375, "text": "\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0003521442413330078 }, { "start_logit": 18.28125, "end_logit": 15.015625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months", "probability": 0.00020062923431396484 }, { "start_logit": 15.25, "end_logit": 17.9375, "text": "Red vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00017702579498291016 }, { "start_logit": 17.125, "end_logit": 15.8984375, "text": "\nBlue", "probability": 0.00015151500701904297 }, { "start_logit": 17.125, "end_logit": 15.734375, "text": "\nBlue vial cap with\npurple", "probability": 0.00012958049774169922 }, { "start_logit": -34.3125, "end_logit": 16.046875, "text": "", "probability": 0.0 } ], "100000000000000000002540": [ { "start_logit": 22.0625, "end_logit": 19.453125, "text": " Monovalent", "probability": 0.7216796875 }, { "start_logit": 21.140625, "end_logit": 19.015625, "text": " Monovalent", "probability": 0.1883544921875 }, { "start_logit": 22.0625, "end_logit": 16.328125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.031707763671875 }, { "start_logit": 18.609375, "end_logit": 19.453125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent", "probability": 0.023193359375 }, { "start_logit": 19.671875, "end_logit": 17.9375, "text": " Monovalent", "probability": 0.01497650146484375 }, { "start_logit": 21.140625, "end_logit": 15.7265625, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.007076263427734375 }, { "start_logit": 17.125, "end_logit": 19.015625, "text": "\nBlue vial cap with\npurple-bordered label\nPrimary series: Monovalent", "probability": 0.0033416748046875 }, { "start_logit": 16.171875, "end_logit": 19.453125, "text": "\nPrimary series: Monovalent", "probability": 0.0020275115966796875 }, { "start_logit": 18.609375, "end_logit": 16.921875, "text": "\nBlue", "probability": 0.0018453598022460938 }, { "start_logit": 18.609375, "end_logit": 16.671875, "text": "\nBlue vial cap with\nmagenta", "probability": 0.0014371871948242188 }, { "start_logit": 18.609375, "end_logit": 16.328125, "text": "\nBlue vial cap with\nmagenta-bordered label\nPrimary series: Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0010194778442382812 }, { "start_logit": 15.5234375, "end_logit": 19.015625, "text": "\nPrimary series: Monovalent", "probability": 0.00067901611328125 }, { "start_logit": 19.671875, "end_logit": 14.8125, "text": " Monovalent\nDose 1 to 2 At least 4\u20138 weeks", "probability": 0.0006580352783203125 }, { "start_logit": 18.28125, "end_logit": 15.890625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months", "probability": 0.0004813671112060547 }, { "start_logit": 18.28125, "end_logit": 15.6171875, "text": " Bivalent\nDose 2 to 3 At least 8 weeks", "probability": 0.00036334991455078125 }, { "start_logit": 15.9375, "end_logit": 17.9375, "text": "\nRed vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0003521442413330078 }, { "start_logit": 18.28125, "end_logit": 15.015625, "text": " Bivalent\nDose 2 to 3 At least 8 weeks (2 months) Dose 3 to 4 At least 8 weeks (2 months", "probability": 0.00020062923431396484 }, { "start_logit": 15.25, "end_logit": 17.9375, "text": "Red vial cap with\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00017702579498291016 }, { "start_logit": 17.125, "end_logit": 15.8984375, "text": "\nBlue", "probability": 0.00015151500701904297 }, { "start_logit": 17.125, "end_logit": 15.734375, "text": "\nBlue vial cap with\npurple", "probability": 0.00012958049774169922 }, { "start_logit": -32.53125, "end_logit": 13.7109375, "text": "", "probability": 0.0 } ], "100000000000000000002546": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030278350245683794 }, { "start_logit": 6.2578125, "end_logit": -0.4619140625, "text": "", "probability": 0.9969721649754317 } ], "100000000000000000002548": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030278350245683794 }, { "start_logit": 6.25390625, "end_logit": -0.4560546875, "text": "", "probability": 0.9969721649754317 } ], "100000000000000000002550": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.3125, "end_logit": -0.53076171875, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000002556": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004924510374080036 }, { "start_logit": 6.0390625, "end_logit": -0.7314453125, "text": "", "probability": 0.99507548962592 } ], "100000000000000000002557": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004755199909833047 }, { "start_logit": 6.0546875, "end_logit": -0.7099609375, "text": "", "probability": 0.9952448000901669 } ], "100000000000000000002558": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004503272417089224 }, { "start_logit": 6.10546875, "end_logit": -0.70556640625, "text": "", "probability": 0.9954967275829107 } ], "100000000000000000002560": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00014653129390717956 }, { "start_logit": 8.2421875, "end_logit": 0.58203125, "text": "", "probability": 0.9998534687060929 } ], "100000000000000000002566": [ { "start_logit": 22.25, "end_logit": 19.5, "text": " Monovalent", "probability": 0.8603515625 }, { "start_logit": 20.390625, "end_logit": 18.359375, "text": " 8 weeks", "probability": 0.042816162109375 }, { "start_logit": 20.40625, "end_logit": 18.0, "text": " Monovalent", "probability": 0.0303802490234375 }, { "start_logit": 20.390625, "end_logit": 17.6875, "text": " 8 weeks\nAt least 8 weeks", "probability": 0.02154541015625 }, { "start_logit": 19.515625, "end_logit": 17.6875, "text": " 8 weeks", "probability": 0.00897979736328125 }, { "start_logit": 18.796875, "end_logit": 18.359375, "text": " Bivalent\nAt least 8 weeks", "probability": 0.00870513916015625 }, { "start_logit": 22.25, "end_logit": 14.6171875, "text": " Monovalent\nAt least 4\u20138\nweeks\u2021\nDose 1 to 2 At least 4 weeks", "probability": 0.00656890869140625 }, { "start_logit": 18.796875, "end_logit": 17.6875, "text": " Bivalent\nAt least 8 weeks\nAt least 8 weeks", "probability": 0.0045166015625 }, { "start_logit": 19.015625, "end_logit": 17.140625, "text": " 8 weeks", "probability": 0.0032024383544921875 }, { "start_logit": 16.453125, "end_logit": 19.5, "text": "Red vial cap with a\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.0025730133056640625 }, { "start_logit": 16.4375, "end_logit": 19.5, "text": "\nPrimary series: Monovalent", "probability": 0.0025730133056640625 }, { "start_logit": 19.015625, "end_logit": 16.546875, "text": " 8 weeks\nAt least 8 weeks", "probability": 0.0017681121826171875 }, { "start_logit": 20.390625, "end_logit": 15.1484375, "text": " 8 weeks\nAt least 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech", "probability": 0.0017137527465820312 }, { "start_logit": 18.234375, "end_logit": 16.546875, "text": " 8 weeks", "probability": 0.0008096694946289062 }, { "start_logit": 19.515625, "end_logit": 15.1484375, "text": " 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech", "probability": 0.0007143020629882812 }, { "start_logit": 20.390625, "end_logit": 14.2421875, "text": " 8 weeks\nAt least 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech\nGray", "probability": 0.0006928443908691406 }, { "start_logit": 20.40625, "end_logit": 14.078125, "text": " Monovalent\nAt least 3-8\nweeks\u2021\nDose 1 to 2 At least 3 weeks", "probability": 0.0006108283996582031 }, { "start_logit": 17.125, "end_logit": 17.140625, "text": " Bivalent\nAt least 8 weeks", "probability": 0.00047588348388671875 }, { "start_logit": 16.234375, "end_logit": 18.0, "text": "Gray vial cap with\ngray-bordered label\nPrimary series: Monovalent", "probability": 0.00047588348388671875 }, { "start_logit": 15.7109375, "end_logit": 18.359375, "text": "BIVALENT Moderna\nBlue cap with\ngray-bordered label\nBooster dose\u00a7: Bivalent\nAt least 8 weeks", "probability": 0.00039458274841308594 }, { "start_logit": 8.796875, "end_logit": 0.8212890625, "text": "", "probability": 0.0 } ], "100000000000000000002569": [ { "start_logit": 22.25, "end_logit": 19.484375, "text": " Monovalent", "probability": 0.85986328125 }, { "start_logit": 20.390625, "end_logit": 18.359375, "text": " 8 weeks", "probability": 0.04278564453125 }, { "start_logit": 20.40625, "end_logit": 18.0, "text": " Monovalent", "probability": 0.030364990234375 }, { "start_logit": 20.390625, "end_logit": 17.703125, "text": " 8 weeks\nAt least 8 weeks", "probability": 0.022216796875 }, { "start_logit": 19.515625, "end_logit": 17.703125, "text": " 8 weeks", "probability": 0.00925445556640625 }, { "start_logit": 18.78125, "end_logit": 18.359375, "text": " Bivalent\nAt least 8 weeks", "probability": 0.00843048095703125 }, { "start_logit": 22.25, "end_logit": 14.625, "text": " Monovalent\nAt least 4\u20138\nweeks\u2021\nDose 1 to 2 At least 4 weeks", "probability": 0.006561279296875 }, { "start_logit": 18.78125, "end_logit": 17.703125, "text": " Bivalent\nAt least 8 weeks\nAt least 8 weeks", "probability": 0.004512786865234375 }, { "start_logit": 19.015625, "end_logit": 17.140625, "text": " 8 weeks", "probability": 0.0031986236572265625 }, { "start_logit": 16.46875, "end_logit": 19.484375, "text": "Red vial cap with a\nblue-bordered label\nPrimary series: Monovalent", "probability": 0.00257110595703125 }, { "start_logit": 16.4375, "end_logit": 19.484375, "text": "\nPrimary series: Monovalent", "probability": 0.00257110595703125 }, { "start_logit": 19.015625, "end_logit": 16.5625, "text": " 8 weeks\nAt least 8 weeks", "probability": 0.001766204833984375 }, { "start_logit": 20.390625, "end_logit": 15.1484375, "text": " 8 weeks\nAt least 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech", "probability": 0.0017118453979492188 }, { "start_logit": 18.21875, "end_logit": 16.5625, "text": " 8 weeks", "probability": 0.0008087158203125 }, { "start_logit": 19.515625, "end_logit": 15.1484375, "text": " 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech", "probability": 0.0007138252258300781 }, { "start_logit": 20.390625, "end_logit": 14.25, "text": " 8 weeks\nAt least 8 weeks\nand older\nMONOVALENT Pfizer-BioNTech\nGray", "probability": 0.0006918907165527344 }, { "start_logit": 20.40625, "end_logit": 14.0703125, "text": " Monovalent\nAt least 3-8\nweeks\u2021\nDose 1 to 2 At least 3 weeks", "probability": 0.0005922317504882812 }, { "start_logit": 17.140625, "end_logit": 17.140625, "text": " Bivalent\nAt least 8 weeks", "probability": 0.0004906654357910156 }, { "start_logit": 16.234375, "end_logit": 18.0, "text": "Gray vial cap with\ngray-bordered label\nPrimary series: Monovalent", "probability": 0.0004756450653076172 }, { "start_logit": 15.703125, "end_logit": 18.359375, "text": "BIVALENT Moderna\nBlue cap with\ngray-bordered label\nBooster dose\u00a7: Bivalent\nAt least 8 weeks", "probability": 0.0003941059112548828 }, { "start_logit": 8.71875, "end_logit": 0.71044921875, "text": "", "probability": 0.0 } ], "100000000000000000002571": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003135835877283034 }, { "start_logit": 6.36328125, "end_logit": -0.60009765625, "text": "", "probability": 0.9968641641227171 } ], "100000000000000000002576": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003363492495187692 }, { "start_logit": 6.375, "end_logit": -0.68408203125, "text": "", "probability": 0.9966365075048124 } ], "100000000000000000002585": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004086002694204712 }, { "start_logit": 5.6796875, "end_logit": -0.183837890625, "text": "", "probability": 0.9959139973057952 } ], "100000000000000000002591": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.07421875, "end_logit": 0.1357421875, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000002598": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.69921875, "end_logit": -0.391357421875, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000002617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 7.02734375, "end_logit": -0.67919921875, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000002618": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 7.02734375, "end_logit": -0.6982421875, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000002622": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001919237453341115 }, { "start_logit": 6.9140625, "end_logit": -0.66015625, "text": "", "probability": 0.998080762546659 } ], "100000000000000000002632": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.53125, "end_logit": -0.6015625, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000002636": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999957707875 }, { "start_logit": -33.53125, "end_logit": 14.25, "text": "", "probability": 4.22921261504982e-09 } ], "100000000000000000002637": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999956365377 }, { "start_logit": -33.5625, "end_logit": 14.3203125, "text": "", "probability": 4.363462233903899e-09 } ], "100000000000000000002645": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.5, "end_logit": -0.89306640625, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000002646": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.78515625, "end_logit": -0.7158203125, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000002655": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.59765625, "end_logit": -0.82373046875, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000002657": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.60546875, "end_logit": -0.78857421875, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000002659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.765625, "end_logit": -0.60009765625, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000002661": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007947254956253316 }, { "start_logit": 7.7109375, "end_logit": -0.5751953125, "text": "", "probability": 0.9992052745043747 } ], "100000000000000000002664": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.78125, "end_logit": -0.79541015625, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000002665": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.6484375, "end_logit": -0.72998046875, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000002666": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.765625, "end_logit": -0.83984375, "text": "", "probability": 0.999018828118793 } ], "100000000000000000002670": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020427647806347724 }, { "start_logit": 6.40625, "end_logit": -0.2144775390625, "text": "", "probability": 0.9979572352193652 } ], "100000000000000000002673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021657671990027 }, { "start_logit": 6.34375, "end_logit": -0.21240234375, "text": "", "probability": 0.9978342328009973 } ], "100000000000000000002675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999988437975 }, { "start_logit": -33.5, "end_logit": 12.921875, "text": "", "probability": 1.1562023934798114e-09 } ], "100000000000000000002678": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999988070958 }, { "start_logit": -33.5625, "end_logit": 13.015625, "text": "", "probability": 1.1929041971636973e-09 } ], "100000000000000000002684": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007702931971871536 }, { "start_logit": 7.8046875, "end_logit": -0.6376953125, "text": "", "probability": 0.9992297068028129 } ], "100000000000000000002689": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.7265625, "end_logit": -1.037109375, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000002690": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.82421875, "end_logit": -1.048828125, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000002691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.70703125, "end_logit": -0.97998046875, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000002695": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.46875, "end_logit": -0.39990234375, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000002696": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000872767030892148 }, { "start_logit": 7.4765625, "end_logit": -0.43212890625, "text": "", "probability": 0.9991272329691079 } ], "100000000000000000002704": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.3046875, "end_logit": -0.5908203125, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000002708": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.984375, "end_logit": -0.425048828125, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000002710": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 6.96875, "end_logit": -0.408203125, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000002715": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990110477 }, { "start_logit": -33.90625, "end_logit": 13.171875, "text": "", "probability": 9.889523148500171e-10 } ], "100000000000000000002716": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991928405 }, { "start_logit": -33.8125, "end_logit": 12.875, "text": "", "probability": 8.071593553406995e-10 } ], "100000000000000000002721": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990709654 }, { "start_logit": -33.8125, "end_logit": 13.015625, "text": "", "probability": 9.290347231253972e-10 } ], "100000000000000000002722": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989635868 }, { "start_logit": -33.84375, "end_logit": 13.1484375, "text": "", "probability": 1.0364131273371489e-09 } ], "100000000000000000002729": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.06548521078320749 }, { "start_logit": 5.5234375, "end_logit": -2.865234375, "text": "", "probability": 0.9345147892167925 } ], "100000000000000000002731": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.4140625, "end_logit": -0.712890625, "text": "", "probability": 0.998774432551617 } ], "100000000000000000002733": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012743262913872736 }, { "start_logit": 7.43359375, "end_logit": -0.77099609375, "text": "", "probability": 0.9987256737086126 } ], "100000000000000000002736": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.33984375, "end_logit": -0.68603515625, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000002744": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.79296875, "end_logit": -0.5751953125, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000002748": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.875, "end_logit": -0.658203125, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000002753": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007793660930208433 }, { "start_logit": 7.79296875, "end_logit": -0.6376953125, "text": "", "probability": 0.9992206339069791 } ], "100000000000000000002755": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006932422985664928 }, { "start_logit": 8.0, "end_logit": -0.724609375, "text": "", "probability": 0.9993067577014336 } ], "100000000000000000002756": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.9140625, "end_logit": -0.693359375, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000002757": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 7.98046875, "end_logit": -0.69189453125, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000002759": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.890625, "end_logit": -0.66259765625, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000002762": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006986756664856787 }, { "start_logit": 7.58984375, "end_logit": -0.32373046875, "text": "", "probability": 0.9993013243335144 } ], "100000000000000000002763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007096703991005882 }, { "start_logit": 7.58984375, "end_logit": -0.339599609375, "text": "", "probability": 0.9992903296008995 } ], "100000000000000000002764": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007916296072837431 }, { "start_logit": 7.4296875, "end_logit": -0.287841796875, "text": "", "probability": 0.9992083703927161 } ], "100000000000000000002765": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.4375, "end_logit": -0.28955078125, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000002768": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007978334816343424 }, { "start_logit": 7.41015625, "end_logit": -0.279296875, "text": "", "probability": 0.9992021665183656 } ], "100000000000000000002774": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007069056122424319 }, { "start_logit": 8.0859375, "end_logit": -0.8310546875, "text": "", "probability": 0.9992930943877577 } ], "100000000000000000002775": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006986756664856787 }, { "start_logit": 8.0625, "end_logit": -0.796875, "text": "", "probability": 0.9993013243335144 } ], "100000000000000000002779": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 7.77734375, "end_logit": -0.47607421875, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000002780": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 7.6953125, "end_logit": -0.412353515625, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000002785": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007947254956253316 }, { "start_logit": 7.70703125, "end_logit": -0.5712890625, "text": "", "probability": 0.9992052745043747 } ], "100000000000000000002792": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005747861775648728 }, { "start_logit": 7.5703125, "end_logit": -0.10845947265625, "text": "", "probability": 0.9994252138224351 } ], "100000000000000000002793": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006070755804415096 }, { "start_logit": 7.52734375, "end_logit": -0.1214599609375, "text": "", "probability": 0.9993929244195585 } ], "100000000000000000002798": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007763299914246077 }, { "start_logit": 7.41796875, "end_logit": -0.256591796875, "text": "", "probability": 0.9992236700085755 } ], "100000000000000000002803": [ { "start_logit": 22.15625, "end_logit": 11.6328125, "text": " maintaining healthy behaviors and seeking additional support", "probability": 0.849609375 }, { "start_logit": 22.15625, "end_logit": 8.8828125, "text": " maintaining healthy behaviors", "probability": 0.054290771484375 }, { "start_logit": 22.15625, "end_logit": 8.0078125, "text": " maintaining healthy behaviors and seeking", "probability": 0.02264404296875 }, { "start_logit": 22.15625, "end_logit": 7.69921875, "text": " maintaining healthy behaviors and seeking additional", "probability": 0.0168304443359375 }, { "start_logit": 22.15625, "end_logit": 7.12890625, "text": " maintaining healthy", "probability": 0.00943756103515625 }, { "start_logit": 22.15625, "end_logit": 7.0703125, "text": " maintaining healthy behaviors and seeking additional support is an important part of\nhelping other people. Support Groups", "probability": 0.00887298583984375 }, { "start_logit": 17.5625, "end_logit": 11.6328125, "text": " healthy behaviors and seeking additional support", "probability": 0.00859832763671875 }, { "start_logit": 22.15625, "end_logit": 6.7421875, "text": " maintaining", "probability": 0.0064849853515625 }, { "start_logit": 17.046875, "end_logit": 11.6328125, "text": " caregiver, remember that maintaining healthy behaviors and seeking additional support", "probability": 0.00521087646484375 }, { "start_logit": 16.921875, "end_logit": 11.6328125, "text": "If you are a caregiver, remember that maintaining healthy behaviors and seeking additional support", "probability": 0.00460052490234375 }, { "start_logit": 22.15625, "end_logit": 6.22265625, "text": " maintaining healthy behaviors and seeking additional support is an important part of\nhelping other people. Support", "probability": 0.003814697265625 }, { "start_logit": 22.15625, "end_logit": 5.8203125, "text": " maintaining healthy behaviors and seeking additional support is an important", "probability": 0.00254058837890625 }, { "start_logit": 22.15625, "end_logit": 5.69140625, "text": " maintaining healthy behaviors and seeking additional support is an important part", "probability": 0.0022411346435546875 }, { "start_logit": 22.15625, "end_logit": 5.4609375, "text": " maintaining healthy behaviors and seeking additional support is an important part of\nhelping other people. Support Groups\nBody", "probability": 0.0018024444580078125 }, { "start_logit": 22.15625, "end_logit": 4.9609375, "text": " maintaining healthy behaviors and seeking additional support is an important part of\nhelping", "probability": 0.0010929107666015625 }, { "start_logit": 17.5625, "end_logit": 8.8828125, "text": " healthy behaviors", "probability": 0.00054931640625 }, { "start_logit": 17.046875, "end_logit": 8.8828125, "text": " caregiver, remember that maintaining healthy behaviors", "probability": 0.0003333091735839844 }, { "start_logit": 16.921875, "end_logit": 8.8828125, "text": "If you are a caregiver, remember that maintaining healthy behaviors", "probability": 0.0002942085266113281 }, { "start_logit": 17.5625, "end_logit": 8.0078125, "text": " healthy behaviors and seeking", "probability": 0.00022912025451660156 }, { "start_logit": 17.5625, "end_logit": 7.69921875, "text": " healthy behaviors and seeking additional", "probability": 0.00017023086547851562 }, { "start_logit": 8.984375, "end_logit": -1.2900390625, "text": "", "probability": 0.0 } ], "100000000000000000002816": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010566838241698937 }, { "start_logit": 7.421875, "end_logit": -0.56884765625, "text": "", "probability": 0.9989433161758301 } ], "100000000000000000002818": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.40625, "end_logit": -0.578125, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000002821": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.38671875, "end_logit": -0.58203125, "text": "", "probability": 0.99889266101491 } ], "100000000000000000002827": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 6.68359375, "end_logit": -0.3525390625, "text": "", "probability": 0.998224739467894 } ], "100000000000000000002831": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.26953125, "end_logit": -0.6435546875, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000002832": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.234375, "end_logit": -0.6416015625, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000002834": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.23046875, "end_logit": -0.607421875, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000002835": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.3125, "end_logit": -0.14697265625, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000002837": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000767292412858718 }, { "start_logit": 7.30078125, "end_logit": -0.1304931640625, "text": "", "probability": 0.9992327075871412 } ], "100000000000000000002858": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 7.08203125, "end_logit": -0.470703125, "text": "", "probability": 0.998654139598703 } ], "100000000000000000002860": [ { "start_logit": 16.390625, "end_logit": 10.296875, "text": " three", "probability": 0.3310546875 }, { "start_logit": 16.390625, "end_logit": 9.2421875, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.11444091796875 }, { "start_logit": 14.7421875, "end_logit": 10.296875, "text": "The following COVID-19 vaccines, categorized into three", "probability": 0.06317138671875 }, { "start_logit": 16.390625, "end_logit": 8.609375, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.06121826171875 }, { "start_logit": 16.390625, "end_logit": 8.6015625, "text": " three vaccine types, are currently approved under a Biologics License", "probability": 0.06121826171875 }, { "start_logit": 16.390625, "end_logit": 8.5625, "text": " three vaccine", "probability": 0.05841064453125 }, { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.050750732421875 }, { "start_logit": 14.2578125, "end_logit": 10.296875, "text": " COVID-19 vaccines, categorized into three", "probability": 0.039520263671875 }, { "start_logit": 14.21875, "end_logit": 10.2109375, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna COVID-19 Vaccine/SPIKEVAX", "probability": 0.034881591796875 }, { "start_logit": 16.390625, "end_logit": 7.84765625, "text": " three vaccine types, are currently approved under a Biologics", "probability": 0.0284576416015625 }, { "start_logit": 13.9296875, "end_logit": 10.2109375, "text": "Moderna COVID-19 Vaccine/SPIKEVAX", "probability": 0.0259246826171875 }, { "start_logit": 14.21875, "end_logit": 9.796875, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines", "probability": 0.02288818359375 }, { "start_logit": 14.7421875, "end_logit": 9.1484375, "text": "The following COVID-19 vaccines", "probability": 0.0201873779296875 }, { "start_logit": 14.7421875, "end_logit": 8.9453125, "text": "The following COVID-19", "probability": 0.0164794921875 }, { "start_logit": 14.21875, "end_logit": 9.2421875, "text": "BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.01324462890625 }, { "start_logit": 14.2578125, "end_logit": 9.1484375, "text": " COVID-19 vaccines", "probability": 0.0124359130859375 }, { "start_logit": 14.7421875, "end_logit": 8.609375, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.011688232421875 }, { "start_logit": 14.7421875, "end_logit": 8.6015625, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License", "probability": 0.011688232421875 }, { "start_logit": 14.7421875, "end_logit": 8.5625, "text": "The following COVID-19 vaccines, categorized into three vaccine", "probability": 0.011322021484375 }, { "start_logit": 14.21875, "end_logit": 9.0625, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna", "probability": 0.01097869873046875 }, { "start_logit": 7.359375, "end_logit": -0.7490234375, "text": "", "probability": 0.0 } ], "100000000000000000002863": [ { "start_logit": 16.40625, "end_logit": 10.2890625, "text": " three", "probability": 0.328857421875 }, { "start_logit": 16.40625, "end_logit": 9.2578125, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.1171875 }, { "start_logit": 16.40625, "end_logit": 8.6171875, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.062744140625 }, { "start_logit": 14.7421875, "end_logit": 10.2890625, "text": "The following COVID-19 vaccines, categorized into three", "probability": 0.062744140625 }, { "start_logit": 16.40625, "end_logit": 8.6015625, "text": " three vaccine types, are currently approved under a Biologics License", "probability": 0.060821533203125 }, { "start_logit": 16.40625, "end_logit": 8.5625, "text": " three vaccine", "probability": 0.0589599609375 }, { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.0504150390625 }, { "start_logit": 14.2578125, "end_logit": 10.2890625, "text": " COVID-19 vaccines, categorized into three", "probability": 0.038665771484375 }, { "start_logit": 14.2109375, "end_logit": 10.2109375, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna COVID-19 Vaccine/SPIKEVAX", "probability": 0.03411865234375 }, { "start_logit": 16.40625, "end_logit": 7.8359375, "text": " three vaccine types, are currently approved under a Biologics", "probability": 0.02874755859375 }, { "start_logit": 13.9375, "end_logit": 10.2109375, "text": "Moderna COVID-19 Vaccine/SPIKEVAX", "probability": 0.0261688232421875 }, { "start_logit": 14.2109375, "end_logit": 9.8203125, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines", "probability": 0.0230865478515625 }, { "start_logit": 14.7421875, "end_logit": 9.1484375, "text": "The following COVID-19 vaccines", "probability": 0.0200653076171875 }, { "start_logit": 14.7421875, "end_logit": 8.9453125, "text": "The following COVID-19", "probability": 0.0163726806640625 }, { "start_logit": 14.2109375, "end_logit": 9.2578125, "text": "BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.013153076171875 }, { "start_logit": 14.2578125, "end_logit": 9.1484375, "text": " COVID-19 vaccines", "probability": 0.01235198974609375 }, { "start_logit": 14.7421875, "end_logit": 8.6171875, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.0117950439453125 }, { "start_logit": 14.7421875, "end_logit": 8.6015625, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License", "probability": 0.0116119384765625 }, { "start_logit": 14.7421875, "end_logit": 8.5625, "text": "The following COVID-19 vaccines, categorized into three vaccine", "probability": 0.01125335693359375 }, { "start_logit": 14.2109375, "end_logit": 9.0625, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna", "probability": 0.0109100341796875 }, { "start_logit": 7.421875, "end_logit": -0.75390625, "text": "", "probability": 0.0 } ], "100000000000000000002864": [ { "start_logit": 16.390625, "end_logit": 10.296875, "text": " three", "probability": 0.3310546875 }, { "start_logit": 16.390625, "end_logit": 9.2421875, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.11444091796875 }, { "start_logit": 14.7421875, "end_logit": 10.296875, "text": "The following COVID-19 vaccines, categorized into three", "probability": 0.06317138671875 }, { "start_logit": 16.390625, "end_logit": 8.609375, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.06121826171875 }, { "start_logit": 16.390625, "end_logit": 8.6015625, "text": " three vaccine types, are currently approved under a Biologics License", "probability": 0.06121826171875 }, { "start_logit": 16.390625, "end_logit": 8.5625, "text": " three vaccine", "probability": 0.05841064453125 }, { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.050750732421875 }, { "start_logit": 14.2578125, "end_logit": 10.296875, "text": " COVID-19 vaccines, categorized into three", "probability": 0.039520263671875 }, { "start_logit": 14.21875, "end_logit": 10.2109375, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna COVID-19 Vaccine/SPIKEVAX", "probability": 0.034881591796875 }, { "start_logit": 16.390625, "end_logit": 7.84765625, "text": " three vaccine types, are currently approved under a Biologics", "probability": 0.0284576416015625 }, { "start_logit": 13.9296875, "end_logit": 10.2109375, "text": "Moderna COVID-19 Vaccine/SPIKEVAX", "probability": 0.0259246826171875 }, { "start_logit": 14.21875, "end_logit": 9.796875, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines", "probability": 0.02288818359375 }, { "start_logit": 14.7421875, "end_logit": 9.1484375, "text": "The following COVID-19 vaccines", "probability": 0.0201873779296875 }, { "start_logit": 14.7421875, "end_logit": 8.9453125, "text": "The following COVID-19", "probability": 0.0164794921875 }, { "start_logit": 14.21875, "end_logit": 9.2421875, "text": "BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.01324462890625 }, { "start_logit": 14.2578125, "end_logit": 9.1484375, "text": " COVID-19 vaccines", "probability": 0.0124359130859375 }, { "start_logit": 14.7421875, "end_logit": 8.609375, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.011688232421875 }, { "start_logit": 14.7421875, "end_logit": 8.6015625, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License", "probability": 0.011688232421875 }, { "start_logit": 14.7421875, "end_logit": 8.5625, "text": "The following COVID-19 vaccines, categorized into three vaccine", "probability": 0.011322021484375 }, { "start_logit": 14.21875, "end_logit": 9.0625, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna", "probability": 0.01097869873046875 }, { "start_logit": 7.40625, "end_logit": -0.7646484375, "text": "", "probability": 0.0 } ], "100000000000000000002865": [ { "start_logit": 16.40625, "end_logit": 10.2890625, "text": " three", "probability": 0.328857421875 }, { "start_logit": 16.40625, "end_logit": 9.2578125, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.1171875 }, { "start_logit": 16.40625, "end_logit": 8.6171875, "text": " three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.062744140625 }, { "start_logit": 14.7421875, "end_logit": 10.2890625, "text": "The following COVID-19 vaccines, categorized into three", "probability": 0.062744140625 }, { "start_logit": 16.40625, "end_logit": 8.6015625, "text": " three vaccine types, are currently approved under a Biologics License", "probability": 0.060821533203125 }, { "start_logit": 16.40625, "end_logit": 8.5625, "text": " three vaccine", "probability": 0.0589599609375 }, { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.0504150390625 }, { "start_logit": 14.2578125, "end_logit": 10.2890625, "text": " COVID-19 vaccines, categorized into three", "probability": 0.038665771484375 }, { "start_logit": 14.2109375, "end_logit": 10.2109375, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna COVID-19 Vaccine/SPIKEVAX", "probability": 0.03411865234375 }, { "start_logit": 16.40625, "end_logit": 7.8359375, "text": " three vaccine types, are currently approved under a Biologics", "probability": 0.02874755859375 }, { "start_logit": 13.9375, "end_logit": 10.2109375, "text": "Moderna COVID-19 Vaccine/SPIKEVAX", "probability": 0.0261688232421875 }, { "start_logit": 14.2109375, "end_logit": 9.8203125, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines", "probability": 0.0230865478515625 }, { "start_logit": 14.7421875, "end_logit": 9.1484375, "text": "The following COVID-19 vaccines", "probability": 0.0200653076171875 }, { "start_logit": 14.7421875, "end_logit": 8.9453125, "text": "The following COVID-19", "probability": 0.0163726806640625 }, { "start_logit": 14.2109375, "end_logit": 9.2578125, "text": "BLA) or authorized under an EUA by FDA (Table 1", "probability": 0.013153076171875 }, { "start_logit": 14.2578125, "end_logit": 9.1484375, "text": " COVID-19 vaccines", "probability": 0.01235198974609375 }, { "start_logit": 14.7421875, "end_logit": 8.6171875, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License\nApplication (BLA", "probability": 0.0117950439453125 }, { "start_logit": 14.7421875, "end_logit": 8.6015625, "text": "The following COVID-19 vaccines, categorized into three vaccine types, are currently approved under a Biologics License", "probability": 0.0116119384765625 }, { "start_logit": 14.7421875, "end_logit": 8.5625, "text": "The following COVID-19 vaccines, categorized into three vaccine", "probability": 0.01125335693359375 }, { "start_logit": 14.2109375, "end_logit": 9.0625, "text": "BLA) or authorized under an EUA by FDA (Table 1):\nmRNA vaccines\nModerna", "probability": 0.0109100341796875 }, { "start_logit": 7.30078125, "end_logit": -0.75537109375, "text": "", "probability": 0.0 } ], "100000000000000000002876": [ { "start_logit": 15.8671875, "end_logit": 6.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue Gray", "probability": 0.1341552734375 }, { "start_logit": 15.78125, "end_logit": 6.61328125, "text": " Dark blue Gray", "probability": 0.1221923828125 }, { "start_logit": 15.78125, "end_logit": 6.50390625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray", "probability": 0.10955810546875 }, { "start_logit": 15.765625, "end_logit": 6.50390625, "text": " Dark blue Gray", "probability": 0.10784912109375 }, { "start_logit": 15.8671875, "end_logit": 5.5078125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue", "probability": 0.04425048828125 }, { "start_logit": 15.78125, "end_logit": 5.5078125, "text": " Dark blue", "probability": 0.040283203125 }, { "start_logit": 15.8671875, "end_logit": 5.38671875, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.039031982421875 }, { "start_logit": 14.953125, "end_logit": 6.29296875, "text": "6 months\u20135 years Monovalent Dark blue Magenta", "probability": 0.039031982421875 }, { "start_logit": 15.78125, "end_logit": 5.43359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue", "probability": 0.037841796875 }, { "start_logit": 15.765625, "end_logit": 5.43359375, "text": " Dark blue", "probability": 0.0372314453125 }, { "start_logit": 15.78125, "end_logit": 5.359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.035003662109375 }, { "start_logit": 15.765625, "end_logit": 5.359375, "text": " Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.034454345703125 }, { "start_logit": 16.203125, "end_logit": 4.8828125, "text": "COVID-19 vaccine products currently approved or authorized in the United States*\nModerna", "probability": 0.03338623046875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0318603515625 }, { "start_logit": 16.140625, "end_logit": 4.8828125, "text": "Moderna", "probability": 0.0313720703125 }, { "start_logit": 14.40625, "end_logit": 6.50390625, "text": " Bivalent Dark blue Gray", "probability": 0.0276947021484375 }, { "start_logit": 15.78125, "end_logit": 5.1015625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL", "probability": 0.0268402099609375 }, { "start_logit": 15.828125, "end_logit": 4.9609375, "text": " Monovalent Royal blue No color No 5 \u00b5g rS and\n50 \u00b5g of Matrix-M\u2122", "probability": 0.0244293212890625 }, { "start_logit": 14.4140625, "end_logit": 6.29296875, "text": " Monovalent Dark blue Magenta", "probability": 0.0225982666015625 }, { "start_logit": 14.3359375, "end_logit": 6.29296875, "text": "\u20135 years Monovalent Dark blue Magenta", "probability": 0.020904541015625 }, { "start_logit": -31.28125, "end_logit": 10.75, "text": "", "probability": 0.0 } ], "100000000000000000002879": [ { "start_logit": 15.8671875, "end_logit": 6.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue Gray", "probability": 0.1341552734375 }, { "start_logit": 15.78125, "end_logit": 6.61328125, "text": " Dark blue Gray", "probability": 0.1221923828125 }, { "start_logit": 15.78125, "end_logit": 6.50390625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray", "probability": 0.10955810546875 }, { "start_logit": 15.765625, "end_logit": 6.50390625, "text": " Dark blue Gray", "probability": 0.10784912109375 }, { "start_logit": 15.8671875, "end_logit": 5.5078125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue", "probability": 0.04425048828125 }, { "start_logit": 15.78125, "end_logit": 5.5078125, "text": " Dark blue", "probability": 0.040283203125 }, { "start_logit": 15.8671875, "end_logit": 5.38671875, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.039031982421875 }, { "start_logit": 14.953125, "end_logit": 6.29296875, "text": "6 months\u20135 years Monovalent Dark blue Magenta", "probability": 0.039031982421875 }, { "start_logit": 15.78125, "end_logit": 5.43359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue", "probability": 0.037841796875 }, { "start_logit": 15.765625, "end_logit": 5.43359375, "text": " Dark blue", "probability": 0.0372314453125 }, { "start_logit": 15.78125, "end_logit": 5.359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.035003662109375 }, { "start_logit": 15.765625, "end_logit": 5.359375, "text": " Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.034454345703125 }, { "start_logit": 16.203125, "end_logit": 4.8828125, "text": "COVID-19 vaccine products currently approved or authorized in the United States*\nModerna", "probability": 0.03338623046875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0318603515625 }, { "start_logit": 16.140625, "end_logit": 4.8828125, "text": "Moderna", "probability": 0.0313720703125 }, { "start_logit": 14.40625, "end_logit": 6.50390625, "text": " Bivalent Dark blue Gray", "probability": 0.0276947021484375 }, { "start_logit": 15.78125, "end_logit": 5.1015625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL", "probability": 0.0268402099609375 }, { "start_logit": 15.828125, "end_logit": 4.9609375, "text": " Monovalent Royal blue No color No 5 \u00b5g rS and\n50 \u00b5g of Matrix-M\u2122", "probability": 0.0244293212890625 }, { "start_logit": 14.4140625, "end_logit": 6.29296875, "text": " Monovalent Dark blue Magenta", "probability": 0.0225982666015625 }, { "start_logit": 14.3359375, "end_logit": 6.29296875, "text": "\u20135 years Monovalent Dark blue Magenta", "probability": 0.020904541015625 }, { "start_logit": -32.625, "end_logit": 14.171875, "text": "", "probability": 0.0 } ], "100000000000000000002880": [ { "start_logit": 15.8671875, "end_logit": 6.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue Gray", "probability": 0.1341552734375 }, { "start_logit": 15.78125, "end_logit": 6.61328125, "text": " Dark blue Gray", "probability": 0.1221923828125 }, { "start_logit": 15.78125, "end_logit": 6.50390625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray", "probability": 0.10955810546875 }, { "start_logit": 15.765625, "end_logit": 6.50390625, "text": " Dark blue Gray", "probability": 0.10784912109375 }, { "start_logit": 15.8671875, "end_logit": 5.5078125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL\nBooster vaccination\n6\u201311 years Bivalent Dark blue", "probability": 0.04425048828125 }, { "start_logit": 15.78125, "end_logit": 5.5078125, "text": " Dark blue", "probability": 0.040283203125 }, { "start_logit": 15.8671875, "end_logit": 5.38671875, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.039031982421875 }, { "start_logit": 14.953125, "end_logit": 6.29296875, "text": "6 months\u20135 years Monovalent Dark blue Magenta", "probability": 0.039031982421875 }, { "start_logit": 15.78125, "end_logit": 5.43359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue", "probability": 0.037841796875 }, { "start_logit": 15.765625, "end_logit": 5.43359375, "text": " Dark blue", "probability": 0.0372314453125 }, { "start_logit": 15.78125, "end_logit": 5.359375, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL\n12 years and older Bivalent Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.035003662109375 }, { "start_logit": 15.765625, "end_logit": 5.359375, "text": " Dark blue Gray No 50 \u00b5g 0.5 mL", "probability": 0.034454345703125 }, { "start_logit": 16.203125, "end_logit": 4.8828125, "text": "COVID-19 vaccine products currently approved or authorized in the United States*\nModerna", "probability": 0.03338623046875 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0318603515625 }, { "start_logit": 16.140625, "end_logit": 4.8828125, "text": "Moderna", "probability": 0.0313720703125 }, { "start_logit": 14.40625, "end_logit": 6.50390625, "text": " Bivalent Dark blue Gray", "probability": 0.0276947021484375 }, { "start_logit": 15.78125, "end_logit": 5.1015625, "text": " Dark blue Gray No 25 \u00b5g 0.25 mL", "probability": 0.0268402099609375 }, { "start_logit": 15.828125, "end_logit": 4.9609375, "text": " Monovalent Royal blue No color No 5 \u00b5g rS and\n50 \u00b5g of Matrix-M\u2122", "probability": 0.0244293212890625 }, { "start_logit": 14.4140625, "end_logit": 6.29296875, "text": " Monovalent Dark blue Magenta", "probability": 0.0225982666015625 }, { "start_logit": 14.3359375, "end_logit": 6.29296875, "text": "\u20135 years Monovalent Dark blue Magenta", "probability": 0.020904541015625 }, { "start_logit": 7.7109375, "end_logit": -0.86181640625, "text": "", "probability": 0.0 } ], "100000000000000000002884": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001455062938532843 }, { "start_logit": 6.484375, "end_logit": 0.0455322265625, "text": "", "probability": 0.9985449370614672 } ], "100000000000000000002893": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 7.16015625, "end_logit": -0.751953125, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000002896": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.18359375, "end_logit": -0.72900390625, "text": "", "probability": 0.998426887834651 } ], "100000000000000000002902": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029579027682491575 }, { "start_logit": 6.46484375, "end_logit": -0.646484375, "text": "", "probability": 0.997042097231751 } ], "100000000000000000002906": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002540992626578983 }, { "start_logit": 6.4453125, "end_logit": -0.472900390625, "text": "", "probability": 0.997459007373421 } ], "100000000000000000002908": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00268343980885746 }, { "start_logit": 6.28125, "end_logit": -0.36279296875, "text": "", "probability": 0.9973165601911425 } ], "100000000000000000002918": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.94921875, "end_logit": -0.75341796875, "text": "", "probability": 0.997965182999252 } ], "100000000000000000002919": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 6.94140625, "end_logit": -0.69091796875, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000002925": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024822767076302155 }, { "start_logit": 6.99609375, "end_logit": -1.0, "text": "", "probability": 0.9975177232923699 } ], "100000000000000000002934": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.77734375, "end_logit": -0.70947265625, "text": "", "probability": 0.999147433358729 } ], "100000000000000000002940": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 7.015625, "end_logit": -0.52880859375, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000002941": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 6.98046875, "end_logit": -0.59228515625, "text": "", "probability": 0.998319058298613 } ], "100000000000000000002949": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002341340651047526 }, { "start_logit": 6.80859375, "end_logit": -0.75537109375, "text": "", "probability": 0.9976586593489525 } ], "100000000000000000002951": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 6.83984375, "end_logit": -0.7763671875, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000002952": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 6.8671875, "end_logit": -0.78369140625, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000002953": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00225184727950302 }, { "start_logit": 6.94921875, "end_logit": -0.85400390625, "text": "", "probability": 0.997748152720497 } ], "100000000000000000002962": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.68359375, "end_logit": -0.37353515625, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000002968": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.421875, "end_logit": -0.343505859375, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000002973": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0028671585933937862 }, { "start_logit": 6.03515625, "end_logit": -0.1849365234375, "text": "", "probability": 0.9971328414066062 } ], "100000000000000000002974": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027362210991480392 }, { "start_logit": 6.04296875, "end_logit": -0.1431884765625, "text": "", "probability": 0.997263778900852 } ], "100000000000000000002976": [ { "start_logit": 17.09375, "end_logit": 7.44140625, "text": " mRNA", "probability": 0.1748046875 }, { "start_logit": 17.015625, "end_logit": 7.44140625, "text": " monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.1617431640625 }, { "start_logit": 16.625, "end_logit": 7.44140625, "text": " NA = not authorized\nA monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.10943603515625 }, { "start_logit": 17.09375, "end_logit": 6.5234375, "text": " mRNA booster", "probability": 0.0706787109375 }, { "start_logit": 17.015625, "end_logit": 6.5234375, "text": " monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.0643310546875 }, { "start_logit": 17.09375, "end_logit": 6.2421875, "text": " mRNA booster dose) may be used in limited situations in people ages 18 years and older", "probability": 0.053314208984375 }, { "start_logit": 17.0625, "end_logit": 6.13671875, "text": " 3\u20138 weeks", "probability": 0.04632568359375 }, { "start_logit": 16.625, "end_logit": 6.5234375, "text": " NA = not authorized\nA monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.044219970703125 }, { "start_logit": 17.015625, "end_logit": 6.04296875, "text": " monovalent", "probability": 0.040252685546875 }, { "start_logit": 15.421875, "end_logit": 7.44140625, "text": " 2 months\nAbbreviation: NA = not authorized\nA monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.0328369140625 }, { "start_logit": 17.0625, "end_logit": 5.72265625, "text": " 3\u20138 weeks At least 8 weeks NA\nyears\nPfizer-BioNTech\n3\u20138 weeks NA At least 2 months", "probability": 0.0303955078125 }, { "start_logit": 17.0625, "end_logit": 5.67578125, "text": " 3", "probability": 0.02899169921875 }, { "start_logit": 16.625, "end_logit": 6.04296875, "text": " NA = not authorized\nA monovalent", "probability": 0.0272369384765625 }, { "start_logit": 16.625, "end_logit": 6.0078125, "text": " NA", "probability": 0.0260009765625 }, { "start_logit": 15.8828125, "end_logit": 6.39453125, "text": "Moderna primary series\nyears\n2 NA NA 4\u20138 weeks", "probability": 0.0184326171875 }, { "start_logit": 15.8828125, "end_logit": 6.39453125, "text": " 4\u20138 weeks", "probability": 0.0184326171875 }, { "start_logit": 17.0625, "end_logit": 5.15625, "text": " 3\u20138 weeks At least 8 weeks NA\nyears", "probability": 0.0173187255859375 }, { "start_logit": 17.0625, "end_logit": 5.1328125, "text": " 3\u20138 weeks At least 8 weeks NA\nyears\nPfizer-BioNTech\n3\u20138 weeks", "probability": 0.01678466796875 }, { "start_logit": 15.5078125, "end_logit": 6.13671875, "text": "3 NA NA 3\u20138 weeks", "probability": 0.00971221923828125 }, { "start_logit": 15.8828125, "end_logit": 5.68359375, "text": " 4\u20138 weeks NA NA\nyears\nPfizer-BioNTech\n4\u20138 weeks NA At least 2 months", "probability": 0.00897979736328125 }, { "start_logit": 6.421875, "end_logit": -0.01922607421875, "text": "", "probability": 0.0 } ], "100000000000000000002992": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.12109375, "end_logit": -0.260498046875, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000002995": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0039607875302097575 }, { "start_logit": 5.7890625, "end_logit": -0.262939453125, "text": "", "probability": 0.9960392124697902 } ], "100000000000000000002999": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 6.41796875, "end_logit": -0.336669921875, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000003000": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 6.55859375, "end_logit": -0.3857421875, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000003007": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001524786391225749 }, { "start_logit": 7.37890625, "end_logit": -0.8935546875, "text": "", "probability": 0.9984752136087741 } ], "100000000000000000003019": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.007039045597401514 }, { "start_logit": 6.06640625, "end_logit": -1.1171875, "text": "", "probability": 0.9929609544025984 } ], "100000000000000000003021": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.007093861878911533 }, { "start_logit": 6.03125, "end_logit": -1.0908203125, "text": "", "probability": 0.9929061381210885 } ], "100000000000000000003025": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.8671875, "end_logit": -0.49853515625, "text": "", "probability": 0.998285961520812 } ], "100000000000000000003028": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 6.94140625, "end_logit": -0.60302734375, "text": "", "probability": 0.998238530319926 } ], "100000000000000000003031": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.39453125, "end_logit": -0.7431640625, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000003032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.30078125, "end_logit": -0.69580078125, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000003038": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.68359375, "end_logit": -0.8037109375, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000003040": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.73828125, "end_logit": -0.78759765625, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000003041": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 6.73046875, "end_logit": -0.31396484375, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000003046": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016103573704565953 }, { "start_logit": 6.7265625, "end_logit": -0.29736328125, "text": "", "probability": 0.9983896426295433 } ], "100000000000000000003051": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.5234375, "end_logit": -0.78955078125, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000003054": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.6953125, "end_logit": -0.880859375, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000003055": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.64453125, "end_logit": -0.82666015625, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000003065": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 7.04296875, "end_logit": -0.65478515625, "text": "", "probability": 0.998319058298613 } ], "100000000000000000003069": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019723357407638166 }, { "start_logit": 7.28515625, "end_logit": -1.0595703125, "text": "", "probability": 0.9980276642592362 } ], "100000000000000000003080": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027469009484408103 }, { "start_logit": 6.109375, "end_logit": -0.215576171875, "text": "", "probability": 0.9972530990515591 } ], "100000000000000000003081": [ { "start_logit": 17.140625, "end_logit": 7.515625, "text": " mRNA", "probability": 0.1739501953125 }, { "start_logit": 16.765625, "end_logit": 7.515625, "text": " NA = not authorized\n*A monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.11956787109375 }, { "start_logit": 16.765625, "end_logit": 7.515625, "text": "*A monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.11956787109375 }, { "start_logit": 17.140625, "end_logit": 6.6484375, "text": " mRNA booster", "probability": 0.07244873046875 }, { "start_logit": 16.765625, "end_logit": 6.9453125, "text": " NA = not authorized\n*A", "probability": 0.068115234375 }, { "start_logit": 16.765625, "end_logit": 6.9453125, "text": "*A", "probability": 0.068115234375 }, { "start_logit": 17.140625, "end_logit": 6.27734375, "text": " mRNA booster dose) may be used in limited situations in people ages 18 years and older", "probability": 0.05059814453125 }, { "start_logit": 16.765625, "end_logit": 6.6484375, "text": " NA = not authorized\n*A monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.049835205078125 }, { "start_logit": 16.765625, "end_logit": 6.6484375, "text": "*A monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.049835205078125 }, { "start_logit": 17.015625, "end_logit": 6.1640625, "text": " 3 weeks", "probability": 0.0400390625 }, { "start_logit": 16.765625, "end_logit": 6.38671875, "text": " NA", "probability": 0.038818359375 }, { "start_logit": 16.765625, "end_logit": 6.21875, "text": " NA = not authorized\n*A monovalent", "probability": 0.032684326171875 }, { "start_logit": 16.765625, "end_logit": 6.21875, "text": "*A monovalent", "probability": 0.032684326171875 }, { "start_logit": 17.015625, "end_logit": 5.7421875, "text": " 3", "probability": 0.0258636474609375 }, { "start_logit": 17.015625, "end_logit": 5.15234375, "text": " 3 weeks At least 8 weeks NA\n5 years 3 1 Pfizer-BioNTech 3 weeks", "probability": 0.01450347900390625 }, { "start_logit": 15.8984375, "end_logit": 5.99609375, "text": "Moderna primary series\nyears\n3 NA NA 4 weeks", "probability": 0.0109405517578125 }, { "start_logit": 15.5703125, "end_logit": 6.1640625, "text": "3 NA NA 3 weeks", "probability": 0.00936126708984375 }, { "start_logit": 14.6328125, "end_logit": 6.9453125, "text": "3 weeks At least 4 weeks At least 2 months\nAbbreviation: NA = not authorized\n*A", "probability": 0.0080108642578125 }, { "start_logit": 15.5234375, "end_logit": 6.0, "text": " mRNA vaccine (i.e.,\nmRNA vaccine", "probability": 0.007640838623046875 }, { "start_logit": 15.4921875, "end_logit": 5.99609375, "text": "3 NA NA 4 weeks", "probability": 0.007293701171875 }, { "start_logit": -34.65625, "end_logit": 15.765625, "text": "", "probability": 0.0 } ], "100000000000000000003084": [ { "start_logit": 17.140625, "end_logit": 7.515625, "text": " mRNA", "probability": 0.174072265625 }, { "start_logit": 16.765625, "end_logit": 7.515625, "text": " NA = not authorized\n*A monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.11962890625 }, { "start_logit": 16.765625, "end_logit": 7.515625, "text": "*A monovalent Novavax booster dose (instead of a bivalent mRNA", "probability": 0.11962890625 }, { "start_logit": 17.140625, "end_logit": 6.6484375, "text": " mRNA booster", "probability": 0.072509765625 }, { "start_logit": 16.765625, "end_logit": 6.9453125, "text": " NA = not authorized\n*A", "probability": 0.06817626953125 }, { "start_logit": 16.765625, "end_logit": 6.9453125, "text": "*A", "probability": 0.06817626953125 }, { "start_logit": 17.140625, "end_logit": 6.27734375, "text": " mRNA booster dose) may be used in limited situations in people ages 18 years and older", "probability": 0.0506591796875 }, { "start_logit": 16.765625, "end_logit": 6.6484375, "text": " NA = not authorized\n*A monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.049896240234375 }, { "start_logit": 16.765625, "end_logit": 6.6484375, "text": "*A monovalent Novavax booster dose (instead of a bivalent mRNA booster", "probability": 0.049896240234375 }, { "start_logit": 17.015625, "end_logit": 6.1640625, "text": " 3 weeks", "probability": 0.040069580078125 }, { "start_logit": 16.765625, "end_logit": 6.38671875, "text": " NA", "probability": 0.038848876953125 }, { "start_logit": 16.765625, "end_logit": 6.21875, "text": " NA = not authorized\n*A monovalent", "probability": 0.032684326171875 }, { "start_logit": 16.765625, "end_logit": 6.21875, "text": "*A monovalent", "probability": 0.032684326171875 }, { "start_logit": 17.015625, "end_logit": 5.7421875, "text": " 3", "probability": 0.02587890625 }, { "start_logit": 17.015625, "end_logit": 5.15234375, "text": " 3 weeks At least 8 weeks NA\n5 years 3 1 Pfizer-BioNTech 3 weeks", "probability": 0.0145111083984375 }, { "start_logit": 15.8984375, "end_logit": 5.99609375, "text": "Moderna primary series\nyears\n3 NA NA 4 weeks", "probability": 0.01094818115234375 }, { "start_logit": 15.5703125, "end_logit": 6.1640625, "text": "3 NA NA 3 weeks", "probability": 0.009368896484375 }, { "start_logit": 12.3046875, "end_logit": 9.40625, "text": " 3", "probability": 0.00922393798828125 }, { "start_logit": 15.4921875, "end_logit": 5.99609375, "text": "3 NA NA 4 weeks", "probability": 0.007297515869140625 }, { "start_logit": 15.5703125, "end_logit": 5.7421875, "text": "3 NA NA 3", "probability": 0.006145477294921875 }, { "start_logit": 6.98828125, "end_logit": -0.27587890625, "text": "", "probability": 0.0 } ], "100000000000000000003091": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 6.7421875, "end_logit": -0.2086181640625, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000003092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 6.7421875, "end_logit": -0.1802978515625, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000003094": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002157341888452641 }, { "start_logit": 6.41015625, "end_logit": -0.27294921875, "text": "", "probability": 0.9978426581115474 } ], "100000000000000000003096": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022170130229473865 }, { "start_logit": 6.45703125, "end_logit": -0.345703125, "text": "", "probability": 0.9977829869770526 } ], "100000000000000000003098": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 6.3046875, "end_logit": -0.24365234375, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000003101": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005322535451112772 }, { "start_logit": 5.96484375, "end_logit": -0.734375, "text": "", "probability": 0.9946774645488873 } ], "100000000000000000003102": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0053640566906201104 }, { "start_logit": 5.98828125, "end_logit": -0.7666015625, "text": "", "probability": 0.99463594330938 } ], "100000000000000000003103": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.006073934440886245 }, { "start_logit": 5.91796875, "end_logit": -0.8203125, "text": "", "probability": 0.9939260655591138 } ], "100000000000000000003108": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0077555367808475675 }, { "start_logit": 5.90234375, "end_logit": -1.0498046875, "text": "", "probability": 0.9922444632191525 } ], "100000000000000000003109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0039607875302097575 }, { "start_logit": 6.03515625, "end_logit": -0.5068359375, "text": "", "probability": 0.9960392124697902 } ], "100000000000000000003111": [ { "start_logit": 16.71875, "end_logit": 8.7109375, "text": " 20", "probability": 0.2015380859375 }, { "start_logit": 16.6875, "end_logit": 8.640625, "text": " chimeric antigen receptor", "probability": 0.1806640625 }, { "start_logit": 16.6875, "end_logit": 8.5625, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant", "probability": 0.1671142578125 }, { "start_logit": 16.6875, "end_logit": 7.4453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant (HCT) (within 2 years", "probability": 0.054229736328125 }, { "start_logit": 16.171875, "end_logit": 7.7109375, "text": "Advanced", "probability": 0.042236328125 }, { "start_logit": 16.171875, "end_logit": 7.50390625, "text": "Advanced HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.03448486328125 }, { "start_logit": 15.109375, "end_logit": 8.5625, "text": " hematopoietic cell transplant", "probability": 0.03448486328125 }, { "start_logit": 14.9453125, "end_logit": 8.7109375, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids (i.e., 20", "probability": 0.033966064453125 }, { "start_logit": 16.171875, "end_logit": 7.35546875, "text": "Advanced HIV", "probability": 0.02996826171875 }, { "start_logit": 15.6875, "end_logit": 7.8359375, "text": "HCT) (within 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.02996826171875 }, { "start_logit": 16.171875, "end_logit": 7.3359375, "text": "Advanced HIV infection", "probability": 0.0290374755859375 }, { "start_logit": 15.640625, "end_logit": 7.8359375, "text": "Moderate or severe primary immunodeficiency", "probability": 0.0281524658203125 }, { "start_logit": 14.734375, "end_logit": 8.7109375, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.02728271484375 }, { "start_logit": 15.6875, "end_logit": 7.4453125, "text": "HCT) (within 2 years", "probability": 0.01995849609375 }, { "start_logit": 14.9453125, "end_logit": 7.96875, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids", "probability": 0.0160369873046875 }, { "start_logit": 15.015625, "end_logit": 7.8359375, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01506805419921875 }, { "start_logit": 15.2890625, "end_logit": 7.50390625, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.014373779296875 }, { "start_logit": 15.890625, "end_logit": 6.8828125, "text": " disease severity, duration,\nclinical stability, complications, comorbidities, and any potentially immune-suppressing", "probability": 0.0141448974609375 }, { "start_logit": 15.640625, "end_logit": 7.10546875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.0137176513671875 }, { "start_logit": 14.734375, "end_logit": 7.96875, "text": " high-dose corticosteroids", "probability": 0.013092041015625 }, { "start_logit": 8.515625, "end_logit": 0.54736328125, "text": "", "probability": 0.0 } ], "100000000000000000003114": [ { "start_logit": 16.71875, "end_logit": 8.703125, "text": " 20", "probability": 0.1988525390625 }, { "start_logit": 16.6875, "end_logit": 8.640625, "text": " chimeric antigen receptor", "probability": 0.18115234375 }, { "start_logit": 16.6875, "end_logit": 8.578125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant", "probability": 0.170166015625 }, { "start_logit": 16.6875, "end_logit": 7.4453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant (HCT) (within 2 years", "probability": 0.05438232421875 }, { "start_logit": 16.171875, "end_logit": 7.71875, "text": "Advanced", "probability": 0.04302978515625 }, { "start_logit": 16.171875, "end_logit": 7.5078125, "text": "Advanced HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.035125732421875 }, { "start_logit": 15.1015625, "end_logit": 8.578125, "text": " hematopoietic cell transplant", "probability": 0.035125732421875 }, { "start_logit": 14.9453125, "end_logit": 8.703125, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids (i.e., 20", "probability": 0.034027099609375 }, { "start_logit": 16.171875, "end_logit": 7.35546875, "text": "Advanced HIV", "probability": 0.030029296875 }, { "start_logit": 15.6953125, "end_logit": 7.83984375, "text": "HCT) (within 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.030029296875 }, { "start_logit": 16.171875, "end_logit": 7.33203125, "text": "Advanced HIV infection", "probability": 0.02911376953125 }, { "start_logit": 15.6328125, "end_logit": 7.83984375, "text": "Moderate or severe primary immunodeficiency", "probability": 0.0282135009765625 }, { "start_logit": 14.71875, "end_logit": 8.703125, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0269317626953125 }, { "start_logit": 15.6953125, "end_logit": 7.4453125, "text": "HCT) (within 2 years", "probability": 0.02032470703125 }, { "start_logit": 14.9453125, "end_logit": 7.9609375, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids", "probability": 0.0160675048828125 }, { "start_logit": 15.015625, "end_logit": 7.83984375, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0153350830078125 }, { "start_logit": 15.2890625, "end_logit": 7.5078125, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.01441192626953125 }, { "start_logit": 15.6328125, "end_logit": 7.10546875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.0135345458984375 }, { "start_logit": 14.71875, "end_logit": 7.9609375, "text": " high-dose corticosteroids", "probability": 0.01291656494140625 }, { "start_logit": 15.1015625, "end_logit": 7.4453125, "text": " hematopoietic cell transplant (HCT) (within 2 years", "probability": 0.01122283935546875 }, { "start_logit": 8.453125, "end_logit": 0.50244140625, "text": "", "probability": 0.0 } ], "100000000000000000003120": [ { "start_logit": 16.71875, "end_logit": 8.7109375, "text": " 20", "probability": 0.2025146484375 }, { "start_logit": 16.6875, "end_logit": 8.6328125, "text": " chimeric antigen receptor", "probability": 0.1787109375 }, { "start_logit": 16.6875, "end_logit": 8.5703125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant", "probability": 0.16796875 }, { "start_logit": 16.6875, "end_logit": 7.4375, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic cell transplant (HCT) (within 2 years", "probability": 0.05450439453125 }, { "start_logit": 16.171875, "end_logit": 7.71875, "text": "Advanced", "probability": 0.043121337890625 }, { "start_logit": 16.171875, "end_logit": 7.51171875, "text": "Advanced HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.03521728515625 }, { "start_logit": 15.1015625, "end_logit": 8.5703125, "text": " hematopoietic cell transplant", "probability": 0.034637451171875 }, { "start_logit": 14.9453125, "end_logit": 8.7109375, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids (i.e., 20", "probability": 0.03411865234375 }, { "start_logit": 16.171875, "end_logit": 7.3515625, "text": "Advanced HIV", "probability": 0.0301055908203125 }, { "start_logit": 15.6953125, "end_logit": 7.8359375, "text": "HCT) (within 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0301055908203125 }, { "start_logit": 16.171875, "end_logit": 7.33984375, "text": "Advanced HIV infection", "probability": 0.0296478271484375 }, { "start_logit": 15.640625, "end_logit": 7.8359375, "text": "Moderate or severe primary immunodeficiency", "probability": 0.028289794921875 }, { "start_logit": 14.7265625, "end_logit": 8.7109375, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0274200439453125 }, { "start_logit": 15.6953125, "end_logit": 7.4375, "text": "HCT) (within 2 years", "probability": 0.020050048828125 }, { "start_logit": 14.9453125, "end_logit": 7.9609375, "text": " untreated HIV infection\nActive treatment with high-dose corticosteroids", "probability": 0.01611328125 }, { "start_logit": 15.015625, "end_logit": 7.8359375, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.01514434814453125 }, { "start_logit": 15.2890625, "end_logit": 7.51171875, "text": "people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.014434814453125 }, { "start_logit": 15.640625, "end_logit": 7.10546875, "text": "Moderate or severe primary immunodeficiency (e.g., common variable immunodeficiency", "probability": 0.01378631591796875 }, { "start_logit": 14.7265625, "end_logit": 7.9609375, "text": " high-dose corticosteroids", "probability": 0.012939453125 }, { "start_logit": 15.1015625, "end_logit": 7.4375, "text": " hematopoietic cell transplant (HCT) (within 2 years", "probability": 0.011077880859375 }, { "start_logit": -34.09375, "end_logit": 15.390625, "text": "", "probability": 0.0 } ], "100000000000000000003127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016875096190311083 }, { "start_logit": 7.12890625, "end_logit": -0.74609375, "text": "", "probability": 0.9983124903809688 } ], "100000000000000000003131": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 6.84765625, "end_logit": -0.494384765625, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000003132": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.06640625, "end_logit": -0.59326171875, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003139": [ { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.63232421875 }, { "start_logit": 16.203125, "end_logit": 4.01171875, "text": "COVID-19 vaccination and EVUSHELD\u2122", "probability": 0.2763671875 }, { "start_logit": 16.203125, "end_logit": 2.90625, "text": "COVID-19 vaccination", "probability": 0.09112548828125 }, { "start_logit": 8.0390625, "end_logit": -1.5810546875, "text": "", "probability": 2.980232238769531e-07 } ], "100000000000000000003148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030994155155094484 }, { "start_logit": 5.73828125, "end_logit": 0.036285400390625, "text": "", "probability": 0.9969005844844906 } ], "100000000000000000003152": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.26171875, "end_logit": -0.58056640625, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000003153": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.25390625, "end_logit": -0.5703125, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000003155": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.21484375, "end_logit": -0.48681640625, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000003158": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.36328125, "end_logit": -0.708984375, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000003162": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00040290520927668155 }, { "start_logit": 7.81640625, "end_logit": 0.0006570816040039062, "text": "", "probability": 0.9995970947907232 } ], "100000000000000000003165": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 7.47265625, "end_logit": -1.0751953125, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000003167": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 7.28125, "end_logit": -1.0185546875, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000003170": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999954980265 }, { "start_logit": -33.96875, "end_logit": 14.75, "text": "", "probability": 4.501973393078082e-09 } ], "100000000000000000003172": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999959009065 }, { "start_logit": -33.9375, "end_logit": 14.6328125, "text": "", "probability": 4.099093422706265e-09 } ], "100000000000000000003174": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 6.77734375, "end_logit": -0.38232421875, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000003178": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002621440946167595 }, { "start_logit": 6.44140625, "end_logit": -0.49951171875, "text": "", "probability": 0.9973785590538324 } ], "100000000000000000003179": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026522597057856566 }, { "start_logit": 6.37109375, "end_logit": -0.43994140625, "text": "", "probability": 0.9973477402942144 } ], "100000000000000000003180": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027044293694093243 }, { "start_logit": 6.37890625, "end_logit": -0.46728515625, "text": "", "probability": 0.9972955706305906 } ], "100000000000000000003188": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015669887925500437 }, { "start_logit": 7.0859375, "end_logit": -0.62939453125, "text": "", "probability": 0.99843301120745 } ], "100000000000000000003189": [ { "start_logit": 15.46875, "end_logit": 8.6953125, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.140869140625 }, { "start_logit": 15.4375, "end_logit": 8.6953125, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.1365966796875 }, { "start_logit": 14.953125, "end_logit": 8.6953125, "text": "Vaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.08544921875 }, { "start_logit": 14.71875, "end_logit": 8.6953125, "text": "Interchangeability of COVID-19 vaccine products", "probability": 0.06658935546875 }, { "start_logit": 14.71875, "end_logit": 8.6953125, "text": " SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.06658935546875 }, { "start_logit": 14.6171875, "end_logit": 8.6953125, "text": "Orthopoxvirus vaccination:\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.06060791015625 }, { "start_logit": 14.4375, "end_logit": 8.6953125, "text": " COVID-19 vaccine products", "probability": 0.05023193359375 }, { "start_logit": 15.4375, "end_logit": 7.53515625, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products\n\uf20c\nCoadministration of COVID-19 vaccines", "probability": 0.04296875 }, { "start_logit": 15.46875, "end_logit": 7.34765625, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine", "probability": 0.036773681640625 }, { "start_logit": 15.4375, "end_logit": 7.34765625, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine", "probability": 0.03564453125 }, { "start_logit": 14.6171875, "end_logit": 8.0078125, "text": "Orthopoxvirus vaccination", "probability": 0.0304718017578125 }, { "start_logit": 15.46875, "end_logit": 7.125, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19", "probability": 0.0295257568359375 }, { "start_logit": 15.46875, "end_logit": 7.11328125, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2", "probability": 0.029083251953125 }, { "start_logit": 15.46875, "end_logit": 7.109375, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability", "probability": 0.029083251953125 }, { "start_logit": 15.4375, "end_logit": 7.125, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19", "probability": 0.02862548828125 }, { "start_logit": 15.4375, "end_logit": 7.11328125, "text": "\nVaccination after SARS-CoV-2", "probability": 0.0281829833984375 }, { "start_logit": 15.4375, "end_logit": 7.109375, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability", "probability": 0.0281829833984375 }, { "start_logit": 14.953125, "end_logit": 7.53515625, "text": "Vaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products\n\uf20c\nCoadministration of COVID-19 vaccines", "probability": 0.0264739990234375 }, { "start_logit": 14.875, "end_logit": 7.53515625, "text": "Coadministration of COVID-19 vaccines", "probability": 0.0244903564453125 }, { "start_logit": 15.46875, "end_logit": 6.9140625, "text": "\n\uf20c \uf20c\nVaccination", "probability": 0.0237274169921875 }, { "start_logit": 7.8359375, "end_logit": -0.9296875, "text": "", "probability": 0.0 } ], "100000000000000000003191": [ { "start_logit": 15.4765625, "end_logit": 8.6953125, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.1424560546875 }, { "start_logit": 15.4375, "end_logit": 8.6953125, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.1358642578125 }, { "start_logit": 14.9453125, "end_logit": 8.6953125, "text": "Vaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.083740234375 }, { "start_logit": 14.7265625, "end_logit": 8.6953125, "text": "Interchangeability of COVID-19 vaccine products", "probability": 0.06732177734375 }, { "start_logit": 14.7109375, "end_logit": 8.6953125, "text": " SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.0662841796875 }, { "start_logit": 14.6171875, "end_logit": 8.6953125, "text": "Orthopoxvirus vaccination:\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products", "probability": 0.060302734375 }, { "start_logit": 14.4375, "end_logit": 8.6953125, "text": " COVID-19 vaccine products", "probability": 0.050018310546875 }, { "start_logit": 15.4375, "end_logit": 7.53515625, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products\n\uf20c\nCoadministration of COVID-19 vaccines", "probability": 0.04278564453125 }, { "start_logit": 15.4765625, "end_logit": 7.34765625, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine", "probability": 0.03717041015625 }, { "start_logit": 15.4375, "end_logit": 7.34765625, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine", "probability": 0.03546142578125 }, { "start_logit": 14.6171875, "end_logit": 8.0078125, "text": "Orthopoxvirus vaccination", "probability": 0.03033447265625 }, { "start_logit": 15.4765625, "end_logit": 7.12890625, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19", "probability": 0.0298614501953125 }, { "start_logit": 15.4765625, "end_logit": 7.11328125, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2", "probability": 0.0294036865234375 }, { "start_logit": 15.4765625, "end_logit": 7.109375, "text": "\n\uf20c \uf20c\nVaccination after SARS-CoV-2 Infection\nInterchangeability", "probability": 0.0294036865234375 }, { "start_logit": 15.4375, "end_logit": 7.12890625, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19", "probability": 0.02850341796875 }, { "start_logit": 15.4375, "end_logit": 7.11328125, "text": "\nVaccination after SARS-CoV-2", "probability": 0.028045654296875 }, { "start_logit": 15.4375, "end_logit": 7.109375, "text": "\nVaccination after SARS-CoV-2 Infection\nInterchangeability", "probability": 0.028045654296875 }, { "start_logit": 14.9453125, "end_logit": 7.53515625, "text": "Vaccination after SARS-CoV-2 Infection\nInterchangeability of COVID-19 vaccine products\n\uf20c\nCoadministration of COVID-19 vaccines", "probability": 0.0263519287109375 }, { "start_logit": 14.875, "end_logit": 7.53515625, "text": "Coadministration of COVID-19 vaccines", "probability": 0.0243682861328125 }, { "start_logit": 15.4765625, "end_logit": 6.9140625, "text": "\n\uf20c \uf20c\nVaccination", "probability": 0.0240020751953125 }, { "start_logit": 7.70703125, "end_logit": -0.9189453125, "text": "", "probability": 0.0 } ], "100000000000000000003201": [ { "start_logit": 14.296875, "end_logit": 6.875, "text": " Pfizer-BioNTech", "probability": 0.27099609375 }, { "start_logit": 14.140625, "end_logit": 6.875, "text": "Moderna, Novavax, or Pfizer-BioNTech", "probability": 0.2318115234375 }, { "start_logit": 14.0390625, "end_logit": 6.875, "text": " Novavax, or Pfizer-BioNTech", "probability": 0.207763671875 }, { "start_logit": 14.140625, "end_logit": 6.49609375, "text": "Moderna", "probability": 0.1593017578125 }, { "start_logit": 14.140625, "end_logit": 5.65625, "text": "Moderna, Novavax", "probability": 0.06854248046875 }, { "start_logit": 14.0390625, "end_logit": 5.65625, "text": " Novavax", "probability": 0.061431884765625 }, { "start_logit": 7.41015625, "end_logit": -0.98876953125, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000003204": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012399961359154668 }, { "start_logit": 7.125, "end_logit": -0.43505859375, "text": "", "probability": 0.9987600038640845 } ], "100000000000000000003210": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.359375, "end_logit": -0.71484375, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000003212": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.36328125, "end_logit": -0.666015625, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000003214": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.0390625, "end_logit": -0.560546875, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000003215": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.06640625, "end_logit": -0.59326171875, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003218": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.046875, "end_logit": -0.6533203125, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000003219": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 7.0234375, "end_logit": -0.6240234375, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000003220": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000509265714385189 }, { "start_logit": 7.33203125, "end_logit": 0.2491455078125, "text": "", "probability": 0.9994907342856149 } ], "100000000000000000003221": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005213363066504585 }, { "start_logit": 7.28125, "end_logit": 0.276611328125, "text": "", "probability": 0.9994786636933496 } ], "100000000000000000003223": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005336928427664175 }, { "start_logit": 7.2421875, "end_logit": 0.293701171875, "text": "", "probability": 0.9994663071572335 } ], "100000000000000000003224": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015548133490423032 }, { "start_logit": 6.81640625, "end_logit": -0.35205078125, "text": "", "probability": 0.9984451866509576 } ], "100000000000000000003226": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016103573704565953 }, { "start_logit": 6.80078125, "end_logit": -0.369873046875, "text": "", "probability": 0.9983896426295433 } ], "100000000000000000003227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 6.79296875, "end_logit": -0.388671875, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000003228": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.78515625, "end_logit": -0.33984375, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000003231": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010691263618290232 }, { "start_logit": 7.3203125, "end_logit": -0.48046875, "text": "", "probability": 0.998930873638171 } ], "100000000000000000003232": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.40234375, "end_logit": -0.5244140625, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000003233": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.4921875, "end_logit": -0.4208984375, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000003244": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027044293694093243 }, { "start_logit": 6.875, "end_logit": -0.96630859375, "text": "", "probability": 0.9972955706305906 } ], "100000000000000000003248": [ { "start_logit": 18.40625, "end_logit": 7.80078125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1585693359375 }, { "start_logit": 18.203125, "end_logit": 7.80078125, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1295166015625 }, { "start_logit": 18.40625, "end_logit": 7.47265625, "text": "Precaution\nManagement of post-COVID-19", "probability": 0.1142578125 }, { "start_logit": 18.40625, "end_logit": 7.36328125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms", "probability": 0.10235595703125 }, { "start_logit": 18.203125, "end_logit": 7.47265625, "text": "Management of post-COVID-19", "probability": 0.09326171875 }, { "start_logit": 18.203125, "end_logit": 7.36328125, "text": "Management of post-COVID-19-vaccination symptoms", "probability": 0.08355712890625 }, { "start_logit": 18.40625, "end_logit": 6.3203125, "text": "Precaution\nManagement of post-COVID-19-vaccination", "probability": 0.03594970703125 }, { "start_logit": 18.40625, "end_logit": 6.265625, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.0343017578125 }, { "start_logit": 18.40625, "end_logit": 6.15625, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.0307464599609375 }, { "start_logit": 18.203125, "end_logit": 6.3203125, "text": "Management of post-COVID-19-vaccination", "probability": 0.0298004150390625 }, { "start_logit": 18.203125, "end_logit": 6.265625, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.0279998779296875 }, { "start_logit": 16.609375, "end_logit": 7.80078125, "text": "Table of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.0262908935546875 }, { "start_logit": 18.203125, "end_logit": 6.15625, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.02508544921875 }, { "start_logit": 18.40625, "end_logit": 5.8671875, "text": "Precaution\nManagement", "probability": 0.0232086181640625 }, { "start_logit": 18.203125, "end_logit": 5.8671875, "text": "Management", "probability": 0.018646240234375 }, { "start_logit": 16.125, "end_logit": 7.80078125, "text": "COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.016204833984375 }, { "start_logit": 16.09375, "end_logit": 7.80078125, "text": " SARS-CoV-2 laboratory", "probability": 0.0157012939453125 }, { "start_logit": 15.875, "end_logit": 7.80078125, "text": "Vaccination and SARS-CoV-2 laboratory", "probability": 0.01262664794921875 }, { "start_logit": 16.125, "end_logit": 7.47265625, "text": "COVID-19", "probability": 0.0116729736328125 }, { "start_logit": 16.125, "end_logit": 7.36328125, "text": "COVID-19-vaccination symptoms", "probability": 0.010467529296875 }, { "start_logit": 8.578125, "end_logit": -1.17578125, "text": "", "probability": 0.0 } ], "100000000000000000003251": [ { "start_logit": 18.40625, "end_logit": 7.80078125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1583251953125 }, { "start_logit": 18.203125, "end_logit": 7.80078125, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1292724609375 }, { "start_logit": 18.40625, "end_logit": 7.4765625, "text": "Precaution\nManagement of post-COVID-19", "probability": 0.114013671875 }, { "start_logit": 18.40625, "end_logit": 7.359375, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms", "probability": 0.1021728515625 }, { "start_logit": 18.203125, "end_logit": 7.4765625, "text": "Management of post-COVID-19", "probability": 0.09454345703125 }, { "start_logit": 18.203125, "end_logit": 7.359375, "text": "Management of post-COVID-19-vaccination symptoms", "probability": 0.08343505859375 }, { "start_logit": 18.40625, "end_logit": 6.30859375, "text": "Precaution\nManagement of post-COVID-19-vaccination", "probability": 0.035888671875 }, { "start_logit": 18.40625, "end_logit": 6.2578125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.03369140625 }, { "start_logit": 18.40625, "end_logit": 6.13671875, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.03021240234375 }, { "start_logit": 18.203125, "end_logit": 6.30859375, "text": "Management of post-COVID-19-vaccination", "probability": 0.0292816162109375 }, { "start_logit": 18.203125, "end_logit": 6.2578125, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.0279388427734375 }, { "start_logit": 16.609375, "end_logit": 7.80078125, "text": "Table of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.0262451171875 }, { "start_logit": 18.203125, "end_logit": 6.13671875, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.024658203125 }, { "start_logit": 18.40625, "end_logit": 5.8671875, "text": "Precaution\nManagement", "probability": 0.0231781005859375 }, { "start_logit": 18.203125, "end_logit": 5.8671875, "text": "Management", "probability": 0.01861572265625 }, { "start_logit": 16.109375, "end_logit": 7.80078125, "text": "COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.01593017578125 }, { "start_logit": 16.09375, "end_logit": 7.80078125, "text": " SARS-CoV-2 laboratory", "probability": 0.0156707763671875 }, { "start_logit": 18.40625, "end_logit": 5.2734375, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination", "probability": 0.01279449462890625 }, { "start_logit": 15.875, "end_logit": 7.80078125, "text": "Vaccination and SARS-CoV-2 laboratory", "probability": 0.012603759765625 }, { "start_logit": 15.8046875, "end_logit": 7.80078125, "text": "\nVaccination and SARS-CoV-2 laboratory", "probability": 0.0118408203125 }, { "start_logit": 8.640625, "end_logit": -1.240234375, "text": "", "probability": 0.0 } ], "100000000000000000003253": [ { "start_logit": 18.40625, "end_logit": 7.80078125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1583251953125 }, { "start_logit": 18.203125, "end_logit": 7.80078125, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.1292724609375 }, { "start_logit": 18.40625, "end_logit": 7.4765625, "text": "Precaution\nManagement of post-COVID-19", "probability": 0.114013671875 }, { "start_logit": 18.40625, "end_logit": 7.359375, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms", "probability": 0.1021728515625 }, { "start_logit": 18.203125, "end_logit": 7.4765625, "text": "Management of post-COVID-19", "probability": 0.09454345703125 }, { "start_logit": 18.203125, "end_logit": 7.359375, "text": "Management of post-COVID-19-vaccination symptoms", "probability": 0.08343505859375 }, { "start_logit": 18.40625, "end_logit": 6.30859375, "text": "Precaution\nManagement of post-COVID-19-vaccination", "probability": 0.035888671875 }, { "start_logit": 18.40625, "end_logit": 6.2578125, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.03369140625 }, { "start_logit": 18.40625, "end_logit": 6.13671875, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.03021240234375 }, { "start_logit": 18.203125, "end_logit": 6.30859375, "text": "Management of post-COVID-19-vaccination", "probability": 0.0292816162109375 }, { "start_logit": 18.203125, "end_logit": 6.2578125, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory testing", "probability": 0.0279388427734375 }, { "start_logit": 16.609375, "end_logit": 7.80078125, "text": "Table of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.0262451171875 }, { "start_logit": 18.203125, "end_logit": 6.13671875, "text": "Management of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2", "probability": 0.024658203125 }, { "start_logit": 18.40625, "end_logit": 5.8671875, "text": "Precaution\nManagement", "probability": 0.0231781005859375 }, { "start_logit": 18.203125, "end_logit": 5.8671875, "text": "Management", "probability": 0.01861572265625 }, { "start_logit": 16.109375, "end_logit": 7.80078125, "text": "COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination and SARS-CoV-2 laboratory", "probability": 0.01593017578125 }, { "start_logit": 16.09375, "end_logit": 7.80078125, "text": " SARS-CoV-2 laboratory", "probability": 0.0156707763671875 }, { "start_logit": 18.40625, "end_logit": 5.2734375, "text": "Precaution\nManagement of post-COVID-19-vaccination symptoms\nTable of Contents \uf426\nVaccination", "probability": 0.01279449462890625 }, { "start_logit": 15.875, "end_logit": 7.80078125, "text": "Vaccination and SARS-CoV-2 laboratory", "probability": 0.012603759765625 }, { "start_logit": 16.109375, "end_logit": 7.4765625, "text": "COVID-19", "probability": 0.01165008544921875 }, { "start_logit": 8.6015625, "end_logit": -1.21875, "text": "", "probability": 0.0 } ], "100000000000000000003256": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.10546875, "end_logit": -0.470947265625, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000003263": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003682979260160596 }, { "start_logit": 7.79296875, "end_logit": 0.1141357421875, "text": "", "probability": 0.999631702073984 } ], "100000000000000000003264": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042554307397400885 }, { "start_logit": 7.73828125, "end_logit": 0.0241546630859375, "text": "", "probability": 0.9995744569260261 } ], "100000000000000000003265": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.12890625, "end_logit": -0.65625, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003267": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 7.19140625, "end_logit": -0.70361328125, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000003269": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 7.1328125, "end_logit": -0.6279296875, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000003274": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007041515890570883 }, { "start_logit": 7.39453125, "end_logit": -0.1378173828125, "text": "", "probability": 0.9992958484109428 } ], "100000000000000000003277": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999952076744 }, { "start_logit": -33.5, "end_logit": 14.3515625, "text": "", "probability": 4.79232572973579e-09 } ], "100000000000000000003278": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999962677331 }, { "start_logit": -33.53125, "end_logit": 14.125, "text": "", "probability": 3.732267035007897e-09 } ], "100000000000000000003285": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015669887925500437 }, { "start_logit": 7.171875, "end_logit": -0.7158203125, "text": "", "probability": 0.99843301120745 } ], "100000000000000000003287": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.07421875, "end_logit": -0.62060546875, "text": "", "probability": 0.998426887834651 } ], "100000000000000000003290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 7.04296875, "end_logit": -0.6416015625, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000003291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 7.07421875, "end_logit": -0.6728515625, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000003300": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.3671875, "end_logit": -0.66162109375, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000003302": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023781237181166506 }, { "start_logit": 6.21875, "end_logit": -0.1788330078125, "text": "", "probability": 0.9976218762818835 } ], "100000000000000000003309": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 7.23828125, "end_logit": -0.67431640625, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000003310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 7.359375, "end_logit": -0.72119140625, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000003313": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 7.30078125, "end_logit": -0.71044921875, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000003314": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 7.21875, "end_logit": -0.7294921875, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000003315": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014895173647107272 }, { "start_logit": 7.22265625, "end_logit": -0.71484375, "text": "", "probability": 0.9985104826352893 } ], "100000000000000000003319": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.29296875, "end_logit": -0.6923828125, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000003320": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.2890625, "end_logit": -0.689453125, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000003321": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.36328125, "end_logit": -0.73681640625, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000003331": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029235429042710408 }, { "start_logit": 6.328125, "end_logit": -0.496826171875, "text": "", "probability": 0.9970764570957289 } ], "100000000000000000003341": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 7.08203125, "end_logit": -0.767578125, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000003342": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019418168866865045 }, { "start_logit": 6.9765625, "end_logit": -0.7333984375, "text": "", "probability": 0.9980581831133134 } ], "100000000000000000003343": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 6.99609375, "end_logit": -0.7099609375, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000003344": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024630070555115235 }, { "start_logit": 7.19140625, "end_logit": -1.1865234375, "text": "", "probability": 0.9975369929444886 } ], "100000000000000000003345": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 7.09765625, "end_logit": -1.138671875, "text": "", "probability": 0.997429131960124 } ], "100000000000000000003346": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002287227605869875 }, { "start_logit": 7.25390625, "end_logit": -1.17578125, "text": "", "probability": 0.9977127723941301 } ], "100000000000000000003347": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002590979364429334 }, { "start_logit": 7.11328125, "end_logit": -1.158203125, "text": "", "probability": 0.9974090206355707 } ], "100000000000000000003350": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002611247603490656 }, { "start_logit": 7.1171875, "end_logit": -1.169921875, "text": "", "probability": 0.9973887523965093 } ], "100000000000000000003351": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.41796875, "end_logit": -0.77490234375, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000003352": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.33203125, "end_logit": -0.7822265625, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000003355": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 7.2265625, "end_logit": -0.72216796875, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000003359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.18359375, "end_logit": -0.42431640625, "text": "", "probability": 0.99883958037482 } ], "100000000000000000003361": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.11328125, "end_logit": -0.4287109375, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000003364": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021827164453451808 }, { "start_logit": 7.00390625, "end_logit": -0.8779296875, "text": "", "probability": 0.9978172835546547 } ], "100000000000000000003365": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 7.17578125, "end_logit": -0.91552734375, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000003366": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001987774212383911 }, { "start_logit": 7.15234375, "end_logit": -0.93310546875, "text": "", "probability": 0.998012225787616 } ], "100000000000000000003367": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002107472437884964 }, { "start_logit": 7.01953125, "end_logit": -0.85888671875, "text": "", "probability": 0.997892527562115 } ], "100000000000000000003372": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.22265625, "end_logit": -0.69677734375, "text": "", "probability": 0.998539250425049 } ], "100000000000000000003373": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009362828177560106 }, { "start_logit": 7.546875, "end_logit": -0.57275390625, "text": "", "probability": 0.9990637171822441 } ], "100000000000000000003378": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002123966441797725 }, { "start_logit": 6.60546875, "end_logit": -0.451904296875, "text": "", "probability": 0.9978760335582023 } ], "100000000000000000003379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.76171875, "end_logit": -0.433349609375, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000003380": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 6.6953125, "end_logit": -0.397216796875, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000003382": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021912406363963407 }, { "start_logit": 6.3984375, "end_logit": -0.2783203125, "text": "", "probability": 0.9978087593636037 } ], "100000000000000000003390": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020587533988500944 }, { "start_logit": 6.7109375, "end_logit": -0.52783203125, "text": "", "probability": 0.9979412466011499 } ], "100000000000000000003392": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013831174237397678 }, { "start_logit": 7.37109375, "end_logit": -0.78955078125, "text": "", "probability": 0.9986168825762602 } ], "100000000000000000003396": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.02734375, "end_logit": -0.425537109375, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000003397": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.02734375, "end_logit": -0.3837890625, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000003398": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 6.96484375, "end_logit": -0.343994140625, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000003407": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024534282596974846 }, { "start_logit": 6.30078125, "end_logit": -0.291748046875, "text": "", "probability": 0.9975465717403025 } ], "100000000000000000003408": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024438866251821328 }, { "start_logit": 6.3046875, "end_logit": -0.29150390625, "text": "", "probability": 0.997556113374818 } ], "100000000000000000003409": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023322339175873403 }, { "start_logit": 6.3671875, "end_logit": -0.307373046875, "text": "", "probability": 0.9976677660824127 } ], "100000000000000000003413": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020190139004485808 }, { "start_logit": 6.05859375, "end_logit": 0.144287109375, "text": "", "probability": 0.9979809860995514 } ], "100000000000000000003415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.63671875, "end_logit": -0.78271484375, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000003416": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.5, "end_logit": -0.73291015625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000003417": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.640625, "end_logit": -0.744140625, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000003420": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 7.56640625, "end_logit": -0.78076171875, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000003422": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015669887925500437 }, { "start_logit": 6.984375, "end_logit": -0.52587890625, "text": "", "probability": 0.99843301120745 } ], "100000000000000000003426": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001919237453341115 }, { "start_logit": 7.1171875, "end_logit": -0.86328125, "text": "", "probability": 0.998080762546659 } ], "100000000000000000003431": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003692853038725799 }, { "start_logit": 5.73828125, "end_logit": -0.1424560546875, "text": "", "probability": 0.9963071469612743 } ], "100000000000000000003437": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.140625, "end_logit": -0.501953125, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000003442": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013831174237397678 }, { "start_logit": 7.08984375, "end_logit": -0.50830078125, "text": "", "probability": 0.9986168825762602 } ], "100000000000000000003443": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 7.1328125, "end_logit": -0.5224609375, "text": "", "probability": 0.998654139598703 } ], "100000000000000000003446": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.51953125, "end_logit": -0.92529296875, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000003449": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.43359375, "end_logit": -0.9052734375, "text": "", "probability": 0.998539250425049 } ], "100000000000000000003451": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00020184421628825368 }, { "start_logit": 8.3671875, "end_logit": 0.140869140625, "text": "", "probability": 0.9997981557837118 } ], "100000000000000000003453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007096703991005882 }, { "start_logit": 7.7578125, "end_logit": -0.50927734375, "text": "", "probability": 0.9992903296008995 } ], "100000000000000000003455": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007916296072837431 }, { "start_logit": 7.74609375, "end_logit": -0.60546875, "text": "", "probability": 0.9992083703927161 } ], "100000000000000000003461": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007208380258812108 }, { "start_logit": 7.671875, "end_logit": -0.4365234375, "text": "", "probability": 0.9992791619741188 } ], "100000000000000000003465": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.4375, "end_logit": -0.5712890625, "text": "", "probability": 0.998959681497187 } ], "100000000000000000003466": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.4609375, "end_logit": -0.55517578125, "text": "", "probability": 0.99899949559909 } ], "100000000000000000003477": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007947254956253316 }, { "start_logit": 7.6484375, "end_logit": -0.51220703125, "text": "", "probability": 0.9992052745043747 } ], "100000000000000000003479": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.26171875, "end_logit": -0.49755859375, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000003483": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.4609375, "end_logit": -0.56640625, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000003485": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.54296875, "end_logit": -0.58349609375, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000003486": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.55859375, "end_logit": -0.5908203125, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000003496": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.3359375, "end_logit": -0.40283203125, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000003497": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.3125, "end_logit": -0.377685546875, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000003498": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.39453125, "end_logit": -0.37109375, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000003502": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001455062938532843 }, { "start_logit": 6.828125, "end_logit": -0.295654296875, "text": "", "probability": 0.9985449370614672 } ], "100000000000000000003507": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 6.76171875, "end_logit": -0.290283203125, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003508": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005953406662444657 }, { "start_logit": 7.9765625, "end_logit": -0.55029296875, "text": "", "probability": 0.9994046593337557 } ], "100000000000000000003515": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 6.70703125, "end_logit": -0.11444091796875, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000003520": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004673480880780747 }, { "start_logit": 8.3828125, "end_logit": -0.7158203125, "text": "", "probability": 0.999532651911922 } ], "100000000000000000003521": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004765613104188452 }, { "start_logit": 8.3515625, "end_logit": -0.70166015625, "text": "", "probability": 0.999523438689581 } ], "100000000000000000003522": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004547479032588127 }, { "start_logit": 8.3671875, "end_logit": -0.67236328125, "text": "", "probability": 0.9995452520967412 } ], "100000000000000000003525": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046552691875201524 }, { "start_logit": 8.3828125, "end_logit": -0.7119140625, "text": "", "probability": 0.9995344730812479 } ], "100000000000000000003528": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.12109375, "end_logit": -0.64697265625, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003530": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.95703125, "end_logit": -0.58984375, "text": "", "probability": 0.998285961520812 } ], "100000000000000000003532": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001727458626729702 }, { "start_logit": 6.9453125, "end_logit": -0.58740234375, "text": "", "probability": 0.9982725413732704 } ], "100000000000000000003533": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 7.0234375, "end_logit": -0.65576171875, "text": "", "probability": 0.998285961520812 } ], "100000000000000000003534": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.1015625, "end_logit": -0.63134765625, "text": "", "probability": 0.998451238905712 } ], "100000000000000000003535": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.1640625, "end_logit": -0.43994140625, "text": "", "probability": 0.998798108681489 } ], "100000000000000000003541": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010608151804637727 }, { "start_logit": 7.2890625, "end_logit": -0.441650390625, "text": "", "probability": 0.9989391848195363 } ], "100000000000000000003543": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.49609375, "end_logit": -0.501953125, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000003547": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.359375, "end_logit": -0.433349609375, "text": "", "probability": 0.999018828118793 } ], "100000000000000000003549": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009966076912722927 }, { "start_logit": 7.359375, "end_logit": -0.44873046875, "text": "", "probability": 0.9990033923087277 } ], "100000000000000000003551": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.35546875, "end_logit": -0.192626953125, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000003552": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006798428944286137 }, { "start_logit": 7.3984375, "end_logit": -0.1068115234375, "text": "", "probability": 0.9993201571055714 } ], "100000000000000000003557": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005213363066504585 }, { "start_logit": 8.1015625, "end_logit": -0.54345703125, "text": "", "probability": 0.9994786636933496 } ], "100000000000000000003558": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005680935199787149 }, { "start_logit": 8.0078125, "end_logit": -0.53662109375, "text": "", "probability": 0.9994319064800213 } ], "100000000000000000003560": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.6796875, "end_logit": -0.60986328125, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000003562": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.40234375, "end_logit": -0.55859375, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000003568": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.69921875, "end_logit": -0.392333984375, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000003571": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.3203125, "end_logit": -0.60791015625, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000003574": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.23828125, "end_logit": -0.70166015625, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000003575": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 6.5078125, "end_logit": -0.1546630859375, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000003576": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.6015625, "end_logit": -0.27392578125, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000003581": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023141263296893675 }, { "start_logit": 6.51171875, "end_logit": -0.444580078125, "text": "", "probability": 0.9976858736703106 } ], "100000000000000000003585": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.05078125, "end_logit": -0.286376953125, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000003598": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992987278 }, { "start_logit": -34.0, "end_logit": 12.921875, "text": "", "probability": 7.012722007976659e-10 } ], "100000000000000000003599": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992176742 }, { "start_logit": -34.03125, "end_logit": 13.0546875, "text": "", "probability": 7.82325672734135e-10 } ], "100000000000000000003602": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007466114612710287 }, { "start_logit": 7.37109375, "end_logit": -0.171630859375, "text": "", "probability": 0.999253388538729 } ], "100000000000000000003607": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019570169401946333 }, { "start_logit": 6.3984375, "end_logit": -0.164306640625, "text": "", "probability": 0.9980429830598053 } ], "100000000000000000003608": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 6.37109375, "end_logit": -0.11065673828125, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000003617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00025714197979577713 }, { "start_logit": 7.86328125, "end_logit": 0.39990234375, "text": "", "probability": 0.9997428580202044 } ], "100000000000000000003619": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000302973407808812 }, { "start_logit": 7.75390625, "end_logit": 0.351318359375, "text": "", "probability": 0.9996970265921912 } ], "100000000000000000003622": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.59375, "end_logit": -0.493896484375, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000003629": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006361912109467575 }, { "start_logit": 8.0703125, "end_logit": -0.7109375, "text": "", "probability": 0.9993638087890532 } ], "100000000000000000003631": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 7.99609375, "end_logit": -0.65087890625, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000003632": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.4453125, "end_logit": -0.382568359375, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000003642": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007643033095615911 }, { "start_logit": 7.7890625, "end_logit": -0.61474609375, "text": "", "probability": 0.9992356966904383 } ], "100000000000000000003647": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 7.7265625, "end_logit": -0.53173828125, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000003648": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006190416612984411 }, { "start_logit": 8.2734375, "end_logit": -0.8876953125, "text": "", "probability": 0.9993809583387016 } ], "100000000000000000003651": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006693099618068043 }, { "start_logit": 8.1328125, "end_logit": -0.82373046875, "text": "", "probability": 0.9993306900381931 } ], "100000000000000000003652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006538155503558285 }, { "start_logit": 8.1484375, "end_logit": -0.8173828125, "text": "", "probability": 0.9993461844496442 } ], "100000000000000000003657": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.71484375, "end_logit": -0.63134765625, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000003659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.66015625, "end_logit": -0.5673828125, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000003665": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 7.984375, "end_logit": -0.697265625, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000003672": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004955359475635505 }, { "start_logit": 8.328125, "end_logit": -0.720703125, "text": "", "probability": 0.9995044640524365 } ], "100000000000000000003673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005884088185569387 }, { "start_logit": 8.2109375, "end_logit": -0.7724609375, "text": "", "probability": 0.9994115911814431 } ], "100000000000000000003674": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005463420892147277 }, { "start_logit": 8.203125, "end_logit": -0.69091796875, "text": "", "probability": 0.9994536579107853 } ], "100000000000000000003675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 6.8984375, "end_logit": -0.2841796875, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000003676": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 6.87109375, "end_logit": -0.3271484375, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000003680": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.109375, "end_logit": -0.297119140625, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000003682": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.07421875, "end_logit": -0.274658203125, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000003685": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.00390625, "end_logit": -0.53271484375, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000003694": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995254956 }, { "start_logit": -33.78125, "end_logit": 12.3203125, "text": "", "probability": 4.745045065396272e-10 } ], "100000000000000000003699": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999988967441 }, { "start_logit": -34.125, "end_logit": 13.5078125, "text": "", "probability": 1.1032560311263802e-09 } ], "100000000000000000003701": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999988793702 }, { "start_logit": -34.125, "end_logit": 13.515625, "text": "", "probability": 1.1206297855815922e-09 } ], "100000000000000000003705": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005021149947632315 }, { "start_logit": 5.46875, "end_logit": -0.1785888671875, "text": "", "probability": 0.9949788500523676 } ], "100000000000000000003706": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004627530047867153 }, { "start_logit": 5.59765625, "end_logit": -0.22509765625, "text": "", "probability": 0.9953724699521328 } ], "100000000000000000003708": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0042646346921872726 }, { "start_logit": 5.6171875, "end_logit": -0.1639404296875, "text": "", "probability": 0.9957353653078126 } ], "100000000000000000003710": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005021149947632315 }, { "start_logit": 5.53125, "end_logit": -0.2420654296875, "text": "", "probability": 0.9949788500523676 } ], "100000000000000000003716": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0034564096680654286 }, { "start_logit": 6.02734375, "end_logit": -0.365234375, "text": "", "probability": 0.9965435903319345 } ], "100000000000000000003720": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003869391008494932 }, { "start_logit": 5.91015625, "end_logit": -0.361083984375, "text": "", "probability": 0.9961306089915051 } ], "100000000000000000003722": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.009449081319055452 }, { "start_logit": 5.35546875, "end_logit": -0.7021484375, "text": "", "probability": 0.9905509186809447 } ], "100000000000000000003724": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00912563738918052 }, { "start_logit": 5.4140625, "end_logit": -0.7255859375, "text": "", "probability": 0.9908743626108194 } ], "100000000000000000003725": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.009020279501402172 }, { "start_logit": 5.41015625, "end_logit": -0.7119140625, "text": "", "probability": 0.9909797204985978 } ], "100000000000000000003727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.008315778477474129 }, { "start_logit": 5.53125, "end_logit": -0.751953125, "text": "", "probability": 0.9916842215225259 } ], "100000000000000000003735": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0032099613758647793 }, { "start_logit": 6.23046875, "end_logit": -0.493408203125, "text": "", "probability": 0.9967900386241352 } ], "100000000000000000003739": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004365326111393966 }, { "start_logit": 5.87890625, "end_logit": -0.448974609375, "text": "", "probability": 0.9956346738886059 } ], "100000000000000000003742": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005819959584259008 }, { "start_logit": 5.71875, "end_logit": -0.576171875, "text": "", "probability": 0.994180040415741 } ], "100000000000000000003748": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 6.3046875, "end_logit": 0.196533203125, "text": "", "probability": 0.998498817743263 } ], "100000000000000000003749": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.3203125, "end_logit": 0.125244140625, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000003755": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00033666221188972684 }, { "start_logit": 7.53125, "end_logit": 0.46337890625, "text": "", "probability": 0.9996633377881102 } ], "100000000000000000003763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.63671875, "end_logit": -0.71923828125, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000003768": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.16796875, "end_logit": -0.64794921875, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000003770": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.1640625, "end_logit": -0.4541015625, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000003779": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 7.109375, "end_logit": -0.55078125, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000003782": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015548133490423032 }, { "start_logit": 7.046875, "end_logit": -0.58203125, "text": "", "probability": 0.9984451866509576 } ], "100000000000000000003784": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016229670614688403 }, { "start_logit": 6.9921875, "end_logit": -0.57177734375, "text": "", "probability": 0.9983770329385311 } ], "100000000000000000003790": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.74609375, "end_logit": -0.92431640625, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000003793": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005658799865413885 }, { "start_logit": 8.0625, "end_logit": -0.58642578125, "text": "", "probability": 0.9994341200134585 } ], "100000000000000000003798": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 8.1484375, "end_logit": -0.85986328125, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000003807": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010775025886693324 }, { "start_logit": 7.578125, "end_logit": -0.74560546875, "text": "", "probability": 0.9989224974113308 } ], "100000000000000000003816": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030160662173845665 }, { "start_logit": 6.9140625, "end_logit": -1.11328125, "text": "", "probability": 0.9969839337826155 } ], "100000000000000000003821": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003111508539858309 }, { "start_logit": 6.8359375, "end_logit": -1.0654296875, "text": "", "probability": 0.9968884914601416 } ], "100000000000000000003824": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.2890625, "end_logit": -0.56884765625, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000003825": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.234375, "end_logit": -0.6123046875, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000003826": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 7.0703125, "end_logit": -0.77294921875, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000003830": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021997980436915168 }, { "start_logit": 6.796875, "end_logit": -0.6787109375, "text": "", "probability": 0.9978002019563085 } ], "100000000000000000003835": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 6.49609375, "end_logit": -0.43505859375, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000003839": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021405892581107663 }, { "start_logit": 6.6015625, "end_logit": -0.45703125, "text": "", "probability": 0.9978594107418892 } ], "100000000000000000003842": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006118340200729555 }, { "start_logit": 7.87109375, "end_logit": -0.4716796875, "text": "", "probability": 0.9993881659799271 } ], "100000000000000000003849": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 7.24609375, "end_logit": -0.75830078125, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000003852": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014895173647107272 }, { "start_logit": 7.26171875, "end_logit": -0.751953125, "text": "", "probability": 0.9985104826352893 } ], "100000000000000000003853": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002341340651047526 }, { "start_logit": 7.32421875, "end_logit": -1.26953125, "text": "", "probability": 0.9976586593489525 } ], "100000000000000000003857": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002550912421286719 }, { "start_logit": 7.2265625, "end_logit": -1.2578125, "text": "", "probability": 0.9974490875787134 } ], "100000000000000000003865": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025311113093281793 }, { "start_logit": 6.9296875, "end_logit": -0.95166015625, "text": "", "probability": 0.9974688886906717 } ], "100000000000000000003869": [ { "start_logit": 17.8125, "end_logit": 11.65625, "text": "VAERS", "probability": 0.413818359375 }, { "start_logit": 17.140625, "end_logit": 11.5234375, "text": "Vaccine adverse events", "probability": 0.1837158203125 }, { "start_logit": 16.5, "end_logit": 11.65625, "text": "Healthcare providers are required under Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event\nReporting System (VAERS", "probability": 0.111328125 }, { "start_logit": 17.8125, "end_logit": 9.6796875, "text": "VAERS) the following adverse events", "probability": 0.05780029296875 }, { "start_logit": 17.140625, "end_logit": 10.109375, "text": "Vaccine adverse", "probability": 0.045013427734375 }, { "start_logit": 17.8125, "end_logit": 9.3359375, "text": "VA", "probability": 0.040985107421875 }, { "start_logit": 15.4453125, "end_logit": 11.65625, "text": "EUA) to report to the Vaccine Adverse Event\nReporting System (VAERS", "probability": 0.03851318359375 }, { "start_logit": 17.140625, "end_logit": 9.6171875, "text": "Vaccine", "probability": 0.027313232421875 }, { "start_logit": 14.5703125, "end_logit": 11.65625, "text": " Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event\nReporting System (VAERS", "probability": 0.01605224609375 }, { "start_logit": 16.5, "end_logit": 9.3359375, "text": "Healthcare providers are required under Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event\nReporting System (VA", "probability": 0.01102447509765625 }, { "start_logit": 14.2578125, "end_logit": 11.5234375, "text": " adverse events", "probability": 0.0103607177734375 }, { "start_logit": 17.140625, "end_logit": 8.421875, "text": "V", "probability": 0.00832366943359375 }, { "start_logit": 17.140625, "end_logit": 8.2109375, "text": "Vaccine adverse events\nHealthcare providers", "probability": 0.006687164306640625 }, { "start_logit": 17.140625, "end_logit": 8.140625, "text": "Vaccine adverse events\nHealthcare providers are required under Emergency Use Authorization (EUA", "probability": 0.006282806396484375 }, { "start_logit": 15.4453125, "end_logit": 9.6796875, "text": "EUA) to report to the Vaccine Adverse Event\nReporting System (VAERS) the following adverse events", "probability": 0.005374908447265625 }, { "start_logit": 15.4453125, "end_logit": 9.3359375, "text": "EUA) to report to the Vaccine Adverse Event\nReporting System (VA", "probability": 0.003810882568359375 }, { "start_logit": 16.5, "end_logit": 8.234375, "text": "Healthcare providers are required under Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event\nReporting", "probability": 0.0036373138427734375 }, { "start_logit": 16.5, "end_logit": 8.2109375, "text": "Healthcare providers", "probability": 0.0035800933837890625 }, { "start_logit": 16.5, "end_logit": 8.140625, "text": "Healthcare providers are required under Emergency Use Authorization (EUA", "probability": 0.0033130645751953125 }, { "start_logit": 17.140625, "end_logit": 7.4921875, "text": "Vaccine adverse events\nHealthcare providers are required under Emergency Use Authorization (EUA) to report to the Vaccine Adverse Event", "probability": 0.003261566162109375 }, { "start_logit": 7.87890625, "end_logit": -0.556640625, "text": "", "probability": 0.0 } ], "100000000000000000003872": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002107472437884964 }, { "start_logit": 6.4609375, "end_logit": -0.30224609375, "text": "", "probability": 0.997892527562115 } ], "100000000000000000003873": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020911062524060888 }, { "start_logit": 6.45703125, "end_logit": -0.28857421875, "text": "", "probability": 0.9979088937475938 } ], "100000000000000000003876": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021322616859826855 }, { "start_logit": 6.46484375, "end_logit": -0.317626953125, "text": "", "probability": 0.9978677383140173 } ], "100000000000000000003877": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.34375, "end_logit": -0.5546875, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000003884": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.1328125, "end_logit": -0.257568359375, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000003887": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.20703125, "end_logit": -0.251220703125, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000003890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001700722411435288 }, { "start_logit": 7.05859375, "end_logit": -0.68408203125, "text": "", "probability": 0.9982992775885648 } ], "100000000000000000003891": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.15234375, "end_logit": -0.673828125, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000003896": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.61328125, "end_logit": -0.9306640625, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000003900": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000900446683890779 }, { "start_logit": 7.546875, "end_logit": -0.53662109375, "text": "", "probability": 0.9990995533161093 } ], "100000000000000000003901": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.3828125, "end_logit": -0.5576171875, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000003908": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018895386578398716 }, { "start_logit": 6.12890625, "end_logit": 0.140869140625, "text": "", "probability": 0.9981104613421601 } ], "100000000000000000003910": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020667944781501153 }, { "start_logit": 6.00390625, "end_logit": 0.175537109375, "text": "", "probability": 0.9979332055218498 } ], "100000000000000000003912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 6.171875, "end_logit": 0.140380859375, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000003913": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 6.1953125, "end_logit": 0.147705078125, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000003921": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009362828177560106 }, { "start_logit": 7.11328125, "end_logit": -0.141357421875, "text": "", "probability": 0.9990637171822441 } ], "100000000000000000003923": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008796062064765496 }, { "start_logit": 7.1328125, "end_logit": -0.0966796875, "text": "", "probability": 0.9991203937935235 } ], "100000000000000000003944": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003053489321118595 }, { "start_logit": 8.203125, "end_logit": -0.1077880859375, "text": "", "probability": 0.999694651067888 } ], "100000000000000000003947": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003432999995057122 }, { "start_logit": 8.0546875, "end_logit": -0.0782470703125, "text": "", "probability": 0.9996567000004942 } ], "100000000000000000003950": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006263341581094201 }, { "start_logit": 8.234375, "end_logit": -0.859375, "text": "", "probability": 0.9993736658418905 } ], "100000000000000000003953": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006615174228741224 }, { "start_logit": 8.1875, "end_logit": -0.8681640625, "text": "", "probability": 0.999338482577126 } ], "100000000000000000003974": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.6796875, "end_logit": -1.0634765625, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000003976": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.6171875, "end_logit": -1.0009765625, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000003978": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003874761338151445 }, { "start_logit": 7.6328125, "end_logit": 0.2227783203125, "text": "", "probability": 0.9996125238661848 } ], "100000000000000000003980": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.5390625, "end_logit": -0.71630859375, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000003981": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.5390625, "end_logit": -0.68212890625, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000003989": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006361912109467575 }, { "start_logit": 7.96484375, "end_logit": -0.60693359375, "text": "", "probability": 0.9993638087890532 } ], "100000000000000000003994": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 7.12890625, "end_logit": -0.5166015625, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000003995": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.20703125, "end_logit": -0.470703125, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000003998": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 7.1796875, "end_logit": -0.50439453125, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000004000": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.2109375, "end_logit": -0.5390625, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000004001": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.203125, "end_logit": -0.52392578125, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000004002": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.08984375, "end_logit": -0.39404296875, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000004003": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.0625, "end_logit": -0.3818359375, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000004006": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 7.234375, "end_logit": -0.4423828125, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000004007": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.13671875, "end_logit": -0.394775390625, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000004013": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.57421875, "end_logit": -0.7099609375, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000004014": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009697519677825861 }, { "start_logit": 7.61328125, "end_logit": -0.67529296875, "text": "", "probability": 0.9990302480322174 } ], "100000000000000000004017": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.609375, "end_logit": -0.75244140625, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000004019": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.2109375, "end_logit": -0.2900390625, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000004020": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.28125, "end_logit": -0.35595703125, "text": "", "probability": 0.999018828118793 } ], "100000000000000000004024": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 7.46484375, "end_logit": 0.0195159912109375, "text": "", "probability": 0.99943852125386 } ], "100000000000000000004026": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005233756913394546 }, { "start_logit": 7.515625, "end_logit": 0.038665771484375, "text": "", "probability": 0.9994766243086606 } ], "100000000000000000004029": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019418168866865045 }, { "start_logit": 6.265625, "end_logit": -0.0228118896484375, "text": "", "probability": 0.9980581831133134 } ], "100000000000000000004031": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 6.37890625, "end_logit": -0.028564453125, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000004035": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.35546875, "end_logit": -0.65234375, "text": "", "probability": 0.998774432551617 } ], "100000000000000000004041": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015548133490423032 }, { "start_logit": 6.99609375, "end_logit": -0.53271484375, "text": "", "probability": 0.9984451866509576 } ], "100000000000000000004045": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005316132776684706 }, { "start_logit": 8.09375, "end_logit": -0.5556640625, "text": "", "probability": 0.9994683867223316 } ], "100000000000000000004049": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005792916699214215 }, { "start_logit": 8.0390625, "end_logit": -0.58544921875, "text": "", "probability": 0.9994207083300786 } ], "100000000000000000004053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.46875, "end_logit": -0.461669921875, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000004056": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 6.91015625, "end_logit": -0.318603515625, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000004058": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.10546875, "end_logit": -0.325927734375, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000004059": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 6.98046875, "end_logit": -0.30419921875, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000004062": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.59375, "end_logit": -0.89697265625, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000004065": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.55859375, "end_logit": -0.90771484375, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000004067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008693673928062171 }, { "start_logit": 7.890625, "end_logit": -0.84326171875, "text": "", "probability": 0.9991306326071938 } ], "100000000000000000004068": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.8046875, "end_logit": -0.7890625, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000004069": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.9140625, "end_logit": -0.8349609375, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000004072": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 8.046875, "end_logit": -0.8662109375, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000004074": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.4140625, "end_logit": -0.68701171875, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000004081": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 6.8671875, "end_logit": -0.414306640625, "text": "", "probability": 0.998426887834651 } ], "100000000000000000004085": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017342079835090854 }, { "start_logit": 6.734375, "end_logit": -0.378662109375, "text": "", "probability": 0.998265792016491 } ], "100000000000000000004086": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0031974869372464253 }, { "start_logit": 6.0, "end_logit": -0.25927734375, "text": "", "probability": 0.9968025130627537 } ], "100000000000000000004095": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002662612717117335 }, { "start_logit": 7.05078125, "end_logit": -1.1259765625, "text": "", "probability": 0.9973373872828826 } ], "100000000000000000004097": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002662612717117335 }, { "start_logit": 7.05859375, "end_logit": -1.1328125, "text": "", "probability": 0.9973373872828826 } ], "100000000000000000004098": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.62109375, "end_logit": -0.6611328125, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000004104": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 7.18359375, "end_logit": -0.89794921875, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000004108": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 6.73046875, "end_logit": -0.64794921875, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000004109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002287227605869875 }, { "start_logit": 6.7109375, "end_logit": -0.6328125, "text": "", "probability": 0.9977127723941301 } ], "100000000000000000004113": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 6.7109375, "end_logit": -0.68115234375, "text": "", "probability": 0.997603269129871 } ], "100000000000000000004115": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042887921825186283 }, { "start_logit": 8.1953125, "end_logit": -0.439697265625, "text": "", "probability": 0.9995711207817481 } ], "100000000000000000004121": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001707367485760838 }, { "start_logit": 7.046875, "end_logit": -0.6767578125, "text": "", "probability": 0.9982926325142392 } ], "100000000000000000004124": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.2109375, "end_logit": -0.66064453125, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000004126": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.28515625, "end_logit": -0.658203125, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000004127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013885232756900101 }, { "start_logit": 7.26171875, "end_logit": -0.68505859375, "text": "", "probability": 0.99861147672431 } ], "100000000000000000004129": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.1796875, "end_logit": -0.60498046875, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000004140": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018031664077959439 }, { "start_logit": 7.12109375, "end_logit": -0.80517578125, "text": "", "probability": 0.998196833592204 } ], "100000000000000000004142": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 7.06640625, "end_logit": -0.810546875, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000004145": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 7.0546875, "end_logit": -0.72314453125, "text": "", "probability": 0.998224739467894 } ], "100000000000000000004146": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.484375, "end_logit": -0.654296875, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000004147": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.4765625, "end_logit": -0.70947265625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000004148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.4765625, "end_logit": -0.66796875, "text": "", "probability": 0.998896973358602 } ], "100000000000000000004151": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.41015625, "end_logit": -0.63232421875, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000004153": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015916259996820179 }, { "start_logit": 7.125, "end_logit": -0.68408203125, "text": "", "probability": 0.998408374000318 } ], "100000000000000000004159": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 7.13671875, "end_logit": -0.689453125, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000004160": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016166499416422906 }, { "start_logit": 7.09375, "end_logit": -0.66845703125, "text": "", "probability": 0.9983833500583577 } ], "100000000000000000004165": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 6.921875, "end_logit": -0.3095703125, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000004168": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015307451011758208 }, { "start_logit": 6.80078125, "end_logit": -0.322021484375, "text": "", "probability": 0.9984692548988241 } ], "100000000000000000004170": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.75, "end_logit": -0.305908203125, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000004171": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 6.79296875, "end_logit": -0.31689453125, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000004174": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 6.80859375, "end_logit": -0.316650390625, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000004186": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.36328125, "end_logit": -0.480224609375, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000004191": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.26953125, "end_logit": -0.387451171875, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000004192": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.234375, "end_logit": -0.42578125, "text": "", "probability": 0.998896973358602 } ], "100000000000000000004194": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.25390625, "end_logit": -0.409912109375, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000004195": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.20703125, "end_logit": -0.432373046875, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000004196": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.2890625, "end_logit": -0.4345703125, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000004204": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.109375, "end_logit": -0.408447265625, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000004206": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.23828125, "end_logit": -0.419677734375, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000004207": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.23046875, "end_logit": -0.439453125, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000004208": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.2421875, "end_logit": -0.441650390625, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000004209": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 7.18359375, "end_logit": -0.7666015625, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000004212": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016040892528226655 }, { "start_logit": 7.1328125, "end_logit": -0.70068359375, "text": "", "probability": 0.9983959107471775 } ], "100000000000000000004213": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.16796875, "end_logit": -0.8046875, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000004214": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.19921875, "end_logit": -0.237060546875, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000004219": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.14453125, "end_logit": -0.187744140625, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000004223": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.828125, "end_logit": -0.62451171875, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000004224": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007096703991005882 }, { "start_logit": 7.96484375, "end_logit": -0.7158203125, "text": "", "probability": 0.9992903296008995 } ], "100000000000000000004227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007408055889950227 }, { "start_logit": 7.64453125, "end_logit": -0.436767578125, "text": "", "probability": 0.999259194411005 } ], "100000000000000000004229": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.640625, "end_logit": -0.56005859375, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000004230": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005571117181506888 }, { "start_logit": 7.7265625, "end_logit": -0.235595703125, "text": "", "probability": 0.9994428882818492 } ], "100000000000000000004233": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 7.6875, "end_logit": -0.2012939453125, "text": "", "probability": 0.99943852125386 } ], "100000000000000000004236": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 7.3046875, "end_logit": -0.7568359375, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000004237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.28515625, "end_logit": -0.75927734375, "text": "", "probability": 0.998539250425049 } ], "100000000000000000004244": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.20703125, "end_logit": -0.497314453125, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000004247": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.1484375, "end_logit": -0.347412109375, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000004253": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 6.78515625, "end_logit": -0.287109375, "text": "", "probability": 0.998498817743263 } ], "100000000000000000004255": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.30078125, "end_logit": -0.426025390625, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000004256": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.30859375, "end_logit": -0.428955078125, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000004257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009927261432440737 }, { "start_logit": 7.34375, "end_logit": -0.431640625, "text": "", "probability": 0.9990072738567558 } ], "100000000000000000004259": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.12890625, "end_logit": -0.51318359375, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000004260": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.015625, "end_logit": -0.398681640625, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000004261": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.11328125, "end_logit": -0.439453125, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000004262": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.12890625, "end_logit": -0.42578125, "text": "", "probability": 0.998774432551617 } ], "100000000000000000004266": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.51953125, "end_logit": -0.876953125, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000004270": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.48046875, "end_logit": -0.9052734375, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000004271": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999985384231 }, { "start_logit": -33.875, "end_logit": 13.5234375, "text": "", "probability": 1.4615767744882139e-09 } ], "100000000000000000004274": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998394772 }, { "start_logit": -33.84375, "end_logit": 13.59375, "text": "", "probability": 1.6052280526088547e-09 } ], "100000000000000000004280": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.33203125, "end_logit": -0.445068359375, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000004281": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.3046875, "end_logit": -0.41552734375, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000004282": [ { "start_logit": 11.953125, "end_logit": 9.5859375, "text": "Biologics or biologic response modifiers", "probability": 0.276123046875 }, { "start_logit": 11.953125, "end_logit": 8.8828125, "text": "Bi", "probability": 0.138916015625 }, { "start_logit": 11.953125, "end_logit": 8.84375, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases", "probability": 0.1324462890625 }, { "start_logit": 11.953125, "end_logit": 8.7578125, "text": "Biologics", "probability": 0.12255859375 }, { "start_logit": 11.8671875, "end_logit": 8.84375, "text": " treat autoimmune\u202fdiseases", "probability": 0.12255859375 }, { "start_logit": 11.953125, "end_logit": 7.8828125, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdise", "probability": 0.05108642578125 }, { "start_logit": 11.8671875, "end_logit": 7.8828125, "text": " treat autoimmune\u202fdise", "probability": 0.0465087890625 }, { "start_logit": 11.953125, "end_logit": 7.62109375, "text": "Biolog", "probability": 0.0391845703125 }, { "start_logit": 11.953125, "end_logit": 7.55859375, "text": "Biologics or biologic response modifiers that treat autoimmune", "probability": 0.036773681640625 }, { "start_logit": 11.8671875, "end_logit": 7.55859375, "text": " treat autoimmune", "probability": 0.03350830078125 }, { "start_logit": 7.40234375, "end_logit": -0.468505859375, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000004283": [ { "start_logit": 13.9609375, "end_logit": 8.703125, "text": "Chemotherapy or other cancer treatment", "probability": 0.300537109375 }, { "start_logit": 13.9609375, "end_logit": 8.3515625, "text": "Chemotherapy or other cancer treatment medications", "probability": 0.2130126953125 }, { "start_logit": 11.953125, "end_logit": 9.5859375, "text": "Biologics or biologic response modifiers", "probability": 0.0975341796875 }, { "start_logit": 11.953125, "end_logit": 8.8828125, "text": "Bi", "probability": 0.049041748046875 }, { "start_logit": 11.953125, "end_logit": 8.8515625, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases", "probability": 0.04754638671875 }, { "start_logit": 11.953125, "end_logit": 8.7578125, "text": "Biologics", "probability": 0.04327392578125 }, { "start_logit": 11.859375, "end_logit": 8.8515625, "text": " treat autoimmune\u202fdiseases", "probability": 0.04327392578125 }, { "start_logit": 11.953125, "end_logit": 8.703125, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases\nChemotherapy or other cancer treatment", "probability": 0.040679931640625 }, { "start_logit": 11.859375, "end_logit": 8.703125, "text": " treat autoimmune\u202fdiseases\nChemotherapy or other cancer treatment", "probability": 0.037017822265625 }, { "start_logit": 11.953125, "end_logit": 8.3515625, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases\nChemotherapy or other cancer treatment medications", "probability": 0.0288238525390625 }, { "start_logit": 11.859375, "end_logit": 8.3515625, "text": " treat autoimmune\u202fdiseases\nChemotherapy or other cancer treatment medications", "probability": 0.0262603759765625 }, { "start_logit": 11.953125, "end_logit": 7.890625, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdise", "probability": 0.0180511474609375 }, { "start_logit": 11.859375, "end_logit": 7.890625, "text": " treat autoimmune\u202fdise", "probability": 0.0164337158203125 }, { "start_logit": 11.953125, "end_logit": 7.62109375, "text": "Biolog", "probability": 0.0138397216796875 }, { "start_logit": 11.953125, "end_logit": 7.5625, "text": "Biologics or biologic response modifiers that treat autoimmune", "probability": 0.01299285888671875 }, { "start_logit": 11.859375, "end_logit": 7.5625, "text": " treat autoimmune", "probability": 0.0118408203125 }, { "start_logit": 7.48828125, "end_logit": -0.471923828125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000004284": [ { "start_logit": 11.953125, "end_logit": 9.5859375, "text": "Biologics or biologic response modifiers", "probability": 0.276123046875 }, { "start_logit": 11.953125, "end_logit": 8.8828125, "text": "Bi", "probability": 0.138916015625 }, { "start_logit": 11.953125, "end_logit": 8.84375, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdiseases", "probability": 0.1324462890625 }, { "start_logit": 11.953125, "end_logit": 8.7578125, "text": "Biologics", "probability": 0.12255859375 }, { "start_logit": 11.8671875, "end_logit": 8.84375, "text": " treat autoimmune\u202fdiseases", "probability": 0.12255859375 }, { "start_logit": 11.953125, "end_logit": 7.890625, "text": "Biologics or biologic response modifiers that treat autoimmune\u202fdise", "probability": 0.05108642578125 }, { "start_logit": 11.8671875, "end_logit": 7.890625, "text": " treat autoimmune\u202fdise", "probability": 0.0465087890625 }, { "start_logit": 11.953125, "end_logit": 7.62109375, "text": "Biolog", "probability": 0.0391845703125 }, { "start_logit": 11.953125, "end_logit": 7.5625, "text": "Biologics or biologic response modifiers that treat autoimmune", "probability": 0.036773681640625 }, { "start_logit": 11.8671875, "end_logit": 7.5625, "text": " treat autoimmune", "probability": 0.034027099609375 }, { "start_logit": 7.38671875, "end_logit": -0.4990234375, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000004286": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000900446683890779 }, { "start_logit": 7.8203125, "end_logit": -0.80712890625, "text": "", "probability": 0.9990995533161093 } ], "100000000000000000004290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.7578125, "end_logit": -0.89697265625, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000004291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.63671875, "end_logit": -0.7705078125, "text": "", "probability": 0.998959681497187 } ], "100000000000000000004293": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005658799865413885 }, { "start_logit": 7.77734375, "end_logit": -0.299560546875, "text": "", "probability": 0.9994341200134585 } ], "100000000000000000004301": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.85546875, "end_logit": -0.84912109375, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000004308": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991135089 }, { "start_logit": -33.8125, "end_logit": 12.96875, "text": "", "probability": 8.864911257608076e-10 } ], "100000000000000000004311": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001466458403084568 }, { "start_logit": 6.95703125, "end_logit": -0.434814453125, "text": "", "probability": 0.9985335415969153 } ], "100000000000000000004319": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.80859375, "end_logit": -0.41015625, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000004323": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.5390625, "end_logit": -0.4462890625, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000004327": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008040859356292355 }, { "start_logit": 7.5546875, "end_logit": -0.431396484375, "text": "", "probability": 0.9991959140643708 } ], "100000000000000000004328": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990853685 }, { "start_logit": -33.4375, "end_logit": 12.625, "text": "", "probability": 9.146313747844331e-10 } ], "100000000000000000004329": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989138484 }, { "start_logit": -33.46875, "end_logit": 12.828125, "text": "", "probability": 1.086151631767227e-09 } ], "100000000000000000004331": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989796549 }, { "start_logit": -33.5, "end_logit": 12.796875, "text": "", "probability": 1.0203450311454508e-09 } ], "100000000000000000004333": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.2734375, "end_logit": -0.45068359375, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000004334": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.26171875, "end_logit": -0.42529296875, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000004338": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008040859356292355 }, { "start_logit": 7.80859375, "end_logit": -0.681640625, "text": "", "probability": 0.9991959140643708 } ], "100000000000000000004340": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007702931971871536 }, { "start_logit": 7.78125, "end_logit": -0.61376953125, "text": "", "probability": 0.9992297068028129 } ], "100000000000000000004346": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.1328125, "end_logit": -0.30615234375, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000004348": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009927261432440737 }, { "start_logit": 7.2109375, "end_logit": -0.297119140625, "text": "", "probability": 0.9990072738567558 } ], "100000000000000000004349": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.7734375, "end_logit": -0.611328125, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000004352": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.7421875, "end_logit": -0.6298828125, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000004356": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995027236 }, { "start_logit": -33.4375, "end_logit": 12.015625, "text": "", "probability": 4.972764532585478e-10 } ], "100000000000000000004359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.6171875, "end_logit": -0.392822265625, "text": "", "probability": 0.999270671160687 } ], "100000000000000000004369": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007824140590241951 }, { "start_logit": 7.78125, "end_logit": -0.6298828125, "text": "", "probability": 0.9992175859409759 } ], "100000000000000000004376": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000487857122782266 }, { "start_logit": 7.7578125, "end_logit": -0.132080078125, "text": "", "probability": 0.9995121428772178 } ], "100000000000000000004382": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.66015625, "end_logit": -0.51025390625, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000004383": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006851713149506406 }, { "start_logit": 7.71484375, "end_logit": -0.428466796875, "text": "", "probability": 0.9993148286850494 } ], "100000000000000000004388": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005680935199787149 }, { "start_logit": 7.6484375, "end_logit": -0.1751708984375, "text": "", "probability": 0.9994319064800213 } ], "100000000000000000004389": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.5546875, "end_logit": -0.55078125, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000004392": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008693673928062171 }, { "start_logit": 7.56640625, "end_logit": -0.521484375, "text": "", "probability": 0.9991306326071938 } ], "100000000000000000004393": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008796062064765496 }, { "start_logit": 7.57421875, "end_logit": -0.5390625, "text": "", "probability": 0.9991203937935235 } ], "100000000000000000004395": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006693099618068043 }, { "start_logit": 8.0390625, "end_logit": -0.7314453125, "text": "", "probability": 0.9993306900381931 } ], "100000000000000000004399": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006411777211655285 }, { "start_logit": 8.0859375, "end_logit": -0.73291015625, "text": "", "probability": 0.9993588222788345 } ], "100000000000000000004400": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002800926967120973 }, { "start_logit": 6.66796875, "end_logit": -0.794921875, "text": "", "probability": 0.9971990730328789 } ], "100000000000000000004401": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029926652453546383 }, { "start_logit": 6.61328125, "end_logit": -0.8056640625, "text": "", "probability": 0.9970073347546454 } ], "100000000000000000004403": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002833849844246685 }, { "start_logit": 6.6640625, "end_logit": -0.80126953125, "text": "", "probability": 0.9971661501557534 } ], "100000000000000000004410": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986692192 }, { "start_logit": -33.3125, "end_logit": 12.8828125, "text": "", "probability": 1.330780797297989e-09 } ], "100000000000000000004413": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005233756913394546 }, { "start_logit": 7.93359375, "end_logit": -0.379638671875, "text": "", "probability": 0.9994766243086606 } ], "100000000000000000004415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005770345289316386 }, { "start_logit": 7.89453125, "end_logit": -0.4384765625, "text": "", "probability": 0.9994229654710683 } ], "100000000000000000004417": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000499420543153358 }, { "start_logit": 7.8984375, "end_logit": -0.295654296875, "text": "", "probability": 0.9995005794568467 } ], "100000000000000000004419": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006263341581094201 }, { "start_logit": 8.3046875, "end_logit": -0.9296875, "text": "", "probability": 0.9993736658418905 } ], "100000000000000000004421": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006142271998613951 }, { "start_logit": 8.3359375, "end_logit": -0.94091796875, "text": "", "probability": 0.9993857728001386 } ], "100000000000000000004423": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000572546581632441 }, { "start_logit": 8.375, "end_logit": -0.91015625, "text": "", "probability": 0.9994274534183676 } ], "100000000000000000004425": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.4140625, "end_logit": -0.58935546875, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000004437": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.76171875, "end_logit": -0.39404296875, "text": "", "probability": 0.998285961520812 } ], "100000000000000000004438": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015669887925500437 }, { "start_logit": 6.78125, "end_logit": -0.322998046875, "text": "", "probability": 0.99843301120745 } ], "100000000000000000004439": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 6.60546875, "end_logit": -0.291015625, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000004440": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.70703125, "end_logit": -0.26171875, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000004441": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 6.75390625, "end_logit": -0.318115234375, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000004443": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 6.85546875, "end_logit": -0.131103515625, "text": "", "probability": 0.998798108681489 } ], "100000000000000000004444": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 6.72265625, "end_logit": -0.11151123046875, "text": "", "probability": 0.998654139598703 } ], "100000000000000000004446": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 6.73046875, "end_logit": -0.217041015625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000004450": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993096 }, { "start_logit": -33.375, "end_logit": 12.2734375, "text": "", "probability": 6.903999830637495e-10 } ], "100000000000000000004457": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.78125, "end_logit": -0.482666015625, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000004458": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 7.7265625, "end_logit": -0.42529296875, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000004459": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 7.68359375, "end_logit": -0.40380859375, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000004461": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 6.7109375, "end_logit": -0.095703125, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000004464": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001294368035454269 }, { "start_logit": 6.7578125, "end_logit": -0.111328125, "text": "", "probability": 0.9987056319645456 } ], "100000000000000000004466": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 6.73828125, "end_logit": -0.0948486328125, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000004467": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996983866 }, { "start_logit": -33.1875, "end_logit": 11.265625, "text": "", "probability": 3.016134153134801e-10 } ], "100000000000000000004469": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999997296354 }, { "start_logit": -33.125, "end_logit": 11.0859375, "text": "", "probability": 2.703645181388937e-10 } ], "100000000000000000004470": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996304556 }, { "start_logit": -33.25, "end_logit": 11.5390625, "text": "", "probability": 3.695444813027597e-10 } ], "100000000000000000004472": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006959536838949576 }, { "start_logit": 8.0859375, "end_logit": -0.81689453125, "text": "", "probability": 0.999304046316105 } ], "100000000000000000004475": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006932422985664928 }, { "start_logit": 8.1796875, "end_logit": -0.90625, "text": "", "probability": 0.9993067577014336 } ], "100000000000000000004479": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.69140625, "end_logit": -0.91845703125, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000004481": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.6796875, "end_logit": -0.923828125, "text": "", "probability": 0.99883958037482 } ], "100000000000000000004482": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.703125, "end_logit": -0.94287109375, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000004484": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005571117181506888 }, { "start_logit": 7.8671875, "end_logit": -0.375, "text": "", "probability": 0.9994428882818492 } ], "100000000000000000004485": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005658799865413885 }, { "start_logit": 7.8359375, "end_logit": -0.360107421875, "text": "", "probability": 0.9994341200134585 } ], "100000000000000000004491": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.63671875, "end_logit": -0.83251953125, "text": "", "probability": 0.99889266101491 } ], "100000000000000000004493": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.0546875, "end_logit": -0.36572265625, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000004499": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 6.91796875, "end_logit": -0.353759765625, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000004504": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 7.08203125, "end_logit": 0.2073974609375, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000004505": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.7734375, "end_logit": -0.68798828125, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000004506": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.76953125, "end_logit": -0.685546875, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000004517": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.734375, "end_logit": -1.0078125, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000004519": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.80859375, "end_logit": -1.0126953125, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000004527": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.765625, "end_logit": -0.61669921875, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000004532": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 6.25, "end_logit": 0.08026123046875, "text": "", "probability": 0.998224739467894 } ], "100000000000000000004535": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000800953612508541 }, { "start_logit": 7.828125, "end_logit": -0.7001953125, "text": "", "probability": 0.9991990463874916 } ], "100000000000000000004546": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.37890625, "end_logit": -0.6513671875, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000004548": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.30859375, "end_logit": -0.5908203125, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000004553": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.39453125, "end_logit": -0.556640625, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000004555": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010775025886693324 }, { "start_logit": 7.4140625, "end_logit": -0.58056640625, "text": "", "probability": 0.9989224974113308 } ], "100000000000000000004567": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.53515625, "end_logit": -0.30859375, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000004569": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007069056122424319 }, { "start_logit": 7.5390625, "end_logit": -0.285400390625, "text": "", "probability": 0.9992930943877577 } ], "100000000000000000004570": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019342611032703307 }, { "start_logit": 6.26171875, "end_logit": -0.01483917236328125, "text": "", "probability": 0.9980657388967297 } ], "100000000000000000004573": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.328125, "end_logit": 0.00023365020751953125, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000004578": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989138484 }, { "start_logit": -33.84375, "end_logit": 13.203125, "text": "", "probability": 1.086151631767227e-09 } ], "100000000000000000004582": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013406204230996853 }, { "start_logit": 7.43359375, "end_logit": -0.8203125, "text": "", "probability": 0.9986593795769002 } ], "100000000000000000004591": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.2890625, "end_logit": -0.646484375, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000004592": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.37890625, "end_logit": -0.72119140625, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000004594": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 7.265625, "end_logit": -0.58984375, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000004597": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.2578125, "end_logit": -0.5732421875, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000004598": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009110511944006454 }, { "start_logit": 6.93359375, "end_logit": 0.06768798828125, "text": "", "probability": 0.9990889488055994 } ], "100000000000000000004606": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 6.44140625, "end_logit": 0.099365234375, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000004608": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007916296072837431 }, { "start_logit": 7.484375, "end_logit": -0.34375, "text": "", "probability": 0.9992083703927161 } ], "100000000000000000004610": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000859247658728013 }, { "start_logit": 7.46484375, "end_logit": -0.406494140625, "text": "", "probability": 0.999140752341272 } ], "100000000000000000004612": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007793660930208433 }, { "start_logit": 7.48046875, "end_logit": -0.32421875, "text": "", "probability": 0.9992206339069791 } ], "100000000000000000004613": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008263575992788699 }, { "start_logit": 7.5, "end_logit": -0.400634765625, "text": "", "probability": 0.9991736424007212 } ], "100000000000000000004614": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.51171875, "end_logit": -0.396240234375, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000004617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00030061635882429376 }, { "start_logit": 8.140625, "end_logit": -0.032806396484375, "text": "", "probability": 0.9996993836411757 } ], "100000000000000000004628": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.625, "end_logit": -0.60791015625, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000004634": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003859660905807735 }, { "start_logit": 8.046875, "end_logit": -0.18798828125, "text": "", "probability": 0.9996140339094192 } ], "100000000000000000004636": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003755592236470211 }, { "start_logit": 8.046875, "end_logit": -0.15869140625, "text": "", "probability": 0.999624440776353 } ], "100000000000000000004639": [ { "start_logit": 16.09375, "end_logit": 8.53125, "text": " Moderna or Pfizer-BioNTech", "probability": 0.228759765625 }, { "start_logit": 16.09375, "end_logit": 7.734375, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.10308837890625 }, { "start_logit": 16.09375, "end_logit": 7.67578125, "text": " Moderna", "probability": 0.09686279296875 }, { "start_logit": 15.484375, "end_logit": 8.09375, "text": " October 19, 2022", "probability": 0.080322265625 }, { "start_logit": 14.9921875, "end_logit": 8.53125, "text": " Pfizer-BioNTech", "probability": 0.07666015625 }, { "start_logit": 14.671875, "end_logit": 8.53125, "text": " contraindication to mRNA (i.e., Moderna or Pfizer-BioNTech", "probability": 0.05517578125 }, { "start_logit": 15.265625, "end_logit": 7.9296875, "text": "Janssen", "probability": 0.054351806640625 }, { "start_logit": 15.265625, "end_logit": 7.5390625, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older for the primary series dose and 1 booster dose in\ncertain limited situations", "probability": 0.037322998046875 }, { "start_logit": 15.484375, "end_logit": 7.29296875, "text": " October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older", "probability": 0.03619384765625 }, { "start_logit": 14.9921875, "end_logit": 7.734375, "text": " Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.034027099609375 }, { "start_logit": 16.09375, "end_logit": 6.48828125, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines", "probability": 0.029541015625 }, { "start_logit": 15.265625, "end_logit": 7.2109375, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older", "probability": 0.0264892578125 }, { "start_logit": 14.671875, "end_logit": 7.67578125, "text": " contraindication to mRNA (i.e., Moderna", "probability": 0.02337646484375 }, { "start_logit": 16.09375, "end_logit": 6.1875, "text": " Moderna or Pfizer", "probability": 0.0219573974609375 }, { "start_logit": 15.484375, "end_logit": 6.78515625, "text": " October 19, 2022):\nGuidance for use of a monovalent", "probability": 0.0216217041015625 }, { "start_logit": 14.671875, "end_logit": 7.35546875, "text": " contraindication to mRNA", "probability": 0.0171051025390625 }, { "start_logit": 15.265625, "end_logit": 6.62109375, "text": "Janssen COVID-19", "probability": 0.01485443115234375 }, { "start_logit": 16.09375, "end_logit": 5.765625, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19", "probability": 0.01439666748046875 }, { "start_logit": 14.671875, "end_logit": 7.15625, "text": " contraindication", "probability": 0.01395416259765625 }, { "start_logit": 16.09375, "end_logit": 5.7109375, "text": " Moderna or Pfizer-Bio", "probability": 0.01374053955078125 }, { "start_logit": 8.1328125, "end_logit": -0.7392578125, "text": "", "probability": 0.0 } ], "100000000000000000004640": [ { "start_logit": 16.09375, "end_logit": 8.53125, "text": " Moderna or Pfizer-BioNTech", "probability": 0.2279052734375 }, { "start_logit": 16.09375, "end_logit": 7.75390625, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.1043701171875 }, { "start_logit": 16.09375, "end_logit": 7.6796875, "text": " Moderna", "probability": 0.09808349609375 }, { "start_logit": 15.46875, "end_logit": 8.109375, "text": " October 19, 2022", "probability": 0.08001708984375 }, { "start_logit": 15.0078125, "end_logit": 8.53125, "text": " Pfizer-BioNTech", "probability": 0.07635498046875 }, { "start_logit": 15.265625, "end_logit": 7.953125, "text": "Janssen", "probability": 0.055877685546875 }, { "start_logit": 14.6640625, "end_logit": 8.53125, "text": " contraindication to mRNA (i.e., Moderna or Pfizer-BioNTech", "probability": 0.05413818359375 }, { "start_logit": 15.265625, "end_logit": 7.54296875, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older for the primary series dose and 1 booster dose in\ncertain limited situations", "probability": 0.037200927734375 }, { "start_logit": 15.46875, "end_logit": 7.29296875, "text": " October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older", "probability": 0.0355224609375 }, { "start_logit": 15.0078125, "end_logit": 7.75390625, "text": " Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.0355224609375 }, { "start_logit": 16.09375, "end_logit": 6.48828125, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines", "probability": 0.0294342041015625 }, { "start_logit": 15.265625, "end_logit": 7.2109375, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older", "probability": 0.026397705078125 }, { "start_logit": 14.6640625, "end_logit": 7.6796875, "text": " contraindication to mRNA (i.e., Moderna", "probability": 0.023284912109375 }, { "start_logit": 16.09375, "end_logit": 6.18359375, "text": " Moderna or Pfizer", "probability": 0.0218658447265625 }, { "start_logit": 15.46875, "end_logit": 6.78125, "text": " October 19, 2022):\nGuidance for use of a monovalent", "probability": 0.021209716796875 }, { "start_logit": 14.6640625, "end_logit": 7.35546875, "text": " contraindication to mRNA", "probability": 0.01678466796875 }, { "start_logit": 15.265625, "end_logit": 6.62109375, "text": "Janssen COVID-19", "probability": 0.014801025390625 }, { "start_logit": 16.09375, "end_logit": 5.76171875, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19", "probability": 0.01434326171875 }, { "start_logit": 14.6640625, "end_logit": 7.15625, "text": " contraindication", "probability": 0.01369476318359375 }, { "start_logit": 16.09375, "end_logit": 5.70703125, "text": " Moderna or Pfizer-BioNTech) and Novavax", "probability": 0.0134735107421875 }, { "start_logit": 8.140625, "end_logit": -0.69189453125, "text": "", "probability": 0.0 } ], "100000000000000000004645": [ { "start_logit": 16.09375, "end_logit": 8.53125, "text": " Moderna or Pfizer-BioNTech", "probability": 0.2279052734375 }, { "start_logit": 16.09375, "end_logit": 7.75390625, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.1043701171875 }, { "start_logit": 16.09375, "end_logit": 7.6796875, "text": " Moderna", "probability": 0.09808349609375 }, { "start_logit": 15.46875, "end_logit": 8.109375, "text": " October 19, 2022", "probability": 0.08001708984375 }, { "start_logit": 15.0078125, "end_logit": 8.53125, "text": " Pfizer-BioNTech", "probability": 0.07635498046875 }, { "start_logit": 15.265625, "end_logit": 7.953125, "text": "Janssen", "probability": 0.055877685546875 }, { "start_logit": 14.6640625, "end_logit": 8.53125, "text": " contraindication to mRNA (i.e., Moderna or Pfizer-BioNTech", "probability": 0.05413818359375 }, { "start_logit": 15.265625, "end_logit": 7.54296875, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older for the primary series dose and 1 booster dose in\ncertain limited situations", "probability": 0.037200927734375 }, { "start_logit": 15.46875, "end_logit": 7.29296875, "text": " October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older", "probability": 0.0355224609375 }, { "start_logit": 15.0078125, "end_logit": 7.75390625, "text": " Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.0355224609375 }, { "start_logit": 16.09375, "end_logit": 6.48828125, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines", "probability": 0.0294342041015625 }, { "start_logit": 15.265625, "end_logit": 7.2109375, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older", "probability": 0.026397705078125 }, { "start_logit": 14.6640625, "end_logit": 7.6796875, "text": " contraindication to mRNA (i.e., Moderna", "probability": 0.023284912109375 }, { "start_logit": 16.09375, "end_logit": 6.18359375, "text": " Moderna or Pfizer", "probability": 0.0218658447265625 }, { "start_logit": 15.46875, "end_logit": 6.78125, "text": " October 19, 2022):\nGuidance for use of a monovalent", "probability": 0.021209716796875 }, { "start_logit": 14.6640625, "end_logit": 7.35546875, "text": " contraindication to mRNA", "probability": 0.01678466796875 }, { "start_logit": 15.265625, "end_logit": 6.62109375, "text": "Janssen COVID-19", "probability": 0.014801025390625 }, { "start_logit": 16.09375, "end_logit": 5.76171875, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19", "probability": 0.01434326171875 }, { "start_logit": 14.6640625, "end_logit": 7.15625, "text": " contraindication", "probability": 0.01369476318359375 }, { "start_logit": 16.09375, "end_logit": 5.70703125, "text": " Moderna or Pfizer-BioNTech) and Novavax", "probability": 0.0134735107421875 }, { "start_logit": 8.1015625, "end_logit": -0.71533203125, "text": "", "probability": 0.0 } ], "100000000000000000004648": [ { "start_logit": 16.09375, "end_logit": 8.53125, "text": " Moderna or Pfizer-BioNTech", "probability": 0.2279052734375 }, { "start_logit": 16.09375, "end_logit": 7.73828125, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.10272216796875 }, { "start_logit": 16.09375, "end_logit": 7.6796875, "text": " Moderna", "probability": 0.09808349609375 }, { "start_logit": 15.46875, "end_logit": 8.109375, "text": " October 19, 2022", "probability": 0.08001708984375 }, { "start_logit": 15.0, "end_logit": 8.53125, "text": " Pfizer-BioNTech", "probability": 0.07635498046875 }, { "start_logit": 15.2734375, "end_logit": 7.93359375, "text": "Janssen", "probability": 0.05499267578125 }, { "start_logit": 14.671875, "end_logit": 8.53125, "text": " contraindication to mRNA (i.e., Moderna or Pfizer-BioNTech", "probability": 0.05499267578125 }, { "start_logit": 15.2734375, "end_logit": 7.5390625, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older for the primary series dose and 1 booster dose in\ncertain limited situations", "probability": 0.037200927734375 }, { "start_logit": 15.46875, "end_logit": 7.3046875, "text": " October 19, 2022):\nGuidance for use of a monovalent Novavax COVID-19 booster dose in people ages 18 years and older", "probability": 0.03607177734375 }, { "start_logit": 15.0, "end_logit": 7.73828125, "text": " Pfizer-BioNTech) and Novavax COVID-19 vaccines (e.g.,\nsevere allergic reaction", "probability": 0.034423828125 }, { "start_logit": 16.09375, "end_logit": 6.4921875, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines", "probability": 0.0299072265625 }, { "start_logit": 15.2734375, "end_logit": 7.20703125, "text": "Janssen COVID-19 Vaccine is authorized for adults ages 18 years and older", "probability": 0.02679443359375 }, { "start_logit": 14.671875, "end_logit": 7.6796875, "text": " contraindication to mRNA (i.e., Moderna", "probability": 0.023284912109375 }, { "start_logit": 16.09375, "end_logit": 6.1875, "text": " Moderna or Pfizer", "probability": 0.0218658447265625 }, { "start_logit": 15.46875, "end_logit": 6.78125, "text": " October 19, 2022):\nGuidance for use of a monovalent", "probability": 0.021209716796875 }, { "start_logit": 14.671875, "end_logit": 7.35546875, "text": " contraindication to mRNA", "probability": 0.0170440673828125 }, { "start_logit": 15.2734375, "end_logit": 6.62109375, "text": "Janssen COVID-19", "probability": 0.014801025390625 }, { "start_logit": 16.09375, "end_logit": 5.765625, "text": " Moderna or Pfizer-BioNTech) and Novavax COVID-19", "probability": 0.01434326171875 }, { "start_logit": 14.671875, "end_logit": 7.15625, "text": " contraindication", "probability": 0.01390838623046875 }, { "start_logit": 16.09375, "end_logit": 5.7109375, "text": " Moderna or Pfizer-Bio", "probability": 0.01369476318359375 }, { "start_logit": 8.1015625, "end_logit": -0.736328125, "text": "", "probability": 0.0 } ], "100000000000000000004650": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 6.49609375, "end_logit": -0.10986328125, "text": "", "probability": 0.998319058298613 } ], "100000000000000000004659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 6.50390625, "end_logit": -0.109130859375, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000004666": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021405892581107663 }, { "start_logit": 6.4609375, "end_logit": -0.3173828125, "text": "", "probability": 0.9978594107418892 } ], "100000000000000000004670": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018031664077959439 }, { "start_logit": 6.86328125, "end_logit": -0.5478515625, "text": "", "probability": 0.998196833592204 } ], "100000000000000000004671": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001874861720261248 }, { "start_logit": 6.78515625, "end_logit": -0.5078125, "text": "", "probability": 0.9981251382797387 } ], "100000000000000000004673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004101929257867252 }, { "start_logit": 5.359375, "end_logit": 0.134033203125, "text": "", "probability": 0.9958980707421329 } ], "100000000000000000004674": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005139611097568844 }, { "start_logit": 5.17578125, "end_logit": 0.09100341796875, "text": "", "probability": 0.9948603889024311 } ], "100000000000000000004677": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004848533090448643 }, { "start_logit": 5.234375, "end_logit": 0.0897216796875, "text": "", "probability": 0.9951514669095514 } ], "100000000000000000004679": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.1640625, "end_logit": -0.425537109375, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000004680": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.1875, "end_logit": -0.41650390625, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000004681": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.21875, "end_logit": -0.479248046875, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000004693": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 6.9140625, "end_logit": -0.288818359375, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000004697": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 6.71875, "end_logit": -0.06756591796875, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000004705": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002611247603490656 }, { "start_logit": 6.41796875, "end_logit": -0.473388671875, "text": "", "probability": 0.9973887523965093 } ], "100000000000000000004709": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022170130229473865 }, { "start_logit": 6.515625, "end_logit": -0.40625, "text": "", "probability": 0.9977829869770526 } ], "100000000000000000004713": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00028240807799315707 }, { "start_logit": 7.68359375, "end_logit": 0.49072265625, "text": "", "probability": 0.9997175919220068 } ], "100000000000000000004714": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00028021097671886315 }, { "start_logit": 7.703125, "end_logit": 0.47998046875, "text": "", "probability": 0.9997197890232813 } ], "100000000000000000004716": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001700722411435288 }, { "start_logit": 6.67578125, "end_logit": -0.302490234375, "text": "", "probability": 0.9982992775885648 } ], "100000000000000000004726": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.91015625, "end_logit": -0.51318359375, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000004727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018895386578398716 }, { "start_logit": 6.80078125, "end_logit": -0.53173828125, "text": "", "probability": 0.9981104613421601 } ], "100000000000000000004737": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0035936025814200896 }, { "start_logit": 5.859375, "end_logit": -0.2337646484375, "text": "", "probability": 0.9964063974185798 } ], "100000000000000000004742": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999952076744 }, { "start_logit": -33.84375, "end_logit": 14.6796875, "text": "", "probability": 4.79232572973579e-09 } ], "100000000000000000004750": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.34375, "end_logit": -0.6259765625, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000004758": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973944578 }, { "start_logit": -33.75, "end_logit": 13.984375, "text": "", "probability": 2.6055423109896135e-09 } ], "100000000000000000004763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999979063878 }, { "start_logit": -33.78125, "end_logit": 13.796875, "text": "", "probability": 2.0936120646539e-09 } ], "100000000000000000004764": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999972694151 }, { "start_logit": -33.8125, "end_logit": 14.09375, "text": "", "probability": 2.730584896949298e-09 } ], "100000000000000000004765": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973944578 }, { "start_logit": -33.84375, "end_logit": 14.078125, "text": "", "probability": 2.6055423109896135e-09 } ], "100000000000000000004768": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.1328125, "end_logit": -0.402099609375, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000004771": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 7.21484375, "end_logit": -0.81396484375, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000004778": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029926652453546383 }, { "start_logit": 6.078125, "end_logit": -0.2705078125, "text": "", "probability": 0.9970073347546454 } ], "100000000000000000004780": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002912178283114333 }, { "start_logit": 6.1015625, "end_logit": -0.265625, "text": "", "probability": 0.9970878217168856 } ], "100000000000000000004789": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.4609375, "end_logit": -0.60595703125, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000004790": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.53515625, "end_logit": -0.5771484375, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000004792": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 6.6875, "end_logit": -0.2105712890625, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000004793": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 6.76953125, "end_logit": -0.25439453125, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000004796": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 6.71484375, "end_logit": -0.203369140625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000004802": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 7.28515625, "end_logit": -0.7138671875, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000004811": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0038543638269116958 }, { "start_logit": 5.9375, "end_logit": -0.381103515625, "text": "", "probability": 0.9961456361730884 } ], "100000000000000000004813": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.96875, "end_logit": -1.2685546875, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000004823": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022961590064970627 }, { "start_logit": 6.40234375, "end_logit": -0.32958984375, "text": "", "probability": 0.9977038409935028 } ], "100000000000000000004831": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.625, "end_logit": -0.8603515625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000004832": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.6328125, "end_logit": -0.8544921875, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000004843": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.51953125, "end_logit": -0.9462890625, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000004844": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 7.53125, "end_logit": -0.9853515625, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000004845": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.44921875, "end_logit": -0.9482421875, "text": "", "probability": 0.998498817743263 } ], "100000000000000000004848": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.98046875, "end_logit": -1.2587890625, "text": "", "probability": 0.998798108681489 } ], "100000000000000000004852": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002107472437884964 }, { "start_logit": 7.11328125, "end_logit": -0.95263671875, "text": "", "probability": 0.997892527562115 } ], "100000000000000000004853": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021322616859826855 }, { "start_logit": 7.109375, "end_logit": -0.962890625, "text": "", "probability": 0.9978677383140173 } ], "100000000000000000004855": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020667944781501153 }, { "start_logit": 7.1875, "end_logit": -1.009765625, "text": "", "probability": 0.9979332055218498 } ], "100000000000000000004856": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010362668882466278 }, { "start_logit": 7.1953125, "end_logit": -0.32421875, "text": "", "probability": 0.9989637331117535 } ], "100000000000000000004857": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.1328125, "end_logit": -0.28955078125, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000004858": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.9453125, "end_logit": -0.38623046875, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000004862": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018458483368165377 }, { "start_logit": 7.21484375, "end_logit": -0.92138671875, "text": "", "probability": 0.9981541516631836 } ], "100000000000000000004863": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.80859375, "end_logit": -1.0634765625, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000004870": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.359375, "end_logit": -0.70703125, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000004876": [ { "start_logit": 14.2734375, "end_logit": 8.3046875, "text": "Severe allergic reaction (e.g.,\nanaphylaxis", "probability": 0.224609375 }, { "start_logit": 14.2734375, "end_logit": 8.1484375, "text": "Severe allergic reaction", "probability": 0.192138671875 }, { "start_logit": 13.59375, "end_logit": 8.1484375, "text": "NO CONTRAINDICATION OR\nPRECAUTION TO COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction", "probability": 0.09808349609375 }, { "start_logit": 13.1328125, "end_logit": 8.34375, "text": " allergies or allergic reactions", "probability": 0.0740966796875 }, { "start_logit": 13.0546875, "end_logit": 8.34375, "text": " COVID-19\nVACCINATION\nAppendix E. Triage of people with a history of allergies or allergic reactions", "probability": 0.069580078125 }, { "start_logit": 12.7578125, "end_logit": 8.3046875, "text": "anaphylaxis", "probability": 0.049346923828125 }, { "start_logit": 12.5390625, "end_logit": 8.3046875, "text": "\nSevere allergic reaction (e.g.,\nanaphylaxis", "probability": 0.039642333984375 }, { "start_logit": 12.4140625, "end_logit": 8.34375, "text": "Appendix E. Triage of people with a history of allergies or allergic reactions", "probability": 0.036102294921875 }, { "start_logit": 12.5390625, "end_logit": 8.1484375, "text": "\nSevere allergic reaction", "probability": 0.033905029296875 }, { "start_logit": 12.3828125, "end_logit": 8.3046875, "text": " COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction (e.g.,\nanaphylaxis", "probability": 0.033905029296875 }, { "start_logit": 12.3828125, "end_logit": 8.1484375, "text": " COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction", "probability": 0.0290069580078125 }, { "start_logit": 13.59375, "end_logit": 6.73828125, "text": "NO CONTRAINDICATION", "probability": 0.0236663818359375 }, { "start_logit": 13.5390625, "end_logit": 6.54296875, "text": "NO CONTRAINDICATION", "probability": 0.0184326171875 }, { "start_logit": 12.4609375, "end_logit": 7.34765625, "text": " contraindication, a history\nof:\nAnaphylaxis", "probability": 0.014129638671875 }, { "start_logit": 12.453125, "end_logit": 7.34765625, "text": "Anaphylaxis", "probability": 0.01390838623046875 }, { "start_logit": 12.25, "end_logit": 7.34765625, "text": " COVID-19\nvaccine\nAmong people without a contraindication, a history\nof:\nAnaphylaxis", "probability": 0.0113525390625 }, { "start_logit": 12.1875, "end_logit": 7.34765625, "text": "\nAnaphylaxis", "probability": 0.01067352294921875 }, { "start_logit": 12.1640625, "end_logit": 7.34765625, "text": " people without a contraindication, a history\nof:\nAnaphylaxis", "probability": 0.01050567626953125 }, { "start_logit": 12.9609375, "end_logit": 6.54296875, "text": " COVID-19 VACCINATION\nNO CONTRAINDICATION", "probability": 0.01033782958984375 }, { "start_logit": 13.59375, "end_logit": 5.48828125, "text": "NO CONTRAINDICATION OR", "probability": 0.00678253173828125 }, { "start_logit": 8.6171875, "end_logit": -0.771484375, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000004877": [ { "start_logit": 14.2734375, "end_logit": 8.296875, "text": "Severe allergic reaction (e.g.,\nanaphylaxis", "probability": 0.223388671875 }, { "start_logit": 14.2734375, "end_logit": 8.140625, "text": "Severe allergic reaction", "probability": 0.1910400390625 }, { "start_logit": 13.5859375, "end_logit": 8.140625, "text": "NO CONTRAINDICATION OR\nPRECAUTION TO COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction", "probability": 0.0960693359375 }, { "start_logit": 13.125, "end_logit": 8.34375, "text": " allergies or allergic reactions", "probability": 0.0748291015625 }, { "start_logit": 13.0546875, "end_logit": 8.34375, "text": " COVID-19\nVACCINATION\nAppendix E. Triage of people with a history of allergies or allergic reactions", "probability": 0.0703125 }, { "start_logit": 12.7578125, "end_logit": 8.296875, "text": "anaphylaxis", "probability": 0.049835205078125 }, { "start_logit": 12.53125, "end_logit": 8.296875, "text": "\nSevere allergic reaction (e.g.,\nanaphylaxis", "probability": 0.0394287109375 }, { "start_logit": 12.40625, "end_logit": 8.34375, "text": "Appendix E. Triage of people with a history of allergies or allergic reactions", "probability": 0.036468505859375 }, { "start_logit": 12.390625, "end_logit": 8.296875, "text": " COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction (e.g.,\nanaphylaxis", "probability": 0.03424072265625 }, { "start_logit": 12.53125, "end_logit": 8.140625, "text": "\nSevere allergic reaction", "probability": 0.033721923828125 }, { "start_logit": 12.390625, "end_logit": 8.140625, "text": " COVID-19\nVACCINATION\nHistory of the following:\nSevere allergic reaction", "probability": 0.0293121337890625 }, { "start_logit": 13.5859375, "end_logit": 6.73828125, "text": "NO CONTRAINDICATION", "probability": 0.0239105224609375 }, { "start_logit": 13.5390625, "end_logit": 6.5546875, "text": "NO CONTRAINDICATION", "probability": 0.0189208984375 }, { "start_logit": 12.4609375, "end_logit": 7.34765625, "text": " contraindication, a history\nof:\nAnaphylaxis", "probability": 0.01427459716796875 }, { "start_logit": 12.453125, "end_logit": 7.34765625, "text": "Anaphylaxis", "probability": 0.0140533447265625 }, { "start_logit": 12.25, "end_logit": 7.34765625, "text": " COVID-19\nvaccine\nAmong people without a contraindication, a history\nof:\nAnaphylaxis", "probability": 0.011474609375 }, { "start_logit": 12.1875, "end_logit": 7.34765625, "text": "\nAnaphylaxis", "probability": 0.01078033447265625 }, { "start_logit": 12.9609375, "end_logit": 6.5546875, "text": " COVID-19 VACCINATION\nNO CONTRAINDICATION", "probability": 0.01061248779296875 }, { "start_logit": 12.1640625, "end_logit": 7.34765625, "text": " people without a contraindication, a history\nof:\nAnaphylaxis", "probability": 0.01061248779296875 }, { "start_logit": 13.5859375, "end_logit": 5.48828125, "text": "NO CONTRAINDICATION OR", "probability": 0.0068511962890625 }, { "start_logit": 8.65625, "end_logit": -0.75244140625, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000004882": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.54296875, "end_logit": -0.74169921875, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000004886": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.07421875, "end_logit": -0.292236328125, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000004887": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.0703125, "end_logit": -0.296630859375, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000004888": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.11328125, "end_logit": -0.310791015625, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000004889": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.05859375, "end_logit": -0.24609375, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000004891": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.03515625, "end_logit": -0.2353515625, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000004892": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.046875, "end_logit": -0.2384033203125, "text": "", "probability": 0.998896973358602 } ], "100000000000000000004906": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027791905585136147 }, { "start_logit": 6.49609375, "end_logit": -0.61328125, "text": "", "probability": 0.9972208094414864 } ], "100000000000000000004908": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027362210991480392 }, { "start_logit": 6.4921875, "end_logit": -0.5927734375, "text": "", "probability": 0.997263778900852 } ], "100000000000000000004909": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00045121062377819225 }, { "start_logit": 7.48828125, "end_logit": 0.2142333984375, "text": "", "probability": 0.9995487893762218 } ], "100000000000000000004910": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004784256262873459 }, { "start_logit": 7.5, "end_logit": 0.14404296875, "text": "", "probability": 0.9995215743737126 } ], "100000000000000000004918": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0035657366623610266 }, { "start_logit": 5.88671875, "end_logit": -0.252685546875, "text": "", "probability": 0.9964342633376391 } ], "100000000000000000004920": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029235429042710408 }, { "start_logit": 6.10546875, "end_logit": -0.27294921875, "text": "", "probability": 0.9970764570957289 } ], "100000000000000000004921": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027469009484408103 }, { "start_logit": 6.0859375, "end_logit": -0.1917724609375, "text": "", "probability": 0.9972530990515591 } ], "100000000000000000004925": [ { "start_logit": 14.7890625, "end_logit": 35.40625, "text": " September 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.37451171875 }, { "start_logit": 11.921875, "end_logit": 38.09375, "text": " Advisory Committee\non Immunization Practices", "probability": 0.310546875 }, { "start_logit": 13.4375, "end_logit": 35.40625, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0977783203125 }, { "start_logit": 10.2578125, "end_logit": 38.09375, "text": " Pfizer-BioNTech COVID-19 Vaccine in Persons Aged \u226516 Years: Recommendations of the Advisory Committee\non Immunization Practices", "probability": 0.05926513671875 }, { "start_logit": 10.1953125, "end_logit": 38.09375, "text": " \u226516 Years: Recommendations of the Advisory Committee\non Immunization Practices", "probability": 0.055694580078125 }, { "start_logit": 12.296875, "end_logit": 35.40625, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0307464599609375 }, { "start_logit": 11.921875, "end_logit": 35.40625, "text": " Advisory Committee\non Immunization Practices \u2014 United States, September 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.0211334228515625 }, { "start_logit": 11.0, "end_logit": 35.9375, "text": " Advisory Committee on Immunization\nPractices", "probability": 0.0145263671875 }, { "start_logit": 9.8984375, "end_logit": 36.25, "text": "Pfizer-BioNTech", "probability": 0.00664520263671875 }, { "start_logit": 9.8671875, "end_logit": 36.25, "text": "Johnson & Johnson) and\nmRNA COVID-19 Vaccines (Pfizer-BioNTech", "probability": 0.00644683837890625 }, { "start_logit": 11.0, "end_logit": 35.03125, "text": " Advisory Committee on Immunization\nPractices \u2014 United States", "probability": 0.005870819091796875 }, { "start_logit": 9.8984375, "end_logit": 35.9375, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization\nPractices", "probability": 0.004863739013671875 }, { "start_logit": 9.578125, "end_logit": 35.9375, "text": " Update from the Advisory Committee on Immunization\nPractices", "probability": 0.003448486328125 }, { "start_logit": 9.8984375, "end_logit": 35.03125, "text": "Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization\nPractices \u2014 United States", "probability": 0.0019664764404296875 }, { "start_logit": 9.578125, "end_logit": 35.03125, "text": " Update from the Advisory Committee on Immunization\nPractices \u2014 United States", "probability": 0.001438140869140625 }, { "start_logit": 11.921875, "end_logit": 32.625, "text": " Advisory Committee\non Immunization Practices \u2014 United States", "probability": 0.0013513565063476562 }, { "start_logit": 15.28125, "end_logit": 29.140625, "text": " July 2021\nUse of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged \u226516 Years: Recommendations of the Advisory Committee", "probability": 0.0011920928955078125 }, { "start_logit": 6.09765625, "end_logit": 38.09375, "text": " COVID-19 Vaccine in Persons Aged \u226516 Years: Recommendations of the Advisory Committee\non Immunization Practices", "probability": 0.0009288787841796875 }, { "start_logit": 6.01171875, "end_logit": 38.09375, "text": " the Advisory Committee\non Immunization Practices", "probability": 0.0008449554443359375 }, { "start_logit": 8.1328125, "end_logit": 35.40625, "text": " Advisory Committee on Immunization Practices", "probability": 0.00048160552978515625 }, { "start_logit": 4.6796875, "end_logit": 16.765625, "text": "", "probability": 0.0 } ], "100000000000000000004929": [ { "start_logit": 17.84375, "end_logit": 10.796875, "text": " July 2021", "probability": 0.14208984375 }, { "start_logit": 17.9375, "end_logit": 10.359375, "text": " 2021", "probability": 0.1007080078125 }, { "start_logit": 17.40625, "end_logit": 10.734375, "text": " 2021", "probability": 0.086181640625 }, { "start_logit": 17.15625, "end_logit": 10.734375, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.067138671875 }, { "start_logit": 17.375, "end_logit": 10.3984375, "text": " September 2021", "probability": 0.060150146484375 }, { "start_logit": 16.90625, "end_logit": 10.734375, "text": " February 2021", "probability": 0.052276611328125 }, { "start_logit": 16.78125, "end_logit": 10.796875, "text": " 2021", "probability": 0.049102783203125 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " June 2021", "probability": 0.046844482421875 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " 2021", "probability": 0.046844482421875 }, { "start_logit": 17.46875, "end_logit": 9.984375, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0433349609375 }, { "start_logit": 17.453125, "end_logit": 9.96875, "text": " December 2020", "probability": 0.0419921875 }, { "start_logit": 17.546875, "end_logit": 9.8046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.038848876953125 }, { "start_logit": 17.453125, "end_logit": 9.8046875, "text": " December 2020\nThe Advisory Committee on Immunization Practices", "probability": 0.035369873046875 }, { "start_logit": 17.234375, "end_logit": 9.96875, "text": " Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020", "probability": 0.03375244140625 }, { "start_logit": 16.46875, "end_logit": 10.734375, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.03375244140625 }, { "start_logit": 17.546875, "end_logit": 9.4453125, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0275421142578125 }, { "start_logit": 17.453125, "end_logit": 9.4453125, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0250701904296875 }, { "start_logit": 16.5, "end_logit": 10.3984375, "text": " 2021", "probability": 0.0250701904296875 }, { "start_logit": 17.15625, "end_logit": 9.671875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.023193359375 }, { "start_logit": 17.40625, "end_logit": 9.3125, "text": " 2021\nUpdated Recommendations from the Advisory Committee on Immunization Practices", "probability": 0.0207977294921875 }, { "start_logit": 5.859375, "end_logit": -0.74560546875, "text": "", "probability": 0.0 } ], "100000000000000000004931": [ { "start_logit": 9.375, "end_logit": 21.9375, "text": " June 2022\nInterim Recommendation of the Advisory Committee on Immunization", "probability": 0.408935546875 }, { "start_logit": 8.5859375, "end_logit": 21.9375, "text": " Advisory Committee on Immunization", "probability": 0.187255859375 }, { "start_logit": 8.5625, "end_logit": 21.9375, "text": " 6 Months\u20135 Years \u2014 United States, June 2022\nInterim Recommendation of the Advisory Committee on Immunization", "probability": 0.1815185546875 }, { "start_logit": 7.3984375, "end_logit": 21.9375, "text": "\u20135 Years \u2014 United States, June 2022\nInterim Recommendation of the Advisory Committee on Immunization", "probability": 0.057098388671875 }, { "start_logit": 17.84375, "end_logit": 10.796875, "text": " July 2021", "probability": 0.0282745361328125 }, { "start_logit": 17.40625, "end_logit": 10.734375, "text": " 2021", "probability": 0.01715087890625 }, { "start_logit": 17.15625, "end_logit": 10.734375, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.0133514404296875 }, { "start_logit": 17.375, "end_logit": 10.3984375, "text": " September 2021", "probability": 0.01197052001953125 }, { "start_logit": 16.90625, "end_logit": 10.734375, "text": " February 2021", "probability": 0.01039886474609375 }, { "start_logit": 16.78125, "end_logit": 10.796875, "text": " 2021", "probability": 0.00977325439453125 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " June 2021", "probability": 0.0093231201171875 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " 2021", "probability": 0.0093231201171875 }, { "start_logit": 17.46875, "end_logit": 9.984375, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0086212158203125 }, { "start_logit": 17.453125, "end_logit": 9.96875, "text": " December 2020", "probability": 0.00835418701171875 }, { "start_logit": 17.546875, "end_logit": 9.8046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.007724761962890625 }, { "start_logit": 17.453125, "end_logit": 9.8046875, "text": " December 2020\nThe Advisory Committee on Immunization Practices", "probability": 0.007038116455078125 }, { "start_logit": 17.234375, "end_logit": 9.96875, "text": " Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020", "probability": 0.0067138671875 }, { "start_logit": 16.46875, "end_logit": 10.734375, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.0067138671875 }, { "start_logit": 17.546875, "end_logit": 9.4453125, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0054779052734375 }, { "start_logit": 17.453125, "end_logit": 9.4453125, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0049896240234375 }, { "start_logit": -34.09375, "end_logit": 15.2890625, "text": "", "probability": 0.0 } ], "100000000000000000004934": [ { "start_logit": 17.84375, "end_logit": 10.796875, "text": " July 2021", "probability": 0.13671875 }, { "start_logit": 17.9375, "end_logit": 10.359375, "text": " 2021", "probability": 0.096923828125 }, { "start_logit": 17.40625, "end_logit": 10.734375, "text": " 2021", "probability": 0.0828857421875 }, { "start_logit": 17.15625, "end_logit": 10.734375, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.0645751953125 }, { "start_logit": 17.375, "end_logit": 10.3984375, "text": " September 2021", "probability": 0.057861328125 }, { "start_logit": 15.078125, "end_logit": 12.7109375, "text": " July 2021", "probability": 0.057861328125 }, { "start_logit": 16.90625, "end_logit": 10.734375, "text": " February 2021", "probability": 0.05029296875 }, { "start_logit": 16.78125, "end_logit": 10.796875, "text": " 2021", "probability": 0.0472412109375 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " 2021", "probability": 0.045074462890625 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " June 2021", "probability": 0.045074462890625 }, { "start_logit": 17.46875, "end_logit": 9.984375, "text": "The Advisory Committee on Immunization Practices", "probability": 0.04168701171875 }, { "start_logit": 17.453125, "end_logit": 9.96875, "text": " December 2020", "probability": 0.0404052734375 }, { "start_logit": 17.546875, "end_logit": 9.8046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.037384033203125 }, { "start_logit": 17.453125, "end_logit": 9.8046875, "text": " December 2020\nThe Advisory Committee on Immunization Practices", "probability": 0.034027099609375 }, { "start_logit": 17.234375, "end_logit": 9.96875, "text": " Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020", "probability": 0.032470703125 }, { "start_logit": 16.46875, "end_logit": 10.734375, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.032470703125 }, { "start_logit": 17.546875, "end_logit": 9.4453125, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0264892578125 }, { "start_logit": 17.453125, "end_logit": 9.4453125, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0241241455078125 }, { "start_logit": 16.5, "end_logit": 10.3984375, "text": " 2021", "probability": 0.0241241455078125 }, { "start_logit": 17.15625, "end_logit": 9.671875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.022308349609375 }, { "start_logit": -34.625, "end_logit": 15.9765625, "text": "", "probability": 0.0 } ], "100000000000000000004935": [ { "start_logit": 17.84375, "end_logit": 10.796875, "text": " July 2021", "probability": 0.154541015625 }, { "start_logit": 17.40625, "end_logit": 10.734375, "text": " 2021", "probability": 0.09368896484375 }, { "start_logit": 17.15625, "end_logit": 10.734375, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.072998046875 }, { "start_logit": 17.375, "end_logit": 10.3984375, "text": " September 2021", "probability": 0.0654296875 }, { "start_logit": 16.90625, "end_logit": 10.734375, "text": " February 2021", "probability": 0.056854248046875 }, { "start_logit": 16.78125, "end_logit": 10.796875, "text": " 2021", "probability": 0.05340576171875 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " 2021", "probability": 0.05096435546875 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " June 2021", "probability": 0.05096435546875 }, { "start_logit": 17.46875, "end_logit": 9.984375, "text": "The Advisory Committee on Immunization Practices", "probability": 0.047119140625 }, { "start_logit": 17.453125, "end_logit": 9.96875, "text": " December 2020", "probability": 0.045684814453125 }, { "start_logit": 17.546875, "end_logit": 9.8046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.042236328125 }, { "start_logit": 17.453125, "end_logit": 9.8046875, "text": " December 2020\nThe Advisory Committee on Immunization Practices", "probability": 0.0384521484375 }, { "start_logit": 17.234375, "end_logit": 9.96875, "text": " Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020", "probability": 0.036712646484375 }, { "start_logit": 16.46875, "end_logit": 10.734375, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.036712646484375 }, { "start_logit": 17.546875, "end_logit": 9.4453125, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0299530029296875 }, { "start_logit": 17.453125, "end_logit": 9.4453125, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0272674560546875 }, { "start_logit": 16.5, "end_logit": 10.3984375, "text": " 2021", "probability": 0.0272674560546875 }, { "start_logit": 17.15625, "end_logit": 9.671875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.02520751953125 }, { "start_logit": 17.40625, "end_logit": 9.3125, "text": " 2021\nUpdated Recommendations from the Advisory Committee on Immunization Practices", "probability": 0.022613525390625 }, { "start_logit": 17.375, "end_logit": 9.3046875, "text": " September 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.02191162109375 }, { "start_logit": -33.9375, "end_logit": 14.890625, "text": "", "probability": 0.0 } ], "100000000000000000004936": [ { "start_logit": 17.84375, "end_logit": 10.796875, "text": " July 2021", "probability": 0.1395263671875 }, { "start_logit": 17.9375, "end_logit": 10.359375, "text": " 2021", "probability": 0.09893798828125 }, { "start_logit": 17.40625, "end_logit": 10.734375, "text": " 2021", "probability": 0.08465576171875 }, { "start_logit": 17.15625, "end_logit": 10.734375, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.06591796875 }, { "start_logit": 17.375, "end_logit": 10.3984375, "text": " September 2021", "probability": 0.05908203125 }, { "start_logit": 16.90625, "end_logit": 10.734375, "text": " February 2021", "probability": 0.051361083984375 }, { "start_logit": 16.78125, "end_logit": 10.796875, "text": " 2021", "probability": 0.048248291015625 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " 2021", "probability": 0.046051025390625 }, { "start_logit": 17.078125, "end_logit": 10.453125, "text": " June 2021", "probability": 0.046051025390625 }, { "start_logit": 17.46875, "end_logit": 9.984375, "text": "The Advisory Committee on Immunization Practices", "probability": 0.042572021484375 }, { "start_logit": 17.453125, "end_logit": 9.96875, "text": " December 2020", "probability": 0.041259765625 }, { "start_logit": 17.9375, "end_logit": 9.3984375, "text": " 2021\nThe Advisory Committee on Immunization Practices", "probability": 0.038177490234375 }, { "start_logit": 17.546875, "end_logit": 9.8046875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.038177490234375 }, { "start_logit": 17.453125, "end_logit": 9.8046875, "text": " December 2020\nThe Advisory Committee on Immunization Practices", "probability": 0.03472900390625 }, { "start_logit": 17.234375, "end_logit": 9.96875, "text": " Interim Recommendation for Use of Pfizer-BioNTech COVID-19\nVaccine \u2014 United States, December 2020", "probability": 0.033172607421875 }, { "start_logit": 16.46875, "end_logit": 10.734375, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Janssen COVID-19 Vaccine \u2014\nUnited States, February 2021", "probability": 0.033172607421875 }, { "start_logit": 17.546875, "end_logit": 9.4453125, "text": "The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0270538330078125 }, { "start_logit": 17.453125, "end_logit": 9.4453125, "text": " December 2020\nThe Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Moderna COVID-19 Vaccine\n\u2014 United States, December 2020", "probability": 0.0246429443359375 }, { "start_logit": 16.5, "end_logit": 10.3984375, "text": " 2021", "probability": 0.0246429443359375 }, { "start_logit": 17.15625, "end_logit": 9.671875, "text": "The Advisory Committee on Immunization Practices", "probability": 0.0227813720703125 }, { "start_logit": -39.75, "end_logit": 30.203125, "text": "", "probability": 0.0 } ], "100000000000000000004943": [ { "start_logit": 16.796875, "end_logit": 9.265625, "text": " 1 bivalent mRNA booster", "probability": 0.09698486328125 }, { "start_logit": 16.796875, "end_logit": 9.0078125, "text": " 1 bivalent mRNA", "probability": 0.07550048828125 }, { "start_logit": 16.515625, "end_logit": 9.265625, "text": "New COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA booster", "probability": 0.07318115234375 }, { "start_logit": 17.3125, "end_logit": 8.453125, "text": " Moderna", "probability": 0.07208251953125 }, { "start_logit": 16.84375, "end_logit": 8.921875, "text": "Pfizer-BioNTech", "probability": 0.07208251953125 }, { "start_logit": 16.859375, "end_logit": 8.7109375, "text": "Moderna", "probability": 0.058807373046875 }, { "start_logit": 16.84375, "end_logit": 8.7109375, "text": "Pfizer-BioNTech COVID-19 Vaccine Fact Sheet for Healthcare Providers (fda.gov)\nModerna", "probability": 0.058807373046875 }, { "start_logit": 16.515625, "end_logit": 9.0078125, "text": "New COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA", "probability": 0.0570068359375 }, { "start_logit": 16.796875, "end_logit": 8.5859375, "text": " 1", "probability": 0.04876708984375 }, { "start_logit": 16.0625, "end_logit": 9.265625, "text": " mRNA booster", "probability": 0.0465087890625 }, { "start_logit": 16.046875, "end_logit": 9.265625, "text": " COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA booster", "probability": 0.045806884765625 }, { "start_logit": 16.84375, "end_logit": 8.3203125, "text": "Pfizer", "probability": 0.0391845703125 }, { "start_logit": 16.515625, "end_logit": 8.6328125, "text": "New COVID-19 booster recommendations for people ages 5 years and older", "probability": 0.0391845703125 }, { "start_logit": 16.515625, "end_logit": 8.5859375, "text": "New COVID-19 booster recommendations for people ages 5 years and older to receive 1", "probability": 0.03680419921875 }, { "start_logit": 16.0625, "end_logit": 9.0078125, "text": " mRNA", "probability": 0.035675048828125 }, { "start_logit": 16.046875, "end_logit": 9.0078125, "text": " COVID-19 booster recommendations for people ages 5 years and older to receive 1 bivalent mRNA", "probability": 0.035675048828125 }, { "start_logit": 16.84375, "end_logit": 8.0625, "text": "Pfizer-BioNTech COVID-19", "probability": 0.030517578125 }, { "start_logit": 16.15625, "end_logit": 8.7109375, "text": " COVID-19 Vaccine Fact Sheet for Healthcare Providers (fda.gov)\nModerna", "probability": 0.029571533203125 }, { "start_logit": 16.046875, "end_logit": 8.6328125, "text": " COVID-19 booster recommendations for people ages 5 years and older", "probability": 0.0245208740234375 }, { "start_logit": 16.046875, "end_logit": 8.5859375, "text": " COVID-19 booster recommendations for people ages 5 years and older to receive 1", "probability": 0.023040771484375 }, { "start_logit": 9.046875, "end_logit": -0.211181640625, "text": "", "probability": 0.0 } ], "100000000000000000004954": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -35.0, "end_logit": 17.1875, "text": "", "probability": 0.0 } ], "100000000000000000004959": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.71875, "end_logit": 16.875, "text": "", "probability": 0.0 } ], "100000000000000000004962": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.78125, "end_logit": 16.578125, "text": "", "probability": 0.0 } ], "100000000000000000004963": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -37.8125, "end_logit": 15.59375, "text": "", "probability": 0.0 } ], "100000000000000000004965": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.96875, "end_logit": 17.1875, "text": "", "probability": 0.0 } ], "100000000000000000004968": [ { "start_logit": 18.265625, "end_logit": 8.609375, "text": " 50 years and older", "probability": 0.2196044921875 }, { "start_logit": 17.78125, "end_logit": 8.609375, "text": " adults ages 50 years and older", "probability": 0.13525390625 }, { "start_logit": 17.078125, "end_logit": 8.609375, "text": " 4 months after the first booster\ndose\nAdded guidance that adults ages 50 years and older", "probability": 0.06695556640625 }, { "start_logit": 17.078125, "end_logit": 8.5859375, "text": " 4 months", "probability": 0.06494140625 }, { "start_logit": 18.265625, "end_logit": 7.3515625, "text": " 50 years", "probability": 0.06292724609375 }, { "start_logit": 16.953125, "end_logit": 8.609375, "text": " mRNA COVID-19 vaccine at least 4 months after the first booster\ndose\nAdded guidance that adults ages 50 years and older", "probability": 0.05908203125 }, { "start_logit": 16.953125, "end_logit": 8.5859375, "text": " mRNA COVID-19 vaccine at least 4 months", "probability": 0.05731201171875 }, { "start_logit": 17.5, "end_logit": 8.0078125, "text": " 12 years and older", "probability": 0.0555419921875 }, { "start_logit": 16.90625, "end_logit": 8.3671875, "text": " 4 months", "probability": 0.044586181640625 }, { "start_logit": 16.828125, "end_logit": 8.3671875, "text": " mRNA COVID-19 vaccine at least 4 months", "probability": 0.04058837890625 }, { "start_logit": 17.78125, "end_logit": 7.3515625, "text": " adults ages 50 years", "probability": 0.038177490234375 }, { "start_logit": 18.265625, "end_logit": 6.48046875, "text": " 50 years and older who are not moderately or severely immunocompromised may\nchoose to receive a second booster dose using an mRNA COVID-19 vaccine", "probability": 0.0262298583984375 }, { "start_logit": 17.078125, "end_logit": 7.3515625, "text": " 4 months after the first booster\ndose\nAdded guidance that adults ages 50 years", "probability": 0.019195556640625 }, { "start_logit": 18.265625, "end_logit": 6.125, "text": " 50 years and older who are not moderately or severely immunocompromised may\nchoose to receive a second booster dose using an mRNA", "probability": 0.018310546875 }, { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.0174713134765625 }, { "start_logit": 16.953125, "end_logit": 7.3515625, "text": " mRNA COVID-19 vaccine at least 4 months after the first booster\ndose\nAdded guidance that adults ages 50 years", "probability": 0.0169219970703125 }, { "start_logit": 16.25, "end_logit": 8.0078125, "text": " people ages 12 years and older", "probability": 0.015899658203125 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.01403045654296875 }, { "start_logit": 17.5, "end_logit": 6.6328125, "text": " 12 years and older who are moderately or severely immunocompromised may\nchoose to receive a second booster dose using an mRNA COVID-19 vaccine", "probability": 0.01403045654296875 }, { "start_logit": 16.375, "end_logit": 7.68359375, "text": " 4 months", "probability": 0.01318359375 }, { "start_logit": -43.75, "end_logit": 32.03125, "text": "", "probability": 0.0 } ], "100000000000000000004976": [ { "start_logit": 16.359375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.1519775390625 }, { "start_logit": 16.265625, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.1383056640625 }, { "start_logit": 16.265625, "end_logit": 10.0078125, "text": " 6 months\u20134 years", "probability": 0.12213134765625 }, { "start_logit": 15.9296875, "end_logit": 10.0078125, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.0865478515625 }, { "start_logit": 15.6953125, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07757568359375 }, { "start_logit": 16.375, "end_logit": 9.078125, "text": " 5\u201311 years", "probability": 0.0533447265625 }, { "start_logit": 16.359375, "end_logit": 8.9765625, "text": "MIS-C) and adults\n(MIS-A", "probability": 0.047821044921875 }, { "start_logit": 16.234375, "end_logit": 8.9765625, "text": "MIS-A", "probability": 0.04217529296875 }, { "start_logit": 16.375, "end_logit": 8.609375, "text": " 5\u201311 years\nUpdated guidance that the following people should receive a second COVID-19 booster dose:\nPeople ages 12 years and older", "probability": 0.03338623046875 }, { "start_logit": 15.9375, "end_logit": 8.8359375, "text": " 50 years and older", "probability": 0.0272369384765625 }, { "start_logit": 15.7109375, "end_logit": 9.078125, "text": " Special populations for infants and young children\nNew guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5\u201311 years", "probability": 0.0272369384765625 }, { "start_logit": 16.359375, "end_logit": 8.390625, "text": " 6 months", "probability": 0.0264129638671875 }, { "start_logit": 16.265625, "end_logit": 8.421875, "text": " 6 months", "probability": 0.0247955322265625 }, { "start_logit": 16.265625, "end_logit": 8.390625, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months", "probability": 0.0240325927734375 }, { "start_logit": 16.359375, "end_logit": 8.25, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0229339599609375 }, { "start_logit": 16.359375, "end_logit": 8.140625, "text": "MIS-C) and adults\n(MIS", "probability": 0.02056884765625 }, { "start_logit": 16.359375, "end_logit": 8.1015625, "text": "MIS-C", "probability": 0.0199432373046875 }, { "start_logit": 16.234375, "end_logit": 8.140625, "text": "MIS", "probability": 0.0181427001953125 }, { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.0175933837890625 }, { "start_logit": 16.359375, "end_logit": 7.9921875, "text": "MIS", "probability": 0.0175933837890625 }, { "start_logit": -34.46875, "end_logit": 16.75, "text": "", "probability": 0.0 } ], "100000000000000000004980": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.90625, "end_logit": 17.46875, "text": "", "probability": 0.0 } ], "100000000000000000004982": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.1407470703125 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11309814453125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09375 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.082763671875 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.07769775390625 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.0718994140625 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05096435546875 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.04290771484375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037872314453125 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.0367431640625 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.033935546875 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031402587890625 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.0304412841796875 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.0304412841796875 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.026031494140625 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0222625732421875 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0202789306640625 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.0196533203125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0190582275390625 }, { "start_logit": 13.984375, "end_logit": 8.296875, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months", "probability": 0.01788330078125 }, { "start_logit": -38.25, "end_logit": 24.28125, "text": "", "probability": 0.0 } ], "100000000000000000004983": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.78125, "end_logit": 16.625, "text": "", "probability": 0.0 } ], "100000000000000000004984": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.0, "end_logit": 16.203125, "text": "", "probability": 0.0 } ], "100000000000000000004985": [ { "start_logit": 16.359375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.1519775390625 }, { "start_logit": 16.265625, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.1383056640625 }, { "start_logit": 16.265625, "end_logit": 10.0078125, "text": " 6 months\u20134 years", "probability": 0.12213134765625 }, { "start_logit": 15.9296875, "end_logit": 10.0078125, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.0865478515625 }, { "start_logit": 15.6953125, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07757568359375 }, { "start_logit": 16.375, "end_logit": 9.078125, "text": " 5\u201311 years", "probability": 0.0533447265625 }, { "start_logit": 16.359375, "end_logit": 8.9765625, "text": "MIS-C) and adults\n(MIS-A", "probability": 0.047821044921875 }, { "start_logit": 16.234375, "end_logit": 8.9765625, "text": "MIS-A", "probability": 0.04217529296875 }, { "start_logit": 16.375, "end_logit": 8.609375, "text": " 5\u201311 years\nUpdated guidance that the following people should receive a second COVID-19 booster dose:\nPeople ages 12 years and older", "probability": 0.03338623046875 }, { "start_logit": 15.9375, "end_logit": 8.8359375, "text": " 50 years and older", "probability": 0.0272369384765625 }, { "start_logit": 15.7109375, "end_logit": 9.078125, "text": " Special populations for infants and young children\nNew guidance for use of a Pfizer-BioNTech COVID-19 Vaccine booster dose in children ages 5\u201311 years", "probability": 0.0272369384765625 }, { "start_logit": 16.359375, "end_logit": 8.390625, "text": " 6 months", "probability": 0.0264129638671875 }, { "start_logit": 16.265625, "end_logit": 8.421875, "text": " 6 months", "probability": 0.0247955322265625 }, { "start_logit": 16.265625, "end_logit": 8.390625, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months", "probability": 0.0240325927734375 }, { "start_logit": 16.359375, "end_logit": 8.25, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0229339599609375 }, { "start_logit": 16.359375, "end_logit": 8.140625, "text": "MIS-C) and adults\n(MIS", "probability": 0.02056884765625 }, { "start_logit": 16.359375, "end_logit": 8.1015625, "text": "MIS-C", "probability": 0.0199432373046875 }, { "start_logit": 16.234375, "end_logit": 8.140625, "text": "MIS", "probability": 0.0181427001953125 }, { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.0175933837890625 }, { "start_logit": 16.359375, "end_logit": 7.9921875, "text": "MIS", "probability": 0.0175933837890625 }, { "start_logit": -34.4375, "end_logit": 16.734375, "text": "", "probability": 0.0 } ], "100000000000000000004986": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.1407470703125 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11309814453125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09375 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.082763671875 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.07769775390625 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.0718994140625 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05096435546875 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.04290771484375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037872314453125 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.0367431640625 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.033935546875 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031402587890625 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.0304412841796875 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.0304412841796875 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.026031494140625 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0222625732421875 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0202789306640625 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.0196533203125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0190582275390625 }, { "start_logit": 13.984375, "end_logit": 8.296875, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months", "probability": 0.01788330078125 }, { "start_logit": -34.125, "end_logit": 17.0625, "text": "", "probability": 0.0 } ], "100000000000000000004988": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -35.0, "end_logit": 17.1875, "text": "", "probability": 0.0 } ], "100000000000000000004990": [ { "start_logit": 14.2109375, "end_logit": 10.1328125, "text": " 6 months\u20135 years", "probability": 0.14013671875 }, { "start_logit": 13.984375, "end_logit": 10.1328125, "text": " 6 months\u20134 years\nNew guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.11260986328125 }, { "start_logit": 14.765625, "end_logit": 9.1796875, "text": " 1 bivalent mRNA booster", "probability": 0.09332275390625 }, { "start_logit": 13.984375, "end_logit": 9.8359375, "text": " 6 months\u20134 years", "probability": 0.0823974609375 }, { "start_logit": 14.765625, "end_logit": 8.9921875, "text": " 1 bivalent mRNA", "probability": 0.077392578125 }, { "start_logit": 13.5390625, "end_logit": 10.1328125, "text": "\u20135 years", "probability": 0.07159423828125 }, { "start_logit": 13.4921875, "end_logit": 9.8359375, "text": " 6\u201317 years\nNew guidance for use of Pfizer-BioNTech COVID-19 Vaccine in children ages 6 months\u20134 years", "probability": 0.05072021484375 }, { "start_logit": 14.765625, "end_logit": 8.390625, "text": " 1", "probability": 0.042724609375 }, { "start_logit": 13.859375, "end_logit": 9.1796875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA booster", "probability": 0.037689208984375 }, { "start_logit": 13.828125, "end_logit": 9.1796875, "text": " mRNA booster", "probability": 0.03656005859375 }, { "start_logit": 14.4296875, "end_logit": 8.4921875, "text": "MIS", "probability": 0.0338134765625 }, { "start_logit": 13.859375, "end_logit": 8.9921875, "text": "New booster recommendation for people ages 12 years and older to receive 1 bivalent mRNA", "probability": 0.031280517578125 }, { "start_logit": 14.4296875, "end_logit": 8.3828125, "text": "MIS) in children (MIS-C) and in\nadults (MIS-A", "probability": 0.030303955078125 }, { "start_logit": 13.828125, "end_logit": 8.9921875, "text": " mRNA", "probability": 0.030303955078125 }, { "start_logit": 14.265625, "end_logit": 8.3828125, "text": "MIS-C) and in\nadults (MIS-A", "probability": 0.025909423828125 }, { "start_logit": 14.2109375, "end_logit": 8.296875, "text": " 6 months", "probability": 0.0221710205078125 }, { "start_logit": 14.2109375, "end_logit": 8.28125, "text": " 6 months\u20135 years\nReorganization of sections on COVID-19 vaccination recommendations and schedules\nAddition of new section in Special populations for infants and young children", "probability": 0.0221710205078125 }, { "start_logit": 12.28125, "end_logit": 10.1328125, "text": "New guidance for use of Moderna COVID-19 Vaccine in children ages 6 months\u20135 years", "probability": 0.0201873779296875 }, { "start_logit": 14.4296875, "end_logit": 7.953125, "text": "MIS) in children (MIS", "probability": 0.019561767578125 }, { "start_logit": 13.859375, "end_logit": 8.4765625, "text": "New booster recommendation for people ages 12 years and older", "probability": 0.0189666748046875 }, { "start_logit": -34.71875, "end_logit": 16.921875, "text": "", "probability": 0.0 } ], "100000000000000000004992": [ { "start_logit": 11.921875, "end_logit": 13.234375, "text": " 5 months", "probability": 0.72314453125 }, { "start_logit": 10.1640625, "end_logit": 13.234375, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 0.125732421875 }, { "start_logit": 11.921875, "end_logit": 10.234375, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 0.035980224609375 }, { "start_logit": 11.921875, "end_logit": 9.78125, "text": " 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech", "probability": 0.02288818359375 }, { "start_logit": 11.921875, "end_logit": 9.484375, "text": " 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance", "probability": 0.016998291015625 }, { "start_logit": 10.1640625, "end_logit": 11.2421875, "text": " 12\u201317 years", "probability": 0.016998291015625 }, { "start_logit": 8.0546875, "end_logit": 13.234375, "text": "Updated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 0.01500701904296875 }, { "start_logit": 11.921875, "end_logit": 9.21875, "text": " 5", "probability": 0.0130462646484375 }, { "start_logit": 10.1640625, "end_logit": 10.234375, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine", "probability": 0.006256103515625 }, { "start_logit": 9.5078125, "end_logit": 10.734375, "text": " 12 years and older", "probability": 0.005352020263671875 }, { "start_logit": 10.1640625, "end_logit": 10.0078125, "text": " 12\u201317 years\nUpdated guidance", "probability": 0.004947662353515625 }, { "start_logit": 10.1640625, "end_logit": 9.21875, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5", "probability": 0.0022296905517578125 }, { "start_logit": 8.5078125, "end_logit": 10.7734375, "text": "Updated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years", "probability": 0.0020313262939453125 }, { "start_logit": 7.9375, "end_logit": 11.2421875, "text": "Updated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.001850128173828125 }, { "start_logit": 8.2421875, "end_logit": 10.7734375, "text": " guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years", "probability": 0.0015573501586914062 }, { "start_logit": 7.75390625, "end_logit": 11.2421875, "text": " Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.00153350830078125 }, { "start_logit": 7.65234375, "end_logit": 11.2421875, "text": " guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.0013742446899414062 }, { "start_logit": 7.859375, "end_logit": 10.734375, "text": " Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older", "probability": 0.0010213851928710938 }, { "start_logit": 8.1953125, "end_logit": 10.3359375, "text": "Updated recommendations for people who received COVID-19 vaccines outside the United States", "probability": 0.0009593963623046875 }, { "start_logit": 8.15625, "end_logit": 10.3359375, "text": " Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States", "probability": 0.0009298324584960938 }, { "start_logit": -34.75, "end_logit": 17.6875, "text": "", "probability": 0.0 } ], "100000000000000000004993": [ { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 31.203125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on", "probability": 0.09967041015625 }, { "start_logit": -34.21875, "end_logit": 26.8125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 0.0012350082397460938 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 0.00067138671875 }, { "start_logit": -37.71875, "end_logit": 28.953125, "text": " 5 months", "probability": 0.0003173351287841797 }, { "start_logit": -36.03125, "end_logit": 26.546875, "text": " 3", "probability": 0.00015473365783691406 }, { "start_logit": -36.34375, "end_logit": 26.828125, "text": " 3", "probability": 0.00014984607696533203 }, { "start_logit": -36.3125, "end_logit": 26.75, "text": " 3 months", "probability": 0.00014293193817138672 }, { "start_logit": -34.21875, "end_logit": 24.625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine", "probability": 0.0001386404037475586 }, { "start_logit": -34.21875, "end_logit": 24.625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine", "probability": 0.0001386404037475586 }, { "start_logit": -34.21875, "end_logit": 24.625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine", "probability": 0.0001386404037475586 }, { "start_logit": -34.21875, "end_logit": 24.625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine", "probability": 0.0001386404037475586 }, { "start_logit": -34.21875, "end_logit": 16.90625, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000005000": [ { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1248779296875 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -34.28125, "end_logit": 26.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 7.241964340209961e-05 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 4.673004150390625e-05 }, { "start_logit": -37.4375, "end_logit": 28.796875, "text": " 5 months", "probability": 2.5033950805664062e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.424551010131836e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.424551010131836e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.424551010131836e-05 }, { "start_logit": -34.28125, "end_logit": 17.109375, "text": "", "probability": 0.0 } ], "100000000000000000005002": [ { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.28125, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 6.240606307983398e-05 }, { "start_logit": -37.4375, "end_logit": 28.796875, "text": " 5 months", "probability": 3.337860107421875e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -34.28125, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -36.03125, "end_logit": 26.546875, "text": " 3", "probability": 1.436471939086914e-05 }, { "start_logit": -36.34375, "end_logit": 26.828125, "text": " 3", "probability": 1.3947486877441406e-05 }, { "start_logit": -36.3125, "end_logit": 26.75, "text": " 3 months", "probability": 1.329183578491211e-05 }, { "start_logit": -37.4375, "end_logit": 27.828125, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 1.2695789337158203e-05 }, { "start_logit": -38.78125, "end_logit": 28.796875, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 8.702278137207031e-06 }, { "start_logit": -36.3125, "end_logit": 26.234375, "text": " 3 months (instead of 5 months", "probability": 7.927417755126953e-06 }, { "start_logit": -35.84375, "end_logit": 25.40625, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 5.543231964111328e-06 }, { "start_logit": -37.4375, "end_logit": 26.6875, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 4.0531158447265625e-06 }, { "start_logit": -38.625, "end_logit": 27.828125, "text": "Updated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 3.874301910400391e-06 }, { "start_logit": -34.28125, "end_logit": 17.109375, "text": "", "probability": 0.0 } ], "100000000000000000005005": [ { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -34.9375, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for", "probability": 0.052642822265625 }, { "start_logit": -36.40625, "end_logit": 28.53125, "text": " 5 months", "probability": 2.8192996978759766e-05 }, { "start_logit": -34.9375, "end_logit": 17.671875, "text": "", "probability": 0.0 } ], "100000000000000000005010": [ { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -34.25, "end_logit": 34.15625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.1666259765625 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 6.0439109802246094e-05 }, { "start_logit": -37.4375, "end_logit": 28.796875, "text": " 5 months", "probability": 3.236532211303711e-05 }, { "start_logit": -34.25, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -34.25, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -34.25, "end_logit": 25.078125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance", "probability": 1.901388168334961e-05 }, { "start_logit": -36.03125, "end_logit": 26.546875, "text": " 3", "probability": 1.3947486877441406e-05 }, { "start_logit": -36.34375, "end_logit": 26.828125, "text": " 3", "probability": 1.3470649719238281e-05 }, { "start_logit": -36.3125, "end_logit": 26.75, "text": " 3 months", "probability": 1.2874603271484375e-05 }, { "start_logit": -37.4375, "end_logit": 27.828125, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 1.2278556823730469e-05 }, { "start_logit": -38.78125, "end_logit": 28.796875, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 8.463859558105469e-06 }, { "start_logit": -36.3125, "end_logit": 26.234375, "text": " 3 months (instead of 5 months", "probability": 7.68899917602539e-06 }, { "start_logit": -35.84375, "end_logit": 25.40625, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 5.364418029785156e-06 }, { "start_logit": -37.4375, "end_logit": 26.6875, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 3.933906555175781e-06 }, { "start_logit": -38.625, "end_logit": 27.828125, "text": "Updated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 3.7550926208496094e-06 }, { "start_logit": -34.25, "end_logit": 17.109375, "text": "", "probability": 0.0 } ], "100000000000000000005012": [ { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 33.65625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine", "probability": 0.04998779296875 }, { "start_logit": -34.59375, "end_logit": 17.828125, "text": "", "probability": 0.0 } ], "100000000000000000005015": [ { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -33.71875, "end_logit": 30.25, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses", "probability": 0.076416015625 }, { "start_logit": -34.75, "end_logit": 28.0, "text": " 5 months", "probability": 0.0028705596923828125 }, { "start_logit": -33.71875, "end_logit": 26.0625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines\nUpdated guidance in section on People who received COVID-19 vaccine outside the United States", "probability": 0.0011606216430664062 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 0.0008096694946289062 }, { "start_logit": -36.1875, "end_logit": 28.0, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 0.0006823539733886719 }, { "start_logit": -33.71875, "end_logit": 24.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.0002980232238769531 }, { "start_logit": -33.71875, "end_logit": 24.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.0002980232238769531 }, { "start_logit": -33.71875, "end_logit": 24.703125, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for receipt of a COVID-19 vaccine booster dose\nUpdated guidance for COVID-19 booster doses in recipients of mRNA COVID-19 vaccines", "probability": 0.0002980232238769531 }, { "start_logit": -33.71875, "end_logit": 16.671875, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000005017": [ { "start_logit": 11.921875, "end_logit": 13.234375, "text": " 5 months", "probability": 0.72314453125 }, { "start_logit": 10.1640625, "end_logit": 13.234375, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 0.125732421875 }, { "start_logit": 11.921875, "end_logit": 10.234375, "text": " 5 months after completion of an\nmRNA vaccine", "probability": 0.035980224609375 }, { "start_logit": 11.921875, "end_logit": 9.78125, "text": " 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech", "probability": 0.02288818359375 }, { "start_logit": 11.921875, "end_logit": 9.484375, "text": " 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance", "probability": 0.016998291015625 }, { "start_logit": 10.1640625, "end_logit": 11.2421875, "text": " 12\u201317 years", "probability": 0.016998291015625 }, { "start_logit": 8.0546875, "end_logit": 13.234375, "text": "Updated guidance for administration of a COVID-19 vaccine booster dose at least 5 months", "probability": 0.01500701904296875 }, { "start_logit": 11.921875, "end_logit": 9.21875, "text": " 5", "probability": 0.0130462646484375 }, { "start_logit": 10.1640625, "end_logit": 10.234375, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine", "probability": 0.006256103515625 }, { "start_logit": 9.5078125, "end_logit": 10.734375, "text": " 12 years and older", "probability": 0.005352020263671875 }, { "start_logit": 10.1640625, "end_logit": 10.0078125, "text": " 12\u201317 years\nUpdated guidance", "probability": 0.004947662353515625 }, { "start_logit": 10.1640625, "end_logit": 9.21875, "text": " 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5", "probability": 0.0022296905517578125 }, { "start_logit": 8.5078125, "end_logit": 10.7734375, "text": "Updated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years", "probability": 0.0020313262939453125 }, { "start_logit": 7.9375, "end_logit": 11.2421875, "text": "Updated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.001850128173828125 }, { "start_logit": 8.2421875, "end_logit": 10.7734375, "text": " guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years", "probability": 0.0015573501586914062 }, { "start_logit": 7.75390625, "end_logit": 11.2421875, "text": " Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.00153350830078125 }, { "start_logit": 7.65234375, "end_logit": 11.2421875, "text": " guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years", "probability": 0.0013742446899414062 }, { "start_logit": 7.859375, "end_logit": 10.734375, "text": " Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older", "probability": 0.0010213851928710938 }, { "start_logit": 8.1953125, "end_logit": 10.3359375, "text": "Updated recommendations for people who received COVID-19 vaccines outside the United States", "probability": 0.0009593963623046875 }, { "start_logit": 8.15625, "end_logit": 10.3359375, "text": " Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States", "probability": 0.0009298324584960938 }, { "start_logit": -34.71875, "end_logit": 17.671875, "text": "", "probability": 0.0 } ], "100000000000000000005019": [ { "start_logit": 10.4921875, "end_logit": 7.421875, "text": " COVID-19", "probability": 0.37646484375 }, { "start_logit": 10.4921875, "end_logit": 6.71875, "text": " COVID-19 vaccine outside the United States", "probability": 0.1893310546875 }, { "start_logit": 10.4921875, "end_logit": 6.28515625, "text": " COVID-19 vaccine outside the United States\nUpdated guidance", "probability": 0.12225341796875 }, { "start_logit": 10.4921875, "end_logit": 5.84765625, "text": " COVID-19 vaccine", "probability": 0.07891845703125 }, { "start_logit": 10.171875, "end_logit": 5.90625, "text": " Pfizer-BioNTech", "probability": 0.060516357421875 }, { "start_logit": 9.09375, "end_logit": 6.28515625, "text": "Updated guidance", "probability": 0.02996826171875 }, { "start_logit": 10.171875, "end_logit": 4.99609375, "text": " Pfizer-BioNTech and Moderna", "probability": 0.024444580078125 }, { "start_logit": 8.7421875, "end_logit": 6.28515625, "text": " guidance", "probability": 0.021240234375 }, { "start_logit": 10.171875, "end_logit": 4.7578125, "text": " Pfizer-BioNTech and Moderna\nNew guidance for people who received passive antibody products", "probability": 0.0191802978515625 }, { "start_logit": 8.5703125, "end_logit": 5.90625, "text": " mRNA COVID-19 vaccines: Pfizer-BioNTech", "probability": 0.01219940185546875 }, { "start_logit": 9.5, "end_logit": 4.7578125, "text": "New guidance for people who received passive antibody products", "probability": 0.00980377197265625 }, { "start_logit": 8.734375, "end_logit": 5.3359375, "text": "Updated guidance", "probability": 0.00812530517578125 }, { "start_logit": 8.6484375, "end_logit": 5.40625, "text": "Updated guidance", "probability": 0.00799560546875 }, { "start_logit": 8.6484375, "end_logit": 5.3359375, "text": "Updated guidance in section on People who received COVID-19 as part of a clinical trial in the United States\nUpdated guidance", "probability": 0.007457733154296875 }, { "start_logit": 8.609375, "end_logit": 5.3359375, "text": " People who received COVID-19 as part of a clinical trial in the United States\nUpdated guidance", "probability": 0.007167816162109375 }, { "start_logit": 8.6484375, "end_logit": 5.06640625, "text": "Updated guidance in section on People who received COVID-19 as part of a clinical trial in the United States", "probability": 0.00571441650390625 }, { "start_logit": 8.609375, "end_logit": 5.06640625, "text": " People who received COVID-19 as part of a clinical trial in the United States", "probability": 0.00545501708984375 }, { "start_logit": 8.734375, "end_logit": 4.890625, "text": "Updated guidance on Considerations for COVID-19 vaccination in moderately and severely immunocompromised\npeople\nUpdated guidance", "probability": 0.0052032470703125 }, { "start_logit": 8.5703125, "end_logit": 4.99609375, "text": " mRNA COVID-19 vaccines: Pfizer-BioNTech and Moderna", "probability": 0.00489044189453125 }, { "start_logit": 8.5703125, "end_logit": 4.7578125, "text": " mRNA COVID-19 vaccines: Pfizer-BioNTech and Moderna\nNew guidance for people who received passive antibody products", "probability": 0.00386810302734375 }, { "start_logit": -41.5, "end_logit": 26.40625, "text": "", "probability": 0.0 } ], "100000000000000000005022": [ { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 34.59375, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated recommendations for", "probability": 0.04998779296875 }, { "start_logit": -35.0625, "end_logit": 17.9375, "text": "", "probability": 0.0 } ], "100000000000000000005024": [ { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -34.09375, "end_logit": 28.296875, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen", "probability": 0.08514404296875 }, { "start_logit": -35.84375, "end_logit": 27.828125, "text": " 5 months", "probability": 0.0092620849609375 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 25.765625, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson", "probability": 0.006778717041015625 }, { "start_logit": -34.09375, "end_logit": 17.34375, "text": "", "probability": 1.4901161193847656e-06 } ], "100000000000000000005027": [ { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 35.0, "text": "Added considerations for an 8-week interval between the first and second doses of a primary mRNA vaccine schedule\f10/30/22, 9:16 AM Interim Clinical Considerations for Use of COVID-19 Vaccines: Appendices, References, and Previous Updates | CDC\nUpdated guidance for moderately or severely immunocompromised people\nClarification of existing recommendation to receive a 3-dose mRNA vaccine primary series followed by a booster\ndose for a total of 4 doses\nNew guidance to shorten the interval between completion of the mRNA vaccine primary series and the booster\ndose to at least 3 months (instead of 5 months)\nNew guidance for those who received the Janssen COVID-19 Vaccine primary series to receive an additional dose\nand a booster dose, for a total of 3 doses to be up to date\nUpdated guidance that it is no longer necessary to delay COVID-19 vaccination following receipt of monoclonal\nantibodies or convalescent plasma\nUpdated guidance on receiving a booster dose if vaccinated outside the United States\nUpdated contraindication and precaution section to include history of myocarditis or pericarditis after an mRNA\nCOVID-19 vaccine as a precaution\nReorganized and condensed multiple sections\nUpdated guidance for use of Pfizer-BioNTech COVID-19 Vaccine as a booster in people ages 12\u201317 years\nUpdated guidance for administration of a COVID-19 vaccine booster dose at least 5 months after completion of an\nmRNA vaccine (Pfizer-BioNTech or Moderna) primary series\nUpdated guidance for use of an additional primary dose for moderately or severely immunocompromised people ages\n5\u201311 years who received a Pfizer-BioNTech vaccine primary series\nUpdated recommendations for people who received COVID-19 vaccines outside the United States that are not FDA-\nauthorized or approved\nUpdated information about a second formulation of Pfizer-BioNTech COVID-19 Vaccine that is authorized for use in\npersons ages 12 years and older\nUpdated information on vaccinating people during quarantine after a known SARS-CoV-2 exposure or during COVID-\nUpdate to alert providers of possible false positive Rapid Plasma Reagin (RPR; non-treponemal) test results in some\npeople after COVID-19 vaccines\nUpdated information on vaccine administration errors and deviations\nUpdated guidance on use of Janssen (Johnson & Johnson) COVID-19 Vaccine\nUpdated", "probability": 0.04998779296875 }, { "start_logit": -34.78125, "end_logit": 17.96875, "text": "", "probability": 0.0 } ], "100000000000000000005029": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 7.015625, "end_logit": -0.6708984375, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000005032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 6.8828125, "end_logit": -0.623046875, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000005034": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 7.00390625, "end_logit": -0.634765625, "text": "", "probability": 0.998285961520812 } ], "100000000000000000005039": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999938465318 }, { "start_logit": -34.21875, "end_logit": 15.3125, "text": "", "probability": 6.1534680336516355e-09 } ], "100000000000000000005041": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999934496673 }, { "start_logit": -34.15625, "end_logit": 15.3203125, "text": "", "probability": 6.550332622350746e-09 } ], "100000000000000000005042": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999940358542 }, { "start_logit": -34.09375, "end_logit": 15.15625, "text": "", "probability": 5.964145726632109e-09 } ], "100000000000000000005054": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999945695834 }, { "start_logit": -34.53125, "end_logit": 15.5, "text": "", "probability": 5.4304164837773595e-09 } ], "100000000000000000005058": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 6.79296875, "end_logit": -0.30517578125, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000005059": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 6.84765625, "end_logit": -0.321044921875, "text": "", "probability": 0.998539250425049 } ], "100000000000000000005061": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018243827852769423 }, { "start_logit": 7.125, "end_logit": -0.82177734375, "text": "", "probability": 0.998175617214723 } ], "100000000000000000005063": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018243827852769423 }, { "start_logit": 7.09375, "end_logit": -0.791015625, "text": "", "probability": 0.998175617214723 } ], "100000000000000000005067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004503272417089224 }, { "start_logit": 5.36328125, "end_logit": 0.03436279296875, "text": "", "probability": 0.9954967275829107 } ], "100000000000000000005070": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00517971277035707 }, { "start_logit": 5.2265625, "end_logit": 0.031646728515625, "text": "", "probability": 0.9948202872296429 } ], "100000000000000000005080": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999925775007 }, { "start_logit": -34.90625, "end_logit": 16.1875, "text": "", "probability": 7.4224992716162615e-09 } ], "100000000000000000005082": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999923418853 }, { "start_logit": -34.90625, "end_logit": 16.21875, "text": "", "probability": 7.658114688852598e-09 } ], "100000000000000000005089": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023781237181166506 }, { "start_logit": 6.8671875, "end_logit": -0.82666015625, "text": "", "probability": 0.9976218762818835 } ], "100000000000000000005094": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027149854690051763 }, { "start_logit": 6.390625, "end_logit": -0.4833984375, "text": "", "probability": 0.9972850145309949 } ], "100000000000000000005098": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.73828125, "end_logit": -0.1788330078125, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000005099": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 6.72265625, "end_logit": -0.09088134765625, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000005105": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.19140625, "end_logit": -0.6650390625, "text": "", "probability": 0.998539250425049 } ], "100000000000000000005109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027362210991480392 }, { "start_logit": 5.78515625, "end_logit": 0.11328125, "text": "", "probability": 0.997263778900852 } ], "100000000000000000005111": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008693673928062171 }, { "start_logit": 7.5703125, "end_logit": -0.52294921875, "text": "", "probability": 0.9991306326071938 } ], "100000000000000000005112": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.484375, "end_logit": -0.40478515625, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000005117": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002225670854115196 }, { "start_logit": 6.99609375, "end_logit": -0.88916015625, "text": "", "probability": 0.9977743291458849 } ], "100000000000000000005118": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024726231566347748 }, { "start_logit": 6.93359375, "end_logit": -0.93310546875, "text": "", "probability": 0.9975273768433653 } ], "100000000000000000005120": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006905414693000791 }, { "start_logit": 7.76171875, "end_logit": -0.483154296875, "text": "", "probability": 0.9993094585307 } ], "100000000000000000005124": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 7.78125, "end_logit": -0.477783203125, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000005126": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 8.1953125, "end_logit": -0.8798828125, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000005128": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007069056122424319 }, { "start_logit": 8.109375, "end_logit": -0.8544921875, "text": "", "probability": 0.9992930943877577 } ], "100000000000000000005130": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006905414693000791 }, { "start_logit": 8.15625, "end_logit": -0.87939453125, "text": "", "probability": 0.9993094585307 } ], "100000000000000000005134": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006263341581094201 }, { "start_logit": 8.09375, "end_logit": -0.71728515625, "text": "", "probability": 0.9993736658418905 } ], "100000000000000000005136": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000602354126495203 }, { "start_logit": 8.125, "end_logit": -0.7119140625, "text": "", "probability": 0.9993976458735048 } ], "100000000000000000005138": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006166297347617124 }, { "start_logit": 8.09375, "end_logit": -0.701171875, "text": "", "probability": 0.9993833702652382 } ], "100000000000000000005140": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006386796026437197 }, { "start_logit": 8.0703125, "end_logit": -0.71533203125, "text": "", "probability": 0.9993613203973564 } ], "100000000000000000005146": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 7.0078125, "end_logit": -0.6064453125, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000005148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 7.4296875, "end_logit": -0.93701171875, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000005156": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006487308181403439 }, { "start_logit": 7.50390625, "end_logit": -0.1646728515625, "text": "", "probability": 0.9993512691818597 } ], "100000000000000000005157": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 7.55859375, "end_logit": -0.2410888671875, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000005161": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 7.50390625, "end_logit": -0.82666015625, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000005162": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012743262913872736 }, { "start_logit": 7.453125, "end_logit": -0.7890625, "text": "", "probability": 0.9987256737086126 } ], "100000000000000000005163": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.55859375, "end_logit": -0.8291015625, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000005172": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000593021029357059 }, { "start_logit": 7.921875, "end_logit": -0.493408203125, "text": "", "probability": 0.999406978970643 } ], "100000000000000000005173": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005703157070783359 }, { "start_logit": 7.79296875, "end_logit": -0.32470703125, "text": "", "probability": 0.9994296842929216 } ], "100000000000000000005174": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005815576348560962 }, { "start_logit": 7.74609375, "end_logit": -0.29638671875, "text": "", "probability": 0.9994184423651439 } ], "100000000000000000005177": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046552691875201524 }, { "start_logit": 8.140625, "end_logit": -0.4677734375, "text": "", "probability": 0.9995344730812479 } ], "100000000000000000005179": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004897656064061081 }, { "start_logit": 8.0703125, "end_logit": -0.449462890625, "text": "", "probability": 0.9995102343935939 } ], "100000000000000000005181": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006287840192903181 }, { "start_logit": 7.828125, "end_logit": -0.457763671875, "text": "", "probability": 0.9993712159807097 } ], "100000000000000000005183": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000631243456875032 }, { "start_logit": 7.80859375, "end_logit": -0.44189453125, "text": "", "probability": 0.9993687565431251 } ], "100000000000000000005187": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00033666221188972684 }, { "start_logit": 8.1171875, "end_logit": -0.119384765625, "text": "", "probability": 0.9996633377881102 } ], "100000000000000000005189": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003640086870995012 }, { "start_logit": 8.0625, "end_logit": -0.1458740234375, "text": "", "probability": 0.9996359913129005 } ], "100000000000000000005190": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003275842978596865 }, { "start_logit": 8.171875, "end_logit": -0.1453857421875, "text": "", "probability": 0.9996724157021403 } ], "100000000000000000005191": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999978059133 }, { "start_logit": -33.8125, "end_logit": 13.8671875, "text": "", "probability": 2.1940866052503023e-09 } ], "100000000000000000005195": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.94921875, "end_logit": -0.75537109375, "text": "", "probability": 0.997965182999252 } ], "100000000000000000005204": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000631243456875032 }, { "start_logit": 7.94140625, "end_logit": -0.576171875, "text": "", "probability": 0.9993687565431251 } ], "100000000000000000005210": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003982130906163543 }, { "start_logit": 8.109375, "end_logit": -0.280029296875, "text": "", "probability": 0.9996017869093836 } ], "100000000000000000005216": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.41796875, "end_logit": -0.630859375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000005217": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.44921875, "end_logit": -0.6611328125, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000005221": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 7.3828125, "end_logit": -0.62841796875, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000005222": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.4765625, "end_logit": -0.55224609375, "text": "", "probability": 0.999018828118793 } ], "100000000000000000005225": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.5546875, "end_logit": -0.57275390625, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000005226": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.40625, "end_logit": -0.5400390625, "text": "", "probability": 0.998959681497187 } ], "100000000000000000005227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.49609375, "end_logit": -0.5478515625, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000005231": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004339325170191996 }, { "start_logit": 8.5078125, "end_logit": -0.76611328125, "text": "", "probability": 0.9995660674829807 } ], "100000000000000000005236": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00041568947702267777 }, { "start_logit": 8.609375, "end_logit": -0.8251953125, "text": "", "probability": 0.9995843105229772 } ], "100000000000000000005237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 6.9609375, "end_logit": -0.077880859375, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000005241": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.05078125, "end_logit": -0.0667724609375, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000005242": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009697519677825861 }, { "start_logit": 7.0390625, "end_logit": -0.10028076171875, "text": "", "probability": 0.9990302480322174 } ], "100000000000000000005244": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.0390625, "end_logit": -0.08111572265625, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000005246": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003175087886569813 }, { "start_logit": 7.6015625, "end_logit": 0.450439453125, "text": "", "probability": 0.9996824912113431 } ], "100000000000000000005248": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006142271998613951 }, { "start_logit": 8.7890625, "end_logit": -1.3955078125, "text": "", "probability": 0.9993857728001386 } ], "100000000000000000005249": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 8.65625, "end_logit": -1.3662109375, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000005256": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990563351 }, { "start_logit": -33.6875, "end_logit": 12.8984375, "text": "", "probability": 9.43664891198282e-10 } ], "100000000000000000005257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989796549 }, { "start_logit": -33.6875, "end_logit": 12.984375, "text": "", "probability": 1.0203450311454508e-09 } ], "100000000000000000005258": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989472657 }, { "start_logit": -33.6875, "end_logit": 13.015625, "text": "", "probability": 1.052734259224688e-09 } ], "100000000000000000005259": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998995474 }, { "start_logit": -33.65625, "end_logit": 12.9375, "text": "", "probability": 1.0045260476947595e-09 } ], "100000000000000000005260": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998769229 }, { "start_logit": -33.78125, "end_logit": 13.265625, "text": "", "probability": 1.2307710411550491e-09 } ], "100000000000000000005262": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021997980436915168 }, { "start_logit": 6.28125, "end_logit": -0.1646728515625, "text": "", "probability": 0.9978002019563085 } ], "100000000000000000005263": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 6.34765625, "end_logit": -0.11053466796875, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000005264": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 6.44921875, "end_logit": -0.10760498046875, "text": "", "probability": 0.998238530319926 } ], "100000000000000000005266": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990563351 }, { "start_logit": -33.59375, "end_logit": 12.8203125, "text": "", "probability": 9.43664891198282e-10 } ], "100000000000000000005270": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998995474 }, { "start_logit": -33.59375, "end_logit": 12.875, "text": "", "probability": 1.0045260476947595e-09 } ], "100000000000000000005271": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990263799 }, { "start_logit": -33.59375, "end_logit": 12.84375, "text": "", "probability": 9.736200303530205e-10 } ], "100000000000000000005273": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009697519677825861 }, { "start_logit": 7.5703125, "end_logit": -0.63232421875, "text": "", "probability": 0.9990302480322174 } ], "100000000000000000005275": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.5546875, "end_logit": -0.6318359375, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000005285": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.140625, "end_logit": -0.23291015625, "text": "", "probability": 0.99899949559909 } ], "100000000000000000005290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.1484375, "end_logit": -0.2410888671875, "text": "", "probability": 0.99899949559909 } ], "100000000000000000005293": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0032350559690690625 }, { "start_logit": 6.23828125, "end_logit": -0.50927734375, "text": "", "probability": 0.996764944030931 } ], "100000000000000000005296": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.8046875, "end_logit": -0.849609375, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000005298": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.76171875, "end_logit": -0.77490234375, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000005305": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 7.1171875, "end_logit": -0.77734375, "text": "", "probability": 0.998238530319926 } ], "100000000000000000005306": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 7.0078125, "end_logit": -0.74853515625, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000005313": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030396496140834887 }, { "start_logit": 6.87109375, "end_logit": -1.0771484375, "text": "", "probability": 0.9969603503859165 } ], "100000000000000000005317": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002621440946167595 }, { "start_logit": 6.84375, "end_logit": -0.90185546875, "text": "", "probability": 0.9973785590538324 } ], "100000000000000000005318": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973534264 }, { "start_logit": -34.125, "end_logit": 14.375, "text": "", "probability": 2.646573631904765e-09 } ], "100000000000000000005322": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999974746219 }, { "start_logit": -34.125, "end_logit": 14.328125, "text": "", "probability": 2.525378201847876e-09 } ], "100000000000000000005327": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999938465318 }, { "start_logit": -34.375, "end_logit": 15.4609375, "text": "", "probability": 6.1534680336516355e-09 } ], "100000000000000000005328": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.16796875, "end_logit": -0.61865234375, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000005331": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014048677545435851 }, { "start_logit": 7.1796875, "end_logit": -0.61279296875, "text": "", "probability": 0.9985951322454563 } ], "100000000000000000005332": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 7.2265625, "end_logit": -0.6376953125, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000005334": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986692192 }, { "start_logit": -34.0, "end_logit": 13.5625, "text": "", "probability": 1.330780797297989e-09 } ], "100000000000000000005336": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986692192 }, { "start_logit": -34.0625, "end_logit": 13.625, "text": "", "probability": 1.330780797297989e-09 } ], "100000000000000000005339": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999984441597 }, { "start_logit": -34.09375, "end_logit": 13.8046875, "text": "", "probability": 1.5558403775790826e-09 } ], "100000000000000000005340": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999985833912 }, { "start_logit": -34.0625, "end_logit": 13.6796875, "text": "", "probability": 1.4166087846364157e-09 } ], "100000000000000000005345": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 7.3203125, "end_logit": -0.5361328125, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000005349": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 6.97265625, "end_logit": -0.4736328125, "text": "", "probability": 0.998498817743263 } ], "100000000000000000005354": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.35546875, "end_logit": -0.599609375, "text": "", "probability": 0.99883958037482 } ], "100000000000000000005360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 6.859375, "end_logit": -0.6220703125, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000005363": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 6.8984375, "end_logit": -0.66162109375, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000005365": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 6.69140625, "end_logit": -0.5185546875, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000005368": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999985384231 }, { "start_logit": -33.75, "end_logit": 13.4140625, "text": "", "probability": 1.4615767744882139e-09 } ], "100000000000000000005371": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007236572645054245 }, { "start_logit": 8.1171875, "end_logit": -0.88623046875, "text": "", "probability": 0.9992763427354946 } ], "100000000000000000005374": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007014082876992124 }, { "start_logit": 8.15625, "end_logit": -0.8955078125, "text": "", "probability": 0.9992985917123008 } ], "100000000000000000005376": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007124459916397521 }, { "start_logit": 7.73046875, "end_logit": -0.485595703125, "text": "", "probability": 0.9992875540083602 } ], "100000000000000000005379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007180297626119062 }, { "start_logit": 7.73828125, "end_logit": -0.5, "text": "", "probability": 0.9992819702373881 } ], "100000000000000000005380": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.62109375, "end_logit": -0.473388671875, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000005390": [ { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 22.546875, "text": "K", "probability": 0.052581787109375 }, { "start_logit": 11.6953125, "end_logit": 17.9375, "text": "KEE", "probability": 0.0005154609680175781 }, { "start_logit": 11.6953125, "end_logit": -2.150390625, "text": "", "probability": 0.0 } ], "100000000000000000005395": [ { "start_logit": 11.1484375, "end_logit": 20.0625, "text": " a vaccination card", "probability": 0.990234375 }, { "start_logit": 11.1484375, "end_logit": 15.4609375, "text": " a vaccination", "probability": 0.009857177734375 }, { "start_logit": 10.9921875, "end_logit": -1.8642578125, "text": "", "probability": 0.0 } ], "100000000000000000005402": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.23828125, "end_logit": -0.41455078125, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000005404": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.5625, "end_logit": -0.7333984375, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000005405": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.55078125, "end_logit": -0.77197265625, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000005409": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.19140625, "end_logit": -0.4599609375, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000005410": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012743262913872736 }, { "start_logit": 7.20703125, "end_logit": -0.5439453125, "text": "", "probability": 0.9987256737086126 } ], "100000000000000000005413": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.11328125, "end_logit": -0.4130859375, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000005414": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 6.93359375, "end_logit": -0.1552734375, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000005415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 6.921875, "end_logit": -0.160400390625, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000005416": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 6.765625, "end_logit": -0.266845703125, "text": "", "probability": 0.998498817743263 } ], "100000000000000000005417": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 6.94140625, "end_logit": -0.1708984375, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000005419": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020992734296664648 }, { "start_logit": 6.93359375, "end_logit": -0.767578125, "text": "", "probability": 0.9979007265703336 } ], "100000000000000000005420": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 6.98828125, "end_logit": -0.8154296875, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000005421": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021742253421720634 }, { "start_logit": 6.9375, "end_logit": -0.80810546875, "text": "", "probability": 0.9978257746578281 } ], "100000000000000000005427": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025212683210456455 }, { "start_logit": 6.24609375, "end_logit": -0.265380859375, "text": "", "probability": 0.9974787316789544 } ], "100000000000000000005436": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.75390625, "end_logit": -0.426025390625, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000005438": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016103573704565953 }, { "start_logit": 6.8125, "end_logit": -0.38330078125, "text": "", "probability": 0.9983896426295433 } ], "100000000000000000005447": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000859247658728013 }, { "start_logit": 7.70703125, "end_logit": -0.6494140625, "text": "", "probability": 0.999140752341272 } ], "100000000000000000005455": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.57421875, "end_logit": -0.56787109375, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000005459": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005274784125231481 }, { "start_logit": 7.44140625, "end_logit": 0.1053466796875, "text": "", "probability": 0.9994725215874769 } ], "100000000000000000005461": [ { "start_logit": 15.1796875, "end_logit": 10.4453125, "text": "People", "probability": 0.13818359375 }, { "start_logit": 15.1875, "end_logit": 10.359375, "text": "Fast-beating or pounding heart", "probability": 0.1278076171875 }, { "start_logit": 15.1015625, "end_logit": 10.359375, "text": "Respiratory and heart symptoms\nDifficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding heart", "probability": 0.11822509765625 }, { "start_logit": 15.1015625, "end_logit": 10.0078125, "text": "Respiratory and heart", "probability": 0.08251953125 }, { "start_logit": 14.328125, "end_logit": 10.359375, "text": "Chest pain\nFast-beating or pounding heart", "probability": 0.05413818359375 }, { "start_logit": 14.296875, "end_logit": 10.359375, "text": "Difficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding heart", "probability": 0.052490234375 }, { "start_logit": 15.1875, "end_logit": 9.4375, "text": "Fast-beating or pounding heart (also known as heart palpitations", "probability": 0.05084228515625 }, { "start_logit": 13.921875, "end_logit": 10.421875, "text": "Symptoms that get worse after physical or mental effort (also known as \u201cpost-exertional malaise", "probability": 0.038360595703125 }, { "start_logit": 15.1875, "end_logit": 9.1171875, "text": "Fast-beating or pounding", "probability": 0.037200927734375 }, { "start_logit": 15.1796875, "end_logit": 9.140625, "text": "People who experience post-COVID", "probability": 0.037200927734375 }, { "start_logit": 15.1875, "end_logit": 9.078125, "text": "Fast-beating or pounding heart (also known as heart", "probability": 0.035491943359375 }, { "start_logit": 15.1015625, "end_logit": 9.1171875, "text": "Respiratory and heart symptoms\nDifficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding", "probability": 0.03387451171875 }, { "start_logit": 15.1796875, "end_logit": 8.9921875, "text": "People who experience post-COVID conditions most commonly report:\nGeneral symptoms\nTiredness or fatigue that interferes with daily life", "probability": 0.032318115234375 }, { "start_logit": 15.1015625, "end_logit": 8.8671875, "text": "Respiratory and heart symptoms", "probability": 0.0263671875 }, { "start_logit": 13.53125, "end_logit": 10.421875, "text": " worse after physical or mental effort (also known as \u201cpost-exertional malaise", "probability": 0.025970458984375 }, { "start_logit": 13.84375, "end_logit": 10.0078125, "text": "Fever\nRespiratory and heart", "probability": 0.023284912109375 }, { "start_logit": 13.921875, "end_logit": 9.875, "text": "Symptoms that get worse after physical or mental effort (also known as \u201cpost-exertional malaise\u201d)\nFever", "probability": 0.022216796875 }, { "start_logit": 14.328125, "end_logit": 9.4375, "text": "Chest pain\nFast-beating or pounding heart (also known as heart palpitations", "probability": 0.0215301513671875 }, { "start_logit": 14.6015625, "end_logit": 9.140625, "text": "\nGeneral symptoms\nTiredness or fatigue that interferes with daily life\nSymptoms that get worse after physical or mental effort", "probability": 0.0211944580078125 }, { "start_logit": 13.84375, "end_logit": 9.875, "text": "Fever", "probability": 0.0205535888671875 }, { "start_logit": 8.7734375, "end_logit": -0.333984375, "text": "", "probability": 0.0 } ], "100000000000000000005466": [ { "start_logit": 15.1796875, "end_logit": 10.4453125, "text": "People", "probability": 0.13916015625 }, { "start_logit": 15.1875, "end_logit": 10.359375, "text": "Fast-beating or pounding heart", "probability": 0.128662109375 }, { "start_logit": 15.0859375, "end_logit": 10.359375, "text": "Respiratory and heart symptoms\nDifficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding heart", "probability": 0.1153564453125 }, { "start_logit": 15.0859375, "end_logit": 10.0078125, "text": "Respiratory and heart", "probability": 0.081787109375 }, { "start_logit": 14.3203125, "end_logit": 10.359375, "text": "Chest pain\nFast-beating or pounding heart", "probability": 0.054473876953125 }, { "start_logit": 14.3046875, "end_logit": 10.359375, "text": "Difficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding heart", "probability": 0.052825927734375 }, { "start_logit": 15.1875, "end_logit": 9.4375, "text": "Fast-beating or pounding heart (also known as heart palpitations", "probability": 0.051177978515625 }, { "start_logit": 13.921875, "end_logit": 10.421875, "text": "Symptoms that get worse after physical or mental effort (also known as \u201cpost-exertional malaise", "probability": 0.03863525390625 }, { "start_logit": 15.1796875, "end_logit": 9.1484375, "text": "People who experience post-COVID", "probability": 0.038055419921875 }, { "start_logit": 15.1875, "end_logit": 9.1171875, "text": "Fast-beating or pounding", "probability": 0.037445068359375 }, { "start_logit": 15.1875, "end_logit": 9.078125, "text": "Fast-beating or pounding heart (also known as heart", "probability": 0.035736083984375 }, { "start_logit": 15.0859375, "end_logit": 9.1171875, "text": "Respiratory and heart symptoms\nDifficulty breathing or shortness of breath\nCough\nChest pain\nFast-beating or pounding", "probability": 0.0335693359375 }, { "start_logit": 15.1796875, "end_logit": 8.984375, "text": "People who experience post-COVID conditions most commonly report:\nGeneral symptoms\nTiredness or fatigue that interferes with daily life", "probability": 0.03204345703125 }, { "start_logit": 15.0859375, "end_logit": 8.8671875, "text": "Respiratory and heart symptoms", "probability": 0.0261383056640625 }, { "start_logit": 13.53125, "end_logit": 10.421875, "text": " worse after physical or mental effort (also known as \u201cpost-exertional malaise", "probability": 0.0261383056640625 }, { "start_logit": 13.84375, "end_logit": 10.0078125, "text": "Fever\nRespiratory and heart", "probability": 0.0234375 }, { "start_logit": 13.921875, "end_logit": 9.875, "text": "Symptoms that get worse after physical or mental effort (also known as \u201cpost-exertional malaise\u201d)\nFever", "probability": 0.022369384765625 }, { "start_logit": 14.3203125, "end_logit": 9.4375, "text": "Chest pain\nFast-beating or pounding heart (also known as heart palpitations", "probability": 0.021331787109375 }, { "start_logit": 14.59375, "end_logit": 9.140625, "text": "\nGeneral symptoms\nTiredness or fatigue that interferes with daily life\nSymptoms that get worse after physical or mental effort", "probability": 0.0210113525390625 }, { "start_logit": 13.84375, "end_logit": 9.875, "text": "Fever", "probability": 0.02069091796875 }, { "start_logit": 8.796875, "end_logit": -0.34375, "text": "", "probability": 0.0 } ], "100000000000000000005483": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.47265625, "end_logit": -0.401123046875, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000005484": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000788545769594649 }, { "start_logit": 7.45703125, "end_logit": -0.311767578125, "text": "", "probability": 0.9992114542304054 } ], "100000000000000000005485": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008328334044949594 }, { "start_logit": 7.4296875, "end_logit": -0.3408203125, "text": "", "probability": 0.999167166595505 } ], "100000000000000000005486": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009927261432440737 }, { "start_logit": 7.73828125, "end_logit": -0.82275390625, "text": "", "probability": 0.9990072738567558 } ], "100000000000000000005488": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.625, "end_logit": -0.74365234375, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000005494": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.2109375, "end_logit": -0.5146484375, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000005496": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.2265625, "end_logit": -0.5205078125, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000005501": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008864989276457546 }, { "start_logit": 7.0234375, "end_logit": 0.00377655029296875, "text": "", "probability": 0.9991135010723542 } ], "100000000000000000005506": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999683912 }, { "start_logit": -33.28125, "end_logit": 11.40625, "text": "", "probability": 3.160881453314576e-10 } ], "100000000000000000005507": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996936368 }, { "start_logit": -33.28125, "end_logit": 11.3671875, "text": "", "probability": 3.063631354822167e-10 } ], "100000000000000000005513": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.265625, "end_logit": -0.457275390625, "text": "", "probability": 0.998896973358602 } ], "100000000000000000005514": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007124459916397521 }, { "start_logit": 7.80859375, "end_logit": -0.56201171875, "text": "", "probability": 0.9992875540083602 } ], "100000000000000000005518": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006411777211655285 }, { "start_logit": 7.75390625, "end_logit": -0.40283203125, "text": "", "probability": 0.9993588222788345 } ], "100000000000000000005519": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006214630161383599 }, { "start_logit": 7.73828125, "end_logit": -0.354736328125, "text": "", "probability": 0.9993785369838617 } ], "100000000000000000005520": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.6953125, "end_logit": -0.477783203125, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000005524": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008040859356292355 }, { "start_logit": 7.765625, "end_logit": -0.64208984375, "text": "", "probability": 0.9991959140643708 } ], "100000000000000000005530": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.25390625, "end_logit": -0.1842041015625, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000005536": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003487043026945987 }, { "start_logit": 8.0, "end_logit": -0.038787841796875, "text": "", "probability": 0.9996512956973053 } ], "100000000000000000005539": [ { "start_logit": 14.6796875, "end_logit": 8.921875, "text": " professional medical groups", "probability": 0.481689453125 }, { "start_logit": 14.2734375, "end_logit": 8.921875, "text": "Collaborate with professional medical groups", "probability": 0.32080078125 }, { "start_logit": 14.2734375, "end_logit": 7.453125, "text": "Collaborate", "probability": 0.0738525390625 }, { "start_logit": 14.2734375, "end_logit": 7.26953125, "text": "Coll", "probability": 0.06219482421875 }, { "start_logit": 14.2734375, "end_logit": 7.265625, "text": "Collabor", "probability": 0.06121826171875 }, { "start_logit": 7.82421875, "end_logit": -0.94384765625, "text": "", "probability": 0.0 } ], "100000000000000000005541": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.82421875, "end_logit": -0.9658203125, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000005545": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.48828125, "end_logit": -0.60107421875, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000005547": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.51953125, "end_logit": -0.626953125, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000005548": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.44140625, "end_logit": -0.583984375, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000005550": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006094501590135561 }, { "start_logit": 7.8046875, "end_logit": -0.403076171875, "text": "", "probability": 0.9993905498409864 } ], "100000000000000000005551": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006337125082498782 }, { "start_logit": 7.81640625, "end_logit": -0.45361328125, "text": "", "probability": 0.9993662874917502 } ], "100000000000000000005552": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006238938360910443 }, { "start_logit": 7.7890625, "end_logit": -0.409423828125, "text": "", "probability": 0.9993761061639089 } ], "100000000000000000005561": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.265625, "end_logit": -0.87109375, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000005565": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.17578125, "end_logit": -0.537109375, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000005573": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006190416612984411 }, { "start_logit": 7.7578125, "end_logit": -0.3720703125, "text": "", "probability": 0.9993809583387016 } ], "100000000000000000005575": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005792916699214215 }, { "start_logit": 7.7890625, "end_logit": -0.3359375, "text": "", "probability": 0.9994207083300786 } ], "100000000000000000005576": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005747861775648728 }, { "start_logit": 7.8671875, "end_logit": -0.406005859375, "text": "", "probability": 0.9994252138224351 } ], "100000000000000000005578": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.7421875, "end_logit": -0.44384765625, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000005581": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006932422985664928 }, { "start_logit": 7.78515625, "end_logit": -0.51171875, "text": "", "probability": 0.9993067577014336 } ], "100000000000000000005588": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025212683210456455 }, { "start_logit": 6.15234375, "end_logit": -0.1732177734375, "text": "", "probability": 0.9974787316789544 } ], "100000000000000000005595": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001294368035454269 }, { "start_logit": 6.33984375, "end_logit": 0.30859375, "text": "", "probability": 0.9987056319645456 } ], "100000000000000000005596": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.234375, "end_logit": 0.208984375, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000005600": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009362828177560106 }, { "start_logit": 7.78515625, "end_logit": -0.8115234375, "text": "", "probability": 0.9990637171822441 } ], "100000000000000000005604": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.2109375, "end_logit": -0.44140625, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000005612": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006487308181403439 }, { "start_logit": 8.0078125, "end_logit": -0.66943359375, "text": "", "probability": 0.9993512691818597 } ], "100000000000000000005614": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006851713149506406 }, { "start_logit": 7.95703125, "end_logit": -0.67236328125, "text": "", "probability": 0.9993148286850494 } ], "100000000000000000005615": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.9140625, "end_logit": -0.71142578125, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000005620": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999920987906 }, { "start_logit": -34.1875, "end_logit": 15.5234375, "text": "", "probability": 7.901209342174968e-09 } ], "100000000000000000005622": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003514382632807918 }, { "start_logit": 7.671875, "end_logit": 0.281982421875, "text": "", "probability": 0.9996485617367191 } ], "100000000000000000005625": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.48046875, "end_logit": -0.6826171875, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000005626": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.39453125, "end_logit": -0.66357421875, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000005633": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.328125, "end_logit": -0.52783203125, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000005634": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 7.5546875, "end_logit": -0.48291015625, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000005637": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000800953612508541 }, { "start_logit": 7.59375, "end_logit": -0.463134765625, "text": "", "probability": 0.9991990463874916 } ], "100000000000000000005641": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003053489321118595 }, { "start_logit": 7.80859375, "end_logit": 0.285400390625, "text": "", "probability": 0.999694651067888 } ], "100000000000000000005643": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 7.55859375, "end_logit": -0.3427734375, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000005645": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.58984375, "end_logit": -0.36767578125, "text": "", "probability": 0.999270671160687 } ], "100000000000000000005646": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007524628013059865 }, { "start_logit": 7.48828125, "end_logit": -0.29638671875, "text": "", "probability": 0.9992475371986941 } ], "100000000000000000005651": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999979388463 }, { "start_logit": -33.84375, "end_logit": 13.8359375, "text": "", "probability": 2.0611536181902033e-09 } ], "100000000000000000005655": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999980637253 }, { "start_logit": -33.84375, "end_logit": 13.78125, "text": "", "probability": 1.9362746336349366e-09 } ], "100000000000000000005659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006166297347617124 }, { "start_logit": 8.1796875, "end_logit": -0.791015625, "text": "", "probability": 0.9993833702652382 } ], "100000000000000000005660": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006070755804415096 }, { "start_logit": 8.25, "end_logit": -0.84228515625, "text": "", "probability": 0.9993929244195585 } ], "100000000000000000005663": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 8.109375, "end_logit": -0.822265625, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000005664": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008459375275953215 }, { "start_logit": 7.328125, "end_logit": -0.2529296875, "text": "", "probability": 0.9991540624724046 } ], "100000000000000000005673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000900446683890779 }, { "start_logit": 7.42578125, "end_logit": -0.414306640625, "text": "", "probability": 0.9990995533161093 } ], "100000000000000000005675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.6171875, "end_logit": -0.630859375, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000005680": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009622125595974061 }, { "start_logit": 7.625, "end_logit": -0.6787109375, "text": "", "probability": 0.9990377874404025 } ], "100000000000000000005681": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006214630161383599 }, { "start_logit": 7.77734375, "end_logit": -0.392822265625, "text": "", "probability": 0.9993785369838617 } ], "100000000000000000005686": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00040765259231579384 }, { "start_logit": 7.953125, "end_logit": -0.1480712890625, "text": "", "probability": 0.9995923474076841 } ], "100000000000000000005687": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00043055708132461493 }, { "start_logit": 7.9453125, "end_logit": -0.19677734375, "text": "", "probability": 0.9995694429186754 } ], "100000000000000000005689": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999975137741 }, { "start_logit": -33.75, "end_logit": 13.9296875, "text": "", "probability": 2.4862258419077007e-09 } ], "100000000000000000005691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999972694151 }, { "start_logit": -33.8125, "end_logit": 14.0859375, "text": "", "probability": 2.730584896949298e-09 } ], "100000000000000000005696": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0001355207856240677 }, { "start_logit": 8.1328125, "end_logit": 0.77587890625, "text": "", "probability": 0.9998644792143758 } ], "100000000000000000005706": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009362828177560106 }, { "start_logit": 7.39453125, "end_logit": -0.42236328125, "text": "", "probability": 0.9990637171822441 } ], "100000000000000000005708": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.3828125, "end_logit": -0.413330078125, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000005715": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.734375, "end_logit": -0.74072265625, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000005719": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.63671875, "end_logit": -0.75146484375, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000005720": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.71484375, "end_logit": -0.748046875, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000005727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020033332861764124 }, { "start_logit": 6.94140625, "end_logit": -0.72998046875, "text": "", "probability": 0.9979966667138236 } ], "100000000000000000005729": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001980039959665187 }, { "start_logit": 6.84765625, "end_logit": -0.62353515625, "text": "", "probability": 0.9980199600403347 } ], "100000000000000000005730": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020190139004485808 }, { "start_logit": 6.80859375, "end_logit": -0.60595703125, "text": "", "probability": 0.9979809860995514 } ], "100000000000000000005731": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.83984375, "end_logit": -0.6513671875, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000005734": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.06640625, "end_logit": -0.58935546875, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000005737": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0511774944058295 }, { "start_logit": 6.078125, "end_logit": -3.158203125, "text": "", "probability": 0.9488225055941706 } ], "100000000000000000005739": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.02615561835382285 }, { "start_logit": 5.08203125, "end_logit": -1.46484375, "text": "", "probability": 0.9738443816461771 } ], "100000000000000000005746": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994094697 }, { "start_logit": -33.75, "end_logit": 12.5078125, "text": "", "probability": 5.905303995456778e-10 } ], "100000000000000000005747": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999977006169 }, { "start_logit": -34.03125, "end_logit": 14.140625, "text": "", "probability": 2.2993830197054193e-09 } ], "100000000000000000005753": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999977006169 }, { "start_logit": -34.03125, "end_logit": 14.140625, "text": "", "probability": 2.2993830197054193e-09 } ], "100000000000000000005760": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.012920473039078976 }, { "start_logit": 4.921875, "end_logit": -0.58740234375, "text": "", "probability": 0.9870795269609209 } ], "100000000000000000005763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.012007350547633841 }, { "start_logit": 4.93359375, "end_logit": -0.52294921875, "text": "", "probability": 0.9879926494523661 } ], "100000000000000000005764": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.012527931992744795 }, { "start_logit": 4.90625, "end_logit": -0.5400390625, "text": "", "probability": 0.9874720680072551 } ], "100000000000000000005765": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.012870749215746782 }, { "start_logit": 4.9453125, "end_logit": -0.6064453125, "text": "", "probability": 0.9871292507842533 } ], "100000000000000000005766": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007702931971871536 }, { "start_logit": 6.97265625, "end_logit": 0.1962890625, "text": "", "probability": 0.9992297068028129 } ], "100000000000000000005767": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.01953125, "end_logit": 0.07476806640625, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000005772": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.1796875, "end_logit": -0.286865234375, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000005773": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.23046875, "end_logit": -0.27734375, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000005780": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017683516861090472 }, { "start_logit": 6.828125, "end_logit": -0.494140625, "text": "", "probability": 0.998231648313891 } ], "100000000000000000005782": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018458483368165377 }, { "start_logit": 7.046875, "end_logit": -0.7529296875, "text": "", "probability": 0.9981541516631836 } ], "100000000000000000005783": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 7.109375, "end_logit": -0.765625, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000005785": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018895386578398716 }, { "start_logit": 7.07421875, "end_logit": -0.8037109375, "text": "", "probability": 0.9981104613421601 } ], "100000000000000000005786": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 7.10546875, "end_logit": -0.7939453125, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000005787": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019267346633274755 }, { "start_logit": 7.0546875, "end_logit": -0.8046875, "text": "", "probability": 0.9980732653366725 } ], "100000000000000000005788": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018243827852769423 }, { "start_logit": 7.10546875, "end_logit": -0.8017578125, "text": "", "probability": 0.998175617214723 } ], "100000000000000000005790": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 6.91015625, "end_logit": -0.578125, "text": "", "probability": 0.998224739467894 } ], "100000000000000000005794": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.06640625, "end_logit": -0.323974609375, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000005796": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 6.94140625, "end_logit": -0.3046875, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000005797": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 6.93359375, "end_logit": -0.376953125, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000005798": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.06640625, "end_logit": -0.34423828125, "text": "", "probability": 0.998798108681489 } ], "100000000000000000005800": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 6.64453125, "end_logit": -0.1326904296875, "text": "", "probability": 0.998516281097091 } ], "100000000000000000005802": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 6.62890625, "end_logit": -0.139892578125, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000005803": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002511463513809854 }, { "start_logit": 6.2734375, "end_logit": -0.29052734375, "text": "", "probability": 0.9974885364861902 } ], "100000000000000000005805": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024630070555115235 }, { "start_logit": 6.2265625, "end_logit": -0.2210693359375, "text": "", "probability": 0.9975369929444886 } ], "100000000000000000005807": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002580904163589908 }, { "start_logit": 6.17578125, "end_logit": -0.21923828125, "text": "", "probability": 0.9974190958364102 } ], "100000000000000000005813": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.578125, "end_logit": -0.458984375, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000005814": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008040859356292355 }, { "start_logit": 7.68359375, "end_logit": -0.56005859375, "text": "", "probability": 0.9991959140643708 } ], "100000000000000000005818": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.50390625, "end_logit": -0.70458984375, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000005829": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.01953125, "end_logit": -0.365966796875, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000005831": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 7.19140625, "end_logit": -0.67822265625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000005833": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 7.18359375, "end_logit": -0.67041015625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000005836": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993308415 }, { "start_logit": -33.84375, "end_logit": 12.7109375, "text": "", "probability": 6.69158608681505e-10 } ], "100000000000000000005840": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991135089 }, { "start_logit": -34.03125, "end_logit": 13.1796875, "text": "", "probability": 8.864911257608076e-10 } ], "100000000000000000005841": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999967062858 }, { "start_logit": -34.15625, "end_logit": 14.625, "text": "", "probability": 3.293714099457528e-09 } ], "100000000000000000005843": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970010391 }, { "start_logit": -34.125, "end_logit": 14.4921875, "text": "", "probability": 2.998960815863541e-09 } ], "100000000000000000005846": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970933076 }, { "start_logit": -34.125, "end_logit": 14.4765625, "text": "", "probability": 2.9066924918954316e-09 } ], "100000000000000000005847": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.57421875, "end_logit": -0.6494140625, "text": "", "probability": 0.999018828118793 } ], "100000000000000000005850": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.48828125, "end_logit": -0.49951171875, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000005854": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.15625, "end_logit": -0.6279296875, "text": "", "probability": 0.998539250425049 } ], "100000000000000000005855": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.265625, "end_logit": -0.6220703125, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000005859": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 6.9609375, "end_logit": -0.317626953125, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000005862": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00643810255548328 }, { "start_logit": 5.1171875, "end_logit": -0.07818603515625, "text": "", "probability": 0.9935618974445167 } ], "100000000000000000005864": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.008187909901696235 }, { "start_logit": 4.98046875, "end_logit": -0.185302734375, "text": "", "probability": 0.9918120900983038 } ], "100000000000000000005865": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.007518718061432194 }, { "start_logit": 4.91015625, "end_logit": -0.02777099609375, "text": "", "probability": 0.9924812819385679 } ], "100000000000000000005867": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 7.2421875, "end_logit": -0.79736328125, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000005869": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 7.21484375, "end_logit": -0.82861328125, "text": "", "probability": 0.998319058298613 } ], "100000000000000000005877": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020748668989992733 }, { "start_logit": 6.9921875, "end_logit": -0.81640625, "text": "", "probability": 0.9979251331010007 } ], "100000000000000000005881": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 6.796875, "end_logit": -0.39599609375, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000005887": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999998818865 }, { "start_logit": -32.84375, "end_logit": 9.984375, "text": "", "probability": 1.1811351053963882e-10 } ], "100000000000000000005889": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973944578 }, { "start_logit": -34.09375, "end_logit": 14.328125, "text": "", "probability": 2.6055423109896135e-09 } ], "100000000000000000005890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999977362657 }, { "start_logit": -34.125, "end_logit": 14.2109375, "text": "", "probability": 2.263734390291422e-09 } ], "100000000000000000005896": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.008779108866911802 }, { "start_logit": 5.30859375, "end_logit": -0.58349609375, "text": "", "probability": 0.9912208911330882 } ], "100000000000000000005897": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.009055264186722086 }, { "start_logit": 5.26953125, "end_logit": -0.572265625, "text": "", "probability": 0.9909447358132779 } ], "100000000000000000005903": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970010391 }, { "start_logit": -34.375, "end_logit": 14.7421875, "text": "", "probability": 2.998960815863541e-09 } ], "100000000000000000005904": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999996905842 }, { "start_logit": -34.375, "end_logit": 14.7890625, "text": "", "probability": 3.094158050820784e-09 } ], "100000000000000000005905": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970010391 }, { "start_logit": -34.375, "end_logit": 14.7421875, "text": "", "probability": 2.998960815863541e-09 } ], "100000000000000000005909": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995746569 }, { "start_logit": -33.5625, "end_logit": 11.984375, "text": "", "probability": 4.253430907053031e-10 } ], "100000000000000000005910": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029810327298548972 }, { "start_logit": 6.21875, "end_logit": -0.408203125, "text": "", "probability": 0.9970189672701452 } ], "100000000000000000005911": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0032603461032026495 }, { "start_logit": 6.1953125, "end_logit": -0.471923828125, "text": "", "probability": 0.9967396538967973 } ], "100000000000000000005914": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030634168488034644 }, { "start_logit": 6.1953125, "end_logit": -0.411865234375, "text": "", "probability": 0.9969365831511966 } ], "100000000000000000005919": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999943089724 }, { "start_logit": -34.125, "end_logit": 15.140625, "text": "", "probability": 5.69102761071833e-09 } ], "100000000000000000005923": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.37890625, "end_logit": -0.6552734375, "text": "", "probability": 0.998798108681489 } ], "100000000000000000005928": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.15234375, "end_logit": -0.6181640625, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000005929": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.25, "end_logit": -0.60888671875, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000005930": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 7.18359375, "end_logit": -0.62158203125, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000005934": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.15625, "end_logit": -0.60009765625, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000005936": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 6.95703125, "end_logit": -0.41748046875, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000005944": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 7.30078125, "end_logit": -0.7314453125, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000005951": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002946404975477049 }, { "start_logit": 6.2734375, "end_logit": -0.450439453125, "text": "", "probability": 0.9970535950245228 } ], "100000000000000000005955": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991672186 }, { "start_logit": -33.875, "end_logit": 12.96875, "text": "", "probability": 8.327813436526549e-10 } ], "100000000000000000005957": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990853685 }, { "start_logit": -33.84375, "end_logit": 13.0390625, "text": "", "probability": 9.146313747844331e-10 } ], "100000000000000000005960": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.33984375, "end_logit": -0.39111328125, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000005964": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021742253421720634 }, { "start_logit": 6.66015625, "end_logit": -0.53271484375, "text": "", "probability": 0.9978257746578281 } ], "100000000000000000005965": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020427647806347724 }, { "start_logit": 6.7421875, "end_logit": -0.54931640625, "text": "", "probability": 0.9979572352193652 } ], "100000000000000000005970": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 6.94921875, "end_logit": -0.5107421875, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000005971": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.8828125, "end_logit": -0.48291015625, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000005978": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.02734375, "end_logit": -0.0789794921875, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000005981": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008626077580284025 }, { "start_logit": 7.1171875, "end_logit": -0.06304931640625, "text": "", "probability": 0.9991373922419715 } ], "100000000000000000005983": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024630070555115235 }, { "start_logit": 6.44140625, "end_logit": -0.437255859375, "text": "", "probability": 0.9975369929444886 } ], "100000000000000000005985": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 6.4765625, "end_logit": -0.41455078125, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000005986": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021912406363963407 }, { "start_logit": 6.5703125, "end_logit": -0.450439453125, "text": "", "probability": 0.9978087593636037 } ], "100000000000000000005988": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.12890625, "end_logit": -0.6611328125, "text": "", "probability": 0.998451238905712 } ], "100000000000000000005990": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016941031558503918 }, { "start_logit": 7.0234375, "end_logit": -0.64453125, "text": "", "probability": 0.9983058968441496 } ], "100000000000000000005992": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024534282596974846 }, { "start_logit": 6.23046875, "end_logit": -0.22265625, "text": "", "probability": 0.9975465717403025 } ], "100000000000000000005993": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025311113093281793 }, { "start_logit": 6.15234375, "end_logit": -0.1741943359375, "text": "", "probability": 0.9974688886906717 } ], "100000000000000000005998": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 7.54296875, "end_logit": -1.0009765625, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000006000": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 7.546875, "end_logit": -0.978515625, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000006001": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001524786391225749 }, { "start_logit": 7.4140625, "end_logit": -0.93017578125, "text": "", "probability": 0.9984752136087741 } ], "100000000000000000006004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.65625, "end_logit": -0.66650390625, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000006017": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996361848 }, { "start_logit": -33.09375, "end_logit": 11.359375, "text": "", "probability": 3.63815225159663e-10 } ], "100000000000000000006018": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996635258 }, { "start_logit": -33.125, "end_logit": 11.3203125, "text": "", "probability": 3.364740792281002e-10 } ], "100000000000000000006019": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995679587 }, { "start_logit": -33.09375, "end_logit": 11.5234375, "text": "", "probability": 4.320412697441966e-10 } ], "100000000000000000006024": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002790037654330648 }, { "start_logit": 6.01171875, "end_logit": -0.134521484375, "text": "", "probability": 0.9972099623456693 } ], "100000000000000000006030": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999980637253 }, { "start_logit": -33.96875, "end_logit": 13.8984375, "text": "", "probability": 1.9362746336349366e-09 } ], "100000000000000000006031": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.546875, "end_logit": -0.68798828125, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000006032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.640625, "end_logit": -0.7431640625, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000006037": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.64453125, "end_logit": -0.76220703125, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000006038": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999966017321 }, { "start_logit": -33.71875, "end_logit": 14.2265625, "text": "", "probability": 3.3982678079468468e-09 } ], "100000000000000000006041": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999968076227 }, { "start_logit": -33.65625, "end_logit": 14.0859375, "text": "", "probability": 3.1923771703810644e-09 } ], "100000000000000000006046": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0034296039240944865 }, { "start_logit": 5.765625, "end_logit": -0.09222412109375, "text": "", "probability": 0.9965703960759055 } ], "100000000000000000006047": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 7.9453125, "end_logit": -0.62890625, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000006049": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 7.80078125, "end_logit": -0.58642578125, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000006050": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007096703991005882 }, { "start_logit": 7.890625, "end_logit": -0.64013671875, "text": "", "probability": 0.9992903296008995 } ], "100000000000000000006053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001455062938532843 }, { "start_logit": 6.69140625, "end_logit": -0.160888671875, "text": "", "probability": 0.9985449370614672 } ], "100000000000000000006056": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016356753292389016 }, { "start_logit": 6.62890625, "end_logit": -0.2166748046875, "text": "", "probability": 0.998364324670761 } ], "100000000000000000006058": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022961590064970627 }, { "start_logit": 6.41796875, "end_logit": -0.344482421875, "text": "", "probability": 0.9977038409935028 } ], "100000000000000000006062": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024726231566347748 }, { "start_logit": 6.3671875, "end_logit": -0.36669921875, "text": "", "probability": 0.9975273768433653 } ], "100000000000000000006063": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.1171875, "end_logit": -0.638671875, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000006066": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021912406363963407 }, { "start_logit": 6.71875, "end_logit": -0.5966796875, "text": "", "probability": 0.9978087593636037 } ], "100000000000000000006067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.84375, "end_logit": -0.6484375, "text": "", "probability": 0.997965182999252 } ], "100000000000000000006068": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001964661439513743 }, { "start_logit": 6.828125, "end_logit": -0.59814453125, "text": "", "probability": 0.9980353385604862 } ], "100000000000000000006073": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006411777211655285 }, { "start_logit": 8.0234375, "end_logit": -0.6708984375, "text": "", "probability": 0.9993588222788345 } ], "100000000000000000006075": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 8.09375, "end_logit": -0.75146484375, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000006083": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 7.1796875, "end_logit": -0.84765625, "text": "", "probability": 0.998224739467894 } ], "100000000000000000006084": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018969200744787132 }, { "start_logit": 7.03515625, "end_logit": -0.77001953125, "text": "", "probability": 0.9981030799255213 } ], "100000000000000000006087": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030873693457091405 }, { "start_logit": 6.37109375, "end_logit": -0.59326171875, "text": "", "probability": 0.9969126306542909 } ], "100000000000000000006088": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027791905585136147 }, { "start_logit": 6.40234375, "end_logit": -0.51953125, "text": "", "probability": 0.9972208094414864 } ], "100000000000000000006092": [ { "start_logit": 17.40625, "end_logit": 11.21875, "text": "Advisory\nCommittee on Immunization Practices meeting", "probability": 0.49365234375 }, { "start_logit": 17.40625, "end_logit": 10.3984375, "text": "Advisory\nCommittee on Immunization Practices", "probability": 0.2191162109375 }, { "start_logit": 17.40625, "end_logit": 9.640625, "text": "Advisory\nCommittee", "probability": 0.1019287109375 }, { "start_logit": 15.40625, "end_logit": 11.21875, "text": "Committee on Immunization Practices meeting", "probability": 0.06683349609375 }, { "start_logit": 15.40625, "end_logit": 10.3984375, "text": "Committee on Immunization Practices", "probability": 0.0296478271484375 }, { "start_logit": 17.40625, "end_logit": 7.68359375, "text": "Advisory\nCommit", "probability": 0.0144500732421875 }, { "start_logit": 15.40625, "end_logit": 9.640625, "text": "Committee", "probability": 0.01378631591796875 }, { "start_logit": 17.40625, "end_logit": 7.26953125, "text": "Advisory", "probability": 0.0094757080078125 }, { "start_logit": 13.265625, "end_logit": 11.21875, "text": "\nCommittee on Immunization Practices meeting", "probability": 0.0078582763671875 }, { "start_logit": 17.40625, "end_logit": 7.02734375, "text": "Advisory\nCommittee on Immunization Practices meeting, November 19, 2021:", "probability": 0.007495880126953125 }, { "start_logit": 17.40625, "end_logit": 6.90625, "text": "Advisory\nCommittee on Immunization", "probability": 0.00661468505859375 }, { "start_logit": 16.9375, "end_logit": 7.02734375, "text": " November 19, 2021:", "probability": 0.004688262939453125 }, { "start_logit": 12.65625, "end_logit": 11.21875, "text": " meeting", "probability": 0.0042724609375 }, { "start_logit": 17.40625, "end_logit": 6.3828125, "text": "Advisory\nCommittee on Immunization Practices meeting, November 19, 2021:\nDisanto G, Sacco R, Bernasconi", "probability": 0.0038909912109375 }, { "start_logit": 17.40625, "end_logit": 6.3046875, "text": "Advisory\nCommittee on Immunization Practices meeting, November", "probability": 0.00365447998046875 }, { "start_logit": 13.265625, "end_logit": 10.3984375, "text": "\nCommittee on Immunization Practices", "probability": 0.0034313201904296875 }, { "start_logit": 16.9375, "end_logit": 6.3828125, "text": " November 19, 2021:\nDisanto G, Sacco R, Bernasconi", "probability": 0.00243377685546875 }, { "start_logit": 16.9375, "end_logit": 6.3046875, "text": " November", "probability": 0.0022869110107421875 }, { "start_logit": 17.40625, "end_logit": 5.7578125, "text": "Ad", "probability": 0.0020809173583984375 }, { "start_logit": 15.40625, "end_logit": 7.68359375, "text": "Commit", "probability": 0.0019550323486328125 }, { "start_logit": 7.58203125, "end_logit": -0.96728515625, "text": "", "probability": 0.0 } ], "100000000000000000006093": [ { "start_logit": 17.40625, "end_logit": 11.21875, "text": "Advisory\nCommittee on Immunization Practices meeting", "probability": 0.49560546875 }, { "start_logit": 17.40625, "end_logit": 10.3984375, "text": "Advisory\nCommittee on Immunization Practices", "probability": 0.219970703125 }, { "start_logit": 17.40625, "end_logit": 9.640625, "text": "Advisory\nCommittee", "probability": 0.102294921875 }, { "start_logit": 15.40625, "end_logit": 11.21875, "text": "Committee on Immunization Practices meeting", "probability": 0.06707763671875 }, { "start_logit": 15.40625, "end_logit": 10.3984375, "text": "Committee on Immunization Practices", "probability": 0.0297698974609375 }, { "start_logit": 17.40625, "end_logit": 7.68359375, "text": "Advisory\nCommit", "probability": 0.01450347900390625 }, { "start_logit": 15.40625, "end_logit": 9.640625, "text": "Committee", "probability": 0.0138397216796875 }, { "start_logit": 17.40625, "end_logit": 7.26953125, "text": "Advisory", "probability": 0.00951385498046875 }, { "start_logit": 13.265625, "end_logit": 11.21875, "text": "\nCommittee on Immunization Practices meeting", "probability": 0.0078887939453125 }, { "start_logit": 17.40625, "end_logit": 7.02734375, "text": "Advisory\nCommittee on Immunization Practices meeting, November 19, 2021:", "probability": 0.007526397705078125 }, { "start_logit": 17.40625, "end_logit": 6.90625, "text": "Advisory\nCommittee on Immunization", "probability": 0.006641387939453125 }, { "start_logit": 16.9375, "end_logit": 7.02734375, "text": " November 19, 2021:", "probability": 0.00470733642578125 }, { "start_logit": 12.65625, "end_logit": 11.21875, "text": " meeting", "probability": 0.0042877197265625 }, { "start_logit": 17.40625, "end_logit": 6.3046875, "text": "Advisory\nCommittee on Immunization Practices meeting, November", "probability": 0.0036678314208984375 }, { "start_logit": 13.265625, "end_logit": 10.3984375, "text": "\nCommittee on Immunization Practices", "probability": 0.003444671630859375 }, { "start_logit": 16.9375, "end_logit": 6.3046875, "text": " November", "probability": 0.0022945404052734375 }, { "start_logit": 17.40625, "end_logit": 5.7578125, "text": "Ad", "probability": 0.0020885467529296875 }, { "start_logit": 15.40625, "end_logit": 7.68359375, "text": "Commit", "probability": 0.0019626617431640625 }, { "start_logit": 13.265625, "end_logit": 9.640625, "text": "\nCommittee", "probability": 0.0016279220581054688 }, { "start_logit": 15.40625, "end_logit": 7.02734375, "text": "Committee on Immunization Practices meeting, November 19, 2021:", "probability": 0.001018524169921875 }, { "start_logit": 7.34765625, "end_logit": -0.9482421875, "text": "", "probability": 0.0 } ], "100000000000000000006098": [ { "start_logit": 17.40625, "end_logit": 11.2265625, "text": "Advisory\nCommittee on Immunization Practices meeting", "probability": 0.50146484375 }, { "start_logit": 17.40625, "end_logit": 10.390625, "text": "Advisory\nCommittee on Immunization Practices", "probability": 0.2188720703125 }, { "start_logit": 17.40625, "end_logit": 9.6484375, "text": "Advisory\nCommittee", "probability": 0.10504150390625 }, { "start_logit": 15.421875, "end_logit": 11.2265625, "text": "Committee on Immunization Practices meeting", "probability": 0.07000732421875 }, { "start_logit": 15.421875, "end_logit": 10.390625, "text": "Committee on Immunization Practices", "probability": 0.0301055908203125 }, { "start_logit": 17.40625, "end_logit": 7.6796875, "text": "Advisory\nCommit", "probability": 0.01467132568359375 }, { "start_logit": 15.421875, "end_logit": 9.6484375, "text": "Committee", "probability": 0.01422119140625 }, { "start_logit": 17.40625, "end_logit": 7.26953125, "text": "Advisory", "probability": 0.00962066650390625 }, { "start_logit": 13.2578125, "end_logit": 11.2265625, "text": "\nCommittee on Immunization Practices meeting", "probability": 0.0079803466796875 }, { "start_logit": 17.40625, "end_logit": 6.90234375, "text": "Advisory\nCommittee on Immunization", "probability": 0.0067138671875 }, { "start_logit": 12.6640625, "end_logit": 11.2265625, "text": " meeting", "probability": 0.004405975341796875 }, { "start_logit": 17.40625, "end_logit": 6.31640625, "text": "Advisory\nCommittee on Immunization Practices meeting, November", "probability": 0.0037097930908203125 }, { "start_logit": 13.2578125, "end_logit": 10.390625, "text": "\nCommittee on Immunization Practices", "probability": 0.003482818603515625 }, { "start_logit": 16.9375, "end_logit": 6.31640625, "text": " November", "probability": 0.0023212432861328125 }, { "start_logit": 17.40625, "end_logit": 5.7578125, "text": "Ad", "probability": 0.00211334228515625 }, { "start_logit": 15.421875, "end_logit": 7.6796875, "text": "Commit", "probability": 0.0019855499267578125 }, { "start_logit": 13.2578125, "end_logit": 9.6484375, "text": "\nCommittee", "probability": 0.0016460418701171875 }, { "start_logit": 15.421875, "end_logit": 6.90234375, "text": "Committee on Immunization", "probability": 0.0009236335754394531 }, { "start_logit": 15.421875, "end_logit": 6.31640625, "text": "Committee on Immunization Practices meeting, November", "probability": 0.0005102157592773438 }, { "start_logit": 13.2578125, "end_logit": 7.6796875, "text": "\nCommit", "probability": 0.00022983551025390625 }, { "start_logit": 7.26953125, "end_logit": -0.93896484375, "text": "", "probability": 0.0 } ], "100000000000000000006106": [ { "start_logit": 20.078125, "end_logit": 9.1171875, "text": "Three-dose mRNA-1273", "probability": 0.340087890625 }, { "start_logit": 20.078125, "end_logit": 8.5546875, "text": "Three-dose mRNA", "probability": 0.19384765625 }, { "start_logit": 20.078125, "end_logit": 8.4296875, "text": "Three-dose", "probability": 0.171142578125 }, { "start_logit": 20.078125, "end_logit": 7.6875, "text": "Three-dose mRNA-1273 vaccination", "probability": 0.08203125 }, { "start_logit": 18.046875, "end_logit": 9.1171875, "text": " mRNA-1273", "probability": 0.044647216796875 }, { "start_logit": 20.078125, "end_logit": 6.58984375, "text": "Three-dose mRNA-12", "probability": 0.027496337890625 }, { "start_logit": 18.046875, "end_logit": 8.5546875, "text": " mRNA", "probability": 0.0254364013671875 }, { "start_logit": 20.078125, "end_logit": 6.171875, "text": "Three", "probability": 0.018035888671875 }, { "start_logit": 20.078125, "end_logit": 6.0390625, "text": "Three-dose mRNA-1273 vaccination schedule: sufficient\nantibody response in majority of immunocompromised", "probability": 0.0159149169921875 }, { "start_logit": 16.9375, "end_logit": 9.1171875, "text": "-dose mRNA-1273", "probability": 0.01495361328125 }, { "start_logit": 18.046875, "end_logit": 7.73046875, "text": " mRNA-1273 vaccination schedule: sufficient\nantibody response in majority of immunocompromised hematology patients. medRxiv. 2022", "probability": 0.01128387451171875 }, { "start_logit": 18.046875, "end_logit": 7.6875, "text": " mRNA-1273 vaccination", "probability": 0.01076507568359375 }, { "start_logit": 17.546875, "end_logit": 7.98046875, "text": " 2022;", "probability": 0.0087890625 }, { "start_logit": 16.9375, "end_logit": 8.5546875, "text": "-dose mRNA", "probability": 0.00852203369140625 }, { "start_logit": 16.9375, "end_logit": 8.4296875, "text": "-dose", "probability": 0.00751495361328125 }, { "start_logit": 17.875, "end_logit": 7.0546875, "text": "Joint Committee on Vaccination and Immunisation", "probability": 0.004852294921875 }, { "start_logit": 16.9375, "end_logit": 7.73046875, "text": "-dose mRNA-1273 vaccination schedule: sufficient\nantibody response in majority of immunocompromised hematology patients. medRxiv. 2022", "probability": 0.0037212371826171875 }, { "start_logit": 18.046875, "end_logit": 6.58984375, "text": " mRNA-12", "probability": 0.003604888916015625 }, { "start_logit": 17.578125, "end_logit": 7.0546875, "text": " Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nJoint Committee on Vaccination and Immunisation", "probability": 0.003551483154296875 }, { "start_logit": 16.9375, "end_logit": 7.6875, "text": "-dose mRNA-1273 vaccination", "probability": 0.003551483154296875 }, { "start_logit": 8.234375, "end_logit": -0.994140625, "text": "", "probability": 0.0 } ], "100000000000000000006110": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999999869535 }, { "start_logit": -11.3046875, "end_logit": -13.7578125, "text": "", "probability": 1.304651588219726e-11 } ], "100000000000000000006113": [ { "start_logit": 17.96875, "end_logit": 8.6015625, "text": " The Lancet", "probability": 0.474853515625 }, { "start_logit": 17.96875, "end_logit": 7.75, "text": " The Lancet (2021", "probability": 0.204345703125 }, { "start_logit": 16.40625, "end_logit": 7.9921875, "text": " seven COVID-19 vaccines", "probability": 0.05499267578125 }, { "start_logit": 17.96875, "end_logit": 6.015625, "text": " The Lancet (2021). National Advisory Committee", "probability": 0.03607177734375 }, { "start_logit": 16.40625, "end_logit": 7.4296875, "text": " seven COVID-19", "probability": 0.031341552734375 }, { "start_logit": 16.40625, "end_logit": 7.12890625, "text": " seven", "probability": 0.022918701171875 }, { "start_logit": 15.703125, "end_logit": 7.75, "text": "2021", "probability": 0.0211944580078125 }, { "start_logit": 16.40625, "end_logit": 6.984375, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0199127197265625 }, { "start_logit": 14.6953125, "end_logit": 8.6015625, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.01812744140625 }, { "start_logit": 15.296875, "end_logit": 7.9921875, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines", "probability": 0.0178375244140625 }, { "start_logit": 16.40625, "end_logit": 6.83203125, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.01702880859375 }, { "start_logit": 15.0546875, "end_logit": 7.9921875, "text": " COVID-19 vaccines", "probability": 0.0141143798828125 }, { "start_logit": 14.359375, "end_logit": 8.6015625, "text": " UK (COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.0130615234375 }, { "start_logit": 15.296875, "end_logit": 7.4296875, "text": "\"Safety and immunogenicity of seven COVID-19", "probability": 0.01016998291015625 }, { "start_logit": 16.40625, "end_logit": 6.23046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two", "probability": 0.00940704345703125 }, { "start_logit": 15.0546875, "end_logit": 7.4296875, "text": " COVID-19", "probability": 0.0080413818359375 }, { "start_logit": 14.6953125, "end_logit": 7.75, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet (2021", "probability": 0.0076751708984375 }, { "start_logit": 15.296875, "end_logit": 7.12890625, "text": "\"Safety and immunogenicity of seven", "probability": 0.00756072998046875 }, { "start_logit": 16.40625, "end_logit": 5.77734375, "text": " seven COVID-19 vaccines as a third dose (booster", "probability": 0.005977630615234375 }, { "start_logit": 15.296875, "end_logit": 6.83203125, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.005615234375 }, { "start_logit": 7.85546875, "end_logit": -1.1875, "text": "", "probability": 0.0 } ], "100000000000000000006114": [ { "start_logit": 17.96875, "end_logit": 8.6015625, "text": " The Lancet", "probability": 0.441650390625 }, { "start_logit": 17.96875, "end_logit": 7.75, "text": " The Lancet (2021", "probability": 0.1900634765625 }, { "start_logit": 16.40625, "end_logit": 7.9921875, "text": " seven COVID-19 vaccines", "probability": 0.0511474609375 }, { "start_logit": 17.96875, "end_logit": 6.3515625, "text": " The Lancet (2021). National Advisory Committee on Vaccination", "probability": 0.04656982421875 }, { "start_logit": 17.96875, "end_logit": 6.03125, "text": " The Lancet (2021). National Advisory Committee on Vaccination. An Advisory Committee", "probability": 0.0340576171875 }, { "start_logit": 17.96875, "end_logit": 6.015625, "text": " The Lancet (2021). National Advisory Committee", "probability": 0.033538818359375 }, { "start_logit": 16.40625, "end_logit": 7.4296875, "text": " seven COVID-19", "probability": 0.029144287109375 }, { "start_logit": 16.40625, "end_logit": 7.12890625, "text": " seven", "probability": 0.0213165283203125 }, { "start_logit": 15.703125, "end_logit": 7.75, "text": "2021", "probability": 0.01971435546875 }, { "start_logit": 16.40625, "end_logit": 6.984375, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.018524169921875 }, { "start_logit": 14.6953125, "end_logit": 8.6015625, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.0168609619140625 }, { "start_logit": 15.296875, "end_logit": 7.9921875, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines", "probability": 0.0166015625 }, { "start_logit": 16.40625, "end_logit": 6.83203125, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.015838623046875 }, { "start_logit": 15.0546875, "end_logit": 7.9921875, "text": " COVID-19 vaccines", "probability": 0.01313018798828125 }, { "start_logit": 14.359375, "end_logit": 8.6015625, "text": " UK (COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.01214599609375 }, { "start_logit": 15.296875, "end_logit": 7.4296875, "text": "\"Safety and immunogenicity of seven COVID-19", "probability": 0.00946044921875 }, { "start_logit": 16.40625, "end_logit": 6.23046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two", "probability": 0.00875091552734375 }, { "start_logit": 15.0546875, "end_logit": 7.4296875, "text": " COVID-19", "probability": 0.007480621337890625 }, { "start_logit": 14.6953125, "end_logit": 7.75, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet (2021", "probability": 0.007137298583984375 }, { "start_logit": 15.296875, "end_logit": 7.12890625, "text": "\"Safety and immunogenicity of seven", "probability": 0.007030487060546875 }, { "start_logit": 7.91015625, "end_logit": -1.2294921875, "text": "", "probability": 0.0 } ], "100000000000000000006115": [ { "start_logit": 17.984375, "end_logit": 8.59375, "text": " The Lancet", "probability": 0.64501953125 }, { "start_logit": 16.40625, "end_logit": 7.99609375, "text": " seven COVID-19 vaccines", "probability": 0.07354736328125 }, { "start_logit": 16.40625, "end_logit": 7.4296875, "text": " seven COVID-19", "probability": 0.041900634765625 }, { "start_logit": 16.40625, "end_logit": 7.125, "text": " seven", "probability": 0.0306549072265625 }, { "start_logit": 16.40625, "end_logit": 6.98046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0266265869140625 }, { "start_logit": 15.296875, "end_logit": 7.99609375, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines", "probability": 0.0242462158203125 }, { "start_logit": 14.6875, "end_logit": 8.59375, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.02386474609375 }, { "start_logit": 16.40625, "end_logit": 6.8359375, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.02313232421875 }, { "start_logit": 15.0546875, "end_logit": 7.99609375, "text": " COVID-19 vaccines", "probability": 0.018890380859375 }, { "start_logit": 15.296875, "end_logit": 7.4296875, "text": "\"Safety and immunogenicity of seven COVID-19", "probability": 0.01360321044921875 }, { "start_logit": 16.40625, "end_logit": 6.23046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two", "probability": 0.01258087158203125 }, { "start_logit": 15.0546875, "end_logit": 7.4296875, "text": " COVID-19", "probability": 0.01076507568359375 }, { "start_logit": 15.296875, "end_logit": 7.125, "text": "\"Safety and immunogenicity of seven", "probability": 0.01010894775390625 }, { "start_logit": 15.296875, "end_logit": 6.8359375, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.007511138916015625 }, { "start_logit": 15.0546875, "end_logit": 6.98046875, "text": " COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0068359375 }, { "start_logit": 15.015625, "end_logit": 6.98046875, "text": " ChAdOx1 nCov-19 or BNT162b2", "probability": 0.00662994384765625 }, { "start_logit": 14.9921875, "end_logit": 6.98046875, "text": " third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0064239501953125 }, { "start_logit": 14.6875, "end_logit": 7.2265625, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2", "probability": 0.00603485107421875 }, { "start_logit": 15.0546875, "end_logit": 6.8359375, "text": " COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.00594329833984375 }, { "start_logit": 15.015625, "end_logit": 6.8359375, "text": " ChAdOx1", "probability": 0.005672454833984375 }, { "start_logit": 7.71875, "end_logit": -1.1953125, "text": "", "probability": 0.0 } ], "100000000000000000006119": [ { "start_logit": 17.984375, "end_logit": 8.6015625, "text": " The Lancet", "probability": 0.481201171875 }, { "start_logit": 17.984375, "end_logit": 7.75, "text": " The Lancet (2021", "probability": 0.2037353515625 }, { "start_logit": 16.40625, "end_logit": 7.9921875, "text": " seven COVID-19 vaccines", "probability": 0.053985595703125 }, { "start_logit": 17.984375, "end_logit": 6.0078125, "text": " The Lancet (2021). National Advisory Committee", "probability": 0.035980224609375 }, { "start_logit": 16.40625, "end_logit": 7.4296875, "text": " seven COVID-19", "probability": 0.0307464599609375 }, { "start_logit": 16.40625, "end_logit": 7.125, "text": " seven", "probability": 0.0225067138671875 }, { "start_logit": 15.703125, "end_logit": 7.75, "text": "2021", "probability": 0.02081298828125 }, { "start_logit": 16.40625, "end_logit": 6.98046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.019561767578125 }, { "start_logit": 14.6953125, "end_logit": 8.6015625, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.017791748046875 }, { "start_logit": 15.296875, "end_logit": 7.9921875, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines", "probability": 0.0175323486328125 }, { "start_logit": 16.40625, "end_logit": 6.83203125, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.0167236328125 }, { "start_logit": 15.0546875, "end_logit": 7.9921875, "text": " COVID-19 vaccines", "probability": 0.01386260986328125 }, { "start_logit": 14.3515625, "end_logit": 8.6015625, "text": " UK (COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet", "probability": 0.0126190185546875 }, { "start_logit": 15.296875, "end_logit": 7.4296875, "text": "\"Safety and immunogenicity of seven COVID-19", "probability": 0.00998687744140625 }, { "start_logit": 16.40625, "end_logit": 6.22265625, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two", "probability": 0.00908660888671875 }, { "start_logit": 15.0546875, "end_logit": 7.4296875, "text": " COVID-19", "probability": 0.007904052734375 }, { "start_logit": 14.6953125, "end_logit": 7.75, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2 trial.\" The Lancet (2021", "probability": 0.007541656494140625 }, { "start_logit": 15.296875, "end_logit": 7.125, "text": "\"Safety and immunogenicity of seven", "probability": 0.00742340087890625 }, { "start_logit": 16.40625, "end_logit": 5.7734375, "text": " seven COVID-19 vaccines as a third dose (booster", "probability": 0.005870819091796875 }, { "start_logit": 15.296875, "end_logit": 6.83203125, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.00551605224609375 }, { "start_logit": 7.796875, "end_logit": -1.1796875, "text": "", "probability": 0.0 } ], "100000000000000000006120": [ { "start_logit": 16.40625, "end_logit": 7.99609375, "text": " seven COVID-19 vaccines", "probability": 0.2127685546875 }, { "start_logit": 16.40625, "end_logit": 7.4296875, "text": " seven COVID-19", "probability": 0.12127685546875 }, { "start_logit": 16.40625, "end_logit": 7.125, "text": " seven", "probability": 0.08868408203125 }, { "start_logit": 16.40625, "end_logit": 6.98046875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0770263671875 }, { "start_logit": 15.296875, "end_logit": 7.99609375, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines", "probability": 0.0701904296875 }, { "start_logit": 16.40625, "end_logit": 6.84375, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.06695556640625 }, { "start_logit": 15.0625, "end_logit": 7.99609375, "text": " COVID-19 vaccines", "probability": 0.0555419921875 }, { "start_logit": 15.296875, "end_logit": 7.4296875, "text": "\"Safety and immunogenicity of seven COVID-19", "probability": 0.03936767578125 }, { "start_logit": 16.40625, "end_logit": 6.21875, "text": " seven COVID-19 vaccines as a third dose (booster)\nfollowing two", "probability": 0.035858154296875 }, { "start_logit": 15.0625, "end_logit": 7.4296875, "text": " COVID-19", "probability": 0.031646728515625 }, { "start_logit": 15.296875, "end_logit": 7.125, "text": "\"Safety and immunogenicity of seven", "probability": 0.0292510986328125 }, { "start_logit": 16.40625, "end_logit": 5.7734375, "text": " seven COVID-19 vaccines as a third dose (booster", "probability": 0.0231475830078125 }, { "start_logit": 15.296875, "end_logit": 6.84375, "text": "\"Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.0220794677734375 }, { "start_logit": 15.0625, "end_logit": 6.98046875, "text": " COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.020111083984375 }, { "start_logit": 15.015625, "end_logit": 6.98046875, "text": " ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0191802978515625 }, { "start_logit": 14.9921875, "end_logit": 6.98046875, "text": " third dose (booster)\nfollowing two doses of ChAdOx1 nCov-19 or BNT162b2", "probability": 0.0186004638671875 }, { "start_logit": 15.0625, "end_logit": 6.84375, "text": " COVID-19 vaccines as a third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.0174713134765625 }, { "start_logit": 14.6875, "end_logit": 7.22265625, "text": "COV-BOOST): a blinded, multicentre,\nrandomised, controlled, phase 2", "probability": 0.0174713134765625 }, { "start_logit": 15.015625, "end_logit": 6.84375, "text": " ChAdOx1", "probability": 0.01666259765625 }, { "start_logit": 14.9921875, "end_logit": 6.84375, "text": " third dose (booster)\nfollowing two doses of ChAdOx1", "probability": 0.0164031982421875 }, { "start_logit": 7.72265625, "end_logit": -1.2021484375, "text": "", "probability": 0.0 } ], "100000000000000000006124": [ { "start_logit": 16.84375, "end_logit": 8.1796875, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.292236328125 }, { "start_logit": 16.84375, "end_logit": 7.296875, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.11993408203125 }, { "start_logit": 16.84375, "end_logit": 7.26171875, "text": "Parry", "probability": 0.1162109375 }, { "start_logit": 16.84375, "end_logit": 7.2578125, "text": "P", "probability": 0.11444091796875 }, { "start_logit": 15.4765625, "end_logit": 8.1796875, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.07391357421875 }, { "start_logit": 16.84375, "end_logit": 6.19140625, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody", "probability": 0.03955078125 }, { "start_logit": 16.84375, "end_logit": 6.15234375, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne", "probability": 0.038360595703125 }, { "start_logit": 15.4765625, "end_logit": 7.296875, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.0308074951171875 }, { "start_logit": 14.5390625, "end_logit": 8.1796875, "text": " Stephens C, et al. Extended interval BNT162b2", "probability": 0.0289306640625 }, { "start_logit": 14.390625, "end_logit": 8.1796875, "text": " H, Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.0247650146484375 }, { "start_logit": 15.6328125, "end_logit": 6.82421875, "text": " Austin", "probability": 0.022186279296875 }, { "start_logit": 13.9296875, "end_logit": 8.1796875, "text": " Extended interval BNT162b2", "probability": 0.0157318115234375 }, { "start_logit": 15.6328125, "end_logit": 6.30859375, "text": " Austin JA", "probability": 0.01324462890625 }, { "start_logit": 14.5390625, "end_logit": 7.296875, "text": " Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.012054443359375 }, { "start_logit": 14.9296875, "end_logit": 6.82421875, "text": "Payne RP, Longet S, Austin", "probability": 0.01097869873046875 }, { "start_logit": 14.390625, "end_logit": 7.296875, "text": " H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.01031494140625 }, { "start_logit": 15.4765625, "end_logit": 6.19140625, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody", "probability": 0.01015472412109375 }, { "start_logit": 15.4765625, "end_logit": 6.15234375, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne", "probability": 0.00969696044921875 }, { "start_logit": 13.3671875, "end_logit": 8.1796875, "text": " R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.00896453857421875 }, { "start_logit": 14.5390625, "end_logit": 6.82421875, "text": " Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne RP, Longet S, Austin", "probability": 0.007427215576171875 }, { "start_logit": 7.7734375, "end_logit": -1.1484375, "text": "", "probability": 0.0 } ], "100000000000000000006125": [ { "start_logit": 16.84375, "end_logit": 8.1796875, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.292236328125 }, { "start_logit": 16.84375, "end_logit": 7.296875, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.11993408203125 }, { "start_logit": 16.84375, "end_logit": 7.26171875, "text": "Parry", "probability": 0.1162109375 }, { "start_logit": 16.84375, "end_logit": 7.2578125, "text": "P", "probability": 0.11444091796875 }, { "start_logit": 15.4765625, "end_logit": 8.1796875, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.07391357421875 }, { "start_logit": 16.84375, "end_logit": 6.19140625, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody", "probability": 0.03955078125 }, { "start_logit": 16.84375, "end_logit": 6.15234375, "text": "Parry H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne", "probability": 0.038360595703125 }, { "start_logit": 15.4765625, "end_logit": 7.296875, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.0308074951171875 }, { "start_logit": 14.5390625, "end_logit": 8.1796875, "text": " Stephens C, et al. Extended interval BNT162b2", "probability": 0.0289306640625 }, { "start_logit": 14.390625, "end_logit": 8.1796875, "text": " H, Bruton R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.0247650146484375 }, { "start_logit": 15.6328125, "end_logit": 6.82421875, "text": " Austin", "probability": 0.022186279296875 }, { "start_logit": 13.9296875, "end_logit": 8.1796875, "text": " Extended interval BNT162b2", "probability": 0.0157318115234375 }, { "start_logit": 15.6328125, "end_logit": 6.30859375, "text": " Austin JA", "probability": 0.01324462890625 }, { "start_logit": 14.5390625, "end_logit": 7.296875, "text": " Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.012054443359375 }, { "start_logit": 14.9296875, "end_logit": 6.82421875, "text": "Payne RP, Longet S, Austin", "probability": 0.01097869873046875 }, { "start_logit": 14.390625, "end_logit": 7.296875, "text": " H, Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination", "probability": 0.01031494140625 }, { "start_logit": 15.4765625, "end_logit": 6.19140625, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody", "probability": 0.01015472412109375 }, { "start_logit": 15.4765625, "end_logit": 6.15234375, "text": " Bruton R, Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne", "probability": 0.00969696044921875 }, { "start_logit": 13.3671875, "end_logit": 8.1796875, "text": " R, Stephens C, et al. Extended interval BNT162b2", "probability": 0.00896453857421875 }, { "start_logit": 14.5390625, "end_logit": 6.82421875, "text": " Stephens C, et al. Extended interval BNT162b2 vaccination enhances peak antibody\nPayne RP, Longet S, Austin", "probability": 0.007427215576171875 }, { "start_logit": 7.76953125, "end_logit": -1.111328125, "text": "", "probability": 0.0 } ], "100000000000000000006132": [ { "start_logit": 16.546875, "end_logit": 8.484375, "text": " MedRxiv preprint", "probability": 0.319091796875 }, { "start_logit": 15.3359375, "end_logit": 8.484375, "text": " 2021, MedRxiv preprint", "probability": 0.0943603515625 }, { "start_logit": 15.3359375, "end_logit": 8.2734375, "text": " 2021", "probability": 0.07696533203125 }, { "start_logit": 14.734375, "end_logit": 8.59375, "text": "\nSkowronski DM", "probability": 0.058135986328125 }, { "start_logit": 14.6796875, "end_logit": 8.59375, "text": "Skowronski DM", "probability": 0.05548095703125 }, { "start_logit": 14.734375, "end_logit": 8.484375, "text": "\nSkowronski DM. 2021, MedRxiv preprint", "probability": 0.052093505859375 }, { "start_logit": 14.6796875, "end_logit": 8.484375, "text": "Skowronski DM. 2021, MedRxiv preprint", "probability": 0.0489501953125 }, { "start_logit": 14.46875, "end_logit": 8.59375, "text": " COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM", "probability": 0.044586181640625 }, { "start_logit": 14.734375, "end_logit": 8.2734375, "text": "\nSkowronski DM. 2021", "probability": 0.041900634765625 }, { "start_logit": 14.6796875, "end_logit": 8.2734375, "text": "Skowronski DM. 2021", "probability": 0.039947509765625 }, { "start_logit": 14.46875, "end_logit": 8.2734375, "text": " COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM. 2021", "probability": 0.032623291015625 }, { "start_logit": 14.140625, "end_logit": 8.59375, "text": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM", "probability": 0.0321044921875 }, { "start_logit": 14.140625, "end_logit": 8.2734375, "text": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM. 2021", "probability": 0.02313232421875 }, { "start_logit": 16.546875, "end_logit": 5.546875, "text": " MedRxiv preprint. Two-dose SARS-CoV-2 vaccine", "probability": 0.0169219970703125 }, { "start_logit": 16.546875, "end_logit": 5.390625, "text": " MedRxiv preprint. Two-dose", "probability": 0.01446533203125 }, { "start_logit": 16.546875, "end_logit": 5.26953125, "text": " MedRxiv preprint. Two-dose SARS-CoV-2", "probability": 0.0127716064453125 }, { "start_logit": 14.734375, "end_logit": 6.81640625, "text": "\nSkowrons", "probability": 0.00978851318359375 }, { "start_logit": 16.546875, "end_logit": 4.96875, "text": " MedRxiv preprint. Two-dose SARS-CoV-2 vaccine effectiveness", "probability": 0.009490966796875 }, { "start_logit": 14.6796875, "end_logit": 6.81640625, "text": "Skowrons", "probability": 0.00933837890625 }, { "start_logit": 16.546875, "end_logit": 4.734375, "text": " MedRx", "probability": 0.00750732421875 }, { "start_logit": 7.42578125, "end_logit": -1.1796875, "text": "", "probability": 0.0 } ], "100000000000000000006133": [ { "start_logit": 16.546875, "end_logit": 8.484375, "text": " MedRxiv preprint", "probability": 0.319091796875 }, { "start_logit": 15.3359375, "end_logit": 8.484375, "text": " 2021, MedRxiv preprint", "probability": 0.0943603515625 }, { "start_logit": 15.3359375, "end_logit": 8.2734375, "text": " 2021", "probability": 0.07696533203125 }, { "start_logit": 14.734375, "end_logit": 8.59375, "text": "\nSkowronski DM", "probability": 0.058135986328125 }, { "start_logit": 14.6796875, "end_logit": 8.59375, "text": "Skowronski DM", "probability": 0.05548095703125 }, { "start_logit": 14.734375, "end_logit": 8.484375, "text": "\nSkowronski DM. 2021, MedRxiv preprint", "probability": 0.052093505859375 }, { "start_logit": 14.6796875, "end_logit": 8.484375, "text": "Skowronski DM. 2021, MedRxiv preprint", "probability": 0.0489501953125 }, { "start_logit": 14.46875, "end_logit": 8.59375, "text": " COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM", "probability": 0.044586181640625 }, { "start_logit": 14.734375, "end_logit": 8.2734375, "text": "\nSkowronski DM. 2021", "probability": 0.041900634765625 }, { "start_logit": 14.6796875, "end_logit": 8.2734375, "text": "Skowronski DM. 2021", "probability": 0.039947509765625 }, { "start_logit": 14.46875, "end_logit": 8.2734375, "text": " COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM. 2021", "probability": 0.032623291015625 }, { "start_logit": 14.140625, "end_logit": 8.59375, "text": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM", "probability": 0.0321044921875 }, { "start_logit": 14.140625, "end_logit": 8.2734375, "text": "Moderna COVID-19 Vaccine EUI Healthcare Providers Fact Sheet, ver 09/02/22;\nSkowronski DM. 2021", "probability": 0.02313232421875 }, { "start_logit": 16.546875, "end_logit": 5.546875, "text": " MedRxiv preprint. Two-dose SARS-CoV-2 vaccine", "probability": 0.0169219970703125 }, { "start_logit": 16.546875, "end_logit": 5.390625, "text": " MedRxiv preprint. Two-dose", "probability": 0.01446533203125 }, { "start_logit": 16.546875, "end_logit": 5.26953125, "text": " MedRxiv preprint. Two-dose SARS-CoV-2", "probability": 0.0127716064453125 }, { "start_logit": 14.734375, "end_logit": 6.81640625, "text": "\nSkowrons", "probability": 0.00978851318359375 }, { "start_logit": 16.546875, "end_logit": 4.96875, "text": " MedRxiv preprint. Two-dose SARS-CoV-2 vaccine effectiveness", "probability": 0.009490966796875 }, { "start_logit": 14.6796875, "end_logit": 6.81640625, "text": "Skowrons", "probability": 0.00933837890625 }, { "start_logit": 16.546875, "end_logit": 4.734375, "text": " MedRx", "probability": 0.00750732421875 }, { "start_logit": 7.4765625, "end_logit": -1.22265625, "text": "", "probability": 0.0 } ], "100000000000000000006140": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025608708425093117 }, { "start_logit": 6.49609375, "end_logit": -0.5302734375, "text": "", "probability": 0.9974391291574908 } ], "100000000000000000006141": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.3984375, "end_logit": -0.4765625, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000006142": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024154832575663415 }, { "start_logit": 6.54296875, "end_logit": -0.51806640625, "text": "", "probability": 0.9975845167424336 } ], "100000000000000000006150": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006436856044842308 }, { "start_logit": 7.33203125, "end_logit": 0.0169830322265625, "text": "", "probability": 0.9993563143955159 } ], "100000000000000000006152": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.265625, "end_logit": 0.03118896484375, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000006155": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992053545 }, { "start_logit": -33.78125, "end_logit": 12.828125, "text": "", "probability": 7.946455094384453e-10 } ], "100000000000000000006156": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990414745 }, { "start_logit": -33.875, "end_logit": 13.109375, "text": "", "probability": 9.585254508941148e-10 } ], "100000000000000000006157": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991928405 }, { "start_logit": -33.78125, "end_logit": 12.84375, "text": "", "probability": 8.071593553406995e-10 } ], "100000000000000000006160": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.63671875, "end_logit": -0.82177734375, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000006166": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.29296875, "end_logit": -0.3134765625, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000006168": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.28515625, "end_logit": -0.322265625, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000006171": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005463420892147277 }, { "start_logit": 7.67578125, "end_logit": -0.1636962890625, "text": "", "probability": 0.9994536579107853 } ], "100000000000000000006175": [ { "start_logit": 20.046875, "end_logit": 8.671875, "text": "MIS", "probability": 0.466796875 }, { "start_logit": 20.046875, "end_logit": 7.59765625, "text": "MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.1588134765625 }, { "start_logit": 19.09375, "end_logit": 8.2734375, "text": "Lower", "probability": 0.121826171875 }, { "start_logit": 20.046875, "end_logit": 6.07421875, "text": "MIS)\nPrevent spreading COVID-19", "probability": 0.034881591796875 }, { "start_logit": 18.3125, "end_logit": 7.59765625, "text": "Provide long- and short-term protection", "probability": 0.0280303955078125 }, { "start_logit": 17.578125, "end_logit": 8.2734375, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.026336669921875 }, { "start_logit": 17.4375, "end_logit": 8.2734375, "text": " adults ages 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.023223876953125 }, { "start_logit": 16.953125, "end_logit": 8.671875, "text": " hospitalization or death\nPrevent complications from COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.021148681640625 }, { "start_logit": 16.75, "end_logit": 8.671875, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0172576904296875 }, { "start_logit": 17.09375, "end_logit": 8.2734375, "text": " 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.0164794921875 }, { "start_logit": 16.703125, "end_logit": 8.671875, "text": " COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0164794921875 }, { "start_logit": 19.09375, "end_logit": 5.90625, "text": "Lower the risk of infection, including infection without symptoms\nProtect against milder COVID-19", "probability": 0.011322021484375 }, { "start_logit": 18.671875, "end_logit": 6.21484375, "text": " COVID-19 vaccine effectiveness to understand how well the vaccines:\nProtect different age groups", "probability": 0.0101470947265625 }, { "start_logit": 18.671875, "end_logit": 5.98046875, "text": " COVID-19", "probability": 0.00803375244140625 }, { "start_logit": 17.4375, "end_logit": 7.140625, "text": " adults ages 65 and older", "probability": 0.007427215576171875 }, { "start_logit": 17.421875, "end_logit": 7.140625, "text": "\nProtect different age groups, such as children, adolescents, and adults, including adults ages 65 and older", "probability": 0.007312774658203125 }, { "start_logit": 19.09375, "end_logit": 5.4140625, "text": "Lower the risk of infection", "probability": 0.006870269775390625 }, { "start_logit": 18.671875, "end_logit": 5.6953125, "text": " COVID-19 vaccine", "probability": 0.006061553955078125 }, { "start_logit": 16.75, "end_logit": 7.59765625, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.0058746337890625 }, { "start_logit": 17.578125, "end_logit": 6.72265625, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants", "probability": 0.005603790283203125 }, { "start_logit": 8.8984375, "end_logit": -1.2626953125, "text": "", "probability": 0.0 } ], "100000000000000000006178": [ { "start_logit": 20.046875, "end_logit": 8.671875, "text": "MIS", "probability": 0.465576171875 }, { "start_logit": 20.046875, "end_logit": 7.61328125, "text": "MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.160888671875 }, { "start_logit": 19.09375, "end_logit": 8.2734375, "text": "Lower", "probability": 0.1214599609375 }, { "start_logit": 20.046875, "end_logit": 6.07421875, "text": "MIS)\nPrevent spreading COVID-19", "probability": 0.0347900390625 }, { "start_logit": 18.3125, "end_logit": 7.61328125, "text": "Provide long- and short-term protection", "probability": 0.0283966064453125 }, { "start_logit": 17.578125, "end_logit": 8.2734375, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.0262603759765625 }, { "start_logit": 17.4375, "end_logit": 8.2734375, "text": " adults ages 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.023162841796875 }, { "start_logit": 16.953125, "end_logit": 8.671875, "text": " hospitalization or death\nPrevent complications from COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.021087646484375 }, { "start_logit": 16.75, "end_logit": 8.671875, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0172119140625 }, { "start_logit": 17.09375, "end_logit": 8.2734375, "text": " 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.0164337158203125 }, { "start_logit": 16.703125, "end_logit": 8.671875, "text": " COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0164337158203125 }, { "start_logit": 19.09375, "end_logit": 5.90625, "text": "Lower the risk of infection, including infection without symptoms\nProtect against milder COVID-19", "probability": 0.01129150390625 }, { "start_logit": 18.671875, "end_logit": 6.21484375, "text": " COVID-19 vaccine effectiveness to understand how well the vaccines:\nProtect different age groups", "probability": 0.01012420654296875 }, { "start_logit": 18.671875, "end_logit": 5.98046875, "text": " COVID-19", "probability": 0.0080108642578125 }, { "start_logit": 17.4375, "end_logit": 7.1328125, "text": " adults ages 65 and older", "probability": 0.007293701171875 }, { "start_logit": 17.421875, "end_logit": 7.1328125, "text": "\nProtect different age groups, such as children, adolescents, and adults, including adults ages 65 and older", "probability": 0.007293701171875 }, { "start_logit": 19.09375, "end_logit": 5.4140625, "text": "Lower the risk of infection", "probability": 0.0068511962890625 }, { "start_logit": 18.671875, "end_logit": 5.6953125, "text": " COVID-19 vaccine", "probability": 0.00604248046875 }, { "start_logit": 16.75, "end_logit": 7.61328125, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.005950927734375 }, { "start_logit": 17.578125, "end_logit": 6.734375, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants", "probability": 0.005680084228515625 }, { "start_logit": 9.046875, "end_logit": -1.2724609375, "text": "", "probability": 0.0 } ], "100000000000000000006182": [ { "start_logit": 20.046875, "end_logit": 8.671875, "text": "MIS", "probability": 0.465576171875 }, { "start_logit": 20.046875, "end_logit": 7.61328125, "text": "MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.160888671875 }, { "start_logit": 19.09375, "end_logit": 8.2734375, "text": "Lower", "probability": 0.1214599609375 }, { "start_logit": 20.046875, "end_logit": 6.07421875, "text": "MIS)\nPrevent spreading COVID-19", "probability": 0.0347900390625 }, { "start_logit": 18.3125, "end_logit": 7.61328125, "text": "Provide long- and short-term protection", "probability": 0.0283966064453125 }, { "start_logit": 17.578125, "end_logit": 8.2734375, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.0262603759765625 }, { "start_logit": 17.4375, "end_logit": 8.2734375, "text": " adults ages 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.023162841796875 }, { "start_logit": 16.953125, "end_logit": 8.671875, "text": " hospitalization or death\nPrevent complications from COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.021087646484375 }, { "start_logit": 16.75, "end_logit": 8.671875, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0172119140625 }, { "start_logit": 17.09375, "end_logit": 8.2734375, "text": " 65 and older\nProtect specific groups, such as people with underlying health conditions or healthcare workers\nProtect against new variants\nLower", "probability": 0.0164337158203125 }, { "start_logit": 16.703125, "end_logit": 8.671875, "text": " COVID-19, such as post-COVID conditions and multisystem inflammatory syndrome\n(MIS", "probability": 0.0164337158203125 }, { "start_logit": 19.09375, "end_logit": 5.90625, "text": "Lower the risk of infection, including infection without symptoms\nProtect against milder COVID-19", "probability": 0.01129150390625 }, { "start_logit": 18.671875, "end_logit": 6.21484375, "text": " COVID-19 vaccine effectiveness to understand how well the vaccines:\nProtect different age groups", "probability": 0.01012420654296875 }, { "start_logit": 18.671875, "end_logit": 5.98046875, "text": " COVID-19", "probability": 0.0080108642578125 }, { "start_logit": 17.4375, "end_logit": 7.1328125, "text": " adults ages 65 and older", "probability": 0.007293701171875 }, { "start_logit": 17.421875, "end_logit": 7.1328125, "text": "\nProtect different age groups, such as children, adolescents, and adults, including adults ages 65 and older", "probability": 0.007293701171875 }, { "start_logit": 19.09375, "end_logit": 5.4140625, "text": "Lower the risk of infection", "probability": 0.0068511962890625 }, { "start_logit": 18.671875, "end_logit": 5.6953125, "text": " COVID-19 vaccine", "probability": 0.00604248046875 }, { "start_logit": 16.75, "end_logit": 7.61328125, "text": " post-COVID conditions and multisystem inflammatory syndrome\n(MIS)\nPrevent spreading COVID-19 to others\nProvide long- and short-term protection", "probability": 0.005950927734375 }, { "start_logit": 17.578125, "end_logit": 6.734375, "text": " people with underlying health conditions or healthcare workers\nProtect against new variants", "probability": 0.005680084228515625 }, { "start_logit": 8.96875, "end_logit": -1.29296875, "text": "", "probability": 0.0 } ], "100000000000000000006183": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.3046875, "end_logit": -0.241455078125, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000006186": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010987310729246428 }, { "start_logit": 7.3671875, "end_logit": -0.55517578125, "text": "", "probability": 0.9989012689270753 } ], "100000000000000000006187": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.43359375, "end_logit": -0.5888671875, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000006190": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.37890625, "end_logit": -0.57421875, "text": "", "probability": 0.99889266101491 } ], "100000000000000000006192": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 7.04296875, "end_logit": -0.40673828125, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000006194": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 6.9609375, "end_logit": -0.323974609375, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000006195": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 6.98828125, "end_logit": -0.356689453125, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000006198": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.15625, "end_logit": -0.68603515625, "text": "", "probability": 0.998451238905712 } ], "100000000000000000006199": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.296875, "end_logit": -0.70361328125, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000006200": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015669887925500437 }, { "start_logit": 7.16796875, "end_logit": -0.7119140625, "text": "", "probability": 0.99843301120745 } ], "100000000000000000006201": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001466458403084568 }, { "start_logit": 7.24609375, "end_logit": -0.72216796875, "text": "", "probability": 0.9985335415969153 } ], "100000000000000000006203": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 7.68359375, "end_logit": -0.8916015625, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000006209": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000302973407808812 }, { "start_logit": 7.9609375, "end_logit": 0.1431884765625, "text": "", "probability": 0.9996970265921912 } ], "100000000000000000006210": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00027586790663379127 }, { "start_logit": 7.9765625, "end_logit": 0.220458984375, "text": "", "probability": 0.9997241320933663 } ], "100000000000000000006212": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010362668882466278 }, { "start_logit": 7.5078125, "end_logit": -0.63818359375, "text": "", "probability": 0.9989637331117535 } ], "100000000000000000006217": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011695102650555148 }, { "start_logit": 7.3515625, "end_logit": -0.60302734375, "text": "", "probability": 0.9988304897349445 } ], "100000000000000000006221": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 7.50390625, "end_logit": -1.15234375, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000006227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.4765625, "end_logit": -0.66943359375, "text": "", "probability": 0.998896973358602 } ], "100000000000000000006228": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.23828125, "end_logit": -0.73876953125, "text": "", "probability": 0.998498817743263 } ], "100000000000000000006231": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.24609375, "end_logit": -0.7724609375, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000006238": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.40625, "end_logit": -0.513671875, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000006242": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.359375, "end_logit": -0.50341796875, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000006245": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.73046875, "end_logit": -0.544921875, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000006252": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.27734375, "end_logit": -0.358154296875, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000006254": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016103573704565953 }, { "start_logit": 7.17578125, "end_logit": -0.74658203125, "text": "", "probability": 0.9983896426295433 } ], "100000000000000000006255": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.23046875, "end_logit": -0.77880859375, "text": "", "probability": 0.998426887834651 } ], "100000000000000000006259": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.140625, "end_logit": -0.74658203125, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000006272": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025212683210456455 }, { "start_logit": 6.87890625, "end_logit": -0.89990234375, "text": "", "probability": 0.9974787316789544 } ], "100000000000000000006273": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002305125202793809 }, { "start_logit": 7.0078125, "end_logit": -0.93896484375, "text": "", "probability": 0.9976948747972061 } ], "100000000000000000006276": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001964661439513743 }, { "start_logit": 7.3671875, "end_logit": -1.1376953125, "text": "", "probability": 0.9980353385604862 } ], "100000000000000000006279": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018821859100764038 }, { "start_logit": 6.59765625, "end_logit": -0.32568359375, "text": "", "probability": 0.9981178140899236 } ], "100000000000000000006287": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 6.91015625, "end_logit": 0.0252838134765625, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000006290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 7.4296875, "end_logit": -0.12469482421875, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000006294": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007014082876992124 }, { "start_logit": 7.53515625, "end_logit": -0.275146484375, "text": "", "probability": 0.9992985917123008 } ], "100000000000000000006297": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.0546875, "end_logit": -0.414794921875, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000006305": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 7.3671875, "end_logit": -0.96826171875, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000006307": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 7.3515625, "end_logit": -0.9140625, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000006309": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.80078125, "end_logit": -0.81787109375, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000006310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.7421875, "end_logit": -0.79296875, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000006311": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.796875, "end_logit": -0.80859375, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000006314": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.78125, "end_logit": -0.79736328125, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000006315": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999999572222 }, { "start_logit": -31.828125, "end_logit": 7.95703125, "text": "", "probability": 4.277787868786004e-11 } ], "100000000000000000006317": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999998640521 }, { "start_logit": -32.84375, "end_logit": 10.1171875, "text": "", "probability": 1.3594781730140666e-10 } ], "100000000000000000006319": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000347345305659471 }, { "start_logit": 8.203125, "end_logit": -0.2396240234375, "text": "", "probability": 0.9996526546943404 } ], "100000000000000000006324": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.9453125, "end_logit": -0.93994140625, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000006331": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007069056122424319 }, { "start_logit": 7.63671875, "end_logit": -0.384033203125, "text": "", "probability": 0.9992930943877577 } ], "100000000000000000006337": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 8.0078125, "end_logit": -0.779296875, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000006340": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 7.95703125, "end_logit": -0.77783203125, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000006342": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005884088185569387 }, { "start_logit": 8.0390625, "end_logit": -0.6005859375, "text": "", "probability": 0.9994115911814431 } ], "100000000000000000006346": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.15625, "end_logit": -0.5380859375, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000006347": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013777325890227494 }, { "start_logit": 7.14453125, "end_logit": -0.5595703125, "text": "", "probability": 0.9986222674109773 } ], "100000000000000000006348": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 7.21875, "end_logit": -0.6787109375, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000006349": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.1328125, "end_logit": -0.5107421875, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000006352": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.3515625, "end_logit": -0.491455078125, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000006356": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 7.71875, "end_logit": -0.4189453125, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000006359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006118340200729555 }, { "start_logit": 7.81640625, "end_logit": -0.4189453125, "text": "", "probability": 0.9993881659799271 } ], "100000000000000000006360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999934496673 }, { "start_logit": -34.15625, "end_logit": 15.3125, "text": "", "probability": 6.550332622350746e-09 } ], "100000000000000000006373": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00044595620507126955 }, { "start_logit": 7.84765625, "end_logit": -0.132568359375, "text": "", "probability": 0.9995540437949288 } ], "100000000000000000006380": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.81640625, "end_logit": -0.86279296875, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000006381": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.7734375, "end_logit": -0.849609375, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000006383": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.05859375, "end_logit": -0.290771484375, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000006384": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011695102650555148 }, { "start_logit": 6.9921875, "end_logit": -0.2425537109375, "text": "", "probability": 0.9988304897349445 } ], "100000000000000000006390": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.06640625, "end_logit": -0.424560546875, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000006394": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004916815522926534 }, { "start_logit": 7.984375, "end_logit": -0.3681640625, "text": "", "probability": 0.9995083184477073 } ], "100000000000000000006400": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999999843525 }, { "start_logit": -31.515625, "end_logit": 8.9375, "text": "", "probability": 1.5647497855687212e-10 } ], "100000000000000000006403": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -34.625, "end_logit": 15.515625, "text": "", "probability": 0.0 } ], "100000000000000000006406": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -34.5625, "end_logit": 15.484375, "text": "", "probability": 0.0 } ], "100000000000000000006408": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -34.40625, "end_logit": 15.28125, "text": "", "probability": 0.0 } ], "100000000000000000006409": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -34.4375, "end_logit": 15.5625, "text": "", "probability": 0.0 } ], "100000000000000000006411": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -33.9375, "end_logit": 14.3984375, "text": "", "probability": 0.0 } ], "100000000000000000006412": [ { "start_logit": 17.78125, "end_logit": 9.203125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant", "probability": 0.1737060546875 }, { "start_logit": 17.78125, "end_logit": 9.1953125, "text": " chimeric antigen receptor", "probability": 0.1710205078125 }, { "start_logit": 17.640625, "end_logit": 8.921875, "text": " 20", "probability": 0.1138916015625 }, { "start_logit": 17.78125, "end_logit": 8.671875, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years", "probability": 0.10211181640625 }, { "start_logit": 17.0, "end_logit": 8.671875, "text": " 2 years", "probability": 0.046722412109375 }, { "start_logit": 17.171875, "end_logit": 8.4296875, "text": "Advanced or untreated", "probability": 0.043243408203125 }, { "start_logit": 16.96875, "end_logit": 8.5546875, "text": "Active treatment for solid tumor and hematologic malignancies", "probability": 0.040618896484375 }, { "start_logit": 16.125, "end_logit": 9.203125, "text": " hematopoietic stem cell transplant", "probability": 0.03314208984375 }, { "start_logit": 17.171875, "end_logit": 8.1328125, "text": "Advanced", "probability": 0.032623291015625 }, { "start_logit": 17.0, "end_logit": 8.2578125, "text": " 2 years of\ntransplantation or taking immunosuppressive therapy)\nModerate or severe primary immunodeficiency", "probability": 0.0306549072265625 }, { "start_logit": 16.96875, "end_logit": 8.2734375, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies associated with poor responses to COVID-19 vaccines", "probability": 0.0306549072265625 }, { "start_logit": 17.171875, "end_logit": 7.8671875, "text": "Advanced or untreated HIV infection (people with HIV and CD4 cell counts less than 200/mm3", "probability": 0.0246429443359375 }, { "start_logit": 16.96875, "end_logit": 8.0703125, "text": "Active treatment for solid tumor and hematologic malignancies\nHematologic malignancies", "probability": 0.0246429443359375 }, { "start_logit": 17.78125, "end_logit": 7.14453125, "text": " chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2", "probability": 0.022064208984375 }, { "start_logit": 16.65625, "end_logit": 8.2578125, "text": "Moderate or severe primary immunodeficiency", "probability": 0.021728515625 }, { "start_logit": 17.171875, "end_logit": 7.66796875, "text": "Advanced or untreated HIV infection", "probability": 0.020416259765625 }, { "start_logit": 16.125, "end_logit": 8.671875, "text": " hematopoietic stem cell transplant (within 2 years", "probability": 0.0194854736328125 }, { "start_logit": 16.96875, "end_logit": 7.78515625, "text": "Active treatment", "probability": 0.0186004638671875 }, { "start_logit": 17.171875, "end_logit": 7.390625, "text": "Advanced or untreated HIV", "probability": 0.015411376953125 }, { "start_logit": 15.578125, "end_logit": 8.921875, "text": " high-dose corticosteroids (i.e., 20", "probability": 0.0144805908203125 }, { "start_logit": -34.53125, "end_logit": 15.5, "text": "", "probability": 0.0 } ], "100000000000000000006417": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.26171875, "end_logit": -0.30712890625, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000006420": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.265625, "end_logit": -0.3310546875, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000006425": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006287840192903181 }, { "start_logit": 7.58203125, "end_logit": -0.209228515625, "text": "", "probability": 0.9993712159807097 } ], "100000000000000000006428": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.44140625, "end_logit": -0.439208984375, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000006431": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009075025657146729 }, { "start_logit": 7.375, "end_logit": -0.370849609375, "text": "", "probability": 0.9990924974342854 } ], "100000000000000000006434": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002305125202793809 }, { "start_logit": 6.63671875, "end_logit": -0.564453125, "text": "", "probability": 0.9976948747972061 } ], "100000000000000000006442": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006142271998613951 }, { "start_logit": 7.51953125, "end_logit": -0.1251220703125, "text": "", "probability": 0.9993857728001386 } ], "100000000000000000006443": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 8.1015625, "end_logit": -0.87451171875, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000006448": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 7.8125, "end_logit": -0.50732421875, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000006449": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 7.80859375, "end_logit": -0.49267578125, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000006451": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006287840192903181 }, { "start_logit": 7.83984375, "end_logit": -0.468505859375, "text": "", "probability": 0.9993712159807097 } ], "100000000000000000006453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 7.73828125, "end_logit": -0.393798828125, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000006454": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.7890625, "end_logit": -0.576171875, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000006455": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007643033095615911 }, { "start_logit": 7.76953125, "end_logit": -0.59228515625, "text": "", "probability": 0.9992356966904383 } ], "100000000000000000006456": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.80859375, "end_logit": -0.607421875, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000006457": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.6640625, "end_logit": -0.560546875, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000006460": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008199321062135582 }, { "start_logit": 7.5703125, "end_logit": -0.4638671875, "text": "", "probability": 0.9991800678937864 } ], "100000000000000000006465": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 7.62890625, "end_logit": -0.449462890625, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000006475": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.23828125, "end_logit": -0.638671875, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000006478": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.35546875, "end_logit": -0.6845703125, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000006480": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003755592236470211 }, { "start_logit": 8.0703125, "end_logit": -0.1820068359375, "text": "", "probability": 0.999624440776353 } ], "100000000000000000006483": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003799845147518645 }, { "start_logit": 8.046875, "end_logit": -0.1712646484375, "text": "", "probability": 0.999620015485248 } ], "100000000000000000006487": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.546875, "end_logit": -0.56005859375, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000006490": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.50390625, "end_logit": -0.54833984375, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000006494": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00032503584523654725 }, { "start_logit": 8.3984375, "end_logit": -0.366455078125, "text": "", "probability": 0.9996749641547633 } ], "100000000000000000006495": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.515625, "end_logit": -0.52587890625, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000006497": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.546875, "end_logit": -0.552734375, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000006498": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.4765625, "end_logit": -0.61865234375, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000006499": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.4453125, "end_logit": -0.4931640625, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000006505": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000509265714385189 }, { "start_logit": 8.21875, "end_logit": -0.63623046875, "text": "", "probability": 0.9994907342856149 } ], "100000000000000000006507": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004784256262873459 }, { "start_logit": 8.125, "end_logit": -0.480224609375, "text": "", "probability": 0.9995215743737126 } ], "100000000000000000006509": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 6.95703125, "end_logit": -0.25634765625, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000006511": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 6.953125, "end_logit": -0.355712890625, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000006513": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995941349 }, { "start_logit": -33.59375, "end_logit": 11.9765625, "text": "", "probability": 4.0586521248284276e-10 } ], "100000000000000000006514": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996361848 }, { "start_logit": -33.53125, "end_logit": 11.796875, "text": "", "probability": 3.63815225159663e-10 } ], "100000000000000000006518": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 6.73046875, "end_logit": -0.09613037109375, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000006520": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 6.97265625, "end_logit": -0.1815185546875, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000006521": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 6.69921875, "end_logit": -0.10162353515625, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000006522": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 6.85546875, "end_logit": -0.093505859375, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000006523": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 6.85546875, "end_logit": 0.10693359375, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000006528": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.640625, "end_logit": -0.74951171875, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000006529": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010691263618290232 }, { "start_logit": 7.53515625, "end_logit": -0.69482421875, "text": "", "probability": 0.998930873638171 } ], "100000000000000000006532": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.5078125, "end_logit": -0.68408203125, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000006533": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010566838241698937 }, { "start_logit": 7.57421875, "end_logit": -0.72412109375, "text": "", "probability": 0.9989433161758301 } ], "100000000000000000006535": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 6.921875, "end_logit": -0.379150390625, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000006536": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014048677545435851 }, { "start_logit": 6.98828125, "end_logit": -0.421630859375, "text": "", "probability": 0.9985951322454563 } ], "100000000000000000006537": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 7.0078125, "end_logit": -0.416259765625, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000006540": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.10546875, "end_logit": -0.40185546875, "text": "", "probability": 0.998774432551617 } ], "100000000000000000006546": [ { "start_logit": 18.90625, "end_logit": 8.9921875, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.50537109375 }, { "start_logit": 18.90625, "end_logit": 8.109375, "text": "Asthma", "probability": 0.2073974609375 }, { "start_logit": 18.90625, "end_logit": 7.4296875, "text": "Ast", "probability": 0.10595703125 }, { "start_logit": 16.90625, "end_logit": 8.9921875, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.06842041015625 }, { "start_logit": 16.90625, "end_logit": 8.109375, "text": "\nAsthma", "probability": 0.028076171875 }, { "start_logit": 15.9453125, "end_logit": 8.9921875, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.0259552001953125 }, { "start_logit": 15.5703125, "end_logit": 8.9921875, "text": "Bronchiectasis", "probability": 0.017852783203125 }, { "start_logit": 16.90625, "end_logit": 7.4296875, "text": "\nAst", "probability": 0.01433563232421875 }, { "start_logit": 15.9453125, "end_logit": 8.109375, "text": "Chronic lung diseases can include:\nAsthma", "probability": 0.0108184814453125 }, { "start_logit": 15.9453125, "end_logit": 7.4296875, "text": "Chronic lung diseases can include:\nAst", "probability": 0.00543975830078125 }, { "start_logit": 15.9453125, "end_logit": 7.36328125, "text": "Chronic lung diseases", "probability": 0.0051116943359375 }, { "start_logit": 15.9453125, "end_logit": 7.35546875, "text": "Chronic lung", "probability": 0.005031585693359375 }, { "start_logit": 7.59375, "end_logit": -0.4296875, "text": "", "probability": 0.0 } ], "100000000000000000006547": [ { "start_logit": 18.90625, "end_logit": 8.9921875, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.32080078125 }, { "start_logit": 18.90625, "end_logit": 8.109375, "text": "Asthma", "probability": 0.1317138671875 }, { "start_logit": 18.90625, "end_logit": 8.0078125, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs\u2019 airways", "probability": 0.1180419921875 }, { "start_logit": 18.90625, "end_logit": 7.8359375, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis (thickening", "probability": 0.1009521484375 }, { "start_logit": 18.90625, "end_logit": 7.734375, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs", "probability": 0.0904541015625 }, { "start_logit": 18.90625, "end_logit": 7.4296875, "text": "Ast", "probability": 0.0672607421875 }, { "start_logit": 16.90625, "end_logit": 8.9921875, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.043426513671875 }, { "start_logit": 16.90625, "end_logit": 8.109375, "text": "\nAsthma", "probability": 0.017822265625 }, { "start_logit": 15.9453125, "end_logit": 8.9921875, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.0164794921875 }, { "start_logit": 16.90625, "end_logit": 8.0078125, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs\u2019 airways", "probability": 0.015960693359375 }, { "start_logit": 16.90625, "end_logit": 7.8359375, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening", "probability": 0.0136566162109375 }, { "start_logit": 16.90625, "end_logit": 7.734375, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs", "probability": 0.01224517822265625 }, { "start_logit": 15.5703125, "end_logit": 8.9921875, "text": "Bronchiectasis", "probability": 0.01132965087890625 }, { "start_logit": 16.90625, "end_logit": 7.4296875, "text": "\nAst", "probability": 0.00910186767578125 }, { "start_logit": 15.9453125, "end_logit": 8.109375, "text": "Chronic lung diseases can include:\nAsthma", "probability": 0.006866455078125 }, { "start_logit": 15.9453125, "end_logit": 8.0078125, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs\u2019 airways", "probability": 0.00615692138671875 }, { "start_logit": 15.9453125, "end_logit": 7.8359375, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening", "probability": 0.005184173583984375 }, { "start_logit": 15.9453125, "end_logit": 7.734375, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis (thickening of the lungs", "probability": 0.00472259521484375 }, { "start_logit": 15.5703125, "end_logit": 8.0078125, "text": "Bronchiectasis (thickening of the lungs\u2019 airways", "probability": 0.004230499267578125 }, { "start_logit": 15.4921875, "end_logit": 8.0078125, "text": "thickening of the lungs\u2019 airways", "probability": 0.00391387939453125 }, { "start_logit": 7.6328125, "end_logit": -0.4140625, "text": "", "probability": 0.0 } ], "100000000000000000006548": [ { "start_logit": 18.890625, "end_logit": 8.9921875, "text": "Asthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.50244140625 }, { "start_logit": 18.890625, "end_logit": 8.1015625, "text": "Asthma", "probability": 0.2093505859375 }, { "start_logit": 18.890625, "end_logit": 7.41015625, "text": "Ast", "probability": 0.10369873046875 }, { "start_logit": 16.90625, "end_logit": 8.9921875, "text": "\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.0701904296875 }, { "start_logit": 16.90625, "end_logit": 8.1015625, "text": "\nAsthma", "probability": 0.028350830078125 }, { "start_logit": 15.9453125, "end_logit": 8.9921875, "text": "Chronic lung diseases can include:\nAsthma, if it\u2019s moderate to severe\nBronchiectasis", "probability": 0.026641845703125 }, { "start_logit": 15.5625, "end_logit": 8.9921875, "text": "Bronchiectasis", "probability": 0.018310546875 }, { "start_logit": 16.90625, "end_logit": 7.41015625, "text": "\nAst", "probability": 0.014251708984375 }, { "start_logit": 15.9453125, "end_logit": 8.1015625, "text": "Chronic lung diseases can include:\nAsthma", "probability": 0.01092529296875 }, { "start_logit": 15.9453125, "end_logit": 7.41015625, "text": "Chronic lung diseases can include:\nAst", "probability": 0.005496978759765625 }, { "start_logit": 15.9453125, "end_logit": 7.36328125, "text": "Chronic lung diseases", "probability": 0.005245208740234375 }, { "start_logit": 15.9453125, "end_logit": 7.359375, "text": "Chronic lung", "probability": 0.005245208740234375 }, { "start_logit": 7.578125, "end_logit": -0.442626953125, "text": "", "probability": 0.0 } ], "100000000000000000006554": [ { "start_logit": 15.4453125, "end_logit": 7.3515625, "text": "Get", "probability": 1.0 }, { "start_logit": 7.6640625, "end_logit": -1.126953125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000006556": [ { "start_logit": 16.796875, "end_logit": 8.59375, "text": "American Diabetes Association", "probability": 0.47705078125 }, { "start_logit": 15.4453125, "end_logit": 8.59375, "text": "Get more information:\nDiabetes\nAmerican Diabetes Association", "probability": 0.12255859375 }, { "start_logit": 15.3515625, "end_logit": 8.59375, "text": "Diabetes\nAmerican Diabetes Association", "probability": 0.11163330078125 }, { "start_logit": 15.4453125, "end_logit": 8.3671875, "text": "Get more information:\nDiabetes", "probability": 0.0985107421875 }, { "start_logit": 15.3515625, "end_logit": 8.3671875, "text": "Diabetes", "probability": 0.08966064453125 }, { "start_logit": 14.6484375, "end_logit": 8.59375, "text": "\nDiabetes\nAmerican Diabetes Association", "probability": 0.05609130859375 }, { "start_logit": 14.6484375, "end_logit": 8.3671875, "text": "\nDiabetes", "probability": 0.04437255859375 }, { "start_logit": 8.1640625, "end_logit": -0.2274169921875, "text": "", "probability": 0.0 } ], "100000000000000000006563": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 7.5859375, "end_logit": -1.0234375, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000006564": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 7.5078125, "end_logit": -1.013671875, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000006566": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 7.6484375, "end_logit": -1.0537109375, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000006572": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009659749152204077 }, { "start_logit": 7.1640625, "end_logit": -0.22314453125, "text": "", "probability": 0.9990340250847796 } ], "100000000000000000006574": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008263575992788699 }, { "start_logit": 7.15625, "end_logit": -0.058929443359375, "text": "", "probability": 0.9991736424007212 } ], "100000000000000000006580": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.50390625, "end_logit": -0.416015625, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000006585": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.31640625, "end_logit": -0.52734375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000006589": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.4375, "end_logit": -0.57421875, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000006593": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 7.015625, "end_logit": -0.986328125, "text": "", "probability": 0.997603269129871 } ], "100000000000000000006594": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 7.00390625, "end_logit": -0.97119140625, "text": "", "probability": 0.997603269129871 } ], "100000000000000000006604": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004955359475635505 }, { "start_logit": 7.73046875, "end_logit": -0.12078857421875, "text": "", "probability": 0.9995044640524365 } ], "100000000000000000006605": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004710118180887959 }, { "start_logit": 7.9609375, "end_logit": -0.30224609375, "text": "", "probability": 0.9995289881819112 } ], "100000000000000000006611": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 7.70703125, "end_logit": -0.91259765625, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000006612": [ { "start_logit": 15.4453125, "end_logit": 7.3515625, "text": "Get", "probability": 1.0 }, { "start_logit": 7.734375, "end_logit": -0.91455078125, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000006614": [ { "start_logit": 15.4453125, "end_logit": 7.3515625, "text": "Get", "probability": 0.53369140625 }, { "start_logit": 15.4453125, "end_logit": 6.34765625, "text": "Get more", "probability": 0.1964111328125 }, { "start_logit": 15.4453125, "end_logit": 6.23046875, "text": "Get more information:", "probability": 0.17333984375 }, { "start_logit": 14.1015625, "end_logit": 6.34765625, "text": " more", "probability": 0.051239013671875 }, { "start_logit": 14.1015625, "end_logit": 6.23046875, "text": " more information:", "probability": 0.04522705078125 }, { "start_logit": 7.7578125, "end_logit": -0.9306640625, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000006615": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.703125, "end_logit": -0.9267578125, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000006621": [ { "start_logit": 15.75, "end_logit": 7.85546875, "text": "Stroke", "probability": 0.16455078125 }, { "start_logit": 15.4453125, "end_logit": 7.85546875, "text": "Get more information:\nStroke", "probability": 0.120361328125 }, { "start_logit": 15.75, "end_logit": 7.46875, "text": "Stroke\nCOVID", "probability": 0.111328125 }, { "start_logit": 15.4453125, "end_logit": 7.46875, "text": "Get more information:\nStroke\nCOVID", "probability": 0.08148193359375 }, { "start_logit": 15.4453125, "end_logit": 7.3515625, "text": "Get", "probability": 0.072998046875 }, { "start_logit": 15.75, "end_logit": 6.7734375, "text": "Stroke\nCOVID19 Stroke Podcast", "probability": 0.055999755859375 }, { "start_logit": 14.6484375, "end_logit": 7.85546875, "text": "\nStroke", "probability": 0.05426025390625 }, { "start_logit": 14.8671875, "end_logit": 7.46875, "text": "COVID", "probability": 0.04638671875 }, { "start_logit": 15.4453125, "end_logit": 6.7734375, "text": "Get more information:\nStroke\nCOVID19 Stroke Podcast", "probability": 0.04095458984375 }, { "start_logit": 14.6484375, "end_logit": 7.46875, "text": "\nStroke\nCOVID", "probability": 0.03729248046875 }, { "start_logit": 14.1015625, "end_logit": 7.85546875, "text": " more information:\nStroke", "probability": 0.031402587890625 }, { "start_logit": 15.75, "end_logit": 6.07421875, "text": "Stroke\nCOVID19 Stroke", "probability": 0.0277099609375 }, { "start_logit": 15.4453125, "end_logit": 6.34765625, "text": "Get more", "probability": 0.02685546875 }, { "start_logit": 15.4453125, "end_logit": 6.23046875, "text": "Get more information:", "probability": 0.0236968994140625 }, { "start_logit": 14.8671875, "end_logit": 6.7734375, "text": "COVID19 Stroke Podcast", "probability": 0.022979736328125 }, { "start_logit": 14.1015625, "end_logit": 7.46875, "text": " more information:\nStroke\nCOVID", "probability": 0.0212554931640625 }, { "start_logit": 15.4453125, "end_logit": 6.07421875, "text": "Get more information:\nStroke\nCOVID19 Stroke", "probability": 0.0202789306640625 }, { "start_logit": 14.6484375, "end_logit": 6.7734375, "text": "\nStroke\nCOVID19 Stroke Podcast", "probability": 0.018463134765625 }, { "start_logit": 14.8671875, "end_logit": 6.07421875, "text": "COVID19 Stroke", "probability": 0.01137542724609375 }, { "start_logit": 14.1015625, "end_logit": 6.7734375, "text": " more information:\nStroke\nCOVID19 Stroke Podcast", "probability": 0.01068115234375 }, { "start_logit": 8.0, "end_logit": -1.037109375, "text": "", "probability": 0.0 } ], "100000000000000000006624": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.203125, "end_logit": -0.499755859375, "text": "", "probability": 0.998774432551617 } ], "100000000000000000006632": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007978334816343424 }, { "start_logit": 7.5625, "end_logit": -0.428466796875, "text": "", "probability": 0.9992021665183656 } ], "100000000000000000006634": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 7.57421875, "end_logit": -0.379638671875, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000006635": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.6328125, "end_logit": -0.423095703125, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000006637": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007763299914246077 }, { "start_logit": 7.55078125, "end_logit": -0.390380859375, "text": "", "probability": 0.9992236700085755 } ], "100000000000000000006638": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007524628013059865 }, { "start_logit": 7.57421875, "end_logit": -0.384033203125, "text": "", "probability": 0.9992475371986941 } ], "100000000000000000006641": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 6.140625, "end_logit": -0.07769775390625, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000006644": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 6.234375, "end_logit": -0.0633544921875, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000006649": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.15234375, "end_logit": -0.442138671875, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000006652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.4296875, "end_logit": -0.91552734375, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000006653": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.44921875, "end_logit": -0.89892578125, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000006654": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.52734375, "end_logit": -0.953125, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000006656": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.0078125, "end_logit": -0.30029296875, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000006659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.05078125, "end_logit": -0.320556640625, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000006661": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 6.94921875, "end_logit": -0.28076171875, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000006663": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.484375, "end_logit": -0.5849609375, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000006665": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.4609375, "end_logit": -0.564453125, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000006667": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.37109375, "end_logit": -0.5693359375, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000006672": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 6.6171875, "end_logit": 0.1702880859375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000006673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 6.640625, "end_logit": 0.162109375, "text": "", "probability": 0.99889266101491 } ], "100000000000000000006674": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025708680398760864 }, { "start_logit": 7.2109375, "end_logit": -1.25, "text": "", "probability": 0.997429131960124 } ], "100000000000000000006690": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.21484375, "end_logit": -0.3720703125, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000006691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009326360013054126 }, { "start_logit": 7.26171875, "end_logit": -0.28369140625, "text": "", "probability": 0.9990673639986946 } ], "100000000000000000006697": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.14453125, "end_logit": -0.2178955078125, "text": "", "probability": 0.999018828118793 } ], "100000000000000000006701": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989306876 }, { "start_logit": -32.46875, "end_logit": 11.8046875, "text": "", "probability": 1.0693124115404517e-09 } ], "100000000000000000006702": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986269756 }, { "start_logit": -32.59375, "end_logit": 12.1796875, "text": "", "probability": 1.3730243143805984e-09 } ], "100000000000000000006704": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999987101631 }, { "start_logit": -32.625, "end_logit": 12.15625, "text": "", "probability": 1.289836976596949e-09 } ], "100000000000000000006705": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990853685 }, { "start_logit": -32.4375, "end_logit": 11.625, "text": "", "probability": 9.146313747844331e-10 } ], "100000000000000000006706": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002287227605869875 }, { "start_logit": 6.8046875, "end_logit": -0.7275390625, "text": "", "probability": 0.9977127723941301 } ], "100000000000000000006711": [ { "start_logit": 16.171875, "end_logit": 5.68359375, "text": "For more information on coping", "probability": 0.51171875 }, { "start_logit": 16.125, "end_logit": 5.68359375, "text": " coping", "probability": 0.48828125 }, { "start_logit": 8.3125, "end_logit": -1.0546875, "text": "", "probability": 2.384185791015625e-07 } ], "100000000000000000006712": [ { "start_logit": 16.171875, "end_logit": 5.68359375, "text": "For more information on coping", "probability": 0.51171875 }, { "start_logit": 16.125, "end_logit": 5.68359375, "text": " coping", "probability": 0.48828125 }, { "start_logit": 8.296875, "end_logit": -1.10546875, "text": "", "probability": 2.384185791015625e-07 } ], "100000000000000000006717": [ { "start_logit": 15.625, "end_logit": 9.5546875, "text": "F", "probability": 0.5634765625 }, { "start_logit": 15.625, "end_logit": 9.0234375, "text": "FACT", "probability": 0.3310546875 }, { "start_logit": 15.625, "end_logit": 6.9453125, "text": "FACT SHE", "probability": 0.040802001953125 }, { "start_logit": 15.625, "end_logit": 6.76953125, "text": "FACT S", "probability": 0.03436279296875 }, { "start_logit": 13.03125, "end_logit": 9.0234375, "text": "ACT", "probability": 0.024749755859375 }, { "start_logit": 13.03125, "end_logit": 6.9453125, "text": "ACT SHE", "probability": 0.0030498504638671875 }, { "start_logit": 13.03125, "end_logit": 6.76953125, "text": "ACT S", "probability": 0.002567291259765625 }, { "start_logit": 8.703125, "end_logit": -0.6982421875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000006721": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 7.43359375, "end_logit": -0.94140625, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000006728": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.453125, "end_logit": -0.6884765625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000006729": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.46484375, "end_logit": -0.775390625, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000006733": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013831174237397678 }, { "start_logit": 7.109375, "end_logit": -0.52734375, "text": "", "probability": 0.9986168825762602 } ], "100000000000000000006734": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 7.27734375, "end_logit": -0.732421875, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000006741": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.890625, "end_logit": -0.82275390625, "text": "", "probability": 0.999147433358729 } ], "100000000000000000006742": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.875, "end_logit": -0.8125, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000006745": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.83984375, "end_logit": -0.818359375, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000006749": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.25390625, "end_logit": -0.734375, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000006751": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.1875, "end_logit": -0.71484375, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000006755": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.5859375, "end_logit": -0.65869140625, "text": "", "probability": 0.999018828118793 } ], "100000000000000000006758": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.59765625, "end_logit": -0.6640625, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000006763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002157341888452641 }, { "start_logit": 7.12890625, "end_logit": -0.99169921875, "text": "", "probability": 0.9978426581115474 } ], "100000000000000000006767": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0034564096680654286 }, { "start_logit": 6.3671875, "end_logit": -0.705078125, "text": "", "probability": 0.9965435903319345 } ], "100000000000000000006768": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003004343016200306 }, { "start_logit": 6.4609375, "end_logit": -0.65576171875, "text": "", "probability": 0.9969956569837995 } ], "100000000000000000006775": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.30859375, "end_logit": -0.91259765625, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000006776": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.3359375, "end_logit": -0.8369140625, "text": "", "probability": 0.998498817743263 } ], "100000000000000000006778": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 7.3046875, "end_logit": -0.89697265625, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000006779": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 7.359375, "end_logit": -0.78515625, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000006782": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001455062938532843 }, { "start_logit": 7.2265625, "end_logit": -0.69677734375, "text": "", "probability": 0.9985449370614672 } ], "100000000000000000006789": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004070137715896127 }, { "start_logit": 5.90234375, "end_logit": -0.40380859375, "text": "", "probability": 0.995929862284104 } ], "100000000000000000006791": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0039148236056371685 }, { "start_logit": 5.97265625, "end_logit": -0.43505859375, "text": "", "probability": 0.9960851763943629 } ], "100000000000000000006803": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008072304985619872 }, { "start_logit": 7.8359375, "end_logit": -0.71484375, "text": "", "probability": 0.9991927695014381 } ], "100000000000000000006805": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007916296072837431 }, { "start_logit": 7.84765625, "end_logit": -0.708984375, "text": "", "probability": 0.9992083703927161 } ], "100000000000000000006806": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.4921875, "end_logit": -0.75732421875, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000006810": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000507281282699237 }, { "start_logit": 8.203125, "end_logit": -0.61865234375, "text": "", "probability": 0.9994927187173008 } ], "100000000000000000006814": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 8.1328125, "end_logit": -0.650390625, "text": "", "probability": 0.99943852125386 } ], "100000000000000000006815": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999996149258 }, { "start_logit": -32.21875, "end_logit": 12.84375, "text": "", "probability": 3.850741907939403e-09 } ], "100000000000000000006819": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.953125, "end_logit": -0.740234375, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000006822": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007041515890570883 }, { "start_logit": 7.93359375, "end_logit": -0.67578125, "text": "", "probability": 0.9992958484109428 } ], "100000000000000000006827": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.5234375, "end_logit": -0.429931640625, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000006831": [ { "start_logit": 15.625, "end_logit": 15.03125, "text": " the card", "probability": 0.8388671875 }, { "start_logit": 13.546875, "end_logit": 15.03125, "text": "Remember to bring the card", "probability": 0.10491943359375 }, { "start_logit": 12.0546875, "end_logit": 15.03125, "text": " bring the card", "probability": 0.0237884521484375 }, { "start_logit": 13.546875, "end_logit": 12.4375, "text": "Remember to", "probability": 0.007843017578125 }, { "start_logit": 15.625, "end_logit": 10.25, "text": " the", "probability": 0.007030487060546875 }, { "start_logit": 10.25, "end_logit": 15.03125, "text": " to bring the card", "probability": 0.00388336181640625 }, { "start_logit": 15.625, "end_logit": 9.625, "text": " the card when your child returns. ADDITION", "probability": 0.003765106201171875 }, { "start_logit": 15.625, "end_logit": 9.09375, "text": " the card when your child returns. ADDITIONAL", "probability": 0.0022125244140625 }, { "start_logit": 13.546875, "end_logit": 11.1484375, "text": "Remember", "probability": 0.0021457672119140625 }, { "start_logit": 15.625, "end_logit": 8.453125, "text": " the card when your child returns. ADD", "probability": 0.0011663436889648438 }, { "start_logit": 13.546875, "end_logit": 10.25, "text": "Remember to bring the", "probability": 0.0008807182312011719 }, { "start_logit": 15.625, "end_logit": 8.046875, "text": " the card when your child", "probability": 0.0007767677307128906 }, { "start_logit": 15.625, "end_logit": 7.62109375, "text": " the card when your child returns", "probability": 0.0005092620849609375 }, { "start_logit": 13.546875, "end_logit": 9.6328125, "text": "Remember to bring", "probability": 0.0004787445068359375 }, { "start_logit": 13.546875, "end_logit": 9.625, "text": "Remember to bring the card when your child returns. ADDITION", "probability": 0.0004711151123046875 }, { "start_logit": 13.3515625, "end_logit": 9.625, "text": " ADDITION", "probability": 0.0003845691680908203 }, { "start_logit": 10.25, "end_logit": 12.4375, "text": " to", "probability": 0.0002903938293457031 }, { "start_logit": 13.546875, "end_logit": 9.09375, "text": "Remember to bring the card when your child returns. ADDITIONAL", "probability": 0.0002770423889160156 }, { "start_logit": 13.3515625, "end_logit": 9.09375, "text": " ADDITIONAL", "probability": 0.00022614002227783203 }, { "start_logit": 12.0546875, "end_logit": 10.25, "text": " bring the", "probability": 0.00019943714141845703 }, { "start_logit": 6.4921875, "end_logit": -0.72900390625, "text": "", "probability": 0.0 } ], "100000000000000000006833": [ { "start_logit": 15.625, "end_logit": 15.03125, "text": " the card", "probability": 0.8388671875 }, { "start_logit": 13.546875, "end_logit": 15.03125, "text": "Remember to bring the card", "probability": 0.10491943359375 }, { "start_logit": 12.0546875, "end_logit": 15.03125, "text": " bring the card", "probability": 0.0237884521484375 }, { "start_logit": 13.546875, "end_logit": 12.4375, "text": "Remember to", "probability": 0.007843017578125 }, { "start_logit": 15.625, "end_logit": 10.25, "text": " the", "probability": 0.007030487060546875 }, { "start_logit": 10.25, "end_logit": 15.03125, "text": " to bring the card", "probability": 0.00388336181640625 }, { "start_logit": 15.625, "end_logit": 9.625, "text": " the card when your child returns. ADDITION", "probability": 0.003765106201171875 }, { "start_logit": 15.625, "end_logit": 9.09375, "text": " the card when your child returns. ADDITIONAL", "probability": 0.0022125244140625 }, { "start_logit": 13.546875, "end_logit": 11.1484375, "text": "Remember", "probability": 0.0021457672119140625 }, { "start_logit": 15.625, "end_logit": 8.453125, "text": " the card when your child returns. ADD", "probability": 0.0011663436889648438 }, { "start_logit": 13.546875, "end_logit": 10.25, "text": "Remember to bring the", "probability": 0.0008807182312011719 }, { "start_logit": 15.625, "end_logit": 8.046875, "text": " the card when your child", "probability": 0.0007767677307128906 }, { "start_logit": 15.625, "end_logit": 7.62109375, "text": " the card when your child returns", "probability": 0.0005092620849609375 }, { "start_logit": 13.546875, "end_logit": 9.6328125, "text": "Remember to bring", "probability": 0.0004787445068359375 }, { "start_logit": 13.546875, "end_logit": 9.625, "text": "Remember to bring the card when your child returns. ADDITION", "probability": 0.0004711151123046875 }, { "start_logit": 13.3515625, "end_logit": 9.625, "text": " ADDITION", "probability": 0.0003845691680908203 }, { "start_logit": 10.25, "end_logit": 12.4375, "text": " to", "probability": 0.0002903938293457031 }, { "start_logit": 13.546875, "end_logit": 9.09375, "text": "Remember to bring the card when your child returns. ADDITIONAL", "probability": 0.0002770423889160156 }, { "start_logit": 13.3515625, "end_logit": 9.09375, "text": " ADDITIONAL", "probability": 0.00022614002227783203 }, { "start_logit": 12.0546875, "end_logit": 10.25, "text": " bring the", "probability": 0.00019943714141845703 }, { "start_logit": 6.44140625, "end_logit": -0.7099609375, "text": "", "probability": 0.0 } ], "100000000000000000006834": [ { "start_logit": 15.625, "end_logit": 15.015625, "text": " the card", "probability": 0.8388671875 }, { "start_logit": 13.546875, "end_logit": 15.015625, "text": "Remember to bring the card", "probability": 0.10491943359375 }, { "start_logit": 12.0546875, "end_logit": 15.015625, "text": " bring the card", "probability": 0.0234222412109375 }, { "start_logit": 13.546875, "end_logit": 12.4375, "text": "Remember to", "probability": 0.007965087890625 }, { "start_logit": 15.625, "end_logit": 10.25, "text": " the", "probability": 0.00714111328125 }, { "start_logit": 10.25, "end_logit": 15.015625, "text": " to bring the card", "probability": 0.00388336181640625 }, { "start_logit": 15.625, "end_logit": 9.625, "text": " the card when your child returns. ADDITION", "probability": 0.00382232666015625 }, { "start_logit": 15.625, "end_logit": 9.0703125, "text": " the card when your child returns. ADDITIONAL", "probability": 0.002178192138671875 }, { "start_logit": 13.546875, "end_logit": 11.1484375, "text": "Remember", "probability": 0.002178192138671875 }, { "start_logit": 15.625, "end_logit": 8.4609375, "text": " the card when your child returns. ADD", "probability": 0.0012025833129882812 }, { "start_logit": 13.546875, "end_logit": 10.25, "text": "Remember to bring the", "probability": 0.0008940696716308594 }, { "start_logit": 15.625, "end_logit": 8.0390625, "text": " the card when your child", "probability": 0.0007767677307128906 }, { "start_logit": 15.625, "end_logit": 7.62109375, "text": " the card when your child returns", "probability": 0.0005173683166503906 }, { "start_logit": 13.546875, "end_logit": 9.6328125, "text": "Remember to bring", "probability": 0.0004863739013671875 }, { "start_logit": 13.546875, "end_logit": 9.625, "text": "Remember to bring the card when your child returns. ADDITION", "probability": 0.0004787445068359375 }, { "start_logit": 13.34375, "end_logit": 9.625, "text": " ADDITION", "probability": 0.0003905296325683594 }, { "start_logit": 10.25, "end_logit": 12.4375, "text": " to", "probability": 0.0002949237823486328 }, { "start_logit": 13.546875, "end_logit": 9.0703125, "text": "Remember to bring the card when your child returns. ADDITIONAL", "probability": 0.0002770423889160156 }, { "start_logit": 13.34375, "end_logit": 9.0703125, "text": " ADDITIONAL", "probability": 0.0002225637435913086 }, { "start_logit": 12.0546875, "end_logit": 10.25, "text": " bring the", "probability": 0.00020265579223632812 }, { "start_logit": 6.48046875, "end_logit": -0.72509765625, "text": "", "probability": 0.0 } ], "100000000000000000006836": [ { "start_logit": 15.625, "end_logit": 15.03125, "text": " the card", "probability": 0.8388671875 }, { "start_logit": 13.546875, "end_logit": 15.03125, "text": "Remember to bring the card", "probability": 0.10491943359375 }, { "start_logit": 12.0546875, "end_logit": 15.03125, "text": " bring the card", "probability": 0.0237884521484375 }, { "start_logit": 13.546875, "end_logit": 12.4375, "text": "Remember to", "probability": 0.007843017578125 }, { "start_logit": 15.625, "end_logit": 10.25, "text": " the", "probability": 0.007030487060546875 }, { "start_logit": 10.25, "end_logit": 15.03125, "text": " to bring the card", "probability": 0.00388336181640625 }, { "start_logit": 15.625, "end_logit": 9.6171875, "text": " the card when your child returns. ADDITION", "probability": 0.003765106201171875 }, { "start_logit": 15.625, "end_logit": 9.0703125, "text": " the card when your child returns. ADDITIONAL", "probability": 0.0021457672119140625 }, { "start_logit": 13.546875, "end_logit": 11.1484375, "text": "Remember", "probability": 0.0021457672119140625 }, { "start_logit": 15.625, "end_logit": 8.4609375, "text": " the card when your child returns. ADD", "probability": 0.0011844635009765625 }, { "start_logit": 13.546875, "end_logit": 10.25, "text": "Remember to bring the", "probability": 0.0008807182312011719 }, { "start_logit": 15.625, "end_logit": 8.046875, "text": " the card when your child", "probability": 0.0007767677307128906 }, { "start_logit": 15.625, "end_logit": 7.62109375, "text": " the card when your child returns", "probability": 0.0005092620849609375 }, { "start_logit": 13.546875, "end_logit": 9.6328125, "text": "Remember to bring", "probability": 0.0004787445068359375 }, { "start_logit": 13.546875, "end_logit": 9.6171875, "text": "Remember to bring the card when your child returns. ADDITION", "probability": 0.0004639625549316406 }, { "start_logit": 13.34375, "end_logit": 9.6171875, "text": " ADDITION", "probability": 0.0003845691680908203 }, { "start_logit": 10.25, "end_logit": 12.4375, "text": " to", "probability": 0.0002903938293457031 }, { "start_logit": 13.546875, "end_logit": 9.0703125, "text": "Remember to bring the card when your child returns. ADDITIONAL", "probability": 0.0002727508544921875 }, { "start_logit": 13.34375, "end_logit": 9.0703125, "text": " ADDITIONAL", "probability": 0.00021910667419433594 }, { "start_logit": 12.0546875, "end_logit": 10.25, "text": " bring the", "probability": 0.00019943714141845703 }, { "start_logit": 6.41015625, "end_logit": -0.74755859375, "text": "", "probability": 0.0 } ], "100000000000000000006838": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012255674483830526 }, { "start_logit": 7.31640625, "end_logit": -0.61376953125, "text": "", "probability": 0.998774432551617 } ], "100000000000000000006843": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.58203125, "end_logit": -0.85595703125, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000006844": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.59375, "end_logit": -0.87548828125, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000006847": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.3671875, "end_logit": -0.55810546875, "text": "", "probability": 0.998896973358602 } ], "100000000000000000006851": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.296875, "end_logit": -0.517578125, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000006856": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.26953125, "end_logit": -0.396240234375, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000006860": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 7.0, "end_logit": -0.828125, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000006865": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 7.1171875, "end_logit": 0.07806396484375, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000006867": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006436856044842308 }, { "start_logit": 7.9296875, "end_logit": -0.58251953125, "text": "", "probability": 0.9993563143955159 } ], "100000000000000000006871": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.81640625, "end_logit": -0.59716796875, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000006890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018821859100764038 }, { "start_logit": 6.859375, "end_logit": -0.58544921875, "text": "", "probability": 0.9981178140899236 } ], "100000000000000000006892": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 6.8671875, "end_logit": -0.6103515625, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000006893": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002115703400593114 }, { "start_logit": 6.75, "end_logit": -0.59375, "text": "", "probability": 0.9978842965994068 } ], "100000000000000000006894": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 6.8203125, "end_logit": -0.564453125, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000006895": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 6.8125, "end_logit": -0.55029296875, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000006897": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 7.12890625, "end_logit": -0.6904296875, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000006898": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.9140625, "end_logit": -0.54541015625, "text": "", "probability": 0.998285961520812 } ], "100000000000000000006899": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016356753292389016 }, { "start_logit": 6.9765625, "end_logit": -0.564453125, "text": "", "probability": 0.998364324670761 } ], "100000000000000000006901": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0352111364215758 }, { "start_logit": 5.19921875, "end_logit": -1.888671875, "text": "", "probability": 0.9647888635784241 } ], "100000000000000000006905": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991672186 }, { "start_logit": -33.875, "end_logit": 12.9765625, "text": "", "probability": 8.327813436526549e-10 } ], "100000000000000000006906": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991672186 }, { "start_logit": -33.875, "end_logit": 12.9609375, "text": "", "probability": 8.327813436526549e-10 } ], "100000000000000000006907": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991541042 }, { "start_logit": -33.84375, "end_logit": 12.953125, "text": "", "probability": 8.45895741557832e-10 } ], "100000000000000000006909": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992176742 }, { "start_logit": -33.84375, "end_logit": 12.8671875, "text": "", "probability": 7.82325672734135e-10 } ], "100000000000000000006911": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973534264 }, { "start_logit": -34.03125, "end_logit": 14.2890625, "text": "", "probability": 2.646573631904765e-09 } ], "100000000000000000006912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999997664407 }, { "start_logit": -34.0, "end_logit": 14.125, "text": "", "probability": 2.3355930333443423e-09 } ], "100000000000000000006918": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029008577108601222 }, { "start_logit": 6.25, "end_logit": -0.410400390625, "text": "", "probability": 0.99709914228914 } ], "100000000000000000006931": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008492456216931709 }, { "start_logit": 6.94140625, "end_logit": 0.126953125, "text": "", "probability": 0.9991507543783068 } ], "100000000000000000006932": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.28515625, "end_logit": -0.57958984375, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000006933": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.18359375, "end_logit": -0.438232421875, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000006936": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017342079835090854 }, { "start_logit": 6.9453125, "end_logit": -0.58984375, "text": "", "probability": 0.998265792016491 } ], "100000000000000000006937": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017140384791880213 }, { "start_logit": 6.93359375, "end_logit": -0.564453125, "text": "", "probability": 0.998285961520812 } ], "100000000000000000006938": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001707367485760838 }, { "start_logit": 6.96484375, "end_logit": -0.5927734375, "text": "", "probability": 0.9982926325142392 } ], "100000000000000000006945": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 7.0390625, "end_logit": -0.80224609375, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000006947": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001754614410099487 }, { "start_logit": 7.1171875, "end_logit": -0.7734375, "text": "", "probability": 0.9982453855899006 } ], "100000000000000000006948": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018102110262026487 }, { "start_logit": 7.13671875, "end_logit": -0.82470703125, "text": "", "probability": 0.9981897889737974 } ], "100000000000000000006949": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001919237453341115 }, { "start_logit": 7.08984375, "end_logit": -0.83740234375, "text": "", "probability": 0.998080762546659 } ], "100000000000000000006950": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.8125, "end_logit": -0.50439453125, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000006957": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 6.8828125, "end_logit": -0.3837890625, "text": "", "probability": 0.998498817743263 } ], "100000000000000000006958": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 6.95703125, "end_logit": -0.4384765625, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000006959": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 6.90625, "end_logit": -0.386962890625, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000006965": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 6.6796875, "end_logit": -0.3330078125, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000006966": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016809417013868683 }, { "start_logit": 6.7109375, "end_logit": -0.324951171875, "text": "", "probability": 0.998319058298613 } ], "100000000000000000006967": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016103573704565953 }, { "start_logit": 6.8046875, "end_logit": -0.376220703125, "text": "", "probability": 0.9983896426295433 } ], "100000000000000000006975": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003311519060269664 }, { "start_logit": 6.21484375, "end_logit": -0.5078125, "text": "", "probability": 0.9966884809397303 } ], "100000000000000000006979": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 6.56640625, "end_logit": -0.48486328125, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000006983": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 6.8515625, "end_logit": -0.300537109375, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000006985": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013670256456563563 }, { "start_logit": 6.91015625, "end_logit": -0.318115234375, "text": "", "probability": 0.9986329743543437 } ], "100000000000000000006986": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 6.8046875, "end_logit": -0.337646484375, "text": "", "probability": 0.998451238905712 } ], "100000000000000000006988": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.47265625, "end_logit": -0.80078125, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000006989": [ { "start_logit": 14.7421875, "end_logit": 10.1015625, "text": "The Countermeasures", "probability": 0.3046875 }, { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 0.29541015625 }, { "start_logit": 14.7421875, "end_logit": 9.2890625, "text": "The Counterme", "probability": 0.13525390625 }, { "start_logit": 14.7421875, "end_logit": 8.4453125, "text": "The Countermeasures Injury Compensation", "probability": 0.058135986328125 }, { "start_logit": 14.7421875, "end_logit": 8.390625, "text": "The Counter", "probability": 0.054656982421875 }, { "start_logit": 12.828125, "end_logit": 10.1015625, "text": " Countermeasures", "probability": 0.045318603515625 }, { "start_logit": 14.7421875, "end_logit": 8.09375, "text": "The Countermeasures Injury", "probability": 0.041259765625 }, { "start_logit": 12.828125, "end_logit": 9.2890625, "text": " Counterme", "probability": 0.020111083984375 }, { "start_logit": 13.1328125, "end_logit": 8.4453125, "text": " Injury Compensation", "probability": 0.01163482666015625 }, { "start_logit": 12.828125, "end_logit": 8.4453125, "text": " Countermeasures Injury Compensation", "probability": 0.00864410400390625 }, { "start_logit": 13.1328125, "end_logit": 8.09375, "text": " Injury", "probability": 0.00811767578125 }, { "start_logit": 12.828125, "end_logit": 8.390625, "text": " Counter", "probability": 0.00811767578125 }, { "start_logit": 12.828125, "end_logit": 8.09375, "text": " Countermeasures Injury", "probability": 0.00603485107421875 }, { "start_logit": 11.6171875, "end_logit": 8.4453125, "text": " Compensation", "probability": 0.00255584716796875 }, { "start_logit": 7.51171875, "end_logit": -0.85400390625, "text": "", "probability": 0.0 } ], "100000000000000000006990": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 7.3984375, "end_logit": -0.78857421875, "text": "", "probability": 0.998654139598703 } ], "100000000000000000006994": [ { "start_logit": 14.7421875, "end_logit": 10.0703125, "text": "The", "probability": 1.0 }, { "start_logit": 7.47265625, "end_logit": -0.8134765625, "text": "", "probability": 0.0 } ], "100000000000000000007001": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.3515625, "end_logit": -0.46826171875, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000007004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003275842978596865 }, { "start_logit": 7.90625, "end_logit": 0.11920166015625, "text": "", "probability": 0.9996724157021403 } ], "100000000000000000007009": [ { "start_logit": -33.65625, "end_logit": 22.453125, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes\nIrritability or crying\nSleepiness", "probability": 0.50390625 }, { "start_logit": -33.65625, "end_logit": 21.90625, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes\nIrritability", "probability": 0.29150390625 }, { "start_logit": -33.65625, "end_logit": 21.078125, "text": "Pain on the leg or arm", "probability": 0.12744140625 }, { "start_logit": -33.65625, "end_logit": 20.578125, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes", "probability": 0.07720947265625 }, { "start_logit": -33.96875, "end_logit": 13.875, "text": "", "probability": 6.937980651855469e-05 } ], "100000000000000000007013": [ { "start_logit": -33.65625, "end_logit": 22.453125, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes\nIrritability or crying\nSleepiness", "probability": 0.47802734375 }, { "start_logit": -33.65625, "end_logit": 21.90625, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes\nIrritability", "probability": 0.276611328125 }, { "start_logit": -33.65625, "end_logit": 21.078125, "text": "Pain on the leg or arm", "probability": 0.12091064453125 }, { "start_logit": -33.65625, "end_logit": 20.578125, "text": "Pain on the leg or arm where the shot was given\nSwollen lymph nodes", "probability": 0.07330322265625 }, { "start_logit": -33.65625, "end_logit": 20.21875, "text": "Pain on the leg", "probability": 0.051177978515625 }, { "start_logit": -33.90625, "end_logit": 13.6484375, "text": "", "probability": 5.632638931274414e-05 } ], "100000000000000000007015": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.19140625, "end_logit": -0.476806640625, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000007016": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 7.29296875, "end_logit": -0.50146484375, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000007020": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046552691875201524 }, { "start_logit": 7.45703125, "end_logit": 0.2159423828125, "text": "", "probability": 0.9995344730812479 } ], "100000000000000000007030": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006771942330385673 }, { "start_logit": 7.80859375, "end_logit": -0.5107421875, "text": "", "probability": 0.9993228057669614 } ], "100000000000000000007037": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.5546875, "end_logit": -0.487548828125, "text": "", "probability": 0.999147433358729 } ], "100000000000000000007038": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.5546875, "end_logit": -0.455078125, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000007043": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008040859356292355 }, { "start_logit": 7.6015625, "end_logit": -0.476318359375, "text": "", "probability": 0.9991959140643708 } ], "100000000000000000007047": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009473089682583146 }, { "start_logit": 7.48046875, "end_logit": -0.521484375, "text": "", "probability": 0.9990526910317417 } ], "100000000000000000007053": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 6.91015625, "end_logit": -0.168701171875, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000007056": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000499420543153358 }, { "start_logit": 7.5078125, "end_logit": 0.09405517578125, "text": "", "probability": 0.9995005794568467 } ], "100000000000000000007065": [ { "start_logit": 16.75, "end_logit": 7.37890625, "text": "Other factors can further increase", "probability": 0.1636962890625 }, { "start_logit": 16.75, "end_logit": 6.9453125, "text": "Other factors", "probability": 0.10565185546875 }, { "start_logit": 16.171875, "end_logit": 7.37890625, "text": "Certain factors can increase risk\nOther factors can further increase", "probability": 0.09185791015625 }, { "start_logit": 16.015625, "end_logit": 7.37890625, "text": " risk\nOther factors can further increase", "probability": 0.07855224609375 }, { "start_logit": 16.171875, "end_logit": 7.09375, "text": "Certain factors can increase", "probability": 0.06927490234375 }, { "start_logit": 16.171875, "end_logit": 6.9453125, "text": "Certain factors can increase risk\nOther factors", "probability": 0.060211181640625 }, { "start_logit": 16.75, "end_logit": 6.29296875, "text": "Other factors can further increase the risk for getting very sick from COVID-19", "probability": 0.055694580078125 }, { "start_logit": 16.171875, "end_logit": 6.828125, "text": "Certain factors", "probability": 0.05316162109375 }, { "start_logit": 16.015625, "end_logit": 6.9453125, "text": " risk\nOther factors", "probability": 0.051513671875 }, { "start_logit": 16.75, "end_logit": 5.85546875, "text": "Other factors can further increase the risk", "probability": 0.035980224609375 }, { "start_logit": 16.171875, "end_logit": 6.30078125, "text": "Certain factors can increase risk", "probability": 0.0312347412109375 }, { "start_logit": 16.171875, "end_logit": 6.29296875, "text": "Certain factors can increase risk\nOther factors can further increase the risk for getting very sick from COVID-19", "probability": 0.0312347412109375 }, { "start_logit": 16.015625, "end_logit": 6.30078125, "text": " risk", "probability": 0.0267181396484375 }, { "start_logit": 16.015625, "end_logit": 6.29296875, "text": " risk\nOther factors can further increase the risk for getting very sick from COVID-19", "probability": 0.0267181396484375 }, { "start_logit": 14.7890625, "end_logit": 7.37890625, "text": "\nOther factors can further increase", "probability": 0.023223876953125 }, { "start_logit": 14.75, "end_logit": 7.37890625, "text": " increase risk\nOther factors can further increase", "probability": 0.02215576171875 }, { "start_logit": 16.171875, "end_logit": 5.85546875, "text": "Certain factors can increase risk\nOther factors can further increase the risk", "probability": 0.020172119140625 }, { "start_logit": 15.6953125, "end_logit": 6.29296875, "text": " COVID-19", "probability": 0.0192413330078125 }, { "start_logit": 16.015625, "end_logit": 5.85546875, "text": " risk\nOther factors can further increase the risk", "probability": 0.0172576904296875 }, { "start_logit": 14.75, "end_logit": 7.09375, "text": " increase", "probability": 0.0167236328125 }, { "start_logit": 8.03125, "end_logit": -0.97607421875, "text": "", "probability": 0.0 } ], "100000000000000000007070": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.2890625, "end_logit": -0.62109375, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000007077": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008796062064765496 }, { "start_logit": 7.48828125, "end_logit": -0.451904296875, "text": "", "probability": 0.9991203937935235 } ], "100000000000000000007078": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008830458477845482 }, { "start_logit": 7.48828125, "end_logit": -0.455810546875, "text": "", "probability": 0.9991169541522155 } ], "100000000000000000007079": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009436192455752619 }, { "start_logit": 7.125, "end_logit": -0.158935546875, "text": "", "probability": 0.9990563807544247 } ], "100000000000000000007083": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.1328125, "end_logit": -0.272216796875, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000007086": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.1171875, "end_logit": -0.348388671875, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000007090": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.078125, "end_logit": -0.290771484375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000007091": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.015625, "end_logit": -0.392578125, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000007092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.0078125, "end_logit": -0.355224609375, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000007107": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.10546875, "end_logit": -0.232421875, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000007111": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.03515625, "end_logit": -0.246337890625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000007112": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.09765625, "end_logit": -0.2420654296875, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000007113": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 6.99609375, "end_logit": -0.2203369140625, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000007114": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.0546875, "end_logit": -0.2646484375, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000007116": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005336928427664175 }, { "start_logit": 7.8984375, "end_logit": -0.361572265625, "text": "", "probability": 0.9994663071572335 } ], "100000000000000000007121": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 7.4765625, "end_logit": -0.195068359375, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000007124": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019043302713475422 }, { "start_logit": 7.1171875, "end_logit": -0.85498046875, "text": "", "probability": 0.9980956697286526 } ], "100000000000000000007127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001919237453341115 }, { "start_logit": 7.0703125, "end_logit": -0.81591796875, "text": "", "probability": 0.998080762546659 } ], "100000000000000000007129": [ { "start_logit": 17.765625, "end_logit": 6.98828125, "text": "COVID-19", "probability": 0.486572265625 }, { "start_logit": 16.53125, "end_logit": 6.98828125, "text": "Related Pages\nCOVID-19", "probability": 0.1416015625 }, { "start_logit": 17.765625, "end_logit": 5.7109375, "text": "COVID-19 Toolkit", "probability": 0.1351318359375 }, { "start_logit": 17.765625, "end_logit": 4.92578125, "text": "COVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.061859130859375 }, { "start_logit": 16.53125, "end_logit": 5.7109375, "text": "Related Pages\nCOVID-19 Toolkit", "probability": 0.039947509765625 }, { "start_logit": 15.0390625, "end_logit": 6.98828125, "text": "\nCOVID-19", "probability": 0.0321044921875 }, { "start_logit": 14.90625, "end_logit": 6.98828125, "text": " Pages\nCOVID-19", "probability": 0.02789306640625 }, { "start_logit": 16.53125, "end_logit": 4.92578125, "text": "Related Pages\nCOVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.01800537109375 }, { "start_logit": 16.109375, "end_logit": 4.92578125, "text": " Pregnant People and New Parents", "probability": 0.011810302734375 }, { "start_logit": 15.1171875, "end_logit": 5.7109375, "text": " Toolkit", "probability": 0.00963592529296875 }, { "start_logit": 15.0390625, "end_logit": 5.7109375, "text": "\nCOVID-19 Toolkit", "probability": 0.0089111328125 }, { "start_logit": 14.90625, "end_logit": 5.7109375, "text": " Pages\nCOVID-19 Toolkit", "probability": 0.00786590576171875 }, { "start_logit": 15.5390625, "end_logit": 4.92578125, "text": " New Parents", "probability": 0.0067291259765625 }, { "start_logit": 15.1171875, "end_logit": 4.92578125, "text": " Toolkit for Pregnant People and New Parents", "probability": 0.0044097900390625 }, { "start_logit": 15.0390625, "end_logit": 4.92578125, "text": "\nCOVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.00408172607421875 }, { "start_logit": 14.90625, "end_logit": 4.92578125, "text": " Pages\nCOVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.0035457611083984375 }, { "start_logit": 8.9609375, "end_logit": -1.2490234375, "text": "", "probability": 0.0 } ], "100000000000000000007130": [ { "start_logit": 17.765625, "end_logit": 6.98828125, "text": "COVID-19", "probability": 0.2392578125 }, { "start_logit": 17.765625, "end_logit": 6.890625, "text": "COVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.2178955078125 }, { "start_logit": 17.1875, "end_logit": 6.890625, "text": "COVID-19", "probability": 0.1221923828125 }, { "start_logit": 16.53125, "end_logit": 6.98828125, "text": "Related Pages\nCOVID-19", "probability": 0.06964111328125 }, { "start_logit": 17.765625, "end_logit": 5.703125, "text": "COVID-19 Toolkit", "probability": 0.06640625 }, { "start_logit": 16.53125, "end_logit": 6.890625, "text": "Related Pages\nCOVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.0633544921875 }, { "start_logit": 16.109375, "end_logit": 6.890625, "text": " Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.041595458984375 }, { "start_logit": 17.765625, "end_logit": 4.9296875, "text": "COVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.0303955078125 }, { "start_logit": 15.53125, "end_logit": 6.890625, "text": " New Parents\n\u203a\nCOVID-19", "probability": 0.0233154296875 }, { "start_logit": 16.53125, "end_logit": 5.703125, "text": "Related Pages\nCOVID-19 Toolkit", "probability": 0.0193328857421875 }, { "start_logit": 15.0390625, "end_logit": 6.98828125, "text": "\nCOVID-19", "probability": 0.0157928466796875 }, { "start_logit": 15.1171875, "end_logit": 6.890625, "text": " Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.015289306640625 }, { "start_logit": 15.0390625, "end_logit": 6.890625, "text": "\nCOVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.01436614990234375 }, { "start_logit": 14.90625, "end_logit": 6.98828125, "text": " Pages\nCOVID-19", "probability": 0.01371002197265625 }, { "start_logit": 14.90625, "end_logit": 6.890625, "text": " Pages\nCOVID-19 Toolkit for Pregnant People and New Parents\n\u203a\nCOVID-19", "probability": 0.012481689453125 }, { "start_logit": 14.75, "end_logit": 6.890625, "text": "\nCOVID-19", "probability": 0.01067352294921875 }, { "start_logit": 16.53125, "end_logit": 4.9296875, "text": "Related Pages\nCOVID-19 Toolkit for Pregnant People and New Parents", "probability": 0.0089874267578125 }, { "start_logit": 16.109375, "end_logit": 4.9296875, "text": " Pregnant People and New Parents", "probability": 0.00580596923828125 }, { "start_logit": 15.1171875, "end_logit": 5.703125, "text": " Toolkit", "probability": 0.004665374755859375 }, { "start_logit": 15.0390625, "end_logit": 5.703125, "text": "\nCOVID-19 Toolkit", "probability": 0.0043792724609375 }, { "start_logit": 8.9375, "end_logit": -1.2724609375, "text": "", "probability": 0.0 } ], "100000000000000000007134": [ { "start_logit": 17.765625, "end_logit": 6.98828125, "text": "COVID-19", "probability": 0.546875 }, { "start_logit": 16.53125, "end_logit": 6.98828125, "text": "Related Pages\nCOVID-19", "probability": 0.1591796875 }, { "start_logit": 17.765625, "end_logit": 5.7109375, "text": "COVID-19 Toolkit", "probability": 0.15185546875 }, { "start_logit": 16.53125, "end_logit": 5.7109375, "text": "Related Pages\nCOVID-19 Toolkit", "probability": 0.044891357421875 }, { "start_logit": 15.0390625, "end_logit": 6.98828125, "text": "\nCOVID-19", "probability": 0.036102294921875 }, { "start_logit": 14.90625, "end_logit": 6.98828125, "text": " Pages\nCOVID-19", "probability": 0.031341552734375 }, { "start_logit": 15.1171875, "end_logit": 5.7109375, "text": " Toolkit", "probability": 0.010833740234375 }, { "start_logit": 15.0390625, "end_logit": 5.7109375, "text": "\nCOVID-19 Toolkit", "probability": 0.01001739501953125 }, { "start_logit": 14.90625, "end_logit": 5.7109375, "text": " Pages\nCOVID-19 Toolkit", "probability": 0.00884246826171875 }, { "start_logit": 8.875, "end_logit": -1.232421875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000007135": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 7.453125, "end_logit": -0.94091796875, "text": "", "probability": 0.998516281097091 } ], "100000000000000000007137": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 7.4453125, "end_logit": -0.94287109375, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000007144": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 7.18359375, "end_logit": -0.70849609375, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000007147": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 7.19140625, "end_logit": -0.74560546875, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000007148": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 7.1953125, "end_logit": -0.65625, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000007149": [ { "start_logit": 17.140625, "end_logit": 9.5703125, "text": "VACCINE", "probability": 0.28466796875 }, { "start_logit": 17.140625, "end_logit": 8.8984375, "text": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.1431884765625 }, { "start_logit": 17.140625, "end_logit": 8.421875, "text": "V", "probability": 0.08953857421875 }, { "start_logit": 17.140625, "end_logit": 8.3125, "text": "VACC", "probability": 0.08026123046875 }, { "start_logit": 16.25, "end_logit": 8.8984375, "text": "COVID-19", "probability": 0.059661865234375 }, { "start_logit": 16.25, "end_logit": 8.6328125, "text": "COVID-19 VACCINE, mRNA", "probability": 0.045013427734375 }, { "start_logit": 16.71875, "end_logit": 8.0859375, "text": " THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.042327880859375 }, { "start_logit": 15.15625, "end_logit": 9.5703125, "text": "ACCINE", "probability": 0.03851318359375 }, { "start_logit": 15.765625, "end_logit": 8.6328125, "text": " mRNA", "probability": 0.0281829833984375 }, { "start_logit": 16.25, "end_logit": 8.0859375, "text": "COVID-19 VACCINE, mRNA), THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.0264739990234375 }, { "start_logit": 17.140625, "end_logit": 7.16796875, "text": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY", "probability": 0.0256500244140625 }, { "start_logit": 15.1953125, "end_logit": 8.8984375, "text": " INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.0206146240234375 }, { "start_logit": 15.15625, "end_logit": 8.8984375, "text": "ACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.0199737548828125 }, { "start_logit": 16.71875, "end_logit": 7.328125, "text": " THE PFIZER", "probability": 0.019683837890625 }, { "start_logit": 15.765625, "end_logit": 8.0859375, "text": " mRNA), THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.01605224609375 }, { "start_logit": 16.71875, "end_logit": 6.9375, "text": " THE PFIZER-BIONTECH\nCOVID-19 VACCINE, AND THE PFIZER-BIONTECH COVID-19", "probability": 0.01331329345703125 }, { "start_logit": 16.71875, "end_logit": 6.86328125, "text": " THE PFIZER-BIONTECH\nCOVID-19 VACCINE, AND THE PFIZER", "probability": 0.01230621337890625 }, { "start_logit": 16.25, "end_logit": 7.328125, "text": "COVID-19 VACCINE, mRNA), THE PFIZER", "probability": 0.01230621337890625 }, { "start_logit": 15.40625, "end_logit": 8.0859375, "text": "COVID-19", "probability": 0.011383056640625 }, { "start_logit": 15.15625, "end_logit": 8.3125, "text": "ACC", "probability": 0.01103973388671875 }, { "start_logit": 8.859375, "end_logit": -0.716796875, "text": "", "probability": 0.0 } ], "100000000000000000007150": [ { "start_logit": 17.140625, "end_logit": 9.5703125, "text": "VACCINE", "probability": 0.2861328125 }, { "start_logit": 17.140625, "end_logit": 8.890625, "text": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.143798828125 }, { "start_logit": 17.140625, "end_logit": 8.421875, "text": "V", "probability": 0.09002685546875 }, { "start_logit": 17.140625, "end_logit": 8.3125, "text": "VACC", "probability": 0.08062744140625 }, { "start_logit": 16.25, "end_logit": 8.890625, "text": "COVID-19", "probability": 0.059051513671875 }, { "start_logit": 16.25, "end_logit": 8.6328125, "text": "COVID-19 VACCINE, mRNA", "probability": 0.045257568359375 }, { "start_logit": 16.703125, "end_logit": 8.0859375, "text": " THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.04119873046875 }, { "start_logit": 15.15625, "end_logit": 9.5703125, "text": "ACCINE", "probability": 0.038726806640625 }, { "start_logit": 15.7734375, "end_logit": 8.6328125, "text": " mRNA", "probability": 0.0283203125 }, { "start_logit": 16.25, "end_logit": 8.0859375, "text": "COVID-19 VACCINE, mRNA), THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.026611328125 }, { "start_logit": 17.140625, "end_logit": 7.18359375, "text": "VACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY", "probability": 0.02618408203125 }, { "start_logit": 15.1953125, "end_logit": 8.890625, "text": " INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.020721435546875 }, { "start_logit": 15.15625, "end_logit": 8.890625, "text": "ACCINE INFORMATION FACT SHEET FOR RECIPIENTS AND CAREGIVERS\nABOUT COMIRNATY (COVID-19", "probability": 0.019775390625 }, { "start_logit": 16.703125, "end_logit": 7.328125, "text": " THE PFIZER", "probability": 0.01947021484375 }, { "start_logit": 15.7734375, "end_logit": 8.0859375, "text": " mRNA), THE PFIZER-BIONTECH\nCOVID-19", "probability": 0.016387939453125 }, { "start_logit": 16.703125, "end_logit": 6.87109375, "text": " THE PFIZER-BIONTECH\nCOVID-19 VACCINE, AND THE PFIZER", "probability": 0.01236724853515625 }, { "start_logit": 16.25, "end_logit": 7.328125, "text": "COVID-19 VACCINE, mRNA), THE PFIZER", "probability": 0.01236724853515625 }, { "start_logit": 15.4140625, "end_logit": 8.0859375, "text": "COVID-19", "probability": 0.011444091796875 }, { "start_logit": 15.15625, "end_logit": 8.3125, "text": "ACC", "probability": 0.0110931396484375 }, { "start_logit": 14.53125, "end_logit": 8.890625, "text": " COMIRNATY (COVID-19", "probability": 0.01058197021484375 }, { "start_logit": 8.8828125, "end_logit": -0.72216796875, "text": "", "probability": 0.0 } ], "100000000000000000007153": [ { "start_logit": 16.796875, "end_logit": 7.5625, "text": "This", "probability": 0.6298828125 }, { "start_logit": 16.796875, "end_logit": 7.03125, "text": "This Vaccine", "probability": 0.3701171875 }, { "start_logit": 7.53125, "end_logit": -0.87744140625, "text": "", "probability": 0.0 } ], "100000000000000000007154": [ { "start_logit": 16.796875, "end_logit": 7.5625, "text": "This", "probability": 0.6298828125 }, { "start_logit": 16.796875, "end_logit": 7.03125, "text": "This Vaccine", "probability": 0.3701171875 }, { "start_logit": 7.53125, "end_logit": -0.86083984375, "text": "", "probability": 0.0 } ], "100000000000000000007160": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.46484375, "end_logit": -0.260986328125, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000007161": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007524628013059865 }, { "start_logit": 7.41015625, "end_logit": -0.2205810546875, "text": "", "probability": 0.9992475371986941 } ], "100000000000000000007167": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016941031558503918 }, { "start_logit": 7.109375, "end_logit": -0.72900390625, "text": "", "probability": 0.9983058968441496 } ], "100000000000000000007168": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0033244368916556374 }, { "start_logit": 5.99609375, "end_logit": -0.294921875, "text": "", "probability": 0.9966755631083445 } ], "100000000000000000007171": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003510649113774665 }, { "start_logit": 5.953125, "end_logit": -0.303466796875, "text": "", "probability": 0.9964893508862253 } ], "100000000000000000007175": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.67578125, "end_logit": -0.8310546875, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000007178": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.57421875, "end_logit": -0.82763671875, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000007181": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.59375, "end_logit": -0.70947265625, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000007183": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.6171875, "end_logit": -0.7177734375, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000007185": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.61328125, "end_logit": -0.71826171875, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000007187": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.33203125, "end_logit": -0.78076171875, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000007189": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 7.30078125, "end_logit": -0.806640625, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000007192": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.2890625, "end_logit": -0.791015625, "text": "", "probability": 0.998498817743263 } ], "100000000000000000007201": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018530593956144392 }, { "start_logit": 6.91796875, "end_logit": -0.63037109375, "text": "", "probability": 0.9981469406043857 } ], "100000000000000000007203": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018530593956144392 }, { "start_logit": 6.88671875, "end_logit": -0.59912109375, "text": "", "probability": 0.9981469406043857 } ], "100000000000000000007206": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001727458626729702 }, { "start_logit": 6.98046875, "end_logit": -0.623046875, "text": "", "probability": 0.9982725413732704 } ], "100000000000000000007209": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030753698500482337 }, { "start_logit": 6.23828125, "end_logit": -0.455810546875, "text": "", "probability": 0.9969246301499518 } ], "100000000000000000007211": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030278350245683794 }, { "start_logit": 6.26171875, "end_logit": -0.466796875, "text": "", "probability": 0.9969721649754317 } ], "100000000000000000007213": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.578125, "end_logit": -0.833984375, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000007220": [ { "start_logit": 16.84375, "end_logit": 8.921875, "text": "Pfizer-BioNTech", "probability": 0.291015625 }, { "start_logit": 16.84375, "end_logit": 8.3203125, "text": "Pfizer", "probability": 0.1580810546875 }, { "start_logit": 16.84375, "end_logit": 8.0625, "text": "Pfizer-BioNTech COVID-19", "probability": 0.1231689453125 }, { "start_logit": 16.15625, "end_logit": 8.0625, "text": " COVID-19", "probability": 0.061920166015625 }, { "start_logit": 16.84375, "end_logit": 7.33203125, "text": "Pf", "probability": 0.05908203125 }, { "start_logit": 16.84375, "end_logit": 7.28515625, "text": "Pfizer-Bio", "probability": 0.056396484375 }, { "start_logit": 16.84375, "end_logit": 7.2578125, "text": "P", "probability": 0.054656982421875 }, { "start_logit": 16.84375, "end_logit": 6.91796875, "text": "Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older", "probability": 0.03936767578125 }, { "start_logit": 16.84375, "end_logit": 6.82421875, "text": "Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age", "probability": 0.035858154296875 }, { "start_logit": 16.15625, "end_logit": 6.91796875, "text": " COVID-19 Vaccine for individuals 12 years of age and older", "probability": 0.0197906494140625 }, { "start_logit": 16.15625, "end_logit": 6.82421875, "text": " COVID-19 Vaccine for individuals 12 years of age", "probability": 0.0180206298828125 }, { "start_logit": 16.84375, "end_logit": 5.921875, "text": "Pfizer-BioNTech COVID-19 Vaccine for individuals 12 years of age and older contains\n1 of the following sets of additional ingredients", "probability": 0.0144805908203125 }, { "start_logit": 16.625, "end_logit": 5.921875, "text": "\n1 of the following sets of additional ingredients", "probability": 0.0116424560546875 }, { "start_logit": 13.5234375, "end_logit": 8.921875, "text": "-BioNTech", "probability": 0.01042938232421875 }, { "start_logit": 13.4921875, "end_logit": 8.921875, "text": "NTech", "probability": 0.01010894775390625 }, { "start_logit": 16.84375, "end_logit": 5.47265625, "text": "Pfizer-B", "probability": 0.00920867919921875 }, { "start_logit": 16.15625, "end_logit": 5.921875, "text": " COVID-19 Vaccine for individuals 12 years of age and older contains\n1 of the following sets of additional ingredients", "probability": 0.00728607177734375 }, { "start_logit": 13.1484375, "end_logit": 8.921875, "text": "fizer-BioNTech", "probability": 0.007167816162109375 }, { "start_logit": 13.03125, "end_logit": 8.921875, "text": "izer-BioNTech", "probability": 0.006427764892578125 }, { "start_logit": 16.625, "end_logit": 5.28125, "text": "\n1 of the following sets of additional ingredients; ask the vaccination", "probability": 0.006134033203125 }, { "start_logit": 7.93359375, "end_logit": -1.0966796875, "text": "", "probability": 0.0 } ], "100000000000000000007222": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020190139004485808 }, { "start_logit": 7.08984375, "end_logit": -0.88623046875, "text": "", "probability": 0.9979809860995514 } ], "100000000000000000007224": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 7.17578125, "end_logit": -0.91650390625, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000007225": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020033332861764124 }, { "start_logit": 7.0703125, "end_logit": -0.8583984375, "text": "", "probability": 0.9979966667138236 } ], "100000000000000000007227": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015916259996820179 }, { "start_logit": 7.25390625, "end_logit": -0.8125, "text": "", "probability": 0.998408374000318 } ], "100000000000000000007228": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 7.3203125, "end_logit": -0.82373046875, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000007229": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.27734375, "end_logit": -0.75634765625, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000007231": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001524786391225749 }, { "start_logit": 7.3515625, "end_logit": -0.86865234375, "text": "", "probability": 0.9984752136087741 } ], "100000000000000000007235": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 7.765625, "end_logit": -0.9794921875, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000007237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.66796875, "end_logit": -0.97412109375, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000007239": [ { "start_logit": 18.40625, "end_logit": 11.125, "text": " rash, itching, hives, or swelling of the face", "probability": 0.2142333984375 }, { "start_logit": 18.921875, "end_logit": 10.53125, "text": " Severe allergic reactions", "probability": 0.1981201171875 }, { "start_logit": 18.328125, "end_logit": 10.5625, "text": " seek medical attention right away", "probability": 0.11285400390625 }, { "start_logit": 18.921875, "end_logit": 9.859375, "text": " Severe allergic reactions\n\uf0b7 Non-severe allergic reactions", "probability": 0.1011962890625 }, { "start_logit": 18.40625, "end_logit": 10.3203125, "text": " rash, itching, hives, or swelling of the face\n\uf0b7 Myocarditis", "probability": 0.0950927734375 }, { "start_logit": 18.3125, "end_logit": 10.3203125, "text": " Myocarditis", "probability": 0.0865478515625 }, { "start_logit": 18.3125, "end_logit": 9.90625, "text": " Myocarditis (inflammation of the heart muscle)\n\uf0b7 Pericarditis (inflammation of the lining outside the heart", "probability": 0.057647705078125 }, { "start_logit": 18.3125, "end_logit": 9.1953125, "text": " Myocarditis (inflammation of the heart muscle)\n\uf0b7 Pericarditis", "probability": 0.028106689453125 }, { "start_logit": 18.40625, "end_logit": 8.7265625, "text": " rash, itching, hives, or swelling of the face\n\uf0b7 Myocarditis (inflammation of the heart", "probability": 0.019317626953125 }, { "start_logit": 18.3125, "end_logit": 8.7265625, "text": " Myocarditis (inflammation of the heart", "probability": 0.0175933837890625 }, { "start_logit": 18.3125, "end_logit": 8.3515625, "text": " Myocarditis (inflammation of the heart muscle)\n\uf0b7 Pericarditis (inflammation of the lining", "probability": 0.0120849609375 }, { "start_logit": 15.8515625, "end_logit": 10.5625, "text": "You should seek medical attention right away", "probability": 0.0094146728515625 }, { "start_logit": 16.421875, "end_logit": 9.90625, "text": " lining outside the heart", "probability": 0.00870513916015625 }, { "start_logit": 18.328125, "end_logit": 7.97265625, "text": " seek medical attention", "probability": 0.0084381103515625 }, { "start_logit": 15.0, "end_logit": 11.125, "text": " Non-severe allergic reactions such as rash, itching, hives, or swelling of the face", "probability": 0.007106781005859375 }, { "start_logit": 18.328125, "end_logit": 7.5390625, "text": " seek medical attention right", "probability": 0.005535125732421875 }, { "start_logit": 18.40625, "end_logit": 7.3671875, "text": " rash, itching, hives, or swelling of the face\n\uf0b7 Myocard", "probability": 0.005035400390625 }, { "start_logit": 18.3125, "end_logit": 7.3671875, "text": " Myocard", "probability": 0.00458526611328125 }, { "start_logit": 14.5546875, "end_logit": 11.125, "text": " hives, or swelling of the face", "probability": 0.00458526611328125 }, { "start_logit": 14.9140625, "end_logit": 10.53125, "text": "\n\uf0b7 Severe allergic reactions", "probability": 0.0035724639892578125 }, { "start_logit": 9.296875, "end_logit": -0.66650390625, "text": "", "probability": 0.0 } ], "100000000000000000007248": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.890625, "end_logit": -0.81298828125, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000007257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.61328125, "end_logit": -0.77587890625, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000007260": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005484792388673105 }, { "start_logit": 8.1484375, "end_logit": -0.638671875, "text": "", "probability": 0.9994515207611326 } ], "100000000000000000007265": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999950555496 }, { "start_logit": -32.40625, "end_logit": 13.2734375, "text": "", "probability": 4.944450477491054e-09 } ], "100000000000000000007266": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999994484067 }, { "start_logit": -32.40625, "end_logit": 13.390625, "text": "", "probability": 5.5159330995965176e-09 } ], "100000000000000000007271": [ { "start_logit": 15.046875, "end_logit": 12.515625, "text": "Data", "probability": 1.0 }, { "start_logit": 7.59765625, "end_logit": -0.5361328125, "text": "", "probability": 0.0 } ], "100000000000000000007273": [ { "start_logit": 15.046875, "end_logit": 12.515625, "text": "Data", "probability": 1.0 }, { "start_logit": 7.609375, "end_logit": -0.55224609375, "text": "", "probability": 0.0 } ], "100000000000000000007274": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.55078125, "end_logit": -0.474365234375, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000007278": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.54296875, "end_logit": -0.462646484375, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000007280": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000872767030892148 }, { "start_logit": 7.484375, "end_logit": -0.441650390625, "text": "", "probability": 0.9991272329691079 } ], "100000000000000000007289": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.484375, "end_logit": -1.0322265625, "text": "", "probability": 0.998426887834651 } ], "100000000000000000007295": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.41796875, "end_logit": -0.72021484375, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000007304": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003930085574505154 }, { "start_logit": 5.90234375, "end_logit": -0.365478515625, "text": "", "probability": 0.9960699144254949 } ], "100000000000000000007308": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.484375, "end_logit": -0.82958984375, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000007310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.2578125, "end_logit": -0.375, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000007311": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.26171875, "end_logit": -0.425048828125, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000007315": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005884088185569387 }, { "start_logit": 7.86328125, "end_logit": -0.42578125, "text": "", "probability": 0.9994115911814431 } ], "100000000000000000007318": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005747861775648728 }, { "start_logit": 7.9140625, "end_logit": -0.45263671875, "text": "", "probability": 0.9994252138224351 } ], "100000000000000000007319": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005976693711028652 }, { "start_logit": 7.89453125, "end_logit": -0.474365234375, "text": "", "probability": 0.999402330628897 } ], "100000000000000000007321": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008459375275953215 }, { "start_logit": 7.66015625, "end_logit": -0.58447265625, "text": "", "probability": 0.9991540624724046 } ], "100000000000000000007324": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.66015625, "end_logit": -0.578125, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000007330": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005274784125231481 }, { "start_logit": 8.5078125, "end_logit": -0.96142578125, "text": "", "probability": 0.9994725215874769 } ], "100000000000000000007332": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.15625, "end_logit": -0.44580078125, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000007341": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017891591615951197 }, { "start_logit": 7.1484375, "end_logit": -0.82275390625, "text": "", "probability": 0.9982108408384048 } ], "100000000000000000007351": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008626077580284025 }, { "start_logit": 7.921875, "end_logit": -0.86865234375, "text": "", "probability": 0.9991373922419715 } ], "100000000000000000007366": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 6.9453125, "end_logit": -0.5498046875, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000007372": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999978059133 }, { "start_logit": -33.34375, "end_logit": 13.40625, "text": "", "probability": 2.1940866052503023e-09 } ], "100000000000000000007379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021657671990027 }, { "start_logit": 6.61328125, "end_logit": -0.480224609375, "text": "", "probability": 0.9978342328009973 } ], "100000000000000000007381": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00226946865448694 }, { "start_logit": 6.5234375, "end_logit": -0.435791015625, "text": "", "probability": 0.997730531345513 } ], "100000000000000000007383": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015608892178478949 }, { "start_logit": 6.75390625, "end_logit": -0.2919921875, "text": "", "probability": 0.9984391107821522 } ], "100000000000000000007384": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 6.74609375, "end_logit": -0.27880859375, "text": "", "probability": 0.998451238905712 } ], "100000000000000000007388": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002123966441797725 }, { "start_logit": 7.171875, "end_logit": -1.0185546875, "text": "", "probability": 0.9978760335582023 } ], "100000000000000000007389": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002323162522631283 }, { "start_logit": 7.0625, "end_logit": -1.0, "text": "", "probability": 0.9976768374773688 } ], "100000000000000000007397": [ { "start_logit": 20.390625, "end_logit": 11.09375, "text": "Persons on diplomatic or official foreign government travel", "probability": 0.58740234375 }, { "start_logit": 20.390625, "end_logit": 9.1875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age", "probability": 0.08734130859375 }, { "start_logit": 20.390625, "end_logit": 8.5, "text": "Persons on diplomatic or official foreign government", "probability": 0.043914794921875 }, { "start_logit": 20.390625, "end_logit": 8.453125, "text": "Persons on diplomatic or official foreign government travel\nChildren", "probability": 0.0418701171875 }, { "start_logit": 19.34375, "end_logit": 9.1875, "text": "Children under 18 years of age", "probability": 0.0306549072265625 }, { "start_logit": 20.390625, "end_logit": 8.09375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications", "probability": 0.02923583984375 }, { "start_logit": 20.390625, "end_logit": 7.9921875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.026214599609375 }, { "start_logit": 19.3125, "end_logit": 8.921875, "text": "Persons with valid visas", "probability": 0.0227813720703125 }, { "start_logit": 19.203125, "end_logit": 8.921875, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas", "probability": 0.020416259765625 }, { "start_logit": 16.75, "end_logit": 11.09375, "text": " the criteria for an exception under the Proclamation and CDC\u2019s Amended\nOrder include:\nPersons on diplomatic or official foreign government travel", "probability": 0.015411376953125 }, { "start_logit": 19.34375, "end_logit": 8.453125, "text": "Children", "probability": 0.01470947265625 }, { "start_logit": 19.34375, "end_logit": 8.09375, "text": "Children under 18 years of age\nPersons with documented medical contraindications", "probability": 0.01026153564453125 }, { "start_logit": 16.328125, "end_logit": 11.09375, "text": "\nPersons on diplomatic or official foreign government travel", "probability": 0.01010894775390625 }, { "start_logit": 20.390625, "end_logit": 7.01953125, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19", "probability": 0.00994873046875 }, { "start_logit": 20.390625, "end_logit": 7.00390625, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years", "probability": 0.009796142578125 }, { "start_logit": 19.34375, "end_logit": 7.9921875, "text": "Children under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.0093536376953125 }, { "start_logit": 19.3125, "end_logit": 7.8828125, "text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.00799560546875 }, { "start_logit": 19.078125, "end_logit": 8.09375, "text": "Persons with documented medical contraindications", "probability": 0.00787353515625 }, { "start_logit": 19.203125, "end_logit": 7.8828125, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.0072784423828125 }, { "start_logit": 19.078125, "end_logit": 7.9921875, "text": "Persons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.007053375244140625 }, { "start_logit": 8.4609375, "end_logit": -0.921875, "text": "", "probability": 0.0 } ], "100000000000000000007398": [ { "start_logit": 20.390625, "end_logit": 11.09375, "text": "Persons on diplomatic or official foreign government travel", "probability": 0.58740234375 }, { "start_logit": 20.390625, "end_logit": 9.1875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age", "probability": 0.08734130859375 }, { "start_logit": 20.390625, "end_logit": 8.5, "text": "Persons on diplomatic or official foreign government", "probability": 0.043914794921875 }, { "start_logit": 20.390625, "end_logit": 8.453125, "text": "Persons on diplomatic or official foreign government travel\nChildren", "probability": 0.0418701171875 }, { "start_logit": 19.34375, "end_logit": 9.1875, "text": "Children under 18 years of age", "probability": 0.0306549072265625 }, { "start_logit": 20.390625, "end_logit": 8.09375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications", "probability": 0.02923583984375 }, { "start_logit": 20.390625, "end_logit": 7.9921875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.026214599609375 }, { "start_logit": 19.3125, "end_logit": 8.921875, "text": "Persons with valid visas", "probability": 0.0227813720703125 }, { "start_logit": 19.203125, "end_logit": 8.921875, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas", "probability": 0.020416259765625 }, { "start_logit": 16.75, "end_logit": 11.09375, "text": " the criteria for an exception under the Proclamation and CDC\u2019s Amended\nOrder include:\nPersons on diplomatic or official foreign government travel", "probability": 0.015411376953125 }, { "start_logit": 19.34375, "end_logit": 8.453125, "text": "Children", "probability": 0.01470947265625 }, { "start_logit": 19.34375, "end_logit": 8.09375, "text": "Children under 18 years of age\nPersons with documented medical contraindications", "probability": 0.01026153564453125 }, { "start_logit": 16.328125, "end_logit": 11.09375, "text": "\nPersons on diplomatic or official foreign government travel", "probability": 0.01010894775390625 }, { "start_logit": 20.390625, "end_logit": 7.01953125, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19", "probability": 0.00994873046875 }, { "start_logit": 20.390625, "end_logit": 7.00390625, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years", "probability": 0.009796142578125 }, { "start_logit": 19.34375, "end_logit": 7.9921875, "text": "Children under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.0093536376953125 }, { "start_logit": 19.3125, "end_logit": 7.8828125, "text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.00799560546875 }, { "start_logit": 19.078125, "end_logit": 8.09375, "text": "Persons with documented medical contraindications", "probability": 0.00787353515625 }, { "start_logit": 19.203125, "end_logit": 7.8828125, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.0072784423828125 }, { "start_logit": 19.078125, "end_logit": 7.9921875, "text": "Persons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.007053375244140625 }, { "start_logit": 8.4453125, "end_logit": -0.92431640625, "text": "", "probability": 0.0 } ], "100000000000000000007401": [ { "start_logit": 20.390625, "end_logit": 11.09375, "text": "Persons on diplomatic or official foreign government travel", "probability": 0.58740234375 }, { "start_logit": 20.390625, "end_logit": 9.1875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age", "probability": 0.08734130859375 }, { "start_logit": 20.390625, "end_logit": 8.5, "text": "Persons on diplomatic or official foreign government", "probability": 0.043914794921875 }, { "start_logit": 20.390625, "end_logit": 8.453125, "text": "Persons on diplomatic or official foreign government travel\nChildren", "probability": 0.0418701171875 }, { "start_logit": 19.34375, "end_logit": 9.1875, "text": "Children under 18 years of age", "probability": 0.0306549072265625 }, { "start_logit": 20.390625, "end_logit": 8.09375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications", "probability": 0.02923583984375 }, { "start_logit": 20.390625, "end_logit": 7.9921875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.026214599609375 }, { "start_logit": 19.3125, "end_logit": 8.921875, "text": "Persons with valid visas", "probability": 0.0227813720703125 }, { "start_logit": 19.203125, "end_logit": 8.921875, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas", "probability": 0.020416259765625 }, { "start_logit": 16.75, "end_logit": 11.09375, "text": " the criteria for an exception under the Proclamation and CDC\u2019s Amended\nOrder include:\nPersons on diplomatic or official foreign government travel", "probability": 0.015411376953125 }, { "start_logit": 19.34375, "end_logit": 8.453125, "text": "Children", "probability": 0.01470947265625 }, { "start_logit": 19.34375, "end_logit": 8.09375, "text": "Children under 18 years of age\nPersons with documented medical contraindications", "probability": 0.01026153564453125 }, { "start_logit": 16.328125, "end_logit": 11.09375, "text": "\nPersons on diplomatic or official foreign government travel", "probability": 0.01010894775390625 }, { "start_logit": 20.390625, "end_logit": 7.01953125, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19", "probability": 0.00994873046875 }, { "start_logit": 20.390625, "end_logit": 7.00390625, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years", "probability": 0.009796142578125 }, { "start_logit": 19.34375, "end_logit": 7.9921875, "text": "Children under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.0093536376953125 }, { "start_logit": 19.3125, "end_logit": 7.8828125, "text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.00799560546875 }, { "start_logit": 19.078125, "end_logit": 8.09375, "text": "Persons with documented medical contraindications", "probability": 0.00787353515625 }, { "start_logit": 19.203125, "end_logit": 7.8828125, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.0072784423828125 }, { "start_logit": 19.078125, "end_logit": 7.9921875, "text": "Persons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.007053375244140625 }, { "start_logit": 8.7109375, "end_logit": -0.8603515625, "text": "", "probability": 0.0 } ], "100000000000000000007402": [ { "start_logit": 20.40625, "end_logit": 11.078125, "text": "Persons on diplomatic or official foreign government travel", "probability": 0.5849609375 }, { "start_logit": 20.40625, "end_logit": 9.1796875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age", "probability": 0.08831787109375 }, { "start_logit": 20.40625, "end_logit": 8.5078125, "text": "Persons on diplomatic or official foreign government", "probability": 0.044403076171875 }, { "start_logit": 20.40625, "end_logit": 8.4609375, "text": "Persons on diplomatic or official foreign government travel\nChildren", "probability": 0.043060302734375 }, { "start_logit": 19.34375, "end_logit": 9.1796875, "text": "Children under 18 years of age", "probability": 0.030517578125 }, { "start_logit": 20.40625, "end_logit": 8.09375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications", "probability": 0.029571533203125 }, { "start_logit": 20.40625, "end_logit": 7.9921875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.0269317626953125 }, { "start_logit": 19.3125, "end_logit": 8.921875, "text": "Persons with valid visas", "probability": 0.0226898193359375 }, { "start_logit": 19.203125, "end_logit": 8.921875, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas", "probability": 0.02032470703125 }, { "start_logit": 16.75, "end_logit": 11.078125, "text": " the criteria for an exception under the Proclamation and CDC\u2019s Amended\nOrder include:\nPersons on diplomatic or official foreign government travel", "probability": 0.015106201171875 }, { "start_logit": 19.34375, "end_logit": 8.4609375, "text": "Children", "probability": 0.01486968994140625 }, { "start_logit": 19.34375, "end_logit": 8.09375, "text": "Children under 18 years of age\nPersons with documented medical contraindications", "probability": 0.01021575927734375 }, { "start_logit": 20.40625, "end_logit": 7.01953125, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19", "probability": 0.01006317138671875 }, { "start_logit": 20.40625, "end_logit": 6.99609375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years", "probability": 0.0099029541015625 }, { "start_logit": 16.328125, "end_logit": 11.078125, "text": "\nPersons on diplomatic or official foreign government travel", "probability": 0.0099029541015625 }, { "start_logit": 19.34375, "end_logit": 7.9921875, "text": "Children under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.009307861328125 }, { "start_logit": 19.3125, "end_logit": 7.8828125, "text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.00795745849609375 }, { "start_logit": 19.078125, "end_logit": 8.09375, "text": "Persons with documented medical contraindications", "probability": 0.00783538818359375 }, { "start_logit": 19.203125, "end_logit": 7.8828125, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.007244110107421875 }, { "start_logit": 19.078125, "end_logit": 7.9921875, "text": "Persons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.007022857666015625 }, { "start_logit": 8.5546875, "end_logit": -0.8955078125, "text": "", "probability": 0.0 } ], "100000000000000000007403": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.73046875, "end_logit": -0.92919921875, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000007414": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046917637858393793 }, { "start_logit": 7.43359375, "end_logit": 0.228759765625, "text": "", "probability": 0.999530823621416 } ], "100000000000000000007416": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007824140590241951 }, { "start_logit": 7.6875, "end_logit": -0.53466796875, "text": "", "probability": 0.9992175859409759 } ], "100000000000000000007421": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006118340200729555 }, { "start_logit": 7.6796875, "end_logit": -0.279541015625, "text": "", "probability": 0.9993881659799271 } ], "100000000000000000007422": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006166297347617124 }, { "start_logit": 7.71875, "end_logit": -0.32958984375, "text": "", "probability": 0.9993833702652382 } ], "100000000000000000007423": [ { "start_logit": 17.28125, "end_logit": 8.578125, "text": "Printout of COVID-19 vaccination record", "probability": 0.248291015625 }, { "start_logit": 17.0, "end_logit": 8.578125, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records\nPrintout of COVID-19 vaccination record", "probability": 0.1875 }, { "start_logit": 16.9375, "end_logit": 8.21875, "text": "Verifiable\nrecords", "probability": 0.1229248046875 }, { "start_logit": 17.0, "end_logit": 8.09375, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate", "probability": 0.115478515625 }, { "start_logit": 16.328125, "end_logit": 7.9375, "text": " the CDC vaccination card", "probability": 0.050445556640625 }, { "start_logit": 17.0, "end_logit": 7.06640625, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records", "probability": 0.041168212890625 }, { "start_logit": 16.96875, "end_logit": 6.75390625, "text": " Clinical Trial Vaccines", "probability": 0.0291900634765625 }, { "start_logit": 16.328125, "end_logit": 6.90234375, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card or record, downloaded vaccine record", "probability": 0.0179901123046875 }, { "start_logit": 16.328125, "end_logit": 6.890625, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card", "probability": 0.0177001953125 }, { "start_logit": 16.578125, "end_logit": 6.62890625, "text": "Moderna", "probability": 0.017425537109375 }, { "start_logit": 16.546875, "end_logit": 6.640625, "text": "Moderna", "probability": 0.0171661376953125 }, { "start_logit": 16.546875, "end_logit": 6.62890625, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0168914794921875 }, { "start_logit": 16.53125, "end_logit": 6.62890625, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0166473388671875 }, { "start_logit": 17.28125, "end_logit": 5.78515625, "text": "Printout of COVID-19 vaccination", "probability": 0.01514434814453125 }, { "start_logit": 16.546875, "end_logit": 6.51953125, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.01514434814453125 }, { "start_logit": 16.53125, "end_logit": 6.51953125, "text": "Pfizer-BioNTech", "probability": 0.01491546630859375 }, { "start_logit": 16.40625, "end_logit": 6.640625, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.01491546630859375 }, { "start_logit": 16.40625, "end_logit": 6.640625, "text": "Pfizer-BioNTech", "probability": 0.01491546630859375 }, { "start_logit": 16.40625, "end_logit": 6.51953125, "text": "Pfizer-BioNTech)\nSpikevax (Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.01316070556640625 }, { "start_logit": 17.28125, "end_logit": 5.6171875, "text": "Printout of COVID-19 vaccination record or a COVID-19 vaccination certificate", "probability": 0.0129547119140625 }, { "start_logit": 9.421875, "end_logit": -0.7021484375, "text": "", "probability": 0.0 } ], "100000000000000000007426": [ { "start_logit": 17.28125, "end_logit": 8.59375, "text": "Printout of COVID-19 vaccination record", "probability": 0.24951171875 }, { "start_logit": 17.0, "end_logit": 8.59375, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records\nPrintout of COVID-19 vaccination record", "probability": 0.1883544921875 }, { "start_logit": 16.9375, "end_logit": 8.21875, "text": "Verifiable\nrecords", "probability": 0.12158203125 }, { "start_logit": 17.0, "end_logit": 8.1171875, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate", "probability": 0.11785888671875 }, { "start_logit": 16.3125, "end_logit": 7.93359375, "text": " the CDC vaccination card", "probability": 0.04913330078125 }, { "start_logit": 17.0, "end_logit": 7.05859375, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records", "probability": 0.04071044921875 }, { "start_logit": 16.96875, "end_logit": 6.7421875, "text": " Clinical Trial Vaccines", "probability": 0.0288848876953125 }, { "start_logit": 16.5625, "end_logit": 6.6484375, "text": "Moderna", "probability": 0.01751708984375 }, { "start_logit": 16.3125, "end_logit": 6.8984375, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card or record, downloaded vaccine record", "probability": 0.01751708984375 }, { "start_logit": 16.3125, "end_logit": 6.890625, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card", "probability": 0.0172576904296875 }, { "start_logit": 16.546875, "end_logit": 6.6484375, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0169830322265625 }, { "start_logit": 16.546875, "end_logit": 6.64453125, "text": "Moderna", "probability": 0.0169830322265625 }, { "start_logit": 16.53125, "end_logit": 6.6484375, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0169830322265625 }, { "start_logit": 17.28125, "end_logit": 5.78125, "text": "Printout of COVID-19 vaccination", "probability": 0.014984130859375 }, { "start_logit": 16.546875, "end_logit": 6.515625, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.014984130859375 }, { "start_logit": 16.421875, "end_logit": 6.64453125, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.014984130859375 }, { "start_logit": 16.53125, "end_logit": 6.515625, "text": "Pfizer-BioNTech", "probability": 0.01474761962890625 }, { "start_logit": 16.421875, "end_logit": 6.62890625, "text": "Pfizer-BioNTech", "probability": 0.01474761962890625 }, { "start_logit": 16.421875, "end_logit": 6.515625, "text": "Pfizer-BioNTech)\nSpikevax (Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.0132293701171875 }, { "start_logit": 17.28125, "end_logit": 5.62890625, "text": "Printout of COVID-19 vaccination record or a COVID-19 vaccination certificate", "probability": 0.0128173828125 }, { "start_logit": 9.375, "end_logit": -0.73193359375, "text": "", "probability": 0.0 } ], "100000000000000000007429": [ { "start_logit": 17.296875, "end_logit": 8.5859375, "text": "Printout of COVID-19 vaccination record", "probability": 0.24853515625 }, { "start_logit": 17.0, "end_logit": 8.5859375, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records\nPrintout of COVID-19 vaccination record", "probability": 0.1876220703125 }, { "start_logit": 16.953125, "end_logit": 8.234375, "text": "Verifiable\nrecords", "probability": 0.125 }, { "start_logit": 17.0, "end_logit": 8.125, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate", "probability": 0.117431640625 }, { "start_logit": 16.328125, "end_logit": 7.93359375, "text": " the CDC vaccination card", "probability": 0.049713134765625 }, { "start_logit": 17.0, "end_logit": 7.0703125, "text": "United Kingdom National Health Service COVID Pass, European Union Digital COVID Certificate)\nNon-verifiable\npaper records", "probability": 0.040557861328125 }, { "start_logit": 16.96875, "end_logit": 6.7421875, "text": " Clinical Trial Vaccines", "probability": 0.028778076171875 }, { "start_logit": 16.328125, "end_logit": 6.90234375, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card or record, downloaded vaccine record", "probability": 0.0177154541015625 }, { "start_logit": 16.59375, "end_logit": 6.62890625, "text": "Moderna", "probability": 0.0174407958984375 }, { "start_logit": 16.328125, "end_logit": 6.890625, "text": " the CDC vaccination card)\nNon-verifiable\ndigital records\nDigital photos of vaccination card", "probability": 0.0174407958984375 }, { "start_logit": 16.546875, "end_logit": 6.64453125, "text": "Moderna", "probability": 0.0169219970703125 }, { "start_logit": 16.546875, "end_logit": 6.62890625, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.01666259765625 }, { "start_logit": 16.53125, "end_logit": 6.62890625, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0164031982421875 }, { "start_logit": 17.296875, "end_logit": 5.78515625, "text": "Printout of COVID-19 vaccination", "probability": 0.01515960693359375 }, { "start_logit": 16.546875, "end_logit": 6.51953125, "text": "Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.01493072509765625 }, { "start_logit": 16.53125, "end_logit": 6.51953125, "text": "Pfizer-BioNTech", "probability": 0.0146942138671875 }, { "start_logit": 16.40625, "end_logit": 6.64453125, "text": "Pfizer-BioNTech)\nSpikevax (Moderna", "probability": 0.0146942138671875 }, { "start_logit": 16.40625, "end_logit": 6.640625, "text": "Pfizer-BioNTech", "probability": 0.0146942138671875 }, { "start_logit": 17.296875, "end_logit": 5.62890625, "text": "Printout of COVID-19 vaccination record or a COVID-19 vaccination certificate", "probability": 0.012969970703125 }, { "start_logit": 16.40625, "end_logit": 6.51953125, "text": "Pfizer-BioNTech)\nSpikevax (Moderna)\nNovavax\nComirnaty (Pfizer-BioNTech", "probability": 0.012969970703125 }, { "start_logit": 9.4453125, "end_logit": -0.70947265625, "text": "", "probability": 0.0 } ], "100000000000000000007433": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 7.05859375, "end_logit": -0.5009765625, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000007434": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.109375, "end_logit": -0.57568359375, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000007436": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013564017974613941 }, { "start_logit": 7.1875, "end_logit": -0.5869140625, "text": "", "probability": 0.9986435982025386 } ], "100000000000000000007437": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.37890625, "end_logit": -0.61962890625, "text": "", "probability": 0.99883958037482 } ], "100000000000000000007441": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.51171875, "end_logit": -0.705078125, "text": "", "probability": 0.99889266101491 } ], "100000000000000000007450": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.7578125, "end_logit": -0.8505859375, "text": "", "probability": 0.99899949559909 } ], "100000000000000000007453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.7421875, "end_logit": -0.84326171875, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000007455": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.84765625, "end_logit": -0.6240234375, "text": "", "probability": 0.999270671160687 } ], "100000000000000000007462": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.26171875, "end_logit": -0.72802734375, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000007463": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 7.328125, "end_logit": -0.83154296875, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000007470": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.75, "end_logit": -0.8857421875, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000007471": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.3828125, "end_logit": -0.358642578125, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000007472": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008167381046669486 }, { "start_logit": 7.46875, "end_logit": -0.3603515625, "text": "", "probability": 0.999183261895333 } ], "100000000000000000007473": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.3671875, "end_logit": -0.350341796875, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000007476": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.55078125, "end_logit": -0.40380859375, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000007488": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.37890625, "end_logit": -0.56298828125, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000007491": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000767292412858718 }, { "start_logit": 7.84375, "end_logit": -0.6708984375, "text": "", "probability": 0.9992327075871412 } ], "100000000000000000007498": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 6.84375, "end_logit": -0.44287109375, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000007506": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.515625, "end_logit": -0.75439453125, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000007507": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.609375, "end_logit": -0.8486328125, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000007510": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.5859375, "end_logit": -0.82861328125, "text": "", "probability": 0.99883958037482 } ], "100000000000000000007513": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004314687956362679 }, { "start_logit": 5.71875, "end_logit": -0.27734375, "text": "", "probability": 0.9956853120436374 } ], "100000000000000000007515": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00433150202056399 }, { "start_logit": 5.72265625, "end_logit": -0.285888671875, "text": "", "probability": 0.9956684979794361 } ], "100000000000000000007516": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004382336640730745 }, { "start_logit": 5.734375, "end_logit": -0.30712890625, "text": "", "probability": 0.9956176633592693 } ], "100000000000000000007522": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 8.1171875, "end_logit": -0.9033203125, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000007528": [ { "start_logit": 17.71875, "end_logit": 9.9921875, "text": "Persons on diplomatic or official foreign government travel", "probability": 0.63427734375 }, { "start_logit": 17.71875, "end_logit": 7.8046875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age", "probability": 0.0711669921875 }, { "start_logit": 17.71875, "end_logit": 7.40234375, "text": "Persons on diplomatic or official foreign government", "probability": 0.04742431640625 }, { "start_logit": 17.71875, "end_logit": 7.32421875, "text": "Persons on diplomatic or official foreign government travel\nChildren", "probability": 0.04388427734375 }, { "start_logit": 17.71875, "end_logit": 6.83984375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications", "probability": 0.027008056640625 }, { "start_logit": 16.640625, "end_logit": 7.73046875, "text": "Persons with valid visas", "probability": 0.02239990234375 }, { "start_logit": 17.71875, "end_logit": 6.6171875, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.021697998046875 }, { "start_logit": 16.484375, "end_logit": 7.8046875, "text": "Children under 18 years of age", "probability": 0.0203857421875 }, { "start_logit": 16.5, "end_logit": 7.73046875, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas", "probability": 0.0194549560546875 }, { "start_logit": 13.859375, "end_logit": 9.9921875, "text": "\nPersons on diplomatic or official foreign government travel", "probability": 0.0131683349609375 }, { "start_logit": 16.484375, "end_logit": 7.32421875, "text": "Children", "probability": 0.01275634765625 }, { "start_logit": 13.484375, "end_logit": 9.9921875, "text": "Amended Order include:\nPersons on diplomatic or official foreign government travel", "probability": 0.0090484619140625 }, { "start_logit": 17.71875, "end_logit": 5.7265625, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19", "probability": 0.0087738037109375 }, { "start_logit": 16.484375, "end_logit": 6.83984375, "text": "Children under 18 years of age\nPersons with documented medical contraindications", "probability": 0.0078582763671875 }, { "start_logit": 17.71875, "end_logit": 5.58984375, "text": "Persons on diplomatic or official foreign government travel\nChildren under 18 years", "probability": 0.007740020751953125 }, { "start_logit": 16.640625, "end_logit": 6.62109375, "text": "Persons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.00738525390625 }, { "start_logit": 13.171875, "end_logit": 9.9921875, "text": " the criteria for an exception under the proclamation and CDC\u2019s\nAmended Order include:\nPersons on diplomatic or official foreign government travel", "probability": 0.006622314453125 }, { "start_logit": 16.5, "end_logit": 6.62109375, "text": "Persons issued a humanitarian or emergency exception\nPersons with valid visas [excluding B-1 (business) or B-2 (tourism) visas", "probability": 0.006420135498046875 }, { "start_logit": 16.484375, "end_logit": 6.6171875, "text": "Children under 18 years of age\nPersons with documented medical contraindications to receiving a COVID-19 vaccine", "probability": 0.006221771240234375 }, { "start_logit": 16.25, "end_logit": 6.83984375, "text": "Persons with documented medical contraindications", "probability": 0.006221771240234375 }, { "start_logit": 7.69140625, "end_logit": -1.064453125, "text": "", "probability": 0.0 } ], "100000000000000000007537": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016356753292389016 }, { "start_logit": 6.578125, "end_logit": -0.1654052734375, "text": "", "probability": 0.998364324670761 } ], "100000000000000000007538": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 7.203125, "end_logit": -0.023681640625, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000007539": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.26171875, "end_logit": -0.1827392578125, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000007541": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.359375, "end_logit": -0.61474609375, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000007545": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 6.9140625, "end_logit": -0.32421875, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000007553": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.1953125, "end_logit": -0.51611328125, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000007558": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023596606820630445 }, { "start_logit": 6.59765625, "end_logit": -0.54931640625, "text": "", "probability": 0.9976403393179369 } ], "100000000000000000007566": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016678823271748684 }, { "start_logit": 7.015625, "end_logit": -0.62060546875, "text": "", "probability": 0.9983321176728251 } ], "100000000000000000007567": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016420666692028368 }, { "start_logit": 7.05078125, "end_logit": -0.63916015625, "text": "", "probability": 0.9983579333307973 } ], "100000000000000000007569": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000767292412858718 }, { "start_logit": 7.87890625, "end_logit": -0.70849609375, "text": "", "probability": 0.9992327075871412 } ], "100000000000000000007570": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007437028637763687 }, { "start_logit": 7.953125, "end_logit": -0.74853515625, "text": "", "probability": 0.9992562971362237 } ], "100000000000000000007575": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011925492802088101 }, { "start_logit": 7.21875, "end_logit": -0.4892578125, "text": "", "probability": 0.9988074507197912 } ], "100000000000000000007580": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.234375, "end_logit": -0.251708984375, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000007592": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.5390625, "end_logit": -0.822265625, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000007603": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009659749152204077 }, { "start_logit": 7.6171875, "end_logit": -0.67529296875, "text": "", "probability": 0.9990340250847796 } ], "100000000000000000007604": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.6015625, "end_logit": -0.63427734375, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000007606": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010044163312604223 }, { "start_logit": 7.5625, "end_logit": -0.65966796875, "text": "", "probability": 0.9989955836687396 } ], "100000000000000000007607": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009888596979506557 }, { "start_logit": 7.5625, "end_logit": -0.6435546875, "text": "", "probability": 0.9990111403020493 } ], "100000000000000000007609": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 8.0625, "end_logit": -0.8388671875, "text": "", "probability": 0.999270671160687 } ], "100000000000000000007613": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 8.0390625, "end_logit": -0.9375, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000007615": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009927261432440737 }, { "start_logit": 7.29296875, "end_logit": -0.38037109375, "text": "", "probability": 0.9990072738567558 } ], "100000000000000000007619": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013885232756900101 }, { "start_logit": 7.1328125, "end_logit": -0.5546875, "text": "", "probability": 0.99861147672431 } ], "100000000000000000007620": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.09765625, "end_logit": -0.54345703125, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000007621": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 7.57421875, "end_logit": -0.2294921875, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000007626": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 7.30859375, "end_logit": -0.80322265625, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000007627": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015427323620932462 }, { "start_logit": 7.19140625, "end_logit": -0.7197265625, "text": "", "probability": 0.9984572676379068 } ], "100000000000000000007635": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018602985728957027 }, { "start_logit": 6.16015625, "end_logit": 0.12469482421875, "text": "", "probability": 0.9981397014271043 } ], "100000000000000000007637": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001987774212383911 }, { "start_logit": 6.078125, "end_logit": 0.1407470703125, "text": "", "probability": 0.998012225787616 } ], "100000000000000000007639": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.51953125, "end_logit": -0.96435546875, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000007641": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001466458403084568 }, { "start_logit": 7.484375, "end_logit": -0.96142578125, "text": "", "probability": 0.9985335415969153 } ], "100000000000000000007645": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.48828125, "end_logit": -0.480224609375, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000007651": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001294368035454269 }, { "start_logit": 7.24609375, "end_logit": -0.595703125, "text": "", "probability": 0.9987056319645456 } ], "100000000000000000007652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.046875, "end_logit": -0.51318359375, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000007653": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.140625, "end_logit": -0.46826171875, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000007660": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00226946865448694 }, { "start_logit": 6.1015625, "end_logit": -0.0160980224609375, "text": "", "probability": 0.997730531345513 } ], "100000000000000000007662": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 6.015625, "end_logit": 0.06683349609375, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000007664": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001472189509279534 }, { "start_logit": 7.20703125, "end_logit": -0.6875, "text": "", "probability": 0.9985278104907205 } ], "100000000000000000007669": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023596606820630445 }, { "start_logit": 6.28515625, "end_logit": -0.237548828125, "text": "", "probability": 0.9976403393179369 } ], "100000000000000000007670": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021827164453451808 }, { "start_logit": 6.30859375, "end_logit": -0.185546875, "text": "", "probability": 0.9978172835546547 } ], "100000000000000000007671": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021322616859826855 }, { "start_logit": 6.328125, "end_logit": -0.177978515625, "text": "", "probability": 0.9978677383140173 } ], "100000000000000000007675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002225670854115196 }, { "start_logit": 6.265625, "end_logit": -0.160888671875, "text": "", "probability": 0.9977743291458849 } ], "100000000000000000007679": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006589401102677214 }, { "start_logit": 7.56640625, "end_logit": -0.2435302734375, "text": "", "probability": 0.9993410598897322 } ], "100000000000000000007681": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006538155503558285 }, { "start_logit": 7.56640625, "end_logit": -0.2359619140625, "text": "", "probability": 0.9993461844496442 } ], "100000000000000000007685": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017891591615951197 }, { "start_logit": 6.86328125, "end_logit": -0.53759765625, "text": "", "probability": 0.9982108408384048 } ], "100000000000000000007687": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001796149154900369 }, { "start_logit": 6.87890625, "end_logit": -0.5595703125, "text": "", "probability": 0.9982038508450997 } ], "100000000000000000007688": [ { "start_logit": 16.625, "end_logit": 10.6015625, "text": "Anaphylaxis", "probability": 0.615234375 }, { "start_logit": 15.65625, "end_logit": 10.6015625, "text": "\nAnaphylaxis", "probability": 0.233642578125 }, { "start_logit": 15.21875, "end_logit": 10.6015625, "text": "They are:\nAnaphylaxis", "probability": 0.15087890625 }, { "start_logit": 7.4765625, "end_logit": -0.494873046875, "text": "", "probability": 0.0 } ], "100000000000000000007691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.2109375, "end_logit": -0.5029296875, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000007697": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.19140625, "end_logit": -0.46875, "text": "", "probability": 0.998798108681489 } ], "100000000000000000007702": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.234375, "end_logit": -0.4130859375, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000007704": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010566838241698937 }, { "start_logit": 7.2265625, "end_logit": -0.376708984375, "text": "", "probability": 0.9989433161758301 } ], "100000000000000000007705": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001044385941892429 }, { "start_logit": 7.38671875, "end_logit": -0.52490234375, "text": "", "probability": 0.9989556140581076 } ], "100000000000000000007708": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010525685405347706 }, { "start_logit": 7.08203125, "end_logit": -0.2259521484375, "text": "", "probability": 0.9989474314594652 } ], "100000000000000000007710": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.12890625, "end_logit": -0.24951171875, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000007714": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006094501590135561 }, { "start_logit": 7.56640625, "end_logit": -0.16455078125, "text": "", "probability": 0.9993905498409864 } ], "100000000000000000007715": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008864989276457546 }, { "start_logit": 7.484375, "end_logit": -0.45849609375, "text": "", "probability": 0.9991135010723542 } ], "100000000000000000007717": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.4921875, "end_logit": -0.46728515625, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000007718": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009326360013054126 }, { "start_logit": 7.48828125, "end_logit": -0.5126953125, "text": "", "probability": 0.9990673639986946 } ], "100000000000000000007724": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.41796875, "end_logit": -0.73779296875, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000007725": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994276383 }, { "start_logit": -33.6875, "end_logit": 12.40625, "text": "", "probability": 5.723616892186642e-10 } ], "100000000000000000007729": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993308415 }, { "start_logit": -33.75, "end_logit": 12.625, "text": "", "probability": 6.69158608681505e-10 } ], "100000000000000000007731": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006436856044842308 }, { "start_logit": 7.95703125, "end_logit": -0.60791015625, "text": "", "probability": 0.9993563143955159 } ], "100000000000000000007734": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000758359964634202 }, { "start_logit": 7.8203125, "end_logit": -0.63671875, "text": "", "probability": 0.9992416400353659 } ], "100000000000000000007735": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 7.93359375, "end_logit": -0.62890625, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000007737": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -33.96875, "end_logit": 13.7890625, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000007744": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 8.234375, "end_logit": -1.0400390625, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000007746": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 8.1171875, "end_logit": -1.0244140625, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000007750": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.79296875, "end_logit": -1.1484375, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000007751": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.73828125, "end_logit": -1.0947265625, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000007752": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014269596332777221 }, { "start_logit": 7.62109375, "end_logit": -1.0712890625, "text": "", "probability": 0.9985730403667223 } ], "100000000000000000007757": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.66015625, "end_logit": -1.0419921875, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000007761": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 6.9375, "end_logit": -0.2230224609375, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000007764": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.38671875, "end_logit": -0.6982421875, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000007765": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.45703125, "end_logit": -0.78955078125, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000007767": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 7.44140625, "end_logit": -0.74560546875, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000007769": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 7.48046875, "end_logit": -0.73828125, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000007780": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002912178283114333 }, { "start_logit": 6.13671875, "end_logit": -0.3017578125, "text": "", "probability": 0.9970878217168856 } ], "100000000000000000007782": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021997980436915168 }, { "start_logit": 7.35546875, "end_logit": -1.23828125, "text": "", "probability": 0.9978002019563085 } ], "100000000000000000007783": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002115703400593114 }, { "start_logit": 7.3828125, "end_logit": -1.228515625, "text": "", "probability": 0.9978842965994068 } ], "100000000000000000007794": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 8.0625, "end_logit": -0.7822265625, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000007797": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993614843 }, { "start_logit": -33.21875, "end_logit": 12.046875, "text": "", "probability": 6.385156050141256e-10 } ], "100000000000000000007798": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993514292 }, { "start_logit": -33.15625, "end_logit": 11.9921875, "text": "", "probability": 6.48570762683418e-10 } ], "100000000000000000007799": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993308415 }, { "start_logit": -33.1875, "end_logit": 12.0625, "text": "", "probability": 6.69158608681505e-10 } ], "100000000000000000007801": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994623159 }, { "start_logit": -33.1875, "end_logit": 11.84375, "text": "", "probability": 5.376840475246457e-10 } ], "100000000000000000007805": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999994276383 }, { "start_logit": -33.1875, "end_logit": 11.8984375, "text": "", "probability": 5.723616892186642e-10 } ], "100000000000000000007808": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 8.03125, "end_logit": -0.724609375, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000007811": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.99609375, "end_logit": -0.90087890625, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000007812": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.96484375, "end_logit": -0.8701171875, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000007813": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 8.0078125, "end_logit": -0.92041015625, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000007814": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008072304985619872 }, { "start_logit": 8.0234375, "end_logit": -0.90283203125, "text": "", "probability": 0.9991927695014381 } ], "100000000000000000007816": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008263575992788699 }, { "start_logit": 8.0390625, "end_logit": -0.94189453125, "text": "", "probability": 0.9991736424007212 } ], "100000000000000000007817": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008199321062135582 }, { "start_logit": 8.0625, "end_logit": -0.9560546875, "text": "", "probability": 0.9991800678937864 } ], "100000000000000000007827": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 7.703125, "end_logit": -1.1044921875, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000007841": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007208380258812108 }, { "start_logit": 7.78125, "end_logit": -0.5478515625, "text": "", "probability": 0.9992791619741188 } ], "100000000000000000007842": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006070755804415096 }, { "start_logit": 7.8515625, "end_logit": -0.447265625, "text": "", "probability": 0.9993929244195585 } ], "100000000000000000007844": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.140625, "end_logit": -0.334228515625, "text": "", "probability": 0.99889266101491 } ], "100000000000000000007845": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.140625, "end_logit": -0.336669921875, "text": "", "probability": 0.99889266101491 } ], "100000000000000000007847": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.2109375, "end_logit": -0.376953125, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000007854": [ { "start_logit": 15.296875, "end_logit": 6.8671875, "text": " 4 MB, 2", "probability": 0.234619140625 }, { "start_logit": 15.296875, "end_logit": 6.55078125, "text": " 4", "probability": 0.171630859375 }, { "start_logit": 14.640625, "end_logit": 6.8671875, "text": " 2", "probability": 0.1217041015625 }, { "start_logit": 14.1640625, "end_logit": 6.55078125, "text": " 2 pages]\n\uf20c\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4", "probability": 0.05572509765625 }, { "start_logit": 15.296875, "end_logit": 5.27734375, "text": " 4 MB", "probability": 0.048431396484375 }, { "start_logit": 14.1640625, "end_logit": 6.3203125, "text": " 2", "probability": 0.0440673828125 }, { "start_logit": 13.4296875, "end_logit": 6.8671875, "text": "\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4 MB, 2", "probability": 0.03656005859375 }, { "start_logit": 13.40625, "end_logit": 6.8671875, "text": "PDF - 4 MB, 2", "probability": 0.035980224609375 }, { "start_logit": 13.7890625, "end_logit": 6.421875, "text": " 1", "probability": 0.0338134765625 }, { "start_logit": 13.4296875, "end_logit": 6.55078125, "text": "\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4", "probability": 0.0267333984375 }, { "start_logit": 13.53125, "end_logit": 6.421875, "text": "Print Resources\nDon't Delay: Test Soon and Treat Early\n[PDF - 361 KB, 1", "probability": 0.0259246826171875 }, { "start_logit": 13.40625, "end_logit": 6.55078125, "text": "PDF - 4", "probability": 0.0259246826171875 }, { "start_logit": 13.46875, "end_logit": 6.3203125, "text": " 372 KB, 2", "probability": 0.021820068359375 }, { "start_logit": 13.609375, "end_logit": 6.13671875, "text": " 1", "probability": 0.021148681640625 }, { "start_logit": 15.296875, "end_logit": 4.37109375, "text": " 4 MB, 2 pages", "probability": 0.019561767578125 }, { "start_logit": 14.1640625, "end_logit": 5.48046875, "text": " 2 pages]\n\uf20c\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF", "probability": 0.0189666748046875 }, { "start_logit": 13.1328125, "end_logit": 6.3203125, "text": "PDF - 372 KB, 2", "probability": 0.0157318115234375 }, { "start_logit": 12.5078125, "end_logit": 6.8671875, "text": " Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4 MB, 2", "probability": 0.01453399658203125 }, { "start_logit": 13.53125, "end_logit": 5.78125, "text": "Print Resources", "probability": 0.0136566162109375 }, { "start_logit": 12.8984375, "end_logit": 6.421875, "text": "PDF - 361 KB, 1", "probability": 0.0136566162109375 }, { "start_logit": 9.2578125, "end_logit": -1.197265625, "text": "", "probability": 1.7881393432617188e-07 } ], "100000000000000000007857": [ { "start_logit": 15.296875, "end_logit": 6.8671875, "text": " 4 MB, 2", "probability": 0.234619140625 }, { "start_logit": 15.296875, "end_logit": 6.55078125, "text": " 4", "probability": 0.171630859375 }, { "start_logit": 14.640625, "end_logit": 6.8671875, "text": " 2", "probability": 0.1217041015625 }, { "start_logit": 14.1640625, "end_logit": 6.55078125, "text": " 2 pages]\n\uf20c\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4", "probability": 0.05572509765625 }, { "start_logit": 15.296875, "end_logit": 5.27734375, "text": " 4 MB", "probability": 0.048431396484375 }, { "start_logit": 14.1640625, "end_logit": 6.3203125, "text": " 2", "probability": 0.0440673828125 }, { "start_logit": 13.4296875, "end_logit": 6.8671875, "text": "\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4 MB, 2", "probability": 0.03656005859375 }, { "start_logit": 13.40625, "end_logit": 6.8671875, "text": "PDF - 4 MB, 2", "probability": 0.035980224609375 }, { "start_logit": 13.7890625, "end_logit": 6.421875, "text": " 1", "probability": 0.0338134765625 }, { "start_logit": 13.4296875, "end_logit": 6.55078125, "text": "\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4", "probability": 0.0267333984375 }, { "start_logit": 13.53125, "end_logit": 6.421875, "text": "Print Resources\nDon't Delay: Test Soon and Treat Early\n[PDF - 361 KB, 1", "probability": 0.0259246826171875 }, { "start_logit": 13.40625, "end_logit": 6.55078125, "text": "PDF - 4", "probability": 0.0259246826171875 }, { "start_logit": 13.46875, "end_logit": 6.3203125, "text": " 372 KB, 2", "probability": 0.021820068359375 }, { "start_logit": 13.609375, "end_logit": 6.13671875, "text": " 1", "probability": 0.021148681640625 }, { "start_logit": 15.296875, "end_logit": 4.37109375, "text": " 4 MB, 2 pages", "probability": 0.019561767578125 }, { "start_logit": 14.1640625, "end_logit": 5.48046875, "text": " 2 pages]\n\uf20c\nHow to Collect a Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF", "probability": 0.0189666748046875 }, { "start_logit": 13.1328125, "end_logit": 6.3203125, "text": "PDF - 372 KB, 2", "probability": 0.0157318115234375 }, { "start_logit": 12.5078125, "end_logit": 6.8671875, "text": " Nasal Mid-Turbinate Swab Specimen for COVID-19 Testing\n[PDF - 4 MB, 2", "probability": 0.01453399658203125 }, { "start_logit": 13.53125, "end_logit": 5.78125, "text": "Print Resources", "probability": 0.0136566162109375 }, { "start_logit": 12.8984375, "end_logit": 6.421875, "text": "PDF - 361 KB, 1", "probability": 0.0136566162109375 }, { "start_logit": 9.171875, "end_logit": -1.2373046875, "text": "", "probability": 1.7881393432617188e-07 } ], "100000000000000000007861": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008426423087564059 }, { "start_logit": 7.48828125, "end_logit": -0.4111328125, "text": "", "probability": 0.9991573576912437 } ], "100000000000000000007868": [ { "start_logit": 16.3125, "end_logit": 8.7734375, "text": " ACON Laboratories", "probability": 0.355712890625 }, { "start_logit": 15.6953125, "end_logit": 9.03125, "text": " BD Sensor", "probability": 0.24462890625 }, { "start_logit": 16.3125, "end_logit": 7.71484375, "text": " ACON Laboratories\nFlowFlex", "probability": 0.12298583984375 }, { "start_logit": 14.3046875, "end_logit": 9.03125, "text": "COVID-19 At-Home Test\nManufactured by BD Sensor", "probability": 0.061859130859375 }, { "start_logit": 15.5703125, "end_logit": 7.51171875, "text": " Quidel", "probability": 0.047393798828125 }, { "start_logit": 13.890625, "end_logit": 8.7734375, "text": "\nFlowFlex\nManufactured by ACON Laboratories", "probability": 0.031097412109375 }, { "start_logit": 16.3125, "end_logit": 5.875, "text": " ACON Laboratories\nFlowFlex SARS-CoV-2", "probability": 0.0194549560546875 }, { "start_logit": 13.1484375, "end_logit": 9.03125, "text": "\nCOVID-19 At-Home Test\nManufactured by BD Sensor", "probability": 0.0194549560546875 }, { "start_logit": 15.5703125, "end_logit": 6.23046875, "text": " Quidel\nQuickVue At-Home (quickvueathome.com) \uf209\nCOVID-19", "probability": 0.01316070556640625 }, { "start_logit": 13.890625, "end_logit": 7.71484375, "text": "\nFlowFlex\nManufactured by ACON Laboratories\nFlowFlex", "probability": 0.0109100341796875 }, { "start_logit": 15.390625, "end_logit": 6.14453125, "text": " BD\nSteps for testing \u2013 BD Veritor", "probability": 0.01009368896484375 }, { "start_logit": 13.890625, "end_logit": 7.6484375, "text": "\nFlowFlex", "probability": 0.01009368896484375 }, { "start_logit": 16.3125, "end_logit": 5.109375, "text": " ACON Labor", "probability": 0.0090484619140625 }, { "start_logit": 12.6484375, "end_logit": 8.7734375, "text": " COVID-19 Antigen Self-Test (prefilled extraction tubes)\n\uf209\nFlowFlex\nManufactured by ACON Laboratories", "probability": 0.0090484619140625 }, { "start_logit": 16.3125, "end_logit": 5.09375, "text": " AC", "probability": 0.0089111328125 }, { "start_logit": 15.0078125, "end_logit": 6.34375, "text": " InBios", "probability": 0.00836944580078125 }, { "start_logit": 13.1171875, "end_logit": 7.6484375, "text": " Siemens\nHow to use the CLINITEST\u00ae Rapid COVID-19 Antigen Self-Test (prefilled extraction tubes)\n\uf209\nFlowFlex", "probability": 0.00469207763671875 }, { "start_logit": 15.6953125, "end_logit": 5.04296875, "text": " BD", "probability": 0.004550933837890625 }, { "start_logit": 14.109375, "end_logit": 6.6015625, "text": "\nBD Veritor", "probability": 0.00447845458984375 }, { "start_logit": 13.078125, "end_logit": 7.51171875, "text": "\nQuickVue\nManufactured by Quidel", "probability": 0.0039520263671875 }, { "start_logit": -32.90625, "end_logit": 14.0078125, "text": "", "probability": 0.0 } ], "100000000000000000007873": [ { "start_logit": 16.3125, "end_logit": 8.7734375, "text": " ACON Laboratories", "probability": 0.355712890625 }, { "start_logit": 15.6953125, "end_logit": 9.03125, "text": " BD Sensor", "probability": 0.24462890625 }, { "start_logit": 16.3125, "end_logit": 7.71484375, "text": " ACON Laboratories\nFlowFlex", "probability": 0.12298583984375 }, { "start_logit": 14.3046875, "end_logit": 9.03125, "text": "COVID-19 At-Home Test\nManufactured by BD Sensor", "probability": 0.061859130859375 }, { "start_logit": 15.5703125, "end_logit": 7.51171875, "text": " Quidel", "probability": 0.047393798828125 }, { "start_logit": 13.890625, "end_logit": 8.7734375, "text": "\nFlowFlex\nManufactured by ACON Laboratories", "probability": 0.031097412109375 }, { "start_logit": 16.3125, "end_logit": 5.875, "text": " ACON Laboratories\nFlowFlex SARS-CoV-2", "probability": 0.0194549560546875 }, { "start_logit": 13.1484375, "end_logit": 9.03125, "text": "\nCOVID-19 At-Home Test\nManufactured by BD Sensor", "probability": 0.0194549560546875 }, { "start_logit": 15.5703125, "end_logit": 6.23046875, "text": " Quidel\nQuickVue At-Home (quickvueathome.com) \uf209\nCOVID-19", "probability": 0.01316070556640625 }, { "start_logit": 13.890625, "end_logit": 7.71484375, "text": "\nFlowFlex\nManufactured by ACON Laboratories\nFlowFlex", "probability": 0.0109100341796875 }, { "start_logit": 15.390625, "end_logit": 6.14453125, "text": " BD\nSteps for testing \u2013 BD Veritor", "probability": 0.01009368896484375 }, { "start_logit": 13.890625, "end_logit": 7.6484375, "text": "\nFlowFlex", "probability": 0.01009368896484375 }, { "start_logit": 16.3125, "end_logit": 5.109375, "text": " ACON Labor", "probability": 0.0090484619140625 }, { "start_logit": 12.6484375, "end_logit": 8.7734375, "text": " COVID-19 Antigen Self-Test (prefilled extraction tubes)\n\uf209\nFlowFlex\nManufactured by ACON Laboratories", "probability": 0.0090484619140625 }, { "start_logit": 16.3125, "end_logit": 5.09375, "text": " AC", "probability": 0.0089111328125 }, { "start_logit": 15.0078125, "end_logit": 6.34375, "text": " InBios", "probability": 0.00836944580078125 }, { "start_logit": 13.1171875, "end_logit": 7.6484375, "text": " Siemens\nHow to use the CLINITEST\u00ae Rapid COVID-19 Antigen Self-Test (prefilled extraction tubes)\n\uf209\nFlowFlex", "probability": 0.00469207763671875 }, { "start_logit": 15.6953125, "end_logit": 5.04296875, "text": " BD", "probability": 0.004550933837890625 }, { "start_logit": 14.109375, "end_logit": 6.6015625, "text": "\nBD Veritor", "probability": 0.00447845458984375 }, { "start_logit": 13.078125, "end_logit": 7.51171875, "text": "\nQuickVue\nManufactured by Quidel", "probability": 0.0039520263671875 }, { "start_logit": -32.9375, "end_logit": 13.8671875, "text": "", "probability": 0.0 } ], "100000000000000000007880": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.84375, "end_logit": -0.69580078125, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000007884": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.921875, "end_logit": -0.693359375, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000007886": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003524340980437085 }, { "start_logit": 6.30859375, "end_logit": -0.66259765625, "text": "", "probability": 0.9964756590195629 } ], "100000000000000000007889": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003884476548765805 }, { "start_logit": 6.203125, "end_logit": -0.65576171875, "text": "", "probability": 0.9961155234512341 } ], "100000000000000000007890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003551884549034502 }, { "start_logit": 6.2421875, "end_logit": -0.60498046875, "text": "", "probability": 0.9964481154509656 } ], "100000000000000000007900": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018386652876885773 }, { "start_logit": 6.8515625, "end_logit": -0.55322265625, "text": "", "probability": 0.9981613347123114 } ], "100000000000000000007903": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006563728324346652 }, { "start_logit": 6.9921875, "end_logit": 0.3359375, "text": "", "probability": 0.9993436271675653 } ], "100000000000000000007904": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 6.88671875, "end_logit": 0.32421875, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000007906": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007236572645054245 }, { "start_logit": 7.74609375, "end_logit": -0.51416015625, "text": "", "probability": 0.9992763427354946 } ], "100000000000000000007912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006142271998613951 }, { "start_logit": 8.2734375, "end_logit": -0.8779296875, "text": "", "probability": 0.9993857728001386 } ], "100000000000000000007917": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.74609375, "end_logit": -1.0068359375, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000007918": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.76171875, "end_logit": -0.9951171875, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000007920": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.765625, "end_logit": -0.97509765625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000007932": [ { "start_logit": 18.671875, "end_logit": 9.296875, "text": " myocarditis and pericarditis", "probability": 0.202392578125 }, { "start_logit": 18.65625, "end_logit": 9.296875, "text": "\nvaccine confidence.16,17,18 CDC and its partners are actively monitoring\nreports of myocarditis and pericarditis", "probability": 0.19921875 }, { "start_logit": 18.671875, "end_logit": 8.7890625, "text": " myocarditis and pericarditis after COVID-19 vaccination and CDC\ngives regular public updates about the risks of myocarditis and pericarditis", "probability": 0.12274169921875 }, { "start_logit": 18.65625, "end_logit": 8.8125, "text": "\nvaccine confidence", "probability": 0.12274169921875 }, { "start_logit": 18.375, "end_logit": 7.9609375, "text": " mRNA", "probability": 0.03985595703125 }, { "start_logit": 19.109375, "end_logit": 6.984375, "text": " COVID-19", "probability": 0.0310211181640625 }, { "start_logit": 17.203125, "end_logit": 8.7890625, "text": " myocarditis and pericarditis", "probability": 0.02825927734375 }, { "start_logit": 19.109375, "end_logit": 6.84375, "text": " COVID-19 vaccine-related myocarditis is much\nlower for children", "probability": 0.026947021484375 }, { "start_logit": 18.375, "end_logit": 7.55078125, "text": " mRNA vaccination", "probability": 0.0261383056640625 }, { "start_logit": 17.03125, "end_logit": 8.8125, "text": " myocarditis continue to negatively impact\nvaccine confidence", "probability": 0.024169921875 }, { "start_logit": 16.5, "end_logit": 9.296875, "text": "vaccine confidence.16,17,18 CDC and its partners are actively monitoring\nreports of myocarditis and pericarditis", "probability": 0.0230560302734375 }, { "start_logit": 16.9375, "end_logit": 8.8125, "text": "\nhospitalization15 following myocarditis continue to negatively impact\nvaccine confidence", "probability": 0.0220184326171875 }, { "start_logit": 18.671875, "end_logit": 7.0234375, "text": " myocarditis", "probability": 0.0206756591796875 }, { "start_logit": 18.65625, "end_logit": 7.0234375, "text": "\nvaccine confidence.16,17,18 CDC and its partners are actively monitoring\nreports of myocarditis", "probability": 0.0206756591796875 }, { "start_logit": 16.828125, "end_logit": 8.7890625, "text": " COVID-19 vaccination and CDC\ngives regular public updates about the risks of myocarditis and pericarditis", "probability": 0.0194244384765625 }, { "start_logit": 18.671875, "end_logit": 6.8359375, "text": " myocarditis and pericarditis after COVID-19 vaccination", "probability": 0.01715087890625 }, { "start_logit": 16.5, "end_logit": 8.8125, "text": "vaccine confidence", "probability": 0.0142059326171875 }, { "start_logit": 15.9921875, "end_logit": 9.296875, "text": " CDC and its partners are actively monitoring\nreports of myocarditis and pericarditis", "probability": 0.01377105712890625 }, { "start_logit": 19.109375, "end_logit": 6.1171875, "text": " COVID-19 vaccine", "probability": 0.01293182373046875 }, { "start_logit": 15.9140625, "end_logit": 9.296875, "text": "\nreports of myocarditis and pericarditis", "probability": 0.01293182373046875 }, { "start_logit": 8.359375, "end_logit": -1.3203125, "text": "", "probability": 0.0 } ], "100000000000000000007934": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.3203125, "end_logit": -0.414794921875, "text": "", "probability": 0.99899949559909 } ], "100000000000000000007956": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030753698500482337 }, { "start_logit": 6.36328125, "end_logit": -0.58056640625, "text": "", "probability": 0.9969246301499518 } ], "100000000000000000007961": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002305125202793809 }, { "start_logit": 6.5546875, "end_logit": -0.482421875, "text": "", "probability": 0.9976948747972061 } ], "100000000000000000007963": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 7.23046875, "end_logit": -0.5234375, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000007967": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.25, "end_logit": -0.484619140625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000007973": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.9296875, "end_logit": -0.78173828125, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000007976": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.671875, "end_logit": -0.70263671875, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000007977": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009217804784171763 }, { "start_logit": 7.6796875, "end_logit": -0.6923828125, "text": "", "probability": 0.9990782195215828 } ], "100000000000000000007980": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.703125, "end_logit": -0.677734375, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000007981": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.6484375, "end_logit": -0.71826171875, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000007982": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.60546875, "end_logit": -0.677734375, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000007983": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.58203125, "end_logit": -0.68212890625, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000007986": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.609375, "end_logit": -0.689453125, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000007987": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008864989276457546 }, { "start_logit": 7.45703125, "end_logit": -0.430419921875, "text": "", "probability": 0.9991135010723542 } ], "100000000000000000007990": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.48828125, "end_logit": -0.5087890625, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000007998": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001995538615533461 }, { "start_logit": 6.5546875, "end_logit": -0.3408203125, "text": "", "probability": 0.9980044613844665 } ], "100000000000000000008003": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.078125, "end_logit": -0.302490234375, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000008004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 6.98046875, "end_logit": -0.301025390625, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000008012": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003363492495187692 }, { "start_logit": 6.171875, "end_logit": -0.482177734375, "text": "", "probability": 0.9966365075048124 } ], "100000000000000000008013": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00025315637215092633 }, { "start_logit": 7.76953125, "end_logit": 0.51171875, "text": "", "probability": 0.9997468436278489 } ], "100000000000000000008018": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.6171875, "end_logit": -0.7294921875, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000008020": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.6875, "end_logit": -0.75732421875, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000008021": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009253848866495988 }, { "start_logit": 7.765625, "end_logit": -0.78125, "text": "", "probability": 0.9990746151133504 } ], "100000000000000000008027": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002225670854115196 }, { "start_logit": 6.33984375, "end_logit": -0.234130859375, "text": "", "probability": 0.9977743291458849 } ], "100000000000000000008037": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -34.28125, "end_logit": 16.53125, "text": "", "probability": 0.0 } ], "100000000000000000008039": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -34.03125, "end_logit": 16.09375, "text": "", "probability": 0.0 } ], "100000000000000000008044": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -34.34375, "end_logit": 16.03125, "text": "", "probability": 0.0 } ], "100000000000000000008046": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -33.5625, "end_logit": 15.4609375, "text": "", "probability": 0.0 } ], "100000000000000000008047": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -34.0, "end_logit": 16.015625, "text": "", "probability": 0.0 } ], "100000000000000000008050": [ { "start_logit": 17.34375, "end_logit": 9.7890625, "text": " 11%", "probability": 0.2310791015625 }, { "start_logit": 16.859375, "end_logit": 9.7890625, "text": " 27%\nsay they will definitely not get their child\nvaccinated, and 11%", "probability": 0.1446533203125 }, { "start_logit": 16.859375, "end_logit": 9.3046875, "text": " 27%", "probability": 0.08770751953125 }, { "start_logit": 16.78125, "end_logit": 9.3046875, "text": "38% say they plan to wait and see how\nthe vaccine is working for others, 27%", "probability": 0.08233642578125 }, { "start_logit": 16.78125, "end_logit": 9.171875, "text": "38%", "probability": 0.07159423828125 }, { "start_logit": 17.59375, "end_logit": 8.2421875, "text": " The FDA committee", "probability": 0.06414794921875 }, { "start_logit": 17.21875, "end_logit": 8.546875, "text": " June 14\u201315, 2022", "probability": 0.059326171875 }, { "start_logit": 16.734375, "end_logit": 8.9375, "text": " vaccine uptake", "probability": 0.054046630859375 }, { "start_logit": 16.796875, "end_logit": 8.5, "text": " May 17, 2022", "probability": 0.037139892578125 }, { "start_logit": 16.734375, "end_logit": 8.09375, "text": " vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.0232391357421875 }, { "start_logit": 15.875, "end_logit": 8.9375, "text": " myocarditis, may negatively impact vaccine uptake", "probability": 0.0228729248046875 }, { "start_logit": 16.1875, "end_logit": 8.546875, "text": "Vaccines and Related Biological Products Advisory Committee), meet on June 14\u201315, 2022", "probability": 0.021148681640625 }, { "start_logit": 16.0625, "end_logit": 8.5, "text": "On May 17, 2022", "probability": 0.0178070068359375 }, { "start_logit": 16.21875, "end_logit": 8.2421875, "text": " 5-11 years at least five months after completion of a primary series with the same\nvaccine.101 The FDA committee", "probability": 0.0162200927734375 }, { "start_logit": 16.296875, "end_logit": 8.09375, "text": " this group", "probability": 0.01500701904296875 }, { "start_logit": 16.625, "end_logit": 7.69140625, "text": "ACIP) issued interim recommendations for use of the Moderna COVID-19 vaccine in children ages 6 months to 5\nyears", "probability": 0.01387786865234375 }, { "start_logit": 15.875, "end_logit": 8.09375, "text": " myocarditis, may negatively impact vaccine uptake.109,110\n\u0083 Some consumers believe vaccines are unnecessary because COVID-19 rarely affects this group", "probability": 0.00983428955078125 }, { "start_logit": 17.21875, "end_logit": 6.73828125, "text": " June 14\u201315, 2022 to discuss the\nemergency use authorization of COVID-19 vaccines in this age.102 On June 17, 2022", "probability": 0.0096893310546875 }, { "start_logit": 16.21875, "end_logit": 7.6875, "text": " 5-11 years at least five months", "probability": 0.009246826171875 }, { "start_logit": 16.1875, "end_logit": 7.6796875, "text": "Vaccines and Related Biological Products Advisory Committee", "probability": 0.00896453857421875 }, { "start_logit": -34.71875, "end_logit": 16.1875, "text": "", "probability": 0.0 } ], "100000000000000000008054": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 6.87109375, "end_logit": 0.1947021484375, "text": "", "probability": 0.999147433358729 } ], "100000000000000000008056": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006589401102677214 }, { "start_logit": 7.34375, "end_logit": -0.019134521484375, "text": "", "probability": 0.9993410598897322 } ], "100000000000000000008060": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006214630161383599 }, { "start_logit": 8.5625, "end_logit": -1.177734375, "text": "", "probability": 0.9993785369838617 } ], "100000000000000000008066": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003726376876619113 }, { "start_logit": 7.99609375, "end_logit": -0.10015869140625, "text": "", "probability": 0.9996273623123381 } ], "100000000000000000008068": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.5234375, "end_logit": -0.74169921875, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000008069": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.37109375, "end_logit": -0.7138671875, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000008070": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.3984375, "end_logit": -0.76708984375, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000008074": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.4609375, "end_logit": -0.67236328125, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000008077": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010362668882466278 }, { "start_logit": 6.875, "end_logit": -0.0031452178955078125, "text": "", "probability": 0.9989637331117535 } ], "100000000000000000008081": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.86328125, "end_logit": -1.064453125, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000008087": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.66015625, "end_logit": -0.77392578125, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000008088": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010691263618290232 }, { "start_logit": 7.59765625, "end_logit": -0.75732421875, "text": "", "probability": 0.998930873638171 } ], "100000000000000000008089": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.5078125, "end_logit": -0.720703125, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000008091": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.5390625, "end_logit": -0.7646484375, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000008092": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.60546875, "end_logit": -0.74462890625, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000008095": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0033244368916556374 }, { "start_logit": 6.875, "end_logit": -1.169921875, "text": "", "probability": 0.9966755631083445 } ], "100000000000000000008096": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0036076168032535263 }, { "start_logit": 6.7265625, "end_logit": -1.10546875, "text": "", "probability": 0.9963923831967464 } ], "100000000000000000008097": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003416278843770214 }, { "start_logit": 6.765625, "end_logit": -1.08984375, "text": "", "probability": 0.9965837211562298 } ], "100000000000000000008099": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0035657366623610266 }, { "start_logit": 6.703125, "end_logit": -1.068359375, "text": "", "probability": 0.9964342633376391 } ], "100000000000000000008101": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.97265625, "end_logit": -0.826171875, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000008107": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030160662173845665 }, { "start_logit": 6.2265625, "end_logit": -0.424072265625, "text": "", "probability": 0.9969839337826155 } ], "100000000000000000008110": [ { "start_logit": 19.828125, "end_logit": 8.71875, "text": " More than one sex partner", "probability": 0.34228515625 }, { "start_logit": 19.828125, "end_logit": 7.55859375, "text": " More than one", "probability": 0.10772705078125 }, { "start_logit": 19.1875, "end_logit": 8.140625, "text": " making vaccinated individuals more\nsusceptible to monkeypox", "probability": 0.1011962890625 }, { "start_logit": 18.125, "end_logit": 8.6640625, "text": " take action", "probability": 0.05853271484375 }, { "start_logit": 18.546875, "end_logit": 7.984375, "text": " monkeypox", "probability": 0.04559326171875 }, { "start_logit": 18.734375, "end_logit": 7.61328125, "text": " Monkeypox PrEP", "probability": 0.037811279296875 }, { "start_logit": 17.59375, "end_logit": 8.6640625, "text": " monkeypox pandemic to increase\nWays public health and partners can take action", "probability": 0.034423828125 }, { "start_logit": 19.1875, "end_logit": 7.05078125, "text": " making vaccinated individuals more\nsusceptible to monkeypox.143,144\n\u0083 Some social media users believe monkeypox", "probability": 0.03387451171875 }, { "start_logit": 18.609375, "end_logit": 7.4453125, "text": " vaccine confidence", "probability": 0.028533935546875 }, { "start_logit": 18.734375, "end_logit": 7.23046875, "text": " Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.0259857177734375 }, { "start_logit": 18.734375, "end_logit": 7.1328125, "text": " Monkeypox", "probability": 0.0236663818359375 }, { "start_logit": 18.953125, "end_logit": 6.8515625, "text": " COVID-19 vaccines.145,146\n\u0083 Some social media users believe monkeypox", "probability": 0.0222320556640625 }, { "start_logit": 18.1875, "end_logit": 7.61328125, "text": " October 10, 2022\n\u0082 Monkeypox PrEP", "probability": 0.0218658447265625 }, { "start_logit": 18.953125, "end_logit": 6.82421875, "text": " COVID-19 vaccines", "probability": 0.0215301513671875 }, { "start_logit": 17.59375, "end_logit": 8.0546875, "text": " monkeypox", "probability": 0.019012451171875 }, { "start_logit": 16.921875, "end_logit": 8.6640625, "text": "Ways public health and partners can take action", "probability": 0.017852783203125 }, { "start_logit": 17.453125, "end_logit": 8.0546875, "text": " COVID-19 is not seen as a threat.147,148\n\u0083 Some social media users believe pharmaceutical companies are attempting to create a monkeypox", "probability": 0.016265869140625 }, { "start_logit": 18.1875, "end_logit": 7.23046875, "text": " October 10, 2022\n\u0082 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.01503753662109375 }, { "start_logit": 18.1875, "end_logit": 7.1328125, "text": " October 10, 2022\n\u0082 Monkeypox", "probability": 0.01348114013671875 }, { "start_logit": 18.125, "end_logit": 7.18359375, "text": " take action to improve vaccine confidence", "probability": 0.01348114013671875 }, { "start_logit": -34.0625, "end_logit": 15.21875, "text": "", "probability": 0.0 } ], "100000000000000000008111": [ { "start_logit": 19.828125, "end_logit": 8.71875, "text": " More than one sex partner", "probability": 0.34228515625 }, { "start_logit": 19.828125, "end_logit": 7.55859375, "text": " More than one", "probability": 0.10772705078125 }, { "start_logit": 19.1875, "end_logit": 8.140625, "text": " making vaccinated individuals more\nsusceptible to monkeypox", "probability": 0.1011962890625 }, { "start_logit": 18.125, "end_logit": 8.6640625, "text": " take action", "probability": 0.05853271484375 }, { "start_logit": 18.546875, "end_logit": 7.984375, "text": " monkeypox", "probability": 0.04559326171875 }, { "start_logit": 18.734375, "end_logit": 7.61328125, "text": " Monkeypox PrEP", "probability": 0.037811279296875 }, { "start_logit": 17.59375, "end_logit": 8.6640625, "text": " monkeypox pandemic to increase\nWays public health and partners can take action", "probability": 0.034423828125 }, { "start_logit": 19.1875, "end_logit": 7.05078125, "text": " making vaccinated individuals more\nsusceptible to monkeypox.143,144\n\u0083 Some social media users believe monkeypox", "probability": 0.03387451171875 }, { "start_logit": 18.609375, "end_logit": 7.4453125, "text": " vaccine confidence", "probability": 0.028533935546875 }, { "start_logit": 18.734375, "end_logit": 7.23046875, "text": " Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.0259857177734375 }, { "start_logit": 18.734375, "end_logit": 7.1328125, "text": " Monkeypox", "probability": 0.0236663818359375 }, { "start_logit": 18.953125, "end_logit": 6.8515625, "text": " COVID-19 vaccines.145,146\n\u0083 Some social media users believe monkeypox", "probability": 0.0222320556640625 }, { "start_logit": 18.1875, "end_logit": 7.61328125, "text": " October 10, 2022\n\u0082 Monkeypox PrEP", "probability": 0.0218658447265625 }, { "start_logit": 18.953125, "end_logit": 6.82421875, "text": " COVID-19 vaccines", "probability": 0.0215301513671875 }, { "start_logit": 17.59375, "end_logit": 8.0546875, "text": " monkeypox", "probability": 0.019012451171875 }, { "start_logit": 16.921875, "end_logit": 8.6640625, "text": "Ways public health and partners can take action", "probability": 0.017852783203125 }, { "start_logit": 17.453125, "end_logit": 8.0546875, "text": " COVID-19 is not seen as a threat.147,148\n\u0083 Some social media users believe pharmaceutical companies are attempting to create a monkeypox", "probability": 0.016265869140625 }, { "start_logit": 18.1875, "end_logit": 7.23046875, "text": " October 10, 2022\n\u0082 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.01503753662109375 }, { "start_logit": 18.1875, "end_logit": 7.1328125, "text": " October 10, 2022\n\u0082 Monkeypox", "probability": 0.01348114013671875 }, { "start_logit": 18.125, "end_logit": 7.18359375, "text": " take action to improve vaccine confidence", "probability": 0.01348114013671875 }, { "start_logit": -33.875, "end_logit": 14.9921875, "text": "", "probability": 0.0 } ], "100000000000000000008117": [ { "start_logit": 19.828125, "end_logit": 8.71875, "text": " More than one sex partner", "probability": 0.34228515625 }, { "start_logit": 19.828125, "end_logit": 7.55859375, "text": " More than one", "probability": 0.10772705078125 }, { "start_logit": 19.1875, "end_logit": 8.140625, "text": " making vaccinated individuals more\nsusceptible to monkeypox", "probability": 0.1011962890625 }, { "start_logit": 18.125, "end_logit": 8.6640625, "text": " take action", "probability": 0.05853271484375 }, { "start_logit": 18.546875, "end_logit": 7.984375, "text": " monkeypox", "probability": 0.04559326171875 }, { "start_logit": 18.734375, "end_logit": 7.61328125, "text": " Monkeypox PrEP", "probability": 0.037811279296875 }, { "start_logit": 17.59375, "end_logit": 8.6640625, "text": " monkeypox pandemic to increase\nWays public health and partners can take action", "probability": 0.034423828125 }, { "start_logit": 19.1875, "end_logit": 7.05078125, "text": " making vaccinated individuals more\nsusceptible to monkeypox.143,144\n\u0083 Some social media users believe monkeypox", "probability": 0.03387451171875 }, { "start_logit": 18.609375, "end_logit": 7.4453125, "text": " vaccine confidence", "probability": 0.028533935546875 }, { "start_logit": 18.734375, "end_logit": 7.23046875, "text": " Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.0259857177734375 }, { "start_logit": 18.734375, "end_logit": 7.1328125, "text": " Monkeypox", "probability": 0.0236663818359375 }, { "start_logit": 18.953125, "end_logit": 6.8515625, "text": " COVID-19 vaccines.145,146\n\u0083 Some social media users believe monkeypox", "probability": 0.0222320556640625 }, { "start_logit": 18.1875, "end_logit": 7.61328125, "text": " October 10, 2022\n\u0082 Monkeypox PrEP", "probability": 0.0218658447265625 }, { "start_logit": 18.953125, "end_logit": 6.82421875, "text": " COVID-19 vaccines", "probability": 0.0215301513671875 }, { "start_logit": 17.59375, "end_logit": 8.0546875, "text": " monkeypox", "probability": 0.019012451171875 }, { "start_logit": 16.921875, "end_logit": 8.6640625, "text": "Ways public health and partners can take action", "probability": 0.017852783203125 }, { "start_logit": 17.453125, "end_logit": 8.0546875, "text": " COVID-19 is not seen as a threat.147,148\n\u0083 Some social media users believe pharmaceutical companies are attempting to create a monkeypox", "probability": 0.016265869140625 }, { "start_logit": 18.1875, "end_logit": 7.23046875, "text": " October 10, 2022\n\u0082 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.01503753662109375 }, { "start_logit": 18.1875, "end_logit": 7.1328125, "text": " October 10, 2022\n\u0082 Monkeypox", "probability": 0.01348114013671875 }, { "start_logit": 18.125, "end_logit": 7.18359375, "text": " take action to improve vaccine confidence", "probability": 0.01348114013671875 }, { "start_logit": -33.5, "end_logit": 14.546875, "text": "", "probability": 0.0 } ], "100000000000000000008119": [ { "start_logit": 19.828125, "end_logit": 8.71875, "text": " More than one sex partner", "probability": 0.34228515625 }, { "start_logit": 19.828125, "end_logit": 7.55859375, "text": " More than one", "probability": 0.10772705078125 }, { "start_logit": 19.1875, "end_logit": 8.140625, "text": " making vaccinated individuals more\nsusceptible to monkeypox", "probability": 0.1011962890625 }, { "start_logit": 18.125, "end_logit": 8.6640625, "text": " take action", "probability": 0.05853271484375 }, { "start_logit": 18.546875, "end_logit": 7.984375, "text": " monkeypox", "probability": 0.04559326171875 }, { "start_logit": 18.734375, "end_logit": 7.61328125, "text": " Monkeypox PrEP", "probability": 0.037811279296875 }, { "start_logit": 17.59375, "end_logit": 8.6640625, "text": " monkeypox pandemic to increase\nWays public health and partners can take action", "probability": 0.034423828125 }, { "start_logit": 19.1875, "end_logit": 7.05078125, "text": " making vaccinated individuals more\nsusceptible to monkeypox.143,144\n\u0083 Some social media users believe monkeypox", "probability": 0.03387451171875 }, { "start_logit": 18.609375, "end_logit": 7.4453125, "text": " vaccine confidence", "probability": 0.028533935546875 }, { "start_logit": 18.734375, "end_logit": 7.23046875, "text": " Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.0259857177734375 }, { "start_logit": 18.734375, "end_logit": 7.1328125, "text": " Monkeypox", "probability": 0.0236663818359375 }, { "start_logit": 18.953125, "end_logit": 6.8515625, "text": " COVID-19 vaccines.145,146\n\u0083 Some social media users believe monkeypox", "probability": 0.0222320556640625 }, { "start_logit": 18.1875, "end_logit": 7.61328125, "text": " October 10, 2022\n\u0082 Monkeypox PrEP", "probability": 0.0218658447265625 }, { "start_logit": 18.953125, "end_logit": 6.82421875, "text": " COVID-19 vaccines", "probability": 0.0215301513671875 }, { "start_logit": 17.59375, "end_logit": 8.0546875, "text": " monkeypox", "probability": 0.019012451171875 }, { "start_logit": 16.921875, "end_logit": 8.6640625, "text": "Ways public health and partners can take action", "probability": 0.017852783203125 }, { "start_logit": 17.453125, "end_logit": 8.0546875, "text": " COVID-19 is not seen as a threat.147,148\n\u0083 Some social media users believe pharmaceutical companies are attempting to create a monkeypox", "probability": 0.016265869140625 }, { "start_logit": 18.1875, "end_logit": 7.23046875, "text": " October 10, 2022\n\u0082 Monkeypox PrEP should be offered to people with the highest potential for exposure to monkeypox", "probability": 0.01503753662109375 }, { "start_logit": 18.1875, "end_logit": 7.1328125, "text": " October 10, 2022\n\u0082 Monkeypox", "probability": 0.01348114013671875 }, { "start_logit": 18.125, "end_logit": 7.18359375, "text": " take action to improve vaccine confidence", "probability": 0.01348114013671875 }, { "start_logit": -33.875, "end_logit": 15.0234375, "text": "", "probability": 0.0 } ], "100000000000000000008124": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015367270613186887 }, { "start_logit": 6.66015625, "end_logit": -0.18212890625, "text": "", "probability": 0.9984632729386814 } ], "100000000000000000008125": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 6.6484375, "end_logit": -0.111328125, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000008126": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002050743539917378 }, { "start_logit": 6.53515625, "end_logit": -0.34716796875, "text": "", "probability": 0.9979492564600826 } ], "100000000000000000008130": [ { "start_logit": 16.984375, "end_logit": 10.5625, "text": "Literature Review Weekly", "probability": 0.7265625 }, { "start_logit": 16.984375, "end_logit": 8.265625, "text": "Literature", "probability": 0.0731201171875 }, { "start_logit": 16.609375, "end_logit": 8.0703125, "text": "Leading indicator for news coverage", "probability": 0.041656494140625 }, { "start_logit": 16.984375, "end_logit": 7.67578125, "text": "Literature Review", "probability": 0.040374755859375 }, { "start_logit": 16.609375, "end_logit": 7.703125, "text": "Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.02862548828125 }, { "start_logit": 14.6640625, "end_logit": 9.3515625, "text": "Research\nPoll Review Weekly", "probability": 0.021270751953125 }, { "start_logit": 16.984375, "end_logit": 6.76171875, "text": "Liter", "probability": 0.0163116455078125 }, { "start_logit": 16.609375, "end_logit": 6.86328125, "text": "Leading indicator", "probability": 0.01230621337890625 }, { "start_logit": 14.328125, "end_logit": 8.0703125, "text": "\u0082Media request line list \u0082Leading indicator for news coverage", "probability": 0.0042572021484375 }, { "start_logit": 16.203125, "end_logit": 6.18359375, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.00418853759765625 }, { "start_logit": 14.3203125, "end_logit": 8.0625, "text": "CDC-INFO Metrics Weekly", "probability": 0.004123687744140625 }, { "start_logit": 14.1875, "end_logit": 8.0703125, "text": "\u0082Leading indicator for news coverage", "probability": 0.00363922119140625 }, { "start_logit": 14.1875, "end_logit": 8.0625, "text": "Direct Reports\nCDC-INFO Metrics Weekly", "probability": 0.00363922119140625 }, { "start_logit": 15.0625, "end_logit": 7.0859375, "text": "KFF\n\u0082New data related to vaccine\nhesitancy\n\u0082Identify socio-behavior indicators", "probability": 0.0033130645751953125 }, { "start_logit": 15.9296875, "end_logit": 6.18359375, "text": " October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.0031604766845703125 }, { "start_logit": 16.53125, "end_logit": 5.515625, "text": "Leading indicator for news coverage", "probability": 0.0029697418212890625 }, { "start_logit": 14.328125, "end_logit": 7.703125, "text": "\u0082Media request line list \u0082Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.0029239654541015625 }, { "start_logit": 13.9375, "end_logit": 8.0625, "text": "Identify message gaps/voids\nDirect Reports\nCDC-INFO Metrics Weekly", "probability": 0.002834320068359375 }, { "start_logit": 14.1875, "end_logit": 7.703125, "text": "\u0082Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.00254058837890625 }, { "start_logit": 16.53125, "end_logit": 5.03125, "text": "Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.0018301010131835938 }, { "start_logit": -31.3125, "end_logit": 12.4453125, "text": "", "probability": 0.0 } ], "100000000000000000008135": [ { "start_logit": 16.203125, "end_logit": 6.18359375, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.1829833984375 }, { "start_logit": 15.9296875, "end_logit": 6.18359375, "text": " October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.13818359375 }, { "start_logit": 16.53125, "end_logit": 5.515625, "text": "Leading indicator for news coverage", "probability": 0.1297607421875 }, { "start_logit": 16.53125, "end_logit": 5.03125, "text": "Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.07989501953125 }, { "start_logit": 14.765625, "end_logit": 6.55078125, "text": "ADC", "probability": 0.062286376953125 }, { "start_logit": 15.0390625, "end_logit": 6.18359375, "text": " Input Cadence", "probability": 0.05670166015625 }, { "start_logit": 16.203125, "end_logit": 4.96875, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022", "probability": 0.054107666015625 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.047760009765625 }, { "start_logit": 15.9296875, "end_logit": 4.96875, "text": " October 10, 2022", "probability": 0.041473388671875 }, { "start_logit": 16.53125, "end_logit": 4.234375, "text": "Leading indicator", "probability": 0.036041259765625 }, { "start_logit": 14.5078125, "end_logit": 6.18359375, "text": " Inputs and Sources\nType Input Cadence", "probability": 0.0333251953125 }, { "start_logit": 13.9453125, "end_logit": 6.55078125, "text": "\nOADC", "probability": 0.0276336669921875 }, { "start_logit": 14.296875, "end_logit": 6.18359375, "text": " State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.0272064208984375 }, { "start_logit": 13.9375, "end_logit": 5.9375, "text": "ADC", "probability": 0.0147857666015625 }, { "start_logit": 16.203125, "end_logit": 3.60546875, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs", "probability": 0.01389312744140625 }, { "start_logit": 14.3046875, "end_logit": 5.515625, "text": "\u0082Media request line list \u0082Leading indicator for news coverage", "probability": 0.01389312744140625 }, { "start_logit": 14.1875, "end_logit": 5.515625, "text": "\u0082Leading indicator for news coverage", "probability": 0.012451171875 }, { "start_logit": 15.9296875, "end_logit": 3.60546875, "text": " October 10, 2022\nAppendix: Inputs", "probability": 0.01049041748046875 }, { "start_logit": 14.3046875, "end_logit": 5.03125, "text": "\u0082Media request line list \u0082Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.008697509765625 }, { "start_logit": 14.765625, "end_logit": 4.52734375, "text": "ADC (Office of the\nAssociate Director of\nCommunication) Channel\nCOVID-19", "probability": 0.00829315185546875 }, { "start_logit": -32.875, "end_logit": 14.9453125, "text": "", "probability": 0.0 } ], "100000000000000000008137": [ { "start_logit": 16.203125, "end_logit": 6.18359375, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.1531982421875 }, { "start_logit": 15.359375, "end_logit": 6.9375, "text": "Reports", "probability": 0.1395263671875 }, { "start_logit": 15.9296875, "end_logit": 6.18359375, "text": " October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.11566162109375 }, { "start_logit": 16.53125, "end_logit": 5.515625, "text": "Leading indicator for news coverage", "probability": 0.108642578125 }, { "start_logit": 16.53125, "end_logit": 5.03125, "text": "Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.06689453125 }, { "start_logit": 14.765625, "end_logit": 6.55078125, "text": "ADC", "probability": 0.052154541015625 }, { "start_logit": 15.0390625, "end_logit": 6.18359375, "text": " Input Cadence", "probability": 0.047454833984375 }, { "start_logit": 16.203125, "end_logit": 4.96875, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022", "probability": 0.0452880859375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.03997802734375 }, { "start_logit": 15.9296875, "end_logit": 4.96875, "text": " October 10, 2022", "probability": 0.03472900390625 }, { "start_logit": 16.53125, "end_logit": 4.234375, "text": "Leading indicator", "probability": 0.0301666259765625 }, { "start_logit": 14.5078125, "end_logit": 6.18359375, "text": " Inputs and Sources\nType Input Cadence", "probability": 0.0279083251953125 }, { "start_logit": 13.9453125, "end_logit": 6.55078125, "text": "\nOADC", "probability": 0.02313232421875 }, { "start_logit": 14.296875, "end_logit": 6.18359375, "text": " State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.0227813720703125 }, { "start_logit": 15.640625, "end_logit": 4.7265625, "text": "Tana", "probability": 0.0204010009765625 }, { "start_logit": 15.640625, "end_logit": 4.64453125, "text": "Tanaq Social Listening", "probability": 0.018585205078125 }, { "start_logit": 15.359375, "end_logit": 4.7265625, "text": "Reports\nTana", "probability": 0.015411376953125 }, { "start_logit": 15.359375, "end_logit": 4.64453125, "text": "Reports\nTanaq Social Listening", "probability": 0.0140228271484375 }, { "start_logit": 13.9375, "end_logit": 5.9375, "text": "ADC", "probability": 0.01238250732421875 }, { "start_logit": 15.640625, "end_logit": 4.1875, "text": "Tanaq", "probability": 0.011810302734375 }, { "start_logit": -41.53125, "end_logit": 28.421875, "text": "", "probability": 0.0 } ], "100000000000000000008140": [ { "start_logit": 16.203125, "end_logit": 6.18359375, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.1829833984375 }, { "start_logit": 15.9296875, "end_logit": 6.18359375, "text": " October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.13818359375 }, { "start_logit": 16.53125, "end_logit": 5.515625, "text": "Leading indicator for news coverage", "probability": 0.1297607421875 }, { "start_logit": 16.53125, "end_logit": 5.03125, "text": "Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.07989501953125 }, { "start_logit": 14.765625, "end_logit": 6.55078125, "text": "ADC", "probability": 0.062286376953125 }, { "start_logit": 15.0390625, "end_logit": 6.18359375, "text": " Input Cadence", "probability": 0.05670166015625 }, { "start_logit": 16.203125, "end_logit": 4.96875, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022", "probability": 0.054107666015625 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.047760009765625 }, { "start_logit": 15.9296875, "end_logit": 4.96875, "text": " October 10, 2022", "probability": 0.041473388671875 }, { "start_logit": 16.53125, "end_logit": 4.234375, "text": "Leading indicator", "probability": 0.036041259765625 }, { "start_logit": 14.5078125, "end_logit": 6.18359375, "text": " Inputs and Sources\nType Input Cadence", "probability": 0.0333251953125 }, { "start_logit": 13.9453125, "end_logit": 6.55078125, "text": "\nOADC", "probability": 0.0276336669921875 }, { "start_logit": 14.296875, "end_logit": 6.18359375, "text": " State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs and Sources\nType Input Cadence", "probability": 0.0272064208984375 }, { "start_logit": 13.9375, "end_logit": 5.9375, "text": "ADC", "probability": 0.0147857666015625 }, { "start_logit": 16.203125, "end_logit": 3.60546875, "text": "COVID-19 State of Vaccine Confidence Insights Report | October 10, 2022\nAppendix: Inputs", "probability": 0.01389312744140625 }, { "start_logit": 14.3046875, "end_logit": 5.515625, "text": "\u0082Media request line list \u0082Leading indicator for news coverage", "probability": 0.01389312744140625 }, { "start_logit": 14.1875, "end_logit": 5.515625, "text": "\u0082Leading indicator for news coverage", "probability": 0.012451171875 }, { "start_logit": 15.9296875, "end_logit": 3.60546875, "text": " October 10, 2022\nAppendix: Inputs", "probability": 0.01049041748046875 }, { "start_logit": 14.3046875, "end_logit": 5.03125, "text": "\u0082Media request line list \u0082Leading indicator for news coverage\n\u0082Identify information gaps/voids\nWeb Metrics Weekly", "probability": 0.008697509765625 }, { "start_logit": 14.765625, "end_logit": 4.52734375, "text": "ADC (Office of the\nAssociate Director of\nCommunication) Channel\nCOVID-19", "probability": 0.00829315185546875 }, { "start_logit": -33.1875, "end_logit": 15.421875, "text": "", "probability": 0.0 } ], "100000000000000000008144": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001524786391225749 }, { "start_logit": 7.0859375, "end_logit": -0.603515625, "text": "", "probability": 0.9984752136087741 } ], "100000000000000000008157": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999980937446 }, { "start_logit": -34.15625, "end_logit": 14.078125, "text": "", "probability": 1.906255477934772e-09 } ], "100000000000000000008161": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.6796875, "end_logit": -0.91748046875, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000008163": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012497093922085648 }, { "start_logit": 7.54296875, "end_logit": -0.8603515625, "text": "", "probability": 0.9987502906077915 } ], "100000000000000000008164": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013354008189733722 }, { "start_logit": 7.48046875, "end_logit": -0.861328125, "text": "", "probability": 0.9986645991810267 } ], "100000000000000000008165": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013198634624794732 }, { "start_logit": 7.51171875, "end_logit": -0.8818359375, "text": "", "probability": 0.9986801365375205 } ], "100000000000000000008166": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.6015625, "end_logit": -0.88818359375, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000008168": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 7.02734375, "end_logit": -0.489013671875, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000008169": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 7.03125, "end_logit": -0.43994140625, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000008170": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 7.046875, "end_logit": -0.4755859375, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000008172": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 7.0234375, "end_logit": -0.46337890625, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000008175": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001964661439513743 }, { "start_logit": 7.29296875, "end_logit": -1.0615234375, "text": "", "probability": 0.9980353385604862 } ], "100000000000000000008177": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020111583418261515 }, { "start_logit": 7.25, "end_logit": -1.0419921875, "text": "", "probability": 0.9979888416581738 } ], "100000000000000000008178": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022430878512891728 }, { "start_logit": 7.16796875, "end_logit": -1.0712890625, "text": "", "probability": 0.9977569121487109 } ], "100000000000000000008179": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022343624199449986 }, { "start_logit": 7.19921875, "end_logit": -1.099609375, "text": "", "probability": 0.997765637580055 } ], "100000000000000000008182": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019723357407638166 }, { "start_logit": 7.25, "end_logit": -1.0234375, "text": "", "probability": 0.9980276642592362 } ], "100000000000000000008183": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 7.19921875, "end_logit": -1.00390625, "text": "", "probability": 0.997965182999252 } ], "100000000000000000008187": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012113064505123326 }, { "start_logit": 7.59765625, "end_logit": -0.8818359375, "text": "", "probability": 0.9987886935494876 } ], "100000000000000000008195": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.46484375, "end_logit": -0.69775390625, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000008197": [ { "start_logit": 10.5703125, "end_logit": 12.7421875, "text": " 8 weeks", "probability": 0.58154296875 }, { "start_logit": 9.015625, "end_logit": 12.6015625, "text": "3\u20138 weeks", "probability": 0.1075439453125 }, { "start_logit": 8.421875, "end_logit": 12.7421875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nAt least 8 weeks", "probability": 0.06732177734375 }, { "start_logit": 8.3671875, "end_logit": 12.6015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.0557861328125 }, { "start_logit": 7.890625, "end_logit": 12.6015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.034912109375 }, { "start_logit": 9.015625, "end_logit": 11.421875, "text": "3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.032806396484375 }, { "start_logit": 9.015625, "end_logit": 11.1015625, "text": "3", "probability": 0.02398681640625 }, { "start_logit": 8.421875, "end_logit": 11.421875, "text": "Pfizer-BioNTech", "probability": 0.0181121826171875 }, { "start_logit": 8.3671875, "end_logit": 11.359375, "text": "Pfizer-BioNTech", "probability": 0.0159912109375 }, { "start_logit": 8.3671875, "end_logit": 11.1015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.012451171875 }, { "start_logit": 8.3671875, "end_logit": 11.078125, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech", "probability": 0.0120697021484375 }, { "start_logit": 7.6796875, "end_logit": 11.359375, "text": "Pfizer-BioNTech", "probability": 0.0080413818359375 }, { "start_logit": 7.6796875, "end_logit": 11.359375, "text": "Pfizer-BioNTech\n\uf1aa\nPfizer-BioNTech", "probability": 0.0080413818359375 }, { "start_logit": 7.890625, "end_logit": 11.1015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.00778961181640625 }, { "start_logit": 7.890625, "end_logit": 11.078125, "text": "Pfizer-BioNTech", "probability": 0.007549285888671875 }, { "start_logit": 7.6796875, "end_logit": 11.078125, "text": "Pfizer-BioNTech\n\uf1aa\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech", "probability": 0.006069183349609375 }, { "start_logit": 7.3203125, "end_logit": 0.1478271484375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000008199": [ { "start_logit": 9.03125, "end_logit": 12.6015625, "text": "3\u20138 weeks", "probability": 0.305419921875 }, { "start_logit": 8.375, "end_logit": 12.6015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.158447265625 }, { "start_logit": 7.8828125, "end_logit": 12.6015625, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.09765625 }, { "start_logit": 9.03125, "end_logit": 11.40625, "text": "3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.0931396484375 }, { "start_logit": 9.03125, "end_logit": 11.1171875, "text": "3", "probability": 0.0703125 }, { "start_logit": 8.421875, "end_logit": 11.40625, "text": "Pfizer-BioNTech", "probability": 0.050628662109375 }, { "start_logit": 8.375, "end_logit": 11.359375, "text": "Pfizer-BioNTech", "probability": 0.046142578125 }, { "start_logit": 8.375, "end_logit": 11.1171875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.0364990234375 }, { "start_logit": 8.375, "end_logit": 11.0859375, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech", "probability": 0.035369873046875 }, { "start_logit": 7.671875, "end_logit": 11.359375, "text": "Pfizer-BioNTech", "probability": 0.0228424072265625 }, { "start_logit": 7.671875, "end_logit": 11.359375, "text": "Pfizer-BioNTech\n\uf1aa\nPfizer-BioNTech", "probability": 0.0228424072265625 }, { "start_logit": 7.8828125, "end_logit": 11.1171875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.022125244140625 }, { "start_logit": 7.8828125, "end_logit": 11.0859375, "text": "Pfizer-BioNTech", "probability": 0.0214385986328125 }, { "start_logit": 7.671875, "end_logit": 11.0859375, "text": "Pfizer-BioNTech\n\uf1aa\nPfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech", "probability": 0.017242431640625 }, { "start_logit": 7.3046875, "end_logit": 0.1593017578125, "text": "", "probability": 2.384185791015625e-07 } ], "100000000000000000008204": [ { "start_logit": 15.484375, "end_logit": 9.28125, "text": " 2 months", "probability": 0.315673828125 }, { "start_logit": 15.0390625, "end_logit": 8.8671875, "text": "3\u20138 weeks", "probability": 0.1336669921875 }, { "start_logit": 14.515625, "end_logit": 9.28125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.11981201171875 }, { "start_logit": 14.4609375, "end_logit": 9.28125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.1142578125 }, { "start_logit": 15.0390625, "end_logit": 8.0234375, "text": "3\u20138 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.0574951171875 }, { "start_logit": 13.6875, "end_logit": 8.8671875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.034881591796875 }, { "start_logit": 13.625, "end_logit": 8.8671875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3\u20138 weeks", "probability": 0.032745361328125 }, { "start_logit": 14.4609375, "end_logit": 8.0234375, "text": "Pfizer-BioNTech", "probability": 0.032257080078125 }, { "start_logit": 15.0390625, "end_logit": 7.3671875, "text": "3", "probability": 0.0298309326171875 }, { "start_logit": 14.515625, "end_logit": 7.63671875, "text": "BIVALENT", "probability": 0.0232391357421875 }, { "start_logit": 14.4609375, "end_logit": 7.63671875, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT", "probability": 0.0218353271484375 }, { "start_logit": 13.8828125, "end_logit": 7.921875, "text": "Up", "probability": 0.0164794921875 }, { "start_logit": 13.6875, "end_logit": 7.8359375, "text": "Pfizer-BioNTech", "probability": 0.0124359130859375 }, { "start_logit": 13.6875, "end_logit": 7.78125, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech", "probability": 0.0116729736328125 }, { "start_logit": 13.625, "end_logit": 7.78125, "text": "Pfizer-BioNTech", "probability": 0.0109710693359375 }, { "start_logit": 13.359375, "end_logit": 8.0234375, "text": "More details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.0106353759765625 }, { "start_logit": 13.6875, "end_logit": 7.3671875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\nPfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.007778167724609375 }, { "start_logit": 13.625, "end_logit": 7.3671875, "text": "Pfizer-BioNTech\nPRIMARY SERIES\n3", "probability": 0.007305145263671875 }, { "start_logit": 13.359375, "end_logit": 7.63671875, "text": "More details: Getting your 2nd dose\nPfizer-BioNTech or Moderna\nUPDATED (BIVALENT", "probability": 0.007305145263671875 }, { "start_logit": 8.96875, "end_logit": -0.75390625, "text": "", "probability": 0.0 } ], "100000000000000000008207": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973944578 }, { "start_logit": -33.78125, "end_logit": 14.015625, "text": "", "probability": 2.6055423109896135e-09 } ], "100000000000000000008209": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999973117488 }, { "start_logit": -33.84375, "end_logit": 14.109375, "text": "", "probability": 2.6882511021011682e-09 } ], "100000000000000000008213": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 8.1953125, "end_logit": -0.89404296875, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000008217": [ { "start_logit": 16.421875, "end_logit": 7.36328125, "text": " 2 months", "probability": 0.202392578125 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0941162109375 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0941162109375 }, { "start_logit": 15.9140625, "end_logit": 6.83203125, "text": " 2 months", "probability": 0.0721435546875 }, { "start_logit": 15.7734375, "end_logit": 6.83984375, "text": " 2 months", "probability": 0.06268310546875 }, { "start_logit": 15.9375, "end_logit": 6.34765625, "text": "3-8 weeks", "probability": 0.045166015625 }, { "start_logit": 16.46875, "end_logit": 5.7109375, "text": " Staying", "probability": 0.041107177734375 }, { "start_logit": 15.6953125, "end_logit": 6.49609375, "text": "More details", "probability": 0.041107177734375 }, { "start_logit": 15.4765625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.03302001953125 }, { "start_logit": 15.1328125, "end_logit": 6.83203125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.03302001953125 }, { "start_logit": 15.9375, "end_logit": 6.01171875, "text": "3-8 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.03253173828125 }, { "start_logit": 15.4453125, "end_logit": 6.48828125, "text": "Moderna\n\uf1aa\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.032012939453125 }, { "start_logit": 15.4140625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.0310211181640625 }, { "start_logit": 15.0703125, "end_logit": 6.83203125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0310211181640625 }, { "start_logit": 15.6953125, "end_logit": 6.15625, "text": "More", "probability": 0.029144287109375 }, { "start_logit": 14.921875, "end_logit": 6.83984375, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.026947021484375 }, { "start_logit": 14.859375, "end_logit": 6.83984375, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0253143310546875 }, { "start_logit": 15.9375, "end_logit": 5.73046875, "text": "3", "probability": 0.0245513916015625 }, { "start_logit": 15.4609375, "end_logit": 6.2109375, "text": "3\u20138 weeks", "probability": 0.0245513916015625 }, { "start_logit": 15.6484375, "end_logit": 6.01171875, "text": "Pfizer-BioNTech", "probability": 0.024169921875 }, { "start_logit": 8.6328125, "end_logit": -1.052734375, "text": "", "probability": 0.0 } ], "100000000000000000008218": [ { "start_logit": 16.421875, "end_logit": 7.36328125, "text": " 2 months", "probability": 0.202392578125 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0941162109375 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0941162109375 }, { "start_logit": 15.9140625, "end_logit": 6.83203125, "text": " 2 months", "probability": 0.0721435546875 }, { "start_logit": 15.7734375, "end_logit": 6.83984375, "text": " 2 months", "probability": 0.06268310546875 }, { "start_logit": 15.9375, "end_logit": 6.34765625, "text": "3-8 weeks", "probability": 0.045166015625 }, { "start_logit": 16.46875, "end_logit": 5.7109375, "text": " Staying", "probability": 0.041107177734375 }, { "start_logit": 15.6953125, "end_logit": 6.49609375, "text": "More details", "probability": 0.041107177734375 }, { "start_logit": 15.4765625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.03302001953125 }, { "start_logit": 15.1328125, "end_logit": 6.83203125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.03302001953125 }, { "start_logit": 15.9375, "end_logit": 6.01171875, "text": "3-8 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.03253173828125 }, { "start_logit": 15.4453125, "end_logit": 6.48828125, "text": "Moderna\n\uf1aa\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.032012939453125 }, { "start_logit": 15.4140625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.0310211181640625 }, { "start_logit": 15.0703125, "end_logit": 6.83203125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0310211181640625 }, { "start_logit": 15.6953125, "end_logit": 6.15625, "text": "More", "probability": 0.029144287109375 }, { "start_logit": 14.921875, "end_logit": 6.83984375, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.026947021484375 }, { "start_logit": 14.859375, "end_logit": 6.83984375, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0253143310546875 }, { "start_logit": 15.9375, "end_logit": 5.73046875, "text": "3", "probability": 0.0245513916015625 }, { "start_logit": 15.4609375, "end_logit": 6.2109375, "text": "3\u20138 weeks", "probability": 0.0245513916015625 }, { "start_logit": 15.6484375, "end_logit": 6.01171875, "text": "Pfizer-BioNTech", "probability": 0.024169921875 }, { "start_logit": 8.7421875, "end_logit": -1.072265625, "text": "", "probability": 0.0 } ], "100000000000000000008222": [ { "start_logit": 16.421875, "end_logit": 7.36328125, "text": " 2 months", "probability": 0.2142333984375 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.099609375 }, { "start_logit": 15.6484375, "end_logit": 7.36328125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.099609375 }, { "start_logit": 15.9140625, "end_logit": 6.83203125, "text": " 2 months", "probability": 0.07635498046875 }, { "start_logit": 15.7734375, "end_logit": 6.83984375, "text": " 2 months", "probability": 0.06634521484375 }, { "start_logit": 15.9375, "end_logit": 6.34765625, "text": "3-8 weeks", "probability": 0.04779052734375 }, { "start_logit": 15.4765625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.03497314453125 }, { "start_logit": 15.1328125, "end_logit": 6.83203125, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.03497314453125 }, { "start_logit": 15.9375, "end_logit": 6.01171875, "text": "3-8 weeks after 1st dose\nMore details: Getting your 2nd dose\nPfizer-BioNTech", "probability": 0.034454345703125 }, { "start_logit": 15.4453125, "end_logit": 6.48828125, "text": "Moderna\n\uf1aa\nModerna\nPRIMARY SERIES\nModerna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.033905029296875 }, { "start_logit": 15.4140625, "end_logit": 6.48828125, "text": "Moderna\nPRIMARY SERIES\n4\u20138 weeks", "probability": 0.0328369140625 }, { "start_logit": 15.0703125, "end_logit": 6.83203125, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0328369140625 }, { "start_logit": 14.921875, "end_logit": 6.83984375, "text": "Pfizer-BioNTech or Moderna\nUPDATED (BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.028533935546875 }, { "start_logit": 14.859375, "end_logit": 6.83984375, "text": "BIVALENT) BOOSTER\nAt least 2 months", "probability": 0.0268096923828125 }, { "start_logit": 15.9375, "end_logit": 5.73046875, "text": "3", "probability": 0.0260009765625 }, { "start_logit": 15.4609375, "end_logit": 6.2109375, "text": "3\u20138 weeks", "probability": 0.0260009765625 }, { "start_logit": 15.6484375, "end_logit": 6.01171875, "text": "Pfizer-BioNTech", "probability": 0.0255889892578125 }, { "start_logit": 15.4765625, "end_logit": 5.94921875, "text": "Moderna", "probability": 0.020233154296875 }, { "start_logit": 15.4453125, "end_logit": 5.94921875, "text": "Moderna\n\uf1aa\nModerna", "probability": 0.0196075439453125 }, { "start_logit": 15.4765625, "end_logit": 5.88671875, "text": "Moderna\nPRIMARY SERIES\nModerna", "probability": 0.019012451171875 }, { "start_logit": -34.375, "end_logit": 15.84375, "text": "", "probability": 0.0 } ], "100000000000000000008223": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 8.2265625, "end_logit": -1.296875, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000008231": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.234375, "end_logit": -0.1337890625, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000008233": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013458604012970923 }, { "start_logit": 7.2109375, "end_logit": -0.60205078125, "text": "", "probability": 0.998654139598703 } ], "100000000000000000008235": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014493984078166476 }, { "start_logit": 7.21875, "end_logit": -0.6826171875, "text": "", "probability": 0.9985506015921835 } ], "100000000000000000008237": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.20703125, "end_logit": -0.60009765625, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000008241": [ { "start_logit": 17.625, "end_logit": 7.1484375, "text": "J&J/Janssen", "probability": 0.471923828125 }, { "start_logit": 17.625, "end_logit": 6.88671875, "text": "J", "probability": 0.36181640625 }, { "start_logit": 16.421875, "end_logit": 7.1484375, "text": "J/Janssen", "probability": 0.1395263671875 }, { "start_logit": 14.7734375, "end_logit": 7.1484375, "text": "/Janssen", "probability": 0.02703857421875 }, { "start_logit": 8.578125, "end_logit": -1.2744140625, "text": "", "probability": 0.0 } ], "100000000000000000008244": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 8.2890625, "end_logit": -1.171875, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000008248": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 8.25, "end_logit": -1.1640625, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000008249": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.3203125, "end_logit": -0.76513671875, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000008250": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013198634624794732 }, { "start_logit": 7.453125, "end_logit": -0.82421875, "text": "", "probability": 0.9986801365375205 } ], "100000000000000000008254": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001512938361888412 }, { "start_logit": 7.0625, "end_logit": -0.57177734375, "text": "", "probability": 0.9984870616381116 } ], "100000000000000000008257": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017752605321058419 }, { "start_logit": 6.91796875, "end_logit": -0.58447265625, "text": "", "probability": 0.998224739467894 } ], "100000000000000000008260": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 6.90625, "end_logit": -0.283447265625, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000008262": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014895173647107272 }, { "start_logit": 6.85546875, "end_logit": -0.34814453125, "text": "", "probability": 0.9985104826352893 } ], "100000000000000000008265": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.2421875, "end_logit": -0.412109375, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000008268": [ { "start_logit": 16.65625, "end_logit": 5.8515625, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.177978515625 }, { "start_logit": 16.21875, "end_logit": 5.8515625, "text": "Moderna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.11492919921875 }, { "start_logit": 16.65625, "end_logit": 5.16796875, "text": "Pfizer-BioNTech", "probability": 0.0909423828125 }, { "start_logit": 16.65625, "end_logit": 5.09765625, "text": "Pfizer-BioNTech\nModerna", "probability": 0.0841064453125 }, { "start_logit": 15.8046875, "end_logit": 5.8515625, "text": "Johnson & Johnson\u2019s Janssen", "probability": 0.07659912109375 }, { "start_logit": 16.21875, "end_logit": 5.09765625, "text": "Moderna", "probability": 0.054290771484375 }, { "start_logit": 15.296875, "end_logit": 5.8515625, "text": "\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.04644775390625 }, { "start_logit": 15.28125, "end_logit": 5.8515625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.045013427734375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0416259765625 }, { "start_logit": 16.65625, "end_logit": 4.26953125, "text": "Pfizer-BioNTech\nModerna\nNovavax", "probability": 0.0367431640625 }, { "start_logit": 16.65625, "end_logit": 4.25, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson", "probability": 0.036163330078125 }, { "start_logit": 16.21875, "end_logit": 4.26953125, "text": "Moderna\nNovavax", "probability": 0.023712158203125 }, { "start_logit": 16.21875, "end_logit": 4.25, "text": "Moderna\nNovavax\nJohnson", "probability": 0.0233612060546875 }, { "start_logit": 15.296875, "end_logit": 5.16796875, "text": "\nPfizer-BioNTech", "probability": 0.0233612060546875 }, { "start_logit": 16.65625, "end_logit": 3.79296875, "text": "Pfizer", "probability": 0.0229949951171875 }, { "start_logit": 15.28125, "end_logit": 5.16796875, "text": "FDA) currently include:\nPfizer-BioNTech", "probability": 0.0229949951171875 }, { "start_logit": 15.296875, "end_logit": 5.09765625, "text": "\nPfizer-BioNTech\nModerna", "probability": 0.0216064453125 }, { "start_logit": 15.28125, "end_logit": 5.09765625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna", "probability": 0.021270751953125 }, { "start_logit": 16.203125, "end_logit": 4.12109375, "text": "COVID-19 vaccines available abroad that are accepted in the United States", "probability": 0.0202789306640625 }, { "start_logit": 16.65625, "end_logit": 3.3984375, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson", "probability": 0.01555633544921875 }, { "start_logit": 8.765625, "end_logit": -1.791015625, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000008269": [ { "start_logit": 16.65625, "end_logit": 5.8515625, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.177734375 }, { "start_logit": 16.21875, "end_logit": 5.8515625, "text": "Moderna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.11474609375 }, { "start_logit": 16.65625, "end_logit": 5.16796875, "text": "Pfizer-BioNTech", "probability": 0.0908203125 }, { "start_logit": 16.65625, "end_logit": 5.0859375, "text": "Pfizer-BioNTech\nModerna", "probability": 0.083984375 }, { "start_logit": 15.8046875, "end_logit": 5.8515625, "text": "Johnson & Johnson\u2019s Janssen", "probability": 0.07647705078125 }, { "start_logit": 16.21875, "end_logit": 5.0859375, "text": "Moderna", "probability": 0.05419921875 }, { "start_logit": 15.3125, "end_logit": 5.8515625, "text": "\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.04638671875 }, { "start_logit": 15.28125, "end_logit": 5.8515625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.044952392578125 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.04156494140625 }, { "start_logit": 16.65625, "end_logit": 4.2734375, "text": "Pfizer-BioNTech\nModerna\nNovavax", "probability": 0.037261962890625 }, { "start_logit": 16.65625, "end_logit": 4.25, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson", "probability": 0.036102294921875 }, { "start_logit": 16.21875, "end_logit": 4.2734375, "text": "Moderna\nNovavax", "probability": 0.0240631103515625 }, { "start_logit": 15.3125, "end_logit": 5.16796875, "text": "\nPfizer-BioNTech", "probability": 0.023681640625 }, { "start_logit": 16.21875, "end_logit": 4.25, "text": "Moderna\nNovavax\nJohnson", "probability": 0.0233306884765625 }, { "start_logit": 15.28125, "end_logit": 5.16796875, "text": "FDA) currently include:\nPfizer-BioNTech", "probability": 0.0229644775390625 }, { "start_logit": 16.65625, "end_logit": 3.787109375, "text": "Pfizer", "probability": 0.0225982666015625 }, { "start_logit": 15.3125, "end_logit": 5.0859375, "text": "\nPfizer-BioNTech\nModerna", "probability": 0.02191162109375 }, { "start_logit": 15.28125, "end_logit": 5.0859375, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna", "probability": 0.021240234375 }, { "start_logit": 16.203125, "end_logit": 4.12109375, "text": "COVID-19 vaccines available abroad that are accepted in the United States", "probability": 0.020263671875 }, { "start_logit": 16.65625, "end_logit": 3.40234375, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson", "probability": 0.01554107666015625 }, { "start_logit": 8.7890625, "end_logit": -1.7783203125, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000008270": [ { "start_logit": 16.65625, "end_logit": 5.8515625, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.177978515625 }, { "start_logit": 16.21875, "end_logit": 5.8515625, "text": "Moderna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.11492919921875 }, { "start_logit": 16.65625, "end_logit": 5.16796875, "text": "Pfizer-BioNTech", "probability": 0.0909423828125 }, { "start_logit": 16.65625, "end_logit": 5.09765625, "text": "Pfizer-BioNTech\nModerna", "probability": 0.0841064453125 }, { "start_logit": 15.8046875, "end_logit": 5.8515625, "text": "Johnson & Johnson\u2019s Janssen", "probability": 0.07659912109375 }, { "start_logit": 16.21875, "end_logit": 5.09765625, "text": "Moderna", "probability": 0.054290771484375 }, { "start_logit": 15.296875, "end_logit": 5.8515625, "text": "\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.04644775390625 }, { "start_logit": 15.28125, "end_logit": 5.8515625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.045013427734375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0416259765625 }, { "start_logit": 16.65625, "end_logit": 4.26953125, "text": "Pfizer-BioNTech\nModerna\nNovavax", "probability": 0.0367431640625 }, { "start_logit": 16.65625, "end_logit": 4.25, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson", "probability": 0.036163330078125 }, { "start_logit": 16.21875, "end_logit": 4.26953125, "text": "Moderna\nNovavax", "probability": 0.023712158203125 }, { "start_logit": 16.21875, "end_logit": 4.25, "text": "Moderna\nNovavax\nJohnson", "probability": 0.0233612060546875 }, { "start_logit": 15.296875, "end_logit": 5.16796875, "text": "\nPfizer-BioNTech", "probability": 0.0233612060546875 }, { "start_logit": 16.65625, "end_logit": 3.79296875, "text": "Pfizer", "probability": 0.0229949951171875 }, { "start_logit": 15.28125, "end_logit": 5.16796875, "text": "FDA) currently include:\nPfizer-BioNTech", "probability": 0.0229949951171875 }, { "start_logit": 15.296875, "end_logit": 5.09765625, "text": "\nPfizer-BioNTech\nModerna", "probability": 0.0216064453125 }, { "start_logit": 15.28125, "end_logit": 5.09765625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna", "probability": 0.021270751953125 }, { "start_logit": 16.203125, "end_logit": 4.12109375, "text": "COVID-19 vaccines available abroad that are accepted in the United States", "probability": 0.0202789306640625 }, { "start_logit": 16.65625, "end_logit": 3.3984375, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson", "probability": 0.01555633544921875 }, { "start_logit": 8.8125, "end_logit": -1.7685546875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000008271": [ { "start_logit": 16.65625, "end_logit": 5.8515625, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.177978515625 }, { "start_logit": 16.21875, "end_logit": 5.8515625, "text": "Moderna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.11492919921875 }, { "start_logit": 16.65625, "end_logit": 5.16796875, "text": "Pfizer-BioNTech", "probability": 0.0909423828125 }, { "start_logit": 16.65625, "end_logit": 5.09765625, "text": "Pfizer-BioNTech\nModerna", "probability": 0.0841064453125 }, { "start_logit": 15.8046875, "end_logit": 5.8515625, "text": "Johnson & Johnson\u2019s Janssen", "probability": 0.07659912109375 }, { "start_logit": 16.21875, "end_logit": 5.09765625, "text": "Moderna", "probability": 0.054290771484375 }, { "start_logit": 15.296875, "end_logit": 5.8515625, "text": "\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.04644775390625 }, { "start_logit": 15.28125, "end_logit": 5.8515625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson\u2019s Janssen", "probability": 0.045013427734375 }, { "start_logit": 16.203125, "end_logit": 4.84765625, "text": "COVID-19", "probability": 0.0416259765625 }, { "start_logit": 16.65625, "end_logit": 4.26953125, "text": "Pfizer-BioNTech\nModerna\nNovavax", "probability": 0.0367431640625 }, { "start_logit": 16.65625, "end_logit": 4.25, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson", "probability": 0.036163330078125 }, { "start_logit": 16.21875, "end_logit": 4.26953125, "text": "Moderna\nNovavax", "probability": 0.023712158203125 }, { "start_logit": 16.21875, "end_logit": 4.25, "text": "Moderna\nNovavax\nJohnson", "probability": 0.0233612060546875 }, { "start_logit": 15.296875, "end_logit": 5.16796875, "text": "\nPfizer-BioNTech", "probability": 0.0233612060546875 }, { "start_logit": 16.65625, "end_logit": 3.79296875, "text": "Pfizer", "probability": 0.0229949951171875 }, { "start_logit": 15.28125, "end_logit": 5.16796875, "text": "FDA) currently include:\nPfizer-BioNTech", "probability": 0.0229949951171875 }, { "start_logit": 15.296875, "end_logit": 5.09765625, "text": "\nPfizer-BioNTech\nModerna", "probability": 0.0216064453125 }, { "start_logit": 15.28125, "end_logit": 5.09765625, "text": "FDA) currently include:\nPfizer-BioNTech\nModerna", "probability": 0.021270751953125 }, { "start_logit": 16.203125, "end_logit": 4.12109375, "text": "COVID-19 vaccines available abroad that are accepted in the United States", "probability": 0.0202789306640625 }, { "start_logit": 16.65625, "end_logit": 3.3984375, "text": "Pfizer-BioNTech\nModerna\nNovavax\nJohnson & Johnson", "probability": 0.01555633544921875 }, { "start_logit": 8.75, "end_logit": -1.7919921875, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000008281": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.00390625, "end_logit": -0.400146484375, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000008285": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001579259428801316 }, { "start_logit": 6.7578125, "end_logit": -0.30712890625, "text": "", "probability": 0.9984207405711987 } ], "100000000000000000008290": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.35546875, "end_logit": -0.4501953125, "text": "", "probability": 0.99899949559909 } ], "100000000000000000008291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.3671875, "end_logit": -0.441162109375, "text": "", "probability": 0.999018828118793 } ], "100000000000000000008294": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.31640625, "end_logit": -0.798828125, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000008296": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 8.28125, "end_logit": -0.798828125, "text": "", "probability": 0.99943852125386 } ], "100000000000000000008298": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005976693711028652 }, { "start_logit": 8.2109375, "end_logit": -0.78857421875, "text": "", "probability": 0.999402330628897 } ], "100000000000000000008300": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005636750731053124 }, { "start_logit": 8.25, "end_logit": -0.76806640625, "text": "", "probability": 0.9994363249268947 } ], "100000000000000000008303": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005907104251718618 }, { "start_logit": 8.203125, "end_logit": -0.7685546875, "text": "", "probability": 0.9994092895748281 } ], "100000000000000000008307": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999988255901 }, { "start_logit": -33.34375, "end_logit": 12.7890625, "text": "", "probability": 1.174409931818177e-09 } ], "100000000000000000008308": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986898511 }, { "start_logit": -33.34375, "end_logit": 12.890625, "text": "", "probability": 1.310148953402118e-09 } ], "100000000000000000008310": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004390453304730707 }, { "start_logit": 8.71875, "end_logit": -0.9873046875, "text": "", "probability": 0.9995609546695269 } ], "100000000000000000008314": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004529758122778943 }, { "start_logit": 8.6328125, "end_logit": -0.93505859375, "text": "", "probability": 0.999547024187722 } ], "100000000000000000008319": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012893282790035973 }, { "start_logit": 7.25, "end_logit": -0.5966796875, "text": "", "probability": 0.9987106717209965 } ], "100000000000000000008321": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.23046875, "end_logit": -0.58740234375, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000008322": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012793074828344202 }, { "start_logit": 7.2421875, "end_logit": -0.5810546875, "text": "", "probability": 0.9987206925171654 } ], "100000000000000000008332": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005976693711028652 }, { "start_logit": 7.9765625, "end_logit": -0.55322265625, "text": "", "probability": 0.999402330628897 } ], "100000000000000000008335": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.08984375, "end_logit": -0.40234375, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000008344": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 6.78125, "end_logit": -0.10455322265625, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000008345": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 6.77734375, "end_logit": -0.044525146484375, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000008347": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004974744555872814 }, { "start_logit": 7.85546875, "end_logit": -0.2496337890625, "text": "", "probability": 0.9995025255444128 } ], "100000000000000000008348": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00048217615569212744 }, { "start_logit": 7.7578125, "end_logit": -0.120849609375, "text": "", "probability": 0.9995178238443079 } ], "100000000000000000008352": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.62890625, "end_logit": -0.86669921875, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000008357": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006238938360910443 }, { "start_logit": 7.84765625, "end_logit": -0.4697265625, "text": "", "probability": 0.9993761061639089 } ], "100000000000000000008359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006287840192903181 }, { "start_logit": 7.8359375, "end_logit": -0.466064453125, "text": "", "probability": 0.9993712159807097 } ], "100000000000000000008360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006361912109467575 }, { "start_logit": 7.8671875, "end_logit": -0.5087890625, "text": "", "probability": 0.9993638087890532 } ], "100000000000000000008362": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014437558971204926 }, { "start_logit": 6.9765625, "end_logit": -0.439208984375, "text": "", "probability": 0.9985562441028796 } ], "100000000000000000008364": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 6.94140625, "end_logit": -0.396484375, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000008365": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013777325890227494 }, { "start_logit": 6.9765625, "end_logit": -0.3916015625, "text": "", "probability": 0.9986222674109773 } ], "100000000000000000008366": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004565269236873427 }, { "start_logit": 7.9296875, "end_logit": -0.239501953125, "text": "", "probability": 0.9995434730763126 } ], "100000000000000000008370": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005680935199787149 }, { "start_logit": 7.8203125, "end_logit": -0.3466796875, "text": "", "probability": 0.9994319064800213 } ], "100000000000000000008372": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000529541811423226 }, { "start_logit": 7.9609375, "end_logit": -0.41943359375, "text": "", "probability": 0.9994704581885768 } ], "100000000000000000008374": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005132578848218568 }, { "start_logit": 7.96875, "end_logit": -0.39453125, "text": "", "probability": 0.9994867421151781 } ], "100000000000000000008375": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005484792388673105 }, { "start_logit": 7.8828125, "end_logit": -0.374267578125, "text": "", "probability": 0.9994515207611326 } ], "100000000000000000008377": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001073306312909629 }, { "start_logit": 7.04296875, "end_logit": -0.20556640625, "text": "", "probability": 0.9989266936870904 } ], "100000000000000000008379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011649560882349575 }, { "start_logit": 6.921875, "end_logit": -0.1671142578125, "text": "", "probability": 0.9988350439117649 } ], "100000000000000000008381": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011786720362815634 }, { "start_logit": 6.984375, "end_logit": -0.2408447265625, "text": "", "probability": 0.9988213279637184 } ], "100000000000000000008383": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.30859375, "end_logit": -0.68505859375, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000008387": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.23046875, "end_logit": -0.60888671875, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000008390": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.1640625, "end_logit": -0.402099609375, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000008392": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.1875, "end_logit": -0.366943359375, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000008395": [ { "start_logit": 18.375, "end_logit": 8.7890625, "text": "Trainings, Webinars", "probability": 0.139404296875 }, { "start_logit": 17.890625, "end_logit": 9.1484375, "text": "Administration support staff", "probability": 0.12298583984375 }, { "start_logit": 17.5, "end_logit": 9.1484375, "text": " 12 months\nVaccination support workers (not licensed to administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support staff", "probability": 0.08453369140625 }, { "start_logit": 17.890625, "end_logit": 8.703125, "text": "Administration support", "probability": 0.07940673828125 }, { "start_logit": 17.6875, "end_logit": 8.7890625, "text": " Webinars", "probability": 0.070068359375 }, { "start_logit": 17.328125, "end_logit": 9.1484375, "text": " administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support staff", "probability": 0.070068359375 }, { "start_logit": 17.5, "end_logit": 8.703125, "text": " 12 months\nVaccination support workers (not licensed to administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support", "probability": 0.0537109375 }, { "start_logit": 18.6875, "end_logit": 7.42578125, "text": " COVID-19", "probability": 0.048919677734375 }, { "start_logit": 17.328125, "end_logit": 8.703125, "text": " administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support", "probability": 0.045257568359375 }, { "start_logit": 17.5, "end_logit": 8.4609375, "text": " 12 months", "probability": 0.04248046875 }, { "start_logit": 17.390625, "end_logit": 8.4609375, "text": " physicians, nurses, or practical nurses who are licensed/previously\nlicensed to administer COVID-19 vaccine but have not done so in the last 12 months", "probability": 0.037506103515625 }, { "start_logit": 18.375, "end_logit": 7.42578125, "text": "Trainings, Webinars, and Reference Materials\n\uf17f Training Programs and Reference\nMaterials\n\uf53e COVID-19", "probability": 0.035797119140625 }, { "start_logit": 18.375, "end_logit": 7.35546875, "text": "Trainings", "probability": 0.033599853515625 }, { "start_logit": 17.5, "end_logit": 8.109375, "text": "past 5 years", "probability": 0.0296630859375 }, { "start_logit": 17.890625, "end_logit": 7.54296875, "text": "Administration support staff qualified to store, handle, or transport vaccine\nCOVID-19", "probability": 0.024993896484375 }, { "start_logit": 17.5, "end_logit": 7.72265625, "text": " 12 months\nVaccination support", "probability": 0.02008056640625 }, { "start_logit": 17.6875, "end_logit": 7.42578125, "text": " Webinars, and Reference Materials\n\uf17f Training Programs and Reference\nMaterials\n\uf53e COVID-19", "probability": 0.01800537109375 }, { "start_logit": 15.890625, "end_logit": 9.1484375, "text": " vaccine\nAdministration support staff", "probability": 0.0166473388671875 }, { "start_logit": 17.328125, "end_logit": 7.54296875, "text": " administer vaccine) qualified to prepare, store, handle, or transport vaccine\nAdministration support staff qualified to store, handle, or transport vaccine\nCOVID-19", "probability": 0.0142364501953125 }, { "start_logit": 18.375, "end_logit": 6.39453125, "text": "Trainings, Webin", "probability": 0.01275634765625 }, { "start_logit": 9.7265625, "end_logit": -0.70166015625, "text": "", "probability": 0.0 } ], "100000000000000000008400": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004547479032588127 }, { "start_logit": 7.82421875, "end_logit": -0.128662109375, "text": "", "probability": 0.9995452520967412 } ], "100000000000000000008409": [ { "start_logit": 17.71875, "end_logit": 8.7734375, "text": "past 5 years", "probability": 0.2310791015625 }, { "start_logit": 17.578125, "end_logit": 8.5703125, "text": " 12 months", "probability": 0.163818359375 }, { "start_logit": 17.71875, "end_logit": 7.390625, "text": "Administration requirements\nAnaphylaxis", "probability": 0.0574951171875 }, { "start_logit": 17.71875, "end_logit": 7.390625, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.0574951171875 }, { "start_logit": 16.296875, "end_logit": 8.7734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.05487060546875 }, { "start_logit": 16.1875, "end_logit": 8.5703125, "text": "COVID-19 vaccine but have not done so in the last 12 months", "probability": 0.0401611328125 }, { "start_logit": 15.8828125, "end_logit": 8.7734375, "text": "Healthcare professionals or retired (past 5 years", "probability": 0.03656005859375 }, { "start_logit": 17.25, "end_logit": 7.390625, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.035980224609375 }, { "start_logit": 17.71875, "end_logit": 6.8515625, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements", "probability": 0.033294677734375 }, { "start_logit": 17.71875, "end_logit": 6.828125, "text": "past 5", "probability": 0.03277587890625 }, { "start_logit": 17.71875, "end_logit": 6.80859375, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19", "probability": 0.032257080078125 }, { "start_logit": 17.578125, "end_logit": 6.9453125, "text": " 12 months\n\uf209\n\uf20c\nCOVID-19", "probability": 0.032257080078125 }, { "start_logit": 17.46875, "end_logit": 7.0625, "text": "COVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nVaccination support", "probability": 0.032257080078125 }, { "start_logit": 15.703125, "end_logit": 8.7734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.0303192138671875 }, { "start_logit": 17.46875, "end_logit": 6.9453125, "text": "COVID-19", "probability": 0.028472900390625 }, { "start_logit": 15.84375, "end_logit": 8.5703125, "text": " administer\nCOVID-19 vaccine but have not done so in the last 12 months", "probability": 0.028472900390625 }, { "start_logit": 17.71875, "end_logit": 6.453125, "text": "Administration requirements\nAnaphylaxis guidance", "probability": 0.02252197265625 }, { "start_logit": 17.71875, "end_logit": 6.453125, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.02252197265625 }, { "start_logit": 17.25, "end_logit": 6.453125, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.01409149169921875 }, { "start_logit": 17.71875, "end_logit": 5.95703125, "text": "past 5 years) physicians", "probability": 0.0136566162109375 }, { "start_logit": 9.109375, "end_logit": -0.97607421875, "text": "", "probability": 0.0 } ], "100000000000000000008413": [ { "start_logit": 17.71875, "end_logit": 8.7734375, "text": "past 5 years", "probability": 0.231689453125 }, { "start_logit": 17.578125, "end_logit": 8.5625, "text": " 12 months", "probability": 0.1617431640625 }, { "start_logit": 17.71875, "end_logit": 7.38671875, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.05767822265625 }, { "start_logit": 17.71875, "end_logit": 7.390625, "text": "Administration requirements\nAnaphylaxis", "probability": 0.05767822265625 }, { "start_logit": 16.28125, "end_logit": 8.7734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.055023193359375 }, { "start_logit": 16.203125, "end_logit": 8.5625, "text": "COVID-19 vaccine but have not done so in the last 12 months", "probability": 0.0408935546875 }, { "start_logit": 15.890625, "end_logit": 8.7734375, "text": "Healthcare professionals or retired (past 5 years", "probability": 0.036651611328125 }, { "start_logit": 17.25, "end_logit": 7.38671875, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.03607177734375 }, { "start_logit": 17.71875, "end_logit": 6.86328125, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements", "probability": 0.033905029296875 }, { "start_logit": 17.71875, "end_logit": 6.83203125, "text": "past 5", "probability": 0.032867431640625 }, { "start_logit": 17.71875, "end_logit": 6.80859375, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19", "probability": 0.0323486328125 }, { "start_logit": 17.46875, "end_logit": 7.0625, "text": "COVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nVaccination support", "probability": 0.0323486328125 }, { "start_logit": 17.578125, "end_logit": 6.9296875, "text": " 12 months\n\uf209\n\uf20c\nCOVID-19", "probability": 0.0313720703125 }, { "start_logit": 15.703125, "end_logit": 8.7734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.0303955078125 }, { "start_logit": 17.46875, "end_logit": 6.9296875, "text": "COVID-19", "probability": 0.0285491943359375 }, { "start_logit": 15.84375, "end_logit": 8.5625, "text": " administer\nCOVID-19 vaccine but have not done so in the last 12 months", "probability": 0.0285491943359375 }, { "start_logit": 17.71875, "end_logit": 6.44921875, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.0225830078125 }, { "start_logit": 17.71875, "end_logit": 6.4453125, "text": "Administration requirements\nAnaphylaxis guidance", "probability": 0.0222320556640625 }, { "start_logit": 17.25, "end_logit": 6.44921875, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.014129638671875 }, { "start_logit": 17.71875, "end_logit": 5.95703125, "text": "past 5 years) physicians", "probability": 0.01369476318359375 }, { "start_logit": 8.9296875, "end_logit": -0.9814453125, "text": "", "probability": 0.0 } ], "100000000000000000008415": [ { "start_logit": 17.71875, "end_logit": 8.7734375, "text": "past 5 years", "probability": 0.2310791015625 }, { "start_logit": 17.578125, "end_logit": 8.5703125, "text": " 12 months", "probability": 0.163818359375 }, { "start_logit": 17.71875, "end_logit": 7.390625, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.0574951171875 }, { "start_logit": 17.71875, "end_logit": 7.390625, "text": "Administration requirements\nAnaphylaxis", "probability": 0.0574951171875 }, { "start_logit": 16.296875, "end_logit": 8.7734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.05487060546875 }, { "start_logit": 16.1875, "end_logit": 8.5703125, "text": "COVID-19 vaccine but have not done so in the last 12 months", "probability": 0.0401611328125 }, { "start_logit": 15.8828125, "end_logit": 8.7734375, "text": "Healthcare professionals or retired (past 5 years", "probability": 0.03656005859375 }, { "start_logit": 17.25, "end_logit": 7.390625, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19", "probability": 0.035980224609375 }, { "start_logit": 17.71875, "end_logit": 6.8515625, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements", "probability": 0.033294677734375 }, { "start_logit": 17.71875, "end_logit": 6.828125, "text": "past 5", "probability": 0.03277587890625 }, { "start_logit": 17.71875, "end_logit": 6.80859375, "text": "Administration requirements\nAnaphylaxis guidance\nVaccination documentation and reporting requirements\nRequired and additional information for vaccine recipients\nCOVID-19", "probability": 0.032257080078125 }, { "start_logit": 17.578125, "end_logit": 6.9453125, "text": " 12 months\n\uf209\n\uf20c\nCOVID-19", "probability": 0.032257080078125 }, { "start_logit": 17.46875, "end_logit": 7.0625, "text": "COVID-19 Vaccine Training Routine Vaccine Administration Routine Vaccine Storage and Handling\nVaccination support", "probability": 0.032257080078125 }, { "start_logit": 15.703125, "end_logit": 8.7734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nHealthcare professionals or retired (past 5 years", "probability": 0.0303192138671875 }, { "start_logit": 17.46875, "end_logit": 6.9453125, "text": "COVID-19", "probability": 0.028472900390625 }, { "start_logit": 15.84375, "end_logit": 8.5703125, "text": " administer\nCOVID-19 vaccine but have not done so in the last 12 months", "probability": 0.028472900390625 }, { "start_logit": 17.71875, "end_logit": 6.453125, "text": "past 5 years) physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.02252197265625 }, { "start_logit": 17.71875, "end_logit": 6.453125, "text": "Administration requirements\nAnaphylaxis guidance", "probability": 0.02252197265625 }, { "start_logit": 17.25, "end_logit": 6.453125, "text": " physicians, nurses, or\npractical nurses who are licensed/previously licensed to administer\nCOVID-19 vaccine", "probability": 0.01409149169921875 }, { "start_logit": 17.71875, "end_logit": 5.95703125, "text": "past 5 years) physicians", "probability": 0.0136566162109375 }, { "start_logit": 8.859375, "end_logit": -1.05078125, "text": "", "probability": 0.0 } ], "100000000000000000008419": [ { "start_logit": 17.25, "end_logit": 4.609375, "text": "Core", "probability": 1.0 }, { "start_logit": 8.171875, "end_logit": -1.203125, "text": "", "probability": 3.5762786865234375e-07 } ], "100000000000000000008420": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.890625, "end_logit": -1.1298828125, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000008422": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.95703125, "end_logit": -1.1376953125, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000008423": [ { "start_logit": 19.03125, "end_logit": 9.2734375, "text": "Administration support staff", "probability": 0.46630859375 }, { "start_logit": 19.03125, "end_logit": 9.03125, "text": "Administration support", "probability": 0.36328125 }, { "start_logit": 19.03125, "end_logit": 6.98828125, "text": "Administration support staff qualified to store, handle, or transport\nvaccine\n\uf209\n\uf20c\nAdditional Resources:\nCOVID-19", "probability": 0.046905517578125 }, { "start_logit": 16.234375, "end_logit": 9.2734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.0279998779296875 }, { "start_logit": 16.234375, "end_logit": 9.03125, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.02215576171875 }, { "start_logit": 15.5859375, "end_logit": 9.2734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.0147552490234375 }, { "start_logit": 15.5859375, "end_logit": 9.03125, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.0116729736328125 }, { "start_logit": 19.03125, "end_logit": 5.48828125, "text": "Administration support staff qualified to store, handle, or transport", "probability": 0.010467529296875 }, { "start_logit": 19.03125, "end_logit": 5.41015625, "text": "Administration support staff qualified to store, handle, or transport\nvaccine\n\uf209\n\uf20c\nAdditional Resources", "probability": 0.009674072265625 }, { "start_logit": 19.03125, "end_logit": 5.02734375, "text": "Administration", "probability": 0.00665283203125 }, { "start_logit": 17.25, "end_logit": 6.29296875, "text": "Core Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.003971099853515625 }, { "start_logit": 16.4375, "end_logit": 6.98828125, "text": "COVID-19", "probability": 0.0035037994384765625 }, { "start_logit": 16.234375, "end_logit": 6.84375, "text": "COVID-19", "probability": 0.0024852752685546875 }, { "start_logit": 16.484375, "end_logit": 6.359375, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance", "probability": 0.0019664764404296875 }, { "start_logit": 16.484375, "end_logit": 6.29296875, "text": " Healthcare Providers", "probability": 0.0018463134765625 }, { "start_logit": 15.7421875, "end_logit": 6.98828125, "text": "\n\uf20c\nAdditional Resources:\nCOVID-19", "probability": 0.00176239013671875 }, { "start_logit": 15.6328125, "end_logit": 6.98828125, "text": "\nAdditional Resources:\nCOVID-19", "probability": 0.00157928466796875 }, { "start_logit": 15.5859375, "end_logit": 6.84375, "text": " vaccine recipients\nCOVID-19", "probability": 0.0013103485107421875 }, { "start_logit": 15.90625, "end_logit": 6.29296875, "text": "\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.0010356903076171875 }, { "start_logit": 16.484375, "end_logit": 5.4765625, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance\nVaccination documentation", "probability": 0.0008196830749511719 }, { "start_logit": 8.75, "end_logit": -1.0927734375, "text": "", "probability": 0.0 } ], "100000000000000000008429": [ { "start_logit": 19.046875, "end_logit": 9.2734375, "text": "Administration support staff", "probability": 0.50048828125 }, { "start_logit": 19.046875, "end_logit": 9.0234375, "text": "Administration support", "probability": 0.3896484375 }, { "start_logit": 16.234375, "end_logit": 9.2734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.0300445556640625 }, { "start_logit": 16.234375, "end_logit": 9.0234375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.023406982421875 }, { "start_logit": 15.578125, "end_logit": 9.2734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.01558685302734375 }, { "start_logit": 15.578125, "end_logit": 9.0234375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.01213836669921875 }, { "start_logit": 19.046875, "end_logit": 5.48828125, "text": "Administration support staff qualified to store, handle, or transport", "probability": 0.01140594482421875 }, { "start_logit": 17.25, "end_logit": 6.29296875, "text": "Core Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.004261016845703125 }, { "start_logit": 16.234375, "end_logit": 6.84375, "text": "COVID-19", "probability": 0.002666473388671875 }, { "start_logit": 16.46875, "end_logit": 6.359375, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance", "probability": 0.0020771026611328125 }, { "start_logit": 16.46875, "end_logit": 6.29296875, "text": " Healthcare Providers", "probability": 0.0019512176513671875 }, { "start_logit": 15.578125, "end_logit": 6.84375, "text": " vaccine recipients\nCOVID-19", "probability": 0.0013837814331054688 }, { "start_logit": 15.8984375, "end_logit": 6.29296875, "text": "\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.001094818115234375 }, { "start_logit": 16.46875, "end_logit": 5.4765625, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance\nVaccination documentation", "probability": 0.0008521080017089844 }, { "start_logit": 15.546875, "end_logit": 6.29296875, "text": " Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.0007762908935546875 }, { "start_logit": 16.46875, "end_logit": 5.32421875, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements", "probability": 0.0007405281066894531 }, { "start_logit": 16.234375, "end_logit": 5.48828125, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff qualified to store, handle, or transport", "probability": 0.0006847381591796875 }, { "start_logit": 16.234375, "end_logit": 5.40234375, "text": "COVID-19 Vaccine Administration Competencies", "probability": 0.0006337165832519531 }, { "start_logit": 15.578125, "end_logit": 5.48828125, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff qualified to store, handle, or transport", "probability": 0.0003552436828613281 }, { "start_logit": 15.578125, "end_logit": 5.40234375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies", "probability": 0.0003285408020019531 }, { "start_logit": 8.6484375, "end_logit": -1.0625, "text": "", "probability": 0.0 } ], "100000000000000000008430": [ { "start_logit": 19.03125, "end_logit": 9.2734375, "text": "Administration support staff", "probability": 0.49609375 }, { "start_logit": 19.03125, "end_logit": 9.03125, "text": "Administration support", "probability": 0.386474609375 }, { "start_logit": 16.234375, "end_logit": 9.2734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.0298004150390625 }, { "start_logit": 16.234375, "end_logit": 9.03125, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.0235748291015625 }, { "start_logit": 15.5859375, "end_logit": 9.2734375, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff", "probability": 0.0157012939453125 }, { "start_logit": 15.5859375, "end_logit": 9.03125, "text": " vaccine recipients\nCOVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support", "probability": 0.012420654296875 }, { "start_logit": 19.03125, "end_logit": 5.48828125, "text": "Administration support staff qualified to store, handle, or transport", "probability": 0.011138916015625 }, { "start_logit": 19.03125, "end_logit": 5.02734375, "text": "Administration", "probability": 0.007080078125 }, { "start_logit": 17.25, "end_logit": 6.29296875, "text": "Core Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.004222869873046875 }, { "start_logit": 16.234375, "end_logit": 6.84375, "text": "COVID-19", "probability": 0.002643585205078125 }, { "start_logit": 16.484375, "end_logit": 6.359375, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance", "probability": 0.0020904541015625 }, { "start_logit": 16.484375, "end_logit": 6.29296875, "text": " Healthcare Providers", "probability": 0.001964569091796875 }, { "start_logit": 15.5859375, "end_logit": 6.84375, "text": " vaccine recipients\nCOVID-19", "probability": 0.0013942718505859375 }, { "start_logit": 15.90625, "end_logit": 6.29296875, "text": "\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.001102447509765625 }, { "start_logit": 16.484375, "end_logit": 5.4765625, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements\nTransport guidance\nVaccination documentation", "probability": 0.0008721351623535156 }, { "start_logit": 15.546875, "end_logit": 6.29296875, "text": " Competencies Based on Role:\nRelevant information contained in the EUA Fact Sheet(s) for Healthcare Providers", "probability": 0.0007696151733398438 }, { "start_logit": 16.484375, "end_logit": 5.328125, "text": " Healthcare Providers for the vaccine product(s) in\nyour facility\nStorage and handling requirements", "probability": 0.0007457733154296875 }, { "start_logit": 16.234375, "end_logit": 5.48828125, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration support staff qualified to store, handle, or transport", "probability": 0.00067901611328125 }, { "start_logit": 16.234375, "end_logit": 5.40234375, "text": "COVID-19 Vaccine Administration Competencies", "probability": 0.0006284713745117188 }, { "start_logit": 16.234375, "end_logit": 5.02734375, "text": "COVID-19 Vaccine Administration Competencies Assessment Form\nAdministration", "probability": 0.0004317760467529297 }, { "start_logit": 8.4921875, "end_logit": -1.0673828125, "text": "", "probability": 0.0 } ], "100000000000000000008439": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999999932316 }, { "start_logit": -29.6875, "end_logit": 3.9609375, "text": "", "probability": 6.768443275321354e-12 } ], "100000000000000000008443": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000872767030892148 }, { "start_logit": 7.8984375, "end_logit": -0.85693359375, "text": "", "probability": 0.9991272329691079 } ], "100000000000000000008444": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009110511944006454 }, { "start_logit": 7.875, "end_logit": -0.87548828125, "text": "", "probability": 0.9990889488055994 } ], "100000000000000000008453": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020748668989992733 }, { "start_logit": 6.3125, "end_logit": -0.1370849609375, "text": "", "probability": 0.9979251331010007 } ], "100000000000000000008454": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020911062524060888 }, { "start_logit": 6.3125, "end_logit": -0.1444091796875, "text": "", "probability": 0.9979088937475938 } ], "100000000000000000008458": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002157341888452641 }, { "start_logit": 6.3203125, "end_logit": -0.18408203125, "text": "", "probability": 0.9978426581115474 } ], "100000000000000000008459": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.5703125, "end_logit": -0.5888671875, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000008462": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009547317110805592 }, { "start_logit": 7.5234375, "end_logit": -0.5712890625, "text": "", "probability": 0.9990452682889194 } ], "100000000000000000008469": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 7.66015625, "end_logit": -0.34521484375, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000008477": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005614787461400804 }, { "start_logit": 8.4921875, "end_logit": -1.0087890625, "text": "", "probability": 0.99943852125386 } ], "100000000000000000008481": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004101929257867252 }, { "start_logit": 6.046875, "end_logit": -0.55615234375, "text": "", "probability": 0.9958980707421329 } ], "100000000000000000008482": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.74609375, "end_logit": -0.658203125, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000008484": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.73046875, "end_logit": -0.6123046875, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000008490": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 6.94921875, "end_logit": -0.294677734375, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000008493": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012793074828344202 }, { "start_logit": 6.98828125, "end_logit": -0.329833984375, "text": "", "probability": 0.9987206925171654 } ], "100000000000000000008497": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 6.95703125, "end_logit": -0.249755859375, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000008499": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 6.875, "end_logit": -0.169189453125, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000008500": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004477008468802068 }, { "start_logit": 8.4375, "end_logit": -0.72705078125, "text": "", "probability": 0.9995522991531197 } ], "100000000000000000008501": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004529758122778943 }, { "start_logit": 8.453125, "end_logit": -0.75390625, "text": "", "probability": 0.999547024187722 } ], "100000000000000000008503": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00046552691875201524 }, { "start_logit": 8.4140625, "end_logit": -0.74267578125, "text": "", "probability": 0.9995344730812479 } ], "100000000000000000008504": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00044595620507126955 }, { "start_logit": 8.421875, "end_logit": -0.70556640625, "text": "", "probability": 0.9995540437949288 } ], "100000000000000000008511": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.140625, "end_logit": -0.373046875, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000008518": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022170130229473865 }, { "start_logit": 6.65234375, "end_logit": -0.5439453125, "text": "", "probability": 0.9977829869770526 } ], "100000000000000000008520": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002580904163589908 }, { "start_logit": 6.53515625, "end_logit": -0.5771484375, "text": "", "probability": 0.9974190958364102 } ], "100000000000000000008522": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023322339175873403 }, { "start_logit": 6.61328125, "end_logit": -0.55419921875, "text": "", "probability": 0.9976677660824127 } ], "100000000000000000008523": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006118340200729555 }, { "start_logit": 7.79296875, "end_logit": -0.395263671875, "text": "", "probability": 0.9993881659799271 } ], "100000000000000000008524": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 7.7734375, "end_logit": -0.431396484375, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000008529": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 7.71875, "end_logit": -0.4169921875, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000008530": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006615174228741224 }, { "start_logit": 7.7421875, "end_logit": -0.422119140625, "text": "", "probability": 0.999338482577126 } ], "100000000000000000008534": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007408055889950227 }, { "start_logit": 7.859375, "end_logit": -0.65185546875, "text": "", "probability": 0.999259194411005 } ], "100000000000000000008536": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.8203125, "end_logit": -0.65673828125, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000008537": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 6.94140625, "end_logit": -0.043670654296875, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000008550": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042887921825186283 }, { "start_logit": 8.296875, "end_logit": -0.54150390625, "text": "", "probability": 0.9995711207817481 } ], "100000000000000000008551": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000418948404104125 }, { "start_logit": 8.3828125, "end_logit": -0.6064453125, "text": "", "probability": 0.9995810515958958 } ], "100000000000000000008552": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004092474464933876 }, { "start_logit": 8.40625, "end_logit": -0.60498046875, "text": "", "probability": 0.9995907525535066 } ], "100000000000000000008557": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006745558838422837 }, { "start_logit": 8.0859375, "end_logit": -0.78564453125, "text": "", "probability": 0.9993254441161578 } ], "100000000000000000008565": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005420927261436571 }, { "start_logit": 8.40625, "end_logit": -0.8857421875, "text": "", "probability": 0.9994579072738564 } ], "100000000000000000008567": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005336928427664175 }, { "start_logit": 7.5078125, "end_logit": 0.02667236328125, "text": "", "probability": 0.9994663071572335 } ], "100000000000000000008569": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006118340200729555 }, { "start_logit": 7.87109375, "end_logit": -0.470703125, "text": "", "probability": 0.9993881659799271 } ], "100000000000000000008574": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996888123 }, { "start_logit": -33.5625, "end_logit": 11.671875, "text": "", "probability": 3.111876528599926e-10 } ], "100000000000000000008575": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996127207 }, { "start_logit": -33.65625, "end_logit": 11.984375, "text": "", "probability": 3.872792912433275e-10 } ], "100000000000000000008579": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.02734375, "end_logit": -0.471923828125, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000008580": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 7.06640625, "end_logit": -0.494384765625, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000008583": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 7.328125, "end_logit": -0.56396484375, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000008584": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.1796875, "end_logit": -0.51123046875, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000008586": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.33203125, "end_logit": -0.5537109375, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000008587": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.2890625, "end_logit": -0.5498046875, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000008589": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 6.96484375, "end_logit": -0.323486328125, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000008593": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.05078125, "end_logit": -0.314697265625, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000008594": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 6.9296875, "end_logit": -0.295654296875, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000008597": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018895386578398716 }, { "start_logit": 6.984375, "end_logit": -0.71630859375, "text": "", "probability": 0.9981104613421601 } ], "100000000000000000008602": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 6.90625, "end_logit": -0.2354736328125, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000008608": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.3359375, "end_logit": -0.54541015625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000008615": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018821859100764038 }, { "start_logit": 6.51171875, "end_logit": -0.23974609375, "text": "", "probability": 0.9981178140899236 } ], "100000000000000000008616": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020033332861764124 }, { "start_logit": 6.5546875, "end_logit": -0.343505859375, "text": "", "probability": 0.9979966667138236 } ], "100000000000000000008621": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011513995656772138 }, { "start_logit": 6.6953125, "end_logit": 0.07080078125, "text": "", "probability": 0.9988486004343227 } ], "100000000000000000008623": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002822832897761561 }, { "start_logit": 6.33984375, "end_logit": -0.471923828125, "text": "", "probability": 0.9971771671022386 } ], "100000000000000000008633": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.125, "end_logit": -0.062408447265625, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000008634": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 7.265625, "end_logit": -0.7705078125, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000008640": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 7.06640625, "end_logit": -0.1339111328125, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000008648": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 6.8828125, "end_logit": -0.39599609375, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000008651": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989138484 }, { "start_logit": -33.78125, "end_logit": 13.140625, "text": "", "probability": 1.086151631767227e-09 } ], "100000000000000000008652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990414745 }, { "start_logit": -33.78125, "end_logit": 13.015625, "text": "", "probability": 9.585254508941148e-10 } ], "100000000000000000008655": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999989635868 }, { "start_logit": -33.71875, "end_logit": 13.03125, "text": "", "probability": 1.0364131273371489e-09 } ], "100000000000000000008658": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013993983588144949 }, { "start_logit": 6.921875, "end_logit": -0.350341796875, "text": "", "probability": 0.9986006016411856 } ], "100000000000000000008659": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.9375, "end_logit": -0.377197265625, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000008661": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 6.94140625, "end_logit": -0.353271484375, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000008665": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 6.9765625, "end_logit": -0.24853515625, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000008666": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.359375, "end_logit": -0.85791015625, "text": "", "probability": 0.998498817743263 } ], "100000000000000000008674": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006411777211655285 }, { "start_logit": 7.9296875, "end_logit": -0.57763671875, "text": "", "probability": 0.9993588222788345 } ], "100000000000000000008675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006287840192903181 }, { "start_logit": 7.91015625, "end_logit": -0.5390625, "text": "", "probability": 0.9993712159807097 } ], "100000000000000000008676": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000631243456875032 }, { "start_logit": 7.8671875, "end_logit": -0.501953125, "text": "", "probability": 0.9993687565431251 } ], "100000000000000000008684": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.6015625, "end_logit": -0.52001953125, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000008685": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004955359475635505 }, { "start_logit": 8.484375, "end_logit": -0.87353515625, "text": "", "probability": 0.9995044640524365 } ], "100000000000000000008686": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00045831290063503817 }, { "start_logit": 8.59375, "end_logit": -0.90576171875, "text": "", "probability": 0.999541687099365 } ], "100000000000000000008687": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000487857122782266 }, { "start_logit": 8.515625, "end_logit": -0.888671875, "text": "", "probability": 0.9995121428772178 } ], "100000000000000000008691": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009697519677825861 }, { "start_logit": 7.41796875, "end_logit": -0.48193359375, "text": "", "probability": 0.9990302480322174 } ], "100000000000000000008692": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.421875, "end_logit": -0.53515625, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000008695": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.4453125, "end_logit": -0.5185546875, "text": "", "probability": 0.999018828118793 } ], "100000000000000000008696": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 7.40234375, "end_logit": -0.317138671875, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000008709": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042887921825186283 }, { "start_logit": 7.5234375, "end_logit": 0.231201171875, "text": "", "probability": 0.9995711207817481 } ], "100000000000000000008712": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010484692671610088 }, { "start_logit": 7.4375, "end_logit": -0.57958984375, "text": "", "probability": 0.9989515307328389 } ], "100000000000000000008715": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.4296875, "end_logit": -0.71875, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000008719": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996304556 }, { "start_logit": -32.78125, "end_logit": 11.0703125, "text": "", "probability": 3.695444813027597e-10 } ], "100000000000000000008720": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996127207 }, { "start_logit": -32.8125, "end_logit": 11.140625, "text": "", "probability": 3.872792912433275e-10 } ], "100000000000000000008723": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011559008071517437 }, { "start_logit": 7.21875, "end_logit": -0.45751953125, "text": "", "probability": 0.9988440991928482 } ], "100000000000000000008727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006238938360910443 }, { "start_logit": 7.72265625, "end_logit": -0.344482421875, "text": "", "probability": 0.9993761061639089 } ], "100000000000000000008737": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00042887921825186283 }, { "start_logit": 8.078125, "end_logit": -0.325927734375, "text": "", "probability": 0.9995711207817481 } ], "100000000000000000008741": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008072304985619872 }, { "start_logit": 7.65234375, "end_logit": -0.53271484375, "text": "", "probability": 0.9991927695014381 } ], "100000000000000000008743": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.14453125, "end_logit": -0.406494140625, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000008746": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.109375, "end_logit": -0.340087890625, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000008756": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007321812616608614 }, { "start_logit": 7.9609375, "end_logit": -0.7431640625, "text": "", "probability": 0.9992678187383391 } ], "100000000000000000008758": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000758359964634202 }, { "start_logit": 7.9375, "end_logit": -0.75341796875, "text": "", "probability": 0.9992416400353659 } ], "100000000000000000008759": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009181900965849467 }, { "start_logit": 7.6953125, "end_logit": -0.70458984375, "text": "", "probability": 0.9990818099034151 } ], "100000000000000000008760": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009110511944006454 }, { "start_logit": 7.70703125, "end_logit": -0.705078125, "text": "", "probability": 0.9990889488055994 } ], "100000000000000000008761": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.7109375, "end_logit": -0.6953125, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000008763": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.71484375, "end_logit": -0.68994140625, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000008768": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000800953612508541 }, { "start_logit": 7.65625, "end_logit": -0.52685546875, "text": "", "probability": 0.9991990463874916 } ], "100000000000000000008769": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000788545769594649 }, { "start_logit": 7.69140625, "end_logit": -0.5478515625, "text": "", "probability": 0.9992114542304054 } ], "100000000000000000008770": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007824140590241951 }, { "start_logit": 7.69140625, "end_logit": -0.5400390625, "text": "", "probability": 0.9992175859409759 } ], "100000000000000000008773": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999995542443 }, { "start_logit": -33.34375, "end_logit": 11.8125, "text": "", "probability": 4.457557318200031e-10 } ], "100000000000000000008779": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014895173647107272 }, { "start_logit": 6.625, "end_logit": -0.11749267578125, "text": "", "probability": 0.9985104826352893 } ], "100000000000000000008782": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 6.55078125, "end_logit": -0.083251953125, "text": "", "probability": 0.998451238905712 } ], "100000000000000000008783": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014953384533104661 }, { "start_logit": 6.609375, "end_logit": -0.10382080078125, "text": "", "probability": 0.9985046615466895 } ], "100000000000000000008784": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015307451011758208 }, { "start_logit": 6.6171875, "end_logit": -0.136962890625, "text": "", "probability": 0.9984692548988241 } ], "100000000000000000008786": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007408055889950227 }, { "start_logit": 7.45703125, "end_logit": -0.248291015625, "text": "", "probability": 0.999259194411005 } ], "100000000000000000008787": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007379195929147702 }, { "start_logit": 7.453125, "end_logit": -0.2431640625, "text": "", "probability": 0.9992620804070853 } ], "100000000000000000008797": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001761469680073981 }, { "start_logit": 7.03515625, "end_logit": -0.69384765625, "text": "", "probability": 0.998238530319926 } ], "100000000000000000008800": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 7.046875, "end_logit": -0.697265625, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000008806": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022430878512891728 }, { "start_logit": 6.46484375, "end_logit": -0.36572265625, "text": "", "probability": 0.9977569121487109 } ], "100000000000000000008807": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020992734296664648 }, { "start_logit": 6.61328125, "end_logit": -0.448974609375, "text": "", "probability": 0.9979007265703336 } ], "100000000000000000008809": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017409836647228373 }, { "start_logit": 6.89453125, "end_logit": -0.54248046875, "text": "", "probability": 0.9982590163352771 } ], "100000000000000000008812": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001980039959665187 }, { "start_logit": 6.76953125, "end_logit": -0.54736328125, "text": "", "probability": 0.9980199600403347 } ], "100000000000000000008817": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012994274657913676 }, { "start_logit": 7.05859375, "end_logit": -0.413818359375, "text": "", "probability": 0.9987005725342086 } ], "100000000000000000008819": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015070488633593833 }, { "start_logit": 6.921875, "end_logit": -0.427001953125, "text": "", "probability": 0.9984929511366406 } ], "100000000000000000008824": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005976693711028652 }, { "start_logit": 8.0390625, "end_logit": -0.619140625, "text": "", "probability": 0.999402330628897 } ], "100000000000000000008825": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005274784125231481 }, { "start_logit": 8.25, "end_logit": -0.701171875, "text": "", "probability": 0.9994725215874769 } ], "100000000000000000008828": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000914613686670093 }, { "start_logit": 7.453125, "end_logit": -0.45849609375, "text": "", "probability": 0.99908538631333 } ], "100000000000000000008832": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009110511944006454 }, { "start_logit": 7.5859375, "end_logit": -0.5849609375, "text": "", "probability": 0.9990889488055994 } ], "100000000000000000008839": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001094452214556567 }, { "start_logit": 7.91015625, "end_logit": -1.0947265625, "text": "", "probability": 0.9989055477854435 } ], "100000000000000000008842": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.87109375, "end_logit": -1.080078125, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000008843": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 7.86328125, "end_logit": -1.072265625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000008848": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 6.984375, "end_logit": -0.363525390625, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000008853": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012399961359154668 }, { "start_logit": 7.1953125, "end_logit": -0.50244140625, "text": "", "probability": 0.9987600038640845 } ], "100000000000000000008855": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011740822246468028 }, { "start_logit": 7.171875, "end_logit": -0.42626953125, "text": "", "probability": 0.9988259177753532 } ], "100000000000000000008859": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006263341581094201 }, { "start_logit": 8.359375, "end_logit": -0.98291015625, "text": "", "probability": 0.9993736658418905 } ], "100000000000000000008860": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005172813339721951 }, { "start_logit": 8.1015625, "end_logit": -0.53662109375, "text": "", "probability": 0.9994827186660278 } ], "100000000000000000008883": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 6.703125, "end_logit": 0.2469482421875, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000008886": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 6.7578125, "end_logit": 0.25927734375, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000008888": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.10546875, "end_logit": -0.322509765625, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000008889": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001103026641398157 }, { "start_logit": 7.16015625, "end_logit": -0.35009765625, "text": "", "probability": 0.998896973358602 } ], "100000000000000000008890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.234375, "end_logit": -0.40771484375, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000008891": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.203125, "end_logit": -0.37353515625, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000008892": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010901900014327604 }, { "start_logit": 7.203125, "end_logit": -0.384521484375, "text": "", "probability": 0.9989098099985672 } ], "100000000000000000008894": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999986692192 }, { "start_logit": -33.0625, "end_logit": 12.625, "text": "", "probability": 1.330780797297989e-09 } ], "100000000000000000008898": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010122860916607463 }, { "start_logit": 7.34375, "end_logit": -0.448974609375, "text": "", "probability": 0.9989877139083393 } ], "100000000000000000008902": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.3125, "end_logit": -0.426025390625, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000008911": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013045066466158166 }, { "start_logit": 7.1015625, "end_logit": -0.462646484375, "text": "", "probability": 0.9986954933533843 } ], "100000000000000000008912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.12890625, "end_logit": -0.062408447265625, "text": "", "probability": 0.999147433358729 } ], "100000000000000000008915": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009362828177560106 }, { "start_logit": 7.07421875, "end_logit": -0.10076904296875, "text": "", "probability": 0.9990637171822441 } ], "100000000000000000008918": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012351678202785303 }, { "start_logit": 6.98828125, "end_logit": -0.29296875, "text": "", "probability": 0.9987648321797215 } ], "100000000000000000008919": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012693644703670253 }, { "start_logit": 7.0, "end_logit": -0.330322265625, "text": "", "probability": 0.9987306355296329 } ], "100000000000000000008929": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00017536993773773873 }, { "start_logit": 8.0390625, "end_logit": 0.60791015625, "text": "", "probability": 0.9998246300622622 } ], "100000000000000000008930": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00018522574326531078 }, { "start_logit": 8.0078125, "end_logit": 0.58837890625, "text": "", "probability": 0.9998147742567347 } ], "100000000000000000008931": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000529541811423226 }, { "start_logit": 8.0078125, "end_logit": -0.466552734375, "text": "", "probability": 0.9994704581885768 } ], "100000000000000000008933": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005213363066504585 }, { "start_logit": 8.03125, "end_logit": -0.473388671875, "text": "", "probability": 0.9994786636933496 } ], "100000000000000000008934": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005420927261436571 }, { "start_logit": 7.96484375, "end_logit": -0.44384765625, "text": "", "probability": 0.9994579072738564 } ], "100000000000000000008937": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.171875, "end_logit": -0.022125244140625, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000008938": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007554056327295276 }, { "start_logit": 7.19140625, "end_logit": -0.0023670196533203125, "text": "", "probability": 0.9992445943672705 } ], "100000000000000000008939": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007854739357252539 }, { "start_logit": 7.2109375, "end_logit": -0.061309814453125, "text": "", "probability": 0.9992145260642746 } ], "100000000000000000008940": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007763299914246077 }, { "start_logit": 7.25, "end_logit": -0.0904541015625, "text": "", "probability": 0.9992236700085755 } ], "100000000000000000008941": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0024822767076302155 }, { "start_logit": 5.859375, "end_logit": 0.1363525390625, "text": "", "probability": 0.9975177232923699 } ], "100000000000000000008944": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0025212683210456455 }, { "start_logit": 5.7890625, "end_logit": 0.1904296875, "text": "", "probability": 0.9974787316789544 } ], "100000000000000000008947": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 7.31640625, "end_logit": -0.033233642578125, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000008954": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998394772 }, { "start_logit": -33.90625, "end_logit": 13.6484375, "text": "", "probability": 1.6052280526088547e-09 } ], "100000000000000000008958": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000788545769594649 }, { "start_logit": 6.9921875, "end_logit": 0.1522216796875, "text": "", "probability": 0.9992114542304054 } ], "100000000000000000008961": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000767292412858718 }, { "start_logit": 6.96875, "end_logit": 0.2015380859375, "text": "", "probability": 0.9992327075871412 } ], "100000000000000000008970": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000788545769594649 }, { "start_logit": 7.8046875, "end_logit": -0.66015625, "text": "", "probability": 0.9992114542304054 } ], "100000000000000000008972": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 7.8984375, "end_logit": -0.68505859375, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000008974": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007793660930208433 }, { "start_logit": 7.796875, "end_logit": -0.64111328125, "text": "", "probability": 0.9992206339069791 } ], "100000000000000000008976": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000646203290719727 }, { "start_logit": 7.76953125, "end_logit": -0.42431640625, "text": "", "probability": 0.9993537967092804 } ], "100000000000000000008979": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006538155503558285 }, { "start_logit": 7.72265625, "end_logit": -0.392333984375, "text": "", "probability": 0.9993461844496442 } ], "100000000000000000008981": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013723686900524027 }, { "start_logit": 7.08203125, "end_logit": -0.492431640625, "text": "", "probability": 0.9986276313099476 } ], "100000000000000000008985": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001259498639359374 }, { "start_logit": 7.03515625, "end_logit": -0.360107421875, "text": "", "probability": 0.9987405013606405 } ], "100000000000000000008986": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008199321062135582 }, { "start_logit": 7.97265625, "end_logit": -0.86865234375, "text": "", "probability": 0.9991800678937864 } ], "100000000000000000008987": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.94140625, "end_logit": -0.87841796875, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000008991": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008796062064765496 }, { "start_logit": 7.8828125, "end_logit": -0.84716796875, "text": "", "probability": 0.9991203937935235 } ], "100000000000000000008992": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009659749152204077 }, { "start_logit": 7.26171875, "end_logit": -0.322021484375, "text": "", "probability": 0.9990340250847796 } ], "100000000000000000008996": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007978334816343424 }, { "start_logit": 7.34375, "end_logit": -0.212890625, "text": "", "probability": 0.9992021665183656 } ], "100000000000000000009004": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006263341581094201 }, { "start_logit": 7.9609375, "end_logit": -0.5859375, "text": "", "probability": 0.9993736658418905 } ], "100000000000000000009005": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000687851155055246 }, { "start_logit": 7.83984375, "end_logit": -0.5576171875, "text": "", "probability": 0.9993121488449448 } ], "100000000000000000009016": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004601058612790196 }, { "start_logit": 8.3828125, "end_logit": -0.69873046875, "text": "", "probability": 0.999539894138721 } ], "100000000000000000009017": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001116014259843091 }, { "start_logit": 7.26953125, "end_logit": -0.47314453125, "text": "", "probability": 0.9988839857401568 } ], "100000000000000000009021": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.421875, "end_logit": -0.513671875, "text": "", "probability": 0.99899949559909 } ], "100000000000000000009023": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016356753292389016 }, { "start_logit": 7.0703125, "end_logit": -0.654296875, "text": "", "probability": 0.998364324670761 } ], "100000000000000000009024": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016420666692028368 }, { "start_logit": 7.09765625, "end_logit": -0.6865234375, "text": "", "probability": 0.9983579333307973 } ], "100000000000000000009032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 7.22265625, "end_logit": -0.58447265625, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000009035": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.91015625, "end_logit": -1.0234375, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000009037": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.9375, "end_logit": -1.0458984375, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000009039": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018969200744787132 }, { "start_logit": 6.67578125, "end_logit": -0.411376953125, "text": "", "probability": 0.9981030799255213 } ], "100000000000000000009050": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014048677545435851 }, { "start_logit": 6.91015625, "end_logit": -0.3447265625, "text": "", "probability": 0.9985951322454563 } ], "100000000000000000009054": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.51171875, "end_logit": -0.583984375, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000009056": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010044163312604223 }, { "start_logit": 7.37890625, "end_logit": -0.47705078125, "text": "", "probability": 0.9989955836687396 } ], "100000000000000000009061": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008693673928062171 }, { "start_logit": 7.72265625, "end_logit": -0.67626953125, "text": "", "probability": 0.9991306326071938 } ], "100000000000000000009067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005274784125231481 }, { "start_logit": 8.34375, "end_logit": -0.79638671875, "text": "", "probability": 0.9994725215874769 } ], "100000000000000000009068": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000529541811423226 }, { "start_logit": 8.3203125, "end_logit": -0.77734375, "text": "", "probability": 0.9994704581885768 } ], "100000000000000000009069": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005527786369235996 }, { "start_logit": 8.2578125, "end_logit": -0.759765625, "text": "", "probability": 0.9994472213630764 } ], "100000000000000000009073": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010202174499045606 }, { "start_logit": 7.5078125, "end_logit": -0.61962890625, "text": "", "probability": 0.9989797825500956 } ], "100000000000000000009075": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009436192455752619 }, { "start_logit": 7.51171875, "end_logit": -0.54833984375, "text": "", "probability": 0.9990563807544247 } ], "100000000000000000009076": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.54296875, "end_logit": -0.5341796875, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000009082": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000900446683890779 }, { "start_logit": 7.70703125, "end_logit": -0.6943359375, "text": "", "probability": 0.9990995533161093 } ], "100000000000000000009084": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.734375, "end_logit": -0.65087890625, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000009085": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008899654984705883 }, { "start_logit": 7.6953125, "end_logit": -0.67236328125, "text": "", "probability": 0.9991100345015295 } ], "100000000000000000009093": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.24609375, "end_logit": -0.1329345703125, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000009104": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007069056122424319 }, { "start_logit": 7.6953125, "end_logit": -0.43994140625, "text": "", "probability": 0.9992930943877577 } ], "100000000000000000009106": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006538155503558285 }, { "start_logit": 7.7734375, "end_logit": -0.441650390625, "text": "", "probability": 0.9993461844496442 } ], "100000000000000000009109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.1953125, "end_logit": -0.5146484375, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000009111": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001432536594710079 }, { "start_logit": 7.0625, "end_logit": -0.51513671875, "text": "", "probability": 0.9985674634052898 } ], "100000000000000000009112": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006563728324346652 }, { "start_logit": 7.484375, "end_logit": -0.1575927734375, "text": "", "probability": 0.9993436271675653 } ], "100000000000000000009115": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005680935199787149 }, { "start_logit": 7.6015625, "end_logit": -0.1300048828125, "text": "", "probability": 0.9994319064800213 } ], "100000000000000000009122": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00031999824407395836 }, { "start_logit": 8.4921875, "end_logit": -0.4423828125, "text": "", "probability": 0.9996800017559261 } ], "100000000000000000009124": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00031503869408133935 }, { "start_logit": 8.53125, "end_logit": -0.4697265625, "text": "", "probability": 0.9996849613059188 } ], "100000000000000000009127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011116681693652305 }, { "start_logit": 7.03515625, "end_logit": -0.233154296875, "text": "", "probability": 0.9988883318306349 } ], "100000000000000000009129": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011203773223969365 }, { "start_logit": 7.06640625, "end_logit": -0.274658203125, "text": "", "probability": 0.9988796226776031 } ], "100000000000000000009132": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013250224172131609 }, { "start_logit": 7.91796875, "end_logit": -1.2939453125, "text": "", "probability": 0.9986749775827868 } ], "100000000000000000009134": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.83203125, "end_logit": -1.275390625, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000009136": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 7.80859375, "end_logit": -1.29296875, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000009139": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.5703125, "end_logit": -0.6142578125, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000009149": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014381353210925951 }, { "start_logit": 7.13671875, "end_logit": -0.5927734375, "text": "", "probability": 0.9985618646789075 } ], "100000000000000000009157": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011604196251799289 }, { "start_logit": 7.484375, "end_logit": -0.7275390625, "text": "", "probability": 0.99883958037482 } ], "100000000000000000009159": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010362668882466278 }, { "start_logit": 7.60546875, "end_logit": -0.73291015625, "text": "", "probability": 0.9989637331117535 } ], "100000000000000000009167": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005747861775648728 }, { "start_logit": 8.03125, "end_logit": -0.5693359375, "text": "", "probability": 0.9994252138224351 } ], "100000000000000000009171": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.78125, "end_logit": -0.55712890625, "text": "", "probability": 0.999270671160687 } ], "100000000000000000009174": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008360902969426321 }, { "start_logit": 8.0546875, "end_logit": -0.96875, "text": "", "probability": 0.9991639097030574 } ], "100000000000000000009175": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 8.0703125, "end_logit": -0.966796875, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000009176": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008393599151498077 }, { "start_logit": 7.98828125, "end_logit": -0.90625, "text": "", "probability": 0.9991606400848502 } ], "100000000000000000009179": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000900446683890779 }, { "start_logit": 7.90625, "end_logit": -0.89501953125, "text": "", "probability": 0.9990995533161093 } ], "100000000000000000009186": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001107338985089895 }, { "start_logit": 7.54296875, "end_logit": -0.73974609375, "text": "", "probability": 0.99889266101491 } ], "100000000000000000009187": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008231385881888256 }, { "start_logit": 7.83203125, "end_logit": -0.7294921875, "text": "", "probability": 0.9991768614118112 } ], "100000000000000000009189": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008525666412710382 }, { "start_logit": 7.77734375, "end_logit": -0.7109375, "text": "", "probability": 0.999147433358729 } ], "100000000000000000009191": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.8671875, "end_logit": -0.75439453125, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000009193": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018530593956144392 }, { "start_logit": 6.7734375, "end_logit": -0.482666015625, "text": "", "probability": 0.9981469406043857 } ], "100000000000000000009194": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018243827852769423 }, { "start_logit": 6.8046875, "end_logit": -0.49951171875, "text": "", "probability": 0.998175617214723 } ], "100000000000000000009197": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021827164453451808 }, { "start_logit": 6.64453125, "end_logit": -0.5205078125, "text": "", "probability": 0.9978172835546547 } ], "100000000000000000009198": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018821859100764038 }, { "start_logit": 6.78515625, "end_logit": -0.51318359375, "text": "", "probability": 0.9981178140899236 } ], "100000000000000000009199": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001831510139835083 }, { "start_logit": 6.7890625, "end_logit": -0.486572265625, "text": "", "probability": 0.9981684898601648 } ], "100000000000000000009201": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013096056548252163 }, { "start_logit": 6.78125, "end_logit": -0.1458740234375, "text": "", "probability": 0.9986903943451748 } ], "100000000000000000009210": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999982912435 }, { "start_logit": -33.9375, "end_logit": 13.75, "text": "", "probability": 1.708756367124727e-09 } ], "100000000000000000009213": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014158706681133846 }, { "start_logit": 6.99609375, "end_logit": -0.438232421875, "text": "", "probability": 0.9985841293318867 } ], "100000000000000000009214": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013617033749752196 }, { "start_logit": 6.9140625, "end_logit": -0.316162109375, "text": "", "probability": 0.9986382966250248 } ], "100000000000000000009218": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015011822567369915 }, { "start_logit": 7.1953125, "end_logit": -0.693359375, "text": "", "probability": 0.998498817743263 } ], "100000000000000000009220": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.28125, "end_logit": -0.724609375, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000009225": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.08284562460179112 }, { "start_logit": 5.74609375, "end_logit": -3.341796875, "text": "", "probability": 0.9171543753982089 } ], "100000000000000000009228": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0002673826128617125 }, { "start_logit": 8.7734375, "end_logit": -0.548828125, "text": "", "probability": 0.9997326173871383 } ], "100000000000000000009229": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0002673826128617125 }, { "start_logit": 8.734375, "end_logit": -0.5107421875, "text": "", "probability": 0.9997326173871383 } ], "100000000000000000009233": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003625900662832244 }, { "start_logit": 8.203125, "end_logit": -0.28125, "text": "", "probability": 0.9996374099337169 } ], "100000000000000000009245": [ { "start_logit": 14.3359375, "end_logit": 8.375, "text": " COVID-19", "probability": 0.4580078125 }, { "start_logit": 13.375, "end_logit": 8.375, "text": " Exposed to COVID-19", "probability": 0.173828125 }, { "start_logit": 13.3671875, "end_logit": 8.375, "text": "After Being Exposed to COVID-19", "probability": 0.173828125 }, { "start_logit": 12.6484375, "end_logit": 8.375, "text": " Being Exposed to COVID-19", "probability": 0.084716796875 }, { "start_logit": 13.3671875, "end_logit": 7.1171875, "text": "After", "probability": 0.049041748046875 }, { "start_logit": 13.375, "end_logit": 6.4140625, "text": " Exposed", "probability": 0.0242767333984375 }, { "start_logit": 13.3671875, "end_logit": 6.4140625, "text": "After Being Exposed", "probability": 0.0242767333984375 }, { "start_logit": 12.6484375, "end_logit": 6.4140625, "text": " Being Exposed", "probability": 0.01183319091796875 }, { "start_logit": 8.15625, "end_logit": -0.81689453125, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000009247": [ { "start_logit": 14.328125, "end_logit": 8.3828125, "text": " COVID-19", "probability": 0.4580078125 }, { "start_logit": 13.375, "end_logit": 8.3828125, "text": " Exposed to COVID-19", "probability": 0.173828125 }, { "start_logit": 13.3671875, "end_logit": 8.3828125, "text": "After Being Exposed to COVID-19", "probability": 0.173828125 }, { "start_logit": 12.6484375, "end_logit": 8.3828125, "text": " Being Exposed to COVID-19", "probability": 0.084716796875 }, { "start_logit": 13.3671875, "end_logit": 7.1171875, "text": "After", "probability": 0.049041748046875 }, { "start_logit": 13.375, "end_logit": 6.41015625, "text": " Exposed", "probability": 0.0242767333984375 }, { "start_logit": 13.3671875, "end_logit": 6.41015625, "text": "After Being Exposed", "probability": 0.0242767333984375 }, { "start_logit": 12.6484375, "end_logit": 6.41015625, "text": " Being Exposed", "probability": 0.01183319091796875 }, { "start_logit": 8.1875, "end_logit": -0.8408203125, "text": "", "probability": 1.1920928955078125e-07 } ], "100000000000000000009251": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0005815576348560962 }, { "start_logit": 8.3984375, "end_logit": -0.9482421875, "text": "", "probability": 0.9994184423651439 } ], "100000000000000000009254": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000593021029357059 }, { "start_logit": 8.4296875, "end_logit": -1.001953125, "text": "", "probability": 0.999406978970643 } ], "100000000000000000009259": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.69921875, "end_logit": -0.79443359375, "text": "", "probability": 0.99899949559909 } ], "100000000000000000009262": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00018522574326531078 }, { "start_logit": 7.90234375, "end_logit": 0.69287109375, "text": "", "probability": 0.9998147742567347 } ], "100000000000000000009273": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996304556 }, { "start_logit": -33.3125, "end_logit": 11.6015625, "text": "", "probability": 3.695444813027597e-10 } ], "100000000000000000009276": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0004390453304730707 }, { "start_logit": 7.8515625, "end_logit": -0.1212158203125, "text": "", "probability": 0.9995609546695269 } ], "100000000000000000009280": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008559006367452269 }, { "start_logit": 7.91796875, "end_logit": -0.857421875, "text": "", "probability": 0.9991440993632549 } ], "100000000000000000009283": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 7.80078125, "end_logit": -0.8310546875, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000009291": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.93359375, "end_logit": -0.62353515625, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000009295": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000859247658728013 }, { "start_logit": 7.375, "end_logit": -0.31787109375, "text": "", "probability": 0.999140752341272 } ], "100000000000000000009296": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.33203125, "end_logit": -0.3740234375, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000009297": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003487043026945987 }, { "start_logit": 8.34375, "end_logit": -0.384033203125, "text": "", "probability": 0.9996512956973053 } ], "100000000000000000009298": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0003920417892376281 }, { "start_logit": 8.265625, "end_logit": -0.422607421875, "text": "", "probability": 0.9996079582107623 } ], "100000000000000000009300": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000388992082602597 }, { "start_logit": 8.34375, "end_logit": -0.492919921875, "text": "", "probability": 0.9996110079173974 } ], "100000000000000000009302": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00031999824407395836 }, { "start_logit": 8.453125, "end_logit": -0.408203125, "text": "", "probability": 0.9996800017559261 } ], "100000000000000000009304": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990263799 }, { "start_logit": -33.875, "end_logit": 13.1328125, "text": "", "probability": 9.736200303530205e-10 } ], "100000000000000000009306": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990414745 }, { "start_logit": -33.84375, "end_logit": 13.078125, "text": "", "probability": 9.585254508941148e-10 } ], "100000000000000000009307": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006798428944286137 }, { "start_logit": 7.41796875, "end_logit": -0.126220703125, "text": "", "probability": 0.9993201571055714 } ], "100000000000000000009311": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006693099618068043 }, { "start_logit": 8.0546875, "end_logit": -0.7451171875, "text": "", "probability": 0.9993306900381931 } ], "100000000000000000009316": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006825019082634147 }, { "start_logit": 7.97265625, "end_logit": -0.685546875, "text": "", "probability": 0.9993174980917366 } ], "100000000000000000009324": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010608151804637727 }, { "start_logit": 7.80078125, "end_logit": -0.95361328125, "text": "", "probability": 0.9989391848195363 } ], "100000000000000000009330": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 8.203125, "end_logit": -1.2333984375, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000009332": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 8.171875, "end_logit": -1.2412109375, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000009333": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009735437745828979 }, { "start_logit": 8.15625, "end_logit": -1.22265625, "text": "", "probability": 0.9990264562254172 } ], "100000000000000000009334": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 8.15625, "end_logit": -1.2265625, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000009339": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 7.29296875, "end_logit": -0.94482421875, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000009341": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017477857726837607 }, { "start_logit": 7.24609375, "end_logit": -0.89794921875, "text": "", "probability": 0.9982522142273162 } ], "100000000000000000009342": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001573112165348997 }, { "start_logit": 7.3828125, "end_logit": -0.931640625, "text": "", "probability": 0.998426887834651 } ], "100000000000000000009343": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 7.19921875, "end_logit": -0.8916015625, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000009345": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.25, "end_logit": -0.88525390625, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000009348": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009510131046937042 }, { "start_logit": 7.43359375, "end_logit": -0.477294921875, "text": "", "probability": 0.9990489868953062 } ], "100000000000000000009350": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00098117188120718 }, { "start_logit": 7.4609375, "end_logit": -0.53515625, "text": "", "probability": 0.999018828118793 } ], "100000000000000000009351": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.421875, "end_logit": -0.529296875, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000009352": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.16796875, "end_logit": -0.384765625, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000009353": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.21484375, "end_logit": -0.369873046875, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000009354": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015978454940173438 }, { "start_logit": 7.0546875, "end_logit": -0.6171875, "text": "", "probability": 0.9984021545059827 } ], "100000000000000000009355": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015307451011758208 }, { "start_logit": 7.140625, "end_logit": -0.6591796875, "text": "", "probability": 0.9984692548988241 } ], "100000000000000000009357": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013777325890227494 }, { "start_logit": 7.1328125, "end_logit": -0.5458984375, "text": "", "probability": 0.9986222674109773 } ], "100000000000000000009359": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004086002694204712 }, { "start_logit": 5.8125, "end_logit": -0.31787109375, "text": "", "probability": 0.9959139973057952 } ], "100000000000000000009360": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004101929257867252 }, { "start_logit": 5.83984375, "end_logit": -0.3486328125, "text": "", "probability": 0.9958980707421329 } ], "100000000000000000009361": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004248079086738752 }, { "start_logit": 5.82421875, "end_logit": -0.368408203125, "text": "", "probability": 0.9957519209132613 } ], "100000000000000000009369": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011291546285049482 }, { "start_logit": 7.53125, "end_logit": -0.74755859375, "text": "", "probability": 0.9988708453714951 } ], "100000000000000000009372": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022783308664993352 }, { "start_logit": 7.32421875, "end_logit": -1.2412109375, "text": "", "probability": 0.9977216691335006 } ], "100000000000000000009377": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002260640836446661 }, { "start_logit": 7.359375, "end_logit": -1.2705078125, "text": "", "probability": 0.9977393591635534 } ], "100000000000000000009378": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022170130229473865 }, { "start_logit": 7.3828125, "end_logit": -1.2724609375, "text": "", "probability": 0.9977829869770526 } ], "100000000000000000009379": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00225184727950302 }, { "start_logit": 7.375, "end_logit": -1.2822265625, "text": "", "probability": 0.997748152720497 } ], "100000000000000000009380": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00060000717933842 }, { "start_logit": 7.7578125, "end_logit": -0.3408203125, "text": "", "probability": 0.9993999928206616 } ], "100000000000000000009384": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 7.71484375, "end_logit": -0.39697265625, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000009393": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012743262913872736 }, { "start_logit": 7.4765625, "end_logit": -0.81103515625, "text": "", "probability": 0.9987256737086126 } ], "100000000000000000009403": [ { "start_logit": 18.234375, "end_logit": 11.7109375, "text": " SPIKEVAX", "probability": 0.39599609375 }, { "start_logit": 17.765625, "end_logit": 11.7109375, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIKEVAX", "probability": 0.2479248046875 }, { "start_logit": 17.765625, "end_logit": 10.4765625, "text": " any of these vaccines", "probability": 0.0732421875 }, { "start_logit": 18.234375, "end_logit": 9.828125, "text": " SPIKEVAX (COVID-19", "probability": 0.060699462890625 }, { "start_logit": 17.765625, "end_logit": 10.109375, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction", "probability": 0.050323486328125 }, { "start_logit": 17.765625, "end_logit": 9.828125, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIKEVAX (COVID-19", "probability": 0.037994384765625 }, { "start_logit": 18.234375, "end_logit": 9.0078125, "text": " SPIKEV", "probability": 0.026947021484375 }, { "start_logit": 17.765625, "end_logit": 9.0078125, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIKEV", "probability": 0.0168609619140625 }, { "start_logit": 15.8515625, "end_logit": 10.4765625, "text": "You or your child should not get any of these vaccines", "probability": 0.01071929931640625 }, { "start_logit": 18.234375, "end_logit": 8.0546875, "text": " SPIK", "probability": 0.01023101806640625 }, { "start_logit": 18.234375, "end_logit": 8.0546875, "text": " SPI", "probability": 0.01023101806640625 }, { "start_logit": 14.4609375, "end_logit": 11.7109375, "text": " these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIKEVAX", "probability": 0.00916290283203125 }, { "start_logit": 15.8515625, "end_logit": 10.109375, "text": "You or your child should not get any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction", "probability": 0.007480621337890625 }, { "start_logit": 17.765625, "end_logit": 8.1796875, "text": " any of these", "probability": 0.007251739501953125 }, { "start_logit": 17.765625, "end_logit": 8.0546875, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPIK", "probability": 0.006397247314453125 }, { "start_logit": 17.765625, "end_logit": 8.0546875, "text": " any", "probability": 0.006397247314453125 }, { "start_logit": 17.765625, "end_logit": 8.0546875, "text": " any of these vaccines if you or your child:\n\u2022 had a severe allergic reaction after a previous dose of SPI", "probability": 0.006397247314453125 }, { "start_logit": 14.03125, "end_logit": 11.7109375, "text": " allergic reaction after a previous dose of SPIKEVAX", "probability": 0.006011962890625 }, { "start_logit": 18.234375, "end_logit": 7.3203125, "text": " SPIKEVAX (COVID-19 Vaccine,\nmRNA) or Moderna COVID-19", "probability": 0.004985809326171875 }, { "start_logit": 15.6796875, "end_logit": 9.828125, "text": "COVID-19", "probability": 0.0046844482421875 }, { "start_logit": 7.32421875, "end_logit": -0.76708984375, "text": "", "probability": 0.0 } ], "100000000000000000009406": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993096 }, { "start_logit": -32.65625, "end_logit": 11.5625, "text": "", "probability": 6.903999830637495e-10 } ], "100000000000000000009408": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999991135089 }, { "start_logit": -32.71875, "end_logit": 11.8828125, "text": "", "probability": 8.864911257608076e-10 } ], "100000000000000000009410": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004736748955776685 }, { "start_logit": 5.83203125, "end_logit": -0.4853515625, "text": "", "probability": 0.9952632510442234 } ], "100000000000000000009414": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018458483368165377 }, { "start_logit": 7.03125, "end_logit": -0.7392578125, "text": "", "probability": 0.9981541516631836 } ], "100000000000000000009415": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0018243827852769423 }, { "start_logit": 7.1015625, "end_logit": -0.79638671875, "text": "", "probability": 0.998175617214723 } ], "100000000000000000009418": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00154876109428798 }, { "start_logit": 7.19921875, "end_logit": -0.72998046875, "text": "", "probability": 0.998451238905712 } ], "100000000000000000009433": [ { "start_logit": 18.328125, "end_logit": 10.5625, "text": " seek medical attention right away", "probability": 0.78564453125 }, { "start_logit": 15.8515625, "end_logit": 10.5625, "text": "You should seek medical attention right away", "probability": 0.0655517578125 }, { "start_logit": 18.328125, "end_logit": 7.97265625, "text": " seek medical attention", "probability": 0.058746337890625 }, { "start_logit": 18.328125, "end_logit": 7.5390625, "text": " seek medical attention right", "probability": 0.03851318359375 }, { "start_logit": 18.328125, "end_logit": 7.04296875, "text": " seek", "probability": 0.0233612060546875 }, { "start_logit": 15.515625, "end_logit": 9.015625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding heart", "probability": 0.01004791259765625 }, { "start_logit": 15.8515625, "end_logit": 7.97265625, "text": "You should seek medical attention", "probability": 0.004974365234375 }, { "start_logit": 15.8515625, "end_logit": 7.5390625, "text": "You should seek medical attention right", "probability": 0.0032100677490234375 }, { "start_logit": 14.265625, "end_logit": 9.015625, "text": " pounding heart", "probability": 0.002880096435546875 }, { "start_logit": 15.515625, "end_logit": 7.66015625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding", "probability": 0.0025806427001953125 }, { "start_logit": 15.8515625, "end_logit": 7.04296875, "text": "You should seek", "probability": 0.0019483566284179688 }, { "start_logit": 15.515625, "end_logit": 7.1875, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering", "probability": 0.0016145706176757812 }, { "start_logit": 14.265625, "end_logit": 7.66015625, "text": " pounding", "probability": 0.0007395744323730469 }, { "start_logit": 7.7734375, "end_logit": -0.75048828125, "text": "", "probability": 0.0 } ], "100000000000000000009434": [ { "start_logit": 18.328125, "end_logit": 10.5625, "text": " seek medical attention right away", "probability": 0.79638671875 }, { "start_logit": 15.8515625, "end_logit": 10.5625, "text": "You should seek medical attention right away", "probability": 0.06640625 }, { "start_logit": 18.328125, "end_logit": 7.97265625, "text": " seek medical attention", "probability": 0.059539794921875 }, { "start_logit": 18.328125, "end_logit": 7.5390625, "text": " seek medical attention right", "probability": 0.039031982421875 }, { "start_logit": 18.328125, "end_logit": 7.04296875, "text": " seek", "probability": 0.0236663818359375 }, { "start_logit": 15.8515625, "end_logit": 7.97265625, "text": "You should seek medical attention", "probability": 0.005039215087890625 }, { "start_logit": 15.8515625, "end_logit": 7.5390625, "text": "You should seek medical attention right", "probability": 0.003253936767578125 }, { "start_logit": 15.515625, "end_logit": 7.6640625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding", "probability": 0.0026569366455078125 }, { "start_logit": 15.8515625, "end_logit": 7.04296875, "text": "You should seek", "probability": 0.0019741058349609375 }, { "start_logit": 15.515625, "end_logit": 7.19140625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering", "probability": 0.0016355514526367188 }, { "start_logit": 14.28125, "end_logit": 7.6640625, "text": " pounding", "probability": 0.0007610321044921875 }, { "start_logit": 7.67578125, "end_logit": -0.7333984375, "text": "", "probability": 0.0 } ], "100000000000000000009436": [ { "start_logit": 18.328125, "end_logit": 10.5625, "text": " seek medical attention right away", "probability": 0.76171875 }, { "start_logit": 15.8515625, "end_logit": 10.5625, "text": "You should seek medical attention right away", "probability": 0.06353759765625 }, { "start_logit": 18.328125, "end_logit": 7.97265625, "text": " seek medical attention", "probability": 0.056976318359375 }, { "start_logit": 18.328125, "end_logit": 7.53515625, "text": " seek medical attention right", "probability": 0.036773681640625 }, { "start_logit": 18.328125, "end_logit": 7.0390625, "text": " seek", "probability": 0.02264404296875 }, { "start_logit": 16.1875, "end_logit": 8.8046875, "text": " Injection site reactions", "probability": 0.01556396484375 }, { "start_logit": 15.515625, "end_logit": 9.015625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding heart", "probability": 0.00974273681640625 }, { "start_logit": 16.1875, "end_logit": 8.15625, "text": " Injection site reactions: pain, tenderness", "probability": 0.0080718994140625 }, { "start_logit": 15.8515625, "end_logit": 7.97265625, "text": "You should seek medical attention", "probability": 0.00482177734375 }, { "start_logit": 14.984375, "end_logit": 8.8046875, "text": "\n\u2022 Injection site reactions", "probability": 0.00460052490234375 }, { "start_logit": 15.390625, "end_logit": 8.15625, "text": " pain, tenderness", "probability": 0.0036411285400390625 }, { "start_logit": 15.8515625, "end_logit": 7.53515625, "text": "You should seek medical attention right", "probability": 0.00311279296875 }, { "start_logit": 15.515625, "end_logit": 7.6640625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding", "probability": 0.0025424957275390625 }, { "start_logit": 14.984375, "end_logit": 8.15625, "text": "\n\u2022 Injection site reactions: pain, tenderness", "probability": 0.0024261474609375 }, { "start_logit": 15.8515625, "end_logit": 7.0390625, "text": "You should seek", "probability": 0.0018892288208007812 }, { "start_logit": 15.515625, "end_logit": 7.1875, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering", "probability": 0.0015649795532226562 }, { "start_logit": 7.84375, "end_logit": -0.62744140625, "text": "", "probability": 0.0 } ], "100000000000000000009437": [ { "start_logit": 18.328125, "end_logit": 10.5625, "text": " seek medical attention right away", "probability": 0.78564453125 }, { "start_logit": 15.8515625, "end_logit": 10.5625, "text": "You should seek medical attention right away", "probability": 0.0655517578125 }, { "start_logit": 18.328125, "end_logit": 7.97265625, "text": " seek medical attention", "probability": 0.058746337890625 }, { "start_logit": 18.328125, "end_logit": 7.5390625, "text": " seek medical attention right", "probability": 0.03851318359375 }, { "start_logit": 18.328125, "end_logit": 7.04296875, "text": " seek", "probability": 0.0233612060546875 }, { "start_logit": 15.515625, "end_logit": 9.015625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding heart", "probability": 0.01004791259765625 }, { "start_logit": 15.8515625, "end_logit": 7.97265625, "text": "You should seek medical attention", "probability": 0.004974365234375 }, { "start_logit": 15.8515625, "end_logit": 7.5390625, "text": "You should seek medical attention right", "probability": 0.0032100677490234375 }, { "start_logit": 14.2734375, "end_logit": 9.015625, "text": " pounding heart", "probability": 0.002880096435546875 }, { "start_logit": 15.515625, "end_logit": 7.6640625, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering, or pounding", "probability": 0.0026226043701171875 }, { "start_logit": 15.8515625, "end_logit": 7.04296875, "text": "You should seek", "probability": 0.0019483566284179688 }, { "start_logit": 15.515625, "end_logit": 7.1875, "text": " Chest pain\n\u2022 Shortness of breath\n\u2022 Feelings of having a fast-beating, fluttering", "probability": 0.0016145706176757812 }, { "start_logit": 14.2734375, "end_logit": 7.6640625, "text": " pounding", "probability": 0.0007510185241699219 }, { "start_logit": 7.66796875, "end_logit": -0.72509765625, "text": "", "probability": 0.0 } ], "100000000000000000009441": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000761325841895028 }, { "start_logit": 7.99609375, "end_logit": -0.814453125, "text": "", "probability": 0.9992386741581051 } ], "100000000000000000009444": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000810387349057321 }, { "start_logit": 7.86328125, "end_logit": -0.7470703125, "text": "", "probability": 0.9991896126509426 } ], "100000000000000000009445": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 7.23046875, "end_logit": -0.83349609375, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000009446": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001648482941851288 }, { "start_logit": 7.23828125, "end_logit": -0.8310546875, "text": "", "probability": 0.9983515170581486 } ], "100000000000000000009450": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016293088253926625 }, { "start_logit": 7.24609375, "end_logit": -0.828125, "text": "", "probability": 0.9983706911746074 } ], "100000000000000000009452": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007643033095615911 }, { "start_logit": 7.90625, "end_logit": -0.7294921875, "text": "", "probability": 0.9992356966904383 } ], "100000000000000000009454": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007350448316939618 }, { "start_logit": 7.9609375, "end_logit": -0.74560546875, "text": "", "probability": 0.9992649551683059 } ], "100000000000000000009467": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.21875, "end_logit": -0.560546875, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000009470": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013302015099117559 }, { "start_logit": 7.15625, "end_logit": -0.53369140625, "text": "", "probability": 0.9986697984900882 } ], "100000000000000000009471": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010044163312604223 }, { "start_logit": 7.5625, "end_logit": -0.6611328125, "text": "", "probability": 0.9989955836687396 } ], "100000000000000000009472": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001008343541656317 }, { "start_logit": 7.54296875, "end_logit": -0.64599609375, "text": "", "probability": 0.9989916564583438 } ], "100000000000000000009474": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010242063784298287 }, { "start_logit": 7.5859375, "end_logit": -0.70166015625, "text": "", "probability": 0.9989757936215702 } ], "100000000000000000009475": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009850082967450694 }, { "start_logit": 7.59765625, "end_logit": -0.6748046875, "text": "", "probability": 0.9990149917032549 } ], "100000000000000000009476": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010162440410680167 }, { "start_logit": 7.56640625, "end_logit": -0.67431640625, "text": "", "probability": 0.9989837559589321 } ], "100000000000000000009482": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00017130819343483193 }, { "start_logit": 9.8125, "end_logit": -1.138671875, "text": "", "probability": 0.9998286918065652 } ], "100000000000000000009486": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021742253421720634 }, { "start_logit": 6.80859375, "end_logit": -0.6796875, "text": "", "probability": 0.9978257746578281 } ], "100000000000000000009489": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021742253421720634 }, { "start_logit": 6.83203125, "end_logit": -0.70263671875, "text": "", "probability": 0.9978257746578281 } ], "100000000000000000009493": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.5625, "end_logit": -0.716796875, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000009497": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011335690050875119 }, { "start_logit": 7.3203125, "end_logit": -0.53955078125, "text": "", "probability": 0.9988664309949126 } ], "100000000000000000009500": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.2109375, "end_logit": -0.485107421875, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000009502": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001142449539817763 }, { "start_logit": 7.26171875, "end_logit": -0.489013671875, "text": "", "probability": 0.9988575504601823 } ], "100000000000000000009504": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012303582820496156 }, { "start_logit": 7.2421875, "end_logit": -0.54248046875, "text": "", "probability": 0.9987696417179502 } ], "100000000000000000009508": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 7.0, "end_logit": -0.76220703125, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000009513": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020033332861764124 }, { "start_logit": 7.0078125, "end_logit": -0.7958984375, "text": "", "probability": 0.9979966667138236 } ], "100000000000000000009515": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001466458403084568 }, { "start_logit": 7.3828125, "end_logit": -0.8603515625, "text": "", "probability": 0.9985335415969153 } ], "100000000000000000009516": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014837189029090864 }, { "start_logit": 7.46484375, "end_logit": -0.9541015625, "text": "", "probability": 0.998516281097091 } ], "100000000000000000009517": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001410358496618023 }, { "start_logit": 7.515625, "end_logit": -0.951171875, "text": "", "probability": 0.9985896415033819 } ], "100000000000000000009519": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001518850841377843 }, { "start_logit": 7.33203125, "end_logit": -0.84228515625, "text": "", "probability": 0.9984811491586221 } ], "100000000000000000009526": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008830458477845482 }, { "start_logit": 7.94140625, "end_logit": -0.91015625, "text": "", "probability": 0.9991169541522155 } ], "100000000000000000009529": [ { "start_logit": 18.890625, "end_logit": 10.65625, "text": "dark blue", "probability": 0.306396484375 }, { "start_logit": 17.90625, "end_logit": 10.65625, "text": " 6 months\u20135 years (dark blue", "probability": 0.114501953125 }, { "start_logit": 18.34375, "end_logit": 10.046875, "text": "dark blue", "probability": 0.096435546875 }, { "start_logit": 17.078125, "end_logit": 10.65625, "text": "\u20135 years (dark blue", "probability": 0.050018310546875 }, { "start_logit": 18.890625, "end_logit": 8.75, "text": "dark blue cap/magenta", "probability": 0.045562744140625 }, { "start_logit": 18.890625, "end_logit": 8.703125, "text": "dark blue cap/magenta label border), or\n\u0083 0.50 mL", "probability": 0.04345703125 }, { "start_logit": 16.828125, "end_logit": 10.65625, "text": "\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.0389404296875 }, { "start_logit": 17.40625, "end_logit": 10.046875, "text": " 6\u201311 years (dark blue", "probability": 0.037750244140625 }, { "start_logit": 17.90625, "end_logit": 9.484375, "text": " 6 months\u20135 years", "probability": 0.03546142578125 }, { "start_logit": 18.34375, "end_logit": 8.953125, "text": "dark blue cap/purple", "probability": 0.03228759765625 }, { "start_logit": 16.625, "end_logit": 10.65625, "text": "Either dose may be:\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.03179931640625 }, { "start_logit": 16.59375, "end_logit": 10.65625, "text": " 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.03082275390625 }, { "start_logit": 18.890625, "end_logit": 8.203125, "text": "dark", "probability": 0.0263519287109375 }, { "start_logit": 17.90625, "end_logit": 9.0546875, "text": " 6 months", "probability": 0.0232696533203125 }, { "start_logit": 17.90625, "end_logit": 8.75, "text": " 6 months\u20135 years (dark blue cap/magenta", "probability": 0.0170135498046875 }, { "start_logit": 17.90625, "end_logit": 8.703125, "text": " 6 months\u20135 years (dark blue cap/magenta label border), or\n\u0083 0.50 mL", "probability": 0.0162353515625 }, { "start_logit": 17.078125, "end_logit": 9.484375, "text": "\u20135 years", "probability": 0.01549530029296875 }, { "start_logit": 16.828125, "end_logit": 9.5703125, "text": "\n\u0083 0.25 mL", "probability": 0.01325225830078125 }, { "start_logit": 17.40625, "end_logit": 8.953125, "text": " 6\u201311 years (dark blue cap/purple", "probability": 0.01264190673828125 }, { "start_logit": 16.828125, "end_logit": 9.484375, "text": "\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years", "probability": 0.0120697021484375 }, { "start_logit": 8.6796875, "end_logit": -1.1123046875, "text": "", "probability": 0.0 } ], "100000000000000000009531": [ { "start_logit": 18.90625, "end_logit": 10.65625, "text": "dark blue", "probability": 0.308349609375 }, { "start_logit": 17.90625, "end_logit": 10.65625, "text": " 6 months\u20135 years (dark blue", "probability": 0.11346435546875 }, { "start_logit": 18.34375, "end_logit": 10.046875, "text": "dark blue", "probability": 0.0955810546875 }, { "start_logit": 17.078125, "end_logit": 10.65625, "text": "\u20135 years (dark blue", "probability": 0.049591064453125 }, { "start_logit": 18.90625, "end_logit": 8.7421875, "text": "dark blue cap/magenta", "probability": 0.045867919921875 }, { "start_logit": 18.90625, "end_logit": 8.7109375, "text": "dark blue cap/magenta label border), or\n\u0083 0.50 mL", "probability": 0.04443359375 }, { "start_logit": 16.828125, "end_logit": 10.65625, "text": "\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.038604736328125 }, { "start_logit": 17.421875, "end_logit": 10.046875, "text": " 6\u201311 years (dark blue", "probability": 0.037994384765625 }, { "start_logit": 17.90625, "end_logit": 9.484375, "text": " 6 months\u20135 years", "probability": 0.03515625 }, { "start_logit": 18.34375, "end_logit": 8.96875, "text": "dark blue cap/purple", "probability": 0.032501220703125 }, { "start_logit": 16.625, "end_logit": 10.65625, "text": "Either dose may be:\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.031524658203125 }, { "start_logit": 16.59375, "end_logit": 10.65625, "text": " 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years (dark blue", "probability": 0.0305328369140625 }, { "start_logit": 18.90625, "end_logit": 8.2109375, "text": "dark", "probability": 0.0269622802734375 }, { "start_logit": 17.90625, "end_logit": 9.0625, "text": " 6 months", "probability": 0.0230560302734375 }, { "start_logit": 17.90625, "end_logit": 8.7421875, "text": " 6 months\u20135 years (dark blue cap/magenta", "probability": 0.0168609619140625 }, { "start_logit": 17.90625, "end_logit": 8.7109375, "text": " 6 months\u20135 years (dark blue cap/magenta label border), or\n\u0083 0.50 mL", "probability": 0.0163421630859375 }, { "start_logit": 17.078125, "end_logit": 9.484375, "text": "\u20135 years", "probability": 0.015350341796875 }, { "start_logit": 17.421875, "end_logit": 8.96875, "text": " 6\u201311 years (dark blue cap/purple", "probability": 0.01293182373046875 }, { "start_logit": 16.828125, "end_logit": 9.5546875, "text": "\n\u0083 0.25 mL", "probability": 0.012725830078125 }, { "start_logit": 16.828125, "end_logit": 9.484375, "text": "\n\u0083 0.25 mL (25 mcg) of the product authorized for children ages 6 months\u20135 years", "probability": 0.011962890625 }, { "start_logit": 8.6875, "end_logit": -1.1396484375, "text": "", "probability": 0.0 } ], "100000000000000000009545": [ { "start_logit": 17.8125, "end_logit": 9.65625, "text": " 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren ages 5\u201311\nyears", "probability": 0.2958984375 }, { "start_logit": 17.734375, "end_logit": 9.65625, "text": "maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren ages 5\u201311\nyears", "probability": 0.2734375 }, { "start_logit": 16.984375, "end_logit": 9.65625, "text": " 5\u201311\nyears", "probability": 0.129150390625 }, { "start_logit": 17.8125, "end_logit": 8.375, "text": " 6\n(maroon", "probability": 0.08209228515625 }, { "start_logit": 17.734375, "end_logit": 8.375, "text": "maroon", "probability": 0.07598876953125 }, { "start_logit": 17.578125, "end_logit": 8.375, "text": "\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.06500244140625 }, { "start_logit": 15.0546875, "end_logit": 9.65625, "text": "Child turns 5\nof the product\nauthorized for\nchildren ages 5\u201311\nyears", "probability": 0.0189056396484375 }, { "start_logit": 15.5859375, "end_logit": 8.375, "text": " 1 and dose 2\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.00893402099609375 }, { "start_logit": 17.609375, "end_logit": 6.29296875, "text": "Children who turn from age 4 to age 5 years", "probability": 0.008392333984375 }, { "start_logit": 17.609375, "end_logit": 6.23046875, "text": "Children who turn from age 4 to age 5 years\nRecommended: Children who started a primary series and turned from age 4 to age 5 years", "probability": 0.00788116455078125 }, { "start_logit": 15.2109375, "end_logit": 8.375, "text": " 2\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.006137847900390625 }, { "start_logit": 17.609375, "end_logit": 5.83984375, "text": "Children", "probability": 0.00533294677734375 }, { "start_logit": 14.8515625, "end_logit": 8.375, "text": ":\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.00421905517578125 }, { "start_logit": 16.9375, "end_logit": 6.23046875, "text": " Children who started a primary series and turned from age 4 to age 5 years", "probability": 0.004024505615234375 }, { "start_logit": 17.8125, "end_logit": 5.0625, "text": " 6", "probability": 0.0029926300048828125 }, { "start_logit": 17.578125, "end_logit": 5.078125, "text": "\nof the product\nauthorized for\nchildren", "probability": 0.00240325927734375 }, { "start_logit": 17.578125, "end_logit": 5.0625, "text": "\nof the product\nauthorized for\nchildren ages 6", "probability": 0.0023670196533203125 }, { "start_logit": 17.8125, "end_logit": 4.81640625, "text": " 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren", "probability": 0.002330780029296875 }, { "start_logit": 17.609375, "end_logit": 5.01953125, "text": "Children who turn from age", "probability": 0.002330780029296875 }, { "start_logit": 17.8125, "end_logit": 4.75390625, "text": " 6\n(m", "probability": 0.00218963623046875 }, { "start_logit": 8.546875, "end_logit": -1.3486328125, "text": "", "probability": 0.0 } ], "100000000000000000009549": [ { "start_logit": 17.8125, "end_logit": 8.3671875, "text": " 6\n(maroon", "probability": 0.28466796875 }, { "start_logit": 17.734375, "end_logit": 8.3671875, "text": "maroon", "probability": 0.25927734375 }, { "start_logit": 17.578125, "end_logit": 8.3671875, "text": "\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.2216796875 }, { "start_logit": 15.59375, "end_logit": 8.3671875, "text": " 1 and dose 2\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.0309600830078125 }, { "start_logit": 17.609375, "end_logit": 6.265625, "text": "Children who turn from age 4 to age 5 years", "probability": 0.0281829833984375 }, { "start_logit": 17.609375, "end_logit": 6.234375, "text": "Children who turn from age 4 to age 5 years\nRecommended: Children who started a primary series and turned from age 4 to age 5 years", "probability": 0.027313232421875 }, { "start_logit": 15.21875, "end_logit": 8.3671875, "text": " 2\nin the primary series should receive:\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.0212860107421875 }, { "start_logit": 17.609375, "end_logit": 5.83984375, "text": "Children", "probability": 0.0184783935546875 }, { "start_logit": 14.859375, "end_logit": 8.3671875, "text": ":\nof the product\nauthorized for\nchildren ages 6\n(maroon", "probability": 0.014617919921875 }, { "start_logit": 16.9375, "end_logit": 6.234375, "text": " Children who started a primary series and turned from age 4 to age 5 years", "probability": 0.013946533203125 }, { "start_logit": 17.8125, "end_logit": 5.06640625, "text": " 6", "probability": 0.01036834716796875 }, { "start_logit": 17.578125, "end_logit": 5.078125, "text": "\nof the product\nauthorized for\nchildren", "probability": 0.008331298828125 }, { "start_logit": 17.578125, "end_logit": 5.06640625, "text": "\nof the product\nauthorized for\nchildren ages 6", "probability": 0.00820159912109375 }, { "start_logit": 17.8125, "end_logit": 4.8125, "text": " 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren", "probability": 0.0080718994140625 }, { "start_logit": 17.609375, "end_logit": 5.01953125, "text": "Children who turn from age", "probability": 0.0080718994140625 }, { "start_logit": 17.8125, "end_logit": 4.74609375, "text": " 6\n(m", "probability": 0.0075836181640625 }, { "start_logit": 17.734375, "end_logit": 4.8125, "text": "maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren", "probability": 0.007465362548828125 }, { "start_logit": 17.8125, "end_logit": 4.71484375, "text": " 6\n(maroon cap and\nlabel border)\nChild turns 5\nof the product\nauthorized for\nchildren ages 5", "probability": 0.007350921630859375 }, { "start_logit": 17.8125, "end_logit": 4.69140625, "text": " 6\n(maro", "probability": 0.0071258544921875 }, { "start_logit": 17.734375, "end_logit": 4.74609375, "text": "m", "probability": 0.007015228271484375 }, { "start_logit": 8.453125, "end_logit": -1.337890625, "text": "", "probability": 0.0 } ], "100000000000000000009551": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030994155155094484 }, { "start_logit": 6.44921875, "end_logit": -0.6748046875, "text": "", "probability": 0.9969005844844906 } ], "100000000000000000009553": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003004343016200306 }, { "start_logit": 6.4765625, "end_logit": -0.67236328125, "text": "", "probability": 0.9969956569837995 } ], "100000000000000000009557": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999985384231 }, { "start_logit": -32.78125, "end_logit": 12.4375, "text": "", "probability": 1.4615767744882139e-09 } ], "100000000000000000009558": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.999999998861723 }, { "start_logit": -32.65625, "end_logit": 12.0703125, "text": "", "probability": 1.138277136858404e-09 } ], "100000000000000000009562": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010282108871371872 }, { "start_logit": 7.671875, "end_logit": -0.79150390625, "text": "", "probability": 0.9989717891128628 } ], "100000000000000000009563": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010322310367548194 }, { "start_logit": 7.66015625, "end_logit": -0.78564453125, "text": "", "probability": 0.9989677689632452 } ], "100000000000000000009564": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010649626720559452 }, { "start_logit": 7.640625, "end_logit": -0.798828125, "text": "", "probability": 0.9989350373279441 } ], "100000000000000000009565": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010005044009099887 }, { "start_logit": 7.6171875, "end_logit": -0.70947265625, "text": "", "probability": 0.99899949559909 } ], "100000000000000000009566": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010608151804637727 }, { "start_logit": 7.609375, "end_logit": -0.76220703125, "text": "", "probability": 0.9989391848195363 } ], "100000000000000000009571": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 8.265625, "end_logit": -1.296875, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000009577": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.87890625, "end_logit": -0.71630859375, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000009582": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008135565350514415 }, { "start_logit": 7.7734375, "end_logit": -0.66015625, "text": "", "probability": 0.9991864434649486 } ], "100000000000000000009583": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008263575992788699 }, { "start_logit": 7.78125, "end_logit": -0.68408203125, "text": "", "probability": 0.9991736424007212 } ], "100000000000000000009584": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009290033759766926 }, { "start_logit": 7.14453125, "end_logit": -0.1624755859375, "text": "", "probability": 0.9990709966240232 } ], "100000000000000000009587": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993308415 }, { "start_logit": -33.78125, "end_logit": 12.6640625, "text": "", "probability": 6.69158608681505e-10 } ], "100000000000000000009589": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999993096 }, { "start_logit": -33.8125, "end_logit": 12.71875, "text": "", "probability": 6.903999830637495e-10 } ], "100000000000000000009590": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990853685 }, { "start_logit": -33.96875, "end_logit": 13.1640625, "text": "", "probability": 9.146313747844331e-10 } ], "100000000000000000009591": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999967062858 }, { "start_logit": -34.1875, "end_logit": 14.65625, "text": "", "probability": 3.293714099457528e-09 } ], "100000000000000000009592": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999967573503 }, { "start_logit": -34.1875, "end_logit": 14.640625, "text": "", "probability": 3.242649795595998e-09 } ], "100000000000000000009594": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970933076 }, { "start_logit": -34.125, "end_logit": 14.4609375, "text": "", "probability": 2.9066924918954316e-09 } ], "100000000000000000009595": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999970933076 }, { "start_logit": -34.1875, "end_logit": 14.5390625, "text": "", "probability": 2.9066924918954316e-09 } ], "100000000000000000009599": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008295891883591028 }, { "start_logit": 7.50390625, "end_logit": -0.411376953125, "text": "", "probability": 0.9991704108116409 } ], "100000000000000000009600": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007495314256624536 }, { "start_logit": 7.5546875, "end_logit": -0.3583984375, "text": "", "probability": 0.9992504685743375 } ], "100000000000000000009603": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001187905494116342 }, { "start_logit": 7.4765625, "end_logit": -0.7431640625, "text": "", "probability": 0.9988120945058837 } ], "100000000000000000009613": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008761799515142255 }, { "start_logit": 7.79296875, "end_logit": -0.751953125, "text": "", "probability": 0.9991238200484857 } ], "100000000000000000009614": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008969393236719385 }, { "start_logit": 7.8125, "end_logit": -0.7978515625, "text": "", "probability": 0.9991030606763281 } ], "100000000000000000009616": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008626077580284025 }, { "start_logit": 7.8828125, "end_logit": -0.82763671875, "text": "", "probability": 0.9991373922419715 } ], "100000000000000000009617": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.000903967746759475 }, { "start_logit": 7.80859375, "end_logit": -0.80126953125, "text": "", "probability": 0.9990960322532406 } ], "100000000000000000009623": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020992734296664648 }, { "start_logit": 7.0, "end_logit": -0.8359375, "text": "", "probability": 0.9979007265703336 } ], "100000000000000000009624": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021657671990027 }, { "start_logit": 7.0703125, "end_logit": -0.93603515625, "text": "", "probability": 0.9978342328009973 } ], "100000000000000000009625": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002157341888452641 }, { "start_logit": 7.03125, "end_logit": -0.89453125, "text": "", "probability": 0.9978426581115474 } ], "100000000000000000009628": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016875096190311083 }, { "start_logit": 6.61328125, "end_logit": -0.2318115234375, "text": "", "probability": 0.9983124903809688 } ], "100000000000000000009632": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999996789342 }, { "start_logit": -33.5625, "end_logit": 11.703125, "text": "", "probability": 3.2106580933024515e-10 } ], "100000000000000000009635": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999977006169 }, { "start_logit": -34.03125, "end_logit": 14.140625, "text": "", "probability": 2.2993830197054193e-09 } ], "100000000000000000009639": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999975137741 }, { "start_logit": -34.03125, "end_logit": 14.2265625, "text": "", "probability": 2.4862258419077007e-09 } ], "100000000000000000009642": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.01374232049590237 }, { "start_logit": 5.15234375, "end_logit": -0.8798828125, "text": "", "probability": 0.9862576795040977 } ], "100000000000000000009649": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999971827371 }, { "start_logit": -34.34375, "end_logit": 14.6484375, "text": "", "probability": 2.81726296579986e-09 } ], "100000000000000000009651": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999971383715 }, { "start_logit": -34.375, "end_logit": 14.703125, "text": "", "probability": 2.8616284018703808e-09 } ], "100000000000000000009652": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999969538125 }, { "start_logit": -34.375, "end_logit": 14.765625, "text": "", "probability": 3.046187576710788e-09 } ], "100000000000000000009653": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992176742 }, { "start_logit": -33.84375, "end_logit": 12.8828125, "text": "", "probability": 7.82325672734135e-10 } ], "100000000000000000009661": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0026730060327886528 }, { "start_logit": 6.28515625, "end_logit": -0.364501953125, "text": "", "probability": 0.9973269939672114 } ], "100000000000000000009663": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0029008577108601222 }, { "start_logit": 6.234375, "end_logit": -0.39501953125, "text": "", "probability": 0.99709914228914 } ], "100000000000000000009665": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012545944799717981 }, { "start_logit": 7.4921875, "end_logit": -0.81103515625, "text": "", "probability": 0.9987454055200282 } ], "100000000000000000009666": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.46484375, "end_logit": -0.75390625, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000009670": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.828125, "end_logit": -0.5009765625, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000009673": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001817283116449832 }, { "start_logit": 6.8203125, "end_logit": -0.51025390625, "text": "", "probability": 0.9981827168835503 } ], "100000000000000000009675": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011380006198048291 }, { "start_logit": 7.26171875, "end_logit": -0.48388671875, "text": "", "probability": 0.9988619993801953 } ], "100000000000000000009679": [ { "start_logit": 17.40625, "end_logit": 9.4453125, "text": "Adverse reactions", "probability": 0.93505859375 }, { "start_logit": 17.40625, "end_logit": 6.2265625, "text": "Adverse reactions following administration of the vaccine", "probability": 0.03741455078125 }, { "start_logit": 17.40625, "end_logit": 5.83203125, "text": "Adverse", "probability": 0.0253143310546875 }, { "start_logit": 13.65625, "end_logit": 6.2265625, "text": " administration of the vaccine", "probability": 0.0008797645568847656 }, { "start_logit": 13.3203125, "end_logit": 6.2265625, "text": " vaccine", "probability": 0.0006337165832519531 }, { "start_logit": 12.984375, "end_logit": 6.2265625, "text": " the vaccine", "probability": 0.0004563331604003906 }, { "start_logit": 7.26953125, "end_logit": -0.79541015625, "text": "", "probability": 0.0 } ], "100000000000000000009680": [ { "start_logit": 17.40625, "end_logit": 9.4453125, "text": "Adverse reactions", "probability": 0.9140625 }, { "start_logit": 17.40625, "end_logit": 6.21484375, "text": "Adverse reactions following administration of the vaccine", "probability": 0.036590576171875 }, { "start_logit": 17.40625, "end_logit": 5.83203125, "text": "Adverse", "probability": 0.024749755859375 }, { "start_logit": 17.40625, "end_logit": 5.7578125, "text": "Ad", "probability": 0.02288818359375 }, { "start_logit": 13.65625, "end_logit": 6.21484375, "text": " administration of the vaccine", "probability": 0.0008602142333984375 }, { "start_logit": 13.34375, "end_logit": 6.21484375, "text": " vaccine", "probability": 0.000629425048828125 }, { "start_logit": 12.9921875, "end_logit": 6.21484375, "text": " the vaccine", "probability": 0.0004391670227050781 }, { "start_logit": 7.32421875, "end_logit": -0.8056640625, "text": "", "probability": 0.0 } ], "100000000000000000009683": [ { "start_logit": 17.40625, "end_logit": 9.4453125, "text": "Adverse reactions", "probability": 0.9140625 }, { "start_logit": 17.40625, "end_logit": 6.2265625, "text": "Adverse reactions following administration of the vaccine", "probability": 0.036590576171875 }, { "start_logit": 17.40625, "end_logit": 5.83203125, "text": "Adverse", "probability": 0.024749755859375 }, { "start_logit": 17.40625, "end_logit": 5.7578125, "text": "Ad", "probability": 0.02288818359375 }, { "start_logit": 13.65625, "end_logit": 6.2265625, "text": " administration of the vaccine", "probability": 0.0008602142333984375 }, { "start_logit": 13.328125, "end_logit": 6.2265625, "text": " vaccine", "probability": 0.000629425048828125 }, { "start_logit": 12.984375, "end_logit": 6.2265625, "text": " the vaccine", "probability": 0.000446319580078125 }, { "start_logit": 7.25390625, "end_logit": -0.8017578125, "text": "", "probability": 0.0 } ], "100000000000000000009689": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003524340980437085 }, { "start_logit": 6.203125, "end_logit": -0.55908203125, "text": "", "probability": 0.9964756590195629 } ], "100000000000000000009697": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999992417439 }, { "start_logit": -33.84375, "end_logit": 12.8515625, "text": "", "probability": 7.582560422162384e-10 } ], "100000000000000000009698": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999990853685 }, { "start_logit": -33.84375, "end_logit": 13.0234375, "text": "", "probability": 9.146313747844331e-10 } ], "100000000000000000009703": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009773503931428146 }, { "start_logit": 7.35546875, "end_logit": -0.426025390625, "text": "", "probability": 0.9990226496068572 } ], "100000000000000000009704": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010403185028131415 }, { "start_logit": 7.36328125, "end_logit": -0.49658203125, "text": "", "probability": 0.998959681497187 } ], "100000000000000000009705": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023688742552270873 }, { "start_logit": 6.76953125, "end_logit": -0.7275390625, "text": "", "probability": 0.9976311257447729 } ], "100000000000000000009706": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002260640836446661 }, { "start_logit": 6.765625, "end_logit": -0.67578125, "text": "", "probability": 0.9977393591635534 } ], "100000000000000000009712": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011469158325476325 }, { "start_logit": 7.04296875, "end_logit": -0.2744140625, "text": "", "probability": 0.9988530841674523 } ], "100000000000000000009718": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00439941316273649 }, { "start_logit": 5.86328125, "end_logit": -0.442138671875, "text": "", "probability": 0.9956005868372635 } ], "100000000000000000009722": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011832797695011071 }, { "start_logit": 7.53125, "end_logit": -0.79150390625, "text": "", "probability": 0.9988167202304989 } ], "100000000000000000009723": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001201891318511022 }, { "start_logit": 7.5078125, "end_logit": -0.78564453125, "text": "", "probability": 0.998798108681489 } ], "100000000000000000009725": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.421875, "end_logit": -0.78857421875, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000009727": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 7.00390625, "end_logit": -0.6396484375, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000009735": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009584648438362855 }, { "start_logit": 7.0234375, "end_logit": -0.07366943359375, "text": "", "probability": 0.9990415351561638 } ], "100000000000000000009736": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011247574231557356 }, { "start_logit": 6.94921875, "end_logit": -0.16015625, "text": "", "probability": 0.9988752425768442 } ], "100000000000000000009737": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009110511944006454 }, { "start_logit": 7.078125, "end_logit": -0.0791015625, "text": "", "probability": 0.9990889488055994 } ], "100000000000000000009739": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0009399438806628558 }, { "start_logit": 6.92578125, "end_logit": 0.042022705078125, "text": "", "probability": 0.9990600561193372 } ], "100000000000000000009741": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001477942980215951 }, { "start_logit": 6.98828125, "end_logit": -0.473876953125, "text": "", "probability": 0.9985220570197841 } ], "100000000000000000009744": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021489492836254285 }, { "start_logit": 6.421875, "end_logit": -0.2822265625, "text": "", "probability": 0.9978510507163746 } ], "100000000000000000009745": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023967308701289603 }, { "start_logit": 6.30859375, "end_logit": -0.27734375, "text": "", "probability": 0.997603269129871 } ], "100000000000000000009750": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007733057081242417 }, { "start_logit": 7.20703125, "end_logit": -0.04339599609375, "text": "", "probability": 0.9992266942918758 } ], "100000000000000000009753": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007293288393129922 }, { "start_logit": 7.29296875, "end_logit": -0.07220458984375, "text": "", "probability": 0.999270671160687 } ], "100000000000000000009761": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015854306758212333 }, { "start_logit": 6.98828125, "end_logit": -0.54296875, "text": "", "probability": 0.9984145693241788 } ], "100000000000000000009767": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999984920278 }, { "start_logit": -34.125, "end_logit": 13.8125, "text": "", "probability": 1.5079722015620545e-09 } ], "100000000000000000009777": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999981232983 }, { "start_logit": -33.78125, "end_logit": 13.6796875, "text": "", "probability": 1.8767017261042883e-09 } ], "100000000000000000009783": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020992734296664648 }, { "start_logit": 6.703125, "end_logit": -0.53955078125, "text": "", "probability": 0.9979007265703336 } ], "100000000000000000009789": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001085944368942709 }, { "start_logit": 7.41796875, "end_logit": -0.59326171875, "text": "", "probability": 0.9989140556310573 } ], "100000000000000000009795": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.3125, "end_logit": -0.626953125, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000009796": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012448433020883743 }, { "start_logit": 7.34765625, "end_logit": -0.662109375, "text": "", "probability": 0.9987551566979116 } ], "100000000000000000009797": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 7.3671875, "end_logit": -0.63916015625, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000009798": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0011972111981317268 }, { "start_logit": 6.8671875, "end_logit": -0.1407470703125, "text": "", "probability": 0.9988027888018683 } ], "100000000000000000009800": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012207952467143705 }, { "start_logit": 6.890625, "end_logit": -0.1827392578125, "text": "", "probability": 0.9987792047532855 } ], "100000000000000000009805": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001661390673335242 }, { "start_logit": 6.59375, "end_logit": -0.1961669921875, "text": "", "probability": 0.9983386093266648 } ], "100000000000000000009809": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017821963223663927 }, { "start_logit": 6.54296875, "end_logit": -0.212890625, "text": "", "probability": 0.9982178036776337 } ], "100000000000000000009817": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022083887960902254 }, { "start_logit": 6.25390625, "end_logit": -0.1409912109375, "text": "", "probability": 0.9977916112039098 } ], "100000000000000000009825": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017891591615951197 }, { "start_logit": 6.90625, "end_logit": -0.58056640625, "text": "", "probability": 0.9982108408384048 } ], "100000000000000000009826": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0017207354924652213 }, { "start_logit": 6.9296875, "end_logit": -0.56640625, "text": "", "probability": 0.9982792645075347 } ], "100000000000000000009827": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004718369255027519 }, { "start_logit": 5.875, "end_logit": -0.52294921875, "text": "", "probability": 0.9952816307449724 } ], "100000000000000000009832": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0046818225243337366 }, { "start_logit": 5.86328125, "end_logit": -0.50244140625, "text": "", "probability": 0.9953181774756662 } ], "100000000000000000009833": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006905414693000791 }, { "start_logit": 8.03125, "end_logit": -0.75537109375, "text": "", "probability": 0.9993094585307 } ], "100000000000000000009834": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006719278067448447 }, { "start_logit": 8.0234375, "end_logit": -0.716796875, "text": "", "probability": 0.9993280721932551 } ], "100000000000000000009835": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0007264875213164841 }, { "start_logit": 7.98828125, "end_logit": -0.76318359375, "text": "", "probability": 0.9992735124786836 } ], "100000000000000000009838": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006641048094249014 }, { "start_logit": 8.046875, "end_logit": -0.73193359375, "text": "", "probability": 0.9993358951905751 } ], "100000000000000000009840": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0006563728324346652 }, { "start_logit": 8.0703125, "end_logit": -0.74072265625, "text": "", "probability": 0.9993436271675653 } ], "100000000000000000009848": [ { "start_logit": 14.5859375, "end_logit": 9.2578125, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.1827392578125 }, { "start_logit": 14.234375, "end_logit": 9.2578125, "text": " Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.1295166015625 }, { "start_logit": 14.0390625, "end_logit": 9.2578125, "text": " mRNA-1273", "probability": 0.105712890625 }, { "start_logit": 13.8515625, "end_logit": 9.2578125, "text": " Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.087646484375 }, { "start_logit": 14.5859375, "end_logit": 8.359375, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.0738525390625 }, { "start_logit": 14.234375, "end_logit": 8.359375, "text": " Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.0523681640625 }, { "start_logit": 14.171875, "end_logit": 8.359375, "text": " Planas, D., Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.049163818359375 }, { "start_logit": 14.0390625, "end_logit": 8.359375, "text": " mRNA", "probability": 0.04339599609375 }, { "start_logit": 13.8515625, "end_logit": 8.359375, "text": " Caillard, S. A fourth dose of the mRNA", "probability": 0.035980224609375 }, { "start_logit": 14.5859375, "end_logit": 7.44921875, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS-CoV-2", "probability": 0.029815673828125 }, { "start_logit": 14.5546875, "end_logit": 7.453125, "text": "Benotmane", "probability": 0.0289154052734375 }, { "start_logit": 14.84375, "end_logit": 7.10546875, "text": " Bruel T., Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.027587890625 }, { "start_logit": 14.5859375, "end_logit": 7.10546875, "text": " Schwarz", "probability": 0.0211639404296875 }, { "start_logit": 14.234375, "end_logit": 7.44921875, "text": " Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS-CoV-2", "probability": 0.0211639404296875 }, { "start_logit": 14.5546875, "end_logit": 7.10546875, "text": "Benotmane, I., Bruel T., Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.0204925537109375 }, { "start_logit": 14.5546875, "end_logit": 7.0859375, "text": "Ben", "probability": 0.0201873779296875 }, { "start_logit": 14.84375, "end_logit": 6.69921875, "text": " Bruel T., Planas", "probability": 0.0183868408203125 }, { "start_logit": 14.5859375, "end_logit": 6.93359375, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS-CoV-2 vaccine", "probability": 0.0178070068359375 }, { "start_logit": 14.0390625, "end_logit": 7.44921875, "text": " mRNA-1273\nSARS-CoV-2", "probability": 0.0172576904296875 }, { "start_logit": 14.5859375, "end_logit": 6.84375, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273\nSARS", "probability": 0.0164794921875 }, { "start_logit": 6.828125, "end_logit": -0.849609375, "text": "", "probability": 0.0 } ], "100000000000000000009849": [ { "start_logit": 14.5859375, "end_logit": 9.2578125, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.1923828125 }, { "start_logit": 14.2421875, "end_logit": 9.2578125, "text": " Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.1363525390625 }, { "start_logit": 14.0234375, "end_logit": 9.2578125, "text": " mRNA-1273", "probability": 0.109619140625 }, { "start_logit": 13.859375, "end_logit": 9.2578125, "text": " Caillard, S. A fourth dose of the mRNA-1273", "probability": 0.09375 }, { "start_logit": 14.5859375, "end_logit": 8.3359375, "text": " Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.07647705078125 }, { "start_logit": 14.2421875, "end_logit": 8.3359375, "text": " Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.054229736328125 }, { "start_logit": 14.171875, "end_logit": 8.3359375, "text": " Planas, D., Fafi-Kremer, S., Schwarz, O., Caillard, S. A fourth dose of the mRNA", "probability": 0.050201416015625 }, { "start_logit": 14.0234375, "end_logit": 8.3359375, "text": " mRNA", "probability": 0.043609619140625 }, { "start_logit": 13.859375, "end_logit": 8.3359375, "text": " Caillard, S. A fourth dose of the mRNA", "probability": 0.03668212890625 }, { "start_logit": 14.5546875, "end_logit": 7.453125, "text": "Benotmane", "probability": 0.030426025390625 }, { "start_logit": 14.859375, "end_logit": 7.10546875, "text": " Bruel T., Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.0294952392578125 }, { "start_logit": 14.5859375, "end_logit": 7.10546875, "text": " Schwarz", "probability": 0.0222625732421875 }, { "start_logit": 14.5546875, "end_logit": 7.10546875, "text": "Benotmane, I., Bruel T., Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.021575927734375 }, { "start_logit": 14.5546875, "end_logit": 7.0859375, "text": "Ben", "probability": 0.0212554931640625 }, { "start_logit": 14.859375, "end_logit": 6.69921875, "text": " Bruel T., Planas", "probability": 0.0196533203125 }, { "start_logit": 14.2421875, "end_logit": 7.10546875, "text": " Fafi-Kremer, S., Schwarz", "probability": 0.0157928466796875 }, { "start_logit": 14.171875, "end_logit": 7.10546875, "text": " Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.01482391357421875 }, { "start_logit": 14.5546875, "end_logit": 6.69921875, "text": "Benotmane, I., Bruel T., Planas", "probability": 0.01438140869140625 }, { "start_logit": 14.171875, "end_logit": 6.69921875, "text": " Planas", "probability": 0.00988006591796875 }, { "start_logit": 13.421875, "end_logit": 7.10546875, "text": " I., Bruel T., Planas, D., Fafi-Kremer, S., Schwarz", "probability": 0.007007598876953125 }, { "start_logit": 6.81640625, "end_logit": -0.87939453125, "text": "", "probability": 0.0 } ], "100000000000000000009854": [ { "start_logit": 12.3671875, "end_logit": 14.9296875, "text": " Healthcare Providers", "probability": 0.5107421875 }, { "start_logit": 12.3671875, "end_logit": 14.1875, "text": " Healthcare Providers Administering", "probability": 0.2449951171875 }, { "start_logit": 12.3671875, "end_logit": 12.453125, "text": " Healthcare Providers Administer", "probability": 0.042572021484375 }, { "start_logit": 9.7265625, "end_logit": 14.9296875, "text": "Fact Sheet for Healthcare Providers", "probability": 0.036407470703125 }, { "start_logit": 9.7265625, "end_logit": 14.765625, "text": "Fact", "probability": 0.031158447265625 }, { "start_logit": 12.3671875, "end_logit": 12.0, "text": " Healthcare", "probability": 0.027496337890625 }, { "start_logit": 12.3671875, "end_logit": 11.8203125, "text": " Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Pfizer-\nBioNTech", "probability": 0.0227813720703125 }, { "start_logit": 12.3671875, "end_logit": 11.5703125, "text": " Healthcare Providers Administering Vaccine", "probability": 0.0177459716796875 }, { "start_logit": 9.7265625, "end_logit": 14.1875, "text": "Fact Sheet for Healthcare Providers Administering", "probability": 0.0172119140625 }, { "start_logit": 8.859375, "end_logit": 14.9296875, "text": " Sheet for Healthcare Providers", "probability": 0.0151824951171875 }, { "start_logit": 9.7265625, "end_logit": 13.71875, "text": "Fact Sheet", "probability": 0.010772705078125 }, { "start_logit": 8.859375, "end_logit": 14.1875, "text": " Sheet for Healthcare Providers Administering", "probability": 0.00728607177734375 }, { "start_logit": 8.859375, "end_logit": 13.71875, "text": " Sheet", "probability": 0.004558563232421875 }, { "start_logit": 9.7265625, "end_logit": 12.453125, "text": "Fact Sheet for Healthcare Providers Administer", "probability": 0.0030841827392578125 }, { "start_logit": 9.7265625, "end_logit": 12.0, "text": "Fact Sheet for Healthcare", "probability": 0.0019311904907226562 }, { "start_logit": 9.7265625, "end_logit": 11.8203125, "text": "Fact Sheet for Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Pfizer-\nBioNTech", "probability": 0.0016260147094726562 }, { "start_logit": 8.859375, "end_logit": 12.453125, "text": " Sheet for Healthcare Providers Administer", "probability": 0.001285552978515625 }, { "start_logit": 9.7265625, "end_logit": 11.5703125, "text": "Fact Sheet for Healthcare Providers Administering Vaccine", "probability": 0.0012664794921875 }, { "start_logit": 9.2109375, "end_logit": 11.8203125, "text": " Pfizer-\nBioNTech", "probability": 0.0009708404541015625 }, { "start_logit": 8.859375, "end_logit": 12.0, "text": " Sheet for Healthcare", "probability": 0.0008172988891601562 }, { "start_logit": 6.12109375, "end_logit": -0.42626953125, "text": "", "probability": 0.0 } ], "100000000000000000009858": [ { "start_logit": 12.3671875, "end_logit": 14.9296875, "text": " Healthcare Providers", "probability": 0.5107421875 }, { "start_logit": 12.3671875, "end_logit": 14.1875, "text": " Healthcare Providers Administering", "probability": 0.2449951171875 }, { "start_logit": 12.3671875, "end_logit": 12.453125, "text": " Healthcare Providers Administer", "probability": 0.042572021484375 }, { "start_logit": 9.7265625, "end_logit": 14.9296875, "text": "Fact Sheet for Healthcare Providers", "probability": 0.036407470703125 }, { "start_logit": 9.7265625, "end_logit": 14.765625, "text": "Fact", "probability": 0.031158447265625 }, { "start_logit": 12.3671875, "end_logit": 12.0, "text": " Healthcare", "probability": 0.027496337890625 }, { "start_logit": 12.3671875, "end_logit": 11.8203125, "text": " Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Pfizer-\nBioNTech", "probability": 0.0227813720703125 }, { "start_logit": 12.3671875, "end_logit": 11.5703125, "text": " Healthcare Providers Administering Vaccine", "probability": 0.0177459716796875 }, { "start_logit": 9.7265625, "end_logit": 14.1875, "text": "Fact Sheet for Healthcare Providers Administering", "probability": 0.0172119140625 }, { "start_logit": 8.859375, "end_logit": 14.9296875, "text": " Sheet for Healthcare Providers", "probability": 0.0151824951171875 }, { "start_logit": 9.7265625, "end_logit": 13.71875, "text": "Fact Sheet", "probability": 0.010772705078125 }, { "start_logit": 8.859375, "end_logit": 14.1875, "text": " Sheet for Healthcare Providers Administering", "probability": 0.00728607177734375 }, { "start_logit": 8.859375, "end_logit": 13.71875, "text": " Sheet", "probability": 0.004558563232421875 }, { "start_logit": 9.7265625, "end_logit": 12.453125, "text": "Fact Sheet for Healthcare Providers Administer", "probability": 0.0030841827392578125 }, { "start_logit": 9.7265625, "end_logit": 12.0, "text": "Fact Sheet for Healthcare", "probability": 0.0019311904907226562 }, { "start_logit": 9.7265625, "end_logit": 11.8203125, "text": "Fact Sheet for Healthcare Providers Administering Vaccine. Emergency Use Authorization of the Pfizer-\nBioNTech", "probability": 0.0016260147094726562 }, { "start_logit": 8.859375, "end_logit": 12.453125, "text": " Sheet for Healthcare Providers Administer", "probability": 0.001285552978515625 }, { "start_logit": 9.7265625, "end_logit": 11.5703125, "text": "Fact Sheet for Healthcare Providers Administering Vaccine", "probability": 0.0012664794921875 }, { "start_logit": 9.2109375, "end_logit": 11.8203125, "text": " Pfizer-\nBioNTech", "probability": 0.0009708404541015625 }, { "start_logit": 8.859375, "end_logit": 12.0, "text": " Sheet for Healthcare", "probability": 0.0008172988891601562 }, { "start_logit": 6.05078125, "end_logit": -0.410400390625, "text": "", "probability": 0.0 } ], "100000000000000000009862": [ { "start_logit": 18.5, "end_logit": 9.1640625, "text": " London", "probability": 0.403076171875 }, { "start_logit": 17.296875, "end_logit": 9.1640625, "text": " third primary dose vaccination. London", "probability": 0.1229248046875 }, { "start_logit": 16.90625, "end_logit": 9.1640625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.0819091796875 }, { "start_logit": 17.296875, "end_logit": 8.734375, "text": " third primary dose vaccination", "probability": 0.07940673828125 }, { "start_logit": 16.90625, "end_logit": 8.734375, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination", "probability": 0.053680419921875 }, { "start_logit": 18.5, "end_logit": 6.91015625, "text": " London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.04248046875 }, { "start_logit": 16.90625, "end_logit": 8.2890625, "text": "Joint Committee on Vaccination and Immunisation", "probability": 0.034149169921875 }, { "start_logit": 18.5, "end_logit": 6.578125, "text": " London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021", "probability": 0.030609130859375 }, { "start_logit": 16.90625, "end_logit": 7.70703125, "text": "Joint Committee on Vaccination and Immunisation (JC", "probability": 0.0191497802734375 }, { "start_logit": 15.921875, "end_logit": 8.4921875, "text": " Kamar, N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.0156402587890625 }, { "start_logit": 15.875, "end_logit": 8.4921875, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01514434814453125 }, { "start_logit": 16.90625, "end_logit": 7.4140625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice", "probability": 0.0142364501953125 }, { "start_logit": 15.8046875, "end_logit": 8.4921875, "text": " N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01401519775390625 }, { "start_logit": 17.296875, "end_logit": 6.91015625, "text": " third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.01275634765625 }, { "start_logit": 17.296875, "end_logit": 6.765625, "text": " third", "probability": 0.01108551025390625 }, { "start_logit": 17.109375, "end_logit": 6.91015625, "text": "United Kingdom): Department of Health & Social Care; 1", "probability": 0.0105743408203125 }, { "start_logit": 14.84375, "end_logit": 9.1640625, "text": " Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.01041412353515625 }, { "start_logit": 15.875, "end_logit": 8.0625, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA-based vaccine in\nrecipients of a solid organ transplant. Infection Diseases 2021", "probability": 0.0097808837890625 }, { "start_logit": 16.90625, "end_logit": 7.0, "text": "Joint Committee", "probability": 0.00948333740234375 }, { "start_logit": 16.90625, "end_logit": 7.0, "text": "Joint Committee on Vaccination and Immunisation (JCVI", "probability": 0.00948333740234375 }, { "start_logit": 7.9609375, "end_logit": -1.005859375, "text": "", "probability": 0.0 } ], "100000000000000000009863": [ { "start_logit": 18.5, "end_logit": 9.1640625, "text": " London", "probability": 0.4013671875 }, { "start_logit": 17.3125, "end_logit": 9.1640625, "text": " third primary dose vaccination. London", "probability": 0.12237548828125 }, { "start_logit": 17.3125, "end_logit": 8.7421875, "text": " third primary dose vaccination", "probability": 0.08148193359375 }, { "start_logit": 16.90625, "end_logit": 9.1640625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.08148193359375 }, { "start_logit": 16.90625, "end_logit": 8.7421875, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination", "probability": 0.0543212890625 }, { "start_logit": 18.5, "end_logit": 6.9140625, "text": " London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.04229736328125 }, { "start_logit": 16.90625, "end_logit": 8.2890625, "text": "Joint Committee on Vaccination and Immunisation", "probability": 0.03399658203125 }, { "start_logit": 18.5, "end_logit": 6.59375, "text": " London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021", "probability": 0.0309295654296875 }, { "start_logit": 16.90625, "end_logit": 7.69921875, "text": "Joint Committee on Vaccination and Immunisation (JC", "probability": 0.019073486328125 }, { "start_logit": 15.9140625, "end_logit": 8.4921875, "text": " Kamar, N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01556396484375 }, { "start_logit": 15.875, "end_logit": 8.4921875, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01507568359375 }, { "start_logit": 16.90625, "end_logit": 7.4140625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice", "probability": 0.01416778564453125 }, { "start_logit": 15.8125, "end_logit": 8.4921875, "text": " N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01416778564453125 }, { "start_logit": 17.3125, "end_logit": 6.9140625, "text": " third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.0128936767578125 }, { "start_logit": 17.3125, "end_logit": 6.76953125, "text": " third", "probability": 0.01120758056640625 }, { "start_logit": 17.109375, "end_logit": 6.9140625, "text": "United Kingdom): Department of Health & Social Care; 1", "probability": 0.01068878173828125 }, { "start_logit": 14.84375, "end_logit": 9.1640625, "text": " Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.01036834716796875 }, { "start_logit": 15.875, "end_logit": 8.046875, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA-based vaccine in\nrecipients of a solid organ transplant. Infection Diseases 2021", "probability": 0.00959014892578125 }, { "start_logit": 17.3125, "end_logit": 6.59375, "text": " third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021", "probability": 0.00943756103515625 }, { "start_logit": 16.90625, "end_logit": 7.0, "text": "Joint Committee on Vaccination and Immunisation (JCVI", "probability": 0.00943756103515625 }, { "start_logit": 7.92578125, "end_logit": -1.0029296875, "text": "", "probability": 0.0 } ], "100000000000000000009868": [ { "start_logit": 18.5, "end_logit": 9.1640625, "text": " London", "probability": 0.4013671875 }, { "start_logit": 17.3125, "end_logit": 9.1640625, "text": " third primary dose vaccination. London", "probability": 0.12237548828125 }, { "start_logit": 17.3125, "end_logit": 8.7421875, "text": " third primary dose vaccination", "probability": 0.08148193359375 }, { "start_logit": 16.90625, "end_logit": 9.1640625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.08148193359375 }, { "start_logit": 16.90625, "end_logit": 8.7421875, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination", "probability": 0.0543212890625 }, { "start_logit": 18.5, "end_logit": 6.9140625, "text": " London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.04229736328125 }, { "start_logit": 16.90625, "end_logit": 8.2890625, "text": "Joint Committee on Vaccination and Immunisation", "probability": 0.03399658203125 }, { "start_logit": 18.5, "end_logit": 6.59375, "text": " London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021", "probability": 0.0309295654296875 }, { "start_logit": 16.90625, "end_logit": 7.69921875, "text": "Joint Committee on Vaccination and Immunisation (JC", "probability": 0.019073486328125 }, { "start_logit": 15.9140625, "end_logit": 8.4921875, "text": " Kamar, N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01556396484375 }, { "start_logit": 15.875, "end_logit": 8.4921875, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01507568359375 }, { "start_logit": 16.90625, "end_logit": 7.4140625, "text": "Joint Committee on Vaccination and Immunisation (JCVI) advice", "probability": 0.01416778564453125 }, { "start_logit": 15.8125, "end_logit": 8.4921875, "text": " N., Abravanel, F., Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA", "probability": 0.01416778564453125 }, { "start_logit": 17.3125, "end_logit": 6.9140625, "text": " third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1", "probability": 0.0128936767578125 }, { "start_logit": 17.3125, "end_logit": 6.76953125, "text": " third", "probability": 0.01120758056640625 }, { "start_logit": 17.109375, "end_logit": 6.9140625, "text": "United Kingdom): Department of Health & Social Care; 1", "probability": 0.01068878173828125 }, { "start_logit": 14.84375, "end_logit": 9.1640625, "text": " Committee on Vaccination and Immunisation (JCVI) advice on third primary dose vaccination. London", "probability": 0.01036834716796875 }, { "start_logit": 15.875, "end_logit": 8.046875, "text": " Marion O. Assessment of 4 doses of SARS-CoV-2 messenger RNA-based vaccine in\nrecipients of a solid organ transplant. Infection Diseases 2021", "probability": 0.00959014892578125 }, { "start_logit": 17.3125, "end_logit": 6.59375, "text": " third primary dose vaccination. London\n(United Kingdom): Department of Health & Social Care; 1 Sept 2021", "probability": 0.00943756103515625 }, { "start_logit": 16.90625, "end_logit": 7.0, "text": "Joint Committee on Vaccination and Immunisation (JCVI", "probability": 0.00943756103515625 }, { "start_logit": 7.8828125, "end_logit": -1.052734375, "text": "", "probability": 0.0 } ], "100000000000000000009869": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999983177355 }, { "start_logit": -30.09375, "end_logit": 9.890625, "text": "", "probability": 1.6822645551891657e-09 } ], "100000000000000000009871": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999984441597 }, { "start_logit": -30.5, "end_logit": 10.21875, "text": "", "probability": 1.5558403775790826e-09 } ], "100000000000000000009873": [ { "start_logit": 10.7890625, "end_logit": 22.546875, "text": "K", "probability": 1.0 }, { "start_logit": -30.875, "end_logit": 11.84375, "text": "", "probability": 0.0 } ], "100000000000000000009876": [ { "start_logit": 22.9375, "end_logit": 20.078125, "text": " BNT162b2", "probability": 0.7900390625 }, { "start_logit": 22.9375, "end_logit": 17.609375, "text": " BNT162b2 booster in BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162b2", "probability": 0.06903076171875 }, { "start_logit": 22.9375, "end_logit": 17.515625, "text": " BNT162b2 booster", "probability": 0.0609130859375 }, { "start_logit": 22.9375, "end_logit": 17.25, "text": " BNT162", "probability": 0.047454833984375 }, { "start_logit": 22.9375, "end_logit": 16.03125, "text": " BNT162b2 booster in BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162b2 vaccination", "probability": 0.0140228271484375 }, { "start_logit": 22.9375, "end_logit": 15.3046875, "text": " BNT", "probability": 0.0068359375 }, { "start_logit": 22.9375, "end_logit": 14.8203125, "text": " BNT162b2 booster in BBIB", "probability": 0.004146575927734375 }, { "start_logit": 22.9375, "end_logit": 14.421875, "text": " BNT162b2 booster in BBIBP", "probability": 0.002849578857421875 }, { "start_logit": 22.9375, "end_logit": 14.0, "text": " BNT162b2 booster in BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162", "probability": 0.0018396377563476562 }, { "start_logit": 18.640625, "end_logit": 17.609375, "text": " BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162b2", "probability": 0.0009255409240722656 }, { "start_logit": 15.90625, "end_logit": 20.078125, "text": "Immunogenicity and reactogenicity of BNT162b2", "probability": 0.0007205009460449219 }, { "start_logit": 17.90625, "end_logit": 17.609375, "text": "CorV-vaccinated individuals compared with homologous BNT162b2", "probability": 0.00043702125549316406 }, { "start_logit": 17.421875, "end_logit": 17.609375, "text": " BNT162b2", "probability": 0.0002734661102294922 }, { "start_logit": 18.640625, "end_logit": 16.03125, "text": " BBIBP-\nCorV-vaccinated individuals compared with homologous BNT162b2 vaccination", "probability": 0.0001938343048095703 }, { "start_logit": 17.90625, "end_logit": 16.03125, "text": "CorV-vaccinated individuals compared with homologous BNT162b2 vaccination", "probability": 9.161233901977539e-05 }, { "start_logit": 16.109375, "end_logit": 17.609375, "text": "\nCorV-vaccinated individuals compared with homologous BNT162b2", "probability": 7.361173629760742e-05 }, { "start_logit": 18.640625, "end_logit": 14.8203125, "text": " BBIB", "probability": 5.733966827392578e-05 }, { "start_logit": 17.578125, "end_logit": 15.8828125, "text": " Lebanon. Vaccine 2021", "probability": 5.733966827392578e-05 }, { "start_logit": 15.90625, "end_logit": 17.5625, "text": "Immunogenicity and reactogenicity", "probability": 5.733966827392578e-05 }, { "start_logit": 17.421875, "end_logit": 16.03125, "text": " BNT162b2 vaccination", "probability": 5.555152893066406e-05 }, { "start_logit": 6.65234375, "end_logit": -0.11212158203125, "text": "", "probability": 0.0 } ], "100000000000000000009884": [ { "start_logit": 16.828125, "end_logit": 9.609375, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness", "probability": 0.220703125 }, { "start_logit": 16.828125, "end_logit": 8.8125, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.0994873046875 }, { "start_logit": 16.0625, "end_logit": 9.4609375, "text": " 2021", "probability": 0.08917236328125 }, { "start_logit": 16.046875, "end_logit": 9.4609375, "text": " McMaster University; 2021", "probability": 0.08642578125 }, { "start_logit": 16.03125, "end_logit": 9.4609375, "text": " Hamilton (ON): McMaster University; 2021", "probability": 0.08642578125 }, { "start_logit": 16.828125, "end_logit": 8.5, "text": "Rapid", "probability": 0.07281494140625 }, { "start_logit": 15.53125, "end_logit": 9.4609375, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.05242919921875 }, { "start_logit": 16.828125, "end_logit": 7.9609375, "text": "Rap", "probability": 0.0421142578125 }, { "start_logit": 16.828125, "end_logit": 7.82421875, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19", "probability": 0.03717041015625 }, { "start_logit": 15.109375, "end_logit": 9.4609375, "text": "COVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.033843994140625 }, { "start_logit": 15.53125, "end_logit": 8.8125, "text": " COVID-19 vaccines", "probability": 0.027191162109375 }, { "start_logit": 16.828125, "end_logit": 7.41796875, "text": "Rapid Review", "probability": 0.0247650146484375 }, { "start_logit": 14.6484375, "end_logit": 9.609375, "text": " What is the ongoing\neffectiveness", "probability": 0.0247650146484375 }, { "start_logit": 14.5, "end_logit": 9.609375, "text": " Review Update 1: What is the ongoing\neffectiveness", "probability": 0.021514892578125 }, { "start_logit": 15.53125, "end_logit": 8.3046875, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19", "probability": 0.0164947509765625 }, { "start_logit": 16.828125, "end_logit": 7.0, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity", "probability": 0.0162506103515625 }, { "start_logit": 16.828125, "end_logit": 6.8515625, "text": "Rapid Review Update 1:", "probability": 0.01409912109375 }, { "start_logit": 13.9453125, "end_logit": 9.609375, "text": " 1: What is the ongoing\neffectiveness", "probability": 0.012451171875 }, { "start_logit": 14.6484375, "end_logit": 8.8125, "text": " What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.0113372802734375 }, { "start_logit": 16.828125, "end_logit": 6.61328125, "text": "Rapid Review Update", "probability": 0.010986328125 }, { "start_logit": 8.0078125, "end_logit": -1.158203125, "text": "", "probability": 0.0 } ], "100000000000000000009885": [ { "start_logit": 16.828125, "end_logit": 9.609375, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness", "probability": 0.2213134765625 }, { "start_logit": 16.828125, "end_logit": 8.8125, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.0997314453125 }, { "start_logit": 16.0625, "end_logit": 9.4609375, "text": " McMaster University; 2021", "probability": 0.08941650390625 }, { "start_logit": 16.046875, "end_logit": 9.4609375, "text": " Hamilton (ON): McMaster University; 2021", "probability": 0.086669921875 }, { "start_logit": 16.046875, "end_logit": 9.4609375, "text": " 2021", "probability": 0.086669921875 }, { "start_logit": 16.828125, "end_logit": 8.5, "text": "Rapid", "probability": 0.072998046875 }, { "start_logit": 15.515625, "end_logit": 9.4609375, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.050933837890625 }, { "start_logit": 16.828125, "end_logit": 7.9609375, "text": "Rap", "probability": 0.042205810546875 }, { "start_logit": 16.828125, "end_logit": 7.80859375, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19", "probability": 0.03668212890625 }, { "start_logit": 15.1015625, "end_logit": 9.4609375, "text": "COVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.033935546875 }, { "start_logit": 15.515625, "end_logit": 8.8125, "text": " COVID-19 vaccines", "probability": 0.0268402099609375 }, { "start_logit": 16.828125, "end_logit": 7.41796875, "text": "Rapid Review", "probability": 0.0248260498046875 }, { "start_logit": 14.6484375, "end_logit": 9.609375, "text": " What is the ongoing\neffectiveness", "probability": 0.0248260498046875 }, { "start_logit": 14.5, "end_logit": 9.609375, "text": " Review Update 1: What is the ongoing\neffectiveness", "probability": 0.0215606689453125 }, { "start_logit": 15.515625, "end_logit": 8.3203125, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19", "probability": 0.01654052734375 }, { "start_logit": 16.828125, "end_logit": 7.0, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity", "probability": 0.0162811279296875 }, { "start_logit": 16.828125, "end_logit": 6.83984375, "text": "Rapid Review Update 1:", "probability": 0.01392364501953125 }, { "start_logit": 13.953125, "end_logit": 9.609375, "text": " 1: What is the ongoing\neffectiveness", "probability": 0.012481689453125 }, { "start_logit": 14.6484375, "end_logit": 8.8125, "text": " What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.0113677978515625 }, { "start_logit": 16.828125, "end_logit": 6.61328125, "text": "Rapid Review Update", "probability": 0.011016845703125 }, { "start_logit": 7.98046875, "end_logit": -1.177734375, "text": "", "probability": 0.0 } ], "100000000000000000009886": [ { "start_logit": 16.828125, "end_logit": 9.6015625, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness", "probability": 0.221435546875 }, { "start_logit": 16.828125, "end_logit": 8.8125, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.09979248046875 }, { "start_logit": 16.046875, "end_logit": 9.4609375, "text": " 2021", "probability": 0.08673095703125 }, { "start_logit": 16.046875, "end_logit": 9.4609375, "text": " McMaster University; 2021", "probability": 0.08673095703125 }, { "start_logit": 16.03125, "end_logit": 9.4609375, "text": " Hamilton (ON): McMaster University; 2021", "probability": 0.08673095703125 }, { "start_logit": 16.828125, "end_logit": 8.5, "text": "Rapid", "probability": 0.07305908203125 }, { "start_logit": 15.5234375, "end_logit": 9.4609375, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.051788330078125 }, { "start_logit": 16.828125, "end_logit": 7.9609375, "text": "Rap", "probability": 0.042266845703125 }, { "start_logit": 16.828125, "end_logit": 7.8125, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19", "probability": 0.036712646484375 }, { "start_logit": 15.1171875, "end_logit": 9.4609375, "text": "COVID-19 infection?. Hamilton (ON): McMaster University; 2021", "probability": 0.03448486328125 }, { "start_logit": 15.5234375, "end_logit": 8.8125, "text": " COVID-19 vaccines", "probability": 0.02728271484375 }, { "start_logit": 16.828125, "end_logit": 7.41796875, "text": "Rapid Review", "probability": 0.02484130859375 }, { "start_logit": 14.6484375, "end_logit": 9.6015625, "text": " What is the ongoing\neffectiveness", "probability": 0.02484130859375 }, { "start_logit": 14.5, "end_logit": 9.6015625, "text": " Review Update 1: What is the ongoing\neffectiveness", "probability": 0.021240234375 }, { "start_logit": 15.5234375, "end_logit": 8.3203125, "text": " COVID-19 vaccines in persons who have had a prior, confirmed\nCOVID-19", "probability": 0.0165557861328125 }, { "start_logit": 16.828125, "end_logit": 6.99609375, "text": "Rapid Review Update 1: What is the ongoing\neffectiveness, immunogenicity", "probability": 0.01629638671875 }, { "start_logit": 16.828125, "end_logit": 6.83984375, "text": "Rapid Review Update 1:", "probability": 0.01393890380859375 }, { "start_logit": 13.953125, "end_logit": 9.6015625, "text": " 1: What is the ongoing\neffectiveness", "probability": 0.0124969482421875 }, { "start_logit": 16.828125, "end_logit": 6.6328125, "text": "Rapid Review Update", "probability": 0.01137542724609375 }, { "start_logit": 14.6484375, "end_logit": 8.8125, "text": " What is the ongoing\neffectiveness, immunogenicity, and safety of COVID-19 vaccines", "probability": 0.01137542724609375 }, { "start_logit": 8.1015625, "end_logit": -1.1552734375, "text": "", "probability": 0.0 } ], "100000000000000000009890": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999945695834 }, { "start_logit": -33.25, "end_logit": 14.2109375, "text": "", "probability": 5.4304164837773595e-09 } ], "100000000000000000009892": [ { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 28.953125, "text": "do", "probability": 0.07568359375 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 25.4375, "text": "doi:", "probability": 0.00225067138671875 }, { "start_logit": -33.21875, "end_logit": 14.2109375, "text": "", "probability": 5.960464477539063e-08 } ], "100000000000000000009893": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.9999999940358542 }, { "start_logit": -33.21875, "end_logit": 14.28125, "text": "", "probability": 5.964145726632109e-09 } ], "100000000000000000009901": [ { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 28.953125, "text": "do", "probability": 0.05535888671875 }, { "start_logit": -33.4375, "end_logit": 25.4375, "text": "doi:", "probability": 0.0016460418701171875 }, { "start_logit": -33.4375, "end_logit": 25.4375, "text": "doi:", "probability": 0.0016460418701171875 }, { "start_logit": -33.4375, "end_logit": 14.203125, "text": "", "probability": 0.0 } ], "100000000000000000009902": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0014214043524267083 }, { "start_logit": 7.33203125, "end_logit": -0.77685546875, "text": "", "probability": 0.9985785956475733 } ], "100000000000000000009904": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012843081201339697 }, { "start_logit": 7.4765625, "end_logit": -0.822265625, "text": "", "probability": 0.9987156918798661 } ], "100000000000000000009905": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00131472456761498 }, { "start_logit": 7.4609375, "end_logit": -0.830078125, "text": "", "probability": 0.9986852754323851 } ], "100000000000000000009910": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012793074828344202 }, { "start_logit": 7.02734375, "end_logit": -0.36669921875, "text": "", "probability": 0.9987206925171654 } ], "100000000000000000009912": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.01953125, "end_logit": -0.346435546875, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000009913": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.006241259229821674 }, { "start_logit": 5.33203125, "end_logit": -0.260498046875, "text": "", "probability": 0.9937587407701782 } ], "100000000000000000009914": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.006073934440886245 }, { "start_logit": 5.37109375, "end_logit": -0.272216796875, "text": "", "probability": 0.9939260655591138 } ], "100000000000000000009917": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0062170781422503756 }, { "start_logit": 5.359375, "end_logit": -0.28515625, "text": "", "probability": 0.9937829218577495 } ], "100000000000000000009919": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016356753292389016 }, { "start_logit": 6.95703125, "end_logit": -0.54345703125, "text": "", "probability": 0.998364324670761 } ], "100000000000000000009920": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001700722411435288 }, { "start_logit": 6.9296875, "end_logit": -0.5546875, "text": "", "probability": 0.9982992775885648 } ], "100000000000000000009923": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 6.84765625, "end_logit": -0.609375, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000009926": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019342611032703307 }, { "start_logit": 6.59765625, "end_logit": -0.349853515625, "text": "", "probability": 0.9980657388967297 } ], "100000000000000000009933": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002305125202793809 }, { "start_logit": 6.38671875, "end_logit": -0.317626953125, "text": "", "probability": 0.9976948747972061 } ], "100000000000000000009938": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012160416047592268 }, { "start_logit": 7.6328125, "end_logit": -0.92041015625, "text": "", "probability": 0.9987839583952408 } ], "100000000000000000009939": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.578125, "end_logit": -0.904296875, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000009944": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00202690008046383 }, { "start_logit": 7.03125, "end_logit": -0.83154296875, "text": "", "probability": 0.9979730999195362 } ], "100000000000000000009945": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0021912406363963407 }, { "start_logit": 6.94140625, "end_logit": -0.8212890625, "text": "", "probability": 0.9978087593636037 } ], "100000000000000000009948": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0020829707830458 }, { "start_logit": 7.1171875, "end_logit": -0.94384765625, "text": "", "probability": 0.9979170292169542 } ], "100000000000000000009949": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019494021275301952 }, { "start_logit": 7.19921875, "end_logit": -0.95947265625, "text": "", "probability": 0.9980505978724697 } ], "100000000000000000009952": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002123966441797725 }, { "start_logit": 7.12109375, "end_logit": -0.96728515625, "text": "", "probability": 0.9978760335582023 } ], "100000000000000000009953": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001874861720261248 }, { "start_logit": 7.25390625, "end_logit": -0.9765625, "text": "", "probability": 0.9981251382797387 } ], "100000000000000000009954": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012065897122463891 }, { "start_logit": 7.1015625, "end_logit": -0.380859375, "text": "", "probability": 0.9987934102877537 } ], "100000000000000000009960": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0022430878512891728 }, { "start_logit": 6.33203125, "end_logit": -0.2340087890625, "text": "", "probability": 0.9977569121487109 } ], "100000000000000000009961": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0023596606820630445 }, { "start_logit": 6.31640625, "end_logit": -0.267822265625, "text": "", "probability": 0.9976403393179369 } ], "100000000000000000009963": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001987774212383911 }, { "start_logit": 7.37109375, "end_logit": -1.1533203125, "text": "", "probability": 0.998012225787616 } ], "100000000000000000009968": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0019117693602301454 }, { "start_logit": 7.51953125, "end_logit": -1.2626953125, "text": "", "probability": 0.9980882306397698 } ], "100000000000000000009973": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010817152527255937 }, { "start_logit": 7.21484375, "end_logit": -0.385498046875, "text": "", "probability": 0.9989182847472744 } ], "100000000000000000009975": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0010566838241698937 }, { "start_logit": 7.20703125, "end_logit": -0.354248046875, "text": "", "probability": 0.9989433161758301 } ], "100000000000000000009977": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0012644219446392272 }, { "start_logit": 7.125, "end_logit": -0.4541015625, "text": "", "probability": 0.9987355780553607 } ], "100000000000000000009979": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0027469009484408103 }, { "start_logit": 6.99609375, "end_logit": -1.1005859375, "text": "", "probability": 0.9972530990515591 } ], "100000000000000000009985": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0015608892178478949 }, { "start_logit": 7.26953125, "end_logit": -0.80712890625, "text": "", "probability": 0.9984391107821522 } ], "100000000000000000009988": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001460749574951026 }, { "start_logit": 7.32421875, "end_logit": -0.79541015625, "text": "", "probability": 0.998539250425049 } ], "100000000000000000009994": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004700060535050779 }, { "start_logit": 5.92578125, "end_logit": -0.56884765625, "text": "", "probability": 0.9952999394649492 } ], "100000000000000000009995": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004792316673138821 }, { "start_logit": 5.91796875, "end_logit": -0.583984375, "text": "", "probability": 0.995207683326861 } ], "100000000000000000009998": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016549242441240368 }, { "start_logit": 7.19140625, "end_logit": -0.78759765625, "text": "", "probability": 0.9983450757558759 } ], "100000000000000000010004": [ { "start_logit": 19.375, "end_logit": 10.0, "text": " The myocarditis or pericarditis", "probability": 0.7900390625 }, { "start_logit": 19.375, "end_logit": 8.15625, "text": " The myocarditis", "probability": 0.125 }, { "start_logit": 19.375, "end_logit": 6.71484375, "text": " The", "probability": 0.0296783447265625 }, { "start_logit": 15.96875, "end_logit": 10.0, "text": "\n\u25cb The myocarditis or pericarditis", "probability": 0.026214599609375 }, { "start_logit": 15.1171875, "end_logit": 10.0, "text": "\u25cb The myocarditis or pericarditis", "probability": 0.0112762451171875 }, { "start_logit": 14.8046875, "end_logit": 10.0, "text": " COVID-19\nvaccination may include:\n\u25cb The myocarditis or pericarditis", "probability": 0.00824737548828125 }, { "start_logit": 15.96875, "end_logit": 8.15625, "text": "\n\u25cb The myocarditis", "probability": 0.004146575927734375 }, { "start_logit": 15.1171875, "end_logit": 8.15625, "text": "\u25cb The myocarditis", "probability": 0.0017824172973632812 }, { "start_logit": 14.8046875, "end_logit": 8.15625, "text": " COVID-19\nvaccination may include:\n\u25cb The myocarditis", "probability": 0.00130462646484375 }, { "start_logit": 15.96875, "end_logit": 6.71484375, "text": "\n\u25cb The", "probability": 0.0009851455688476562 }, { "start_logit": 15.1171875, "end_logit": 6.71484375, "text": "\u25cb The", "probability": 0.0004169940948486328 }, { "start_logit": 14.8046875, "end_logit": 6.71484375, "text": " COVID-19\nvaccination may include:\n\u25cb The", "probability": 0.00030493736267089844 }, { "start_logit": 14.8046875, "end_logit": 6.6015625, "text": " COVID-19", "probability": 0.0002734661102294922 }, { "start_logit": 7.1953125, "end_logit": -1.109375, "text": "", "probability": 0.0 } ], "100000000000000000010009": [ { "start_logit": 19.375, "end_logit": 10.0234375, "text": " The myocarditis or pericarditis", "probability": 0.71728515625 }, { "start_logit": 19.375, "end_logit": 8.15625, "text": " The myocarditis", "probability": 0.10992431640625 }, { "start_logit": 19.375, "end_logit": 7.15234375, "text": " The myocarditis or pericarditis was considered unrelated to vaccination with Moderna, Novavax", "probability": 0.04046630859375 }, { "start_logit": 19.375, "end_logit": 6.75, "text": " The myocarditis or pericarditis was considered unrelated to vaccination with Moderna", "probability": 0.0269317626953125 }, { "start_logit": 19.375, "end_logit": 6.71484375, "text": " The", "probability": 0.026123046875 }, { "start_logit": 19.375, "end_logit": 6.68359375, "text": " The myocarditis or pericarditis was considered unrelated to vaccination", "probability": 0.0253143310546875 }, { "start_logit": 15.9609375, "end_logit": 10.0234375, "text": "\n\u25cb The myocarditis or pericarditis", "probability": 0.0234222412109375 }, { "start_logit": 15.1015625, "end_logit": 10.0234375, "text": "\u25cb The myocarditis or pericarditis", "probability": 0.00991058349609375 }, { "start_logit": 14.8046875, "end_logit": 10.0234375, "text": " COVID-19\nvaccination may include:\n\u25cb The myocarditis or pericarditis", "probability": 0.0073699951171875 }, { "start_logit": 15.9609375, "end_logit": 8.15625, "text": "\n\u25cb The myocarditis", "probability": 0.0036468505859375 }, { "start_logit": 15.1015625, "end_logit": 8.15625, "text": "\u25cb The myocarditis", "probability": 0.0015211105346679688 }, { "start_logit": 15.9609375, "end_logit": 7.15234375, "text": "\n\u25cb The myocarditis or pericarditis was considered unrelated to vaccination with Moderna, Novavax", "probability": 0.0013208389282226562 }, { "start_logit": 15.9453125, "end_logit": 7.15234375, "text": " Moderna, Novavax", "probability": 0.001300811767578125 }, { "start_logit": 14.8046875, "end_logit": 8.15625, "text": " COVID-19\nvaccination may include:\n\u25cb The myocarditis", "probability": 0.0011472702026367188 }, { "start_logit": 15.9609375, "end_logit": 6.75, "text": "\n\u25cb The myocarditis or pericarditis was considered unrelated to vaccination with Moderna", "probability": 0.0008935928344726562 }, { "start_logit": 15.9453125, "end_logit": 6.75, "text": " Moderna", "probability": 0.0008664131164550781 }, { "start_logit": 15.9609375, "end_logit": 6.71484375, "text": "\n\u25cb The", "probability": 0.0008525848388671875 }, { "start_logit": 15.9609375, "end_logit": 6.68359375, "text": "\n\u25cb The myocarditis or pericarditis was considered unrelated to vaccination", "probability": 0.0008268356323242188 }, { "start_logit": 15.1015625, "end_logit": 7.15234375, "text": "\u25cb The myocarditis or pericarditis was considered unrelated to vaccination with Moderna, Novavax", "probability": 0.0005593299865722656 }, { "start_logit": 14.984375, "end_logit": 7.15234375, "text": " Novavax", "probability": 0.0005011558532714844 }, { "start_logit": 7.2578125, "end_logit": -1.095703125, "text": "", "probability": 0.0 } ], "100000000000000000010014": [ { "start_logit": 15.9140625, "end_logit": 8.3828125, "text": "History", "probability": 1.0 }, { "start_logit": 7.34765625, "end_logit": -0.82568359375, "text": "", "probability": 0.0 } ], "100000000000000000010015": [ { "start_logit": 16.90625, "end_logit": 9.921875, "text": " MIS-C\n(children) or MIS-A", "probability": 0.1864013671875 }, { "start_logit": 16.765625, "end_logit": 9.921875, "text": "children) or MIS-A", "probability": 0.1619873046875 }, { "start_logit": 16.59375, "end_logit": 9.921875, "text": " MIS-A", "probability": 0.1363525390625 }, { "start_logit": 16.90625, "end_logit": 9.078125, "text": " MIS-C\n(children", "probability": 0.0802001953125 }, { "start_logit": 16.765625, "end_logit": 9.078125, "text": "children", "probability": 0.0697021484375 }, { "start_logit": 15.9140625, "end_logit": 9.921875, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS-C\n(children) or MIS-A", "probability": 0.0697021484375 }, { "start_logit": 16.90625, "end_logit": 8.7109375, "text": " MIS-C", "probability": 0.055999755859375 }, { "start_logit": 15.515625, "end_logit": 9.921875, "text": " multisystem\ninflammatory\nsyndrome; either MIS-C\n(children) or MIS-A", "probability": 0.046417236328125 }, { "start_logit": 15.9140625, "end_logit": 9.078125, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS-C\n(children", "probability": 0.02996826171875 }, { "start_logit": 16.90625, "end_logit": 7.984375, "text": " MIS", "probability": 0.02685546875 }, { "start_logit": 15.9140625, "end_logit": 8.7109375, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS-C", "probability": 0.020599365234375 }, { "start_logit": 15.515625, "end_logit": 9.078125, "text": " multisystem\ninflammatory\nsyndrome; either MIS-C\n(children", "probability": 0.01995849609375 }, { "start_logit": 16.90625, "end_logit": 7.38671875, "text": " MIS-C\n(children) or MIS", "probability": 0.01483917236328125 }, { "start_logit": 15.9140625, "end_logit": 8.3828125, "text": "History", "probability": 0.01483917236328125 }, { "start_logit": 15.515625, "end_logit": 8.7109375, "text": " multisystem\ninflammatory\nsyndrome; either MIS-C", "probability": 0.01372528076171875 }, { "start_logit": 16.765625, "end_logit": 7.38671875, "text": "children) or MIS", "probability": 0.0128936767578125 }, { "start_logit": 15.9140625, "end_logit": 8.09375, "text": "History of multisystem\ninflammatory\nsyndrome", "probability": 0.01102447509765625 }, { "start_logit": 16.59375, "end_logit": 7.38671875, "text": " MIS", "probability": 0.0108489990234375 }, { "start_logit": 15.9140625, "end_logit": 7.984375, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS", "probability": 0.010040283203125 }, { "start_logit": 15.515625, "end_logit": 8.09375, "text": " multisystem\ninflammatory\nsyndrome", "probability": 0.0074615478515625 }, { "start_logit": 7.421875, "end_logit": -0.82177734375, "text": "", "probability": 0.0 } ], "100000000000000000010016": [ { "start_logit": 16.90625, "end_logit": 8.71875, "text": " MIS-C", "probability": 0.33447265625 }, { "start_logit": 16.90625, "end_logit": 7.98828125, "text": " MIS", "probability": 0.160400390625 }, { "start_logit": 15.9140625, "end_logit": 8.71875, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS-C", "probability": 0.123046875 }, { "start_logit": 15.9140625, "end_logit": 8.3828125, "text": "History", "probability": 0.08856201171875 }, { "start_logit": 15.515625, "end_logit": 8.71875, "text": " multisystem\ninflammatory\nsyndrome; either MIS-C", "probability": 0.083251953125 }, { "start_logit": 15.9140625, "end_logit": 8.09375, "text": "History of multisystem\ninflammatory\nsyndrome", "probability": 0.06585693359375 }, { "start_logit": 15.9140625, "end_logit": 7.98828125, "text": "History of multisystem\ninflammatory\nsyndrome; either MIS", "probability": 0.059967041015625 }, { "start_logit": 15.515625, "end_logit": 8.09375, "text": " multisystem\ninflammatory\nsyndrome", "probability": 0.044525146484375 }, { "start_logit": 15.515625, "end_logit": 7.98828125, "text": " multisystem\ninflammatory\nsyndrome; either MIS", "probability": 0.039947509765625 }, { "start_logit": 7.41015625, "end_logit": -0.837890625, "text": "", "probability": 0.0 } ], "100000000000000000010029": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.001796149154900369 }, { "start_logit": 7.09765625, "end_logit": -0.7763671875, "text": "", "probability": 0.9982038508450997 } ], "100000000000000000010032": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0030994155155094484 }, { "start_logit": 6.2109375, "end_logit": -0.437744140625, "text": "", "probability": 0.9969005844844906 } ], "100000000000000000010035": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0033504234148098383 }, { "start_logit": 6.15625, "end_logit": -0.461669921875, "text": "", "probability": 0.9966495765851902 } ], "100000000000000000010044": [ { "start_logit": 20.390625, "end_logit": 9.28125, "text": " https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html", "probability": 0.55615234375 }, { "start_logit": 18.5625, "end_logit": 8.6875, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue Gray", "probability": 0.049346923828125 }, { "start_logit": 19.125, "end_logit": 8.0625, "text": " 3 \u00b5g 0.2 mL NA NA\n5\u201311 years", "probability": 0.04638671875 }, { "start_logit": 18.4375, "end_logit": 8.6875, "text": " Dark blue Gray", "probability": 0.043548583984375 }, { "start_logit": 18.453125, "end_logit": 8.640625, "text": " Dark blue Gray", "probability": 0.042236328125 }, { "start_logit": 18.671875, "end_logit": 8.171875, "text": "Pfizer-BioNTech", "probability": 0.032867431640625 }, { "start_logit": 18.03125, "end_logit": 8.640625, "text": " Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL NA NA\n6-11 years Bivalent Dark blue Gray", "probability": 0.027679443359375 }, { "start_logit": 19.125, "end_logit": 7.3515625, "text": " 3 \u00b5g 0.2 mL", "probability": 0.022613525390625 }, { "start_logit": 18.171875, "end_logit": 8.1328125, "text": "Dilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n6 months\u20134 years", "probability": 0.0193328857421875 }, { "start_logit": 18.125, "end_logit": 8.171875, "text": "COVID-19 vaccine products currently approved or authorized in the United States\nPfizer-BioNTech", "probability": 0.0190277099609375 }, { "start_logit": 18.5625, "end_logit": 7.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue", "probability": 0.0167999267578125 }, { "start_logit": 18.671875, "end_logit": 7.43359375, "text": "Pfizer-BioNTech\n* Booster doses are only indicated for recipients 18 years and age and older", "probability": 0.015777587890625 }, { "start_logit": 18.4375, "end_logit": 7.61328125, "text": " Dark blue", "probability": 0.0148162841796875 }, { "start_logit": 18.1875, "end_logit": 7.859375, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19", "probability": 0.0148162841796875 }, { "start_logit": 18.5625, "end_logit": 7.43359375, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.01413726806640625 }, { "start_logit": 18.453125, "end_logit": 7.52734375, "text": " Dark blue", "probability": 0.0139312744140625 }, { "start_logit": 18.125, "end_logit": 7.859375, "text": "COVID-19", "probability": 0.0139312744140625 }, { "start_logit": 18.1875, "end_logit": 7.69921875, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19 vaccine products", "probability": 0.0126800537109375 }, { "start_logit": 18.125, "end_logit": 7.69921875, "text": "COVID-19 vaccine products", "probability": 0.01190948486328125 }, { "start_logit": 18.421875, "end_logit": 7.39453125, "text": " Monovalent Gray Gray No 30 \u00b5g 0.3 mL NA NA\n12 years and older Bivalent Gray Gray", "probability": 0.01172637939453125 }, { "start_logit": -34.125, "end_logit": 17.125, "text": "", "probability": 0.0 } ], "100000000000000000010052": [ { "start_logit": 20.390625, "end_logit": 9.28125, "text": " https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html", "probability": 0.6005859375 }, { "start_logit": 19.125, "end_logit": 8.0625, "text": " 3 \u00b5g 0.2 mL NA NA\n5\u201311 years", "probability": 0.050079345703125 }, { "start_logit": 18.453125, "end_logit": 8.640625, "text": " Dark blue Gray", "probability": 0.04559326171875 }, { "start_logit": 18.671875, "end_logit": 8.171875, "text": "Pfizer-BioNTech", "probability": 0.035491943359375 }, { "start_logit": 18.03125, "end_logit": 8.640625, "text": " Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL NA NA\n6-11 years Bivalent Dark blue Gray", "probability": 0.0298919677734375 }, { "start_logit": 19.125, "end_logit": 7.3515625, "text": " 3 \u00b5g 0.2 mL", "probability": 0.0244140625 }, { "start_logit": 18.171875, "end_logit": 8.1328125, "text": "Dilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n6 months\u20134 years", "probability": 0.0208740234375 }, { "start_logit": 18.125, "end_logit": 8.171875, "text": "COVID-19 vaccine products currently approved or authorized in the United States\nPfizer-BioNTech", "probability": 0.0205535888671875 }, { "start_logit": 18.5625, "end_logit": 7.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue", "probability": 0.0181427001953125 }, { "start_logit": 18.671875, "end_logit": 7.43359375, "text": "Pfizer-BioNTech\n* Booster doses are only indicated for recipients 18 years and age and older", "probability": 0.01702880859375 }, { "start_logit": 18.4375, "end_logit": 7.61328125, "text": " Dark blue", "probability": 0.0160064697265625 }, { "start_logit": 18.1875, "end_logit": 7.859375, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19", "probability": 0.0160064697265625 }, { "start_logit": 18.5625, "end_logit": 7.43359375, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.01526641845703125 }, { "start_logit": 18.453125, "end_logit": 7.52734375, "text": " Dark blue", "probability": 0.01503753662109375 }, { "start_logit": 18.125, "end_logit": 7.859375, "text": "COVID-19", "probability": 0.01503753662109375 }, { "start_logit": 18.1875, "end_logit": 7.69921875, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19 vaccine products", "probability": 0.01369476318359375 }, { "start_logit": 18.125, "end_logit": 7.69921875, "text": "COVID-19 vaccine products", "probability": 0.01285552978515625 }, { "start_logit": 18.421875, "end_logit": 7.39453125, "text": " Monovalent Gray Gray No 30 \u00b5g 0.3 mL NA NA\n12 years and older Bivalent Gray Gray", "probability": 0.012664794921875 }, { "start_logit": 18.421875, "end_logit": 7.25390625, "text": " Monovalent Gray Gray", "probability": 0.01099395751953125 }, { "start_logit": 18.03125, "end_logit": 7.52734375, "text": " Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL NA NA\n6-11 years Bivalent Dark blue", "probability": 0.009857177734375 }, { "start_logit": -31.078125, "end_logit": 13.203125, "text": "", "probability": 0.0 } ], "100000000000000000010053": [ { "start_logit": 20.390625, "end_logit": 9.28125, "text": " https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html", "probability": 0.55615234375 }, { "start_logit": 18.5625, "end_logit": 8.6875, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue Gray", "probability": 0.049346923828125 }, { "start_logit": 19.125, "end_logit": 8.0625, "text": " 3 \u00b5g 0.2 mL NA NA\n5\u201311 years", "probability": 0.04638671875 }, { "start_logit": 18.4375, "end_logit": 8.6875, "text": " Dark blue Gray", "probability": 0.043548583984375 }, { "start_logit": 18.453125, "end_logit": 8.640625, "text": " Dark blue Gray", "probability": 0.042236328125 }, { "start_logit": 18.671875, "end_logit": 8.171875, "text": "Pfizer-BioNTech", "probability": 0.032867431640625 }, { "start_logit": 18.03125, "end_logit": 8.640625, "text": " Monovalent Dark blue Purple No 50 \u00b5g 0.5 mL NA NA\n6-11 years Bivalent Dark blue Gray", "probability": 0.027679443359375 }, { "start_logit": 19.125, "end_logit": 7.3515625, "text": " 3 \u00b5g 0.2 mL", "probability": 0.022613525390625 }, { "start_logit": 18.171875, "end_logit": 8.1328125, "text": "Dilution\nrequired\nPrimary series Booster doses\nDose Injection volume Dose Injection volume\n6 months\u20134 years", "probability": 0.0193328857421875 }, { "start_logit": 18.125, "end_logit": 8.171875, "text": "COVID-19 vaccine products currently approved or authorized in the United States\nPfizer-BioNTech", "probability": 0.0190277099609375 }, { "start_logit": 18.5625, "end_logit": 7.61328125, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL NA NA\n12 years and older Bivalent Dark blue", "probability": 0.0167999267578125 }, { "start_logit": 18.671875, "end_logit": 7.43359375, "text": "Pfizer-BioNTech\n* Booster doses are only indicated for recipients 18 years and age and older", "probability": 0.015777587890625 }, { "start_logit": 18.4375, "end_logit": 7.61328125, "text": " Dark blue", "probability": 0.0148162841796875 }, { "start_logit": 18.1875, "end_logit": 7.859375, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19", "probability": 0.0148162841796875 }, { "start_logit": 18.5625, "end_logit": 7.43359375, "text": " Monovalent Red Light blue No 100 \u00b5g 0.5 mL", "probability": 0.01413726806640625 }, { "start_logit": 18.453125, "end_logit": 7.52734375, "text": " Dark blue", "probability": 0.0139312744140625 }, { "start_logit": 18.125, "end_logit": 7.859375, "text": "COVID-19", "probability": 0.0139312744140625 }, { "start_logit": 18.1875, "end_logit": 7.69921875, "text": "Summary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States\nCOVID-19 vaccine products", "probability": 0.0126800537109375 }, { "start_logit": 18.125, "end_logit": 7.69921875, "text": "COVID-19 vaccine products", "probability": 0.01190948486328125 }, { "start_logit": 18.421875, "end_logit": 7.39453125, "text": " Monovalent Gray Gray No 30 \u00b5g 0.3 mL NA NA\n12 years and older Bivalent Gray Gray", "probability": 0.01172637939453125 }, { "start_logit": -34.125, "end_logit": 17.125, "text": "", "probability": 0.0 } ], "100000000000000000010055": [ { "start_logit": 18.0, "end_logit": 8.25, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPre-vaccination counseling", "probability": 0.53173828125 }, { "start_logit": 18.0, "end_logit": 6.29296875, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19", "probability": 0.075439453125 }, { "start_logit": 18.0, "end_logit": 5.99609375, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPre-vaccination counsel", "probability": 0.0560302734375 }, { "start_logit": 16.625, "end_logit": 7.046875, "text": "COVID-19", "probability": 0.040374755859375 }, { "start_logit": 17.546875, "end_logit": 5.90234375, "text": " Interim", "probability": 0.032440185546875 }, { "start_logit": 16.203125, "end_logit": 7.16015625, "text": " guidance on respective record\nreview, scheduling and administration of Janssen", "probability": 0.0295257568359375 }, { "start_logit": 16.171875, "end_logit": 7.16015625, "text": "For guidance on respective record\nreview, scheduling and administration of Janssen", "probability": 0.02862548828125 }, { "start_logit": 16.203125, "end_logit": 7.07421875, "text": " guidance on respective record", "probability": 0.027313232421875 }, { "start_logit": 16.171875, "end_logit": 7.07421875, "text": "For guidance on respective record", "probability": 0.026458740234375 }, { "start_logit": 16.21875, "end_logit": 6.76171875, "text": "\n\u0083 Provide the vaccine-specific Fact Sheet for Recipients and Caregivers Pfizer-BioNTech", "probability": 0.020294189453125 }, { "start_logit": 16.625, "end_logit": 6.2578125, "text": "COVID-19 vaccination", "probability": 0.0181884765625 }, { "start_logit": 15.671875, "end_logit": 7.16015625, "text": " scheduling and administration of Janssen", "probability": 0.017364501953125 }, { "start_logit": 15.546875, "end_logit": 7.16015625, "text": "\nreview, scheduling and administration of Janssen", "probability": 0.01531982421875 }, { "start_logit": 16.203125, "end_logit": 6.453125, "text": " guidance on respective record\nreview, scheduling and administration of Janssen vaccine", "probability": 0.014617919921875 }, { "start_logit": 16.171875, "end_logit": 6.453125, "text": "For guidance on respective record\nreview, scheduling and administration of Janssen vaccine", "probability": 0.01416778564453125 }, { "start_logit": 15.4453125, "end_logit": 7.046875, "text": " COVID-19 vaccines\nCOVID-19", "probability": 0.01250457763671875 }, { "start_logit": 16.515625, "end_logit": 5.9609375, "text": " Appendix A\fSummary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States", "probability": 0.01212310791015625 }, { "start_logit": 16.015625, "end_logit": 6.29296875, "text": " 6 Months or Older at https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19", "probability": 0.01036834716796875 }, { "start_logit": 15.671875, "end_logit": 6.453125, "text": " scheduling and administration of Janssen vaccine", "probability": 0.0085906982421875 }, { "start_logit": 16.203125, "end_logit": 5.90234375, "text": " guidance on respective record\nreview, scheduling and administration of Janssen vaccine see Interim", "probability": 0.00846099853515625 }, { "start_logit": 8.84375, "end_logit": -1.2509765625, "text": "", "probability": 0.0 } ], "100000000000000000010058": [ { "start_logit": 18.0, "end_logit": 8.2578125, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPre-vaccination counseling", "probability": 0.53759765625 }, { "start_logit": 18.0, "end_logit": 6.2890625, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19", "probability": 0.07513427734375 }, { "start_logit": 18.0, "end_logit": 6.0, "text": " https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19-\nPre-vaccination counsel", "probability": 0.05670166015625 }, { "start_logit": 16.625, "end_logit": 7.046875, "text": "COVID-19", "probability": 0.04083251953125 }, { "start_logit": 17.5625, "end_logit": 5.8984375, "text": " Interim", "probability": 0.0333251953125 }, { "start_logit": 16.203125, "end_logit": 7.16796875, "text": " guidance on respective record\nreview, scheduling and administration of Janssen", "probability": 0.0303497314453125 }, { "start_logit": 16.171875, "end_logit": 7.16796875, "text": "For guidance on respective record\nreview, scheduling and administration of Janssen", "probability": 0.0294189453125 }, { "start_logit": 16.203125, "end_logit": 7.07421875, "text": " guidance on respective record", "probability": 0.027618408203125 }, { "start_logit": 16.171875, "end_logit": 7.07421875, "text": "For guidance on respective record", "probability": 0.026763916015625 }, { "start_logit": 16.625, "end_logit": 6.2578125, "text": "COVID-19 vaccination", "probability": 0.018402099609375 }, { "start_logit": 15.6796875, "end_logit": 7.16796875, "text": " scheduling and administration of Janssen", "probability": 0.0178375244140625 }, { "start_logit": 15.546875, "end_logit": 7.16796875, "text": "\nreview, scheduling and administration of Janssen", "probability": 0.0157470703125 }, { "start_logit": 16.203125, "end_logit": 6.4609375, "text": " guidance on respective record\nreview, scheduling and administration of Janssen vaccine", "probability": 0.0147857666015625 }, { "start_logit": 16.171875, "end_logit": 6.4609375, "text": "For guidance on respective record\nreview, scheduling and administration of Janssen vaccine", "probability": 0.0143280029296875 }, { "start_logit": 16.515625, "end_logit": 5.96484375, "text": " Appendix A\fSummary Document for\nInterim Clinical Considerations\nfor Use of COVID-19 Vaccines Currently Authorized or Approved in the United States", "probability": 0.012451171875 }, { "start_logit": 15.4375, "end_logit": 7.046875, "text": " COVID-19 vaccines\nCOVID-19", "probability": 0.012451171875 }, { "start_logit": 16.03125, "end_logit": 6.2890625, "text": " 6 Months or Older at https://www.cdc.gov/vaccines/covid-19/downloads/COVID-19", "probability": 0.01049041748046875 }, { "start_logit": 15.6796875, "end_logit": 6.4609375, "text": " scheduling and administration of Janssen vaccine", "probability": 0.00882720947265625 }, { "start_logit": 16.203125, "end_logit": 5.8984375, "text": " guidance on respective record\nreview, scheduling and administration of Janssen vaccine see Interim", "probability": 0.00843048095703125 }, { "start_logit": 15.4375, "end_logit": 6.65234375, "text": " COVID-19 vaccines", "probability": 0.00843048095703125 }, { "start_logit": 8.546875, "end_logit": -1.291015625, "text": "", "probability": 0.0 } ], "100000000000000000010060": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00740301408887263 }, { "start_logit": 5.53125, "end_logit": -0.634765625, "text": "", "probability": 0.9925969859111274 } ], "100000000000000000010063": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.007665874688645945 }, { "start_logit": 5.5625, "end_logit": -0.70068359375, "text": "", "probability": 0.9923341253113541 } ], "100000000000000000010067": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.007460643463940165 }, { "start_logit": 5.59765625, "end_logit": -0.70654296875, "text": "", "probability": 0.9925393565360598 } ], "100000000000000000010074": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016229670614688403 }, { "start_logit": 7.328125, "end_logit": -0.90625, "text": "", "probability": 0.9983770329385311 } ], "100000000000000000010076": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016229670614688403 }, { "start_logit": 7.25390625, "end_logit": -0.83056640625, "text": "", "probability": 0.9983770329385311 } ], "100000000000000000010078": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005685906935227819 }, { "start_logit": 6.015625, "end_logit": -0.849609375, "text": "", "probability": 0.9943140930647723 } ], "100000000000000000010079": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005620036400026994 }, { "start_logit": 6.09765625, "end_logit": -0.92236328125, "text": "", "probability": 0.9943799635999729 } ], "100000000000000000010080": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005554924703691103 }, { "start_logit": 6.0703125, "end_logit": -0.88232421875, "text": "", "probability": 0.994445075296309 } ], "100000000000000000010091": [ { "start_logit": 21.25, "end_logit": 9.875, "text": " Severe allergic reaction (e.g., anaphylaxis", "probability": 0.29541015625 }, { "start_logit": 21.25, "end_logit": 9.8515625, "text": " Severe allergic reaction", "probability": 0.286376953125 }, { "start_logit": 20.140625, "end_logit": 9.875, "text": " anaphylaxis", "probability": 0.09747314453125 }, { "start_logit": 19.890625, "end_logit": 9.4765625, "text": "MIS-A", "probability": 0.051361083984375 }, { "start_logit": 19.84375, "end_logit": 9.4765625, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS-A", "probability": 0.0482177734375 }, { "start_logit": 20.03125, "end_logit": 9.046875, "text": " AstraZeneca", "probability": 0.03814697265625 }, { "start_logit": 18.578125, "end_logit": 9.875, "text": "\n\u0083 Severe allergic reaction (e.g., anaphylaxis", "probability": 0.0204315185546875 }, { "start_logit": 18.578125, "end_logit": 9.8515625, "text": "\n\u0083 Severe allergic reaction", "probability": 0.020111083984375 }, { "start_logit": 20.03125, "end_logit": 8.34375, "text": " AstraZeneca)\u00a7\nPrecautions", "probability": 0.0188751220703125 }, { "start_logit": 19.84375, "end_logit": 8.28125, "text": "MIS-C", "probability": 0.01470184326171875 }, { "start_logit": 21.25, "end_logit": 6.86328125, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine", "probability": 0.0144805908203125 }, { "start_logit": 19.890625, "end_logit": 8.2109375, "text": "MIS", "probability": 0.014251708984375 }, { "start_logit": 19.84375, "end_logit": 8.2109375, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS", "probability": 0.013824462890625 }, { "start_logit": 20.03125, "end_logit": 7.921875, "text": " AstraZeneca)\u00a7\nPrecautions\n\u0083 History of anaphylaxis", "probability": 0.01239013671875 }, { "start_logit": 19.84375, "end_logit": 8.0625, "text": "MIS", "probability": 0.01181793212890625 }, { "start_logit": 19.5, "end_logit": 8.34375, "text": "Precautions", "probability": 0.01110076904296875 }, { "start_logit": 19.890625, "end_logit": 7.6328125, "text": "MIS-A)\n\u0083 History of an immediate (within 4 hours of exposure) non-severe allergic reaction", "probability": 0.00812530517578125 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19", "probability": 0.00787353515625 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., an", "probability": 0.00787353515625 }, { "start_logit": 19.5, "end_logit": 7.921875, "text": "Precautions\n\u0083 History of anaphylaxis", "probability": 0.007282257080078125 }, { "start_logit": 6.359375, "end_logit": -1.2255859375, "text": "", "probability": 0.0 } ], "100000000000000000010092": [ { "start_logit": 21.25, "end_logit": 9.875, "text": " Severe allergic reaction (e.g., anaphylaxis", "probability": 0.29541015625 }, { "start_logit": 21.25, "end_logit": 9.8515625, "text": " Severe allergic reaction", "probability": 0.286376953125 }, { "start_logit": 20.140625, "end_logit": 9.875, "text": " anaphylaxis", "probability": 0.09747314453125 }, { "start_logit": 19.890625, "end_logit": 9.4765625, "text": "MIS-A", "probability": 0.051361083984375 }, { "start_logit": 19.84375, "end_logit": 9.4765625, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS-A", "probability": 0.0482177734375 }, { "start_logit": 20.03125, "end_logit": 9.046875, "text": " AstraZeneca", "probability": 0.03814697265625 }, { "start_logit": 18.578125, "end_logit": 9.875, "text": "\n\u0083 Severe allergic reaction (e.g., anaphylaxis", "probability": 0.0204315185546875 }, { "start_logit": 18.578125, "end_logit": 9.8515625, "text": "\n\u0083 Severe allergic reaction", "probability": 0.020111083984375 }, { "start_logit": 20.03125, "end_logit": 8.34375, "text": " AstraZeneca)\u00a7\nPrecautions", "probability": 0.0188751220703125 }, { "start_logit": 19.84375, "end_logit": 8.28125, "text": "MIS-C", "probability": 0.01470184326171875 }, { "start_logit": 21.25, "end_logit": 6.86328125, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine", "probability": 0.0144805908203125 }, { "start_logit": 19.890625, "end_logit": 8.2109375, "text": "MIS", "probability": 0.014251708984375 }, { "start_logit": 19.84375, "end_logit": 8.2109375, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS", "probability": 0.013824462890625 }, { "start_logit": 20.03125, "end_logit": 7.921875, "text": " AstraZeneca)\u00a7\nPrecautions\n\u0083 History of anaphylaxis", "probability": 0.01239013671875 }, { "start_logit": 19.84375, "end_logit": 8.0625, "text": "MIS", "probability": 0.01181793212890625 }, { "start_logit": 19.5, "end_logit": 8.34375, "text": "Precautions", "probability": 0.01110076904296875 }, { "start_logit": 19.890625, "end_logit": 7.6328125, "text": "MIS-A)\n\u0083 History of an immediate (within 4 hours of exposure) non-severe allergic reaction", "probability": 0.00812530517578125 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19", "probability": 0.00787353515625 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., an", "probability": 0.00787353515625 }, { "start_logit": 19.5, "end_logit": 7.921875, "text": "Precautions\n\u0083 History of anaphylaxis", "probability": 0.007282257080078125 }, { "start_logit": -34.53125, "end_logit": 15.90625, "text": "", "probability": 0.0 } ], "100000000000000000010095": [ { "start_logit": 21.25, "end_logit": 9.875, "text": " Severe allergic reaction (e.g., anaphylaxis", "probability": 0.29541015625 }, { "start_logit": 21.25, "end_logit": 9.8515625, "text": " Severe allergic reaction", "probability": 0.286376953125 }, { "start_logit": 20.140625, "end_logit": 9.875, "text": " anaphylaxis", "probability": 0.09747314453125 }, { "start_logit": 19.890625, "end_logit": 9.4765625, "text": "MIS-A", "probability": 0.051361083984375 }, { "start_logit": 19.84375, "end_logit": 9.4765625, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS-A", "probability": 0.0482177734375 }, { "start_logit": 20.03125, "end_logit": 9.046875, "text": " AstraZeneca", "probability": 0.03814697265625 }, { "start_logit": 18.578125, "end_logit": 9.875, "text": "\n\u0083 Severe allergic reaction (e.g., anaphylaxis", "probability": 0.0204315185546875 }, { "start_logit": 18.578125, "end_logit": 9.8515625, "text": "\n\u0083 Severe allergic reaction", "probability": 0.020111083984375 }, { "start_logit": 20.03125, "end_logit": 8.34375, "text": " AstraZeneca)\u00a7\nPrecautions", "probability": 0.0188751220703125 }, { "start_logit": 19.84375, "end_logit": 8.28125, "text": "MIS-C", "probability": 0.01470184326171875 }, { "start_logit": 21.25, "end_logit": 6.86328125, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine", "probability": 0.0144805908203125 }, { "start_logit": 19.890625, "end_logit": 8.2109375, "text": "MIS", "probability": 0.014251708984375 }, { "start_logit": 19.84375, "end_logit": 8.2109375, "text": "MIS-C) or multisystem inflammatory syndrome in adults (MIS", "probability": 0.013824462890625 }, { "start_logit": 20.03125, "end_logit": 7.921875, "text": " AstraZeneca)\u00a7\nPrecautions\n\u0083 History of anaphylaxis", "probability": 0.01239013671875 }, { "start_logit": 19.84375, "end_logit": 8.0625, "text": "MIS", "probability": 0.01181793212890625 }, { "start_logit": 19.5, "end_logit": 8.34375, "text": "Precautions", "probability": 0.01110076904296875 }, { "start_logit": 19.890625, "end_logit": 7.6328125, "text": "MIS-A)\n\u0083 History of an immediate (within 4 hours of exposure) non-severe allergic reaction", "probability": 0.00812530517578125 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19", "probability": 0.00787353515625 }, { "start_logit": 21.25, "end_logit": 6.2421875, "text": " Severe allergic reaction (e.g., an", "probability": 0.00787353515625 }, { "start_logit": 19.5, "end_logit": 7.921875, "text": "Precautions\n\u0083 History of anaphylaxis", "probability": 0.007282257080078125 }, { "start_logit": -33.21875, "end_logit": 14.40625, "text": "", "probability": 0.0 } ], "100000000000000000010100": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013511208328778794 }, { "start_logit": 7.52734375, "end_logit": -0.92138671875, "text": "", "probability": 0.9986488791671222 } ], "100000000000000000010104": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005021149947632315 }, { "start_logit": 6.015625, "end_logit": -0.7265625, "text": "", "probability": 0.9949788500523676 } ], "100000000000000000010109": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005797401254434213 }, { "start_logit": 5.8515625, "end_logit": -0.70751953125, "text": "", "probability": 0.9942025987455659 } ], "100000000000000000010110": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0013939502266754108 }, { "start_logit": 6.5546875, "end_logit": 0.018646240234375, "text": "", "probability": 0.9986060497733246 } ], "100000000000000000010111": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0016229670614688403 }, { "start_logit": 6.4921875, "end_logit": -0.0711669921875, "text": "", "probability": 0.9983770329385311 } ], "100000000000000000010115": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00039666122071475634 }, { "start_logit": 8.046875, "end_logit": -0.213134765625, "text": "", "probability": 0.9996033387792852 } ], "100000000000000000010120": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005469274598698993 }, { "start_logit": 5.96484375, "end_logit": -0.76318359375, "text": "", "probability": 0.9945307254013009 } ], "100000000000000000010126": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00439941316273649 }, { "start_logit": 6.09375, "end_logit": -0.67138671875, "text": "", "probability": 0.9956005868372635 } ], "100000000000000000010127": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.003780095488712285 }, { "start_logit": 6.3203125, "end_logit": -0.7451171875, "text": "", "probability": 0.9962199045112877 } ], "100000000000000000010130": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.004248079086738752 }, { "start_logit": 6.33984375, "end_logit": -0.8828125, "text": "", "probability": 0.9957519209132613 } ], "100000000000000000010134": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.005533387939014027 }, { "start_logit": 6.12109375, "end_logit": -0.92822265625, "text": "", "probability": 0.994466612060986 } ], "100000000000000000010138": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008626077580284025 }, { "start_logit": 7.83203125, "end_logit": -0.77880859375, "text": "", "probability": 0.9991373922419715 } ], "100000000000000000010141": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.0008761799515142255 }, { "start_logit": 7.796875, "end_logit": -0.75634765625, "text": "", "probability": 0.9991238200484857 } ], "100000000000000000010142": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.002034817000747976 }, { "start_logit": 6.84375, "end_logit": -0.64892578125, "text": "", "probability": 0.997965182999252 } ], "100000000000000000010147": [ { "text": "empty", "start_logit": 0.0, "end_logit": 0.0, "probability": 0.00037118545024576846 }, { "start_logit": 7.37109375, "end_logit": 0.5283203125, "text": "", "probability": 0.9996288145497543 } ] }